,id,pdb,target,seq,comments,topology,nterm,cterm,mod,stereo,db,len
91,dbAMP_00091,,Mycobacterium tuberculosis H37Rv (MIC50=0.5µM)&&Staphylococcus aureus MTCC 1430 (MIC50=4µM)&&Bacillus subtilis MTCC 121 (MIC50=6µM)&&Escherichia coli MTCC 1610 (MIC=100µM)&&Mycobacterium smegmatis mc2-155 (MIC50=45µM)&&Mycobacterium tuberculosis H37Rv (MIC=16µM)&&Staphylococcus aureus MTCC 1430 (MBC=8µM)&&Human breast adenocarcinoma MCF-7 (LC50=6µM)&&Human fibrosarcoma HT1080 (LC50=7.5µM)&&Human lung carcinoma H1299 (LC50=7µM)&&Human cervical carcinoma HeLa (LC50=8µM),ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL,,Linear,Free,Free,,L,dbAMP3,53
217,dbAMP_00217,,Aeromonas salmonicida 99-1 (MIC=32µg/ml)&&Aeromonas salmonicida 97-4 (MIC=16µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=16µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=32µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=8µg/ml)&&Escherichia coli CGSC 4908 (MIC=16µg/ml)&&Escherichia coli UB1005 (MIC=16µg/ml)&&Escherichia coli DC2 (MIC=16µg/ml)&&Staphylococcus epidermidis C621 (MIC=16µg/ml)&&Staphylococcus aureus C623 (MIC=16µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=8µg/ml),AGWGSIFKHIFKAGKFIHGAIQAHND,,Linear,Free,Free,,L,dbAMP3,26
235,dbAMP_00235,6dst,Staphylococcus aureus NCTC 8325 (MIC=3.5µM)&&Escherichia coli ATCC 25922 (MIC=20µM)&&Candida albicans ATCC 90028 (MIC=19µM)&&Mouse T-lymphoma cells EL4 (LC50=14µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Klebsiella pneumoniae KK3 9904 (MIC=50µM)&&Enterobacter cloacae HNTCC 53001 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Salmonella enterica subsp. enterica serovar Typhimurium LT2 (MIC=50µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus NCTC 8325 (MIC=6µM)&&Staphylococcus epidermidis RP62A (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=6µM)&&Streptococcus group B HNTCC 80130 (MIC=12.5µM)&&Candida albicans ATCC 90028 (MIC=12.5µM)&&Staphylococcus aureus T7/5 (MIC=2.5µM)&&Staphylococcus aureus T27/9 (MIC=5µM)&&Staphylococcus aureus T58/7 (MIC=20µM)&&Bacteroides fragilis ATCC 25285 (MIC=>50µM)&&Bacteroides fragilis (MIC=>50µM)&&Prevotella melaninogenica (MIC=3µM)&&Fusobacterium varium ATCC 27725 (MIC=50µM)&&Fusobacterium nucleatum (MIC=>50µM)&&Clostridium tertium ATCC 19465 (MIC=12.5µM)&&Clostridium perfringens ATCC 10543 (MIC=>50µM)&&Clostridium septicum (MIC=12.5µM)&&Cutibacterium acnes ATCC 11828 (MIC=12.5µM)&&Cutibacterium acnes (MIC=25µM)&&Peptoniphilus asaccharolyticus ATCC 29743 (MIC=50µM)&&Peptostreptococcus anaerobius (MIC=25µM)&&Escherichia coli CGMCC 1.8732 (MIC=25µM)&&Pseudomonas aeruginosa CGMCC 1.2421 (MIC=12.5µM)&&Klebsiella pneumoniae CGMCC 1.1736 (MIC=12.5µM)&&Staphylococcus aureus CGMCC 1.8721 (MIC=6.25µM)&&Staphylococcus epidermidis CGMCC 1.4260 (MIC=3.13µM)&&Bacillus subtilis CGMCC 1.3376 (MIC=3.13µM)&&Batrachochytrium dendrobatidis (MIC=25µM)&&Acinetobacter baumannii (MIC=12.5µM)&&HSV-1 (IC50 REP=0.39µM)&&Mink enteritis virus (MeV) (IC50 REP=3.125µM)&&Human parainfluenza Virus 2 ( HPIV2) (IC50 REP=3.125µM)&&HCoV-229E (IC50 REP=3.125µM)&&SARS-CoV-2 (IC50 REP=12.5µM)&&HSV-1 (IC50=3.12µM),AIGSILGALAKGLPTLISWIKNR,,Linear,Free,Free,,L,dbAMP3,23
254,dbAMP_00254,,Escherichia coli ATCC 25922 (MIC=6.6µM)&&Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=1.0µM),AIPCGESCVWIPCISTVIGCSCSNKVCYR,,Linear,Free,Free,,L,dbAMP3,29
283,dbAMP_00283,,Carnobacterium divergens DSM 20623 (MIC=0.625µg/ml)&&Carnobacterium gallinarum DSM 4847 (MIC=0.625µg/ml)&&Carnobacterium maltaromaticum DSM 20730 (MIC=0.625µg/ml)&&Carnobacterium mobile DSM 4848 (MIC=0.625µg/ml)&&Enterococcus durans CIP 55125 (MIC=2µg/ml)&&Enterococcus faecalis CIP 76.117 (MIC=2µg/ml)&&Listeria grayi CIP 6818 (MIC=4µg/ml)&&Listeria innocua CIP 12511 (MIC=4µg/ml)&&Listeria ivanovii CIP 12510 (MIC=4µg/ml)&&Listeria monocytogenes ATCC 15313 (MIC=4µg/ml)&&Listeria monocytogenes CIP 7831 (MIC=4µg/ml)&&Listeria seeligeri SLCC 3954 (MIC=4µg/ml)&&Human colon adenocarcinoma Caco-2 (10% Killing=100µg/ml),AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH,,Linear,Free,Free,,L,dbAMP3,43
296,dbAMP_00296,1KV4,Escherichia coli JM109 (LC=0.31µM)&&Acinetobacter sp. NISL B-4653 (LC=0.27µM)&&Pseudomonas fluorescens IAM 1179 (LC=0.53µM)&&Pseudomonas aeruginosa IAM 15140 (LC=0.81µM)&&Bacillus subtilis IAM 1107 (LC=0.19µM)&&Bacillus megaterium IAM 1030 (LC=0.09µM)&&Bacillus cereus IFO 3457 (LC=0.38µM)&&Staphylococcus aureus ATCC 6538P (LC=0.21µM)&&Staphylococcus aureus ATCC 6538P (LC=0.22µM)&&Staphylococcus aureus IFO 3083 (LC=0.46µM)&&Staphylococcus xylosus IAM 1312 (LC=0.27µM)&&Staphylococcus epidermidis IFO 12993 (LC=0.18µM)&&Streptococcus pyogenes ATCC 21547 (LC=0.25µM)&&Human breast adenocarcinoma MDA-MB-231 (50% Cell death=12.5µg/ml),AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH,,Linear,Free,Free,,L,dbAMP3,42
348,dbAMP_00348,,Escherichia coli ATCC 25922 (MIC=2µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=1µM)&&Klebsiella pneumoniae KPC CAPB053 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Candida albicans ATCC 14053 (MIC=>128µM)&&Mouse skin melanoma B16-F10 (IC50=8.69µM),ALLDKLKSLGKVVGKVALGVVQNYLNPRQ,,Linear,Free,Free,,L,dbAMP3,29
370,dbAMP_00370,,Staphylococcus aureus NCTC 10788 (MIC=256µM)&&Escherichia coli NCTC 10418 (MIC=32µM)&&Candida albicans NCYC 1467 (MIC=64µM)&&Human squamous lung carcinoma NCI-H157 (IC50=15.67µM)&&Human prostate adenocarcinoma PC-3 (IC50=18.20µM),ALWKDILKNAGKAALNEINQIVQ,,Linear,Free,Free,,L,dbAMP3,23
372,dbAMP_00372,,Staphylococcus aureus ATCC 25923 (MIC=3.0µM)&&Pseudomonas aeruginosa CIP A22 (MIC=4.6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=11.6µM)&&Escherichia coli ATCC 25922 (MIC=5.0µM)&&Escherichia coli ATCC 54127 (MIC=2.3µM)&&Human breast adenocarcinoma MCF-7 (IC50=15µM)&&Escherichia coli ATCC 25922 (MIC=5µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus NCTC 10788 (MIC=3µM)&&Escherichia coli NCTC 10418 (MIC=5µM),ALWKDILKNVGKAAGKAVLNTVTDMVNQ,,Linear,Free,Free,,L,dbAMP3,28
379,dbAMP_00379,,Staphylococcus aureus ATCC 25923 (MIC=1.3µM)&&Pseudomonas aeruginosa CIP A22 (MIC=2.3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=5.0µM)&&Escherichia coli ATCC 25922 (MIC=2.6µM)&&Escherichia coli ATCC 54127 (MIC=2.3µM)&&Human breast adenocarcinoma MCF-7 (IC50=12µM),ALWKNMLKGIGKLAGQAALGAVKTLVGA,,Linear,Free,Free,,L,dbAMP3,28
387,dbAMP_00387,,Escherichia coli ATCC 8739 (MIC=1.6µM)&&Escherichia coli ATCC 8739 (MBC=1.6µM)&&Escherichia coli K-12 (MIC=12.5µM)&&Escherichia coli K-12 (MBC=12.5µM)&&Escherichia coli ML-35p (MIC=1.6µM)&&Escherichia coli ML-35p (MBC=1.6µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=6.3µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=6.3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>100µM)&&Klebsiella pneumoniae CIP 52.211 (MIC=0.8µM)&&Klebsiella pneumoniae CIP 52.211 (MBC=0.8µM)&&Klebsiella oxytoca CIP 79.32 (MIC=12.5µM)&&Klebsiella oxytoca CIP 79.32 (MBC=>100µM)&&Salmonella enterica CIP 8297 (MIC=50µM)&&Salmonella enterica CIP 8297 (MBC=100µM)&&Yersinia ruckeri ATCC 29473 (MIC=25µM)&&Yersinia ruckeri ATCC 29473 (MBC=>100µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.3µM)&&Staphylococcus aureus ATCC 25923 (MBC=12.5µM)&&Staphylococcus aureus (MIC=100µM)&&Staphylococcus aureus (MBC=>100µM)&&Staphylococcus aureus ST1065 (MIC=12.5µM)&&Staphylococcus aureus ST1065 (MBC=25µM)&&Staphylococcus epidermidis BM3302 (MIC=12.5µM)&&Staphylococcus epidermidis BM3302 (MBC=>50µM)&&Listeria monocytogenes SOR 100 (MIC=100µM)&&Listeria monocytogenes SOR 100 (MBC=>100µM)&&Enterococcus faecalis CIP A186 (MIC=100µM)&&Enterococcus faecalis CIP A186 (MBC=>100µM)&&Lactococcus garvieae ATCC 43921 (MIC=100µM)&&Lactococcus garvieae ATCC 43921 (MBC=>100µM)&&Enterococcus faecalis CIP 103015 (MIC=12.5µM)&&Enterococcus faecalis CIP 103015 (MBC=12.5µM)&&Kocuria rhizophila ATCC 9341 (MIC=1.6µM)&&Kocuria rhizophila ATCC 9341 (MBC=1.6µM)&&Human lung carcinoma A549 (30% Cytotoxicity=40µM),ALWKTLLKKVGKVAGKAVLNAVTNMANQNEQ,,Linear,Free,Free,,L,dbAMP3,31
389,dbAMP_00389,,Escherichia coli TG1 (IC50=1±0.5µM)&&Escherichia coli MG1655 (MIC=0.39µg/ml)&&Staphylococcus aureus 15981 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=12.5µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=28.11µg/ml)&&Rabies virus (RABV) (IC50 I=5.1µM)&&HSV-2 (EC50=2.7µM)&&HSV-2 Roi2 (EC50=5.1µM),ALWKTLLKKVLKAAAKAALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,28
399,dbAMP_00399,2DD6,Escherichia coli (IC50=106.96µg/ml)&&Escherichia coli (MIC=250.22µg/ml)&&Escherichia coli (IC50=118.46µg/ml)&&Escherichia coli (MIC=269.06µg/ml)&&Klebsiella pneumoniae (IC50=244.47µg/ml)&&Klebsiella pneumoniae (MIC=490.77µg/ml)&&Corynebacterium striatum (IC50=112.86-161.84µg/ml)&&Corynebacterium striatum (MIC=257.4-344.32µg/ml)&&Human colon adenocarcinoma SW620 (44.76±23.77% Cytotoxicity=256µg/ml)&&HIV-1 (IC50 I=2µM),ALWMTLLKKVLKAAAKAALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,28
400,dbAMP_00400,2DCX&&2DD6,Aeromonas caviae IP67-16T (MIC=0.5µM)&&Escherichia coli IP76-24 (MIC=4µM)&&Enterococcus faecalis IP103214 (MIC=20µM)&&Staphylococcus aureus IP76-25 (MIC=10µM)&&Nocardia brasiliensis IP16-80 (MIC=10µM)&&Saccharomyces cerevisiae IP118079 (MIC=20µM)&&Candida albicans IP884-65 (MIC=20µM)&&Candida albicans IP886-65 (MIC=20µM)&&Cryptococcus neoformans IP960-67 (MIC=2µM)&&Cryptococcus neoformans IP962-67 (MIC=1µM)&&Microsporum canis IP1194 (MIC=15µM)&&Trichophyton rubrum IP2043-92 (MIC=40µM)&&Trichophyton mentagrophytes IP877-71 (MIC=20µM)&&Trichophyton simii IP1063-74 (MIC=30µM)&&Trichophyton simii J43 IP903-65 (MIC=20µM)&&Aspergillus niger IP218-53 (MIC=30µM)&&Aspergillus fumigatus IP1025-70 (MIC=20µM)&&Acinetobacter baumannii (MIC=12.5µg/ml)&&Acinetobacter baumannii (MBC=25µg/ml)&&Human epidermoid cancer Hep2 (50% Cytotoxicity=16.51µg/ml),ALWMTLLKKVLKAAAKALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,27
407,dbAMP_00407,2LRD&&2LRE&&2LRD&&1M8A,Bacillus megaterium (MIC=>0.5µM)&&Bacillus megaterium (MBC=>0.5µM)&&Bacillus megaterium (MIC=0.025µM)&&Bacillus megaterium (MBC=0.025µM)&&Bacillus subtilis (MIC=>10µM)&&Bacillus subtilis (MBC=>10µM)&&Bacillus subtilis (MIC=5µM)&&Bacillus subtilis (MBC=5µM)&&Staphylococcus epidermidis (MIC=5µM)&&Staphylococcus epidermidis (MBC=10µM)&&Staphylococcus aureus (MIC=5µM)&&Staphylococcus aureus (MBC=5µM)&&Escherichia coli (MIC=>5µM)&&Escherichia coli (MBC=>5µM)&&Escherichia coli (MIC=>5µM)&&Escherichia coli (MBC=>5µM)&&Pseudomonas aeruginosa (MIC=10µM)&&Pseudomonas aeruginosa (MBC=10µM)&&Yersinia enterocolitica (MIC=>10µM)&&Yersinia enterocolitica (MBC=>10µM)&&Yersinia enterocolitica (MIC=1.25µM)&&Yersinia enterocolitica (MBC=1.25µM)&&Serratia marcescens (MIC=>10µM)&&Serratia marcescens (MBC=>10µM)&&Serratia marcescens (MIC=2.5µM)&&Serratia marcescens (MBC=2.5µM)&&Klebsiella aerogenes (MIC=>10µM)&&Klebsiella aerogenes (MBC=>10µM)&&Klebsiella aerogenes (MIC=>10µM)&&Klebsiella aerogenes (MBC=>10µM)&&Human neuroblastoma (IC50=1.5µM)&&Human neuroblastoma (IC50=7.5µM),AMGKCSVLKKVACAAAIAGAVAACGGIDLPCVLAALKAAEGCASCFCEDHCHGVCKDLHLC,,Linear,Free,Free,,L,dbAMP3,61
479,dbAMP_00479,,Staphylococcus aureus ATCC 6538 (MIC=30µM)&&Staphylococcus aureus ATCC 6538 (MIC50=7.314µM)&&Bacillus subtilis ATCC 6633 (MIC=3.75µM)&&Bacillus subtilis ATCC 6633 (MIC50=0.85µM)&&Escherichia coli ATCC 25922 (MIC=3.75µM)&&Escherichia coli ATCC 25922 (MIC50=0.63µM)&&Plasmodium falciparum 3D7 (IC50=12.4µM)&&Plasmodium falciparum 803 (IC50=9.89µM)&&Plasmodium falciparum Dd2 (IC50=12.81µM)&&Human hepatocellular carcinoma HepG2 (50% Cytotoxicity=60.43µM),APRWKFGKRLEKLGRNVFRAAKKALPVIAGYKAL,,Linear,Free,Free,,L,dbAMP3,34
723,dbAMP_00723,,Escherichia coli ATCC 25922 (MIC=20.2µg/ml)&&Candida albicans ATCC 2002 (MIC=20.2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=10.1µg/ml)&&Pseudomonas aeruginosa CMCCB 10104 (MIC=40.4µg/ml)&&Escherichia coli ATCC 8739 (MIC=32µM)&&Escherichia coli ATCC 8739 (MBC=32µM)&&Escherichia coli ATCC BAA-2340 (MIC=32µM)&&Escherichia coli ATCC BAA-2340 (MBC=32µM)&&Escherichia coli NCTC 13846 (MIC=32µM)&&Escherichia coli NCTC 13846 (MBC=32µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=128µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=128µM)&&Acinetobacter baumannii ATCC BAA-747 (MIC=>512µM)&&Staphylococcus aureus ATCC 6538 (MIC=>512µM)&&Enterococcus faecium NTCC 12697 (MIC=>512µM)&&Staphylococcus aureus NCTC 12493 (MIC=256µM)&&Staphylococcus aureus NCTC 12493 (MBC=256µM)&&Candida albicans ATCC 10231 (MIC=>512µM)&&Human lung adenocarcinoma NCI-H838 (30% Cytotoxicity=100µM)&&Human glioblastoma U251-MG (40% Cytotoxicity=100µM)&&Human breast adenocarcinoma MCF-7 (30% Cytotoxicity=100µM)&&Human colon adenocarcinoma HCT 116 (20% Cytotoxicity=100µM),AVNIPFKVHFRCKAAFC,,Linear,Free,Free,,L,dbAMP3,17
752,dbAMP_00752,,Staphylococcus epidermidis (MIC=60µM)&&Bacillus subtilis (MIC=30µM)&&Pseudomonas aeruginosa (MIC=30µM)&&Escherichia coli ATCC 8739 (MIC=30µM)&&Human epidermoid cancer Hep2 (IC50=1500µM)&&Human colon adenocarcinoma HCT-15 (IC50=1000µM),AWKLFDDGV,,Linear,Free,Free,,L,dbAMP3,9
754,dbAMP_00754,,Escherichia coli ATCC 25922 (MIC=2µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=1µM)&&Klebsiella pneumoniae KPC CAPB053 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Candida albicans ATCC 14053 (MIC=>128µM)&&Mouse skin melanoma B16-F10 (IC50=6.56µM),AWLDKLKSIGKVVGKVAIGVAKNLLNPQ,,Linear,Free,Free,,L,dbAMP3,28
953,dbAMP_00953,2MFS,Staphylococcus aureus ATCC 29213 (MBC=1.25µM)&&Escherichia coli ATCC 25922 (MBC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=80µM)&&Candida albicans ATCC 90028 (MBC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=>100µM)&&Staphylococcus aureus ATCC 29213 (MBC=0.63µM)&&Staphylococcus aureus ATCC 29213 (MBC50=0.31µM)&&Escherichia coli ATCC 25922 (MBC=2.5µM)&&Escherichia coli ATCC 25922 (MBC50=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=10µM)&&Candida albicans ATCC 90028 (MBC=>160µM)&&Candida albicans ATCC 90028 (MBC50=160µM),CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV,,Linear,Free,Free,,L,dbAMP3,35
1001,dbAMP_01001,,Didymella arachidicola (IC50=1.3µM)&&Mouse lymphocytic leukemia L1210 (IC50=8.33µM),DDFLCAGGCL,,Linear,Free,Free,,L,dbAMP3,10
1016,dbAMP_01016,,Staphylococcus aureus ATCC 29213 (MIC=10µg/ml)&&Staphylococcus sciuri (MIC=50µg/ml)&&Rothia nasimurium (MIC=10µg/ml)&&Aerococcus viridans (MIC=20µg/ml)&&Escherichia coli ATCC 25922 (MIC=50µg/ml)&&Escherichia coli O111 (MIC=50µg/ml)&&Klebsiella pneumoniae (MIC=50µg/ml)&&Pseudomonas aeruginosa (MIC=50µg/ml)&&Human breast cancer (LC50=<5µg/ml),DEDDD,,Linear,Free,Free,,L,dbAMP3,5
1146,dbAMP_01146,,Fusarium oxysporum (IC50=95µM)&&Didymella arachidicola (IC50=72µM)&&Pseudomonas aeruginosa (IC50=51±6 µM)&&Pseudomonas fluorescens (IC50=186±12µM)&&Staphylococcus aureus (IC50=34±4 µM)&&Mouse lymphocytic leukemia L1210 (IC50=0.22µM)&&Human hepatocellular carcinoma HepG2 (IC50=0.1µM),DNGEAGRAAR,,Linear,Free,Free,,L,dbAMP3,10
1209,dbAMP_01209,,Listeria innocua ATCC 33091 (MIC90=120µg/ml)&&Listeria innocua CIP 78.44 (MIC90=120µg/ml)&&Listeria monocytogenes ATCC 19112 (MIC90=100µg/ml)&&Listeria welshimeri ATCC 43551 (MIC90=80µg/ml)&&Listeria seeligeri CIP 79.46 (MIC90=80µg/ml)&&Human colon adenocarcinoma SW480 (IC50=40µM),DSIRDVSPTFNKIRRWFDGLFK,,Linear,Free,Free,,L,dbAMP3,22
1214,dbAMP_01214,,Staphylococcus aureus ATCC 25923 (MIC=17µM)&&Enterococcus faecalis ATCC 29212 (MIC=60µM)&&Staphylococcus aureus 10 (MIC=40µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Enterobacter cloacae ATCC 13047 (MIC=40µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=15µM)&&Pseudomonas aeruginosa CMCCB 1010 (MIC=17µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=23µM)&&Shigella dysenteriae (MIC=40µM)&&Escherichia coli 37 (MIC=60µM)&&Pseudomonas aeruginosa (MIC=23µM)&&Klebsiella pneumoniae (MIC=30µM)&&Candida albicans ATCC 2002 (MIC=60µM)&&Human myelogenous leukemia K562 (IC50=46µM)&&Human colon adenocarcinoma HT29 (IC50=40µM),DSMGAVKLAKLLIDKMKCEVTKAC,,Linear,Free,Free,,L,dbAMP3,24
1220,dbAMP_01220,2KEF&&1M4F&&1M4E&&1M4F&&2KEF&&3H0T&&2KEF&&1M4F,Bacillus subtilis ATCC 6051 (IC50=40µg/ml)&&Saccharomyces cerevisiae ATCC 9763 (IC50=50µg/ml)&&Escherichia coli ML-35p (MBC=<30µM)&&Staphylococcus epidermidis (MBC=<30µM)&&Aspergillus niger (MFC=>40µM)&&Human myelogenous leukemia K562 (26% Cytotoxicity=30µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=6.25µg/ml)&&Acinetobacter baumannii (MBC=12.5µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MBC=6.25µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Klebsiella pneumoniae (MBC=50µg/ml)&&Staphylococcus aureus ATCC 29213 (MBC=>100µg/ml)&&Staphylococcus epidermidis (MBC=50µg/ml)&&Enterococcus faecium (MBC=25µg/ml)&&Enterococcus faecium (MBC=12.5µg/ml),DTHFPICIFCCGCCHRSKCGMCCKT,,Linear,Free,Free,,L,dbAMP3,25
1260,dbAMP_01260,,HIV-1 (11% PR activity=1µM)&&Rous sarcoma virus (75.8% PR activity=1µM),DWHLGQGVSIEWRKK,,Linear,Free,Free,,L,dbAMP3,15
1326,dbAMP_01326,,Staphylococcus aureus ATCC 29213 (LD90=58.2±17µg/ml)&&Enterococcus faecalis ATCC 29212 (LD90=18.3±2.1µg/ml)&&Enterococcus faecium ATCC 6057 (LD90=13.5±1.8µg/ml)&&Escherichia coli ATCC 25922 (LD90=9.8±1.9µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (LD90=18±3.2µg/ml)&&Klebsiella pneumoniae ATCC 700603 (LD90=>100µg/ml)&&Acinetobacter baumannii ATCC 19606 (LD90=>100µg/ml)&&Staphylococcus aureus ATCC 29213 (30% Killing=80µg/ml)&&Enterococcus faecalis ATCC 29212 (15% Killing=25µg/ml)&&Enterococcus faecium ATCC 6057 (5% Killing=15µg/ml)&&Escherichia coli ATCC 25922 (<10% Killing=15µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (40% Killing=25µg/ml)&&Klebsiella pneumoniae ATCC 700603 (<5% Killing=150µg/ml)&&Acinetobacter baumannii ATCC 19606 (5% Killing=150µg/ml)&&Acinetobacter baumannii (5% Killing=150µg/ml)&&Human cervical carcinoma HeLa (0% Killing=40µg/ml)&&Human lung carcinoma A549 (0% Killing=40µg/ml),EFELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP,,Linear,Free,Free,,L,dbAMP3,50
1455,dbAMP_01455,,Rhizoctonia solani (MIC=32µg/ml)&&Colletotrichum acutatum (MIC=16µg/ml)&&Botrytis cinerea (MIC=32µg/ml)&&Staphylococcus aureus (MIC=64µg/ml)&&Bacillus subtilis (MIC=32µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi (MIC=32µg/ml)&&Pseudomonas aeruginosa (MIC=64µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=11.2µg/ml)&&Human colon adenocarcinoma HCT-15 (IC50=23.2µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=11.7µg/ml)&&Human lung adenocarcinoma NCI-H23 (IC50=10.9µg/ml)&&Human gastric cancer NUGC-3 (IC50=10.5µg/ml)&&Human renal adenocarcinoma ACHN (IC50=12.3µg/ml),ELLVDLL,,Linear,Free,Free,,L,dbAMP3,7
1576,dbAMP_01576,,HIV-1 (39.2% PR activity=1µM)&&Rous sarcoma virus (91.2% PR activity=1µM),EWRKKRYS,,Linear,Free,Free,,L,dbAMP3,8
1577,dbAMP_01577,,HIV-1 (0% PR activity=1µM)&&Rous sarcoma virus (58.6% PR activity=1µM),EWRKKRYSTQV,,Linear,Free,Free,,L,dbAMP3,11
1580,dbAMP_01580,,Feline immunodeficiency virus (FIV) (IC50 F=0.012µM)&&Feline immunodeficiency virus (FIV) (IC90 F=0.054µM)&&HIV-1 (IC50 F=>2.304 µM)&&HIV-1 (IC90 F=>2.304µM)&&Human cervical carcinoma HeLa (0% Cytotoxicity=23µM),EWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQ,,Linear,Free,Free,,L,dbAMP3,35
1591,dbAMP_01591,,Staphylococcus aureus ATCC 6538 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=25µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=23µg/ml)&&Human colon adenocarcinoma SW480 (LD50=46µg/ml)&&Human melanoma BMKC (LD50=128µg/ml)&&Human lung carcinoma H1299 (LD50=140µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=50µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=44µg/ml),FALALKALKKALKKLKKALKKAL,,Linear,Free,Free,,L,dbAMP3,23
1642,dbAMP_01642,,Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli ATCC 35218 (MIC=>200µM)&&Escherichia coli D21 (MIC=100µM)&&Escherichia coli ML-35p (MIC=30µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µM)&&Enterococcus faecalis ATCC 29212 (MIC=50µM)&&Bacillus megaterium (MIC=3µM)&&Candida albicans ATCC 90028 (MIC=50µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=12.5µM)&&Aspergillus flavus (MIC=>200µM)&&Escherichia coli ATCC 25922 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>100µM)&&Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=25µM)&&Streptococcus pyogenes ATCC 19615 (MIC=25µM)&&Listeria ivanovii (MIC=50µM)&&Enterococcus faecalis ATCC 29212 (MIC=100µM)&&Human acute monocytic leukemia THP-1 (IC50=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=50µM)&&Staphylococcus aureus ATCC 25923 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Staphylococcus aureus USA 100 (MIC=50µM)&&Staphylococcus aureus USA 300 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>100µM)&&Candida albicans ATCC 90028 (MIC=>100µM)&&Staphylococcus aureus JC114 (MIC=121µM)&&Bacillus subtilis JC443 (MIC=149µM)&&Escherichia coli JC113 (MIC=116µM)&&Pseudomonas aeruginosa JC115 (MIC=88µM)&&Staphylococcus aureus ATCC 43300 (MIC=>100µM)&&Staphylococcus aureus USA 300 (MIC=50µM)&&Staphylococcus aureus (MIC=100µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Escherichia coli (MIC=>100µM)&&Acinetobacter baumannii (MIC=>100µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>100µM)&&Klebsiella pneumoniae (MIC=>100µM),FFFLSRIF,,Linear,Free,Free,,L,dbAMP3,8
1651,dbAMP_01651,,Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=3µM)&&Listeria ivanovii (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=3-6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Acinetobacter baumannii ATCC 19606 (MIC=3µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=6µM)&&Candida albicans ATCC 90028 (MIC=25µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Human breast adenocarcinoma MCF-7 (IC50=45-50µM),FFGRLKSVWSAVKHGWKAAKSR,,Linear,Free,Free,,L,dbAMP3,22
1716,dbAMP_01716,,Corynebacterium jeikeium ATCC BAA-949 (MIC=16µM)&&Human lung carcinoma A549 (50% Cytotoxicity=73µM)&&Human Influenza A Virus H1N1 A/PR/8/34 (IC50 REP=13µM)&&Candida albicans ATCC 10231 (MIC=16µM)&&Candida albicans ATCC 10231 (MBC50=48µM)&&Candida albicans ATCC 10231 (MIC=21.3 ± 9.2µM)&&Candida albicans ATCC 24433 (MIC=32µM)&&Candida tropicalis DSM 11953 (MIC=16µM)&&Candida glabrata PMC 0805 (MIC=64µM)&&Candida parapsilosis DSM 11224 (MIC=128µM)&&Candida parapsilosis PMC 0711 (MIC=128µM)&&Candida krusei PMC 0610 (MIC=128µM)&&Candida krusei PMC 0624 (MIC=32µM)&&Cryptococcus neoformans DSM 11759 (MIC=32µM)&&Microsporum gypseum DSM 3824 (MIC=64µM)&&Microsporum gypseum PMC 7330 (MIC=128µM)&&Microsporum canis DSM 10708 (MIC=64µM)&&Trichophyton mentagrophytes DSM 4870 (MIC=16µM)&&Trichophyton mentagrophytes PMC 6530 (MIC=64µM)&&Trichophyton mentagrophytes PMC 6529 (MIC=32µM)&&Trichophyton mentagrophytes PMC 6528 (MIC=32µM)&&Aspergillus brasiliensis DSM 1988 (MIC=128µM)&&Aspergillus niger PMC 7101 (MIC=128µM)&&Aspergillus terreus PMC 7201 (MIC=128µM),FFPVIGRILNGIL,,Linear,Free,Free,,L,dbAMP3,13
1719,dbAMP_01719,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=>64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=64µg/ml)&&Escherichia coli CGSC 4908 (MIC=64µg/ml)&&Escherichia coli UB1005 (MIC=>64µg/ml)&&Escherichia coli DC2 (MIC=>64µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),FFRLLFHGVHHGGGYLNAA,,Linear,Free,Free,,L,dbAMP3,19
1720,dbAMP_01720,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=32µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=16µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=32µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=8µg/ml)&&Escherichia coli CGSC 4908 (MIC=32µg/ml)&&Escherichia coli UB1005 (MIC=32µg/ml)&&Escherichia coli DC2 (MIC=32µg/ml)&&Staphylococcus epidermidis C621 (MIC=32µg/ml)&&Staphylococcus aureus C623 (MIC=64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),FFRLLFHGVHHVGKIKPRA,,Linear,Free,Free,,L,dbAMP3,19
1728,dbAMP_01728,,Staphylococcus aureus ATCC 29213 (MIC=8.68±1.1µM)&&Staphylococcus aureus ATCC 33591 (MIC=17.37±1.2µM)&&Escherichia coli ATCC 25922 (MIC=>139µM)&&Candida albicans ATCC 90028 (MIC=34.75±1.4µM)&&Candida krusei ATCC 6258 (MIC=69.5±4.02µM)&&Candida glabrata ATCC 90030 (MIC=69.5±2.83µM)&&Human cervical carcinoma SiHa (IC50=118µM)&&Staphylococcus aureus S015 (MIC=139.25µM)&&Staphylococcus aureus S015 (MBC=>139.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=>139.25µM)&&Enterococcus faecalis ATCC 29212 (MBC=>139.25µM)&&Human hepatocellular carcinoma HepG2 (IC50=30µM)&&Enterobacter cloacae ATCC 13047 (MIC=>150µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>150µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=9.38µM)&&Enterococcus faecalis ATCC 4028 (MIC=>150µM)&&Human cervical carcinoma HeLa (IC50=30µM)&&Mouse skin melanoma B16 (IC50=12.5µM)&&Trypanosoma cruzi Y (IC90=25µM)&&Staphylococcus aureus ATCC 29213 (MIC=9.37µM)&&Staphylococcus aureus ATCC 29213 (MBC=9.37µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=9.37µM)&&Staphylococcus epidermidis ATCC 12228 (MBC=9.37µM),FFSLIPSLVGGLISAFK,,Linear,Free,Free,,L,dbAMP3,17
1729,dbAMP_01729,,Micrococcus luteus AB93113 (MIC=20µg/ml)&&Bacillus thuringiensis AB92037 (MIC=50µg/ml)&&Staphylococcus aureus AB94004 (MIC=20µg/ml)&&Bacillus subtilis AB91021 (MIC=50µg/ml)&&Escherichia coli AB94012 (MIC=>100µg/ml)&&Pseudomonas aeruginosa AB93066 (MIC=>100µg/ml)&&Staphylococcus aureus P1386 (MIC=50µg/ml)&&Staphylococcus aureus P1374 (MIC=50µg/ml)&&Staphylococcus aureus P1369 (MIC=50µg/ml)&&Staphylococcus epidermidis P1389 (MIC=50µg/ml)&&Staphylococcus epidermidis P1111 (MIC=20µg/ml)&&Human hepatocarcinoma SMMC-7721 (100% Killing=100µg/ml),FFSLLPSLIGGLVSAIK,,Linear,Free,Free,,L,dbAMP3,17
1762,dbAMP_01762,,Bacillus subtilis ATCC 6633 (MIC50=4.83µM)&&Staphylococcus aureus ATCC 6538 (MIC50=5.87µM)&&Staphylococcus aureus DMST 20651 (MIC50=4.83µM)&&Staphylococcus epidermidis ATCC 12228 (MIC50=5.52µM)&&Acinetobacter baumannii ATCC 19606 (MIC50=>69.02µM)&&Escherichia coli ATCC 25922 (MIC50=>69.02µM)&&Salmonella enterica subsp. enterica serovar Typhi DMST 562 (MIC50=>69.02µM)&&Human colon adenocarcinoma SW620 (IC50=40µM)&&Human squamous cell oral carcinoma HSC-4 (IC50=17.26µM)&&Salmonella sp. (MIC=64-128µM),FIGAIARLLSKIF,,Linear,Free,Free,,L,dbAMP3,13
1840,dbAMP_01840,6S6M&&2FBS,Escherichia coli K-12 (MIC=40µM)&&Human epithelial carcinoma KBv (LC50=60±0µM)&&Human epithelial carcinoma KB (LC50=57±3µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli UB1005 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa PAO1 (MIC=16µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=32µM)&&Salmonella typhimurium ATCC 7731 (MIC=16µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Enterococcus faecalis ATCC 29212 (MIC=32µM)&&Bacillus subtilis CMCC 63501 (MIC=16µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Escherichia coli KCTC 1682 (MIC=16µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=32µM)&&Salmonella typhimurium KCTC 1926 (MIC=16µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=16µM)&&Staphylococcus aureus KCTC 1621 (MIC=16µM)&&Escherichia coli DH5alpha (MIC=200µg/ml)&&Mycobacterium smegmatis mc2-155 (MIC=50µg/ml)&&Candida parapsilosis (MIC=200µg/ml)&&Human lung carcinoma A549 (IC50=20.1µg/ml),FKRIVQRIKDFLR,,Linear,Free,Free,,L,dbAMP3,13
1870,dbAMP_01870,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=32µM)&&Candida albicans NCPF 1467 (MIC=4µM)&&Candida albicans NCPF 1467 (MBC=4µM)&&Human lung carcinoma NCI-H460 (IC50=2.75µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=2.94µM)&&Human breast adenocarcinoma MCF-7 (IC50=3.33µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.07µM),FLFKLIPKAIKGLIKAFK,,Linear,Free,Free,,L,dbAMP3,18
1871,dbAMP_01871,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=32µM)&&Candida albicans NCPF 1467 (MIC=4µM)&&Candida albicans NCPF 1467 (MBC=8µM)&&Human lung carcinoma NCI-H460 (IC50=3.60µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=2.75µM)&&Human breast adenocarcinoma MCF-7 (IC50=3.51µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.93µM),FLFKLIPKAIKGLLKAFK,,Linear,Free,Free,,L,dbAMP3,18
1881,dbAMP_01881,,Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Staphylococcus aureus NCTC 10788 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=>250µM)&&Candida albicans NCPF 1467 (MIC=16µM)&&Candida albicans NCPF 1467 (MBC=64µM)&&Human breast adenocarcinoma MCF-7 (IC50=7.222µM)&&Human melanoma A375 (IC50=9.478µM)&&Human glioblastoma U87-MG (IC50=10.21Unknown Unit),FLFSLIPHAISGLISAFK,,Linear,Free,Free,,L,dbAMP3,18
1882,dbAMP_01882,,Escherichia coli NCTC 10418 (MIC=5µM)&&Staphylococcus aureus NCTC 10788 (MIC=3µM)&&Candida albicans NCPF 1467 (MIC=5µM)&&Human prostate adenocarcinoma PC-3 (IC50=28.00µM)&&Human prostate adenocarcinoma LNCaP (IC50=25.58µM)&&Human glioblastoma U251-MG (IC50=29.23µM),FLFSLIPKAIGGLISAFK,,Linear,Free,Free,,L,dbAMP3,18
1891,dbAMP_01891,,Escherichia coli ATCC 25922 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Candida albicans ATCC 90028 (MIC=3µM)&&Human hepatocellular carcinoma HepG2 (LC50=4µM),FLGAIAGVAAKFLPKVFCFITKKC,,Linear,Free,Free,,L,dbAMP3,24
1895,dbAMP_01895,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=>64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=32µg/ml)&&Escherichia coli CGSC 4908 (MIC=64µg/ml)&&Escherichia coli UB1005 (MIC=64µg/ml)&&Escherichia coli DC2 (MIC=>64µg/ml)&&Staphylococcus epidermidis C621 (MIC=32µg/ml)&&Staphylococcus aureus C623 (MIC=32µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=128µg/ml),FLGALIKGAIHGGRFIHGMIQNHH,,Linear,Free,Free,,L,dbAMP3,24
1901,dbAMP_01901,,Hepatitis C virus (HCV) (IC50 REP=1.08µg/ml)&&Human hepatocellular carcinoma Huh-7.5.1 cells (50% Cell death=>500µg/ml),FLGFLHHLF,,Linear,Free,Free,,L,dbAMP3,9
1902,dbAMP_01902,,Hepatitis C virus (HCV) (IC50 REP=1.84µg/ml)&&Human hepatocellular carcinoma Huh-7.5.1 cells (50% Cell death=79.8µg/ml),FLGFLKNLF,,Linear,Free,Free,,L,dbAMP3,9
1910,dbAMP_01910,,Staphylococcus aureus ATCC 29213 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µg/ml)&&Batrachochytrium dendrobatidis (MIC=18.1µM)&&Batrachochytrium dendrobatidis (MIC=12.5µM)&&Staphylococcus aureus ATCC 10442 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 10442 (MBC=8µg/ml)&&Enterococcus faecalis ATCC 31299 (MIC=32µg/ml)&&Enterococcus faecalis ATCC 31299 (MBC=64µg/ml)&&Streptococcus pyogenes ATCC 12344 (MIC=8µg/ml)&&Streptococcus pyogenes ATCC 12344 (MBC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MBC=64µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=128µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MBC=128µg/ml)&&Candida albicans ATCC 90028 (MIC=8µg/ml)&&Candida albicans ATCC 90028 (MBC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=13.4µg/ml)&&Streptococcus pneumoniae (MIC=62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=62.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=31.25µg/ml)&&Staphylococcus aureus (MIC=31.25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=125µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=>250µg/ml)&&Enterobacter cloacae (MIC=>250µg/ml)&&Citrobacter sp. (MIC=>250µg/ml)&&Klebsiella pneumoniae (MIC=>250µg/ml)&&Bacillus megaterium DSM 32 (MIC=4µg/ml)&&Bacillus subtilis DSM 10 (MIC=4µg/ml)&&Clostridium pasteurianum DSM 525 (MIC=16µg/ml)&&Corynebacterium spheniscorum DSM 44757 (MIC=16µg/ml)&&Enterococcus casseliflavus ATCC 700327 (MIC=8µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=16µg/ml)&&Enterococcus faecium (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus NCTC 10442 (MIC=8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=16µg/ml)&&Staphylococcus saprophyticus ATCC 15305 (MIC=8µg/ml)&&Acinetobacter baumannii (MIC=4-8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Escherichia coli O157:H7 ATCC 35150 (MIC=32µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µg/ml)&&Klebsiella pneumoniae (MIC=>64µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µg/ml)&&Pseudomonas fluorescens DSM 50090 (MIC=>64µg/ml)&&Yersinia mollaretii DSM 18520 (MIC=>64µg/ml)&&Escherichia coli (MIC=1µg/ml)&&Pseudomonas aeruginosa (MIC=8µg/ml)&&Staphylococcus aureus (MIC=0.25µg/ml)&&Staphylococcus aureus MR (MIC=1µg/ml),FLGGLIKIVPAMICAVTKKC,,Linear,Free,Free,,L,dbAMP3,20
1931,dbAMP_01931,,Aeromonas salmonicida 99-1 (MIC=64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=>64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=16µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=32µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=8µg/ml)&&Escherichia coli CGSC 4908 (MIC=32µg/ml)&&Escherichia coli UB1005 (MIC=16µg/ml)&&Escherichia coli DC2 (MIC=32µg/ml)&&Staphylococcus epidermidis C621 (MIC=8µg/ml)&&Staphylococcus aureus C623 (MIC=8µg/ml)&&Candida albicans C627 (MIC=64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=32µg/ml),FLGLLFHGVHHVGKWIHGLIHGHH,,Linear,Free,Free,,L,dbAMP3,24
1949,dbAMP_01949,,Hepatitis C virus (HCV) (IC50 REP=0.85µg/ml)&&Human hepatocellular carcinoma Huh-7.5.1 cells (50% Cell death=>500µg/ml),FLHFLHHLF,,Linear,Free,Free,,L,dbAMP3,9
1953,dbAMP_01953,,Micrococcus luteus ATCC 4698 (MIC=6.25µg/ml)&&Staphylococcus aureus KCTC 3881 (MIC=15µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=25µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=25µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=50µg/ml)&&Escherichia coli KCTC 2433 (MIC=60µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=60µg/ml)&&Proteus mirabilis ATCC 25933 (MIC=>100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>100µg/ml)&&Candida albicans ATCC 36232 (MIC=100µg/ml)&&Staphylococcus aureus (MIC=12.8µM)&&Bacillus cereus (MIC=25.6µM)&&Lactococcus lactis (MIC=25.6µM)&&Escherichia coli (MIC=25.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=54µM)&&Human cervical carcinoma HeLa (IC50=42µM),FLIGMTQGLICLITRKC,,Linear,Free,Free,,L,dbAMP3,17
1964,dbAMP_01964,,Escherichia coli ATCC 25922 (MIC=5µM)&&Escherichia coli ATCC 35218 (MIC=50µM)&&Escherichia coli ML-35p (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>200µM)&&Acinetobacter baumannii ATCC 19606 (MIC=25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=100µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ATCC 43300 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=6.25µM)&&Staphylococcus aureus ST1065 (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=25µM)&&Bacillus megaterium (MIC=1.56µM)&&Candida albicans ATCC 90028 (MIC=100µM)&&Candida parapsilosis ATCC 22019 (MIC=>200µM)&&Saccharomyces cerevisiae (MIC=25µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=16.5µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=23.5µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=14.6µM)&&Leishmania tropica MHOM/SU/74/SAF-K27 (IC50=13.9µM)&&Leishmania amazonensis MHOM/BR/73/M2269 (IC50=14.1µM)&&Leishmania braziliensis MHOM/BR/75/M2904 (IC50=17.9µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=6.7µM)&&Trypanosoma brucei (IC50=21.8µM)&&Trypanosoma cruzi (IC50=16.8µM)&&Human acute monocytic leukemia THP-1 (LC50=66µM)&&Human hepatocellular carcinoma HepG2 (LC50=594µM),FLPAALAGIGGILGKLF,,Linear,Free,Free,,L,dbAMP3,17
1971,dbAMP_01971,,Escherichia coli ATCC 25922 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.5µM)&&Candida albicans ATCC 90028 (MIC=6µM)&&Human hepatocellular carcinoma HepG2 (LC50=12µM)&&Batrachochytrium dendrobatidis (MIC=10µM)&&Escherichia coli ATCC 25922 (MIC=17µM),FLPAIVGAAAKFLPKIFCAISKKC,,Linear,Free,Free,,L,dbAMP3,24
1975,dbAMP_01975,,Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli ATCC 35218 (MIC=50µM)&&Escherichia coli ML-35p (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=60µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=100µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.12µM)&&Staphylococcus aureus ATCC 43300 (MIC=3.1µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=3.12µM)&&Staphylococcus aureus ST1065 (MIC=3.12µM)&&Listeria ivanovii (MIC=5µM)&&Enterococcus faecalis ATCC 29212 (MIC=12.5µM)&&Bacillus megaterium (MIC=1.56µM)&&Candida albicans ATCC 90028 (MIC=>100µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=12.5µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=4.6µM)&&Leishmania braziliensis MHOM/BR/75/M2904 (IC50=10.5µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=11.6µM)&&Human acute monocytic leukemia THP-1 (45% Killing=12.5µM)&&Human acute monocytic leukemia THP-1 (96% Killing=25µM),FLPALAGIAGLLGKIF,,Linear,Free,Free,,L,dbAMP3,16
2007,dbAMP_02007,,Staphylococcus aureus USA 300 (MIC=1.6-3.1µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 300 (MIC=6.2µM)&&Staphylococcus aureus USA 300 (MIC=12.5-25µM)&&Staphylococcus aureus USA 200 (MIC=3.1µM)&&Staphylococcus aureus USA 400 (MIC=1.56µM)&&Staphylococcus aureus UAMS-1 (MIC=>25µM)&&Staphylococcus aureus Newman (MIC=1.6µM)&&Staphylococcus aureus MU50 (MIC=3.1µM)&&Staphylococcus epidermidis 1457 (MIC=1.6µM)&&Bacillus subtilis 168 (MIC=12.5-25µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=12.5µM)&&Candida glabrata ATCC 2001 (MIC=12.5µM)&&Candida tropicalis ATCC 13803 (MIC=1.6µM)&&Mouse breast cancer 4T1 (LC50=>80µM)&&Human cervical carcinoma HeLa (LC50=25µM)&&Staphylococcus aureus USA 300 (MBC=3.1µM),FLPFLKSILGKIL,,Linear,Free,Free,,L,dbAMP3,13
2021,dbAMP_02021,,Bacillus subtilis ATCC 6633 (MIC50=>62.54µM)&&Staphylococcus aureus ATCC 6538 (MIC50=>62.54µM)&&Staphylococcus aureus DMST 20651 (MIC50=>62.54µM)&&Staphylococcus epidermidis ATCC 12228 (MIC50=>62.54µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>62.54µM)&&Escherichia coli ATCC 25922 (MIC50=>62.54µM)&&Salmonella enterica subsp. enterica serovar Typhi DMST 562 (MIC50=>62.54µM)&&Human colon adenocarcinoma SW620 (IC50=>62.54µM)&&Human squamous cell oral carcinoma HSC-4 (IC50=>62.54µM),FLPIAGKLLSGLSGLL,,Linear,Free,Free,,L,dbAMP3,16
2028,dbAMP_02028,,Escherichia coli ATCC 25922 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Candida albicans ATCC 90028 (MIC=3-6µM)&&Human hepatocellular carcinoma HepG2 (LC50=11µM),FLPIIAGAAAKVVQKIFCAISKKC,,Linear,Free,Free,,L,dbAMP3,24
2051,dbAMP_02051,6G4U,Candida albicans ATCC 90028 (MIC=3µM)&&Escherichia coli ATCC 25922 (MIC=17µM)&&Staphylococcus aureus NCTC 8325 (MIC=2µM)&&Human hepatocellular carcinoma HepG2 (LC50=6µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=9µM)&&Klebsiella pneumoniae KK3 9904 (MIC=40µM)&&Enterobacter cloacae HNTCC 53001 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Proteus mirabilis ATCC 25933 (MIC=>40µM)&&Staphylococcus epidermidis RP62A (MIC=5µM)&&Enterococcus faecalis ATCC 29212 (MIC=5µM)&&Streptococcus group B HNTCC 80130 (MIC=10µM)&&Candida albicans (MIC=5µM)&&Candida parapsilosis ATCC 22019 (MIC=5µM)&&Candida parapsilosis (MIC=10µM)&&Candida tropicalis (MIC=5µM)&&Candida krusei ATCC 6258 (MIC=5µM)&&Candida krusei (MIC=10µM)&&Batrachochytrium dendrobatidis JEL-197 (MIC=12.5µM),FLPILASLAAKFGPKLFCLVTKKC,,Linear,Free,Free,,L,dbAMP3,24
2066,dbAMP_02066,,Staphylococcus aureus ATCC 2592 (MIC=2.0µg/ml)&&Escherichia coli ATCC 25922 (MIC=3.0µg/ml)&&Shigella dysenteriae (MIC=1.5µg/ml)&&Candida albicans ATCC 2002 (MIC=6.5µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=77µg/ml),FLPIVGKLLSGLSGLL,,Linear,Free,Free,,L,dbAMP3,16
2072,dbAMP_02072,,Staphylococcus aureus USA 300 (MIC=12.5µM)&&Staphylococcus aureus USA 200 (MIC=25µM)&&Staphylococcus aureus USA 400 (MIC=12.5µM)&&Staphylococcus aureus UAMS-1 (MIC=>25µM)&&Staphylococcus aureus Newman (MIC=12.5µM)&&Staphylococcus epidermidis 1457 (MIC=12.5µM)&&Bacillus subtilis 168 (MIC=25-50µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=50µM)&&Candida glabrata ATCC 2001 (MIC=>50µM)&&Candida tropicalis ATCC 13803 (MIC=6.2-12.5µM)&&Mouse breast cancer 4T1 (LC50=>80µM)&&Human cervical carcinoma HeLa (LC50=>80µM)&&Staphylococcus aureus MU50 (MIC=12.5µM),FLPIVGRLISGIL,,Linear,Free,Free,,L,dbAMP3,13
2082,dbAMP_02082,,Staphylococcus aureus ATCC 2592 (MIC=5.50µg/ml)&&Escherichia coli ATCC 25922 (MIC=6.50µg/ml)&&Shigella dysenteriae (MIC=2.20µg/ml)&&Candida albicans ATCC 2002 (MIC=7.50µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=58µg/ml),FLPLAVSLAANFLPKLFCKITKKC,,Linear,Free,Free,,L,dbAMP3,24
2092,dbAMP_02092,,Escherichia coli ATCC 25922 (MIC=>100µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Candida albicans ATCC 90028 (MIC=3µM)&&Human hepatocellular carcinoma HepG2 (LC50=6µM),FLPLIAGVAANFLPKIFCLISKKC,,Linear,Free,Free,,L,dbAMP3,24
2093,dbAMP_02093,,Escherichia coli ATCC 25922 (MIC=>100µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Candida albicans ATCC 90028 (MIC=3µM)&&Human hepatocellular carcinoma HepG2 (LC50=7µM),FLPLIAGVAASILPKIFCFITKKC,,Linear,Free,Free,,L,dbAMP3,24
2106,dbAMP_02106,,Escherichia coli AS1.349 (MIC=12.5µM)&&Pseudomonas aeruginosa (MIC=12.5µM)&&Staphylococcus aureus AS1.72 (MIC=3.13µM)&&Bacillus cereus (MIC=3.13µM)&&Lactococcus lactis (MIC=3.13µM)&&Candida albicans (MIC=6.25µM)&&Human breast adenocarcinoma MCF-7 (IC50=11.4±2.3µM)&&Human cervical carcinoma HeLa (IC50=12.8±8.6µM),FLPLKKLRFGLL,,Linear,Free,Free,,L,dbAMP3,12
2117,dbAMP_02117,,Human lung carcinoma A549 (IC50=6.49±1.39µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=5.75±1.17µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=4.91±0.80µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=4.88±0.53µg/ml)&&Escherichia coli DH5alpha (MIC=25µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=50µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=25µg/ml)&&Micrococcus luteus ATCC 4698 (MIC=2.5µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=10µg/ml)&&Bacillus subtilis KCTC 1021 (MIC=10µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=50µg/ml)&&Pseudomonas putida (MIC=150µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=150µg/ml)&&Escherichia coli (MIC=100µg/ml)&&Saccharomyces cerevisiae (MIC=50µg/ml)&&Candida albicans (MIC=50µg/ml)&&Proteus mirabilis ATCC 25933 (MIC=>200µg/ml)&&Serratia marcescens (MIC=>200µg/ml),FLPLLAGLAANFLPTIICKISYKC,,Linear,Free,Free,,L,dbAMP3,24
2121,dbAMP_02121,,Staphylococcus aureus NCTC 8325 (MIC=2µM)&&Staphylococcus aureus USA 300 (MIC=1.6µM)&&Staphylococcus aureus USA 200 (MIC=1.56µM)&&Staphylococcus aureus USA 400 (MIC=1.56µM)&&Staphylococcus aureus UAMS-1 (MIC=>25µM)&&Staphylococcus aureus Newman (MIC=<0.8µM)&&Staphylococcus aureus MU50 (MIC=1.6µM)&&Staphylococcus epidermidis 1457 (MIC=1.6µM)&&Bacillus subtilis 168 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Candida glabrata ATCC 2001 (MIC=25µM)&&Candida tropicalis ATCC 13803 (MIC=1.6-3.1µM)&&Mouse breast cancer 4T1 (LC50=65µM)&&Human cervical carcinoma HeLa (LC50=50µM)&&Staphylococcus aureus USA 300 (MBC=3.1µM),FLPLLASLFSRLF,,Linear,Free,Free,,L,dbAMP3,13
2161,dbAMP_02161,,Escherichia coli ATCC 25922 (MIC=50µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.5µM)&&Candida albicans ATCC 90028 (MIC=3µM)&&Human hepatocellular carcinoma HepG2 (LC50=4µM),FLPVIASVAAKVLPKVFCFITKKC,,Linear,Free,Free,,L,dbAMP3,24
2178,dbAMP_02178,,Staphylococcus aureus USA 300 (MIC=6.3µM)&&Staphylococcus aureus USA 300 (MBC50=3.1µM)&&Staphylococcus aureus USA 200 (MIC=6.25µM)&&Staphylococcus aureus USA 400 (MIC=6.25µM)&&Staphylococcus aureus UAMS-1 (MIC=>25µM)&&Staphylococcus aureus Newman (MIC=12.5µM)&&Staphylococcus aureus MU50 (MIC=12.5µM)&&Staphylococcus epidermidis 1457 (MIC=6.3µM)&&Bacillus subtilis 168 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Candida glabrata ATCC 2001 (MIC=25µM)&&Candida tropicalis ATCC 13803 (MIC=6.2µM)&&Mouse breast cancer 4T1 (LC50=>80µM)&&Human cervical carcinoma HeLa (LC50=>80µM),FLSAITSILGKFF,,Linear,Free,Free,,L,dbAMP3,13
2187,dbAMP_02187,,Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=10-12µM)&&Bacillus megaterium (MIC=2µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Escherichia coli ATCC 35218 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=31µM)&&Candida albicans ATCC 90028 (MIC=16µM)&&Candida parapsilosis ATCC 22019 (MIC=31µM)&&Saccharomyces cerevisiae (MIC=8µM)&&Leishmania infantum (promastigote) (IC50=18.1µM)&&Leishmania infantum (amastigote) (IC50=22.8µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Escherichia coli ML-35p (MIC=12µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=50µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=12µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ST1065 (MIC=6µM)&&Staphylococcus aureus ATCC 43300 (MIC=6µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=6µM)&&Streptococcus pyogenes ATCC 19615 (MIC=6µM)&&Listeria ivanovii (MIC=6µM)&&Candida albicans ATCC 90028 (MIC=25µM)&&Candida parapsilosis ATCC 22019 (MIC=100µM)&&Saccharomyces cerevisiae (MIC=12µM)&&Human acute monocytic leukemia THP-1 (IC50=>60µM)&&Human hepatocellular carcinoma HepG2 (LC50=560µM)&&Helicobacter pylori ATCC 43504 (MIC=3.12µM)&&Helicobacter pylori ATCC 43504 (MIC=6.25µM)&&Helicobacter pylori ATCC 43504 (MIC=>50µM)&&Helicobacter pylori (MIC=12.5-25µM)&&Human gastric carcinoma NCI-N87 (IC50=1558±324µM)&&Legionella feeleii ATCC 35072 (MIC=<=1.56µM)&&Legionella longbeachae ATCC 33484 (MIC=<=1.56µM)&&Legionella pneumophila ATCC 33155 (MIC=3.12µM)&&Legionella pneumophila Paris (MIC=<=1.56µM)&&HSV-1 (IC50 REP=10µM),FLSGIVGMLGKLF,,Linear,Free,Free,,L,dbAMP3,13
2192,dbAMP_02192,,Escherichia coli ATCC 25922 (MIC=<15µM)&&Staphylococcus aureus ATCC 25923 (MIC=<15µM)&&Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Candida albicans NCPF 1467 (MIC=32µM)&&Staphylococcus aureus ATCC 12493 (MIC=32µM)&&Human squamous lung carcinoma NCI-H157 (IC50=10.6µM)&&Human prostate adenocarcinoma PC-3 (IC50=7.0µM)&&Human glioblastoma U251-MG (IC50=4.1µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=10.3µM)&&Human breast adenocarcinoma MCF-7 (IC50=14.6µM),FLSLALAALPKFLCLVFKKC,,Linear,Free,Free,,L,dbAMP3,20
2193,dbAMP_02193,,Escherichia coli ATCC 25922 (MIC=>60µM)&&Staphylococcus aureus ATCC 25923 (MIC=>60µM)&&Escherichia coli ATCC 11775 (MIC=25µM)&&Staphylococcus aureus ATCC 12600 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Staphylococcus aureus NCTC 8325 (MIC=13µM)&&Candida albicans ATCC 90028 (MIC=100µM)&&Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Candida albicans NCPF 1467 (MIC=32µM)&&Staphylococcus aureus ATCC 12493 (MIC=32µM)&&Human squamous lung carcinoma NCI-H157 (IC50=4.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=6.4µM)&&Human glioblastoma U251-MG (IC50=4.6µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=9.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=9.1µM),FLSLALAALPKLFCLIFKKC,,Linear,Free,Free,,L,dbAMP3,20
2219,dbAMP_02219,,Staphylococcus aureus NCTC 10788 (MIC=5µM)&&Escherichia coli NCTC 10418 (MIC=80µM)&&Candida albicans NCPF 1467 (MIC=100µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ST1065 (MIC=6.25µM)&&Staphylococcus aureus ATCC 43300 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=25µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3.12µM)&&Escherichia coli ATCC 25922 (MIC=70µM)&&Escherichia coli ML-35p (MIC=>100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6.25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>100µM)&&Candida parapsilosis ATCC 22019 (MIC=100µM)&&Saccharomyces cerevisiae (MIC=12.5µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=16.5µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=12.6µM)&&Leishmania braziliensis MHOM/BR/75/M2904 (IC50=15.3µM)&&Human acute monocytic leukemia THP-1 (IC50=23µM)&&Escherichia coli ATCC 25922 (MIC=70µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM),FLSLIPHIVSGVASIAKHF,,Linear,Free,Free,,L,dbAMP3,19
2224,dbAMP_02224,,Staphylococcus aureus NCTC 10788 (MIC=120µM)&&Staphylococcus aureus NCTC 10788 (MBC=>160µM)&&Escherichia coli NCTC 10418 (MIC=160µM)&&Escherichia coli NCTC 10418 (MBC=>160µM)&&Candida albicans NCPF 1467 (MIC=160µM)&&Candida albicans NCPF 1467 (MBC=>160µM)&&Human squamous lung carcinoma NCI-H157 (IC50=55.9µM)&&Human lung adenocarcinoma NCI-H838 (IC50=52.5µM),FLSLIPSLVGGSISAFK,,Linear,Free,Free,,L,dbAMP3,17
2235,dbAMP_02235,,Staphylococcus aureus AB94004 (MIC=16µM)&&Bacillus magaterium AB90008 (MIC=6µM)&&Micrococcus luteus AB2010179 (MIC=8µM)&&Enterococcus sp. S13 (MIC=4µM)&&Staphylococcus aureus 16472 (MIC=12µM)&&Escherichia coli DH5alpha (MIC=36µM)&&Pseudomonas putida (MIC=>87µM)&&Klebsiella oxytoca AB2010143 (MIC=87µM)&&Enterobacter cloacae AB2010162 (MIC=>87µM)&&Salmonella enterica AB2010185 (MIC=84µM)&&Candida tropicalis AY91009 (MIC=17µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=13.5±2.0µM)&&Human prostate cancer DU145 (IC50=17.3±1.0µM),FLSTIWNGIKSLL,,Linear,Free,Free,,L,dbAMP3,13
2296,dbAMP_02296,,Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=125µg/ml)&&Candida albicans FRR 5580 (MIC=250µg/ml)&&Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=125µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>250µg/ml)&&Human cervical carcinoma HeLa (IC50=>250µg/ml),FPVTWRWWKWWKG,,Linear,Free,Free,,L,dbAMP3,13
2370,dbAMP_02370,,Staphylococcus aureus (MIC=14.4µM)&&Bacillus cereus (MIC=14.4µM)&&Lactococcus lactis (MIC=14.4µM)&&Escherichia coli (MIC=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=12µM)&&Human cervical carcinoma HeLa (IC50=36µM)&&Human breast adenocarcinoma MDA-MB-231 ((32±8)% Cytotoxicity=40µM)&&Staphylococcus aureus ATCC 6538 (MIC=3.1µM)&&Escherichia coli NCTC 10418 (MIC=>100µM),FVDLKKIANIINSIF,,Linear,Free,Free,,L,dbAMP3,15
2371,dbAMP_02371,,Human hepatocarcinoma SMMC-7721 (IC50=44.92µM)&&Human hepatocarcinoma BEL-7402 (IC50=36.90µM)&&Human breast cancer Bcap-37 (IC50=37.33µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=63.26µM)&&Human breast adenocarcinoma MCF-7 (IC50=31.78µM)&&Human squamous lung carcinoma LK-2 (IC50=58.32µM)&&Human lung carcinoma A549 (IC50=52.82µM)&&Human lung carcinoma NCI-H446 (IC50=59.45µM)&&Human gastric cancer BGC-823 (IC50=56.47µM)&&Human cervical carcinoma HeLa (IC50=43.87µM)&&Human ovarian carcinoma HO-8910 (IC50=62.84µM)&&Human colon adenocarcinoma HT29 (IC50=88.91µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Pseudomonas syringae pv. syringae EPS 94 (MIC=>50µM)&&Xanthomonas campestris pv. Vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Pseudomonas syringae pv. actinidiae Psa3700.1.1 (MIC=>50µM)&&Xanthomonas fragariae Xf349-9A (MIC=>50µM)&&Xanthomonas arboricola pv. pruni CFBP 5563 (MIC=3.1-2.6µM),FVDLKKIANIINSIFGK,,Linear,Free,Free,,L,dbAMP3,17
2436,dbAMP_02436,,Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Escherichia coli ATCC 25922 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=9.8µM),GASCGETCFTGICFTAGCSCNPWPTCTRN,,Linear,Free,Free,,L,dbAMP3,29
2460,dbAMP_02460,,Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Escherichia coli ATCC 25922 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=9.8µM),GDACGETCFTGICFTAGCSCNPWPTCTRN,,Linear,Free,Free,,L,dbAMP3,29
2478,dbAMP_02478,,Staphylococcus aureus ATCC 12600 (MIC=>100µM)&&Enterococcus faecalis ATCC 47077 (MIC=>100µM)&&Escherichia coli ATCC 700926 (MIC=>100µM)&&Pseudomonas aeruginosa ATCC 39018 (MIC=>100µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>100µM)&&Human cervical carcinoma HeLa (IC50=8.0µM)&&Human lung carcinoma A549 (IC50=7.59µM)&&Human lung carcinoma A549/paclitaxel (IC50=7.92µM),GEFLKCGESCVQGECYTPGCSCDWPICKKN,,Linear,Free,Free,,L,dbAMP3,30
2481,dbAMP_02481,1OF9,Micrococcus luteus 004 (IC50=1.9µM)&&Bacillus megaterium ATCC 14581 (IC50=13µM)&&Bacillus subtilis 60015 (IC50=27µM)&&Staphylococcus aureus (IC50=>15µM)&&Escherichia coli ATCC 23716 (IC50=>15µM)&&Enterobacter cloacae (IC50=>15µM)&&Human histiocytic lymphoma U-937 (LC50=80µM)&&Jurkat cancer cells (LC50=14µM),GEILCNLCTGLINTLENLLTTKGADKVKDYISSLCNKASGFIATLCTKVLDFGIDKLIQLIEDKVDANAICAKIHAC,,Linear,Free,Free,,L,dbAMP3,77
2485,dbAMP_02485,,Escherichia coli KCTC 1682 (MIC=50.0µM)&&Salmonella typhimurium KCTC 1926 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=12.5µM)&&Bacillus subtilis KCTC 1918 (MIC=50.0µM)&&Streptococcus pyogenes KCTC 3096 (MIC=50.0µM)&&Staphylococcus aureus KCTC 1621 (MIC=>50.0µM)&&Candida albicans TIMM 1768 (MIC=50.0µM)&&Aspergillus fumigatus KCTC 4165 (MIC=100.0µM)&&Human lung carcinoma A549 (IC50=>100µM)&&Human myelogenous leukemia K562 (IC50=>100µM)&&Jurkat cells E6-1 (IC50=>100µM),GEKLKKIGQKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,18
2497,dbAMP_02497,,Feline immunodeficiency virus (FIV) (IC50 F=0.012µM)&&Feline immunodeficiency virus (FIV) (IC90 F=0.033µM)&&HIV-1 (IC50 F=>2.342µM)&&HIV-1 (IC90 F=>2.342µM)&&Human cervical carcinoma HeLa (0% Cytotoxicity=23µM),GEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQL,,Linear,Free,Free,,L,dbAMP3,35
2498,dbAMP_02498,,Escherichia coli ATCC 25922 (MIC=>80µM)&&Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=5.0µM),GEYCGESCYLIPCFTPGCYCVSRQCVNKN,,Linear,Free,Free,,L,dbAMP3,29
2516,dbAMP_02516,,Arthrobacter globiformis VKM Ac-1112 (MIC=1.1µM)&&Bacillus subtilis VKM B-501 (MIC=0.6µM)&&Escherichia coli DH5alpha (MIC=0.6µM)&&Escherichia coli MH1 (MIC=0.6µM)&&Pseudomonas aeruginosa PAO1 (MIC=18µM)&&Pichia pastoris GS115 (MIC=>37µM)&&Saccharomyces cerevisiae Y190 (MIC=>37µM)&&Escherichia coli C600 (MIC=0.7µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=0.7µM)&&Human myelogenous leukemia K562 (EC50=12µM)&&Escherichia coli DSM 1116 (MIC=8µg/ml)&&Acinetobacter sp. DSM 586 (MIC=4µg/ml)&&Bacillus subtilis subsp. spizizenii DSM 347 (MIC=4µg/ml)&&Staphylococcus xylosus DSM 20267 (MIC=4µg/ml),GFFGKMKEYFKKFGASFKRRFANLKKRL,,Linear,Free,Free,,L,dbAMP3,28
2575,dbAMP_02575,2RU0,Bacillus megaterium CGMCC 1.0459 (LC=0.11µM)&&Bacillus subtilis CGMCC 1.2428 (LC=1.0µM)&&Staphylococcus aureus CGMCC 1.89 (LC=5.2µM)&&Staphylococcus epidermidis P1111 (LC=5.2µM)&&Staphylococcus epidermidis P1389 (LC=1.14µM)&&Staphylococcus aureus P1383 (LC=4.28µM)&&Staphylococcus aureus P1374 (LC=0.62µM)&&Staphylococcus aureus P1369 (LC=1.07µM)&&Staphylococcus aureus P1386 (LC=0.74µM)&&Staphylococcus aureus J685 (LC=10.4µM)&&Staphylococcus aureus J698 (LC=5.2µM)&&Staphylococcus aureus J700 (LC=5.2µM)&&Staphylococcus aureus J706 (LC=5.2µM)&&Staphylococcus aureus J708 (LC=1.14µM)&&Staphylococcus aureus J710 (LC=2.6µM)&&Streptococcus pneumoniae D39 (LC=0.09µM)&&Streptococcus pneumoniae R6 (LC=0.14µM)&&Streptococcus pneumoniae ST556 (LC=0.14µM)&&Streptococcus pneumoniae TIGR4 (LC=0.14µM)&&Streptococcus mutans ATCC 25175 (LC=1.01µM)&&Streptococcus salivarius ATCC 7073 (LC=0.49µM)&&Streptococcus sanguinis ATCC 49295 (LC=1.41µM)&&Streptomyces griseus NBRC 13350 (LC=2.89µM)&&Streptomyces scabiei CGMCC 4.1765 (LC=2.01µM)&&Lysinibacillus fusiformis (LC=0.27µM)&&Enterococcus faecalis ATCC 700802 (LC=4.65µM)&&Human promyelocytic leukemia HL-60 (5% Killing=25µM)&&Human promyelocytic leukemia HL-60 (42% Killing=50µM)&&Human promyelocytic leukemia HL-60 (75% Killing=100µM),GFGCPWNAYECDRHCVSKGYTGGNCRGKIRQTCHCY,,Linear,Free,Free,,L,dbAMP3,36
2578,dbAMP_02578,,Human cervical carcinoma HeLa S3 (IC50=10±4µM)&&Human colon adenocarcinoma SW480 (IC50=23±4µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=12±6µM)&&Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=3.7µM)&&Escherichia coli B (MIC=3.0µM)&&Pseudomonas aeruginosa (MIC=35.0µM)&&Candida albicans F7-39/IDE99 (MIC=6.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.13µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.13µM)&&Listeria monocytogenes KCTC 3710 (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.25µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=6.25µM)&&Escherichia coli ATCC 25922 (MIC=6.25µM)&&Staphylococcus aureus (MIC=4.43µM)&&Pseudomonas aeruginosa (MIC=4.43µM)&&Staphylococcus aureus 547582 (MIC=8µM)&&Pseudomonas aeruginosa 3320 (MIC=8µM)&&Murine macrophage cells RAW 264.7 (59% Cytotoxicity=25µM),GFGMALKLLKKVL,,Linear,Free,Free,,L,dbAMP3,13
2585,dbAMP_02585,,Human lung carcinoma A549 (10% Killing=50µM)&&Human lung carcinoma A549 (30% Killing=100µM)&&Human lung carcinoma A549 (25% Inhibition=5µM)&&Human lung carcinoma A549 (47% Inhibition=50µM),GFGSKPIDSFGLSWL,,Linear,Free,Free,,L,dbAMP3,15
2586,dbAMP_02586,2N5C,Staphylococcus aureus ATCC 25923 (MIC=30-35µg/ml)&&Bacillus subtilis NCTC 2116 (MIC=30-35µg/ml)&&Human lung carcinoma A549 (28% Inhibition=5µM)&&Human lung carcinoma A549 (56% Inhibition=50µM),GFGSKPLDSFGLNFF,,Linear,Free,Free,,L,dbAMP3,15
2617,dbAMP_02617,2L5M,HIV-1 IIIB (IC50 REP=0.76µM)&&Escherichia coli K-12 (MIC=7.5µM)&&Staphylococcus aureus USA 300 (MIC=7.5µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=3.1µM)&&Escherichia coli ATCC 25922 (MIC=3.1-6.25µM)&&Pseudomonas aeruginosa PAO1 (MIC=25µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Escherichia coli K-12 (MIC=14µM)&&Staphylococcus aureus UAMS-1 (MIC=7µM)&&Staphylococcus aureus USA 300 (MIC=7µM)&&Staphylococcus aureus UAMS-1 (MIC=3.1µM)&&Staphylococcus epidermidis 1457 (MIC=1.6µM)&&Acinetobacter baumannii B28-16 (MIC=1.6µM)&&Enterococcus faecium ATCC 51559 (MIC=6.25µM)&&Ebola virus EBOV-GP PsV (IC50 I=10.1µM)&&Ebola virus EBOV-GP PsV (IC50 I=>20µM)&&Human cervical carcinoma HeLa (50% Cytotoxicity=30µM)&&Enterococcus faecium V284-17 (MIC=2µM)&&Klebsiella pneumoniae E406-17 (MIC=>32µM)&&Acinetobacter baumannii B28-16 (MIC=4µM)&&Pseudomonas aeruginosa E411-17 (MIC=16µM)&&Escherichia coli E423-17 (MIC=16µM),GFKRIVQRIKDFLRNLV,,Linear,Free,Free,,L,dbAMP3,17
2620,dbAMP_02620,,Listeria monocytogenes CMCC 54004 (MIC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=7.8µg/ml)&&Streptococcus suis 2 CVCC 606 (MIC=31.25µg/ml)&&Bacillus subtilis ADB 403 (MIC=30µg/ml)&&Candida albicans ATCC 10231 (MIC=>100µg/ml)&&Salmonella sp. ATCC 20020 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=60µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=30µg/ml)&&Human gastric cancer SGC-7901 (IC50=0.951µg/ml)&&Human gastric cancer MGC-803 (IC50=1.572µg/ml)&&Human hepatocarcinoma SMMC-7721 (IC50=1.077µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=1.375µg/ml)&&Human cervical carcinoma HeLa (IC50=1.202µg/ml),GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP,,Linear,Free,Free,,L,dbAMP3,31
2639,dbAMP_02639,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=>64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=>64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=64µg/ml)&&Escherichia coli CGSC 4908 (MIC=>64µg/ml)&&Escherichia coli UB1005 (MIC=>64µg/ml)&&Escherichia coli DC2 (MIC=>64µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),GFLGILFHGVHHGRKKALHMNSERRS,,Linear,Free,Free,,L,dbAMP3,26
2669,dbAMP_02669,,Staphylococcus aureus ATCC 25923 (MIC=20µM)&&Enterococcus faecalis ATCC 29212 (MIC=20µM)&&Escherichia coli ATCC 25922 (MIC=13µM)&&Pseudomonas aeruginosa CMCCB 1010 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=33µM)&&Shigella dysenteriae (MIC=50µM)&&Pseudomonas aeruginosa (MIC=50µM)&&Klebsiella pneumoniae (MIC=50µM)&&Human myelogenous leukemia K562 (IC50=58µM)&&Human colon adenocarcinoma HT29 (IC50=57µM),GFMDTAKNVAKNVAVTLIDKLRCKVTGGC,,Linear,Free,Free,,L,dbAMP3,29
2696,dbAMP_02696,,Escherichia coli ATCC 25726 (MIC=5µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=5µM)&&Staphylococcus aureus ATCC 25923 (MIC=5µM)&&Candida albicans ATCC 90028 (MIC=10µM)&&Human lung carcinoma A549 (LC50=10µM)&&Staphylococcus aureus 127/08 (MIC=6µM)&&Acinetobacter baumannii NM8 (MIC=6µM)&&Stenotrophomonas maltophilia B32/1 (MIC=6µM)&&Stenotrophomonas maltophilia B32/4 (MIC=3µM),GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC,,Linear,Free,Free,,L,dbAMP3,37
2708,dbAMP_02708,,Aeromonas salmonicida 99-1 (MIC=8µg/ml)&&Aeromonas salmonicida 97-4 (MIC=16µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=16µg/ml)&&Pseudomonas aeruginosa K799 (MIC=8µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=4µg/ml)&&Escherichia coli CGSC 4908 (MIC=8µg/ml)&&Escherichia coli UB1005 (MIC=8µg/ml)&&Escherichia coli DC2 (MIC=8µg/ml)&&Staphylococcus epidermidis C621 (MIC=4µg/ml)&&Staphylococcus aureus C623 (MIC=4µg/ml)&&Candida albicans C627 (MIC=16µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=64µg/ml),GFWGKLFKLGLHGIGLLHLHL,,Linear,Free,Free,,L,dbAMP3,21
2743,dbAMP_02743,2NDC,Escherichia coli K-12 (MIC=2µM)&&Escherichia coli K-12 (MBC=4µM)&&Bacillus subtilis 168 (MIC=8µM)&&Bacillus subtilis 168 (MBC=8µM)&&Bacillus subtilis ATCC 6633 (MIC50=8.74µM)&&Staphylococcus aureus ATCC 6538 (MIC50=>48.56µM)&&Staphylococcus aureus DMST 20651 (MIC50=>48.56µM)&&Staphylococcus epidermidis ATCC 12228 (MIC50=24.28µM)&&Acinetobacter baumannii ATCC 19606 (MIC50=7.28µM)&&Escherichia coli ATCC 25922 (MIC50=16.99µM)&&Salmonella enterica subsp. enterica serovar Typhi DMST 562 (MIC50=6.07µM)&&Human colon adenocarcinoma SW620 (IC50=>48.56µM)&&Human squamous cell oral carcinoma HSC-4 (IC50=>48.56µM),GGLRSLGRKILRAWKKYG,,Linear,Free,Free,,L,dbAMP3,18
2761,dbAMP_02761,1YP8,Escherichia coli ATCC 25922 (MBC50=40µM)&&Escherichia coli ATCC 25922 (MBC99=80µM)&&Escherichia coli ATCC 25922 (MIC=160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=80µM)&&Staphylococcus aureus ATCC 29213 (MBC50=80µM)&&Staphylococcus aureus ATCC 29213 (MBC99=80µM)&&Staphylococcus aureus ATCC 29213 (MIC=160µM)&&Candida albicans ATCC 90028 (MFC50=40µM)&&Candida albicans ATCC 90028 (MFC99=40µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human histiocytic lymphoma U-937/GTB (IC50=8.7µM),GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN,,Linear,Free,Free,,L,dbAMP3,33
2781,dbAMP_02781,,Human histiocytic lymphoma U-937/GTB (IC50=26µM),GIACGESCVFLGCFIPGCSCKSKVCYFN,,Linear,Free,Free,,L,dbAMP3,28
2806,dbAMP_02806,,Escherichia coli ATCC 25922 (MIC=15µM)&&Staphylococcus aureus ATCC 25923 (MIC=15µM)&&Human lung carcinoma A549 (IC50=2.975µM)&&Human breast adenocarcinoma MCF-7 (IC50=25.74µM)&&Human cervical carcinoma HeLa (IC50=19.69µM)&&Human colon adenocarcinoma LoVo (IC50= 8.05µM),GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,,Linear,Free,Free,,L,dbAMP3,33
2827,dbAMP_02827,,Staphylococcus aureus ATCC 25923 (MIC=20µM)&&Escherichia coli ATCC 25726 (MIC=>40µM)&&Staphylococcus aureus ATCC 25923 (MIC=5µM)&&Escherichia coli ATCC 25726 (MIC=>80µM)&&Staphylococcus aureus 127/08 (MIC=5µM)&&Staphylococcus aureus 145/08 (MIC=10µM)&&Staphylococcus epidermidis RP62A (MIC=5µM)&&Staphylococcus epidermidis RP62A/1 (MIC=2.5µM)&&Staphylococcus epidermidis T6/19 (MIC=5µM)&&Staphylococcus epidermidis T37/8 (MIC=10µM)&&Enterococcus faecalis ATCC 29212 (MIC=20µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>80µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>80µM)&&Acinetobacter baumannii NM8 (MIC=20µM)&&Acinetobacter baumannii NM35 (MIC=10µM)&&Stenotrophomonas maltophilia B32/1 (MIC=10µM)&&Stenotrophomonas maltophilia B5/5 (MIC=40µM)&&Stenotrophomonas maltophilia U8908 (MIC=20µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=6.0±0.6µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=6.2±0.6µM)&&Human colon adenocarcinoma HT29 (LC50=11.5±2.6µM),GIFPIFAKLLGKVIKVASSLISKGRTE,,Linear,Free,Free,,L,dbAMP3,27
2908,dbAMP_02908,,Staphylococcus aureus CPCC 100520 (MIC=6.3µM)&&Staphylococcus aureus CPCC 100520 (MBC=100.3µM)&&Escherichia coli CPCC 100521 (MIC=6.3µM)&&Escherichia coli CPCC 100521 (MBC=12.5µM)&&Candida albicans CPCC 400416 (MIC=12.5µM)&&Candida albicans CPCC 400416 (MBC=12.5µM)&&Human hepatocellular carcinoma Huh7 (IC50=3.87µM)&&Human liver carcinoma SK-HEP-1 (IC50=0.61µM)&&Human hepatocellular carcinoma HepG2 (IC50=2.83µM),GIGGALLSAGKSALKGLAKGLAEHFAN,,Linear,Free,Free,,L,dbAMP3,27
2937,dbAMP_02937,6HZ2,Escherichia coli ATCC 25922 (MIC=0.9µg/ml)&&Staphylococcus aureus ATCC 2592 (MIC=3.1µg/ml)&&Pseudomonas aeruginosa CMCCB 10104 (MIC=1.5µg/ml)&&Bacillus megaterium (MIC=0.9µg/ml)&&Shigella dysenteriae (MIC=0.9µg/ml)&&Klebsiella pneumoniae (MIC=3.1µg/ml)&&Candida albicans ATCC 2002 (MIC=15µg/ml)&&HIV-1 (IC50 REP=1.5µg/ml)&&Human T-cell leukemia C8166 (IC50=11.4µg/ml)&&Human lymphoblastic leukemia Molt-4 (IC50=25.2µg/ml)&&Human bladder cancer BIU-87 (IC50=28µg/ml)&&Human bladder carcinoma T24 (IC50=18µg/ml),GIGGKILSGLKTALKGAAKELASTYLH,,Linear,Free,Free,,L,dbAMP3,27
2944,dbAMP_02944,2MHW,Escherichia coli ATCC 25922 (MIC=2.7µg/ml)&&Staphylococcus aureus ATCC 2592 (MIC=2.7µg/ml)&&Pseudomonas aeruginosa CMCCB 10104 (MIC=2.7µg/ml)&&Bacillus megaterium (MIC=1.5µg/ml)&&Shigella dysenteriae (MIC=2.7µg/ml)&&Klebsiella pneumoniae (MIC=15µg/ml)&&Candida albicans ATCC 2002 (MIC=15µg/ml)&&HIV-1 (IC50 REP=21.9µg/ml)&&Human T-cell leukemia C8166 (IC50=24.2µg/ml)&&Human lymphoblastic leukemia Molt-4 (IC50=35.4µg/ml)&&Human bladder cancer BIU-87 (IC50=>50µg/ml)&&Human bladder carcinoma T24 (IC50=>50µg/ml),GIGGVLLSAGKAALKGLAKVLAEKYAN,,Linear,Free,Free,,L,dbAMP3,27
2987,dbAMP_02987,,Escherichia coli ATCC 25922 (MIC=19.5µg/ml)&&Staphylococcus aureus ATCC 2592 (MIC=19.5µg/ml)&&Pseudomonas aeruginosa CMCCB 10104 (MIC=19.5µg/ml)&&Bacillus megaterium (MIC=19.5µg/ml)&&Shigella dysenteriae (MIC=2.7µg/ml)&&Klebsiella pneumoniae (MIC=9µg/ml)&&Candida albicans ATCC 2002 (MIC=3µg/ml)&&HIV-1 (IC50 REP=21.4µg/ml)&&Human T-cell leukemia C8166 (IC50=15.3µg/ml)&&Human lymphoblastic leukemia Molt-4 (IC50=24.3µg/ml)&&Human bladder cancer BIU-87 (IC50=20.5µg/ml)&&Human bladder carcinoma T24 (IC50=35.4µg/ml),GIGTKILGGVKTALKGALKELASTYAN,,Linear,Free,Free,,L,dbAMP3,27
3023,dbAMP_03023,,Ebola virus EBOV-GP PsV (IC50 I=6.84µM)&&Ebola virus EBOV-GP PsV (IC50 I=>20µM)&&Human cervical carcinoma HeLa (50% Cytotoxicity=25.2µM)&&Enterococcus faecium V284-17 (MIC=2µM)&&Staphylococcus aureus USA 300 (MIC=2-4µM)&&Klebsiella pneumoniae E406-17 (MIC=>32µM)&&Acinetobacter baumannii B28-16 (MIC=8µM)&&Pseudomonas aeruginosa E411-17 (MIC=>32µM)&&Escherichia coli E423-17 (MIC=32µM),GIKEFKRIVQRIKDFLRNLV,,Linear,Free,Free,,L,dbAMP3,20
3060,dbAMP_03060,,Staphylococcus aureus AB94004 (MIC=8µM)&&Bacillus magaterium AB90008 (MIC=32µM)&&Micrococcus luteus AB2010179 (MIC=32µM)&&Enterococcus sp. S13 (MIC=28µM)&&Staphylococcus aureus 16472 (MIC=14µM)&&Escherichia coli DH5alpha (MIC=62µM)&&Pseudomonas putida (MIC=>87µM)&&Klebsiella oxytoca AB2010143 (MIC=>87µM)&&Enterobacter cloacae AB2010162 (MIC=76µM)&&Salmonella enterica AB2010185 (MIC=72µM)&&Candida tropicalis AY91009 (MIC=16µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=28.5±1.0µM)&&Human prostate cancer DU145 (IC50=47.5±2.0µM),GILGKLWEGFKSIV,,Linear,Free,Free,,L,dbAMP3,14
3061,dbAMP_03061,,Staphylococcus aureus AB94004 (MIC=12.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=12.5µg/ml)&&Staphylococcus aureus AB208193 (MIC=12.5µg/ml)&&Staphylococcus epidermidis AB208187 (MIC=25µg/ml)&&Staphylococcus epidermidis AB208188 (MIC=25µg/ml)&&Micrococcus luteus AB93113 (MIC=12.5µg/ml)&&Bacillus subtilis AB91021 (MIC=12.5µg/ml)&&Staphylococcus aureus P1381 (MIC=12.5µg/ml)&&Staphylococcus aureus P1374 (MIC=25µg/ml)&&Enterococcus faecium (MIC=12.5µg/ml)&&Streptococcus agalactiae (MIC=25µg/ml)&&Escherichia coli AB94012 (MIC=>100µg/ml)&&Escherichia coli ATCC 25922 (MIC=>100µg/ml)&&Pseudomonas aeruginosa AB93066 (MIC=>100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>100µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Human melanoma A375 (50% Cytotoxicity=>100µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>25µM)&&Pseudomonas aeruginosa 3592 (MIC=6.25µM)&&Pseudomonas aeruginosa 4007 (MIC=25µM)&&Pseudomonas aeruginosa 5018 (MIC=12.5µM)&&Pseudomonas aeruginosa 671973 (MIC=3.13µM)&&Acinetobacter baumannii ATCC 19606 (MIC=5µg/ml)&&Acinetobacter baumannii (MIC=6.4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.13µM)&&Staphylococcus aureus ATCC 29213 (MIC=6.25µM)&&Bacillus cereus KCTC 1012 (MIC=12.5µM)&&Listeria monocytogenes KCTC 3710 (MIC=3.13µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Klebsiella pneumoniae KCTC 2208 (MIC=12.5µM)&&Acinetobacter baumannii KCTC 2508 (MIC=3.13µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=3.13µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Acinetobacter baumannii (MIC=3.13µM)&&Acinetobacter baumannii KCTC 2508 (MIC=6.25µM)&&Acinetobacter baumannii (MIC=3.13-12.5µM),GILGKLWEGVKSIF,,Linear,Free,Free,,L,dbAMP3,14
3082,dbAMP_03082,,Escherichia coli ML-35 (MIC=8µM)&&Escherichia coli (MIC=4µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=8µM)&&Proteus mirabilis (MIC=>32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus (MIC=2µM)&&Bacillus megaterium Bm11 (MIC=4µM)&&Human osteosarcoma Rous II (<=50% Cell death=8µM),GILSKLGKALKKAAKHAAKA,,Linear,Free,Free,,L,dbAMP3,20
3091,dbAMP_03091,,Staphylococcus aureus NCTC 8325 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Candida albicans ATCC 90028 (MIC=62µM)&&Escherichia coli ATCC 25726 (MIC=6µM)&&Staphylococcus aureus ATCC 25923 (MIC=6µM)&&Human lung carcinoma A549 (IC50=15.32µM)&&Human breast adenocarcinoma MCF-7 (IC50=45.25µM)&&Human cervical carcinoma HeLa (IC50=37.23µM)&&Human colon adenocarcinoma LoVo (IC50=59.78µM),GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC,,Linear,Free,Free,,L,dbAMP3,32
3107,dbAMP_03107,,Escherichia coli ATCC 25922 (MIC=75µM)&&Staphylococcus aureus ATCC 25923 (MIC=>150µM)&&Candida albicans ATCC 90028 (MIC=150µM)&&Human hepatocellular carcinoma HepG2 (LC50=30µM),GIMDTIKGAAKDLAGQLLDKLKCKITKC,,Linear,Free,Free,,L,dbAMP3,28
3135,dbAMP_03135,,Human histiocytic lymphoma U-937/GTB (IC50=3.2±0.8µM),GIPCAESCVWIPCTVTALIGCGCSNKVCYN,,Linear,Free,Free,,L,dbAMP3,30
3136,dbAMP_03136,,Escherichia coli ATCC 25922 (MBC50=40µM)&&Escherichia coli ATCC 25922 (MBC99=80µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=1.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=2.5µM),GIPCAESCVWIPCTVTALLGCSCKDKVCYLD,,Linear,Free,Free,,L,dbAMP3,31
3147,dbAMP_03147,,Human skin melanoma MM96L (IC50=2.51±0.03µM)&&Human cervical carcinoma HeLa (IC50=5.24±0.40µM),GIPCGESCVFIPCISSVIGCSCSSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3150,dbAMP_03150,,Staphylococcus aureus ATCC 12600 (MIC=>100µM)&&Enterococcus faecalis ATCC 47077 (MIC=>100µM)&&Escherichia coli ATCC 700926 (MIC=1.0µM)&&Pseudomonas aeruginosa ATCC 39018 (MIC=5.5µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=7.5µM)&&Human cervical carcinoma HeLa (IC50=0.6µM)&&Human lung carcinoma A549 (IC50=0.21µM)&&Human lung carcinoma A549/paclitaxel (IC50=0.45µM),GIPCGESCVFIPCITAAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3151,dbAMP_03151,,Staphylococcus aureus ATCC 12600 (MIC=>100µM)&&Enterococcus faecalis ATCC 47077 (MIC=>100µM)&&Escherichia coli ATCC 700926 (MIC=1.1µM)&&Pseudomonas aeruginosa ATCC 39018 (MIC=2.7µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=4.7µM)&&Human cervical carcinoma HeLa (IC50=0.6µM),GIPCGESCVFIPCITGAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3154,dbAMP_03154,,"Cancer cell lines: BGC-823 (IC50=1.75±0.05 µM), MM96L (IC50=4.91±0.04 µM), HeLa (IC50=15.5±0.06 µM).&&Non-cancer cell line: HFF-1 (IC50=3.19±0.01 µM).",GIPCGESCVFIPCLTSAIDCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3156,dbAMP_03156,,Human lung carcinoma A549 (IC50=0.73µM)&&Human lung carcinoma A549/paclitaxel (IC50=1.76µM)&&Escherichia coli ATCC 700926 (MIC=3.1µM)&&Escherichia coli ATCC 700926 (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC50=10µM)&&Escherichia coli ATCC 25922 (MBC99=20µM)&&Escherichia coli ATCC 25922 (MIC=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=0.313µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=0.629µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=0.625µM)&&Staphylococcus aureus ATCC 29213 (MBC50=80µM)&&Staphylococcus aureus ATCC 29213 (MBC99=160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=40µM)&&Candida albicans ATCC 90028 (MFC99=160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=2.8µM),GIPCGESCVFIPCTVTALLGCSCKDKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
3161,dbAMP_03161,2KNM&&2KCG&&2KNM&&2KCG,Human Myeloma cells RPMI-8226 (IC50=0.12µM)&&Human Myeloma cells RPMI-8226/Dox40 (IC50=0.12µM)&&Human Myeloma cells RPMI-8226/LR-5 (IC50=0.12µM)&&Human histiocytic lymphoma U-937/GTB (IC50=0.26µM)&&Human histiocytic lymphoma U-937-Vcr (IC50=0.20µM)&&Human renal adenocarcinoma ACHN (IC50=0.22µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=0.11µM)&&Human lymphoblastic leukemia CCRF-CEM/VM-1 (IC50=0.14µM)&&Human lung carcinoma NCI-H69 (IC50=0.12µM)&&Human lung carcinoma NCI-H69AR (IC50=0.26µM)&&Chronic lymphocytic leukemia (IC50=0.10µM)&&Human ovarian carcinoma (IC50=1.32µM)&&Human glioblastoma U251-MG (IC50=17.05µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=4.81µg/ml)&&Human lung carcinoma A549 (IC50=5.99µg/ml)&&Human prostate cancer DU145 (IC50=5.08µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=6.07µg/ml)&&Human cervical carcinoma HeLa (IC50=3.43±0.15µM)&&Human gastric cancer BGC-823 (IC50=4.81±0.48µM)&&Escherichia coli ATCC 25922 (MBC50=5µM)&&Escherichia coli ATCC 25922 (MBC=10µM)&&Escherichia coli ATCC 25922 (MIC=20µM)&&Escherichia coli ATCC 25922 (MIC=160µM)&&Escherichia coli ATCC 25922 (MIC=80µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=80µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=10µM)&&Staphylococcus aureus ATCC 29213 (MBC=20µM)&&Staphylococcus aureus ATCC 29213 (MIC=20µM)&&Candida albicans ATCC 90028 (MFC50=10µM)&&Candida albicans ATCC 90028 (MFC=10µM)&&Candida albicans ATCC 90028 (MIC=20µM)&&Haemonchus contortus (IC50=0.12µM)&&Trichostrongylus colubriformis (IC50=0.24µM)&&Human skin melanoma MM96L (50% Cell death=3.7±0.4µM)&&Human myelogenous leukemia K562 (50% Cell death=1.6±0.1µM),GIPCGESCVWIPCISSAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3162,dbAMP_03162,,Human glioblastoma U251-MG (IC50=6.03µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=3.69µg/ml)&&Human lung carcinoma A549 (IC50=3.90µg/ml)&&Human prostate cancer DU145 (IC50=3.07µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=4.94µg/ml)&&Human histiocytic lymphoma U-937/GTB (IC50=0.6µM)&&Human Myeloma cells RPMI-8226 (IC50=1µM),GIPCGESCVWIPCITSAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3165,dbAMP_03165,,Escherichia coli ATCC 25922 (MBC50=5µM)&&Escherichia coli ATCC 25922 (MBC99=10µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Staphylococcus aureus ATCC 29213 (MBC50=5µM)&&Staphylococcus aureus ATCC 29213 (MBC99=10µM)&&Staphylococcus aureus ATCC 29213 (MIC=20µM)&&Candida albicans ATCC 90028 (MFC50=10µM)&&Candida albicans ATCC 90028 (MFC99=10µM)&&Candida albicans ATCC 90028 (MIC=20µM)&&Human histiocytic lymphoma U-937/GTB (IC50=0.42µM)&&Haemonchus contortus (IC50=0.21µM)&&Trichostrongylus colubriformis (IC50=0.23µM),GIPCGESCVWIPCLTSAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
3174,dbAMP_03174,,Human lung carcinoma A549 (IC50=0.78µM)&&Human lung carcinoma A549/paclitaxel (IC50=1.6µM),GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
3204,dbAMP_03204,,Aeromonas salmonicida 99-1 (MIC=64µg/ml)&&Aeromonas salmonicida 99-1 (MBC=64µg/ml)&&Aeromonas salmonicida 99-1 (MBC=640µg/ml)&&Aeromonas salmonicida 97-4 (MIC=64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=16µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MBC=16µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MBC=160µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=32µg/ml)&&Escherichia coli CGSC 4908 (MIC=32µg/ml)&&Escherichia coli UB1005 (MIC=32µg/ml)&&Escherichia coli DC2 (MIC=32µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=64µg/ml)&&Candida albicans C627 (MBC90=640µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=128µg/ml),GKGRWLERIGKAGGIIIGGALDHL,,Linear,Free,Free,,L,dbAMP3,24
3243,dbAMP_03243,,Bacillus subtilis 168 (MIC=1.0µM)&&Staphylococcus aureus (MIC=8.1µM)&&Escherichia coli B (MIC=2.5µM)&&Pseudomonas aeruginosa (MIC=42.1µM)&&Human cervical carcinoma HeLa S3 (IC50=12±1µM)&&Human colon adenocarcinoma SW480 (IC50=35±3µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=34µM)&&Candida albicans F7-39/IDE99 (MIC=6.6±2.0µM)&&Candida albicans F7-39/IDE99 (MIC90=13µM)&&Candida albicans F7-39/IDE99 (MFC=13µM)&&Candida albicans (MIC90=25µM)&&Candida albicans (MFC=25µM)&&Candida albicans ATCC 10231 (MIC90=25µM)&&Candida albicans ATCC 10231 (MFC=25µM)&&Candida albicans ATCC MYA-2876 (MIC90=13µM)&&Candida albicans ATCC MYA-2876 (MFC=25µM)&&Candida parapsilosis ATCC 22019 (MIC90=25µM)&&Candida parapsilosis ATCC 22019 (MFC=50µM)&&Candida tropicalis ATCC 750 (MIC90=1.6µM)&&Candida tropicalis ATCC 750 (MFC=1.6µM),GKWMSLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
3270,dbAMP_03270,,Human lung carcinoma A549 (IC50=28±1µM)&&Human lung carcinoma A549 (IC50=25±2µM),GLFAVIKKVASVIGGL,,Linear,Free,Free,,L,dbAMP3,16
3273,dbAMP_03273,,Bacillus cereus (MIC=100µg/ml)&&Escherichia coli (MIC=>100µg/ml)&&Leuconostoc lactis (MIC=6µg/ml)&&Listeria innocua (MIC=100µg/ml)&&Micrococcus luteus (MIC=25µg/ml)&&Pasteurella multocida (MIC=>100µg/ml)&&Staphylococcus aureus (MIC=50µg/ml)&&Staphylococcus epidermidis (MIC=50µg/ml)&&Streptococcus uberis (MIC=>100µg/ml)&&Human leukemia (LC50=10-100µM)&&Human lung cancer (LC50=10µM)&&Human colon cancer (LC50=10-100µM)&&Human CNS cancer (LC50=10µM)&&Human melanoma (LC50=10µM)&&Human ovarian carcinoma (LC50=10µM)&&Human renal cancer (LC50=10µM)&&Human prostate cancer (LC50=10µM)&&Human breast cancer (LC50=10µM),GLFDIAKKVIGVIGSL,,Linear,Free,Free,,L,dbAMP3,16
3286,dbAMP_03286,,Bacillus cereus (MIC=>100µg/ml)&&Escherichia coli (MIC=>100µg/ml)&&Leuconostoc lactis (MIC=12µg/ml)&&Listeria innocua (MIC=100µg/ml)&&Micrococcus luteus (MIC=100µg/ml)&&Pasteurella multocida (MIC=>100µg/ml)&&Staphylococcus aureus (MIC=50µg/ml)&&Staphylococcus epidermidis (MIC=100µg/ml)&&Streptococcus uberis (MIC=100µg/ml)&&Human leukemia (LC50=100µM)&&Human lung cancer (LC50=100µM)&&Human colon cancer (LC50=10µM)&&Human CNS cancer (LC50=10-100µM)&&Human melanoma (LC50=10-100µM)&&Human ovarian carcinoma (LC50=10-100µM)&&Human renal cancer (LC50=10-100µM)&&Human prostate cancer (LC50=10µM)&&Human breast cancer (LC50=10µM),GLFDIVKKIAGHIAGSI,,Linear,Free,Free,,L,dbAMP3,17
3287,dbAMP_03287,,Bacillus cereus (MIC=>100µg/ml)&&Escherichia coli (MIC=>100µg/ml)&&Leuconostoc lactis (MIC=6µg/ml)&&Listeria innocua (MIC=100µg/ml)&&Micrococcus luteus (MIC=100µg/ml)&&Pasteurella multocida (MIC=>100µg/ml)&&Staphylococcus aureus (MIC=50µg/ml)&&Staphylococcus epidermidis (MIC=50µg/ml)&&Streptococcus uberis (MIC=50µg/ml)&&Human leukemia (LC50=5µM)&&Human lung cancer (LC50=5µM)&&Human colon cancer (LC50=4-5µM)&&Human CNS cancer (LC50=5µM)&&Human melanoma (LC50=5µM)&&Human ovarian carcinoma (LC50=5µM)&&Human renal cancer (LC50=5µM)&&Human prostate cancer (LC50=5µM)&&Human breast cancer (LC50=5µM),GLFDIVKKIAGHIASSI,,Linear,Free,Free,,L,dbAMP3,17
3288,dbAMP_03288,,Bacillus cereus (MIC=>100µg/ml)&&Escherichia coli (MIC=>100µg/ml)&&Leuconostoc lactis (MIC=12µg/ml)&&Listeria innocua (MIC=>100µg/ml)&&Micrococcus luteus (MIC=100µg/ml)&&Pasteurella multocida (MIC=100µg/ml)&&Staphylococcus aureus (MIC=100µg/ml)&&Staphylococcus epidermidis (MIC=50µg/ml)&&Streptococcus uberis (MIC=25µg/ml)&&Human leukemia (LC50=10-100µM)&&Human lung cancer (LC50=10µM)&&Human colon cancer (LC50=10µM)&&Human CNS cancer (LC50=10µM)&&Human melanoma (LC50=10µM)&&Human ovarian carcinoma (LC50=10µM)&&Human renal cancer (LC50=10µM)&&Human prostate cancer (LC50=10µM)&&Human breast cancer (LC50=10µM),GLFDIVKKIAGHIVSSI,,Linear,Free,Free,,L,dbAMP3,17
3291,dbAMP_03291,,Bacillus cereus (MIC=50µg/ml)&&Escherichia coli (MIC=>100µg/ml)&&Leuconostoc lactis (MIC=12µg/ml)&&Listeria innocua (MIC=50µg/ml)&&Micrococcus luteus (MIC=100µg/ml)&&Pasteurella multocida (MIC=>100µg/ml)&&Staphylococcus aureus (MIC=50µg/ml)&&Staphylococcus epidermidis (MIC=100µg/ml)&&Streptococcus uberis (MIC=>100µg/ml)&&Human leukemia (LC50=10-100µM)&&Human lung cancer (LC50=10µM)&&Human colon cancer (LC50=10-100µM)&&Human CNS cancer (LC50=10µM)&&Human melanoma (LC50=10-100µM)&&Human ovarian carcinoma (LC50=10µM)&&Human renal cancer (LC50=10µM)&&Human prostate cancer (LC50=10µM)&&Human breast cancer (LC50=10µM)&&Bacillus cereus C737 (MIC=128µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=>128µg/ml)&&Escherichia coli UB1005 (MIC=64µg/ml)&&Klebsiella pneumoniae NCTC 13368 (MIC=64µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=8µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=128µg/ml)&&Pseudomonas aeruginosa NCTC 13437 (MIC=128µg/ml)&&Escherichia coli NCTC 12923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=8µg/ml)&&Staphylococcus aureus 15 (MIC=32µg/ml)&&Enterococcus faecalis NCTC 775 (MIC=32-64µg/ml)&&Enterococcus faecalis NCTC 12201 (MIC=64µg/ml)&&Candida albicans NCPF 3179 (MIC=16µg/ml),GLFDIVKKVVGAFGSL,,Linear,Free,Free,,L,dbAMP3,16
3307,dbAMP_03307,,Escherichia coli ATCC 25922 (MIC=30µM)&&Staphylococcus aureus ATCC 25923 (MIC=30µM)&&Human lung carcinoma A549 (IC50=24.01µM)&&Human breast adenocarcinoma MCF-7 (IC50=37.84µM)&&Human cervical carcinoma HeLa (IC50=23.26µM)&&Human colon adenocarcinoma LoVo (IC50=35.05µM),GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC,,Linear,Free,Free,,L,dbAMP3,33
3308,dbAMP_03308,,Micrococcus luteus ATCC 4698 (MIC=6.25µg/ml)&&Staphylococcus aureus KCTC 3881 (MIC=30µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=50µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=60µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=60µg/ml)&&Escherichia coli KCTC 2433 (MIC=15µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=15µg/ml)&&Proteus mirabilis ATCC 25933 (MIC=>100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>100µg/ml)&&Candida albicans ATCC 36232 (MIC=100µg/ml)&&Escherichia coli AS1.349 (MIC=>100µM)&&Pseudomonas aeruginosa (MIC=>100µM)&&Staphylococcus aureus AS1.72 (MIC=37.5µM)&&Bacillus cereus (MIC=37.5µM)&&Lactococcus lactis (MIC=37.5µM)&&Candida albicans (MIC=50µM)&&Human breast adenocarcinoma MCF-7 (IC50=49.3±7.2µM)&&Human cervical carcinoma HeLa (IC50=50.2±4.6µM),GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,,Linear,Free,Free,,L,dbAMP3,33
3336,dbAMP_03336,,Staphylococcus aureus (MIC=60µM)&&Human lung carcinoma A549 (IC50=>128µM)&&Human breast adenocarcinoma MCF-7 (IC50=>128µM)&&Human cervical carcinoma HeLa (IC50=>128µM)&&Human colon adenocarcinoma LoVo (IC50=128µM),GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,,Linear,Free,Free,,L,dbAMP3,31
3455,dbAMP_03455,,Staphylococcus aureus ATCC 25923 (MIC=64µM)&&Escherichia coli MG1655 (MIC=16-32µM)&&Pseudomonas aeruginosa PAO1 (MIC=128µM)&&Candida albicans (MIC=16-32µM)&&Human cervical carcinoma HeLa (9% Killing=32µM),GLHKVMREVLGYERNSYKKFFLR,,Linear,Free,Free,,L,dbAMP3,23
3533,dbAMP_03533,,Escherichia coli ATCC 25922 (MIC=25µM)&&Klebsiella pneumoniae KK3 9904 (MIC=100µM)&&Enterobacter cloacae HNTCC 53001 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=100µM)&&Proteus mirabilis ATCC 25933 (MIC=>200µM)&&Staphylococcus aureus NCTC 8325 (MIC=200µM)&&Staphylococcus epidermidis RP62A (MIC=100µM)&&Enterococcus faecalis ATCC 29212 (MIC=200µM)&&Streptococcus group B HNTCC 80130 (MIC=50µM)&&Candida albicans ATCC 90028 (MIC=>200µM)&&Mouse skin melanoma B16-F10 (IC50=25.7µM),GLLDTLKGAAKNVVGSLASKVMEKL,,Linear,Free,Free,,L,dbAMP3,25
3579,dbAMP_03579,,Human histiocytic lymphoma U-937/GTB (IC50=1.6±0.2µM),GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
3590,dbAMP_03590,,Escherichia coli ML-35 (MIC=4µM)&&Escherichia coli (MIC=4µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=4µM)&&Proteus mirabilis (MIC=>32µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus (MIC=2µM)&&Bacillus megaterium Bm11 (MIC=1µM)&&Human osteosarcoma Rous II (<=50% Cell death=20µM),GLLRRLRDFLKKIGEKFKKIGY,,Linear,Free,Free,,L,dbAMP3,22
3655,dbAMP_03655,,Staphylococcus aureus 22401 (MIC=3.125µM)&&Bacillus subtilis A47 (MIC=6.250µM)&&Pseudomonas aeruginosa A62 (MIC=6.250µM)&&Escherichia coli 44102 (MIC=3.125µM)&&Human cervical carcinoma HeLa (LC50=21µM)&&Human promyelocytic leukemia HL-60 (LC50=13µM)&&Human colon adenocarcinoma Caco-2 (LC50=40µM)&&Escherichia coli I1 (MIC=11.60µg/ml)&&Staphylococcus aureus B2 (MIC=23.20µg/ml),GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC,,Linear,Free,Free,,L,dbAMP3,37
3702,dbAMP_03702,,Escherichia coli ATCC 25922 (MBC50=10µM)&&Escherichia coli ATCC 25922 (MBC99=20µM)&&Escherichia coli ATCC 25922 (MIC=40µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=0.313µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=0.625µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=0.625µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=40µM)&&Staphylococcus aureus ATCC 29213 (MBC99=160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=40µM)&&Candida albicans ATCC 90028 (MFC99=80µM)&&Candida albicans ATCC 90028 (MIC=160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=3.0µM),GLPCGESCVFIPCITTVVGCSCKNKVCYNN,,Linear,Free,Free,,L,dbAMP3,30
3707,dbAMP_03707,,Human glioblastoma U251-MG (IC50=46.62µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPICGETCVGGSCNTPGCSCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
3708,dbAMP_03708,,Human glioblastoma U251-MG (IC50=38.84µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml)&&Human histiocytic lymphoma U-937/GTB (IC50=4µM)&&Human Myeloma cells RPMI-8226 (IC50=4µM)&&Haemonchus contortus (IC50=0.90µM)&&Trichostrongylus colubriformis (IC50=3.75µM)&&HIV (EC50=0.35µM),GLPICGETCVGGTCNTPGCSCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
3710,dbAMP_03710,,Human cervical carcinoma HeLa (45% Killing=10µM),GLPLCGETCVGGTCNTPGCSCGWPVCVRN,,Linear,Free,Free,,L,dbAMP3,29
3719,dbAMP_03719,2LAM,Staphylococcus aureus ATCC 12600 (MIC=>100µM)&&Enterococcus faecalis ATCC 47077 (MIC=>100µM)&&Escherichia coli ATCC 700926 (MIC=>100µM)&&Pseudomonas aeruginosa ATCC 39018 (MIC=>100µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>100µM)&&Human cervical carcinoma HeLa (IC50=2.0µM),GLPTCGETCTLGTCYVPDCSCSWPICMKN,,Linear,Free,Free,,L,dbAMP3,29
3723,dbAMP_03723,,Human histiocytic lymphoma U-937/GTB (IC50=7.6µM)&&Salmonella enterica subsp. enterica serovar Typhimurium LT2 (MIC=90µM)&&Escherichia coli MG1655 (MIC=32.5µM)&&Staphylococcus aureus FDA 486 (MIC=>90µM),GLPVCGETCAGGTCNTPGCSCSWPICTRN,,Linear,Free,Free,,L,dbAMP3,29
3724,dbAMP_03724,,Human histiocytic lymphoma U-937/GTB (IC50=>30µM),GLPVCGETCFGGRCNTPGCTCSYPICTRN,,Linear,Free,Free,,L,dbAMP3,29
3725,dbAMP_03725,,Escherichia coli ATCC 25922 (MBC50=40µM)&&Escherichia coli ATCC 25922 (MBC99=80µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Staphylococcus aureus ATCC 29213 (MBC50=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=3.8µM),GLPVCGETCFGGTCNTPGCACDPWPVCTRD,,Linear,Free,Free,,L,dbAMP3,30
3728,dbAMP_03728,,Human glioblastoma U251-MG (IC50=44.70µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPVCGETCFGGTCNTPGCSCETWPVCSRN,,Linear,Free,Free,,L,dbAMP3,30
3732,dbAMP_03732,2KCH&&1PT4,Escherichia coli ATCC 25922 (MBC50=160µM)&&Escherichia coli ATCC 25922 (MBC99=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=80µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=2.6µM)&&Haemonchus contortus (IC50=1.59µM)&&Trichostrongylus colubriformis (IC50=5.69µM)&&Human skin melanoma MM96L (50% Cell death=10.3±0.4µM)&&Human cervical carcinoma HeLa (50% Cell death=7.8±0.7µM)&&Human myelogenous leukemia K562 (50% Cell death=5.2±0.3µM),GLPVCGETCFGGTCNTPGCSCTWPICTRD,,Linear,Free,Free,,L,dbAMP3,29
3733,dbAMP_03733,,Human histiocytic lymphoma U-937/GTB (IC50=2.6µM)&&Salmonella enterica subsp. enterica serovar Typhimurium LT2 (MIC=>90µM)&&Escherichia coli MG1655 (MIC=50µM)&&Staphylococcus aureus FDA 486 (MIC=>90µM),GLPVCGETCFGGTCNTPGCTCDPWPVCTRN,,Linear,Free,Free,,L,dbAMP3,30
3737,dbAMP_03737,2M9O&&2JWM,Escherichia coli ATCC 25922 (MBC50=20µM)&&Escherichia coli ATCC 25922 (MBC99=40µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=0.313µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=0.625µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=80µM)&&Staphylococcus aureus ATCC 29213 (MBC99=160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=40µM)&&Candida albicans ATCC 90028 (MFC99=160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=29µM)&&Haemonchus contortus (IC50=6.29µM)&&Trichostrongylus colubriformis (IC50=5.64µM),GLPVCGETCTLGTCYTQGCTCSWPICKRN,,Linear,Free,Free,,L,dbAMP3,29
3738,dbAMP_03738,,Human skin melanoma MM96L (IC50=3.10±0.06µM)&&Human cervical carcinoma HeLa (IC50=10.21±0.43µM)&&Human gastric cancer BGC-823 (IC50=1.32±0.15µM),GLPVCGETCVGGTCNTPGCACSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
3739,dbAMP_03739,,Human skin melanoma MM96L (IC50=3.10±0.06µM)&&Human cervical carcinoma HeLa (IC50=10.21±0.43µM)&&Human gastric cancer BGC-823 (IC50=1.32±0.15µM),GLPVCGETCVGGTCNTPGCGCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
3741,dbAMP_03741,,Human Myeloma cells RPMI-8226 (IC50=3.24µM)&&Human Myeloma cells RPMI-8226/Dox40 (IC50=2.73µM)&&Human Myeloma cells RPMI-8226/LR-5 (IC50=3.19µM)&&Human histiocytic lymphoma U-937/GTB (IC50=6.35µM)&&Human histiocytic lymphoma U-937-Vcr (IC50=4.84µM)&&Human renal adenocarcinoma ACHN (IC50=4.19µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=3.56µM)&&Human lymphoblastic leukemia CCRF-CEM/VM-1 (IC50=4.97µM)&&Human lung carcinoma NCI-H69 (IC50=4.88µM)&&Human lung carcinoma NCI-H69AR (IC50=4.89µM)&&Chronic lymphocytic leukemia (IC50=1.34µM)&&Human ovarian carcinoma (IC50=11.03µM)&&Human glioblastoma U251-MG (IC50=37.18µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml)&&Human skin melanoma MM96L (IC50=3.10±0.06µM)&&Human cervical carcinoma HeLa (IC50=10.21±0.43µM)&&Human gastric cancer BGC-823 (IC50=1.32±0.15µM)&&Escherichia coli ATCC 25922 (MBC50=80µM)&&Escherichia coli ATCC 25922 (MBC=160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=80µM)&&Staphylococcus aureus ATCC 29213 (MBC50=80µM)&&Staphylococcus aureus ATCC 29213 (MBC=80µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=80µM)&&Candida albicans ATCC 90028 (MFC=80µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Haemonchus contortus (IC50=1.13µM)&&Trichostrongylus colubriformis (IC50=1.89µM)&&Human myelogenous leukemia K562 (50% Cell death=9.5±0.2µM),GLPVCGETCVGGTCNTPGCSCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
3776,dbAMP_03776,,Staphylococcus aureus ATCC 25923 (MIC=125µM)&&Staphylococcus aureus 127/08 (MIC=125µM)&&Staphylococcus aureus 145/08 (MIC=250µM)&&Staphylococcus aureus 274/08 (MIC=250µM)&&Staphylococcus aureus S908 (MIC=125µM)&&Staphylococcus aureus T4/6 (MIC=250µM)&&Staphylococcus aureus V4180 (MIC=250µM)&&Staphylococcus epidermidis RP62A (MIC=125µM)&&Staphylococcus epidermidis RP62A/1 (MIC=125µM)&&Staphylococcus epidermidis T6/19 (MIC=125µM)&&Staphylococcus epidermidis T37/8 (MIC=250µM)&&Escherichia coli ATCC 25726 (MIC=250µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>250µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>250µM)&&Enterococcus faecalis ATCC 29212 (MIC=250µM)&&Candida albicans ATCC 90028 (MIC=>250µM)&&Acinetobacter baumannii NM8 (MIC=250µM)&&Acinetobacter baumannii NM35 (MIC=250µM)&&Acinetobacter baumannii NM75 (MIC=250µM)&&Acinetobacter baumannii NM109 (MIC=250µM)&&Acinetobacter baumannii NM124 (MIC=250µM)&&Stenotrophomonas maltophilia B32/1 (MIC=>250µM)&&Stenotrophomonas maltophilia B32/4 (MIC=250µM)&&Stenotrophomonas maltophilia U8908 (MIC=250µM)&&Stenotrophomonas maltophilia B5/5 (MIC=>250µM)&&Stenotrophomonas maltophilia B6/2 (MIC=250µM)&&Human lung carcinoma A549 (LC50=>100µM),GLVGTLLGHIGKAILG,,Linear,Free,Free,,L,dbAMP3,16
3777,dbAMP_03777,,Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus 127/08 (MIC=8µM)&&Staphylococcus aureus 145/08 (MIC=16µM)&&Staphylococcus aureus 274/08 (MIC=16µM)&&Staphylococcus aureus S908 (MIC=16µM)&&Staphylococcus aureus T4/6 (MIC=16µM)&&Staphylococcus aureus V4180 (MIC=16µM)&&Staphylococcus epidermidis RP62A (MIC=16µM)&&Staphylococcus epidermidis RP62A/1 (MIC=8µM)&&Staphylococcus epidermidis T6/19 (MIC=8µM)&&Staphylococcus epidermidis T37/8 (MIC=16µM)&&Escherichia coli ATCC 25726 (MIC=125µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=250µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=250µM)&&Enterococcus faecalis ATCC 29212 (MIC=62.5µM)&&Candida albicans ATCC 90028 (MIC=62.5µM)&&Acinetobacter baumannii NM8 (MIC=125µM)&&Acinetobacter baumannii NM35 (MIC=125µM)&&Acinetobacter baumannii NM75 (MIC=62.5µM)&&Acinetobacter baumannii NM109 (MIC=125µM)&&Acinetobacter baumannii NM124 (MIC=125µM)&&Stenotrophomonas maltophilia B32/1 (MIC=62.5µM)&&Stenotrophomonas maltophilia B32/4 (MIC=62.5µM)&&Stenotrophomonas maltophilia U8908 (MIC=62.5µM)&&Stenotrophomonas maltophilia B5/5 (MIC=62.5µM)&&Stenotrophomonas maltophilia B6/2 (MIC=31.3µM)&&Human lung carcinoma A549 (LC50=65±5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Pseudomonas syringae pv. syringae EPS 94 (MIC=>50µM)&&Xanthomonas campestris pv. Vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Pseudomonas syringae pv. actinidiae Psa3700.1.1 (MIC=>50µM)&&Xanthomonas fragariae Xf349-9A (MIC=25-50µM)&&Xanthomonas arboricola pv. pruni CFBP 5563 (MIC=6.2-12.5µM),GLVGTLLGHIGKAILS,,Linear,Free,Free,,L,dbAMP3,16
3796,dbAMP_03796,,Staphylococcus aureus 22401 (MIC=50.0µM)&&Bacillus subtilis A47 (MIC=12.5µM)&&Pseudomonas aeruginosa A62 (MIC=3.125µM)&&Escherichia coli 44102 (MIC=12.5µM)&&Human cervical carcinoma HeLa (LC50=22µM)&&Human promyelocytic leukemia HL-60 (LC50=62µM)&&Human colon adenocarcinoma Caco-2 (LC50=65µM),GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP,,Linear,Free,Free,,L,dbAMP3,31
3820,dbAMP_03820,,Escherichia coli ATCC 8739 (MIC=6.3µM)&&Staphylococcus aureus ATCC 6538 (MIC=1.6µM)&&Staphylococcus aureus ATCC 43300 (MIC=12.5µM)&&Candida albicans ATCC 90028 (MIC=100µM)&&Staphylococcus aureus ATCC 6538 (MIC=4µM)&&Staphylococcus aureus ATCC 6538 (MBC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=16µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Staphylococcus aureus ATCC 12493 (MIC=8µM)&&Staphylococcus aureus ATCC 12493 (MBC=8µM)&&Escherichia coli ATCC 8739 (MIC=2µM)&&Escherichia coli ATCC 8739 (MBC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=16µM)&&Candida albicans ATCC 10231 (MIC=128µM)&&Candida albicans ATCC 10231 (MFC=256µM)&&Staphylococcus aureus (MIC=4µM)&&Staphylococcus aureus (MBC=4µM)&&Staphylococcus aureus B038 V1S1A (MIC=2µM)&&Staphylococcus aureus B038 V1S1A (MBC=2µM)&&Escherichia coli ATCC BAA-2340 (MIC=2µM)&&Escherichia coli ATCC BAA-2340 (MBC=4µM)&&Klebsiella pneumoniae ATCC BAA-1705 (MIC=4µM)&&Klebsiella pneumoniae ATCC BAA-1705 (MBC=4µM)&&Human glioblastoma U251-MG (IC50=6.6µM)&&Human colon adenocarcinoma HCT 116 (IC50=17.86µM)&&Human squamous lung carcinoma NCI-H157 (IC50=1.74µM)&&Human lung adenocarcinoma NCI-H838 (IC50=5.38µM),GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,,Linear,Free,Free,,L,dbAMP3,29
3842,dbAMP_03842,,Escherichia coli ATCC 25726 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=>128µM)&&Batrachochytrium dendrobatidis (MIC=>100µM)&&Human hepatocellular carcinoma HepG2 (LC50=45µM),GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,,Linear,Free,Free,,L,dbAMP3,32
3851,dbAMP_03851,,Microsporum canis IP1194 (MIC=10µg/ml)&&Trichophyton rubrum IP1400-82 (MIC=15µg/ml)&&Trichophyton simii IP1063-74 (MIC=30µg/ml)&&Aspergillus fumigatus IP1025-70 (MIC=125µg/ml)&&Aeromonas caviae IP67-16T (MIC=60µg/ml)&&Escherichia coli IP76-24 (MIC=15µg/ml)&&Nocardia brasiliensis IP16-80 (MIC=30µg/ml)&&Cryptococcus neoformans IP960-67 (MIC=15µg/ml)&&Cryptococcus neoformans IP962-67 (MIC=15µg/ml)&&Candida albicans IP884-65 (MIC=15µg/ml)&&Escherichia coli B (MIC=1.5µM)&&Salmonella typhimurium (MIC=3.1µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=3.1µM)&&Enterobacter cloacae (MIC=3.1µM)&&Klebsiella pneumoniae (MIC=1.5µM)&&Bacillus megaterium (MIC=0.4µM)&&Staphylococcus aureus (MIC=12.5µM)&&Staphylococcus haemolyticus (MIC=6.2µM)&&Saccharomyces cerevisiae (MIC=5.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=1.24±0.23µM)&&Human prostate adenocarcinoma LNCaP (IC50=0.31±0.15µM)&&Human prostate cancer DU145 (IC50=0.91±0.04µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=8.06±0.50µM)&&Human B-lymphoma RAJI (IC50=2.57±0.75µM)&&Mesomycoplasma hyorhinis PG29 (MIC=50µM)&&Mesomycoplasma hyorhinis PG29 (MBC=>100µg/ml)&&Mycoplasmopsis fermentans PG18 (MIC=50µg/ml)&&Mycoplasmopsis fermentans PG18 (MBC=>100µg/ml)&&Spiroplasma apis (MIC=0.3µM)&&Spiroplasma citri (MIC=0.4µM)&&Spiroplasma floricola (MIC=12.5µM)&&Spiroplasma melliferum (MIC=1.5µM)&&Acholeplasma laidlawii (MIC=3.1µM)&&Mycoplasma gallisepticum (-=NAµM)&&Escherichia coli K-12 (MIC=1.5µM)&&Pseudomonas aeruginosa (MIC=12.5µM)&&Salmonella typhimurium (MIC=3.1µM)&&Sinorhizobium meliloti (MIC=0.3µM)&&Pasteurella multocida (MIC=12.5µM)&&Enterococcus faecalis (MIC=50µM)&&Corynebacterium glutamicum (MIC=1.5µM)&&Candida albicans (MIC=5µM)&&Cryptococcus neoformans (MIC=1.5µM)&&Microsporum canis (MIC=1.5µM)&&Trichophyton mentagrophytes (MIC=15µM)&&Trichophyton simii (MIC=5µM)&&Aspergillus fumigatus (MIC=3.1µM)&&Leishmania mexicana (MIC=3.1µM)&&Leishmania major (MIC=1.5µM)&&Acinetobacter baumannii (MIC=12.5µg/ml)&&Acinetobacter baumannii (MBC=25µg/ml)&&Human epidermoid cancer Hep2 (50% Cytotoxicity=30.4µg/ml),GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,,Linear,Free,Free,,L,dbAMP3,33
3891,dbAMP_03891,,Bacillus subtilis 168 (MIC=0.8µM)&&Staphylococcus aureus (MIC=7.7µM)&&Escherichia coli B (MIC=3.8µM)&&Pseudomonas aeruginosa (MIC=45.0µM)&&Human cervical carcinoma HeLa S3 (IC50=11±2µM)&&Human colon adenocarcinoma SW480 (IC50=44±8µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=49±9µM)&&Candida albicans F7-39/IDE99 (MIC=6.2±2.2µM),GMWSKILGHLIR,,Linear,Free,Free,,L,dbAMP3,12
4011,dbAMP_04011,,Human promyelocytic leukemia HL-60 (50% Cell death=8µg/ml),GRRKRKWLRRIGKGVKIIGGAALDHL,,Linear,Free,Free,,L,dbAMP3,26
4067,dbAMP_04067,,"Cancer cell lines: BGC-823 (IC50=2.91±0.06 µM), MM96L (IC50=1.03±0.03 µM), HeLa (IC50=6.35±0.31 µM).&&Non-Cancer cell line: HFF-1 (IC50=1.76±0.12 µM).",GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
4068,dbAMP_04068,,Human skin melanoma MM96L (IC50=1.03±0.03µM)&&Human cervical carcinoma HeLa (IC50=6.35±0.31µM)&&Human gastric cancer BGC-823 (IC50=2.91±0.06µM),GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
4069,dbAMP_04069,,Human skin melanoma MM96L (IC50=2.51±0.03µM)&&Human cervical carcinoma HeLa (IC50=5.24±0.40µM),GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
4070,dbAMP_04070,,Human skin melanoma MM96L (IC50=4.91±0.04µM)&&Human cervical carcinoma HeLa (IC50=15.5±0.06µM)&&Human gastric cancer BGC-823 (IC50=1.75±0.05µM),GSIPCGESCVFIPCISSVIGCACKSKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
4118,dbAMP_04118,,Human histiocytic lymphoma U-937/GTB (IC50=0.96±0.1µM),GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
4121,dbAMP_04121,,Human cervical carcinoma HeLa S3 (IC50=>100µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=32µM),GTGLPMSERRKIMLMMR,,Linear,Free,Free,,L,dbAMP3,17
4167,dbAMP_04167,,Escherichia coli ATCC 25922 (MBC50=2.5µM)&&Escherichia coli ATCC 25922 (MBC99=5µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Escherichia coli ATCC 25922 (MIC=160µM)&&Escherichia coli ATCC 25922 (MIC=160µM)&&Escherichia coli ATCC 25922 (MIC=80µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=5µM)&&Staphylococcus aureus ATCC 29213 (MBC99=5µM)&&Staphylococcus aureus ATCC 29213 (MIC=10µM)&&Candida albicans ATCC 90028 (MFC50=5µM)&&Candida albicans ATCC 90028 (MFC99=10µM)&&Candida albicans ATCC 90028 (MIC=20µM)&&Human histiocytic lymphoma U-937/GTB (IC50=0.52µM),GTLPCGESCVWIPCISSVVGCSCKSKVCYKD,,Linear,Free,Free,,L,dbAMP3,31
4242,dbAMP_04242,,Human histiocytic lymphoma U-937/GTB (IC50=0.76µM),GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,,Linear,Free,Free,,L,dbAMP3,31
4262,dbAMP_04262,,Escherichia coli (MIC=8.21µg/ml)&&Staphylococcus aureus (MIC=4.11µg/ml)&&Bacillus subtilis (MIC=16.42µg/ml)&&Candida albicans (MIC=2.05µg/ml)&&Human lung carcinoma A549 (IC50=27.31µM)&&Human breast adenocarcinoma MCF-7 (IC50=41.21µM)&&Human cervical carcinoma HeLa (IC50=52.83µM)&&Human colon adenocarcinoma LoVo (IC50= 55.22µM),GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC,,Linear,Free,Free,,L,dbAMP3,33
4284,dbAMP_04284,,Human lung carcinoma A549 (IC50=0.70µM)&&Human lung carcinoma A549/paclitaxel (IC50=2.53µM)&&Escherichia coli ATCC 25922 (MBC50=80µM)&&Escherichia coli ATCC 25922 (MBC99=160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=1.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Staphylococcus aureus ATCC 29213 (MBC50=160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=3.5µM),GVPCAESCVWIPCTVTALLGCSCKDKVCYLN,,Linear,Free,Free,,L,dbAMP3,31
4287,dbAMP_04287,2K7G,Human Myeloma cells RPMI-8226 (IC50=5.90µM)&&Human Myeloma cells RPMI-8226/Dox40 (IC50=3.14µM)&&Human Myeloma cells RPMI-8226/LR-5 (IC50=6.31µM)&&Human histiocytic lymphoma U-937/GTB (IC50=7.07µM)&&Human histiocytic lymphoma U-937-Vcr (IC50=7.45µM)&&Human renal adenocarcinoma ACHN (IC50=2.63µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=7.13µM)&&Human lymphoblastic leukemia CCRF-CEM/VM-1 (IC50=7.15µM)&&Human lung carcinoma NCI-H69 (IC50=7.49µM)&&Human lung carcinoma NCI-H69AR (IC50=7.12µM)&&Human glioblastoma U251-MG (IC50=44.49µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GVPICGETCTLGTCYTAGCSCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
4327,dbAMP_04327,,Feline leukemia virus,GWFEGWFNRSPWFTT,,Linear,Free,Free,,L,dbAMP3,15
4334,dbAMP_04334,,Staphylococcus aureus ATCC 12600 (MBC=6.3-12.5µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=50µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=12.5-25µg/ml)&&Staphylococcus aureus ATCC 33591 (MBC=6.3µg/ml)&&Staphylococcus aureus ATCC 33591 (MBC=25µg/ml)&&Streptococcus pyogenes ATCC 12344 (MBC=3.1µg/ml)&&Streptococcus pyogenes ATCC 12344 (MBC=50µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MBC=3.1µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MBC=12.5µg/ml)&&Cutibacterium acnes ATCC 6919 (MBC=6.3µg/ml)&&Cutibacterium acnes ATCC 6919 (MBC=12.5µg/ml)&&Escherichia coli ATCC 11775 (MBC=6.3µg/ml)&&Escherichia coli ATCC 11775 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=6.3-12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=100µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MBC=3.1µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MBC=12.5µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=3.1µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=6.3µg/ml)&&Candida albicans ATCC 64549 (MFC=6.3µg/ml)&&Candida albicans ATCC 64549 (MFC=>200µg/ml)&&Human acute monocytic leukemia THP-1 (10% Killing=125µg/ml),GWFKKTFHKVSHAVKSGIHAGQRGCSALGF,,Linear,Free,Free,,L,dbAMP3,30
4343,dbAMP_04343,,Aeromonas salmonicida 99-1 (MIC=4µg/ml)&&Aeromonas salmonicida 97-4 (MIC=4µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=16µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=4µg/ml)&&Escherichia coli CGSC 4908 (MIC=4µg/ml)&&Escherichia coli UB1005 (MIC=4µg/ml)&&Escherichia coli DC2 (MIC=2µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=32µg/ml)&&Candida albicans C627 (MIC=32µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=128µg/ml),GWGSIFKHGRHAAKHIGHAAVNHYL,,Linear,Free,Free,,L,dbAMP3,25
4356,dbAMP_04356,,Aeromonas salmonicida 99-1 (MIC=2µg/ml)&&Aeromonas salmonicida 97-4 (MIC=2µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=2µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=8µg/ml)&&Pseudomonas aeruginosa K799 (MIC=4µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=1µg/ml)&&Escherichia coli CGSC 4908 (MIC=2µg/ml)&&Escherichia coli UB1005 (MIC=8µg/ml)&&Escherichia coli DC2 (MIC=2µg/ml)&&Staphylococcus epidermidis C621 (MIC=8µg/ml)&&Staphylococcus aureus C623 (MIC=16µg/ml)&&Candida albicans C627 (MIC=4µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=64µg/ml),GWKKWFNRAKKVGKTVGGLAVDHYL,,Linear,Free,Free,,L,dbAMP3,25
4358,dbAMP_04358,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=128µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=32µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=64µg/ml)&&Escherichia coli CGSC 4908 (MIC=64µg/ml)&&Escherichia coli UB1005 (MIC=64µg/ml)&&Escherichia coli DC2 (MIC=64µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),GWKKWFTKGERLSQRHFA,,Linear,Free,Free,,L,dbAMP3,18
4359,dbAMP_04359,,Aeromonas salmonicida 99-1 (MIC=2µg/ml)&&Aeromonas salmonicida 97-4 (MIC=1µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=0.5µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=16µg/ml)&&Pseudomonas aeruginosa K799 (MIC=4µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=1µg/ml)&&Escherichia coli CGSC 4908 (MIC=1µg/ml)&&Escherichia coli UB1005 (MIC=2µg/ml)&&Escherichia coli DC2 (MIC=0.5µg/ml)&&Staphylococcus epidermidis C621 (MIC=16µg/ml)&&Staphylococcus aureus C623 (MIC=32µg/ml)&&Candida albicans C627 (MIC=8µg/ml)&&Escherichia coli KCTC 1682 (MIC=2µM)&&Salmonella typhimurium KCTC 1926 (MIC=1µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4µM)&&Staphylococcus aureus KCTC 1621 (MIC=4µM)&&Bacillus subtilis KCTC 1918 (MIC=2µM)&&Candida albicans KCTC 7270 (MIC=8µM)&&Trichosporon beigelii KCTC 7707 (MIC=4µM)&&Escherichia coli CCARM 1229 (MIC=8µM)&&Escherichia coli CCARM 1238 (MIC=4µM)&&Salmonella typhimurium CCARM 8007 (MIC=4µM)&&Salmonella typhimurium CCARM 8009 (MIC=16µM)&&Salmonella typhimurium CCARM 8013 (MIC=4µM)&&Staphylococcus aureus CCARM 3089 (MIC=2µM)&&Staphylococcus aureus CCARM 3090 (MIC=8µM)&&Staphylococcus aureus CCARM 3108 (MIC=2µM)&&Staphylococcus aureus CCARM 3114 (MIC=4µM)&&Staphylococcus aureus CCARM 3126 (MIC=4µM)&&Candida albicans CCARM 14001 (MIC=8µM)&&Pseudomonas aeruginosa (MIC=2-8µM)&&Staphylococcus aureus (MIC=1-8µM)&&Escherichia coli KCTC 1682 (MIC=4µM)&&Salmonella typhimurium KCTC 1926 (MIC=2µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=8µM)&&Staphylococcus aureus KCTC 1621 (MIC=8µM)&&Bacillus subtilis KCTC 1918 (MIC=8µM)&&Candida albicans KCTC 7270 (MIC=16µM)&&Trichosporon beigelii KCTC 7707 (MIC=8µM)&&Human promyelocytic leukemia HL-60 (50% Cell death=32µg/ml),GWKKWLRKGAKHLGQAAIK,,Linear,Free,Free,,L,dbAMP3,19
4360,dbAMP_04360,,Aeromonas salmonicida 99-1 (MIC=2µg/ml)&&Aeromonas salmonicida 97-4 (MIC=1µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=1µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=8µg/ml)&&Pseudomonas aeruginosa K799 (MIC=4µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=2µg/ml)&&Escherichia coli CGSC 4908 (MIC=1µg/ml)&&Escherichia coli UB1005 (MIC=4µg/ml)&&Escherichia coli DC2 (MIC=1µg/ml)&&Staphylococcus epidermidis C621 (MIC=32µg/ml)&&Staphylococcus aureus C623 (MIC=16µg/ml)&&Candida albicans C627 (MIC=8µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=16µg/ml),GWKKWLRKGAKHLGQAAIKGLAS,,Linear,Free,Free,,L,dbAMP3,23
4361,dbAMP_04361,,Aeromonas salmonicida 99-1 (MIC=8µg/ml)&&Aeromonas salmonicida 97-4 (MIC=8µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=32µg/ml)&&Pseudomonas aeruginosa K799 (MIC=32µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=4µg/ml)&&Escherichia coli CGSC 4908 (MIC=4µg/ml)&&Escherichia coli UB1005 (MIC=16µg/ml)&&Escherichia coli DC2 (MIC=4µg/ml)&&Staphylococcus epidermidis C621 (MIC=64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=32µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=16µg/ml),GWKSVFRKAKKVGKTVGGLALDHYL,,Linear,Free,Free,,L,dbAMP3,25
4404,dbAMP_04404,,Bacillus subtilis ATCC 23857 (MIC=1.56µM)&&Corynebacterium glutamicum ATCC 13032 (MIC=0.39µM)&&Staphylococcus aureus ATCC 9144 (MIC=3.13µM)&&Staphylococcus epidermidis 5179-R1 (MIC=6.25µM)&&Staphylococcus epidermidis ATCC 35984 (MIC=3.13µM)&&Escherichia coli ATCC 25922 (MIC=0.78µM)&&Escherichia coli MC4100 NR698 (MIC=1.56µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.56µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=3.13µM)&&Aureobasidium pullulans (MIC=12.5µM)&&Candida albicans ATCC 10231 (MIC=100µM)&&Cladosporium sp. (MIC=>100µM)&&Rhodotorula sp. (MIC=12.5µM)&&Saccharomyces cerevisiae (MIC=50µM)&&Human melanoma A2058 (IC50=56µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Pseudomonas aeruginosa CMCC 10104 (MIC=16µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=64µg/ml)&&Cryptococcus neoformans ATCC 28957 (MIC=128µg/ml),GWWRRTVDKVRNAGRKVAGFASKACGALGH,,Linear,Free,Free,,L,dbAMP3,30
4409,dbAMP_04409,1NKL,Escherichia coli D21 (LC=8µM)&&Escherichia coli Bd2221/75 (LC=39µM)&&Bacillus megaterium Bm11 (LC=0.8µM)&&Staphylococcus aureus Cowan 1 (LC=>190µM)&&Streptococcus pyogenes (LC=34µM)&&Candida albicans (LC=31µM)&&Mouse cancer cells YAC-1 (LC90=50µg/ml)&&Escherichia coli D21 (LC=0.5µM)&&Escherichia coli Bd2221/75 (LC=10µM)&&Pseudomonas aeruginosa OT97 (LC=>190µM)&&Acinetobacter calcoaceticus Ac11 (LC=7µM)&&Bacillus megaterium Bm11 (LC=1.6µM),GYFCESCRKIIQKLEDMVGPQPNEDTVTQAASQVCDKLKILRGLCKKIMRSFLRRISWDILTGKKPQAICVDIKICKE,,Linear,Free,Free,,L,dbAMP3,78
4457,dbAMP_04457,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Candida albicans ATCC 900280 (MIC=16µM)&&Human hepatocellular carcinoma HepG2 (LC50=45µM)&&Escherichia coli ATCC 25922 (MIC=20µM)&&Staphylococcus aureus NCTC 8325 (MIC=5-8µM)&&Candida albicans ATCC 90028 (MIC=40µM)&&Klebsiella pneumoniae KK3 9904 (MIC=32µM)&&Enterobacter cloacae HNTCC 53001 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Salmonella enterica subsp. enterica serovar Typhimurium LT2 (MIC=32µM)&&Proteus mirabilis ATCC 25933 (MIC=>128µM)&&Staphylococcus epidermidis RP62A (MIC=4µM)&&Enterococcus faecalis ATCC 29212 (MIC=16µM)&&Streptococcus group B HNTCC 80130 (MIC=8µM)&&Staphylococcus aureus T7/5 (MIC=10µM)&&Candida albicans ATCC 90028 (MIC=25µM)&&Bacteroides fragilis ATCC 25285 (MIC=50µM)&&Bacteroides fragilis (MIC=>50µM)&&Prevotella melaninogenica (MIC=12.5µM)&&Fusobacterium varium ATCC 27725 (MIC=>50µM)&&Fusobacterium nucleatum (MIC=25µM)&&Clostridium tertium ATCC 19465 (MIC=3µM)&&Clostridium perfringens ATCC 10543 (MIC=6µM)&&Clostridium septicum (MIC=12.5µM)&&Cutibacterium acnes ATCC 11828 (MIC=6µM)&&Cutibacterium acnes (MIC=6µM)&&Peptoniphilus asaccharolyticus ATCC 29743 (MIC=25µM)&&Peptostreptococcus anaerobius (MIC=12.5µM),HFLGTLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
4547,dbAMP_04547,1M4E&&1M4F&&2KEF&&3H0T&&1M4E&&1M4E,Escherichia coli ML-35p (MBC=<30µM)&&Staphylococcus epidermidis (MBC=<30µM)&&Aspergillus niger (MFC=20µM)&&Aspergillus fumigatus (MFC=40µM)&&Human myelogenous leukemia K562 (12% Cytotoxicity=30µM)&&Candida glabrata BPY 40 (MFC=200µg/ml)&&Candida glabrata BPY 40 (MFC=>100µg/ml)&&Candida glabrata BPY 44 (MFC=100µg/ml)&&Candida glabrata BPY 44 (MFC=50µg/ml)&&Candida glabrata BPY 150 (MFC=100µg/ml)&&Candida glabrata BPY 150 (MFC=>100µg/ml)&&Candida glabrata BPY 597 (MFC=200µg/ml)&&Candida glabrata BPY 597 (MFC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=6.25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=3.125µg/ml)&&Acinetobacter baumannii (MBC=6.25µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MBC=6.25µg/ml)&&Escherichia coli ATCC 25922 (MBC=25µg/ml)&&Klebsiella pneumoniae (MBC=25µg/ml)&&Staphylococcus aureus ATCC 29213 (MBC=>100µg/ml)&&Staphylococcus epidermidis (MBC=12.5µg/ml)&&Enterococcus faecium (MBC=12.5µg/ml)&&Enterococcus faecium (MBC=6.25µg/ml)&&Enterococcus faecium (MBC=3.125µg/ml)&&Enterococcus faecium (MBC=6.25µg/ml),ICIFCCGCCHRSKCGMCCKT,,Linear,Free,Free,,L,dbAMP3,20
4560,dbAMP_04560,,Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 15422 (MIC=8µg/ml)&&Bacillus subtilis CCT 2576 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=15µg/ml)&&Candida glabrata ATCC 2001 (MIC=8µM)&&Candida glabrata ATCC 2001 (MFC=32µM)&&Candida albicans ATCC 14053 (MIC=8µM)&&Candida albicans ATCC 14053 (MFC=32µM)&&Human myelogenous leukemia K562 (IC50=26.34±1.67µM)&&Human myelogenous leukemia K562 (IC50=5.06±0.1µM)&&Human myelogenous leukemia K562/ADM (IC50=26.55±1.46µM)&&Human myelogenous leukemia K562/ADM (IC50=7.01±1.4µM)&&Human promyelocytic leukemia HL-60 (IC50=26.53±0.31µM)&&Human promyelocytic leukemia HL-60 (IC50=5.86±0.18µM)&&Mouse lymphocytic leukemia L1210 (IC50=15.91±0.05µM)&&Mouse lymphocytic leukemia L1210 (IC50=6.18±0.53µM)&&Escherichia coli ML-35 (MIC=32µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Cronobacter sakazakii ATCC 29544 (MIC=64µM)&&Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Bacillus subtilis ATCC 23857 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=32µM)&&Candida parapsilosis ATCC 22019 (MIC=64µM)&&Candida tropicalis ATCC 750 (MIC=8µM)&&Candida krusei ATCC 6258 (MIC=8µM)&&Escherichia coli ML-35 (MBC=256µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=256µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>256µM)&&Cronobacter sakazakii ATCC 29544 (MBC=64µM)&&Staphylococcus aureus ATCC 29213 (MBC=128µM)&&Bacillus subtilis ATCC 23857 (MBC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MBC=32µM)&&Candida parapsilosis ATCC 22019 (MFC=128µM)&&Candida tropicalis ATCC 750 (MFC=32µM)&&Candida krusei ATCC 6258 (MFC=16µM)&&Bacillus subtilis (MIC=12.5µg/ml)&&Staphylococcus aureus (MIC=18.8µg/ml)&&Staphylococcus epidermidis (MIC=>100µg/ml)&&Escherichia coli (MIC=75µg/ml)&&Shigella dysenteriae (MIC=75µg/ml)&&Salmonella typhimurium (MIC=>100µg/ml)&&Klebsiella pneumoniae (MIC=37.5µg/ml)&&Pseudomonas aeruginosa (MIC=>100µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=25.2±1.8µM)&&Human prostate adenocarcinoma PC-3 (IC50=23.7±2.9µM)&&Human endometrial adenocarcinoma EJ (IC50=25±1.9µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM),IDWKKLLDAAKQIL,,Linear,Free,Free,,L,dbAMP3,14
4575,dbAMP_04575,,Staphylococcus aureus AB94004 (MIC=48µM)&&Bacillus magaterium AB90008 (MIC=36µM)&&Micrococcus luteus AB2010179 (MIC=18µM)&&Enterococcus sp. S13 (MIC=36µM)&&Staphylococcus aureus 16472 (MIC=28µM)&&Escherichia coli DH5alpha (MIC=48µM)&&Pseudomonas putida (MIC=>87µM)&&Klebsiella oxytoca AB2010143 (MIC=>87µM)&&Enterobacter cloacae AB2010162 (MIC=>87µM)&&Salmonella enterica AB2010185 (MIC=68µM)&&Candida tropicalis AY91009 (MIC=16µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=12.5±1.0µM)&&Human prostate cancer DU145 (IC50=16.5±1.0µM),IFGAIWKGISSLL,,Linear,Free,Free,,L,dbAMP3,13
4600,dbAMP_04600,2FCG&&2FBS&&2FBU&&2FCG&&2K6O&&2LMF&&2FCG,Escherichia coli K-12 (MIC=80µM)&&Human epithelial carcinoma KBv (LC50=39±0µM)&&Human epithelial carcinoma KB (LC50=40±0µM)&&Staphylococcus aureus ATCC 25923 (MIC=512µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=512µg/ml)&&Staphylococcus aureus ATCC 700699 (MIC=1024µg/ml)&&Staphylococcus aureus (MIC=512µg/ml),IGKEFKRIVQRIKDFLRNLVPRTES,,Linear,Free,Free,,L,dbAMP3,25
4656,dbAMP_04656,,Escherichia coli ATCC 25726 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=20µM)&&Staphylococcus aureus ATCC 25923 (MIC=20µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=5.9±0.6µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=11.0±1.7µM)&&Human colon adenocarcinoma HT29 (LC50=14.8±2.0µM)&&Human hepatocellular carcinoma HepG2 (LC50=28.4±0.4µM),IKIPAFVKDTLKKVAKGVISAVAGALTQ,,Linear,Free,Free,,L,dbAMP3,28
4657,dbAMP_04657,,Escherichia coli ATCC 25726 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=40µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=40µM)&&Staphylococcus aureus ATCC 25923 (MIC=40µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=8.8±0.7µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=21.2±2.0µM)&&Human colon adenocarcinoma HT29 (LC50=33.0±2.2µM)&&Human hepatocellular carcinoma HepG2 (LC50=47.9±1.8µM),IKIPAVVKDTLKKVAKGVLSAVAGALTQ,,Linear,Free,Free,,L,dbAMP3,28
4659,dbAMP_04659,,Staphylococcus aureus ATCC 25923 (MIC=5-10µM)&&Escherichia coli ATCC 25726 (MIC=10µM)&&Staphylococcus aureus 127/08 (MIC=5µM)&&Staphylococcus aureus 145/08 (MIC=10µM)&&Staphylococcus epidermidis RP62A (MIC=2.5µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.25µM)&&Staphylococcus epidermidis T6/19 (MIC=2.5µM)&&Enterococcus faecalis ATCC 29212 (MIC=10µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Acinetobacter baumannii NM8 (MIC=10µM)&&Acinetobacter baumannii NM35 (MIC=5µM)&&Stenotrophomonas maltophilia B32/1 (MIC=5µM)&&Stenotrophomonas maltophilia B5/5 (MIC=10µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=2.5±0.2µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=6.6±0.3µM)&&Human colon adenocarcinoma HT29 (LC50=9.5±1.3µM),IKIPSFFRNILKKVGKEAVSLIAGALKQS,,Linear,Free,Free,,L,dbAMP3,29
4667,dbAMP_04667,,Escherichia coli ATCC 25726 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=40µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=20µM)&&Staphylococcus aureus ATCC 25923 (MIC=10µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=2.5±0.2µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=9.0±0.3µM)&&Human colon adenocarcinoma HT29 (LC50=9.7±0.2µM)&&Human hepatocellular carcinoma HepG2 (LC50=22.5±1.4µM)&&Acinetobacter baumannii (MIC=6.25µM)&&Stenotrophomonas maltophilia (MIC=6.25µM)&&Klebsiella pneumoniae (MIC=25µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=12.5µM)&&Staphylococcus epidermidis RP62A (MIC=3.1µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.6µM),IKLSPETKDNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
4689,dbAMP_04689,,Staphylococcus aureus ATCC 25923 (MIC=128µM)&&Staphylococcus epidermidis RP62A/1 (MIC=128µM)&&Staphylococcus epidermidis RP62A (MIC=128µM)&&Escherichia coli ATCC 25726 (MIC=>256µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>256µM)&&Acinetobacter baumannii NM8 (MIC=128µM)&&Stenotrophomonas maltophilia B32/4 (MIC=256µM)&&Candida albicans ATCC 90028 (MIC=64µM)&&Human lung carcinoma A549 (LC50=>100µM),ILGAILPLVSGLLSNKL,,Linear,Free,Free,,L,dbAMP3,17
4707,dbAMP_04707,,Bacillus subtilis ATCC 6633 (MIC50=>66.54µM)&&Staphylococcus aureus ATCC 6538 (MIC50=23.29µM)&&Staphylococcus aureus DMST 20651 (MIC50=>66.54µM)&&Staphylococcus epidermidis ATCC 12228 (MIC50=6.65µM)&&Acinetobacter baumannii ATCC 19606 (MIC50=>66.54µM)&&Escherichia coli ATCC 25922 (MIC50=>66.54µM)&&Salmonella enterica subsp. enterica serovar Typhi DMST 562 (MIC50=>66.54µM)&&Human colon adenocarcinoma SW620 (IC50=>66.54µM)&&Human squamous cell oral carcinoma HSC-4 (IC50=>66.54µM),ILGKIWKGIKSLF,,Linear,Free,Free,,L,dbAMP3,13
4711,dbAMP_04711,,Escherichia coli ATCC 25922 (MIC=150µM)&&Staphylococcus aureus ATCC 25923 (MIC=50µM)&&Escherichia coli ATCC 25726 (MIC=256µM)&&Human lung carcinoma A549 (LC50=80µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=65µM)&&Human colon adenocarcinoma HT29 (LC50=80µM)&&Human hepatocellular carcinoma HepG2 (LC50=85µM)&&Staphylococcus epidermidis RP62A (MIC=64µM)&&Staphylococcus epidermidis RP62A/1 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=256µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=256µM)&&Acinetobacter baumannii NM8 (MIC=64µM)&&Stenotrophomonas maltophilia B32/4 (MIC=128µM)&&Candida albicans ATCC 90028 (MIC=64µM),ILGKLLSTAAGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
4734,dbAMP_04734,6N68,Escherichia coli ATCC 25922 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 15442 (MIC=1.7µg/ml)&&Bacillus subtilis CCT 2576 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=12.5µg/ml)&&Escherichia coli ML-35 (MIC=64µM)&&Staphylococcus aureus ATCC 29213 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM)&&Escherichia coli (MIC=32µM)&&Staphylococcus aureus (MIC=8µM)&&Escherichia coli ATCC 25922 (MBC=64µM)&&Staphylococcus aureus ATCC 29213 (MBC=16µM)&&Bacillus subtilis ATCC 23857 (MBC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=256µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=128µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=128µM)&&Cronobacter sakazakii ATCC 29544 (MIC=64µM)&&Cronobacter sakazakii ATCC 29544 (MBC=128µM)&&Candida glabrata ATCC 2001 (MIC=16µM)&&Candida glabrata ATCC 2001 (MFC=32µM)&&Candida albicans ATCC 14053 (MIC=16µM)&&Candida albicans ATCC 14053 (MFC=32µM)&&Candida parapsilosis ATCC 22019 (MIC=128µM)&&Candida parapsilosis ATCC 22019 (MFC=256µM)&&Candida tropicalis ATCC 750 (MIC=8µM)&&Candida tropicalis ATCC 750 (MFC=8µM)&&Candida krusei ATCC 6258 (MIC=16µM)&&Candida krusei ATCC 6258 (MFC=32µM)&&Candida glabrata (MIC=32µM)&&Candida glabrata (MFC=32µM)&&Candida albicans (MIC=16-32µM)&&Candida albicans (MFC=32-64µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ML-35 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Cronobacter sakazakii ATCC 29544 (MIC=32µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Escherichia coli ATCC 25922 (MBC=64µM)&&Escherichia coli ML-35 (MBC=256µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=>256µM)&&Cronobacter sakazakii ATCC 29544 (MBC=64µM)&&Staphylococcus epidermidis ATCC 12228 (MBC=8µM)&&Staphylococcus aureus ATCC 25923 (MBC=64µM)&&Bacillus subtilis ATCC 23857 (MBC=8µM)&&Staphylococcus aureus ATCC 29213 (MBC=16µM)&&Bacillus megaterium ATCC 13632 (MIC=16µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=16µg/ml)&&Staphylococcus aureus VRSA1 (MIC=16µg/ml)&&Streptococcus pneumoniae ATCC 700677 (MIC=32µg/ml)&&Enterococcus faecium ATCC 35667 (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MIC=256µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=>256µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=256µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µg/ml)&&Candida albicans ATCC 90028 (MIC=128µg/ml)&&Candida tropicalis ATCC 750 (MIC=32µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=16-32µg/ml)&&Human skin melanoma MM96L (LC50=14.8±0.9µM)&&Human colon adenocarcinoma HCT 116 (LC50=8±0.5µM),ILGTILGLLKGL,,Linear,Free,Free,,L,dbAMP3,12
4754,dbAMP_04754,,Staphylococcus aureus 22401 (MIC=6.25µM)&&Bacillus subtilis A47 (MIC=25.0µM)&&Pseudomonas aeruginosa A62 (MIC=12.5µM)&&Escherichia coli 44102 (MIC=50.0µM)&&Human cervical carcinoma HeLa (LC50=58µM)&&Human promyelocytic leukemia HL-60 (LC50=52µM)&&Human colon adenocarcinoma Caco-2 (LC50=50µM),ILPIIGKILSTIFGK,,Linear,Free,Free,,L,dbAMP3,15
4759,dbAMP_04759,,Escherichia coli ATCC 11775 (MIC=>100µM)&&Staphylococcus aureus ATCC 12600 (MIC=>100µM)&&Staphylococcus aureus (MIC=41µM)&&Bacillus cereus (MIC=41µM)&&Lactococcus lactis (MIC=41µM)&&Escherichia coli (MIC=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=56µM)&&Human cervical carcinoma HeLa (IC50=112µM)&&Candida albicans CMCC 98001 (MIC=50µM)&&Streptococcus mutans CGMCC 1.2500 (MIC=50µM)&&Streptococcus salivarius CGMCC 1.2498 (MIC=75µM)&&Streptococcus sanguinis CGMCC 1.2497 (MIC=37.5µM)&&Lactobacillus acidophilus CGMCC 1.1854 (MIC=37.5µM)&&Fusobacterium nucleatum CGMCC 1.2526 (MIC=75µM)&&Candida albicans CMCC 98001 (MBC=>100µM)&&Streptococcus mutans CGMCC 1.2500 (MBC=>100µM)&&Streptococcus salivarius CGMCC 1.2498 (MBC=>100µM)&&Streptococcus sanguinis CGMCC 1.2497 (MBC=100µM)&&Lactobacillus acidophilus CGMCC 1.1854 (MBC=100µM)&&Fusobacterium nucleatum CGMCC 1.2526 (MBC=>100µM)&&Escherichia coli AS1.349 (MIC=125µM)&&Pseudomonas aeruginosa CGMCC 1.860 (MIC=125µM)&&Klebsiella aerogenes CGMCC 1.876 (MIC=250µM)&&Enterobacter cloacae CGMCC 1.58 (MIC=250µM)&&Klebsiella pneumoniae subsp. pneumoniae CGMCC 1.176 (MIC=175µM)&&Staphylococcus aureus AS1.72 (MIC=62.5µM)&&Bacillus cereus AS1.126 (MIC=62.5µM)&&Lactococcus lactis AS1.1690 (MIC=62.5µM)&&Enterococcus faecalis CGMCC 1.595 (MIC=125µM)&&Enterococcus faecium CGMCC 1.2334 (MIC=125µM),ILPILSLIGGLL,,Linear,Free,Free,,L,dbAMP3,12
4761,dbAMP_04761,,Escherichia coli AS1.349 (MIC=25.0µM)&&Pseudomonas aeruginosa (MIC=25.0µM)&&Staphylococcus aureus AS1.72 (MIC=12.5µM)&&Bacillus cereus (MIC=6.25µM)&&Lactococcus lactis (MIC=6.25µM)&&Candida albicans (MIC=12.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=23.4±5.2µM)&&Human cervical carcinoma HeLa (IC50=24.5±3.8µM),ILPIRSLIKKLL,,Linear,Free,Free,,L,dbAMP3,12
4789,dbAMP_04789,,Bacillus subtilis ATCC 6633 (MIC50=>66.76µM)&&Staphylococcus aureus ATCC 6538 (MIC50=>66.76µM)&&Staphylococcus aureus DMST 20651 (MIC50=>66.76µM)&&Staphylococcus epidermidis ATCC 12228 (MIC50=>66.76µM)&&Acinetobacter baumannii ATCC 19606 (MIC50=>66.76µM)&&Escherichia coli ATCC 25922 (MIC50=>66.76µM)&&Salmonella enterica subsp. enterica serovar Typhi DMST 562 (MIC50=>66.76µM)&&Human colon adenocarcinoma SW620 (IC50=>66.76µM)&&Human squamous cell oral carcinoma HSC-4 (IC50=>66.76µM),INLKAIAAMAKKLL,,Linear,Free,Free,,L,dbAMP3,14
4793,dbAMP_04793,1D7N,Human astrocytoma U373-MG (LD50=45.92µM)&&Rat leukemia cells RBL-2H3 (EC50=13.31µM)&&Acinetobacter baumannii CR17 (MIC=2.7µM)&&Human cervical carcinoma HeLa (IC50=10µM),inlkalaalakkil,,Linear,Free,Free,,L,dbAMP3,14
4796,dbAMP_04796,1D7N,Acinetobacter baumannii CR17 (MIC=2.6µM)&&Acinetobacter baumannii CR86 (MIC=2.6µM)&&Acinetobacter baumannii Ab11 (MIC=2.6µM)&&Human cervical carcinoma HeLa (IC50=13µM),INLKALAALAKKIL,,Linear,Free,Free,,L,dbAMP3,14
4829,dbAMP_04829,,Escherichia coli ATCC 25922 (MIC=8.5µM)&&Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=1.2µM),IPCGESCVWIPCISGMFGCSCKDKVCYS,,Linear,Free,Free,,L,dbAMP3,28
4830,dbAMP_04830,,Escherichia coli ATCC 25922 (MIC=6.4µM)&&Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=1.2µM),IPCGESCVWIPCITAIAGCSCKNKVCYT,,Linear,Free,Free,,L,dbAMP3,28
4842,dbAMP_04842,,Staphylococcus aureus ATCC 25923 (MIC=50µM)&&Escherichia coli ATCC 25726 (MIC=25µM)&&Candida albicans ATCC 90028 (MIC=25µM)&&Staphylococcus aureus USA 300 (MIC=>=25µM)&&Staphylococcus aureus USA 200 (MIC=>25µM)&&Staphylococcus aureus USA 400 (MIC=>=25µM)&&Staphylococcus aureus UAMS-1 (MIC=25µM)&&Staphylococcus aureus Newman (MIC=>25µM)&&Staphylococcus epidermidis 1457 (MIC=12.5µM)&&Bacillus subtilis 168 (MIC=50µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Candida glabrata ATCC 2001 (MIC=12.5µM)&&Candida tropicalis ATCC 13803 (MIC=3.1-6.2µM)&&Mouse breast cancer 4T1 (LC50=80µM)&&Human cervical carcinoma HeLa (LC50=>80µM)&&Staphylococcus aureus MU50 (MIC=>25µM),IPPFIKKVLTTVF,,Linear,Free,Free,,L,dbAMP3,13
4880,dbAMP_04880,,Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli ML-35 (MIC=2µM)&&Escherichia coli D21 (MIC=0.5µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Serratia marcescens ATCC 8100 (MIC=4µM)&&Proteus vulgaris ATCC 13315 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus aureus Cowan 1 (MIC=32µM)&&Staphylococcus aureus (MIC=>64µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Enterococcus faecalis ATCC 29212 (MIC=16µM)&&Bacillus megaterium Bm11 (MIC=4µM)&&Candida albicans (MIC=>64µM)&&Cryptococcus neoformans (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC=10µM)&&Staphylococcus aureus ATCC 25923 (MBC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µM)&&Escherichia coli KCTC 1682 (MIC=3.12µM)&&Salmonella typhimurium KCTC 1926 (MIC=3.12µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.12µM)&&Bacillus subtilis KCTC 1918 (MIC=6.25µM)&&Streptococcus pyogenes KCTC 3096 (MIC=6.25µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.12µM)&&Candida albicans TIMM 1768 (MIC=12.5µM)&&Aspergillus fumigatus KCTC 4165 (MIC=12.5µM)&&Human myelogenous leukemia K562 (IC50=28µM)&&Jurkat cells E6-1 (IC50=16µM)&&Human lung carcinoma A549 (IC50=22µM),ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,,Linear,Free,Free,,L,dbAMP3,38
4881,dbAMP_04881,,HIV-1 (60.6% PR activity=1µM)&&Rous sarcoma virus (105% PR activity=1µM),ISSEVHIPLGDARLV,,Linear,Free,Free,,L,dbAMP3,15
4912,dbAMP_04912,,HIV-1 (94.7% PR activity=1µM)&&Rous sarcoma virus (43.4% PR activity=1µM),ITTYWGLHTGERDWHL,,Linear,Free,Free,,L,dbAMP3,16
4924,dbAMP_04924,,HIV-1 (97.5% PR activity=1µM)&&Rous sarcoma virus (63% PR activity=1µM),IVWQVDRM,,Linear,Free,Free,,L,dbAMP3,8
4990,dbAMP_04990,,Pseudomonas aeruginosa ATCC 10145 (IC50=>500µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=500µg/ml)&&Escherichia coli ATCC 2592 (IC50=>250µg/ml)&&Escherichia coli ATCC 2592 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Candida albicans ATCC 10231 (IC50=329µg/ml)&&Candida albicans ATCC 10231 (MIC=>500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=400µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=>500µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (100% Killing=500µg/ml),KFAK,,Linear,Free,Free,,L,dbAMP3,4
5104,dbAMP_05104,,Staphylococcus aureus ATCC 33591 (MIC=256µM)&&Escherichia coli ATCC 25922 (MIC=256µM)&&Human cervical carcinoma HeLa (50% Cell death=>1000µM),KIWFQNKKMKWKK,,Linear,Free,Free,,L,dbAMP3,13
5105,dbAMP_05105,,Staphylococcus aureus ATCC 33591 (MIC=256µM)&&Escherichia coli ATCC 25922 (MIC=128µM)&&Human cervical carcinoma HeLa (50% Cell death=>1000µM),KIWFQNRRMKWKK,,Linear,Free,Free,,L,dbAMP3,13
5134,dbAMP_05134,,Human breast adenocarcinoma MCF-7 (IC50=2.9±0.3µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=3.1±0.2µM)&&Human myelogenous leukemia K562 (IC50=3.1±0.3µM)&&Human myelogenous leukemia K562/ADM (IC50=3.3±0.3µM)&&Human hepatocellular carcinoma HepG2 (IC50=3.7±0.3µM),KKLFKKILKYL,,Linear,Free,Free,,L,dbAMP3,11
5164,dbAMP_05164,,Bacillus subtilis PS832 (MIC=0.5µM)&&Bacillus subtilis PS832 (MIC=0.25µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Escherichia coli DL7 (MIC=1µM)&&Escherichia coli DL7 (MIC=1µM)&&Klebsiella aerogenes ATCC 13048 (MIC=>32µM)&&Escherichia coli ATCC 25922 (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Staphylococcus aureus ATCC 25923 (MIC=6µM)&&Escherichia coli ATCC 25922 (MBC=10µM)&&Human cervical carcinoma HeLa (50% Cell death=>100µM),KLAKLAKKLAKLAK,,Linear,Free,Free,,L,dbAMP3,14
5172,dbAMP_05172,,Human histiocytic lymphoma U-937/GTB (IC50=3.50µM),KLCGETCFKFKCYTPGCSCSYPFCK,,Linear,Free,Free,,L,dbAMP3,25
5185,dbAMP_05185,,"[Swiss_Prot Entry P85095]Cytotoxic to cancer cells, acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death",KLKNFAIGVAQSLLNKASCKLSGQC,,Linear,Free,Free,,L,dbAMP3,25
5205,dbAMP_05205,1HU5,Pseudomonas aeruginosa (MIC=0.125-16µg/ml)&&Pseudomonas aeruginosa (MIC50=8µg/ml)&&Pseudomonas aeruginosa (MIC90=16µg/ml)&&Pseudomonas aeruginosa (MEC=0.7-5.6µg/ml)&&Stenotrophomonas maltophilia (MEC=0.5-2.2µg/ml)&&Listeria monocytogenes EGD (MEC=1.5±0.3µg/ml)&&Staphylococcus aureus 930918 (MEC=1.0±0.13µg/ml)&&Mannheimia haemolytica Serovar 1 (MIC=1.5±0.6µg/ml)&&Mannheimia haemolytica Serovar 1 (MBC=0.8±0.2µg/ml)&&Mannheimia haemolytica Serovar 2 (MIC=0.6±0.0µg/ml)&&Mannheimia haemolytica Serovar 2 (MBC=0.5±0.1µg/ml)&&Mannheimia haemolytica Serovar 6 (MIC=0.2±0.0µg/ml)&&Mannheimia haemolytica Serovar 6 (MBC=0.2±0.0µg/ml)&&Bibersteinia trehalosi (MIC=2.3±1.4µg/ml)&&Bibersteinia trehalosi (MBC=1.0±0.2µg/ml)&&Salmonella enterica subsp. arizonae (MIC=6.7±1.7µg/ml)&&Salmonella enterica subsp. arizonae (MBC=6.7±1.7µg/ml)&&Pasteurella multocida (MIC=0.6±0.0µg/ml)&&Pasteurella multocida (MBC=0.8±0.2µg/ml)&&Klebsiella pneumoniae (MIC=0.8±0.2µg/ml)&&Klebsiella pneumoniae (MBC=0.8±0.2µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=2.1±0.4µg/ml)&&Pseudomonas aeruginosa PAO1 (MBC=2.5±0.0µg/ml)&&Corynebacterium pseudotuberculosis ATCC 19410 (MIC=>20.0µg/ml)&&Corynebacterium pseudotuberculosis ATCC 19410 (MBC=>20.0µg/ml)&&Staphylococcus aureus (MIC=15.0±5.0µg/ml)&&Staphylococcus aureus (MBC=>20.0µg/ml)&&Aspergillus fumigatus (MIC=10.0±5.0µg/ml)&&Aspergillus fumigatus (MBC=20.0±0.0µg/ml)&&Human cervical carcinoma ME-180 (100% Cytotoxicity=200µg/ml)&&Human lung carcinoma A549 (99.7% Cytotoxicity=200µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=138.5±24.5µM)&&Staphylococcus aureus ATCC 29213 (MBC=139.7±25.8µM)&&Staphylococcus aureus ATCC 43300 (MIC=>250µM)&&Staphylococcus aureus ATCC 43300 (MBC=>250µM)&&Enterococcus faecalis ATCC 29212 (MIC=78.8±40.7µM)&&Enterococcus faecalis ATCC 29212 (MBC= 72.4±13.7µM)&&Pseudomonas aeruginosa PAO1 (MIC=90.6±7.5µM)&&Pseudomonas aeruginosa PAO1 (MBC=95.9±9.8µM)&&Klebsiella aerogenes ATCC 13048 (MIC=45.9±13.8µM)&&Klebsiella aerogenes ATCC 13048 (MBC=135.2±26.3µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=7.7±0.1µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=21.7±3.7µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2.6±1.1µM)&&Acinetobacter baumannii ATCC 19606 (MBC=2.0±1.0µM)&&Escherichia coli ATCC 25922 (MIC=9.6±3.9µM)&&Escherichia coli ATCC 25922 (MBC=8.5±0.7µM)&&Fusobacterium nucleatum ATCC 25586 (MIC=4.2±2.9µM)&&Fusobacterium nucleatum ATCC 25586 (MBC=4.7±3.5µM)&&Streptococcus mutans Ingbritt (MIC=16.5±1.7µM)&&Streptococcus mutans Ingbritt (MBC=11.3±5.3µM),KNLRRIIRKIIHIIKKYG,,Linear,Free,Free,,L,dbAMP3,18
5238,dbAMP_05238,,Human myelogenous leukemia K562/ADM (IC50=14.10µM)&&Human myelogenous leukemia K562 (IC50=17.20µM)&&Human promyelocytic leukemia HL-60 (IC50=11.48µM)&&Human acute monocytic leukemia THP-1 (IC50=17.13µM)&&Jurkat cancer cells (IC50=32.19µM),KPWRFRRAIRRVRWRKVAPYIPFVVKTVGKK,,Linear,Free,Free,,L,dbAMP3,31
5244,dbAMP_05244,,Staphylococcus aureus ATCC 33591 (MIC=256µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Human cervical carcinoma HeLa (50% Cell death=>1000µM)&&Staphylococcus aureus ATCC 29213 (MIC=>50µM)&&Staphylococcus aureus ATCC 43300 (MIC=>50µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Escherichia coli (MIC=12.5-25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>50µM)&&Yersinia enterocolitica (MIC=>50µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=25µM)&&Salmonella sp. (MIC=50µM)&&Candida albicans ATCC 10231 (MIC=50µM)&&Cryptococcus neoformans ATCC 32264 (MIC=50µM),KQIKIWFQNKKMKWKK,,Linear,Free,Free,,L,dbAMP3,16
5250,dbAMP_05250,,Didymella arachidicola (IC50=75 ± 5µM)&&Fusarium oxysporum (IC50=81 ± 7µM)&&Physalospora piricola (IC50=89 ± 4µM)&&Botrytis cinerea (IC50=109 ± 5µM)&&Coprinus comatus (IC50=122 ± 7µM)&&Rhizoctonia solani (IC50=134 ± 2µM)&&HIV-1 (IC50 RT RDDP=41µM)&&Mouse lymphocytic leukemia L1210 (IC50=40µM)&&Human promyelocytic leukemia HL-60 (IC50=30µM),KQTENLADTY,,Linear,Free,Free,,L,dbAMP3,10
5264,dbAMP_05264,2MWT,Escherichia coli ATCC 25922 (MIC=0.25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=32µg/ml)&&Escherichia coli (MIC=16µg/ml)&&Pseudomonas aeruginosa (MIC=16µg/ml)&&Klebsiella pneumoniae (MIC=8µg/ml)&&Acinetobacter baumannii (MIC=16µg/ml)&&Enterococcus faecalis (MIC=128µg/ml)&&Staphylococcus aureus (MIC=32µg/ml)&&Streptococcus pyogenes (MIC=16µg/ml)&&Human cervical carcinoma HeLa S3 (IC50=<1µM)&&Human histiocytic lymphoma U-937 (IC50=<1µM)&&Human acute monocytic leukemia THP-1 (IC50=1.56µM)&&Human promyelocytic leukemia HL-60 (IC50=>12.5µM)&&Jurkat cells E6-1 (IC50=>12.5µM)&&Human acute monocytic leukemia MONO-MAC-6 (MIC=3.12µM)&&Candida parapsilosis ATCC 22019 (MIC=>166µg/ml)&&Candida krusei ATCC 6258 (MIC=166µg/ml)&&Candida tropicalis LABMIC 0109 (MIC=166µg/ml)&&Candida albicans LABMIC 0107 (MIC=166µg/ml)&&Candida parapsilosis LABMIC 0113 (MIC=10.38µg/ml)&&Candida tropicalis LABMIC 0112 (MIC=41.5µg/ml)&&Candida albicans LABMIC 0107 (MIC=83µg/ml)&&Papiliotrema laurentii LABMIC 0404 (MIC=83µg/ml)&&Microsporum canis LABMIC 0401 (MIC=5.18µg/ml)&&Trichophyton rubrum LABMIC 0203 (MIC=20.75µg/ml)&&Trypanosoma cruzi Y (EC50=4.47±0.9µM)&&Trypanosoma cruzi Y (EC50=0.22±0.02µM),KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF,,Linear,Free,Free,,L,dbAMP3,34
5285,dbAMP_05285,,Listeria innocua ATCC 33091 (MIC90=150µg/ml)&&Listeria innocua CIP 78.44 (MIC90=200µg/ml)&&Listeria monocytogenes ATCC 19112 (MIC90=100µg/ml)&&Listeria welshimeri ATCC 43551 (MIC90=80µg/ml)&&Listeria seeligeri CIP 79.46 (MIC90=60µg/ml)&&Lacticaseibacillus rhamnosus ATCC 21052 (MIC90=10µg/ml)&&Lactiplantibacillus plantarum ATCC 8014 (MIC90=>400µg/ml)&&Lacticaseibacillus casei ATCC 27139 (MIC90=300µg/ml)&&Lacticaseibacillus casei ATCC 393 (MIC90=>400µg/ml)&&Lacticaseibacillus rhamnosus ATCC 14957 (MIC90=>400µg/ml)&&Human colon adenocarcinoma SW480 (IC50=40µM),KRKCPKTPFDNTPGAWFAHLILGC,,Linear,Free,Free,,L,dbAMP3,24
5331,dbAMP_05331,,Human histiocytic lymphoma U-937/GTB (IC50=1.8µM)&&Human renal adenocarcinoma ACHN (IC50=3.2µM),KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH,,Linear,Free,Free,,L,dbAMP3,46
5373,dbAMP_05373,,Fusarium oxysporum (IC50=2µM)&&Didymella arachidicola (IC50=10µM)&&HIV-1 (IC50 RT RDDP=200µM)&&Mouse lymphocytic leukemia L1210 (40% Cytotoxicity=50.0µM)&&Mouse lymphocytic leukemia L1210 (20% Cytotoxicity=6.25µM)&&Mouse Myeloid Leukemia M1 (49% Cytotoxicity=50.0µM)&&Mouse Myeloid Leukemia M1 (32% Cytotoxicity=6.25µM)&&Human hepatocellular carcinoma HepG2 (37% Cytotoxicity=50.0µM)&&Human hepatocellular carcinoma HepG2 (18% Cytotoxicity=6.25µM),KTCENLADDY,,Linear,Free,Free,,L,dbAMP3,10
5376,dbAMP_05376,,Mycobacterium phlei (IC50=86±6µM)&&Bacillus megaterium (IC50=125±21µM)&&Bacillus subtilis (IC50=101±6µM)&&Proteus vulgaris (IC50=68±8µM)&&Botrytis cinerea (IC50=2.8±0.01µM)&&Botrytis cinerea (IC50=8.6±0.1µM)&&Fusarium oxysporum (IC50=2.3±0.02µM)&&Fusarium oxysporum (IC50=7.8±0.07µM)&&Didymella arachidicola (IC50=0.72±0.02µM)&&Didymella arachidicola (IC50=1.3±0.04µM)&&Human breast adenocarcinoma MCF-7 (IC50=5.7µM)&&HIV-1 (IC50 RT RDDP=120µM),KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFRCWCTRNC,,Linear,Free,Free,,L,dbAMP3,47
5477,dbAMP_05477,6PI3&&1MA2,Escherichia coli ML-35p (MIC=0.062µM)&&Klebsiella pneumoniae CI 287 (MIC=0.5µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.5µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus aureus 209P (MIC=0.5µM)&&Bacillus subtilis B-886 (MIC=1µM)&&Micrococcus luteus B-1314 (MIC=2µM)&&Human promyelocytic leukemia HL-60 (IC50=5±0.4µM)&&Human cervical carcinoma HeLa (IC50=13.7±1.3µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=27.5±0.8µM)&&Human lung carcinoma A549 (IC50=15.3±1µM)&&Candida albicans SC5314 (MIC=14.28µM)&&Candida krusei IFM 56881 (MIC=28.56µM)&&Cryptococcus neoformans var. grubii H99 (MIC=1.79µM)&&Candida parapsilosis ATCC 22019 (MIC=7.14µM),KWCFRVCYRGICYRKCR,,Linear,Free,Free,,L,dbAMP3,17
5481,dbAMP_05481,,Staphylococcus aureus ATCC 33591 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Human cervical carcinoma HeLa (50% Cell death=33±8.5µM),KWFKIQLQIKKWKNKK,,Linear,Free,Free,,L,dbAMP3,16
5483,dbAMP_05483,2LM8,Escherichia coli C25 (MIC=7.1µM)&&Escherichia coli C25 (IC90=9.70µM)&&Staphylococcus aureus ATCC 25923 (MIC=14µM)&&Staphylococcus aureus ATCC 25923 (IC90=33.7µM)&&Human lung carcinoma A549 (IC50=37180µM)&&Escherichia coli ATCC 12014 (MIC=6.25µg/ml)&&Bacillus subtilis ATCC 11774 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=12.5µg/ml)&&Listeria monocytogenes ATCC 15313 (MIC=12.5µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC BAA-215 (MIC=12.5µg/ml)&&Enterococcus faecalis FA1 (MIC=100µg/ml)&&Porphyromonas gingivalis ATCC 33277 (MIC=3.125µg/ml),KWFRVYRGIYRRR,,Linear,Free,Free,,L,dbAMP3,13
5501,dbAMP_05501,,Escherichia coli D21 (LC=0.4µM)&&Pseudomonas aeruginosa OT97 (LC=0.9µM)&&Bacillus subtilis Bs11 (LC=0.3µM)&&Bacillus megaterium Bm11 (LC=0.2µM)&&Staphylococcus aureus Cowan 1 (LC=2µM)&&Streptococcus pyogenes (LC=0.1µM)&&Escherichia coli ATCC 33694 (MIC=6.25-12.5µM)&&Bacillus subtilis ATCC 6633 (MIC=0.78-1.56µM)&&Human lung carcinoma NCI-H146 (IC50=9.0µM)&&Human lung carcinoma NCI-H128 (IC50=5.0µM)&&Human lung carcinoma NCI-H69 (IC50=8.0µM)&&Acinetobacter baumannii KCTC 2508 (MIC=3.12µM)&&Acinetobacter baumannii (MIC=3.12-6.25µM),KWKLFKKIGIGAVLKVLTTG,,Linear,Free,Free,,L,dbAMP3,20
5507,dbAMP_05507,1F0D&&1D9J,Escherichia coli KCTC 1682 (MIC=3.125µM)&&Salmonella typhimurium KCTC 1926 (MIC=0.78µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Streptococcus pyogenes KCTC 3096 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Escherichia coli ATCC 33694 (MIC=6.25µM)&&Bacillus subtilis ATCC 6633 (MIC=0.78-1.56µM)&&Human lung carcinoma NCI-H146 (IC50=13.0µM)&&Human lung carcinoma NCI-H128 (IC50=9.0µM)&&Human lung carcinoma NCI-H69 (IC50=16.0µM)&&Acinetobacter baumannii KCTC 2508 (MIC=12.5µM)&&Acinetobacter baumannii (MIC=3.12-12.5µM)&&Staphylococcus epidermidis KCTC 3096 (MIC=1.56-3.12µM)&&Candida albicans TIMM 1768 (MIC=12.5µM)&&Trichosporon beigelii KCTC 7707 (MIC=6.25µM)&&Escherichia coli CCARM 1229 (MIC=8µM)&&Escherichia coli CCARM 1229 (MIC=32µM)&&Pseudomonas aeruginosa 3552 (MIC=8µM)&&Pseudomonas aeruginosa 3552 (MIC=4µM)&&Staphylococcus aureus 3518 (MIC=2µM)&&Staphylococcus aureus 3518 (MIC=64µM)&&Staphylococcus aureus 1870 (MIC=>64µM)&&Staphylococcus aureus 4716 (MIC=4µM)&&Staphylococcus aureus 3551 (MIC=1µM)&&Campylobacter jejuni (MIC=25-100µg/ml)&&Campylobacter coli (MIC=50-100µg/ml)&&Campylobacter lari (MIC=25-100µg/ml),KWKLFKKIGIGKFLHSAKKF,,Linear,Free,Free,,L,dbAMP3,20
5516,dbAMP_05516,,Pseudomonas aeruginosa (MIC=25µg/ml)&&Acinetobacter baumannii b-01 (MIC=6.25 µg/ml)&&Acinetobacter baumannii b-02 (MIC=25µg/ml)&&Acinetobacter baumannii b-03 (MIC=12.5 µg/ml)&&Acinetobacter baumannii b-04 (MIC=12.5 µg/ml)&&Pyricularia grisea KACC 40425 (MIC=4-8µg/ml)&&Fusarium oxysporum KACC 40902 (MIC=4-8µg/ml)&&Aspergillus terreus KCTC 6178 (MIC=>64µg/ml)&&Aspergillus niger KCTC 6461 (MIC=>64µg/ml)&&Geotrichum candidum KACC 40354 (MIC=8-16µg/ml)&&Cryptococcus neoformans KCCM 50544 (MIC=32-64µg/ml)&&Trichosporon beigelii KCTC 7707 (MIC=2-4µg/ml)&&Candida albicans KCTC 7121 (MIC=<1µg/ml)&&Candida albicans KCTC 7270 (MIC=8-16µg/ml)&&Candida albicans KCTC 7728 (MIC=4-8µg/ml)&&Candida albicans KCTC 7729 (MIC=2-4µg/ml)&&Candida albicans KCTC 7965 (MIC=32-64µg/ml)&&Candida albicans KCTC 7122 (MIC=1-2µg/ml)&&Candida albicans KCTC 7122 (MIC=8-16µg/ml)&&Candida albicans KCTC 7122 (MIC=16-32µg/ml)&&Escherichia coli KCCM 11569 (MIC=<1µg/ml)&&Bacillus subtilis KCCM 11495 (MIC=1-2µg/ml)&&Staphylococcus aureus CCARM 3001 (MIC=4-8µg/ml)&&Staphylococcus aureus CCARM 3001 (MIC=32-64µg/ml)&&Staphylococcus aureus CCARM 3001 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3001 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3543 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3543 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3543 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3543 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=16-32µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=32-64µg/ml)&&Staphylococcus aureus CCARM 3570 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3572 (MIC=8-16µg/ml)&&Staphylococcus aureus CCARM 3572 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3572 (MIC=>64µg/ml)&&Staphylococcus aureus CCARM 3572 (MIC=>64µg/ml)&&Pseudomonas aeruginosa CCARM 2002 (MIC=4-8µg/ml)&&Pseudomonas aeruginosa CCARM 2002 (MIC=4-8µg/ml)&&Pseudomonas aeruginosa CCARM 2002 (MIC=8-16µg/ml)&&Pseudomonas aeruginosa CCARM 2002 (MIC=16-32µg/ml)&&Pseudomonas aeruginosa CCARM 2092 (MIC=8-16µg/ml)&&Pseudomonas aeruginosa CCARM 2092 (MIC=8-16µg/ml)&&Pseudomonas aeruginosa CCARM 2092 (MIC=>64µg/ml)&&Pseudomonas aeruginosa CCARM 2092 (MIC=>64µg/ml)&&Pseudomonas aeruginosa CCARM 2095 (MIC=2-4µg/ml)&&Pseudomonas aeruginosa CCARM 2095 (MIC=4-8µg/ml)&&Pseudomonas aeruginosa CCARM 2095 (MIC=8-16µg/ml)&&Pseudomonas aeruginosa CCARM 2095 (MIC=32-64µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=1-2µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=4-8µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=16-32µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=>64µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=1-2µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=8-16µg/ml)&&Pseudomonas aeruginosa CCARM 2109 (MIC=16-32µg/ml)&&Enterococcus faecium CCARM 5028 (MIC=2-4µg/ml)&&Enterococcus faecium CCARM 5028 (MIC=4-8µg/ml)&&Enterococcus faecium CCARM 5028 (MIC=>64µg/ml)&&Enterococcus faecium CCARM 5028 (MIC=>64µg/ml)&&Enterococcus faecium CCARM 5029 (MIC=4-8µg/ml)&&Enterococcus faecium CCARM 5029 (MIC=4-8µg/ml)&&Enterococcus faecium CCARM 5029 (MIC=>64µg/ml)&&Enterococcus faecium CCARM 5029 (MIC=>64µg/ml)&&Human myelogenous leukemia K562 (IC50=8.28µM)&&Escherichia coli KCTC 1682 (MIC=2µM)&&Salmonella typhimurium KCTC 1926 (MIC=1µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1µM)&&Bacillus subtilis KCTC 3068 (MIC=1µM)&&Staphylococcus aureus KCTC 1621 (MIC=2µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=1µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Bacillus megaterium KCTC 1096 (MIC=0.78µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=8.0µM)&&Jurkat cells E6-1 (IC50=4.0µM)&&Human myelogenous leukemia K562 (IC50=3.5µM),KWKLFKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,18
5517,dbAMP_05517,1F0E&&1D9M,Escherichia coli KCTC 1682 (MIC=6.25µM)&&Salmonella typhimurium KCTC 1926 (MIC=0.78µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Streptococcus pyogenes KCTC 3096 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=28.0µM)&&Jurkat cells E6-1 (IC50=20.0µM)&&Human myelogenous leukemia K562 (IC50=25.0µM),KWKLFKKIPKFLHSAKKF,,Linear,Free,Free,,L,dbAMP3,18
5519,dbAMP_05519,,Escherichia coli KCTC 1682 (MIC=25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=6.25µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=4.0µM)&&Jurkat cells E6-1 (IC50=7.0µM)&&Human myelogenous leukemia K562 (IC50=3.0µM),KWKLFKKISKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,18
5713,dbAMP_05713,,Aspergillus flavus SZMC 3014 (MIC=100µg/ml)&&Aspergillus niger SZMC 0145 (MIC=50µg/ml)&&Aspergillus welwitschiae SZMC 21832 (MIC=12.5µg/ml)&&Botrytis cinerea SZMC 21474 (MIC=50µg/ml)&&Botrytis pseudocinerea SZMC 21470 (MIC=100µg/ml)&&Cladosporium herbarum FSU 1148 (MIC=100µg/ml)&&Fusarium boothii CBS 110250 (MIC=25µg/ml)&&Fusarium graminearum SZMC 6236J (MIC=25µg/ml)&&Fusarium oxysporum SZMC 6237J (MIC=25µg/ml)&&Fusarium solani CBS 115659 (MIC=50µg/ml)&&Fusarium solani CBS 119996 (MIC=100µg/ml)&&Aspergillus flavus SZMC 20745 (MIC=12.5µg/ml)&&Botrytis cinerea SZMC 21472 (MIC=6.25µg/ml)&&Human colon adenocarcinoma HT29 (10% Cytotoxicity=200µg/ml),LEYKGECFTKDNTCKYKIDGKTYLAKCPSAANTKCEKDGNKCTYDSYNRKVKCDFRH,,Linear,Free,Free,,L,dbAMP3,57
5731,dbAMP_05731,,Escherichia coli AB94012 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa AB93066 (MIC=100µg/ml)&&Bacillus thuringiensis AB92037 (MIC=25µg/ml)&&Bacillus subtilis AB91021 (MIC=25µg/ml)&&Staphylococcus aureus AB94004 (MIC=5µg/ml)&&Staphylococcus sp. (MIC=5µg/ml)&&Staphylococcus aureus P1383 (MIC=10µg/ml)&&Staphylococcus epidermidis P1389 (MIC=8µg/ml)&&Staphylococcus aureus P1381 (MIC=20µg/ml)&&Staphylococcus aureus P1386 (MIC=25µg/ml)&&Staphylococcus aureus P1374 (MIC=8µg/ml)&&Staphylococcus aureus P1369 (MIC=8µg/ml)&&Staphylococcus aureus P969 (MIC=40µg/ml)&&Staphylococcus epidermidis P1111 (MIC=20µg/ml)&&Staphylococcus epidermidis P1368 (MIC=8µg/ml)&&Measles/Rubeola Virus (IC50 I=7.15µg/ml)&&SARS-CoV PsV (IC50 I=14.46µg/ml)&&Human Influenza A Virus H5N1 PsV (IC50 I=2.1µg/ml)&&Human cervical carcinoma HeLa-ACE2 (50% Cytotoxicity=61.58µg/ml)&&Hepatitis B virus (HBV) (IC50 REP=11µM)&&Human hepatocellular carcinoma HepG2.2.15 (50% Cytotoxicity=87µM),LFRLIKSLIKRLVSAFK,,Linear,Free,Free,,L,dbAMP3,17
5755,dbAMP_05755,,HIV-1 (15% PR activity=1µM)&&Rous sarcoma virus (103% PR activity=1µM),LGQGVSIE,,Linear,Free,Free,,L,dbAMP3,8
5766,dbAMP_05766,,Bacillus coagulans ATCC 7050 (MIC=12.5µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=50µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=>100µg/ml)&&Escherichia coli MG1655 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=25µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=>100µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=100µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=>100µg/ml),LIAGLAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,21
5781,dbAMP_05781,,Human astrocytoma U373-MG (LD50=95.46µM)&&Rat leukemia cells RBL-2H3 (EC50=>100µM)&&Acinetobacter baumannii CR17 (MIC=173µM),LIKKALAALAKLNI,,Linear,Free,Free,,L,dbAMP3,14
5788,dbAMP_05788,,Escherichia coli ATCC 25726 (MIC=20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=20µM)&&Staphylococcus aureus ATCC 25923 (MIC=40µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (LC50=6.9±0.4µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=14.6±0.6µM)&&Human colon adenocarcinoma HT29 (LC50=17.7±1.2µM)&&Human hepatocellular carcinoma HepG2 (LC50=31.3±1.9µM),LKIPGFVKDTLKKVAKGIFSAVAGAMTPS,,Linear,Free,Free,,L,dbAMP3,29
5806,dbAMP_05806,,Staphylococcus aureus ATCC 25923 (MIC=2.5µM)&&Escherichia coli ATCC 25726 (MIC=10µM)&&Staphylococcus aureus 145/08 (MIC=2.5µM)&&Staphylococcus epidermidis RP62A (MIC=1.25µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.25µM)&&Staphylococcus epidermidis T6/19 (MIC=1.25µM)&&Staphylococcus epidermidis T37/8 (MIC=1.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=20µM)&&Escherichia coli ATCC 25726 (MIC=5µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=20µM)&&Acinetobacter baumannii NM8 (MIC=5µM)&&Acinetobacter baumannii NM35 (MIC=5µM)&&Acinetobacter baumannii NM75 (MIC=2.5µM)&&Acinetobacter baumannii NM109 (MIC=5µM)&&Acinetobacter baumannii NM124 (MIC=2.5µM)&&Stenotrophomonas maltophilia B32/1 (MIC=2.5µM)&&Stenotrophomonas maltophilia B32/4 (MIC=1.25µM)&&Stenotrophomonas maltophilia U8908 (MIC=5µM)&&Stenotrophomonas maltophilia B5/5 (MIC=2.5µM)&&Stenotrophomonas maltophilia B6/2 (MIC=1.25µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (IC50=1.2±0.2µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=3.1±0.2µM)&&Human colon adenocarcinoma HT29 (IC50=12.3±4.7µM),LKLSPKTKDTLKKVLKGAIKGAIAIASMA,,Linear,Free,Free,,L,dbAMP3,29
5834,dbAMP_05834,2FBU,Tumor (Not Available)&&Prostate Cancer (Not Available)&&Oral epidermoid carcinoma KBv &&Oral epidermoid carcinoma KB &&Oral Cancer (Not Available)&&Escherichia coli K-12,LLGDFFRKSKEK,,Linear,Free,Free,,L,dbAMP3,12
5837,dbAMP_05837,2K6O&&2FCG&&2FBU&&2FBS&&2FBU&&2FCG&&2K6O&&2LMF&&2K6O,Ebola virus EBOV-GP PsV (IC50 I=4.03µM)&&Ebola virus EBOV-GP PsV (IC50 I=>20µM)&&Human cervical carcinoma HeLa (50% Cytotoxicity=25.1µM),LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,,Linear,Free,Free,,L,dbAMP3,37
5846,dbAMP_05846,,Escherichia coli ATCC 25726 (MIC=>128µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Batrachochytrium dendrobatidis (MIC=100µM)&&Human hepatocellular carcinoma HepG2 (LC50=35µM)&&Staphylococcus aureus NCTC 10788 (MIC=8µg/ml)&&Candida albicans NCYC 1467 (MIC=32µg/ml),LLGMIPLAISAISALSKL,,Linear,Free,Free,,L,dbAMP3,18
5874,dbAMP_05874,,Staphylococcus aureus ATCC 25923 (MIC=2.5µg/ml)&&Streptococcus suis 2 CVCC 606 (MIC=15.6µg/ml)&&Bacillus subtilis ADB 403 (MIC=>100µg/ml)&&Candida albicans ATCC 10231 (MIC=31.25µg/ml)&&Salmonella sp. ATCC 20020 (MIC=15.6µg/ml)&&Escherichia coli ATCC 25922 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=>100µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=60µg/ml)&&Human gastric cancer SGC-7901 (IC50=2.755µg/ml)&&Human gastric cancer MGC-803 (IC50=3.937µg/ml)&&Human hepatocarcinoma SMMC-7721 (IC50=1.384µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=2.670µg/ml)&&Human cervical carcinoma HeLa (IC50=4.685µg/ml)&&Human colon adenocarcinoma SW1116 (57.62±3.54% Inhibition=50µg/ml)&&Human hepatocellular carcinoma HepG2 (50.90±1.10% Inhibition=50µg/ml)&&Human gastric cancer BGC-823 (48.19±3.78% Inhibition=50µg/ml)&&Human lung carcinoma A549 (45.62±5.90% Inhibition=50µg/ml),LLRHVVKILEKYL,,Linear,Free,Free,,L,dbAMP3,13
6007,dbAMP_06007,,Escherichia coli PTCC 2433 (MIC=28.3µg/ml)&&Klebsiella pneumoniae PTCC 4231 (MIC=26.7µg/ml)&&Pseudomonas aeruginosa PTCC 2834 (MIC=24.2µg/ml)&&Bacillus subtilis PTCC 4533 (MIC=17.6µg/ml)&&Leuconostoc mesenteroides  PTCC 1445 (MIC=19.8µg/ml)&&Bacillus cereus PTCC 1435 (MIC=15.1µg/ml)&&Aspergillus niger (MIC=24.6µg/ml)&&Aspergillus fumigatus (MIC=19.3µg/ml)&&Candida albicans (MIC=20.4µg/ml)&&Human cervical carcinoma HeLa (5% Cytotoxicity=40µg/ml),LRLKSIVSYAKKVL,,Linear,Free,Free,,L,dbAMP3,14
8931,dbAMP_08931,,Bacillus megaterium F04 (MIC=12µg/ml)&&Legionella bozemanae ATCC 33217 (MIC=<50µg/ml)&&Legionella dumoffii ATCC 33279 (MIC=<50µg/ml)&&Legionella feeleii ATCC 35072 (MIC=<50µg/ml)&&Legionella longbeachae ATCC 33484 (MIC=<50µg/ml)&&Legionella micdadei ATCC 33218 (MIC=<50µg/ml)&&Legionella oakridgensis ATCC 33761 (MIC=<50µg/ml)&&Legionella pneumophila Corby (MIC=<50µg/ml)&&Legionella pneumophila Lens (MIC=3µg/ml)&&Legionella pneumophila Paris (MIC=<50µg/ml)&&Legionella pneumophila ATCC 33155 (MIC=<50µg/ml)&&Legionella pneumophila ATCC 33216 (MIC=<50µg/ml)&&Legionella pneumophila ATCC 33215 (MIC=<50µg/ml)&&Human prostate adenocarcinoma LNCaP (LD50=3.98µM)&&Human myelogenous leukemia K562 (LD50=4.22µM)&&Jurkat cancer cells (LD50=2.11µM),MQFITDLIKKAVDFFKGLFGNK,,Linear,Free,Free,,L,dbAMP3,22
9060,dbAMP_09060,,Acute myeloid leukemia AML-2 (IC50=>70µM)&&Human promyelocytic leukemia HL-60 (IC50=>70µM)&&Jurkat cancer cells (IC50=>70µM)&&Human gastric carcinoma SNU 601 (IC50=>70µM)&&Human breast adenocarcinoma MCF-7 (IC50=>70µM),MRKEFHNVLSSGQLLADKRPARDYNRK,,Linear,Free,Free,,L,dbAMP3,27
9742,dbAMP_09742,,Staphylococcus aureus NCTC 10788 (MIC=256µg/ml)&&Staphylococcus aureus NCTC 10788 (MBC=512µg/ml)&&Escherichia coli NCTC 10418 (MIC=32µg/ml)&&Escherichia coli NCTC 10418 (MIC=128µg/ml)&&Escherichia coli NCTC 10418 (MBC=32µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=128µg/ml)&&Candida albicans NCYC 1467 (MIC=64µg/ml)&&Candida albicans NCYC 1467 (MFC=64µg/ml)&&Human squamous lung carcinoma NCI-H157 (IC50=15.41µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=32.25µg/ml),NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN,,Linear,Free,Free,,L,dbAMP3,36
9904,dbAMP_09904,,Staphylococcus aureus ATCC 29213 (MIC=128µM)&&Staphylococcus aureus ATCC 29213 (MBC=128µM)&&Bacillus subtilis ATCC 23857 (MIC=32µM)&&Bacillus subtilis ATCC 23857 (MBC=64µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=64µM)&&Staphylococcus epidermidis ATCC 12228 (MBC=64µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MBC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=256µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=128µM)&&Cronobacter sakazakii ATCC 29544 (MIC=64µM)&&Cronobacter sakazakii ATCC 29544 (MBC=128µM)&&Escherichia coli ATCC 43827 (MIC=32µM)&&Escherichia coli ATCC 43827 (MBC=64µM)&&Candida glabrata ATCC 2001 (MIC=30µg/ml)&&Candida glabrata ATCC 2001 (MFC=61µg/ml)&&Candida albicans ATCC 14053 (MIC=61µg/ml)&&Candida albicans ATCC 14053 (MFC=61µg/ml)&&Candida tropicalis ATCC 750 (MIC=15µg/ml)&&Candida tropicalis ATCC 750 (MFC=30µg/ml)&&Candida krusei ATCC 6258 (MIC=30µg/ml)&&Candida krusei ATCC 6258 (MFC=30µg/ml)&&Candida parapsilosis ATCC 22019 (MIC=61µg/ml)&&Candida parapsilosis ATCC 22019 (MFC=122µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MIC=128µM)&&Bacillus subtilis ATCC 23857 (MIC=32µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=64µM)&&Staphylococcus aureus MR (MIC=128µM)&&Escherichia coli ESBL  (MIC=32µM)&&Pseudomonas aeruginosa (MIC=32µM)&&Human cervical carcinoma HeLa (<15% Killing=256µM)&&Murine macrophage cells RAW 264.7 (<15% Killing=256µM),PFKLSLHL,,Linear,Free,Free,,L,dbAMP3,8
9918,dbAMP_09918,,Human epithelial carcinoma KB (IC50=0.017µM)&&Human epithelial carcinoma KB (IC50=>100µM)&&Escherichia coli (MIC=>10000µg/ml)&&Staphylococcus aureus (MIC=>10000µg/ml),PGLGFY,,Linear,Free,Free,,L,dbAMP3,6
9919,dbAMP_09919,,Human epithelial carcinoma KB (IC50=0.06µM),PGMGIYLPM,,Linear,Free,Free,,L,dbAMP3,9
10311,dbAMP_10311,,Acinetobacter calcoaceticus (MIC=>128µg/ml)&&Proteus vulgaris (MIC=32-64µg/ml)&&Proteus mirabilis (MIC=32-128µg/ml)&&Enterobacter cloacae (MIC=4-8µg/ml)&&Serratia marcescens (MIC=8-16µg/ml)&&Pseudomonas stutzeri (MIC=64-128µg/ml)&&Pseudomonas aeruginosa (MIC=>128µg/ml)&&Klebsiella oxytoca (MIC=32-64µg/ml)&&Klebsiella aerogenes (MIC=16-32µg/ml)&&Citrobacter freundii (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=4-8µg/ml)&&Escherichia coli (MIC=4-8µg/ml)&&Enterococcus faecium (MIC=2-8µg/ml)&&Streptococcus pneumoniae (MIC=16-32µg/ml)&&Staphylococcus haemolyticus (MIC=8-16µg/ml)&&Staphylococcus epidermidis (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=4-8µg/ml)&&Staphylococcus aureus (MIC=4-16µg/ml)&&Human lung carcinoma A549 (8% Inhibition=200µg/ml)&&Bacillus megaterium ATCC 14581 (MIC=1.25µg/ml)&&Bacillus megaterium ATCC 14581 (MIC=10µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=2.5µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=10µg/ml)&&Micrococcus luteus ATCC 7468 (MIC=5µg/ml)&&Micrococcus luteus ATCC 7468 (MIC=20µg/ml)&&Streptococcus agalactiae ATCC 27956 (MIC=160µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=40µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=80µg/ml)&&Streptococcus oralis ATCC 35037 (MIC=80µg/ml)&&Streptococcus oralis ATCC 35037 (MIC=>200µg/ml)&&Streptococcus pneumoniae ATCC 49619 (MIC=20µg/ml)&&Streptococcus pneumoniae ATCC 49619 (MIC=40µg/ml)&&Streptococcus pyogenes ATCC 12344 (MIC=10µg/ml)&&Streptococcus pyogenes ATCC 12344 (MIC=40µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=80µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=>160µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=10µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=10µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=40µg/ml)&&Enterococcus casseliflavus ATCC 700327 (MIC=5µg/ml)&&Enterococcus casseliflavus ATCC 700327 (MIC=20µg/ml)&&Klebsiella oxytoca ATCC 700324 (MIC=40µg/ml)&&Klebsiella oxytoca ATCC 700324 (MIC=>160µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=120µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=160µg/ml)&&Escherichia coli ATCC 25922 (MIC=10µg/ml)&&Escherichia coli ATCC 25922 (MIC=160µg/ml)&&Escherichia coli ATCC 35150 (MIC=8µg/ml)&&Escherichia coli ATCC 35150 (MIC=160µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=160µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µg/ml),QWGRRCCGWGPGRRYCRRWC,,Linear,Free,Free,,L,dbAMP3,20
10340,dbAMP_10340,,Bacillus subtilis (MIC=1µg/ml)&&Staphylococcus aureus (MIC=1µg/ml)&&Streptococcus mutans (MIC=0.5µg/ml)&&Streptococcus pneumoniae (MIC=1µg/ml)&&Escherichia coli (MIC=1µg/ml)&&Salmonella typhimurium (MIC=1µg/ml)&&Serratia marcescens (MIC=1µg/ml)&&Pseudomonas putida (MIC=2µg/ml)&&Candida albicans (MIC=2µg/ml)&&Cryptococcus neoformans (MIC=1µg/ml)&&Saccharomyces cerevisiae (MIC=4µg/ml)&&Escherichia coli ATCC 27325 (MIC=1µg/ml)&&Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076 (MIC=2µg/ml)&&Pseudomonas putida ATCC 17426 (MIC=2µg/ml)&&Bacillus subtilis ATCC 62037 (MIC=1µg/ml)&&Streptococcus mutans ATCC 25175 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 15752 (MIC=2µg/ml)&&Candida albicans ATCC 10231 (MIC=1µg/ml)&&Cryptococcus neoformans ATCC 34881 (MIC=2µg/ml)&&Saccharomyces cerevisiae ATCC 44774 (MIC=2µg/ml)&&Human lymphoblastic leukemia CCRF-CEM (IC50=14.7µg/ml)&&Human promyelocytic leukemia HL-60 (IC50=11.3µg/ml)&&Human myelogenous leukemia K562 (IC50=8.2µg/ml)&&Human lymphoblastic leukemia Molt-4 (IC50=17.0µg/ml)&&Human Myeloma cells RPMI-8226 (IC50=10.5µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=15.1µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=11.3µg/ml)&&Human breast adenocarcinoma MDA-MB-435 (IC50=11.3µg/ml)&&Human lung carcinoma A549 (IC50=11.7µg/ml)&&Human lung adenocarcinoma NCI-H23 (IC50=10.8µg/ml)&&Human lung carcinoma NCI-H460 (IC50=12.1µg/ml)&&Human Astrocytoma SF-268 (IC50=12.4µg/ml)&&Human glioblastoma U251-MG (IC50=10.6µg/ml)&&Human skin melanoma SK-MEL-2 (IC50=11.1µg/ml)&&Human melanoma UACC-62 (IC50=10.6µg/ml)&&Human renal carcinoma A498 (IC50=10.0µg/ml)&&Human renal adenocarcinoma ACHN (IC50=12.0µg/ml)&&Human ovarian adenocarcinoma IGROV1 (IC50=9.0µg/ml)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=12.6µg/ml)&&Human colon adenocarcinoma HCT 116 (IC50=14.6µg/ml)&&Human colon adenocarcinoma HCT-15 (IC50=13.2µg/ml)&&Human colon adenocarcinoma HT29 (IC50=17.6µg/ml)&&Human colon adenocarcinoma SW620 (IC50=12.7µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=12.0µg/ml)&&Human prostate cancer DU145 (IC50=15.3µg/ml),RAGLQFPVGRLLRRLLRRLLR,,Linear,Free,Free,,L,dbAMP3,21
10385,dbAMP_10385,4AAZ&&1MR4&&4AAZ&&4AB0&&1mr4&&4AAZ&&4AB0&&1MR4,Fusarium oxysporum (100% Inhibition=10µg/ml)&&Botrytis cinerea (97% Inhibition=10µg/ml)&&Cryptococcus neoformans var. grubii H99 (IC50=2.04±0.15µM)&&Cryptococcus neoformans var. neoformans JEC20 (IC50=0.91±0.81µM)&&Cryptococcus neoformans var. neoformans JEC21 (IC50=2.38±1.01µM)&&Cryptococcus gattii WM276 (IC50=1.45±0.59µM)&&Cryptococcus gattii R265 (IC50=1.57±0.57µM)&&Aspergillus niger 5181 (IC50=2.1±0.76µM)&&Aspergillus flavus 5310 (IC50=>10µM)&&Candida albicans DAY185 (IC50=2.3±0.6µM)&&Verticillium dahliae (IC50=0.75µM)&&Berkeleyomyces basicola (IC50=1µM)&&Aspergillus nidulans (IC50=0.8µM)&&Puccinia coronata f.sp. avenae (IC50=2.5µM)&&Puccinia sorghi (IC50=2µM)&&Fusarium oxysporum f.sp. vasinfectum (IC50=1.5±0.25µM)&&Fusarium graminearum (IC50=0.4±0.3µM)&&Colletotrichum graminicola (IC50=4.4±0.1µM)&&Aspergillus parasiticus 4467 (IC50=4.5±0.27µM)&&Human histiocytic lymphoma U-937 (LC50=10µM)&&Candida albicans ATCC 90028 (IC50=1.6±0.4µM)&&Candida albicans ATCC 90029 (IC50=>10µM)&&Candida auris (IC50=2.9±0.5µM)&&Candida auris (IC50=>10µM)&&Candida glabrata ATCC 90030 (IC50=2.8±1.0µM)&&Candida glabrata ATCC 90030 (IC50=>10µM)&&Candida krusei (IC50=1.2±0.4µM)&&Candida krusei (IC50=>10µM)&&Candida parapsilosis (IC50=1.2±0.3µM)&&Candida parapsilosis (IC50=3.4±1.2µM)&&Candida tropicalis ATCC 750 (IC50=0.4±0.1µM)&&Candida tropicalis ATCC 750 (IC50=1.3±0.5µM)&&Fusarium graminearum PH-1 (IC50=1.0±0.5µM)&&Escherichia coli (IC50=4.6±1.6µM)&&Escherichia coli (IC50=>10µM)&&Staphylococcus aureus ATCC 9144 (IC50=5.0±0.5µM)&&Bacillus subtilis (IC50=2.0±0.2µM)&&Pseudomonas aeruginosa PAO1 (IC50=4.3±0.3µM)&&Human prostate adenocarcinoma PC-3 (LC=25µM)&&Human histiocytic lymphoma U-937 (LC=25µM)&&Fusarium graminearum PH-1 (MIC=2µM),RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
10412,dbAMP_10412,,Escherichia coli ML-35p (MIC=2µM)&&Acinetobacter baumannii 7226/16 (MIC=4-8µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=4-8µM)&&Pseudomonas aeruginosa 522/17 (MIC=32µM)&&Escherichia coli ESBL 521/17 (MIC=4µM)&&Staphylococcus aureus 1399/17 (MIC=8-16µM)&&Staphylococcus aureus SG511 (MIC=0.5µM)&&Staphylococcus aureus ATCC 33591 (MIC=32µM)&&Human myelogenous leukemia K562 (IC50=24.4±4µM)&&Human histiocytic lymphoma U-937 (IC50=12.9±0.3µM),RFRLPFRRPPIRIHPPPFYPPFRRFL,,Linear,Free,Free,,L,dbAMP3,26
10441,dbAMP_10441,1FRY,Mannheimia haemolytica Serovar 1 (MIC=0.9±0.3µg/ml)&&Mannheimia haemolytica Serovar 1 (MBC=0.5±0.1µg/ml)&&Mannheimia haemolytica Serovar 2 (MIC=1.7±0.4µg/ml)&&Mannheimia haemolytica Serovar 2 (MBC=0.6±0.0µg/ml)&&Mannheimia haemolytica Serovar 6 (MIC=0.6±0.0µg/ml)&&Mannheimia haemolytica Serovar 6 (MBC=0.6±0.0µg/ml)&&Bibersteinia trehalosi (MIC=1.3±0.0µg/ml)&&Bibersteinia trehalosi (MBC=0.8±0.2µg/ml)&&Salmonella enterica subsp. arizonae (MIC=1.3±0.0µg/ml)&&Salmonella enterica subsp. arizonae (MBC=2.1±0.4µg/ml)&&Pasteurella multocida (MIC=0.3±0.0µg/ml)&&Pasteurella multocida (MBC=0.3±0.0µg/ml)&&Klebsiella pneumoniae (MIC=0.4±0.2µg/ml)&&Klebsiella pneumoniae (MBC=0.4±0.2µg/ml)&&Corynebacterium pseudotuberculosis ATCC 19410 (MIC=20.0±0.0µg/ml)&&Corynebacterium pseudotuberculosis ATCC 19410 (MBC=>=20.0µg/ml)&&Staphylococcus aureus (MIC=1.3±0.0µg/ml)&&Staphylococcus aureus (MBC=1.0±0.2µg/ml)&&Aspergillus fumigatus (MIC=5.0±0.0µg/ml)&&Aspergillus fumigatus (MBC=11.7±4.4µg/ml)&&Escherichia coli O111 (MIC=2µg/ml)&&Escherichia coli UB1005 (MIC=0.125µg/ml)&&Escherichia coli DC2 (MIC=0.125µg/ml)&&Escherichia coli O157:H7 (MIC=2µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=0.25µg/ml)&&Salmonella enterica serovar Typhimurium MS4252S (MIC=0.125µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=4µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=1µg/ml)&&Staphylococcus aureus NCTC 4163 (MIC=1µg/ml)&&Staphylococcus aureus R147 (MIC=0.5µg/ml)&&Staphylococcus aureus 1056 (MIC=4µg/ml)&&Staphylococcus epidermidis (MIC=0.25µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=2µg/ml)&&Candida albicans 105 (MIC=2µg/ml)&&Candida albicans 3153A (MIC=4µg/ml)&&Escherichia coli ML-35 (MIC=0.25µM)&&Escherichia coli D21 (MIC=0.12µM)&&Pseudomonas aeruginosa (MIC=0.25-2.0µM)&&Serratia marcescens ATCC 8100 (MIC=0.25µM)&&Proteus vulgaris ATCC 13315 (MIC=>80µM)&&Staphylococcus aureus Cowan 1 (MIC=0.5µM)&&Staphylococcus aureus (MIC=1.0µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=0.25µM)&&Enterococcus faecalis (MIC=1.0µM)&&Bacillus megaterium Bm11 (MIC=0.25µM)&&Candida albicans (MIC=4.0µM)&&Cryptococcus neoformans (MIC=1.0µM)&&Rhodotorula mucilaginosa (MIC=0.5µM)&&Escherichia coli ATCC 25922 (MIC=1.56µM)&&Escherichia coli O157:H7 ATCC 700728 (MIC=0.78µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=0.39µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 700408 (MIC=0.39µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.39µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.12µM)&&Listeria monocytogenes ATCC 19115 (MIC=0.78µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.78µM)&&Staphylococcus aureus ATCC BAA-39 (MIC=0.39µM)&&Staphylococcus aureus ATCC 43300 (MIC=0.39µM)&&Bacillus subtilis KCTC 3068 (MIC=2.0µM)&&Bacillus subtilis KCTC 3068 (MIC=1.0µM)&&Staphylococcus aureus KCTC 1916 (MIC=0.5µM)&&Micrococcus luteus KCTC 1071 (MIC=1.0µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=0.5µM)&&Escherichia coli KCTC 1682 (MIC=2.0µM)&&Escherichia coli KCTC 1682 (MIC=1.0µM)&&Salmonella typhimurium KCTC 1926 (MIC=1.0µM)&&Salmonella typhimurium KCTC 1926 (MIC=0.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4.0µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=2.0µM)&&Candida albicans KCTC 7965 (MIC=2.0µM)&&Candida albicans KCTC 7965 (MIC=8.0µM)&&Escherichia coli ATCC 12795 (MIC=0.1µM)&&Escherichia coli ATCC 12795 (MBC=0.1µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=0.78µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 700408 (MIC=0.78µg/ml)&&Escherichia coli KCTC 1682 (MIC=2µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=2-4µM)&&Salmonella typhimurium KCTC 1926 (MIC=1µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=1-2µM)&&Staphylococcus aureus KCTC 1621 (MIC=1-2µM)&&Murine macrophage cells RAW 264.7 (IC50=20µM)&&Human cervical carcinoma HeLa (IC50=30µM)&&Bacillus subtilis KCTC 3068 (MIC=2µM)&&Staphylococcus aureus CCARM 3089 (MIC=4µM)&&Staphylococcus aureus CCARM 3090 (MIC=2µM)&&Staphylococcus aureus CCARM 3095 (MIC=2µM)&&Escherichia coli O157:H7 (MIC=3.4µg/ml)&&Staphylococcus aureus 1056 (MIC=4.6µg/ml),RGLRRLGRKIAHGVKKYGPTVLRIIRIA,,Linear,Free,Free,,L,dbAMP3,28
10447,dbAMP_10447,,Vibrio cholerae (MIC=61.2µM)&&Bacillus pumilus TISTR 905 (MIC=61.2µM)&&Human cervical carcinoma HeLa (IC50=126.24±3.5µM)&&Human cervical carcinoma CaSki (IC50=168.33±1.6µM),RGSALTHLP,,Linear,Free,Free,,L,dbAMP3,9
10460,dbAMP_10460,,Rous sarcoma virus (113% PR activity=1µM),RHHYESPHPRISSEV,,Linear,Free,Free,,L,dbAMP3,15
10517,dbAMP_10517,,Staphylococcus aureus ATCC 33591 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Human cervical carcinoma HeLa (50% Cell death=36±5.7µM),RIWFQNRRMRWRR,,Linear,Free,Free,,L,dbAMP3,13
10527,dbAMP_10527,,Escherichia coli CGMCC 1.1369 (MIC=25µM)&&Shigella dysenteriae CPCC 160015 (MIC=3.1µM)&&Shigella dysenteriae CPCC 160015 (MIC=50µM)&&Proteus vulgaris CGMCC 1.1651 (MIC=6.2µM)&&Pseudomonas aeruginosa CMCC 10104 (MIC=6.2µM)&&Salmonella typhimurium CGMCC 1.1174 (MIC=12.5µM)&&Klebsiella aerogenes CGMCC 1.2021 (MIC=12.5µM)&&Acetobacterium wieringae CGMCC 1.2033 (MIC=3.1µM)&&Alcaligenes faecalis CGMCC 1.924 (MIC=3.1µM)&&Klebsiella pneumoniae CPCC 160022 (MIC=3.1µM)&&Klebsiella pneumoniae CPCC 160022 (MIC=50µM)&&Enterobacter cloacae CGMCC 1.58 (MIC=50µM)&&Providencia rettgeri CMCC 49256 (MIC=6.2µM)&&Bacillus subtilis CGMCC 1.88 (MIC=12.5µM)&&Staphylococcus aureus AB94004 (MIC=3.1µM)&&Staphylococcus aureus AB94004 (MIC=12.5µM)&&Corynebacterium glutamicum CGMCC 1.818 (MIC=3.1µM)&&Staphylococcus epidermidis ACCC02744 (MIC=3.1µM)&&Staphylococcus epidermidis ACCC02744 (MIC=12.5µM)&&Bacillus thuringiensis serovar israelensis H14 (MIC=12.5µM)&&Micrococcus luteus AB206228 (MIC=3.1µM)&&Bacillus cereus CMCC 1.126 (MIC=6.2µM)&&Enterococcus faecalis CGMCC 1.100 (MIC=25µM)&&Tetragenococcus halophilus CGMCC 1.2492 (MIC=3.1µM)&&Saccharomyces cerevisiae CGMCC 2.1619 (MIC=50µM)&&Candida albicans CMCC 98001 (MIC=50µM)&&Beauveria bassiana CGMCC 3.3576 (MIC=6.2µM)&&Penicillium sp. ATCC 30106 (MIC=3.1µM)&&Aspergillus flavus CGMCC 3.6433 (MIC=3.1µM)&&Human cervical carcinoma HeLa (LC90=40µM)&&Human hepatocellular carcinoma HepG2 (LC90=40µM)&&Human lung carcinoma A549 (LC90=40µM)&&Human lung carcinoma H1299 (LC90=40µM)&&Human fibrosarcoma HT1080 (LC90=40µM)&&Human prostate cancer DU145 (LC90=40µM)&&Human colon adenocarcinoma HCT 116 (LC90=40µM),RKGWFKAMKSIAKFIAKEKLKEHL,,Linear,Free,Free,,L,dbAMP3,24
10565,dbAMP_10565,,Human breast adenocarcinoma MDA-MB-231 (IC50=2.06µg/ml),RLGDGCTR,,Linear,Free,Free,,L,dbAMP3,8
10639,dbAMP_10639,,Staphylococcus aureus ATCC 33591 (MIC=64µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Human cervical carcinoma HeLa (50% Cell death=>1000µM),RQIKIWFQNRRLKWKK,,Linear,Free,Free,,L,dbAMP3,16
10641,dbAMP_10641,,Staphylococcus aureus ATCC 33591 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Human cervical carcinoma HeLa (50% Cell death=36±3.6µM)&&Staphylococcus aureus ATCC 29213 (MIC=>50µM)&&Staphylococcus aureus ATCC 43300 (MIC=>50µM)&&Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>50µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=25µM)&&Salmonella sp. (MIC=50µM)&&Yersinia enterocolitica (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=100µM)&&Cryptococcus neoformans ATCC 32264 (MIC=50µM),RQIRIWFQNRRMRWRR,,Linear,Free,Free,,L,dbAMP3,16
10706,dbAMP_10706,,Escherichia coli ATCC 25922 (MIC=0.9±0.4µM)&&Escherichia coli ATCC 25922 (MBC=1.1±0.3µM)&&Escherichia coli CGSC 5167 (MIC=0.4±0.1µM)&&Escherichia coli CGSC 5167 (MBC=0.5±0.0µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.3±0.2µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=0.4±0.1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=0.6±0.3µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=2.1±0.7µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=2.0±0.0µM)&&Pseudomonas aeruginosa ATCC 10145 (MBC=4.5±1.3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.5±0.3µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=1.5±0.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.0±1.2µM)&&Staphylococcus aureus ATCC 25923 (MBC=8.0±0.0µM)&&Staphylococcus aureus ATCC 33591 (MIC=3.0±0.6µM)&&Staphylococcus aureus ATCC 33591 (MBC=4.0±0.0µM)&&Streptococcus pneumoniae ATCC 33400 (MIC=5.0±1.0µM)&&Streptococcus pneumoniae ATCC 33400 (MBC=7.0±1.0µM)&&Streptococcus pneumoniae ATCC 700677 (MIC=4.0±0.0µM)&&Streptococcus pneumoniae ATCC 700677 (MBC=6.0±1.2µM)&&Enterococcus faecium ATCC 35667 (MIC=4.0±0.0µM)&&Enterococcus faecium ATCC 35667 (MBC=4.0±0.0µM)&&Enterococcus faecium ATCC 51559 (MIC=2.0±0.0µM)&&Enterococcus faecium ATCC 51559 (MBC=2.0±0.0µM)&&Human cervical carcinoma HeLa (IC50=17.5±0.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=64.7±12.5µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=35.7±1.5µM),RRLFRRILRYL,,Linear,Free,Free,,L,dbAMP3,11
10719,dbAMP_10719,,Murine fibrosarcoma MCA205 (50% Killing=<50µM)&&Human neck cancer (50% Killing=<60µM)&&Human head cancer (50% Killing=<50µM),RRQRRTSKLMKRGGKLAKLAKKLAKLAK,,Linear,Free,Free,,L,dbAMP3,28
10744,dbAMP_10744,,Escherichia coli ML-35p (MIC=0.031µM)&&Klebsiella pneumoniae CI 287 (MIC=0.5µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.5µM)&&Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus 209P (MIC=0.5µM)&&Bacillus subtilis B-886 (MIC=0.5µM)&&Micrococcus luteus B-1314 (MIC=1µM)&&Human promyelocytic leukemia HL-60 (IC50=7.2±0.5µM)&&Human cervical carcinoma HeLa (IC50=16.4±1.3µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=17.3±0.6µM)&&Human lung carcinoma A549 (IC50=10.8±0.9µM),RRWCFRVCYKGFCYRKCR,,Linear,Free,Free,,L,dbAMP3,18
10745,dbAMP_10745,1X7K&&1RKK&&1X7K&&2B5K&&1RKK,Escherichia coli ML-35p (MIC=0.062µM)&&Klebsiella pneumoniae CI 287 (MIC=0.5µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.5µM)&&Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus 209P (MIC=0.5µM)&&Bacillus subtilis B-886 (MIC=0.25µM)&&Micrococcus luteus B-1314 (MIC=0.5µM)&&Human promyelocytic leukemia HL-60 (IC50=7.2±0.5µM)&&Human cervical carcinoma HeLa (IC50=12.5±0.9µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=16.0±0.6µM)&&Human lung carcinoma A549 (IC50=8.8±1.3µM)&&Candida albicans SC5314 (MIC=4.07µM)&&Candida krusei IFM 56881 (MIC=4.07µM)&&Cryptococcus neoformans var. grubii H99 (MIC=1.02µM)&&Candida parapsilosis ATCC 22019 (MIC=1.02µM),RRWCFRVCYRGFCYRKCR,,Linear,Free,Free,,L,dbAMP3,18
10779,dbAMP_10779,,Aeromonas salmonicida 99-1 (MIC=>64µg/ml)&&Aeromonas salmonicida 97-4 (MIC=>64µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=>64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=>64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=>64µg/ml)&&Escherichia coli CGSC 4908 (MIC=>64µg/ml)&&Escherichia coli UB1005 (MIC=>64µg/ml)&&Escherichia coli DC2 (MIC=>64µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Aeromonas salmonicida A449 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),RSTEDIIKSISGGGFLNAMNA,,Linear,Free,Free,,L,dbAMP3,21
10846,dbAMP_10846,6PI2,Escherichia coli ML-35p (MIC=0.062µM)&&Klebsiella pneumoniae CI 287 (MIC=1µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.5µM)&&Staphylococcus aureus ATCC 29213 (MIC=8µM)&&Staphylococcus aureus 209P (MIC=0.5µM)&&Bacillus subtilis B-886 (MIC=0.5µM)&&Micrococcus luteus B-1314 (MIC=1µM)&&Human promyelocytic leukemia HL-60 (IC50=5.6±0.5µM)&&Human cervical carcinoma HeLa (IC50=24.4±3µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=34±1.3µM)&&Human lung carcinoma A549 (IC50=28.1±1.7µM),RWCFRVCYRGICYRKCR,,Linear,Free,Free,,L,dbAMP3,17
10848,dbAMP_10848,2JSB&&2jsb&&2JSB&&2JSB,Escherichia coli ML-35p (MIC=1-2µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli M15 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Listeria monocytogenes EGD (MIC=2µM)&&Staphylococcus aureus 710A (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 33591 (MIC=4µM)&&Staphylococcus aureus (MIC=4µM)&&Staphylococcus intermedius (MIC=4µM)&&Pseudomonas aeruginosa (MIC=2µM)&&Acinetobacter baumannii (MIC=4µM)&&Human myelogenous leukemia K562 (IC50=16.2µM),RWCVYAYVRVRGVLVRYRRCW,,Linear,Free,Free,,L,dbAMP3,21
10849,dbAMP_10849,,Staphylococcus aureus ATCC 33591 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Human cervical carcinoma HeLa (50% Cell death=9±0.9µM),RWFKIQLQIRRWKNKK,,Linear,Free,Free,,L,dbAMP3,16
10850,dbAMP_10850,,Staphylococcus aureus ATCC 33591 (MIC=64µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Human cervical carcinoma HeLa (50% Cell death=17±1.2µM),RWFKIQMQIRRWKNKK,,Linear,Free,Free,,L,dbAMP3,16
10851,dbAMP_10851,,Staphylococcus aureus ATCC 33591 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Human cervical carcinoma HeLa (50% Cell death=5±0.2µM),RWFRIQLQIRRWRNRR,,Linear,Free,Free,,L,dbAMP3,16
10852,dbAMP_10852,,Aeromonas salmonicida 99-1 (MIC=4µg/ml)&&Aeromonas salmonicida 97-4 (MIC=2µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=2µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=8µg/ml)&&Pseudomonas aeruginosa K799 (MIC=4µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=2µg/ml)&&Escherichia coli CGSC 4908 (MIC=4µg/ml)&&Escherichia coli UB1005 (MIC=4µg/ml)&&Escherichia coli DC2 (MIC=4µg/ml)&&Staphylococcus epidermidis C621 (MIC=64µg/ml)&&Staphylococcus aureus C623 (MIC=64µg/ml)&&Candida albicans C627 (MIC=16µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=16µg/ml),RWGKWFKKATHVGKHVGKAALTAYL,,Linear,Free,Free,,L,dbAMP3,25
10857,dbAMP_10857,,Escherichia coli ATCC 25922 (MIC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=1µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=1µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=1µg/ml)&&Human esophageal carcinoma Eca 109 (30% Killing=20µM),RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK,,Linear,Free,Free,,L,dbAMP3,37
10858,dbAMP_10858,,Aspergillus niger AS 3.3928 (MIC=4-8µM)&&Trichoderma viride AS 3.2942 (MIC=4-8µM)&&Gibberella saubinetii AS 3.4288 (MIC=2-4µM)&&Human acute monocytic leukemia THP-1 (IC50=14.2µM)&&Human myelogenous leukemia K562 (IC50=15.8µM)&&Human histiocytic lymphoma U-937 (IC50=17.5µM)&&Penicillium chrysogenum (MIC=20µg/ml)&&Aspergillus niger (MIC=6µg/ml)&&Gibberella saubinetii (MIC=4µg/ml)&&Escherichia coli HB101 (MIC=50µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=3.13µg/ml)&&Klebsiella pneumoniae (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>100µg/ml)&&Burkholderia cenocepacia IST 439 (MIC=200µg/ml)&&Burkholderia cenocepacia IST 4113 (MIC=200µg/ml)&&Staphylococcus epidermidis (MIC=12.5µg/ml),RWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI,,Linear,Free,Free,,L,dbAMP3,35
10910,dbAMP_10910,,Escherichia coli ATCC 11775 (MIC=3µM)&&Staphylococcus aureus ATCC 12600 (MIC=6µM)&&Escherichia coli AS1.349 (MIC=>500µM)&&Pseudomonas aeruginosa CGMCC 1.860 (MIC=380µM)&&Klebsiella aerogenes CGMCC 1.876 (MIC=>500µM)&&Enterobacter cloacae CGMCC 1.58 (MIC=>500µM)&&Klebsiella pneumoniae subsp. pneumoniae CGMCC 1.176 (MIC=>500µM)&&Staphylococcus aureus AS1.72 (MIC=58.0µM)&&Bacillus cereus AS1.126 (MIC=11.6µM)&&Lactococcus lactis AS1.1690 (MIC=15.6µM)&&Enterococcus faecalis CGMCC 1.595 (MIC=33.3µM)&&Enterococcus faecium CGMCC 1.2334 (MIC=42.4µM)&&Staphylococcus epidermidis CICC 23664 (MIC=7.2µM)&&Staphylococcus aureus (MIC=58µM)&&Bacillus cereus (MIC=11.6µM)&&Lactococcus lactis (MIC=11.6µM)&&Escherichia coli (MIC=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Human cervical carcinoma HeLa (IC50=>200µM)&&Proteus mirabilis CICC 22931 (MIC=>100µM)&&Acinetobacter baumannii CICC 22934 (MIC=>100µM)&&Pseudomonas aeruginosa (MIC=>50µM)&&Klebsiella pneumoniae (MIC=>50µM)&&Escherichia coli (MIC=>50µM)&&Acinetobacter baumannii (MIC=>50µM)&&Klebsiella aerogenes (MIC=>50µM)&&Enterobacter cloacae (MIC=>50µM)&&Pseudomonas fluorescens (MIC=>50µM)&&Staphylococcus aureus (MIC=>50µM)&&Enterococcus faecium (MIC=>50µM)&&Staphylococcus epidermidis (MIC=>50µM),SAVGRHGRRFGLRKHRKH,,Linear,Free,Free,,L,dbAMP3,18
10939,dbAMP_10939,,Chikungunya virus (CHIKV) PsV (IC50 I=>5µM)&&DENV-1 (IC50 I=12µM)&&DENV-2 (IC50 I=7.6-8µM)&&DENV-2 (IC50 I=4.2-5.2µM)&&DENV-3 (IC50 I=9.4µM)&&DENV-4 (IC50 I=4.0µM)&&Human cytomegalovirus (HCMV) (IC50 I=5.4µM)&&Hepatitis C virus (HCV) (IC50 I=1.7µM)&&HSV-1 (IC50 I=12.4µM)&&HSV-2 (IC50 I=5.5µM)&&Kaposi’s sarcoma-associated herpesvirus (KSHV) (IC50 I=15.0µM)&&Tick Borne Encephalitis virus TBEV (IC50 I=>26µM)&&West Nile virus WNV (IC50 I=0.7µM)&&Zika virus (ZIKV) (IC50 I=9.6µM)&&Zika virus (ZIKV) H/PF (IC50 I=3.4µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>26µM),SDWSLWECCSTGSLFACC,,Linear,Free,Free,,L,dbAMP3,18
11035,dbAMP_11035,,Staphylococcus aureus ATCC 2592 (MIC=3.6µg/ml)&&Pseudomonas aeruginosa CMCCB 10104 (MIC=7.2µg/ml)&&Bacillus megaterium (MIC=12µg/ml)&&Shigella dysenteriae (MIC=12µg/ml)&&Klebsiella pneumoniae (MIC=3.6µg/ml)&&Candida albicans ATCC 2002 (MIC=1.2µg/ml)&&Aspergillus flavus IFFI 4015 (MIC=12µg/ml)&&Penicillium urticae IFFI 2001 (MIC=12µg/ml)&&HIV-1 (IC50 REP=39.8µg/ml)&&Human T-cell leukemia C8166 (IC50=34.4µg/ml)&&Human lymphoblastic leukemia Molt-4 (IC50=>50µg/ml)&&Human bladder cancer BIU-87 (IC50=>50µg/ml)&&Human bladder carcinoma T24 (IC50=>50µg/ml),SIGAKILGGVKTFFKGALKELASTYLQ,,Linear,Free,Free,,L,dbAMP3,27
11047,dbAMP_11047,,Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 200 (MIC=3.1µM)&&Staphylococcus aureus USA 400 (MIC=3.1µM)&&Staphylococcus aureus MU50 (MIC=6.2µM)&&Staphylococcus aureus UAMS-1 (MIC=>25µM)&&Staphylococcus aureus Newman (MIC=3.1µM)&&Staphylococcus epidermidis 1457 (MIC=3.1µM)&&Bacillus subtilis 168 (MIC=6.3µM)&&Escherichia coli ATCC 25922 (MIC=>50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>50µM)&&Pseudomonas aeruginosa PAO1 (MIC=>50µM)&&Candida albicans ATCC 10231 (MIC=12.5µM)&&Candida glabrata ATCC 2001 (MIC=12.5µM)&&Candida tropicalis ATCC 13803 (MIC=3.1µM)&&Mouse breast cancer 4T1 (LC50=20µM)&&Human cervical carcinoma HeLa (LC50=>80µM)&&Staphylococcus aureus USA 300 (MBC=3.1µM),SILPTIVSFLSKVF,,Linear,Free,Free,,L,dbAMP3,14
11136,dbAMP_11136,2N9A,Staphylococcus aureus CCT 6538 (MIC=4µM)&&Staphylococcus saprophyticus (MIC=20µM)&&Bacillus subtilis CCT 2471 (MIC=8µM)&&Bacillus thuringiensis (MIC=20µM)&&Escherichia coli ATCC 25922 (MIC=40µM)&&Escherichia coli CCT 1371 (MIC=20µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=40µM)&&Alcaligenes faecalis ATCC 8750 (MIC=40µM)&&Candida albicans (MIC=20µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=11µM)&&Micrococcus luteus A270 (MIC=0.8µM)&&Escherichia coli SBS 363 (MIC=1.6µM)&&Salmonella enterica subsp. arizonae ATCC 13314 (MIC=25µM)&&Bacillus subtilis ATCC 6633 (MIC=6.2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µM)&&Candida albicans MDM8 (MIC=0.8µM)&&Human breast adenocarcinoma MCF-7 (IC50=12.5µM),SLLSLIRKLIT,,Linear,Free,Free,,L,dbAMP3,11
11155,dbAMP_11155,2GUC&&2GTY,Bovine coronavirus (BCoV)  (EC50=0.057µg/ml)&&Infectious bronchitis virus (IBV/ACoV) (EC50= <0.032µg/ml)&&Murine Hepatitis Virus (MHV/M-CoV) (EC50=0.23µg/ml)&&Transmissible gastroenteritis coronavirus (TGEV/PCoV) (EC50=0.57µg/ml)&&HCoV-OC43 (EC50=0.16µg/ml)&&HCoV-229E (EC50=0.18µg/ml)&&HCoV-NL63 (EC50=<0.0032µg/ml)&&SARS-CoV Urbani (EC50=0.61µg/ml)&&SARS-CoV Tor-II (EC50=0.61µg/ml)&&SARS-CoV CuHK (EC50=0.78µg/ml)&&SARS-CoV Frank (EC50=1.19µg/ml)&&Human colon adenocarcinoma HRT-18G (IC50=32µg/ml)&&Human colon adenocarcinoma HCT-8 (IC50=52µg/ml)&&HIV-1RF (EC50=0.000043µM)&&HIV-1 BaL (IC50 REP=0.000098µM)&&HIV-1 ADA (IC50 REP=0.0005µM)&&HIV-1 ROJO (IC50 REP=0.00063µM)&&HIV-1RF (IC90 F=0.561µM)&&HIV-1 PsV (IC50 I=<0.003µg/ml)&&HIV-1 PsV (IC90 I=0.02-0.50µg/ml),SLTHRKFGGSGGSPFSGLSSIAVRSGSYLDAIIIDGVHHGGSGGNLSPTFTFGSGEYISNMTIRSGDYIDNISFETNMGRRFGPYGGSGGSANTLSNVKVIQINGSAGDYLDSLDIYYEQY,,Linear,Free,Free,,L,dbAMP3,121
11177,dbAMP_11177,2PCO,Arthrobacter globiformis VKM Ac-1112 (MIC=0.5µM)&&Bacillus subtilis VKM B-501 (MIC=1.0µM)&&Escherichia coli DH5alpha (MIC=1.0µM)&&Escherichia coli MH1 (MIC=0.7µM)&&Pseudomonas aeruginosa PAO1 (MIC=4.1µM)&&Pichia pastoris GS115 (MIC=17µM)&&Saccharomyces cerevisiae Y190 (MIC=>33µM)&&DENV-2 (IC50 REP=8.3±1.2µM)&&Human hepatocellular carcinoma HepG2 (50% Cell death=52.51±3.6µM)&&Escherichia coli DSM 1116 (MIC=4µg/ml)&&Acinetobacter sp. DSM 586 (MIC=4µg/ml)&&Bacillus subtilis subsp. spizizenii DSM 347 (MIC=4µg/ml)&&Staphylococcus xylosus DSM 20267 (MIC=4µg/ml),SMWSGMWRRKLKKLRNALKKKLKGE,,Linear,Free,Free,,L,dbAMP3,25
11180,dbAMP_11180,,Didymella arachidicola (IC50=9.8µM)&&Mouse lymphocytic leukemia L1210 (IC50=3.6µM),SNDIYFNFQR,,Linear,Free,Free,,L,dbAMP3,10
11215,dbAMP_11215,,Bacillus subtilis ATCC 9372 (MIC=4µM)&&Bacillus thuringiensis ATCC 1041 (MIC=8µM)&&Staphylococcus aureus ATCC 6538 (MIC=8µM)&&Human acute monocytic leukemia THP-1 (IC50=35µM)&&Human breast adenocarcinoma MCF-7 (IC50=50µM)&&Human hepatocellular carcinoma HepG2 (IC50=92µM),SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK,,Linear,Free,Free,,L,dbAMP3,84
11278,dbAMP_11278,2N0V,Erwinia amylovora PMV 6076 (MIC=>50µM)&&Pseudomonas syringae pv. syringae EPS 94 (MIC=>50µM)&&Xanthomonas campestris pv. Vesicatoria 2133-2 (MIC=>50µM)&&Pseudomonas syringae pv. actinidiae Psa3700.1.1 (MIC=>50µM)&&Xanthomonas fragariae Xf349-9A (MIC=>50µM)&&Xanthomonas arboricola pv. pruni CFBP 5563 (MIC=>50µM)&&Bacillus subtilis ATCC 6633 (MIC=36µM)&&Enterococcus faecalis ATCC 12953 (MIC=36µM)&&Staphylococcus aureus ATCC 29213 (MIC=18µM)&&Streptococcus pyogenes ATCC 19615 (MIC=36µM)&&Escherichia coli ATCC 8739 (MIC=18µM)&&Klebsiella pneumoniae ATCC 13885 (MIC=9µM)&&Proteus mirabilis ATCC 25933 (MIC=18µM)&&Pseudomonas aeruginosa ATCC 15442 (MIC=9µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=18µM)&&Candida albicans 01U (MIC=18µM)&&Candida albicans 38U (MIC=18µM)&&Candida parapsilosis ATCC 22019 (MIC=144µM)&&Cryptococcus neoformans L26 (MIC=144µM)&&Cryptococcus neoformans L30 (MIC=144µM)&&Trichophyton mentagrophytes (MIC=18µM)&&Trichophyton rubrum (MIC=18µM)&&Murine macrophage cells RAW 264.7 (7.5±2.39% Cytotoxicity=400µM)&&Murine macrophage cells RAW 264.7 (0% Cytotoxicity=50µM)&&Human colon adenocarcinoma Caco-2 (44.0±3.10% Cytotoxicity=100µM)&&Human colon adenocarcinoma Caco-2 (12.7±2.37% Cytotoxicity=12.5µM)&&Human breast adenocarcinoma MCF-7 (2.4±1.75% Cytotoxicity=100µM)&&Human breast adenocarcinoma MCF-7 (0% Cytotoxicity=12.5µM)&&Human colon adenocarcinoma HCT 116 (5.8±3.21% Cytotoxicity=100µM)&&Human colon adenocarcinoma HCT 116 (0% Cytotoxicity=12.5µM),SVAGRAQGM,,Linear,Free,Free,,L,dbAMP3,9
11308,dbAMP_11308,,Acinetobacter baumannii (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Escherichia coli KPC 001812446 (MIC=>128µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=128µg/ml)&&Klebsiella pneumoniae (MIC=>128µg/ml)&&Pseudomonas aeruginosa (MIC=128µg/ml)&&Cutibacterium acnes ATCC 51277 C1498 (MIC=>128µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Mouse Myeloid Leukemia C1498 (79.5% Cytotoxicity=50µM)&&Jurkat T-cell leukemia (50% Cytotoxicity=50µM)&&Human myelogenous leukemia K562 (70% Cytotoxicity=50µM)&&Human myeloblastic leukemia Kasumi-1 (90% Cytotoxicity=50µM)&&Human B-lymphoma RAJI (60% Cytotoxicity=50µM)&&Human lymphoblastic leukemia Molt-4 (40% Cytotoxicity=50µM),SWKSMAKKLKEYMEKLKQRA,,Linear,Free,Free,,L,dbAMP3,20
11317,dbAMP_11317,,Hepatitis C virus (HCV) (IC50 REP=0.80±0.09µM)&&HIV (IC50 E=1.30±0.08µM)&&Hepatitis C virus (HCV) JFH-1 (IC50 I=0.79µM)&&Hepatitis C virus (HCV) JFH-1 (IC50 I=0.6µM)&&Hepatitis C virus (HCV) H77 (IC50 I=3.9µM)&&Hepatitis C virus (HCV) Con1 (IC50 I=1.6µM)&&Hepatitis C virus (HCV) J6CF (IC50 I=1.1µM)&&DENV-2 (IC50 I=2.0µM)&&West Nile virus WNV (IC50 I=4.5µM)&&Measles/Rubeola Virus (IC50 I=2.7µM)&&Respiratory syncytial virus (RSV) (IC50 I=4.5µM)&&HIV-1 (IC50 I=1.3µM)&&Adenovirus Ad5 (IC50 I=>18µM)&&Borna disease virus (BDV) (IC50 I=>18µM)&&HCoV-229E (IC50 I=>18µM)&&Coxsackie virus (IC50 I=>18µM)&&Hepatitis B virus (HBV) (IC50 I=>18µM)&&Human Influenza A Virus H1N1 (IC50 I=>18µM)&&Lymphocytic choriomeningitis virus (LCMV) (IC50 I=>18µM)&&Human rhinovirus (HRV) (IC50 I=>18µM)&&Human Rotavirus WISC2 (IC50 I=>18µM)&&Vaccinia virus (VACV) (IC50 I=>18µM)&&Vesicular Stomatitis Virus (VSV) (IC50 I=>18µM)&&Human hepatocellular carcinoma Huh-7.5.1 cells (IC50=79µM),SWLRDIWDWICEVLSDFK,,Linear,Free,Free,,L,dbAMP3,18
11548,dbAMP_11548,,Bacillus subtilis (MIC=2µg/ml)&&Staphylococcus aureus (MIC=4µg/ml)&&Streptococcus mutans (MIC=2µg/ml)&&Streptococcus pneumoniae (MIC=4µg/ml)&&Escherichia coli (MIC=4µg/ml)&&Salmonella typhimurium (MIC=1µg/ml)&&Serratia marcescens (MIC=4µg/ml)&&Pseudomonas putida (MIC=2µg/ml)&&Candida albicans (MIC=1µg/ml)&&Cryptococcus neoformans (MIC=1µg/ml)&&Saccharomyces cerevisiae (MIC=1µg/ml)&&Pyricularia grisea KACC 40425 (MIC=8-16µg/ml)&&Fusarium oxysporum KACC 40902 (MIC=8-16µg/ml)&&Aspergillus terreus KCTC 6178 (MIC=>64µg/ml)&&Aspergillus niger KCTC 6461 (MIC=>64µg/ml)&&Geotrichum candidum KACC 40354 (MIC=16-32µg/ml)&&Cryptococcus neoformans KCCM 50544 (MIC=32-64µg/ml)&&Trichosporon beigelii KCTC 7707 (MIC=16-32µg/ml)&&Candida albicans KCTC 7121 (MIC=32-64µg/ml)&&Candida albicans KCTC 7270 (MIC=>64µg/ml)&&Candida albicans KCTC 7728 (MIC=>64µg/ml)&&Candida albicans KCTC 7729 (MIC=16-32µg/ml)&&Candida albicans KCTC 7965 (MIC=>64µg/ml)&&Candida albicans KCTC 7122 (MIC=32-64µg/ml)&&Candida albicans KCTC 7122 (MIC=>64µg/ml)&&Candida albicans KCTC 7122 (MIC=>64µg/ml)&&HIV-1 IIIB (IC50 REP=>41.1µM)&&Staphylococcus aureus USA 300 (MIC=>71µM)&&Escherichia coli K-12 (MIC=>71µM)&&Escherichia coli BL21 (MBC=0.93µM)&&Escherichia coli BL21 (EC50=0.33±0.005µM)&&Pseudomonas aeruginosa PAO1 (EC50=1.3±0.082µM)&&Pseudomonas aeruginosa PA14 (EC50=1.8±0.005µM)&&Pseudomonas aeruginosa (EC50=>100µM)&&Staphylococcus aureus ATCC 502A (MBC=1.87µM)&&Staphylococcus aureus ATCC 502A (EC50=0.51±0.02µM)&&Staphylococcus aureus 39413 (EC50=6.46±0.002µM)&&Staphylococcus aureus 34026 (EC50=>100µM)&&Staphylococcus aureus 36055 (EC50=>100µM)&&Escherichia coli KCTC 1682 (MIC=8µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=32µM)&&Salmonella typhimurium KCTC 1926 (MIC=8µM)&&Bacillus subtilis KCTC 3068 (MIC=32µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=8µM)&&Staphylococcus aureus KCTC 1621 (MIC=32µM)&&Stenotrophomonas maltophilia (MIC=1-16µg/ml)&&Jurkat T-cell leukemia (IC50=>=65µM)&&Escherichia coli ATCC 23716 (MIC=20µg/ml)&&Bacillus subtilis SMY (MIC=10µg/ml),TRSSRAGLQFPVGRVHRLLRK,,Linear,Free,Free,,L,dbAMP3,21
11686,dbAMP_11686,5HD1&&4EZN&&3DPQ&&3DPP&&3DPO,Escherichia coli JW0013 (MIC=0.150±0.034µM)&&Escherichia coli MC1041 (MIC=0.416±0.205µM)&&Escherichia coli J2210 (MIC=0.786±0.322µM)&&Escherichia coli JJ2489 (MIC=0.600±0.140µM)&&Escherichia coli BW25113 (MIC=0.197±0.088µM)&&Escherichia coli BW25113 (MIC=0.300±0.070µM)&&Escherichia coli BW25113 (MIC=>0.600µM)&&Escherichia coli JW0368 del-sbmA (MIC=2.400±0.499µM)&&Escherichia coli JW2778 del-ygdD (MIC=0.600±0.140µM)&&Escherichia coli (MIC=>0.416µM)&&Escherichia coli (MIC=>0.600µM)&&Salmonella enterica subsp. enterica serovar Enteritidis MH91989 (MIC=1.200±0.278µM)&&Salmonella typhimurium SL1344 (MIC=1.200±0.278µM)&&Salmonella enterica serovar Tennessee (MIC=>0.600µM)&&Salmonella enterica subsp. enterica serovar Newport (MIC=>0.416µM)&&Salmonella enterica subsp. enterica serovar Infantis (MIC=>0.600µM)&&Human epidermoid carcinoma A431 (5% Cytotoxicity=10µM),VDKGSYLPRPTPPRPIYNRN,,Linear,Free,Free,,L,dbAMP3,20
11704,dbAMP_11704,,Feline leukemia virus,VEENMKKLEERLKKREELFKKQEEWFKKWFERSKKFT,,Linear,Free,Free,,L,dbAMP3,37
11765,dbAMP_11765,,HIV-1 (83% PR activity=1µM)&&Rous sarcoma virus (77.7% PR activity=1µM),VHIPLGDA,,Linear,Free,Free,,L,dbAMP3,8
11859,dbAMP_11859,1CW5&&1RY3&&1CW5&&1CW5,Carnobacterium divergens DSM 20623 (MIC=1.25µg/ml)&&Carnobacterium gallinarum DSM 4847 (MIC=1.25µg/ml)&&Carnobacterium maltaromaticum DSM 20730 (MIC=1.25µg/ml)&&Carnobacterium mobile DSM 4848 (MIC=1.25µg/ml)&&Enterococcus durans CIP 55125 (MIC=2µg/ml)&&Enterococcus faecalis CIP 76.117 (MIC=4µg/ml)&&Listeria grayi CIP 6818 (MIC=4µg/ml)&&Listeria innocua CIP 12511 (MIC=4µg/ml)&&Listeria ivanovii CIP 12510 (MIC=4µg/ml)&&Listeria monocytogenes ATCC 15313 (MIC=4µg/ml)&&Listeria monocytogenes CIP 7831 (MIC=4µg/ml)&&Listeria seeligeri SLCC 3954 (MIC=4µg/ml)&&Human colon adenocarcinoma Caco-2 (15% Killing=100µg/ml),VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP,,Linear,Free,Free,,L,dbAMP3,48
11887,dbAMP_11887,,Feline leukemia virus,VRDNMAKLRERLKQRQQLFDSQQGWFEGWFNRSPWFT,,Linear,Free,Free,,L,dbAMP3,37
11913,dbAMP_11913,,HIV-1 (45.4% PR activity=1µM)&&Rous sarcoma virus (75.6% PR activity=1µM),VSIEWRKK,,Linear,Free,Free,,L,dbAMP3,8
11938,dbAMP_11938,,Escherichia coli ATCC 25922 (MIC=>128µM)&&Escherichia coli UB1005 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Salmonella enterica subsp. enterica serovar Pullorum C79-13 (MIC=16µM)&&Salmonella enterica subsp. enterica serovar Typhimurium C77-31 (MIC=>128µM)&&Staphylococcus aureus ATCC 29213 (MIC=>128µM)&&Staphylococcus aureus ATCC 43300 (MIC=>128µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=>128µM)&&Enterococcus faecalis ATCC 29212 (MIC=>128µM)&&Bacillus subtilis CMCC 63501 (MIC=>128µM)&&Human hepatocellular carcinoma HepG2 (20-25% Killing=16-256µM),VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR,,Linear,Free,Free,,L,dbAMP3,32
12052,dbAMP_12052,,Aeromonas salmonicida 99-1 (MIC=>128µg/ml)&&Aeromonas salmonicida 97-4 (MIC=128µg/ml)&&Salmonella enterica serovar typhimurium MS7953s (MIC=64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028s (MIC=>64µg/ml)&&Pseudomonas aeruginosa K799 (MIC=64µg/ml)&&Pseudomonas aeruginosa Z61 (MIC=32µg/ml)&&Escherichia coli CGSC 4908 (MIC=64µg/ml)&&Escherichia coli UB1005 (MIC=64µg/ml)&&Escherichia coli DC2 (MIC=64µg/ml)&&Staphylococcus epidermidis C621 (MIC=>64µg/ml)&&Staphylococcus aureus C623 (MIC=>64µg/ml)&&Candida albicans C627 (MIC=>64µg/ml)&&Human promyelocytic leukemia HL-60 (50% Cell death=>128µg/ml),WLRRIGKGVKIIGGAALDHL,,Linear,Free,Free,,L,dbAMP3,20
12323,dbAMP_12323,,HIV-1 IIIB (IC50 REP=0.006µg/ml)&&HIV-1 098 (IC50 REP=0.05µg/ml)&&HIV-1 098-T20 (IC50 REP=0.526µg/ml)&&HIV-1 098-T1249 (IC50 REP=54.958µg/ml)&&HIV-1 098-T651 (IC50 REP=47.822µg/ml)&&HIV-1 NL4-3 (IC50 REP=0.015±0.001µM)&&HIV-1 NL4-3 D36G (IC50 REP=0.0024±0.0006µM)&&HIV-1 NL4-3 D36G/V38A (IC50 REP=0.023±0.008µM)&&HIV-1 NL4-3 D36G/N43D (IC50 REP=0.049±0.01µM)&&HIV-1 NL4-3 D36G/N43D/S138A (IC50 REP=0.084±0.016µM)&&HIV-1 NL4-3 D36G/N126K (IC50 REP=0.0034±0.0006µM)&&HIV-1 NL4-3 DelV4/D36G/I37K/N126K/L204I (IC50 REP=0.39±0.155µM)&&HIV-1 (IC50 REP=0.0024±0.0006µM)&&HIV-1 NL4-3 V38A (IC50 REP=0.023±0.0082µM)&&HIV-1 NL4-3 N43D (IC50 REP=0.049±0.01µM)&&HIV-1 NL4-3 N43D/S138A (IC50 REP=0.084±0.016µM)&&HIV-1 IIIB (IC50 I=0.0718µM)&&HIV-1 IIIB (IC50 F=0.091µM)&&HIV-1 BaL (IC50 I=0.0705µM)&&HIV-1 (IC50 I=0.0204-0.0462µM)&&HIV-1 PsV (IC50 I=0.0071-0.0293µM)&&HIV-1 9489 (IC50 I=0.0553µM)&&HIV-1 NL4-3 V38A (IC50 I=>0.5µM)&&HIV-1 (IC50 F=0.00253µM)&&HIV-1 IIIB (IC50 I=0.118µM)&&HIV-1 IIIB (IC50 F=0.02297µM)&&HIV-1 BaL (IC50 I=0.01643µM)&&HIV-1 (IC50 I=0.0129-0.0422µM)&&HIV-1 PsV (IC50 I=0.0266-0.055µM)&&HIV-1 NL4-3 V38A (IC50 I=>0.5µM)&&HIV-1 NL4-3 D36G (IC50 I=>0.5µM)&&HIV-1 NL4-3 (IC50 I=0.37µg/ml)&&HIV-1 JRCSF (IC50 I=0.09µg/ml)&&HIV-1 PsV (IC50 I=0.02-3.58µg/ml)&&HIV-2 ROD (IC50 I=0.341508µM)&&HIV-2 (IC50 I=0.630633µM)&&HIV-1 PsV (IC50 I=0.03473667µM)&&HIV-1 NL4-3 (IC50 I=0.05302764µM)&&HIV-1 JRCSF (IC50 I=0.00446808µM)&&HIV-1 NL4-3 D36G (IC50 I=0.008564µM)&&HIV-1 NL4-3 (IC50 I=0.169333µM)&&HIV-1 NL4-3 (IC50 I=0.317333-7.901µM)&&HIV-1 (IC50 F=0.00863144µM)&&Simian immunodeficiency virus (SIV) (IC50 I=0.53433-0.915516µM)&&HIV-1 HxB2 (IC50 F=0.0259051µM)&&HIV-1 NL4-3 D36G PsV (IC50 I=0.008564µM)&&HIV-1 NL4-3 (IC50 I=0.04738667µM)&&HIV-1 JRCSF (IC50 I=0.00296833µM)&&HIV-1 (IC50 I=0.00116333-0.031310µM)&&HIV-1 (IC50 I=0.02995009µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=148.73µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=167.25µM),YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,,Linear,Free,Free,,L,dbAMP3,36
12348,dbAMP_12348,,HIV-1 (24.9% PR activity=1µM)&&Rous sarcoma virus (87.8% PR activity=1µM),YVSGKARGWFYRHHYESPHPRISSEVHIPLGDARLV,,Linear,Free,Free,,L,dbAMP3,36
12359,dbAMP_12359,,Escherichia coli CPCC 100521 (MIC=64µg/ml)&&Escherichia coli CPCC 100521 (MBC=64µg/ml)&&Staphylococcus aureus CPCC 100520 (MIC=64µg/ml)&&Staphylococcus aureus CPCC 100520 (MBC=128µg/ml)&&Candida albicans CPCC 400416 (MIC=128µg/ml)&&Candida albicans CPCC 400416 (MBC=256µg/ml)&&Human liver carcinoma SK-HEP-1 (IC50=0.76µM)&&Human hepatocellular carcinoma HepG2 (IC50=3.75µM)&&Human hepatocellular carcinoma Huh7 (IC50=3.91µM),GIGSAILSAGKSIIKGLAKGLAEHF,,Linear,Free,Free,,L,dbAMP3,25
12360,dbAMP_12360,,Escherichia coli CPCC 100521 (MIC=>256µg/ml)&&Escherichia coli CPCC 100521 (MBC=>256µg/ml)&&Staphylococcus aureus CPCC 100520 (MIC=>256µg/ml)&&Staphylococcus aureus CPCC 100520 (MBC=>256µg/ml)&&Candida albicans CPCC 400416 (MIC=256µg/ml)&&Candida albicans CPCC 400416 (MBC=256µg/ml)&&Human liver carcinoma SK-HEP-1 (IC50=3.61µM)&&Human hepatocellular carcinoma HepG2 (IC50=8.08µM)&&Human hepatocellular carcinoma Huh7 (IC50=8.42µM),IIGPVLGLVGKALGGLL,,Linear,Free,Free,,L,dbAMP3,17
12367,dbAMP_12367,,Candida albicans NCPF 1467 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Human squamous lung carcinoma NCI-H157 (IC50=34.56µM)&&Human glioblastoma U251-MG (IC50=25.13µM)&&Human prostate adenocarcinoma PC-3 (IC50=38.56µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=33.23µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=125µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM)&&Staphylococcus aureus ATCC 25923(RifR) (MIC=16µM)&&Staphylococcus aureus ATCC 25923(GenR) (MIC=8µM)&&Escherichia coli ATCC 25922(RifR) (MIC=32µM)&&Escherichia coli ATCC 25922(GenR) (MIC=32µM),FLPIVAKLLSGLL,,Linear,Free,Free,,L,dbAMP3,13
12767,dbAMP_12767,,Bacillus subtilis MTCC 2756 (MIC=16µg/ml)&&Bacillus subtilis MTCC 2756 (MBC=32µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=16µg/ml)&&Staphylococcus aureus MTCC 902 (MBC=32µg/ml)&&Escherichia coli MTCC 2622 (MIC=500µg/ml)&&Escherichia coli MTCC 2622 (MBC=500µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MIC=125µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MBC=250µg/ml)&&Klebsiella pneumoniae MTCC 109 (MIC=250µg/ml)&&Klebsiella pneumoniae MTCC 109 (MBC=500µg/ml)&&Staphylococcus simulans MTCC 3610 (MIC=64µg/ml)&&Staphylococcus simulans MTCC 3610 (MBC=125µg/ml)&&Aspergillus flavus MTCC 183 (MIC=32µg/ml)&&Candida albicans MTCC 277 (MIC=64µg/ml)&&Fusarium oxysporum MTCC 284 (MIC=16µg/ml)&&Rhizoctonia solani MTCC 4634 (MIC=16µg/ml)&&Penicillium expansum MTCC 2006 (MIC=8µg/ml)&&Goffeauzyma gastrica MTCC 1715 (MIC=32µg/ml)&&Candida tropicalis MTCC 184 (MIC=128µg/ml)&&Trichophyton rubrum MTCC 296 (MIC=64µg/ml)&&Human myelogenous leukemia K562 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM)&&Staphylococcus aureus ATCC 43300 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 43300 (MBC=32µg/ml)&&Human cervical carcinoma HeLa (IC50=>200µM)&&Human hepatocellular carcinoma HepG2 (IC50=>200µM)&&Human lung carcinoma A549 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Bacillus subtilis ATCC 23857 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 12600 (MIC=16µg/ml)&&Staphylococcus simulans ATCC 27848 (MIC=64µg/ml)&&Escherichia coli ATCC 35218 (MIC=512µg/ml)&&Klebsiella pneumoniae ATCC 43816 (MIC=256µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=128µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=32µg/ml)&&Candida albicans ATCC 10231 (MIC=64µg/ml)&&Goffeauzyma gastrica ATCC 32042 (MIC=32µg/ml)&&Trichophyton rubrum ATCC 28191 (MIC=64µg/ml)&&Fusarium oxysporum ATCC 14838 (MIC=16µg/ml)&&Rhizoctonia solani ATCC 10182 (MIC=16µg/ml)&&Penicillium expansum ATCC 16104 (MIC=8µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=128µg/ml)&&Botrytis cinerea (MIC=>100µg/ml)&&Alternaria solani (MIC=>100µg/ml)&&Alternaria alternata (MIC=>100µg/ml)&&Colletotrichum gloeosporioides (MIC=>100µg/ml)&&Fusarium solani (MIC=>100µg/ml)&&Fusarium oxysporum (MIC=>100µg/ml)&&Fusarium graminearum (MIC=>100µg/ml),WP,,Linear,Free,Free,,L,dbAMP3,2
12828,dbAMP_12828,,Staphylococcus aureus NRRLB-767 (MIC=20µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=20µg/ml)&&Human esophageal carcinoma Eca 109 (IC50=20µM)&&Human cervical carcinoma HeLa S3 (45% Inhibition=20µM)&&Human pancreatic carcinoma Panc-1 (56% Inhibition=20µM),PI,,Linear,Free,Free,,L,dbAMP3,2
12830,dbAMP_12830,,Bacillus subtilis MTCC 2756 (MIC=16µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=16µg/ml)&&Escherichia coli MTCC 2622 (MIC=8µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MIC=32µg/ml)&&Aspergillus flavus MTCC 183 (MIC=128µg/ml)&&Candida albicans MTCC 277 (MIC=64µg/ml)&&Fusarium oxysporum MTCC 284 (MIC=4µg/ml)&&Rhizoctonia solani MTCC 4634 (MIC=4µg/ml)&&Penicillium expansum MTCC 2006 (MIC=2µg/ml)&&Staphylococcus epidermidis MTCC 435 (MIC=250µg/ml)&&Staphylococcus epidermidis MTCC 435 (MBC=500µg/ml)&&Klebsiella pneumoniae MTCC 109 (MIC=32µg/ml)&&Klebsiella pneumoniae MTCC 109 (MBC=64µg/ml)&&Proteus mirabilis MTCC 425 (MIC=64µg/ml)&&Proteus mirabilis MTCC 425 (MBC=125µg/ml)&&Vibrio cholerae MTCC 3905 (MIC=125µg/ml)&&Vibrio cholerae MTCC 3905 (MBC=250µg/ml)&&Human esophageal carcinoma Eca 109 (42% Inhibition=20µM)&&Human cervical carcinoma HeLa S3 (36% Inhibition=20µM)&&Human pancreatic carcinoma Panc-1 (IC50=20µM)&&Ralstonia solanacearum ATCC BAA-1114 (MIC=1000µM)&&Pyricularia grisea ATCC 201236 (29.55% Inhibition=50µM)&&Pyricularia grisea ATCC 201236 (70.51% Inhibition=100µM)&&Pyricularia grisea ATCC 201236 (93.56% Inhibition=250µM)&&Staphylococcus aureus NRRLB-767 (MIC=10µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=10µg/ml)&&Escherichia coli ATCC 25922 (MIC=30µg/ml)&&Klebsiella pneumoniae ATCC BAA-1705 (MIC=30µg/ml)&&Proteus vulgaris ATCC 7829 (MIC=30µg/ml),PF,,Linear,Free,Free,,L,dbAMP3,2
12831,dbAMP_12831,,Chromobacterium violaceum ATCC 31532 (59% Inhibition=15000µM)&&Pseudomonas aeruginosa PAO1 (100% Inhibition=15000µM)&&Human lung carcinoma A549 (22% Cytotoxicity=1000µM),WE,,Linear,Free,Free,,L,dbAMP3,2
12832,dbAMP_12832,,Human myelogenous leukemia K562 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM)&&Acinetobacter baumannii (MIC=12.5-25µg/ml)&&Acinetobacter baumannii (MIC=>100µg/ml)&&Candida albicans IFO 6258 (MIC=50µg/ml)&&Micrococcus luteus JCM 1464 (MIC=12.5µg/ml)&&Bacillus subtilis IAM 1069 (MIC=50µg/ml)&&Aspergillus niger ATCC 9642 (MIC=25µg/ml)&&Streptomyces murinus JCM 4333 (MIC=>100µg/ml)&&Staphylococcus aureus TK784 (MIC=0.8µg/ml)&&Saccharomyces cerevisiae IFO 1008 (MIC=25µg/ml)&&Human cervical carcinoma HeLa (IC50=>200µM)&&Human hepatocellular carcinoma HepG2 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Bacillus subtilis ATCC 23857 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 12600 (MIC=16µg/ml)&&Staphylococcus simulans ATCC 27848 (MIC=128µg/ml)&&Escherichia coli ATCC 35218 (MIC=256µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=256µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=64µg/ml)&&Candida albicans ATCC 10231 (MIC=128µg/ml)&&Goffeauzyma gastrica ATCC 32042 (MIC=64µg/ml)&&Trichophyton rubrum ATCC 28191 (MIC=64µg/ml)&&Fusarium oxysporum ATCC 14838 (MIC=64µg/ml)&&Rhizoctonia solani ATCC 10182 (MIC=16µg/ml)&&Penicillium expansum ATCC 16104 (MIC=16µg/ml),WW,,Linear,Free,Free,,L,dbAMP3,2
12838,dbAMP_12838,,Enterococcus faecium K-99-38 (MIC=32µg/ml)&&Enterococcus faecalis K-99-17 (MIC=16µg/ml)&&Enterococcus faecalis K-99-258 (MIC=8µg/ml)&&Enterococcus faecium K-01-312 (MIC=64µg/ml)&&Enterococcus faecalis K-01-511 (MIC=64µg/ml)&&Escherichia coli ATCC 10536 (MIC=16µg/ml)&&Bacillus subtilis IAM 1069 (MIC=32µg/ml)&&Micrococcus luteus ATCC 4698 (MIC=128µg/ml)&&Enterococcus faecalis ATCC 10541 (MIC=256µg/ml)&&Pseudomonas aeruginosa ATCC 14502 (MIC=32µg/ml)&&Staphylococcus aureus TK784 (MIC=64µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=256µg/ml)&&Candida albicans (MIC=32µg/ml)&&Candida glabrata CMPG 681 (MIC=16µg/ml)&&Candida tropicalis CMPG 678 (MIC=8µg/ml)&&Candida tropicalis CMPG 849 (MIC=8µg/ml)&&Cryptococcus neoformans ATCC 13690 (MIC=16µg/ml)&&Cryptococcus neoformans CMPG 682 (MIC=32µg/ml)&&Bacillus subtilis (MIC=13.55µg/ml)&&Staphylococcus aureus (MIC=12.06µg/ml)&&Salmonella typhimurium (MIC=12.98µg/ml)&&Escherichia coli (MIC=10.41µg/ml)&&Human glioblastoma U87-MG (IC50=1.3±0.1µM)&&Human glioblastoma U251-MG (IC50=19.8±0.8µM),LP,,Linear,Free,Free,,L,dbAMP3,2
12941,dbAMP_12941,,Staphylococcus epidermidis MTCC 10623 (MIC=128µg/ml)&&Staphylococcus epidermidis MTCC 10623 (MBC=128µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=32µg/ml)&&Staphylococcus aureus MTCC 902 (MBC=64µg/ml)&&Aspergillus flavus MTCC 183 (MIC=250µg/ml)&&Candida albicans MTCC 277 (MIC=32µg/ml)&&Candida tropicalis MTCC 184 (MIC=16µg/ml)&&Trichophyton rubrum MTCC 296 (MIC=32µg/ml)&&Cryptococcus neoformans (MIC=16µg/ml)&&Human esophageal carcinoma Eca 109 (38% Inhibition=20µM)&&Human cervical carcinoma HeLa S3 (51% Inhibition=20µM)&&Human pancreatic carcinoma Panc-1 (31% Inhibition=20µM),LV,,Linear,Free,Free,,L,dbAMP3,2
13176,dbAMP_13176,,Human lung carcinoma A549 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM),WH,,Linear,Free,Free,,L,dbAMP3,2
13177,dbAMP_13177,,Chromobacterium violaceum ATCC 31532 (11% Inhibition=15000µM)&&Pseudomonas aeruginosa PAO1 (83% Inhibition=15000µM)&&Human lung carcinoma A549 (12% Cytotoxicity=1000µM),WT,,Linear,Free,Free,,L,dbAMP3,2
13206,dbAMP_13206,,Bacillus subtilis MTCC 2756 (MIC=32µg/ml)&&Bacillus subtilis MTCC 2756 (MBC=64µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=64µg/ml)&&Staphylococcus aureus MTCC 902 (MBC=64µg/ml)&&Escherichia coli MTCC 2622 (MIC=32µg/ml)&&Escherichia coli MTCC 2622 (MBC=32µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MIC=16µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MBC=16µg/ml)&&Staphylococcus epidermidis MTCC 435 (MIC=8µg/ml)&&Staphylococcus epidermidis MTCC 435 (MBC=16µg/ml)&&Proteus mirabilis MTCC 425 (MIC=32µg/ml)&&Proteus mirabilis MTCC 425 (MBC=64µg/ml)&&Vibrio cholerae MTCC 3905 (MIC=125µg/ml)&&Vibrio cholerae MTCC 3905 (MBC=250µg/ml)&&Klebsiella pneumoniae MTCC 109 (MIC=64µg/ml)&&Klebsiella pneumoniae MTCC 109 (MBC=64µg/ml)&&Staphylococcus simulans MTCC 3610 (MIC=32µg/ml)&&Staphylococcus simulans MTCC 3610 (MBC=64µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi MTCC 3216 (MIC=16µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi MTCC 3216 (MBC=32µg/ml)&&Aspergillus flavus MTCC 183 (MIC=250µg/ml)&&Candida albicans MTCC 277 (MIC=250µg/ml)&&Fusarium oxysporum MTCC 284 (MIC=64µg/ml)&&Rhizoctonia solani MTCC 4634 (MIC=64µg/ml)&&Penicillium expansum MTCC 2006 (MIC=32µg/ml)&&Candida tropicalis MTCC 184 (MIC=500µg/ml)&&Trichophyton rubrum MTCC 296 (MIC=500µg/ml)&&Human lung carcinoma A549 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM)&&Human cervical carcinoma HeLa (IC50=>200µM)&&Human hepatocellular carcinoma HepG2 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Bacillus subtilis ATCC 23857 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 12600 (MIC=64µg/ml)&&Staphylococcus epidermidis ATCC 51625 (MIC=8µg/ml)&&Staphylococcus simulans ATCC 27848 (MIC=32µg/ml)&&Escherichia coli ATCC 35218 (MIC=32µg/ml)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µg/ml)&&Proteus mirabilis ATCC 21100 (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=16µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=256µg/ml)&&Candida albicans ATCC 10231 (MIC=256µg/ml)&&Trichophyton rubrum ATCC 28191 (MIC=512µg/ml)&&Fusarium oxysporum ATCC 14838 (MIC=64µg/ml)&&Rhizoctonia solani ATCC 10182 (MIC=64µg/ml)&&Penicillium expansum ATCC 16104 (MIC=32µg/ml)&&Alternaria brassicae ATCC 66981 (MIC=512µg/ml),WY,,Linear,Free,Free,,L,dbAMP3,2
13573,dbAMP_13573,,Avian sarcoma and leukosis virus- A,RLASWSVKQANLTTSLLGDLLDDVT,,Linear,Free,Free,,L,dbAMP3,25
13574,dbAMP_13574,,Avian sarcoma and leukosis virus- A,LLGDLLDDVTSIRHAVLQNRAAIDF,,Linear,Free,Free,,L,dbAMP3,25
13575,dbAMP_13575,,Avian sarcoma and leukosis virus- A,FNLSDHSESIQKKFQLMKEHVNKIG,,Linear,Free,Free,,L,dbAMP3,25
13576,dbAMP_13576,,Avian sarcoma and leukosis virus- A,SDHSESIQKKFQLMKEHVNKIGVDS,,Linear,Free,Free,,L,dbAMP3,25
13577,dbAMP_13577,,Avian sarcoma and leukosis virus- A,IEPHDWTKNITDKIDQIIHDFVDKT,,Linear,Free,Free,,L,dbAMP3,25
13578,dbAMP_13578,,Avian sarcoma and leukosis virus- A,HDWTKNITDKIDQIIHDFVDKTLPD,,Linear,Free,Free,,L,dbAMP3,25
14010,dbAMP_14010,,Feline leukemia virus,YADHTGLVRDNMAKLRERLKQRQQLFDSQQGWFEGWFNRSPWFTT,,Linear,Free,Free,,L,dbAMP3,45
14011,dbAMP_14011,,Feline leukemia virus,YADHTGLVRDNMAKL,,Linear,Free,Free,,L,dbAMP3,15
14012,dbAMP_14012,,Feline leukemia virus,GLVRDNMAKLRERLK,,Linear,Free,Free,,L,dbAMP3,15
14013,dbAMP_14013,,Feline leukemia virus,NMAKLRERLKQRQQL,,Linear,Free,Free,,L,dbAMP3,15
14014,dbAMP_14014,,Feline leukemia virus,RERLKQRQQLFDSQQ,,Linear,Free,Free,,L,dbAMP3,15
14015,dbAMP_14015,,Feline leukemia virus,QRQQLFDSQQGWFEG,,Linear,Free,Free,,L,dbAMP3,15
14016,dbAMP_14016,,Feline leukemia virus,FDSQQGWFEGWFNRS,,Linear,Free,Free,,L,dbAMP3,15
14017,dbAMP_14017,,Feline leukemia virus,KQRQQLFDSQQGWFEGWFNRSPWFT,,Linear,Free,Free,,L,dbAMP3,25
14018,dbAMP_14018,,Feline leukemia virus,VEELMKLLEELLKKLEELFKKLEEWFKKWFELSKKFT,,Linear,Free,Free,,L,dbAMP3,37
14040,dbAMP_14040,,Hepatitis C virus (HCV) JFH-1 (IC50 I=0.67µM)&&Human hepatocellular carcinoma Huh-7.5.1 cells (50% Cytotoxicity=>100µg/ml),EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM,,Linear,Free,Free,,L,dbAMP3,61
14263,dbAMP_14263,,Murine leukemia virus,LVRDSMAKLRERLNQRQKLFESTQ,,Linear,Free,Free,,L,dbAMP3,24
14266,dbAMP_14266,,SARS-CoV (IC50 F=3.97µM)&&Human cervical carcinoma HeLa (0% Cytotoxicity=25µM),QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,,Linear,Free,Free,,L,dbAMP3,46
14267,dbAMP_14267,,SARS-CoV (IC50 F=5.07µM)&&Human cervical carcinoma HeLa (0% Cytotoxicity=25µM),QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE,,Linear,Free,Free,,L,dbAMP3,46
14512,dbAMP_14512,,Kaposi's sarcoma-associated herpesvirus,PLETLMAKAIDAGFIR,,Linear,Free,Free,,L,dbAMP3,16
14513,dbAMP_14513,,Kaposi's sarcoma-associated herpesvirus,PSQPTYPGDDAPLEDLMAFAIDLSFYLGVV,,Linear,Free,Free,,L,dbAMP3,30
14643,dbAMP_14643,,Human lung carcinoma A549 (EC50=10µM)&&Ehrlich's ascites carcinoma (50% Cell death=55µg/ml),GIGKFLKKAKKFAKAFVKIINN,,Linear,Free,Free,,L,dbAMP3,22
14647,dbAMP_14647,,Colon Cancer (Not Available),KAQIRAMECNIL,,Linear,Free,Free,,L,dbAMP3,12
14651,dbAMP_14651,,Skin Cancer (Not Available),VAKALKALLKALKAL,,Linear,Free,Free,,L,dbAMP3,15
14652,dbAMP_14652,,Skin Cancer (Not Available),VAKALAKALLKALKAL,,Linear,Free,Free,,L,dbAMP3,16
14655,dbAMP_14655,,Human lung carcinoma A549 (IC50=52±3µM)&&Human lung carcinoma A549 (IC50=27±1µM)&&Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=8µM)&&Micrococcus luteus ATCC 10420 (MIC=2µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=4µM)&&Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus ATCC 43300 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM)&&Human pancreatic carcinoma Panc-1 (IC50=57µM),FLGALFHALSKLL,,Linear,Free,Free,,L,dbAMP3,13
14656,dbAMP_14656,,Human lung carcinoma A549 (IC50=64±3µM)&&Human lung carcinoma A549 (IC50=23±2µM)&&Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=8µM)&&Micrococcus luteus ATCC 10420 (MIC=8µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=8µM)&&Staphylococcus aureus ATCC 43300 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Human pancreatic carcinoma Panc-1 (IC50=77µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM),FLGALFKALSHLL,,Linear,Free,Free,,L,dbAMP3,13
14657,dbAMP_14657,,Colon Cancer (Inhibition at 9-11g/l),YPFPG,,Linear,Free,Free,,L,dbAMP3,5
14658,dbAMP_14658,,Colon Cancer (Inhibition at 12-15g/l),RYLGYL,,Linear,Free,Free,,L,dbAMP3,6
14659,dbAMP_14659,,Colon Cancer (Inhibition at 24-28g/l),PPPEE,,Linear,Free,Free,,L,dbAMP3,5
14660,dbAMP_14660,,Blood Cancer (NA),YGRKKRRQRRRREADFFWSLCTADMS,,Linear,Free,Free,,L,dbAMP3,26
14663,dbAMP_14663,,Pancreatic Cancer (39% inhibition at 7 mg/kg/d),HSHRDFQPVLHLVALNSPLSGGMRG,,Linear,Free,Free,,L,dbAMP3,25
14664,dbAMP_14664,,Pancreatic Cancer (19% inhibition at 7 mg/kg/d),MRGIRGADFQAFQQARAVGLAGTFR,,Linear,Free,Free,,L,dbAMP3,25
14665,dbAMP_14665,,Pancreatic Cancer (No inhibition at 7 mg/kg/d),TFRAFLSSRLQDLYSIVRRADRAAV,,Linear,Free,Free,,L,dbAMP3,25
14666,dbAMP_14666,,Pancreatic Cancer (No inhibition at 7 mg/kg/d),AAVPIVNLKDELLFPSWEALFSGSE,,Linear,Free,Free,,L,dbAMP3,25
14667,dbAMP_14667,,Pancreatic Cancer (29% inhibition at 7 mg/kg/d),GSEGPLKPGARIFSFDGKDVLRHPT,,Linear,Free,Free,,L,dbAMP3,25
14668,dbAMP_14668,,Pancreatic Cancer (No inhibition at 7 mg/kg/d),HPTWPQKSVWHGSDPNGRRLTESY,,Linear,Free,Free,,L,dbAMP3,24
14669,dbAMP_14669,,Pancreatic Cancer (No inhibition at 7 mg/kg/d),ETWRTEAPSATGQASSLLGGRLLGQ,,Linear,Free,Free,,L,dbAMP3,25
14670,dbAMP_14670,,Pancreatic Cancer (No inhibition at 7 mg/kg/d),LGQSAASAHHAYIVLAIENSFMTASKKK,,Linear,Free,Free,,L,dbAMP3,28
14672,dbAMP_14672,,Tumor (Not Available),LIAHNQVRQV,,Linear,Free,Free,,L,dbAMP3,10
14673,dbAMP_14673,,Tumor (Not Available),GVGSPYVSRLLGICL,,Linear,Free,Free,,L,dbAMP3,15
14681,dbAMP_14681,,Prostate Cancer (graph fig 8 A),GLFGKLIKKFARKAISYAVKKARGKH,,Linear,Free,Free,,L,dbAMP3,26
14682,dbAMP_14682,,Oral Cancer (Not Available),FRKSKEKIGKEFKRIVQRIKDFLRNLV,,Linear,Free,Free,,L,dbAMP3,27
14696,dbAMP_14696,,Staphylococcus aureus ATCC 2592 (MIC=17µM)&&Escherichia coli ATCC 25922 (MIC=33µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>44µM)&&Candida albicans ATCC 2002 (MIC=>44µM)&&Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Candida albicans NCPF 1467 (MIC=>512µM)&&Staphylococcus aureus ATCC 12493 (MIC=512µM)&&Human squamous lung carcinoma NCI-H157 (IC50=77.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=300.9µM)&&Human glioblastoma U251-MG (IC50=144.3µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=780.0µM)&&Human breast adenocarcinoma MCF-7 (IC50=498.4µM),FLPLLLSALPSFLCLVFKKC,,Linear,Free,Free,,L,dbAMP3,20
14727,dbAMP_14727,,Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MBC=10.0±2.0µg/ml)&&Salmonella enterica serovar Typhimurium CS009 (MBC=5.7±1.0µg/ml)&&Salmonella enterica serovar Typhimurium CS053 (MBC=6.4±0.9µg/ml)&&Salmonella enterica serovar Typhimurium (MBC=19.0±3.8µg/ml)&&Pseudomonas aeruginosa H103 (MIC=2µg/ml)&&Escherichia coli UB1005 (MIC=0.5-2µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=4µg/ml)&&Staphylococcus epidermidis (MIC=0.2µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=4µg/ml)&&Candida albicans (MIC=4µg/ml)&&Mycobacterium tuberculosis H37Rv (MIC=3.2±0.10µg/ml)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli ATCC 25922 (MBC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MBC=4µM)&&Human cervical carcinoma HeLa (IC50=>50µM)&&Staphylococcus aureus ATCC 29213 (MIC=2µg/ml)&&Staphylococcus aureus MR (MIC=2µg/ml)&&Escherichia coli (MIC=2µg/ml)&&Enterococcus faecalis NCTC 12203 (MIC=2µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=4µg/ml)&&Staphylococcus epidermidis (MIC=0.5µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=8µM)&&Pseudomonas aeruginosa 910 (MIC=16µM)&&Pseudomonas aeruginosa 919 (MIC=16µM)&&Pseudomonas aeruginosa 253 (MIC=8µM),RRWRIVVIRVRR,,Linear,Free,Free,,L,dbAMP3,12
14728,dbAMP_14728,,Mycobacterium tuberculosis lux (MIC90=24.8µM)&&Mycobacterium tuberculosis lux (MIC50=2.6µM)&&Mycobacterium smegmatis mc2-6 (MIC90=6.2µM)&&Pseudomonas aeruginosa H103 (MIC=5.6µM)&&Escherichia coli UB1005 (MIC=1.4µM)&&Salmonella enterica serovar Typhimurium (MIC=2.8µM)&&Candida albicans (MIC=11.1µM)&&Staphylococcus epidermidis (MIC=0.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=1.4µM)&&Human acute monocytic leukemia THP-1 (IC50=33.1µM),RRWKIVVIRWRR,,Linear,Free,Free,,L,dbAMP3,12
14782,dbAMP_14782,,Candida albicans KCTC 7121 (MIC=25µM)&&Trichosporon beigelii KCTC 7251 (MIC=12.5µM)&&Aspergillus flavus KCTC 7375 (MIC=25µM)&&Fusarium oxysporum KCTC 6084 (MIC=50µM)&&Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.125µM)&&Proteus vulgaris (MIC=6.25µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=3.0µM)&&Jurkat cells E6-1 (IC50=9.0µM)&&Human myelogenous leukemia K562 (IC50=3.0µM),KWKLFKKILKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,18
14783,dbAMP_14783,,Candida albicans KCTC 7121 (MIC=50µM)&&Trichosporon beigelii KCTC 7251 (MIC=50µM)&&Aspergillus flavus KCTC 7375 (MIC=50µM)&&Fusarium oxysporum KCTC 6084 (MIC=50µM)&&Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=9.5µM)&&Jurkat cells E6-1 (IC50=12.5µM)&&Human myelogenous leukemia K562 (IC50=6.0µM),WKLFKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,17
14784,dbAMP_14784,,Escherichia coli KCTC 1682 (MIC=6.26µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=0.78µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=11.0µM)&&Jurkat cells E6-1 (IC50=11.0µM)&&Human myelogenous leukemia K562 (IC50=7.0µM),FKLFKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,17
14785,dbAMP_14785,,Candida albicans KCTC 7121 (MIC=50µM)&&Trichosporon beigelii KCTC 7251 (MIC=50µM)&&Aspergillus flavus KCTC 7375 (MIC=100µM)&&Fusarium oxysporum KCTC 6084 (MIC=100µM)&&Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=17.0µM)&&Jurkat cells E6-1 (IC50=17.0µM)&&Human myelogenous leukemia K562 (IC50=11.0µM),KWFKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,16
14786,dbAMP_14786,,Candida albicans KCTC 7121 (MIC=100µM)&&Trichosporon beigelii KCTC 7251 (MIC=100µM)&&Aspergillus flavus KCTC 7375 (MIC=100µM)&&Fusarium oxysporum KCTC 6084 (MIC=100µM)&&Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=32.0µM)&&Jurkat cells E6-1 (IC50=23.0µM)&&Human myelogenous leukemia K562 (IC50=24.0µM),WFKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,15
14787,dbAMP_14787,,Candida albicans KCTC 7121 (MIC=200µM)&&Trichosporon beigelii KCTC 7251 (MIC=200µM)&&Aspergillus flavus KCTC 7375 (MIC=200µM)&&Fusarium oxysporum KCTC 6084 (MIC=200µM)&&Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.125µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=<100µM)&&Jurkat cells E6-1 (IC50=<100µM)&&Human myelogenous leukemia K562 (IC50=<100µM),WKKIPKFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,14
14788,dbAMP_14788,,Escherichia coli KCTC 1682 (MIC=3.125µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.125µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=1.56µM)&&Bacillus megaterium KCTC 1096 (MIC=0.78µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=5.0µM)&&Jurkat cells E6-1 (IC50=4.0µM)&&Human myelogenous leukemia K562 (IC50=4.2µM),KWFKKIPKFLHLLKKF,,Linear,Free,Free,,L,dbAMP3,16
14789,dbAMP_14789,,Escherichia coli KCTC 1682 (MIC=3.125µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=1.56µM)&&Proteus vulgaris (MIC=12.5µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=0.78µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=5.0µM)&&Jurkat cells E6-1 (IC50=6.0µM)&&Human myelogenous leukemia K562 (IC50=3.0µM),WFKKIPKFLHLLKKF,,Linear,Free,Free,,L,dbAMP3,15
14790,dbAMP_14790,,Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.125µM)&&Proteus vulgaris (MIC=12.5µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=17.0µM)&&Jurkat cells E6-1 (IC50=14.0µM)&&Human myelogenous leukemia K562 (IC50=10.0µM),WKKIPKFLHLLKKF,,Linear,Free,Free,,L,dbAMP3,14
14791,dbAMP_14791,,Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=26.0µM)&&Jurkat cells E6-1 (IC50=32.0µM)&&Human myelogenous leukemia K562 (IC50=31.0µM),KWKLFKKIPFLHLAKKF,,Linear,Free,Free,,L,dbAMP3,17
14792,dbAMP_14792,,Candida albicans KCTC 7121 (MIC=25µM)&&Trichosporon beigelii KCTC 7251 (MIC=25µM)&&Aspergillus flavus KCTC 7375 (MIC=25µM)&&Fusarium oxysporum KCTC 6084 (MIC=25µM)&&Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=1.56µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=38.0µM)&&Jurkat cells E6-1 (IC50=26.0µM)&&Human myelogenous leukemia K562 (IC50=23.0µM),KWKLFKKIPKFLHLAKK,,Linear,Free,Free,,L,dbAMP3,17
14793,dbAMP_14793,,Escherichia coli KCTC 1682 (MIC=6.25-12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78-1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=79.0µM)&&Jurkat cells E6-1 (IC50=74.0µM)&&Human myelogenous leukemia K562 (IC50=62.0µM),KWKLFKKIPLHLAKKF,,Linear,Free,Free,,L,dbAMP3,16
14794,dbAMP_14794,,Candida albicans KCTC 7121 (MIC=50µM)&&Trichosporon beigelii KCTC 7251 (MIC=50µM)&&Aspergillus flavus KCTC 7375 (MIC=50µM)&&Fusarium oxysporum KCTC 6084 (MIC=50µM)&&Escherichia coli KCTC 1682 (MIC=3.125-6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=3.125µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=54.0µM)&&Jurkat cells E6-1 (IC50=31.0µM)&&Human myelogenous leukemia K562 (IC50=25.0µM),KWKLFKKIPKFLHLAK,,Linear,Free,Free,,L,dbAMP3,16
14795,dbAMP_14795,,Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=12.5µM)&&Proteus vulgaris (MIC=1.56µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=100.0µM)&&Jurkat cells E6-1 (IC50=81.0µM)&&Human myelogenous leukemia K562 (IC50=67.0µM),KWKLFKKIPHLAKKF,,Linear,Free,Free,,L,dbAMP3,15
14796,dbAMP_14796,,Candida albicans KCTC 7121 (MIC=50µM)&&Trichosporon beigelii KCTC 7251 (MIC=50µM)&&Aspergillus flavus KCTC 7375 (MIC=100µM)&&Fusarium oxysporum KCTC 6084 (MIC=100µM)&&Escherichia coli KCTC 1682 (MIC=6.25-12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=0.78µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=47.0µM)&&Jurkat cells E6-1 (IC50=21.0µM)&&Human myelogenous leukemia K562 (IC50=27.0µM),KWKLFKKIPKFLHLA,,Linear,Free,Free,,L,dbAMP3,15
14797,dbAMP_14797,,Escherichia coli KCTC 1682 (MIC=6.25-12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=12.5µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=<100µM)&&Jurkat cells E6-1 (IC50=<100µM)&&Human myelogenous leukemia K562 (IC50=<100µM),KWKLFKKIPLAKKF,,Linear,Free,Free,,L,dbAMP3,14
14798,dbAMP_14798,,Candida albicans KCTC 7121 (MIC=100µM)&&Trichosporon beigelii KCTC 7251 (MIC=100µM)&&Aspergillus flavus KCTC 7375 (MIC=100µM)&&Fusarium oxysporum KCTC 6084 (MIC=100µM)&&Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=83.0µM)&&Jurkat cells E6-1 (IC50=54.0µM)&&Human myelogenous leukemia K562 (IC50=30.0µM),KWKLFKKIPKFLHL,,Linear,Free,Free,,L,dbAMP3,14
14799,dbAMP_14799,,Escherichia coli KCTC 1682 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=12.5µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=12.5µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=<100µM)&&Jurkat cells E6-1 (IC50=<100µM)&&Human myelogenous leukemia K562 (IC50=<100µM),KWKLFKKIPLKKF,,Linear,Free,Free,,L,dbAMP3,13
14800,dbAMP_14800,,Candida albicans KCTC 7121 (MIC=100µM)&&Trichosporon beigelii KCTC 7251 (MIC=100µM)&&Aspergillus flavus KCTC 7375 (MIC=200µM)&&Fusarium oxysporum KCTC 6084 (MIC=200µM)&&Escherichia coli KCTC 1682 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25-12.5µM)&&Proteus vulgaris (MIC=3.125µM)&&Bacillus subtilis KCTC 1918 (MIC=1.56µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Bacillus megaterium KCTC 1096 (MIC=3.125µM)&&Human breast adenocarcinoma MDA-MB-361 (IC50=<100µM)&&Jurkat cells E6-1 (IC50=<100µM)&&Human myelogenous leukemia K562 (IC50=<100µM),KWKLFKKIPKFLH,,Linear,Free,Free,,L,dbAMP3,13
14825,dbAMP_14825,,Mycobacterium tuberculosis lux (MIC90=30.1µM)&&Mycobacterium tuberculosis lux (MIC50=7.5µM)&&Mycobacterium smegmatis mc2-6 (MIC90=1.6µM)&&Pseudomonas aeruginosa H103 (MIC=2.0µM)&&Escherichia coli UB1005 (MIC=2.0µM)&&Salmonella enterica serovar Typhimurium (MIC=2.0µM)&&Candida albicans (MIC=8.0µM)&&Staphylococcus epidermidis (MIC=1.0µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.0µM)&&Enterococcus faecalis ATCC 29212 (MIC=4.0µM)&&Human acute monocytic leukemia THP-1 (IC50=20.1µM),VRLRIRVRVIRK,,Linear,Free,Free,,L,dbAMP3,12
14839,dbAMP_14839,,Escherichia coli ATCC 25922 (MIC=<=0.005µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>=0.643µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.643µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=<=0.005µM)&&Shigella sonnei ATCC 25931 (MIC=<=0.005µM)&&Human acute monocytic leukemia THP-1 (IC50=5660µM),CVKVSVKVGSGVKVSVKVC,,Linear,Free,Free,,L,dbAMP3,19
14840,dbAMP_14840,,Escherichia coli ATCC 25922 (MIC=0.30µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<=0.005µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.010µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=0.300µM)&&Shigella sonnei ATCC 25931 (MIC=<=0.005µM)&&Human acute monocytic leukemia THP-1 (IC50=42µM),CVKVRVKVGSGVKVRVKVC,,Linear,Free,Free,,L,dbAMP3,19
14841,dbAMP_14841,,Escherichia coli ATCC 25922 (MIC=0.010µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<=0.005µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=<0.005µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=<=0.005µM)&&Shigella sonnei ATCC 25931 (MIC=0.010µM)&&Human acute monocytic leukemia THP-1 (IC50=88µM),CVKVQVKVGSGVKVQVKVC,,Linear,Free,Free,,L,dbAMP3,19
14842,dbAMP_14842,,Escherichia coli ATCC 25922 (MIC=0.173µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<=0.005µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>=0.692µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=<=0.005µM)&&Shigella sonnei ATCC 25931 (MIC=0.692µM)&&Human acute monocytic leukemia THP-1 (IC50=140µM),CAKAKAKAGSGAKAKAKAC,,Linear,Free,Free,,L,dbAMP3,19
14843,dbAMP_14843,,Escherichia coli ATCC 25922 (MIC=0.518µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<=0.004µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=<=0.004µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=0.518µM)&&Shigella sonnei ATCC 25931 (MIC=<=0.004µM)&&Human acute monocytic leukemia THP-1 (IC50=45µM),CFKFKFKFGSGFKFKFKFC,,Linear,Free,Free,,L,dbAMP3,19
14844,dbAMP_14844,,Escherichia coli ATCC 25922 (MIC=0.114µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<=0.004µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.458µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=<=0.004µM)&&Shigella sonnei ATCC 25931 (MIC=0.007µM)&&Human acute monocytic leukemia THP-1 (IC50=85µM),CWKWKWKWGSGWKWKWKWC,,Linear,Free,Free,,L,dbAMP3,19
14965,dbAMP_14965,,"Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).&&Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).",DYPKLTFTTS,,Linear,Free,Free,,L,dbAMP3,10
14966,dbAMP_14966,,"Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).&&Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).",DETXTDEEFN,,Linear,Free,Free,,L,dbAMP3,10
15312,dbAMP_15312,,Mouse lymphocytic leukemia L1210 (IC50=2-4µg/ml)&&Human lymphoblastic leukemia CCRF-CEM (IC50=0.028µg/ml),ITVCISVC,,Linear,Free,Free,,L,dbAMP3,8
15313,dbAMP_15313,,Mouse lymphocytic leukemia L1210 (IC50=2-4µg/ml)&&Human lymphoblastic leukemia CCRF-CEM (IC50=0.028µg/ml),VTACITFC,,Linear,Free,Free,,L,dbAMP3,8
15397,dbAMP_15397,2mwt,Escherichia coli ATCC 25922 (MIC=6.25µg/ml)&&Escherichia coli ML-35p (MIC=3.125µg/ml)&&Escherichia coli (MIC=6.25µg/ml)&&Enterobacter cloacae ATCC 13047 (MIC=25µg/ml)&&Enterobacter cloacae (MIC=3.125µg/ml)&&Klebsiella aerogenes (MIC=6.25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.25µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=6.25µg/ml)&&Pseudomonas aeruginosa (MIC=12.5µg/ml)&&Haemophilus influenzae ATCC 49247 (MIC=3.125µg/ml)&&Haemophilus influenzae ATCC 49766 (MIC=3.125µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=6.25µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=3.125µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.125µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=6.25µg/ml)&&Staphylococcus aureus (MIC=6.25µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=25µg/ml)&&Candida albicans ATCC 2002 (MIC=>200µg/ml)&&Candida albicans (MIC=>200µg/ml)&&Human gastric adenocarcinoma AGS (>90% cell viability=200µg/ml)&&Human colon adenocarcinoma LoVo (>90% cell viability=200µg/ml)&&Human colon adenocarcinoma HT29 (>90% cell viability=200µg/ml)&&Human breast adenocarcinoma MCF-7 (>82% cell viability=200µg/ml)&&Pseudomonas aeruginosa 447 (MIC=6.25µg/ml),KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,,Linear,Free,Free,,L,dbAMP3,30
15567,dbAMP_15567,,Human breast adenocarcinoma MCF-7 (IC50=20.97µM)&&Human breast cancer Bcap-37 (IC50=18.7µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=66.4µM),FVDLKKIANIINSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15568,dbAMP_15568,,Human breast adenocarcinoma MCF-7 (IC50=44.7µM)&&Human breast cancer Bcap-37 (IC50=83.49µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=894.7µM),FKDLKKIANIINSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15569,dbAMP_15569,,Human breast adenocarcinoma MCF-7 (IC50=15.54µM)&&Human breast cancer Bcap-37 (IC50=18.9µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=85.41µM),FVKLKKIANIINSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15570,dbAMP_15570,,Human breast adenocarcinoma MCF-7 (IC50=27.72µM)&&Human breast cancer Bcap-37 (IC50=25.04µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=224.8µM),FKKLKKIANIINSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15571,dbAMP_15571,,Human breast adenocarcinoma MCF-7 (IC50=9.01µM)&&Human breast cancer Bcap-37 (IC50=10.52µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=34.74µM),FVKLKKILNIINSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15572,dbAMP_15572,,Human breast adenocarcinoma MCF-7 (IC50=11µM)&&Human breast cancer Bcap-37 (IC50=9.39µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=41.55µM),FVKLKKILNIILSIFKK,,Linear,Free,Free,,L,dbAMP3,17
15720,dbAMP_15720,,IC50=250 nM on fibrinogen and 300 nM on fibronectin of glioblastoma cell line U87,QDRPKFCYLPADPAECNAYMPRFYYDSASNKCKEFIYGGCRGNANNFKNRAECRHTCVAS,,Linear,Free,Free,,L,dbAMP3,60
15758,dbAMP_15758,,Pseudomonas aeruginosa PAO1 (MIC=15.6µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa PAK (MIC=31.3µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=31.3µg/ml)&&Pseudomonas aeruginosa M2 (MIC=15.6µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=15.6µg/ml)&&Human lung carcinoma A549 (IC50=11.1±0.08µM)&&Human melanoma A375 (IC50=4.3±0.04µM)&&Human breast adenocarcinoma MCF-7 (IC50=5.0±0.03µM)&&Human colon adenocarcinoma SW1116 (IC50=6.4±0.03µM)&&Human rhabdomyosarcoma (IC50=7.5±0.04µM)&&Human lung carcinoma H1299 (IC50=4.4±0.03µM)&&Mouse skin melanoma B16 (IC50=5.2±0.04µM)&&Human cervical carcinoma HeLa (IC50=3.8±0.03µM),KWKSFLKTFKSLKKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
15759,dbAMP_15759,,Pseudomonas aeruginosa PAO1 (MIC=7.8µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=31.3µg/ml)&&Pseudomonas aeruginosa PAK (MIC=31.3µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=15.6µg/ml)&&Pseudomonas aeruginosa M2 (MIC=15.6µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=7.8µg/ml)&&Human lung carcinoma A549 (IC50=8.7±0.05µM)&&Human melanoma A375 (IC50=6.5±0.03µM)&&Human breast adenocarcinoma MCF-7 (IC50=5.1±0.02µM)&&Human colon adenocarcinoma SW1116 (IC50=5.0±0.05µM)&&Human rhabdomyosarcoma (IC50=9.8±0.05µM)&&Human lung carcinoma H1299 (IC50=2.9±0.03µM)&&Mouse skin melanoma B16 (IC50=7.8±0.03µM)&&Human cervical carcinoma HeLa (IC50=4.3±0.03µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Human gastric cancer SGC-7901 (IC50=6.62µM),KWKSFLKTFKSAKKTVLHTLLKAISS,,Linear,Free,Free,,L,dbAMP3,26
15763,dbAMP_15763,,Staphylococcus aureus AB94004 (MIC=3.13µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.13µg/ml)&&Bacillus subtilis AB91021 (MIC=6.25µg/ml)&&Bacillus thuringiensis AB92037 (MIC=6.25µg/ml)&&Micrococcus luteus AB93113 (MIC=6.25µg/ml)&&Escherichia coli AB94012 (MIC=6.25µg/ml)&&Escherichia coli ATCC 25922 (MIC=25µg/ml)&&Pseudomonas aeruginosa AB93066 (MIC=25µg/ml)&&Pseudomonas aeruginosa A092994 (MIC=50µg/ml)&&Pseudomonas aeruginosa A093052 (MIC=100µg/ml)&&Pseudomonas aeruginosa A093056 (MIC=50µg/ml)&&Pseudomonas aeruginosa A093085 (MIC=50µg/ml)&&Pseudomonas aeruginosa A093115 (MIC=100µg/ml)&&Staphylococcus aureus P1383 (MIC=6.25µg/ml)&&Staphylococcus epidermidis P1389 (MIC=6.25µg/ml)&&Staphylococcus aureus P1374 (MIC=3.13µg/ml)&&Staphylococcus aureus P1369 (MIC=3.13µg/ml)&&Staphylococcus aureus P1381 (MIC=6.25µg/ml)&&Staphylococcus epidermidis P1111 (MIC=3.13µg/ml)&&HIV-1 PsV (IC50 I=2.76µg/ml)&&Staphylococcus aureus NBRC 100910 (MIC=4µg/ml)&&Human adenocarcinoma TZM-bl (IC50=38.46µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=5µg/ml)&&Escherichia coli ATCC 25922 (MIC=10µg/ml)&&Staphylococcus aureus (MIC=2.5-5µg/ml)&&Staphylococcus epidermidis (MIC=2.5-5µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=5µg/ml)&&Enterococcus faecalis (MIC=10µg/ml)&&Enterococcus faecium (MIC=5µg/ml)&&Escherichia coli ATCC 35218 (MIC=10µg/ml)&&Escherichia coli (MIC=10-20µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µg/ml)&&Pseudomonas aeruginosa (MIC=10-20µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=5µg/ml)&&Acinetobacter baumannii (MIC=5-10µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=10µg/ml)&&Klebsiella pneumoniae (MIC=10µg/ml),FIKRIARLLRKIF,,Linear,Free,Free,,L,dbAMP3,13
15795,dbAMP_15795,,Bacillus subtilis 168 (MIC=0.7µM)&&Staphylococcus aureus (MIC=9.0µM)&&Escherichia coli B (MIC=1.4µM)&&Pseudomonas aeruginosa (MIC=23.1µM)&&Human colon adenocarcinoma SW480 (IC50=11µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=7±2µM),NVWKKILGKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
15796,dbAMP_15796,,Bacillus subtilis 168 (MIC=0.6µM)&&Staphylococcus aureus (MIC=2.2µM)&&Escherichia coli B (MIC=1.4µM)&&Pseudomonas aeruginosa (MIC=27.1µM)&&Human cervical carcinoma HeLa S3 (IC50=3±1µM)&&Human colon adenocarcinoma SW480 (IC50=12±3µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=3±1µM),VNWKKILAKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
15797,dbAMP_15797,,Bacillus subtilis 168 (MIC=0.7µM)&&Staphylococcus aureus (MIC=9.6µM)&&Escherichia coli B (MIC=0.7µM)&&Pseudomonas aeruginosa (MIC=26.1µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM),VNWKKILKKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
15798,dbAMP_15798,,Bacillus subtilis 168 (MIC=0.8µM)&&Staphylococcus aureus (MIC=32.5µM)&&Escherichia coli B (MIC=1.2µM)&&Pseudomonas aeruginosa (MIC=100µM)&&Human cervical carcinoma HeLa S3 (IC50=>40µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=6±3µM),VNWKKILPKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
15804,dbAMP_15804,,Escherichia coli (MIC=10µg/ml)&&Staphylococcus aureus (MIC=5µg/ml)&&Escherichia coli (MBC=10µg/ml)&&Staphylococcus aureus (MBC=10µg/ml)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Jurkat T-cell leukemia (IC50=12.5µM),VRRFAWWWAFLRR,,Linear,Free,Free,,L,dbAMP3,13
15805,dbAMP_15805,,Escherichia coli (MIC=6µg/ml)&&Staphylococcus aureus (MIC=6µg/ml)&&Escherichia coli (MBC=40µg/ml)&&Staphylococcus aureus (MBC=8µg/ml)&&Jurkat T-cell leukemia (IC50=24.6µM),VRRFPFFFPFLRR,,Linear,Free,Free,,L,dbAMP3,13
15811,dbAMP_15811,,Candida albicans NCPF 1467 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MIC=1µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.398µM)&&Human glioblastoma U251-MG (IC50=3.520µM)&&Human prostate adenocarcinoma PC-3 (IC50=27.62µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=9.864µM),FLYIVAKLLSGLL,,Linear,Free,Free,,L,dbAMP3,13
15812,dbAMP_15812,,Candida albicans NCPF 1467 (MIC=1µM)&&Staphylococcus aureus NCTC 10788 (MIC=1µM)&&Escherichia coli NCTC 10418 (MIC=2µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.464µM)&&Human glioblastoma U251-MG (IC50=3.087µM)&&Human prostate adenocarcinoma PC-3 (IC50=3.051µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=3.483µM),FLPIVAKLLSGLLGRKKRRQRRR,,Linear,Free,Free,,L,dbAMP3,23
15827,dbAMP_15827,,Candida albicans NCPF 1467 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Human squamous lung carcinoma NCI-H157 (IC50=34.56µM)&&Human glioblastoma U251-MG (IC50=25.13µM)&&Human prostate adenocarcinoma PC-3 (IC50=38.56µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=33.23µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=125µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM)&&Staphylococcus aureus ATCC 25923(RifR) (MIC=16µM)&&Staphylococcus aureus ATCC 25923(GenR) (MIC=8µM)&&Escherichia coli ATCC 25922(RifR) (MIC=32µM)&&Escherichia coli ATCC 25922(GenR) (MIC=32µM),FLPIVAKLLSGLL,,Linear,Free,Free,,L,dbAMP3,13
15832,dbAMP_15832,,Escherichia coli KCTC 1682 (MIC=32µM)&&Salmonella typhimurium KCTC 1926 (MIC=>64µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=>64µM)&&Bacillus subtilis KCTC 3068 (MIC=8µM)&&Staphylococcus aureus KCTC 1621 (MIC=64µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=64µM)&&Staphylococcus aureus CCARM 3001 (MIC=>64µM)&&Staphylococcus aureus CCARM 3089 (MIC=>64µM)&&Staphylococcus aureus CCARM 3543 (MIC=>64µM)&&Pseudomonas aeruginosa CCARM 2092 (MIC=32µM)&&Pseudomonas aeruginosa CCARM 2095 (MIC=>64µM)&&Pseudomonas aeruginosa CCARM 2109 (MIC=32µM)&&Escherichia coli DSM 1103 (MIC=>87µM)&&Pseudomonas aeruginosa DSM 1117 (MIC=>87µM)&&Staphylococcus aureus DSM 1104 (MIC=>87µM)&&Staphylococcus epidermidis DSM 1798 (MIC=>87µM)&&Jurkat T-cell leukemia (IC50=>=65µM),KETWWETWWTEWSQPKKKRKV,,Linear,Free,Free,,L,dbAMP3,21
15877,dbAMP_15877,,Staphylococcus aureus ATCC 33591 (MBC=6µM)&&Staphylococcus epidermidis ATCC 35984 (MBC=1.5µM)&&Klebsiella pneumoniae ATCC BAA-1706 (MBC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=6µM)&&Human lung carcinoma A549 (IC50=59µM)&&Klebsiella pneumoniae NCTC 13368 (MIC=32µg/ml)&&Klebsiella pneumoniae NCTC 13368 (MIC=128µg/ml)&&Klebsiella pneumoniae M6 (MIC=32µg/ml)&&Klebsiella pneumoniae M6 (MIC=64µg/ml)&&Acinetobacter baumannii AYE (MIC=8µg/ml)&&Acinetobacter baumannii AYE (MIC=8µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=8µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=16µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=128µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=128µg/ml)&&Pseudomonas aeruginosa NCTC 13437 (MIC=128µg/ml)&&Pseudomonas aeruginosa NCTC 13437 (MIC=>128µg/ml)&&Escherichia coli NCTC 12923 (MIC=8µg/ml)&&Escherichia coli NCTC 12923 (MIC=64µg/ml)&&Staphylococcus aureus NCTC 6571 (MIC=4µg/ml)&&Staphylococcus aureus NCTC 6571 (MIC=8µg/ml)&&Staphylococcus aureus NCTC 13616 (MIC=16µg/ml)&&Staphylococcus aureus NCTC 13616 (MIC=16µg/ml)&&Staphylococcus aureus NCTC 13277 (MIC=16µg/ml)&&Staphylococcus aureus NCTC 13277 (MIC=16µg/ml)&&Enterococcus faecalis NCTC 775 (MIC=32µg/ml)&&Enterococcus faecalis NCTC 775 (MIC=64µg/ml)&&Enterococcus faecalis NCTC 12201 (MIC=64µg/ml)&&Enterococcus faecalis NCTC 12201 (MIC=128µg/ml)&&Candida albicans NCPF 3179 (MIC=16µg/ml)&&Candida albicans NCPF 3179 (MIC=64µg/ml),FLPIVGLLKSLLK,,Linear,Free,Free,,L,dbAMP3,13
15878,dbAMP_15878,6GIJ,Klebsiella pneumoniae NCTC 13368 (MIC=128µg/ml)&&Klebsiella pneumoniae NCTC 13368 (MIC=>128µg/ml)&&Klebsiella pneumoniae M6 (MIC=128µg/ml)&&Klebsiella pneumoniae M6 (MIC=>128µg/ml)&&Acinetobacter baumannii AYE (MIC=32µg/ml)&&Acinetobacter baumannii AYE (MIC=64µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=32µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=64µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=>128µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=128µg/ml)&&Pseudomonas aeruginosa NCTC 13437 (MIC=>128µg/ml)&&Pseudomonas aeruginosa NCTC 13437 (MIC=>128µg/ml)&&Escherichia coli NCTC 12923 (MIC=16µg/ml)&&Escherichia coli NCTC 12923 (MIC=64µg/ml)&&Staphylococcus aureus NCTC 6571 (MIC=128µg/ml)&&Staphylococcus aureus NCTC 6571 (MIC=>128µg/ml)&&Staphylococcus aureus NCTC 13616 (MIC=>128µg/ml)&&Staphylococcus aureus NCTC 13616 (MIC=>128µg/ml)&&Staphylococcus aureus NCTC 13277 (MIC=>128µg/ml)&&Staphylococcus aureus NCTC 13277 (MIC=>128µg/ml)&&Enterococcus faecalis NCTC 775 (MIC=>128µg/ml)&&Enterococcus faecalis NCTC 775 (MIC=>128µg/ml)&&Enterococcus faecalis NCTC 12201 (MIC=>128µg/ml)&&Enterococcus faecalis NCTC 12201 (MIC=>128µg/ml)&&Candida albicans NCPF 3179 (MIC=64µg/ml)&&Candida albicans NCPF 3179 (MIC=128µg/ml)&&Staphylococcus aureus ATCC 33591 (MBC=1.5µM)&&Staphylococcus epidermidis ATCC 35984 (MBC=1.5µM)&&Klebsiella pneumoniae ATCC BAA-1706 (MBC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=3µM)&&Human lung carcinoma A549 (IC50=16µM),KKLLPIVANLLKSLL,,Linear,Free,Free,,L,dbAMP3,15
15879,dbAMP_15879,,Escherichia coli K-12 D31 (MIC=4µg/ml)&&Agrobacterium tumefaciens EHA105 (MIC=8µg/ml)&&Human myelogenous leukemia K562 (IC50=349.5µM)&&Human histiocytic lymphoma U-937 (IC50=303.2µM)&&Human acute monocytic leukemia THP-1 (IC50=228.5µM)&&Candida albicans ATCC 753 (MIC=32-64µg/ml)&&Neurospora crassa ATCC 13837 (MIC=32-64µg/ml)&&Rhizopus sp. ATCC 20577 (MIC=64-128µg/ml)&&Fusarium sp. ATCC 20789 (MIC=32-64µg/ml)&&Alternaria sp. ATCC 20492 (MIC=8-16µg/ml)&&Mucor sp. ATCC 52915 (MIC=16-32µg/ml),RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK,,Linear,Free,Free,,L,dbAMP3,37
15880,dbAMP_15880,,Human myelogenous leukemia K562 (IC50=184.9µM)&&Human histiocytic lymphoma U-937 (IC50=223.9µM)&&Human acute monocytic leukemia THP-1 (IC50=196.1µM),RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,,Linear,Free,Free,,L,dbAMP3,37
15952,dbAMP_15952,,Escherichia coli ATCC 25922 (MIC=1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=0.5µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>128µg/ml)&&Bacillus cereus ATCC 10876 (MIC=10µg/ml)&&Escherichia coli (MIC=4.7µg/ml)&&Klebsiella pneumoniae (MIC=1.18µg/ml)&&Streptococcus iniae KCTC 3657 (MIC=>=32µg/ml)&&Human breast adenocarcinoma MCF-7 (50% Cell death=>30µg/ml),TRSRWRRFIRGAGRFARRYGWRIA,,Linear,Free,Free,,L,dbAMP3,24
15962,dbAMP_15962,,Escherichia coli ATCC 25922 (MIC=4.69µM)&&Enterobacter cloacae ATCC 13047 (MIC=18.75µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=9.38µM)&&Staphylococcus aureus ATCC 29213 (MIC=2.34µM)&&Enterococcus faecalis ATCC 4028 (MIC=1.17µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=1.17µM)&&Candida albicans ATCC 90028 (MIC=9.38µM)&&Candida krusei ATCC 6258 (MIC=37.5µM)&&Candida glabrata ATCC 90030 (MIC=18.75µM)&&Trypanosoma cruzi Y (100% inhibition=2.5µM)&&Trypanosoma cruzi Y (100% inhibition=10µM)&&Human cervical carcinoma HeLa (IC90=40µM)&&Mouse skin melanoma B16 (IC50=12.5µM),FFSLIPKLVKGLISAFK,,Linear,Free,Free,,L,dbAMP3,17
15963,dbAMP_15963,,Escherichia coli ATCC 25922 (MIC=2.34µM)&&Enterobacter cloacae ATCC 13047 (MIC=9.38µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.17µM)&&Staphylococcus aureus ATCC 29213 (MIC=2.34µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=9.38µM)&&Enterococcus faecalis ATCC 4028 (MIC=1.17µM)&&Candida albicans ATCC 90028 (MIC=4.69µM)&&Candida krusei ATCC 6258 (MIC=9.38µM)&&Candida glabrata ATCC 90030 (MIC=9.38µM)&&Trypanosoma cruzi Y (100% inhibition=2.5µM)&&Trypanosoma cruzi Y (100% inhibition=5µM)&&Human cervical carcinoma HeLa (IC90=40µM)&&Mouse skin melanoma B16 (IC50=9µM),FFKLIPKLVKGLISAFK,,Linear,Free,Free,,L,dbAMP3,17
15986,dbAMP_15986,,Escherichia coli ATCC 25922 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Escherichia coli CGSC 5167 (MIC=0.06µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=4-8µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1-2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1-4µM)&&Candida albicans ATCC 90028 (MIC=4-8µM)&&Cryptococcus neoformans ATCC 208821 (MIC=0.5-1µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=39.8±1.0µM)&&Human skin melanoma MM96L (CC50=2.9±0.1µM)&&Human cervical carcinoma HeLa (CC50=>64µM)&&Human breast adenocarcinoma MCF-7 (CC50=15.3±1.4µM)&&Human myelogenous leukemia K562 (CC50=2.7±0.1µM)&&Human promyelocytic leukemia HL-60 (CC50=12.7±1.1µM)&&Plasmodium falciparum W2 (IC50=62.7±1.2µM)&&Escherichia coli DH5alpha (MIC=1.1±1.9µM),GCRRLCYKQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15987,dbAMP_15987,,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=23.3±0.4µM)&&Human skin melanoma MM96L (CC50=5.1±0.3µM)&&Human cervical carcinoma HeLa (CC50=>64µM)&&Human myelogenous leukemia K562 (CC50=3.9±0.2µM),GCRRLCWKQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15988,dbAMP_15988,,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=30.3±1.1µM)&&Human skin melanoma MM96L (CC50=4.0±0.1µM)&&Human cervical carcinoma HeLa (CC50=50.4±2.4µM)&&Human myelogenous leukemia K562 (CC50=2.7±0.1µM),GCRRLCYKQRCVTWCRGR,,Linear,Free,Free,,L,dbAMP3,18
15989,dbAMP_15989,,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=29.4±1.1µM)&&Human skin melanoma MM96L (CC50=5.0±0.3µM)&&Human cervical carcinoma HeLa (CC50=39.4±2.6µM)&&Human myelogenous leukemia K562 (CC50=3.1±0.1µM),GCRRLCYRQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15990,dbAMP_15990,,Escherichia coli ATCC 25922 (MIC=1µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=31.6±1.3µM)&&Human skin melanoma MM96L (CC50=5.4±0.3µM)&&Human cervical carcinoma HeLa (CC50=41.0±4.2µM)&&Human breast adenocarcinoma MCF-7 (CC50=15.1±1.4µM)&&Human myelogenous leukemia K562 (CC50=3.9±0.1µM),GCRRLCWRQRCVTWCRGR,,Linear,Free,Free,,L,dbAMP3,18
15991,dbAMP_15991,,Escherichia coli ATCC 25922 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Escherichia coli CGSC 5167 (MIC=0.5-1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µM)&&Acinetobacter baumannii ATCC 19606 (MIC=8-16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Helicobacter pylori ATCC 43504 (MIC=>80µM)&&Candida albicans ATCC 90028 (MIC=32µM)&&Cryptococcus neoformans ATCC 208821 (MIC=8-16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=>64µM)&&Human skin melanoma MM96L (CC50=10.3±1.1µM)&&Human cervical carcinoma HeLa (CC50=>64µM)&&Human breast adenocarcinoma MCF-7 (CC50=48.4±0.7µM)&&Human myelogenous leukemia K562 (CC50=11.5±0.6µM)&&Human promyelocytic leukemia HL-60 (CC50=34.1±3.9µM),GCRALCYKQRCVTYCRGA,,Linear,Free,Free,,L,dbAMP3,18
15992,dbAMP_15992,,Escherichia coli ATCC 25922 (MIC=0.5-1µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Escherichia coli CGSC 5167 (MIC=<0.015µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=8µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1-2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<0.25µM)&&Helicobacter pylori ATCC 43504 (MIC=>80µM)&&Candida albicans ATCC 90028 (MIC=2µM)&&Cryptococcus neoformans ATCC 208821 (MIC=0.125-0.25µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=19.5±0.5µM)&&Human skin melanoma MM96L (CC50=1.7±0.1µM)&&Human cervical carcinoma HeLa (CC50=44.2±2.2µM)&&Human breast adenocarcinoma MCF-7 (CC50=6.7±0.7µM)&&Human myelogenous leukemia K562 (CC50=2.1±0.2µM)&&Human promyelocytic leukemia HL-60 (CC50=9.0±1.1µM),KCRRLCYRQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15994,dbAMP_15994,,Escherichia coli ATCC 25922 (MIC=2-4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8-16µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=18.3±1.4µM)&&Human skin melanoma MM96L (CC50=4.0±0.1µM)&&Human cervical carcinoma HeLa (CC50=17.1±0.7µM)&&Human myelogenous leukemia K562 (CC50=1.0±0.1µM),GCRRWCYKQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15995,dbAMP_15995,,Escherichia coli ATCC 25922 (MIC=0.5-1µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=4-8µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1-2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=<0.25-0.5µM)&&Candida albicans ATCC 90028 (MIC=4µM)&&Cryptococcus neoformans ATCC 208821 (MIC=0.5µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=26.5±2.4µM)&&Human skin melanoma MM96L (CC50=2.0±0.1µM)&&Human cervical carcinoma HeLa (CC50=20.9±1.4µM)&&Human breast adenocarcinoma MCF-7 (CC50=15.2±1.9µM)&&Human myelogenous leukemia K562 (CC50=1.3±0.1µM)&&Human promyelocytic leukemia HL-60 (CC50=15.7±1.1µM),KCRRYCYRQRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
15997,dbAMP_15997,,Staphylococcus aureus SA113 (MIC=32µg/ml)&&Staphylococcus aureus SA113 (MIC=>256µg/ml)&&Staphylococcus aureus SA113 (MBC=256µg/ml)&&Staphylococcus aureus SA113 (MBC=>256µg/ml)&&Staphylococcus aureus Del-mprF (MIC=8µg/ml)&&Staphylococcus aureus Del-mprF (MIC=8µg/ml)&&Staphylococcus aureus Del-mprF (MBC=16µg/ml)&&Staphylococcus aureus Del-mprF (MBC=16µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MIC=8µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MIC=8µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MBC=16µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MBC=16µg/ml)&&Staphylococcus aureus (MIC=64µg/ml)&&Staphylococcus aureus (MIC=64µg/ml)&&Staphylococcus aureus (MBC=128µg/ml)&&Staphylococcus aureus (MBC=128µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=2µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MIC=4µg/ml)&&Brucella abortus 9.49 (per-) (MIC=32µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MIC=32µg/ml)&&Yersinia pestis KIM pYV (MIC=>256µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=256µg/ml)&&Escherichia coli ATCC 23716 (MIC=0.25µg/ml)&&Escherichia coli ATCC 23716 (MIC=16µg/ml)&&Human cervical carcinoma HeLa ((28.7±9.3)% Cytotoxicity=100µg/ml)&&Plasmodium falciparum (LC50=6.2µM)&&Mycobacterium smegmatis (70% Killing=30µM)&&Mycobacterium bovis BCG (80% Killing=30µM)&&Human histiocytic lymphoma U-937 (LD50=30µM)&&Human colon adenocarcinoma SW480 (LD50=1-4µM)&&Human myelogenous leukemia K562 (LD50=1-4µM)&&Human neuroblastoma LA-N-1 (LD50=1-4µM)&&Human neuroblastoma SH-SY5Y (LD50=1-4µM)&&Escherichia coli ATCC 25922 (MBC=16µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=2µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MBC=4µg/ml)&&Brucella abortus 9.49 (per-) (MBC=32µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MBC=32µg/ml)&&Yersinia pestis KIM pYV (MBC=>256µg/ml)&&Staphylococcus aureus ATCC 43300 (MBC=256µg/ml)&&Escherichia coli ATCC 23716 (MBC=0.25µg/ml)&&Escherichia coli ATCC 23716 (MBC=32µg/ml)&&Mycobacterium smegmatis mc2-155 (=NAµg/ml)&&Mycobacterium smegmatis mc2-155 (MBC90=17.5µg/ml)&&Mycobacterium marinum ATCC 927 (MBC90=3.5µg/ml)&&Human breast adenocarcinoma MCF-7 (EC50=30±3µM)&&Escherichia coli CMCC 44102 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Staphylococcus aureus CMCC 26003 (MIC=2µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µM)&&Human bladder cancer BIU-87 (IC50=25µM)&&Human bladder cancer EJ (IC50=10µM)&&Human prostate adenocarcinoma PC-3 (IC50=5µM)&&Human bladder carcinoma T24 (IC50=12µM)&&Human promyelocytic leukemia HL-60 (IC50=15µM)&&Human myelogenous leukemia K562 (IC50=>50µM),KILRGVCKKIMRTFLRRISKDILTGKK,,Linear,Free,Free,,L,dbAMP3,27
15998,dbAMP_15998,,Escherichia coli CMCC 44102 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Staphylococcus aureus CMCC 26003 (MIC=4µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Human bladder cancer BIU-87 (IC50=50µM)&&Human bladder cancer EJ (IC50=25µM)&&Human prostate adenocarcinoma PC-3 (IC50=10µM)&&Human bladder carcinoma T24 (IC50=35µM)&&Human promyelocytic leukemia HL-60 (IC50=20µM)&&Human myelogenous leukemia K562 (IC50=>50µM),KILRGVCKKIMRPFLRRISKDILTGKK,,Linear,Free,Free,,L,dbAMP3,27
15999,dbAMP_15999,,Escherichia coli CMCC 44102 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Staphylococcus aureus CMCC 26003 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Human bladder cancer BIU-87 (IC50=35µM)&&Human bladder cancer EJ (IC50=35µM)&&Human prostate adenocarcinoma PC-3 (IC50=10µM)&&Human bladder carcinoma T24 (IC50=50µM)&&Human promyelocytic leukemia HL-60 (IC50=40µM),KILPGVCKKIMRPFLRRISKDILTGKK,,Linear,Free,Free,,L,dbAMP3,27
16011,dbAMP_16011,,Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Human squamous lung carcinoma NCI-H157 (IC50=18.20µM)&&Human prostate adenocarcinoma PC-3 (IC50=18.20µM),ALWKKILKNAGKAALNKINQIVQ,,Linear,Free,Free,,L,dbAMP3,23
16012,dbAMP_16012,,Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Candida albicans NCYC 1467 (MIC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=0.12µM)&&Human prostate adenocarcinoma PC-3 (IC50=1.85µM),ALWKDILKNLLKAALNEINQIVQ,,Linear,Free,Free,,L,dbAMP3,23
16062,dbAMP_16062,,Pseudomonas aeruginosa ATCC 27853 (MBC=4.35µg/ml)&&Escherichia coli ATCC 25922 (MBC=1.79µg/ml)&&Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076 (MBC=10.41µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MBC=7.0µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=3.71µg/ml)&&Staphylococcus aureus ATCC 43400 (MBC=2.25µg/ml)&&Human lung carcinoma A549 (2% Cytotoxicity=100µg/ml)&&Pseudomonas aeruginosa (LD90=3.3±2.44µg/ml)&&Pseudomonas aeruginosa (LD90=4.44±3.31µg/ml)&&Pseudomonas aeruginosa (LD90=1.69±1.5µg/ml),HKCAKIKWRGVHVKYCA,,Linear,Free,Free,,L,dbAMP3,17
16063,dbAMP_16063,,Pseudomonas aeruginosa ATCC 27853 (MBC=0.40µg/ml)&&Escherichia coli ATCC 25922 (MBC=2.22µg/ml)&&Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076 (MBC=10.8µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MBC=16.6µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=46.5µg/ml)&&Streptococcus agalactiae ATCC 27956 (MBC=2.81µg/ml)&&Human lung carcinoma A549 (3% Cytotoxicity=100µg/ml),KWCRKWQWRGVKFIKCV,,Linear,Free,Free,,L,dbAMP3,17
16066,dbAMP_16066,,Pseudomonas aeruginosa ATCC 27853 (MBC=3.30µg/ml)&&Escherichia coli ATCC 25922 (MBC=3.40µg/ml)&&Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076 (MBC=3.20µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MBC=18.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=6.88µg/ml)&&Staphylococcus aureus ATCC 43400 (MBC=1.72µg/ml)&&Human lung carcinoma A549 (2% Cytotoxicity=100µg/ml),KGCALVKVRGLTLKVCK,,Linear,Free,Free,,L,dbAMP3,17
16098,dbAMP_16098,,Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Staphylococcus aureus NCTC 10788 (MBC=128µM)&&Staphylococcus aureus ATCC 12493 (MIC=256µM)&&Staphylococcus aureus ATCC 12493 (MBC=512µM)&&Escherichia coli NCTC 10418 (MIC=32µM)&&Escherichia coli NCTC 10418 (MBC=64µM)&&Enterococcus faecalis NCTC 12697 (MIC=128µM)&&Enterococcus faecalis NCTC 12697 (MBC=512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Candida albicans NCTC 1467 (MIC=256µM)&&Candida albicans NCTC 1467 (MBC=512µM)&&Human prostate adenocarcinoma PC-3 (IC50=5.79µM)&&Human squamous lung carcinoma NCI-H157 (IC50=5.90µM)&&Human breast adenocarcinoma MDA-MB-435 (IC50=15.44µM)&&Human glioblastoma U251-MG (IC50=16.14µM)&&Human breast adenocarcinoma MCF-7 (IC50=20.19µM),GIMDTVKNAAKNLAGQLLDKLKCKITAC,,Linear,Free,Free,,L,dbAMP3,28
16119,dbAMP_16119,,Staphylococcus aureus BCRC 10780 (MIC=64µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=64µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=64µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=128µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=128µg/ml)&&Streptococcus iniae (MIC=128µg/ml)&&Lactococcus garvieae (MIC=256µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=128µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=64µg/ml)&&Escherichia coli BCRC 10675 (MIC=32µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=32µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=16µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=256µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=16µg/ml)&&Vibrio anguillarum serotype O1 (MIC=16µg/ml)&&Vibrio harveyi (MIC=16µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=16µg/ml)&&Human gastric adenocarcinoma AGS (IC50=46µM),GANAAKKLATFAKKIFTAYW,,Linear,Free,Free,,L,dbAMP3,20
16121,dbAMP_16121,,Staphylococcus aureus BCRC 10780 (MIC=16µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=8µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=32µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=16µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=128µg/ml)&&Streptococcus iniae (MIC=64µg/ml)&&Lactococcus garvieae (MIC=32µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=16µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=32µg/ml)&&Escherichia coli BCRC 10675 (MIC=8µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=16µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=8µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=32µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=4µg/ml)&&Vibrio anguillarum serotype O1 (MIC=4µg/ml)&&Vibrio harveyi (MIC=8µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=4µg/ml)&&Human gastric adenocarcinoma AGS (IC50=17µM)&&Human hepatocellular carcinoma J5 (IC50=20.3µM)&&Human hepatocellular carcinoma Huh7 (IC50=87.2µM)&&Human hepatocellular carcinoma Hep 3B (IC50=69.2µM),GYNYAKKLANLAKKFANALW,,Linear,Free,Free,,L,dbAMP3,20
16122,dbAMP_16122,,Staphylococcus aureus BCRC 10780 (MIC=128µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=64µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=128µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=128µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=128µg/ml)&&Streptococcus iniae (MIC=128µg/ml)&&Lactococcus garvieae (MIC=128µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=64µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=64µg/ml)&&Escherichia coli BCRC 10675 (MIC=16µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=64µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=32µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=128µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=64µg/ml)&&Vibrio anguillarum serotype O1 (MIC=64µg/ml)&&Vibrio harveyi (MIC=64µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=64µg/ml)&&Human hepatocellular carcinoma J5 (IC50=28.9µM)&&Human hepatocellular carcinoma Hep 3B (IC50=88.2µM),GATYAKKIIKTITKIATTAW,,Linear,Free,Free,,L,dbAMP3,20
16123,dbAMP_16123,,Staphylococcus aureus BCRC 10780 (MIC=128µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=64µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=128µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=64µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=128µg/ml)&&Streptococcus iniae (MIC=128µg/ml)&&Lactococcus garvieae (MIC=128µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=16µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=64µg/ml)&&Escherichia coli BCRC 10675 (MIC=16µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=16µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=16µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=128µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=32µg/ml)&&Vibrio anguillarum serotype O1 (MIC=64µg/ml)&&Vibrio harveyi (MIC=64µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=32µg/ml)&&Human gastric adenocarcinoma AGS (IC50=404µM),GAKALTKAATAFTKFYKTIW,,Linear,Free,Free,,L,dbAMP3,20
16126,dbAMP_16126,,Staphylococcus aureus BCRC 10780 (MIC=32µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=4µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=32µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=32µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=128µg/ml)&&Streptococcus iniae (MIC=128µg/ml)&&Lactococcus garvieae (MIC=128µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=32µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=16µg/ml)&&Escherichia coli BCRC 10675 (MIC=16µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=16µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=8µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=32µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=4µg/ml)&&Vibrio anguillarum serotype O1 (MIC=32µg/ml)&&Vibrio harveyi (MIC=32µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=16µg/ml)&&Human hepatocellular carcinoma J5 (IC50=24.3µM)&&Human hepatocellular carcinoma Huh7 (IC50=107.4µM)&&Human hepatocellular carcinoma Hep 3B (IC50=53.4µM),GIKIAKKAITIAKKIAKIYW,,Linear,Free,Free,,L,dbAMP3,20
16129,dbAMP_16129,,Staphylococcus aureus BCRC 10780 (MIC=128µg/ml)&&Staphylococcus xylosus BCRC 12930 (MIC=64µg/ml)&&Staphylococcus aureus BCRC 10781 (MIC=128µg/ml)&&Listeria monocytogenes BCRC 14845 (MIC=128µg/ml)&&Streptococcus equinus BCRC 14729 (MIC=256µg/ml)&&Streptococcus iniae (MIC=256µg/ml)&&Lactococcus garvieae (MIC=256µg/ml)&&Klebsiella oxytoca BCRC 13985 (MIC=128µg/ml)&&Pseudomonas aeruginosa BCRC 10944 (MIC=128µg/ml)&&Escherichia coli BCRC 10675 (MIC=64µg/ml)&&Klebsiella aerogenes BCRC 10370 (MIC=32µg/ml)&&Enterobacter cloacae BCRC 10401 (MIC=64µg/ml)&&Yersinia enterocolitica BCRC 13999 (MIC=128µg/ml)&&Vibrio alginolyticus BCRC 12829 (MIC=128µg/ml)&&Vibrio alginolyticus (MIC=32µg/ml)&&Vibrio anguillarum serotype O1 (MIC=32µg/ml)&&Vibrio harveyi (MIC=8µg/ml)&&Vibrio parahaemolyticus BCRC 10806 (MIC=128µg/ml)&&Vibrio parahaemolyticus (MIC=16µg/ml)&&Human hepatocellular carcinoma J5 (IC50=30.8µM)&&Human hepatocellular carcinoma Hep 3B (IC50=257.1µM),GANLAKKFYTYINKFINYAW,,Linear,Free,Free,,L,dbAMP3,20
16130,dbAMP_16130,,Escherichia coli O157:H7 CICC 21530 (MIC=3.32µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>53.18µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=1.66µM)&&Escherichia coli ATCC 25922 (MIC=13.29µM)&&Escherichia coli ATCC 35150 (MIC=26.59µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=6.65µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=3.32µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=6.65µM)&&Shigella flexneri CMCC 51571 (MIC=1.66µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=13.29µM)&&Salmonella typhimurium CMCC 51005 (MIC=>53.18µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>53.18µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=6.65µM)&&Staphylococcus aureus ATCC 29213 (MIC=6.65µM)&&Staphylococcus aureus ATCC 29213 (MIC=26.59µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.66µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.66µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.83µM)&&Staphylococcus aureus ATCC 29213 (MIC=13.29µM)&&Staphylococcus aureus ATCC 29213 (MIC=>53.18µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.66µM)&&Listeria monocytogenes CICC 21662 (MIC=3.32µM)&&Listeria monocytogenes CICC 21633 (MIC=3.32µM)&&Bacillus cereus CMCC 63301 (MIC=53.18µM)&&Micrococcus luteus CMCC 28001 (MIC=13.29µM)&&Bacillus pumilus CMCC 63202 (MIC=26.59µM)&&Pseudomonas fluorescens CICC 21620 (MIC=53.18µM)&&Staphylococcus aureus ATCC 43300 (MIC=3.32µM)&&Candida albicans ATCC 10231 (MIC=26.59µM)&&Human hepatocellular carcinoma HepG2 (IC50=>64µM),WLRAFRRLVRRLARLLRR,,Linear,Free,Free,,L,dbAMP3,18
16131,dbAMP_16131,,Escherichia coli O157:H7 CICC 21530 (MIC=0.85µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.40µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=0.85µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=0.85µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=0.85µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.40µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=6.81µM)&&Escherichia coli ATCC 25922 (MIC=1.70µM)&&Escherichia coli ATCC 35150 (MIC=1.70µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=0.43µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=0.85µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=0.43µM)&&Shigella flexneri CMCC 51571 (MIC=0.43µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=1.70µM)&&Salmonella typhimurium CMCC 51005 (MIC=6.81µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=6.81µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=1.70µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.43µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.70µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.21µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.43µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.21µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.43µM)&&Staphylococcus aureus ATCC 29213 (MIC=55.04µM)&&Staphylococcus aureus GIM 1.160 (MIC=0.43µM)&&Listeria monocytogenes CICC 21662 (MIC=0.21µM)&&Listeria monocytogenes CICC 21633 (MIC=0.21µM)&&Bacillus cereus CMCC 63301 (MIC=0.85µM)&&Micrococcus luteus CMCC 28001 (MIC=0.43µM)&&Bacillus pumilus CMCC 63202 (MIC=0.85µM)&&Pseudomonas fluorescens CICC 21620 (MIC=0.43µM)&&Staphylococcus aureus ATCC 43300 (MIC=0.85µM)&&Candida albicans ATCC 10231 (MIC=3.40µM)&&Human hepatocellular carcinoma HepG2 (IC50=32µM),WLRAFRRLVRRLARGLRR,,Linear,Free,Free,,L,dbAMP3,18
16132,dbAMP_16132,,Escherichia coli O157:H7 CICC 21530 (MIC=6.97µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=13.94µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.49µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.49µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=6.97µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=13.94µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>55.78µM)&&Escherichia coli ATCC 25922 (MIC=27.89µM)&&Escherichia coli ATCC 35150 (MIC=13.94µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=3.49µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=6.97µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=3.49µM)&&Shigella flexneri CMCC 51571 (MIC=3.49µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=13.94µM)&&Salmonella typhimurium CMCC 51005 (MIC=13.94µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>55.78µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=13.94µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.49µM)&&Staphylococcus aureus ATCC 29213 (MIC=6.97µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.87µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.74µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.74µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.49µM)&&Staphylococcus aureus ATCC 29213 (MIC=>55.76µM)&&Staphylococcus aureus GIM 1.160 (MIC=1.74µM)&&Listeria monocytogenes CICC 21662 (MIC=1.74µM)&&Listeria monocytogenes CICC 21633 (MIC=1.74µM)&&Bacillus cereus CMCC 63301 (MIC=55.78µM)&&Micrococcus luteus CMCC 28001 (MIC=27.89µM)&&Bacillus pumilus CMCC 63202 (MIC=55.78µM)&&Pseudomonas fluorescens CICC 21620 (MIC=55.78µM)&&Staphylococcus aureus ATCC 43300 (MIC=6.97µM)&&Candida albicans ATCC 10231 (MIC=13.94µM)&&Human hepatocellular carcinoma HepG2 (IC50=32µM),WGRAFRRLVRRLARGLRR,,Linear,Free,Free,,L,dbAMP3,18
16133,dbAMP_16133,,Escherichia coli O157:H7 CICC 21530 (MIC=3.67µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=14.66µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.67µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.67µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.67µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=7.33µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>58.64µM)&&Escherichia coli ATCC 25922 (MIC=14.66µM)&&Escherichia coli ATCC 35150 (MIC=29.32µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=7.33µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=3.67µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=7.33µM)&&Shigella flexneri CMCC 51571 (MIC=7.33µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=14.66µM)&&Salmonella typhimurium CMCC 51005 (MIC=>58.64µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>58.64µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=29.32µM)&&Staphylococcus aureus ATCC 29213 (MIC=14.66µM)&&Staphylococcus aureus ATCC 29213 (MIC=14.66µM)&&Staphylococcus aureus ATCC 29213 (MIC=7.33µM)&&Staphylococcus aureus ATCC 29213 (MIC=7.33µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.67µM)&&Staphylococcus aureus ATCC 29213 (MIC=7.33µM)&&Staphylococcus aureus ATCC 29213 (MIC=>58.64µM)&&Staphylococcus aureus GIM 1.160 (MIC=7.33µM)&&Listeria monocytogenes CICC 21662 (MIC=7.33µM)&&Listeria monocytogenes CICC 21633 (MIC=7.33µM)&&Bacillus cereus CMCC 63301 (MIC=14.66µM)&&Micrococcus luteus CMCC 28001 (MIC=7.33µM)&&Bacillus pumilus CMCC 63202 (MIC=>58.64µM)&&Pseudomonas fluorescens CICC 21620 (MIC=29.32µM)&&Staphylococcus aureus ATCC 43300 (MIC=14.66µM)&&Candida albicans ATCC 10231 (MIC=29.32µM)&&Human hepatocellular carcinoma HepG2 (IC50=>64µM),WGRAFRRGVRRLARGGRR,,Linear,Free,Free,,L,dbAMP3,18
16134,dbAMP_16134,,Escherichia coli O157:H7 CICC 21530 (MIC=7.94µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=15.89µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=3.97µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=7.94µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=7.94µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=15.89µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>63.54µM)&&Escherichia coli ATCC 25922 (MIC=31.77µM)&&Escherichia coli ATCC 35150 (MIC=31.77µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=15.89µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=15.89µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=15.89µM)&&Shigella flexneri CMCC 51571 (MIC=15.89µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=15.89µM)&&Salmonella typhimurium CMCC 51005 (MIC=>63.54µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>63.54µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=>63.54µM)&&Staphylococcus aureus ATCC 29213 (MIC=31.77µM)&&Staphylococcus aureus ATCC 29213 (MIC=>63.54µM)&&Staphylococcus aureus ATCC 29213 (MIC=>63.54µM)&&Staphylococcus aureus GIM 1.160 (MIC=15.89µM)&&Listeria monocytogenes CICC 21662 (MIC=15.89µM)&&Listeria monocytogenes CICC 21633 (MIC=31.77µM)&&Bacillus cereus CMCC 63301 (MIC=>63.54µM)&&Micrococcus luteus CMCC 28001 (MIC=>63.54µM)&&Bacillus pumilus CMCC 63202 (MIC=>63.54µM)&&Pseudomonas fluorescens CICC 21620 (MIC=>63.54µM)&&Staphylococcus aureus ATCC 43300 (MIC=>63.54µM)&&Candida albicans ATCC 10231 (MIC=>63.54µM)&&Human hepatocellular carcinoma HepG2 (IC50=64µM),WGRAFSRGVRRLARGGRG,,Linear,Free,Free,,L,dbAMP3,18
16135,dbAMP_16135,,Escherichia coli O157:H7 CICC 21530 (MIC=16.75µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>67.01µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=4.19µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=8.35µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=67.01µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>67.01µM)&&Escherichia coli O157:H7 CICC 21530 (MIC=>67.01µM)&&Escherichia coli ATCC 25922 (MIC=>67.01µM)&&Escherichia coli ATCC 35150 (MIC=>67.01µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=33.50µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=>67.01µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=>67.01µM)&&Shigella flexneri CMCC 51571 (MIC=>67.01µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=33.50µM)&&Salmonella typhimurium CMCC 51005 (MIC=>67.01µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>67.01µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=>67.01µM)&&Staphylococcus aureus ATCC 29213 (MIC=>67.01µM)&&Staphylococcus aureus GIM 1.160 (MIC=>67.01µM)&&Listeria monocytogenes CICC 21662 (MIC=33.50µM)&&Listeria monocytogenes CICC 21633 (MIC=67.01µM)&&Bacillus cereus CMCC 63301 (MIC=>67.01µM)&&Micrococcus luteus CMCC 28001 (MIC=>67.01µM)&&Bacillus pumilus CMCC 63202 (MIC=>67.01µM)&&Pseudomonas fluorescens CICC 21620 (MIC=>67.01µM)&&Staphylococcus aureus ATCC 43300 (MIC=>67.01µM)&&Candida albicans ATCC 10231 (MIC=>67.01µM)&&Human hepatocellular carcinoma HepG2 (IC50=64µM),WGRAFSAGVHRLARGGRG,,Linear,Free,Free,,L,dbAMP3,18
16136,dbAMP_16136,,Escherichia coli O157:H7 CICC 21530 (MIC=>70.09µM)&&Escherichia coli ATCC 25922 (MIC=>70.09µM)&&Escherichia coli ATCC 35150 (MIC=>70.09µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=>70.09µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=>70.09µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=>70.09µM)&&Shigella flexneri CMCC 51571 (MIC=>70.09µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=>70.09µM)&&Salmonella typhimurium CMCC 51005 (MIC=>70.09µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>70.09µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=>70.09µM)&&Staphylococcus aureus ATCC 29213 (MIC=>70.09µM)&&Staphylococcus aureus GIM 1.160 (MIC=70.09µM)&&Listeria monocytogenes CICC 21662 (MIC=>70.09µM)&&Listeria monocytogenes CICC 21633 (MIC=>70.09µM)&&Bacillus cereus CMCC 63301 (MIC=>70.09µM)&&Micrococcus luteus CMCC 28001 (MIC=>70.09µM)&&Bacillus pumilus CMCC 63202 (MIC=>70.09µM)&&Pseudomonas fluorescens CICC 21620 (MIC=>70.09µM)&&Staphylococcus aureus ATCC 43300 (MIC=>70.09µM)&&Candida albicans ATCC 10231 (MIC=>70.09µM)&&Human hepatocellular carcinoma HepG2 (IC50=>64µM),WGRAFSAGVHRLANGGNG,,Linear,Free,Free,,L,dbAMP3,18
16137,dbAMP_16137,,Escherichia coli O157:H7 CICC 21530 (MIC=>71.15µM)&&Escherichia coli ATCC 25922 (MIC=>71.15µM)&&Escherichia coli ATCC 35150 (MIC=>71.15µM)&&Salmonella enterica subsp. enterica serovar Paratyphi A CICC 20501 (MIC=>71.15µM)&&Salmonella enterica subsp. enterica serovar Paratyphi B CICC 21495 (MIC=>71.15µM)&&Salmonella enterica subsp. enterica serovar Paratyphi C CICC 21512 (MIC=>71.15µM)&&Shigella flexneri CMCC 51571 (MIC=>71.15µM)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 13312 (MIC=>71.15µM)&&Salmonella typhimurium CMCC 51005 (MIC=>71.15µM)&&Salmonella enterica subsp. enterica serovar Enteritidis CICC 21527 (MIC=>71.15µM)&&Vibrio parahaemolyticus CICC 21617 (MIC=>71.15µM)&&Staphylococcus aureus ATCC 29213 (MIC=>71.15µM)&&Staphylococcus aureus GIM 1.160 (MIC=>71.15µM)&&Listeria monocytogenes CICC 21662 (MIC=>71.15µM)&&Listeria monocytogenes CICC 21633 (MIC=>71.15µM)&&Bacillus cereus CMCC 63301 (MIC=>71.15µM)&&Micrococcus luteus CMCC 28001 (MIC=>71.15µM)&&Bacillus pumilus CMCC 63202 (MIC=>71.15µM)&&Pseudomonas fluorescens CICC 21620 (MIC=>71.15µM)&&Staphylococcus aureus ATCC 43300 (MIC=>71.15µM)&&Candida albicans ATCC 10231 (MIC=>71.15µM)&&Human hepatocellular carcinoma HepG2 (IC50=>64µM),WGEAFSAGVHRLANGGNG,,Linear,Free,Free,,L,dbAMP3,18
16157,dbAMP_16157,,Staphylococcus aureus NCTC 10788 (MIC=256µM)&&Staphylococcus aureus NCTC 10788 (MBC=256µM)&&Staphylococcus aureus ATCC 12493 (MIC=>512µM)&&Staphylococcus aureus ATCC 12493 (MBC=>512µM)&&Escherichia coli NCTC 10418 (MIC=128µM)&&Escherichia coli NCTC 10418 (MBC=256µM)&&Enterococcus faecalis NCTC 12697 (MIC=>512µM)&&Enterococcus faecalis NCTC 12697 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Candida albicans NCTC 1467 (MIC=512µM)&&Candida albicans NCTC 1467 (MBC=>512µM)&&Human prostate adenocarcinoma PC-3 (IC50=283.90µM)&&Human squamous lung carcinoma NCI-H157 (IC50=843.40µM)&&Human breast adenocarcinoma MDA-MB-435 (IC50=872.70µM)&&Human glioblastoma U251-MG (IC50=104.10µM)&&Human breast adenocarcinoma MCF-7 (IC50=109.30µM),GIMDTVKNAAKNLAGQLLDKLK,,Linear,Free,Free,,L,dbAMP3,22
16158,dbAMP_16158,,Staphylococcus aureus NCTC 10788 (MIC=2.5µM)&&Staphylococcus aureus NCTC 10788 (MBC=20µM)&&Escherichia coli NCTC 10418 (MIC=5µM)&&Escherichia coli NCTC 10418 (MBC=20µM)&&Candida albicans NCPF 1467 (MIC=2.5µM)&&Candida albicans NCPF 1467 (MBC=5µM)&&Human squamous lung carcinoma NCI-H157 (IC50=1.5µM)&&Human lung adenocarcinoma NCI-H838 (IC50=1.6µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.1µM)&&Human breast adenocarcinoma MCF-7 (IC50=1.8µM)&&Human glioblastoma U251-MG (IC50=2.9µM),FLSLIPKLVKKIIKAFK,,Linear,Free,Free,,L,dbAMP3,17
16159,dbAMP_16159,,Staphylococcus aureus NCTC 10788 (MIC=5µM)&&Staphylococcus aureus NCTC 10788 (MBC=20µM)&&Escherichia coli NCTC 10418 (MIC=5µM)&&Escherichia coli NCTC 10418 (MBC=40µM)&&Candida albicans NCPF 1467 (MIC=2.5µM)&&Candida albicans NCPF 1467 (MBC=10µM)&&Human squamous lung carcinoma NCI-H157 (IC50=0.83µM)&&Human lung adenocarcinoma NCI-H838 (IC50=1.6µM)&&Human prostate adenocarcinoma PC-3 (IC50=1.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=1.8µM)&&Human glioblastoma U251-MG (IC50=2.0µM),FLGMIPKLIKKLIKAFK,,Linear,Free,Free,,L,dbAMP3,17
16165,dbAMP_16165,,Staphylococcus aureus NCTC 10788 (MIC=4µg/ml)&&Escherichia coli NCTC 10418 (MIC=16µg/ml)&&Candida albicans NCPF 1467 (MIC=4µg/ml)&&Staphylococcus aureus NCTC 10788 (MBC=32µg/ml)&&Escherichia coli NCTC 10418 (MBC=32µg/ml)&&Candida albicans NCPF 1467 (MBC=16µg/ml)&&Human lung carcinoma NCI-H460 (90% Killing=100µM)&&Human breast adenocarcinoma MDA-MB-435S (90% Killing=100µM)&&Human breast adenocarcinoma MCF-7 (>90% Killing=100µM)&&Human prostate adenocarcinoma PC-3 (>90% Killing=100µM),FLFKLIPKAIKGLVKAIRK,,Linear,Free,Free,,L,dbAMP3,19
16166,dbAMP_16166,,Staphylococcus aureus NCTC 10788 (MIC=4µg/ml)&&Escherichia coli NCTC 10418 (MIC=16µg/ml)&&Candida albicans NCPF 1467 (MIC=4µg/ml)&&Staphylococcus aureus NCTC 10788 (MBC=32µg/ml)&&Escherichia coli NCTC 10418 (MBC=32µg/ml)&&Candida albicans NCPF 1467 (MBC=16µg/ml)&&Human lung carcinoma NCI-H460 (90% Killing=100µM)&&Human breast adenocarcinoma MDA-MB-435S (90% Killing=100µM)&&Human breast adenocarcinoma MCF-7 (>90% Killing=100µM)&&Human prostate adenocarcinoma PC-3 (>90% Killing=100µM),FLFKLIPKVIKGLVKAIRK,,Linear,Free,Free,,L,dbAMP3,19
16192,dbAMP_16192,,Escherichia coli ATCC 25922 (MIC=10µM)&&Staphylococcus aureus ATCC 29213 (MIC=>40µM)&&Mycobacterium smegmatis mc2-155 (MIC=200µg/ml)&&Human lung carcinoma A549 (IC50=29.8Unknown Unit),AKRIVQRIKDFLR,,Linear,Free,Free,,L,dbAMP3,13
16242,dbAMP_16242,,Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>256µM)&&Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Staphylococcus aureus ATCC 12493 (MIC=16µM)&&Staphylococcus aureus ATCC 12493 (MBC=32µM)&&Enterococcus faecalis NCTC 12697 (MIC=>256µM)&&Enterococcus faecalis NCTC 12697 (MBC=>256µM)&&Candida albicans NCPF 1467 (MIC=8µM)&&Candida albicans NCPF 1467 (MBC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=1.453µM)&&Human breast adenocarcinoma MCF-7 (IC50=7.254µM)&&Human glioblastoma U251-MG (IC50=2.172µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.251µM),SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,,Linear,Free,Free,,L,dbAMP3,34
16243,dbAMP_16243,,Escherichia coli NCTC 10418 (MIC=32µM)&&Escherichia coli NCTC 10418 (MBC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>256µM)&&Staphylococcus aureus NCTC 10788 (MIC=16µM)&&Staphylococcus aureus NCTC 10788 (MBC=32µM)&&Staphylococcus aureus ATCC 12493 (MIC=>256µM)&&Staphylococcus aureus ATCC 12493 (MBC=>256µM)&&Enterococcus faecalis NCTC 12697 (MIC=>256µM)&&Enterococcus faecalis NCTC 12697 (MBC=>256µM)&&Candida albicans NCPF 1467 (MIC=>256µM)&&Candida albicans NCPF 1467 (MBC=>256µM)&&Human squamous lung carcinoma NCI-H157 (IC50=5.841µM),SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,,Linear,Free,Free,,L,dbAMP3,32
16244,dbAMP_16244,,Escherichia coli NCTC 10418 (MIC=16µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=256µM)&&Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Staphylococcus aureus ATCC 12493 (MIC=16µM)&&Staphylococcus aureus ATCC 12493 (MBC=32µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=128µM)&&Candida albicans NCPF 1467 (MIC=16µM)&&Candida albicans NCPF 1467 (MBC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=6.856µM),SFLTTVKKLVTNLAAL,,Linear,Free,Free,,L,dbAMP3,16
16245,dbAMP_16245,2KET,Staphylococcus aureus ATCC 9144 (MIC=2.7±0.8µM)&&Bacillus subtilis ATCC 6633 (MIC=2.6±0.7µM)&&Bacillus subtilis ATCC 6633 (MIC=15.1±0.5µM)&&Escherichia coli DH5alpha (MIC=2.8±0.6µM)&&Escherichia coli ATCC 10536 (MIC=3.2±0.9µM)&&Escherichia coli ATCC 10536 (MIC=7.4±0.7µM)&&Klebsiella pneumoniae (MIC=4µM)&&Escherichia coli ML-35 (MIC=2µM)&&Staphylococcus aureus KCTC 1621 (MIC=1-2µM)&&Escherichia coli KCTC 1682 (MIC=2-4µM)&&Human breast adenocarcinoma MDA-MB-361 (50% Cytotoxicity=4.2µM)&&Human lung carcinoma A549 (50% Cytotoxicity=5.3µM),GRFKRFRKKFKKLFKKLSPVIPLLHL,,Linear,Free,Free,,L,dbAMP3,26
16303,dbAMP_16303,,Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Escherichia coli ATCC 15597 (MIC=3.1µM)&&Staphylococcus aureus ATCC 6538 (MIC=15±2.5µM)&&Micrococcus luteus ATCC 49732 (MIC=1.5µM)&&Bacillus subtilis ATCC 6633 (MIC=15±2.5µM)&&Salmonella typhimurium DA6192 (MIC=40±5µM)&&Klebsiella pneumoniae NCTC 5055 (MIC=50µM)&&Human cervical carcinoma HeLa (EC50=29.8±1µM)&&Human breast adenocarcinoma MCF-7 (EC50=22.5±0.7µM),ITKVITKLLNRLTKILSK,,Linear,Free,Free,,L,dbAMP3,18
16306,dbAMP_16306,,Escherichia coli ATCC 25922 (MIC=0.15µM)&&Escherichia coli ATCC 25922 (MBC=2.5µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=>20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2.2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=5.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>22µM)&&Pseudomonas aeruginosa ATCC 25668 (MIC=2.2µM)&&Pseudomonas aeruginosa ATCC 25668 (MIC=>6µM)&&Pseudomonas aeruginosa ATCC 25668 (MIC=6µM)&&Pseudomonas aeruginosa ATCC 25668 (MIC=5.5µM)&&Pseudomonas aeruginosa ATCC 25668 (MIC=>22µM)&&Staphylococcus epidermidis ATCC 700565 (MIC=8µM)&&Staphylococcus epidermidis ATCC 700565 (MBC=20µM)&&Candida albicans ATCC 1023 (MIC=>20µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=11µM)&&Pseudomonas aeruginosa ATCC 25668 (MBC=11µM)&&Human cervical carcinoma HeLa (5% Killing=200µM),RWKIFKKIEKMGRNIRDGIVKAGPAIQVLGSAKAI,,Linear,Free,Free,,L,dbAMP3,35
16375,dbAMP_16375,,Staphylococcus aureus ATCC 25923 (MIC=125µg/ml)&&Staphylococcus aureus (MIC=62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=125µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=62.5µg/ml)&&Enterobacter cloacae (MIC=125µg/ml)&&Citrobacter sp. (MIC=31.3µg/ml)&&Klebsiella pneumoniae (MIC=>250µg/ml)&&Streptococcus pneumoniae PR (MIC=31.3-125µg/ml)&&Human lung carcinoma A549 (IC50=215.3±19.7µg/ml)&&Streptococcus pneumoniae PS (MIC=62.5-250µg/ml)&&Streptococcus pneumoniae (MIC=31.3-125µg/ml),GLFDKWAWWRWRR,,Linear,Free,Free,,L,dbAMP3,13
16376,dbAMP_16376,,Staphylococcus aureus ATCC 25923 (MIC=31.3µg/ml)&&Staphylococcus aureus (MIC=62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=>250µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=31.3µg/ml)&&Enterobacter cloacae (MIC=>250µg/ml)&&Citrobacter sp. (MIC=62.5µg/ml)&&Klebsiella pneumoniae (MIC=>250µg/ml)&&Streptococcus pneumoniae (MIC=7.81-250µg/ml)&&Human lung carcinoma A549 (IC50=>250µg/ml)&&Streptococcus pneumoniae PR (MIC=15.63-250µg/ml)&&Streptococcus pneumoniae PS (MIC=15.63-250µg/ml),GLFDIWAWWRWRR,,Linear,Free,Free,,L,dbAMP3,13
16377,dbAMP_16377,,Staphylococcus aureus ATCC 25923 (MIC=15.63µg/ml)&&Staphylococcus aureus (MIC=7.81µg/ml)&&Escherichia coli ATCC 25922 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=125µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=15.63µg/ml)&&Enterobacter cloacae (MIC=31.3µg/ml)&&Citrobacter sp. (MIC=15.63µg/ml)&&Klebsiella pneumoniae (MIC=62.5µg/ml)&&Streptococcus pneumoniae (MIC=7.81-62.5µg/ml)&&Human lung carcinoma A549 (IC50=56.0±9.3µg/ml)&&Streptococcus pneumoniae PR (MIC=15.63-62.5µg/ml)&&Streptococcus pneumoniae PS (MIC=7.81-62.5µg/ml),GLFDIWKWWRWRR,,Linear,Free,Free,,L,dbAMP3,13
16378,dbAMP_16378,,Staphylococcus aureus ATCC 25923 (MIC=62.5µg/ml)&&Staphylococcus aureus (MIC=62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=31.3µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=31.3µg/ml)&&Enterobacter cloacae (MIC=250µg/ml)&&Citrobacter sp. (MIC=31.3µg/ml)&&Klebsiella pneumoniae (MIC=>250µg/ml)&&Streptococcus pneumoniae (MIC=15.63-125µg/ml)&&Human lung carcinoma A549 (IC50=93.3±5.1µg/ml)&&Streptococcus pneumoniae PR (MIC=31.3-125µg/ml)&&Streptococcus pneumoniae PS (MIC=15.63-125µg/ml),GLFDIWKKWRWRR,,Linear,Free,Free,,L,dbAMP3,13
16379,dbAMP_16379,,Staphylococcus aureus ATCC 25923 (MIC=125µg/ml)&&Staphylococcus aureus (MIC=62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=31.3µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MIC=31.3µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=31.3µg/ml)&&Enterobacter cloacae (MIC=125µg/ml)&&Citrobacter sp. (MIC=31.3µg/ml)&&Klebsiella pneumoniae (MIC=250µg/ml)&&Streptococcus pneumoniae (MIC=15.63-125µg/ml)&&Human lung carcinoma A549 (IC50=97.0±9.8µg/ml)&&Streptococcus pneumoniae PR (MIC=31.3-125µg/ml)&&Streptococcus pneumoniae PS (MIC=15.63-125µg/ml),GLFDIWKKLRWRR,,Linear,Free,Free,,L,dbAMP3,13
16455,dbAMP_16455,,Pseudomonas aeruginosa (MIC=8µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa PAO1 (MIC=8µM)&&Pseudomonas aeruginosa 1 (MIC=8µM)&&Pseudomonas aeruginosa 2 (MIC=16µM)&&Candida albicans (MIC=2-4µM)&&Candida albicans ATCC 10231 (50% Killing=8µM)&&Candida albicans ATCC 10231 (80% Killing=16µM)&&Corynebacterium jeikeium ATCC BAA-949 (MIC=4µM)&&Corynebacterium jeikeium ATCC BAA-949 (MBC=8µM)&&Murine macrophage cells RAW 264.7 (20% Killing=64µM)&&Human lung carcinoma A549 (20% Killing=64µM),GIFSKLAGKKLKNLLISG,,Linear,Free,Free,,L,dbAMP3,18
16473,dbAMP_16473,,Staphylococcus aureus ATCC 25923 (MIC=100µM)&&Staphylococcus aureus (MIC=100µM)&&Human lung carcinoma A549 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM),FIHHIIGALGHLF,,Linear,Free,Free,,L,dbAMP3,13
16499,dbAMP_16499,,Escherichia coli ATCC 9637 (MIC=7µM)&&Escherichia coli ATCC 25922 (MIC=6.5µM)&&Escherichia coli ATCC 25922 (MIC=10µM)&&Escherichia coli ATCC 25922 (MIC=11.3µM)&&Escherichia coli ATCC 25922 (MIC=45µM)&&Escherichia coli ATCC 25922 (MIC=5.5µM)&&Escherichia coli ATCC 25922 (MIC=26.5µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=15.3µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=7µM)&&Bacillus subtilis ATCC 6633 (MIC=3.8µM)&&Staphylococcus aureus ATCC 25923 (MIC=14µM)&&Staphylococcus aureus ATCC 700698 (MIC=>35µM)&&Staphylococcus aureus ATCC 700699 (MIC=35µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=35µM)&&Staphylococcus aureus ATCC 29213 (MIC=>35µM)&&Staphylococcus aureus ATCC 33592 (MIC=>35µM)&&Candida albicans ATCC 10231 (MIC=2.1µM)&&Cryptococcus neoformans (MIC=2.1µM)&&Candida parapsilosis ATCC 22019 (MIC=1µM)&&Sporothrix schenckii (MIC=2.1µM)&&Trichophyton mentagrophytes (MIC=4.4µM)&&Aspergillus fumigatus (MIC=2.1µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=3.15µM)&&Human cervical carcinoma HeLa (IC50=4.9µM)&&Human colon adenocarcinoma DLD-1 (IC50=6.7µM)&&Human hepatocellular carcinoma HepG2 (IC50=2.5µM),FRRFFKWFRRFFKFF,,Linear,Free,Free,,L,dbAMP3,15
16500,dbAMP_16500,,Escherichia coli ATCC 9637 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=2.7µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=11.3µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=15µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=3.6µM)&&Bacillus subtilis ATCC 6633 (MIC=1.95µM)&&Staphylococcus aureus ATCC 25923 (MIC=5µM)&&Staphylococcus aureus ATCC 700698 (MIC=9µM)&&Staphylococcus aureus ATCC 700699 (MIC=2.1µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=9µM)&&Staphylococcus aureus ATCC 29213 (MIC=9µM)&&Staphylococcus aureus ATCC 33592 (MIC=4.4µM)&&Candida albicans ATCC 10231 (MIC=2.1µM)&&Cryptococcus neoformans (MIC=2.1µM)&&Candida parapsilosis ATCC 22019 (MIC=2.1µM)&&Sporothrix schenckii (MIC=9µM)&&Trichophyton mentagrophytes (MIC=18µM)&&Aspergillus fumigatus (MIC=18µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=6.3µM)&&Human cervical carcinoma HeLa (IC50=7.7µM)&&Human colon adenocarcinoma DLD-1 (IC50=9.4µM)&&Human hepatocellular carcinoma HepG2 (IC50=2.5µM),FRRPFKWFRRFFKFF,,Linear,Free,Free,,L,dbAMP3,15
16501,dbAMP_16501,,Escherichia coli ATCC 9637 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=11µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=11.3µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=7.7µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=3µM)&&Bacillus subtilis ATCC 6633 (MIC=1.95µM)&&Staphylococcus aureus ATCC 25923 (MIC=5µM)&&Staphylococcus aureus ATCC 700698 (MIC=9µM)&&Staphylococcus aureus ATCC 700699 (MIC=4.4µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=9µM)&&Staphylococcus aureus ATCC 29213 (MIC=18µM)&&Staphylococcus aureus ATCC 33592 (MIC=9µM)&&Candida albicans ATCC 10231 (MIC=9µM)&&Cryptococcus neoformans (MIC=9µM)&&Candida parapsilosis ATCC 22019 (MIC=9µM)&&Sporothrix schenckii (MIC=35µM)&&Trichophyton mentagrophytes (MIC=>35µM)&&Aspergillus fumigatus (MIC=>35µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=6.4µM)&&Human cervical carcinoma HeLa (IC50=10.5µM)&&Human colon adenocarcinoma DLD-1 (IC50=10.8µM)&&Human hepatocellular carcinoma HepG2 (IC50=4.2µM),FRRFFKWPRRFFKFF,,Linear,Free,Free,,L,dbAMP3,15
16502,dbAMP_16502,,Escherichia coli ATCC 9637 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=4.5µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=11µM)&&Escherichia coli ATCC 25922 (MIC=22µM)&&Escherichia coli ATCC 25922 (MIC=11.3µM)&&Escherichia coli ATCC 25922 (MIC=5µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=6.4µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=4µM)&&Bacillus subtilis ATCC 6633 (MIC=1.95µM)&&Staphylococcus aureus ATCC 25923 (MIC=5µM)&&Staphylococcus aureus ATCC 700698 (MIC=2.1µM)&&Staphylococcus aureus ATCC 700699 (MIC=1µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=2.1µM)&&Staphylococcus aureus ATCC 29213 (MIC=2.1µM)&&Staphylococcus aureus ATCC 33592 (MIC=4.4µM)&&Candida albicans ATCC 10231 (MIC=9µM)&&Cryptococcus neoformans (MIC=9µM)&&Candida parapsilosis ATCC 22019 (MIC=4.4µM)&&Sporothrix schenckii (MIC=9µM)&&Trichophyton mentagrophytes (MIC=35µM)&&Aspergillus fumigatus (MIC=35µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=7.0µM)&&Human cervical carcinoma HeLa (IC50=11µM)&&Human colon adenocarcinoma DLD-1 (IC50=12.9µM)&&Human hepatocellular carcinoma HepG2 (IC50=4.8µM),FRRFFKWFRRPFKFF,,Linear,Free,Free,,L,dbAMP3,15
16503,dbAMP_16503,,Escherichia coli ATCC 9637 (MIC=4.8µM)&&Escherichia coli ATCC 25922 (MIC=4.8µM)&&Escherichia coli ATCC 25922 (MIC=11.5µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=22µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Escherichia coli ATCC 25922 (MIC=5.6µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=32µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=5.1µM)&&Bacillus subtilis ATCC 6633 (MIC=2.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 700698 (MIC=4.4µM)&&Staphylococcus aureus ATCC 700699 (MIC=4.5µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=4.4µM)&&Staphylococcus aureus ATCC 29213 (MIC=4.4µM)&&Staphylococcus aureus ATCC 33592 (MIC=18µM)&&Candida albicans ATCC 10231 (MIC=9µM)&&Cryptococcus neoformans (MIC=18µM)&&Candida parapsilosis ATCC 22019 (MIC=9µM)&&Sporothrix schenckii (MIC=18µM)&&Trichophyton mentagrophytes (MIC=>35µM)&&Aspergillus fumigatus (MIC=>35µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=15.4µM)&&Human cervical carcinoma HeLa (IC50=13.8µM)&&Human colon adenocarcinoma DLD-1 (IC50=15.3µM)&&Human hepatocellular carcinoma HepG2 (IC50=5µM),FRRPFKWPRRFFKFF,,Linear,Free,Free,,L,dbAMP3,15
16504,dbAMP_16504,,Escherichia coli ATCC 9637 (MIC=4.8µM)&&Escherichia coli ATCC 25922 (MIC=4.8µM)&&Escherichia coli ATCC 25922 (MIC=23.1µM)&&Escherichia coli ATCC 25922 (MIC=>45µM)&&Escherichia coli ATCC 25922 (MIC=22µM)&&Escherichia coli ATCC 25922 (MIC=11.3µM)&&Escherichia coli ATCC 25922 (MIC=11µM)&&Pseudomonas aeruginosa ATCC BAA-427 (MIC=10µM)&&Klebsiella pneumoniae ATCC 27736 (MIC=6.7µM)&&Bacillus subtilis ATCC 6633 (MIC=2.2µM)&&Staphylococcus aureus ATCC 25923 (MIC=7.14µM)&&Staphylococcus aureus ATCC 700698 (MIC=4.4µM)&&Staphylococcus aureus ATCC 700699 (MIC=4.5µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=4.4µM)&&Staphylococcus aureus ATCC 29213 (MIC=9µM)&&Staphylococcus aureus ATCC 33592 (MIC=9µM)&&Candida albicans ATCC 10231 (MIC=18µM)&&Cryptococcus neoformans (MIC=18µM)&&Candida parapsilosis ATCC 22019 (MIC=18µM)&&Sporothrix schenckii (MIC=9µM)&&Trichophyton mentagrophytes (MIC=>35µM)&&Aspergillus fumigatus (MIC=>35µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=27µM)&&Human cervical carcinoma HeLa (IC50=18.9µM)&&Human colon adenocarcinoma DLD-1 (IC50=22µM)&&Human hepatocellular carcinoma HepG2 (IC50=15µM),FRRFFKWPRRPFKFF,,Linear,Free,Free,,L,dbAMP3,15
16512,dbAMP_16512,,Human breast adenocarcinoma MCF-7 (IC50=23.2±2.4µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=21.4±2.7µM)&&Human myelogenous leukemia K562 (IC50=27.4±3.5µM)&&Human myelogenous leukemia K562/ADM (IC50=31.3±4.0µM),KKLFKKILKAL,,Linear,Free,Free,,L,dbAMP3,11
16513,dbAMP_16513,,Human breast adenocarcinoma MCF-7 (IC50=6.6±1.4µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=7.3±0.7µM)&&Human myelogenous leukemia K562 (IC50=7.7±1.4µM)&&Human myelogenous leukemia K562/ADM (IC50=9.3±1.7µM),KKLFKKILKLL,,Linear,Free,Free,,L,dbAMP3,11
16514,dbAMP_16514,,Human breast adenocarcinoma MCF-7 (IC50=21.5±1.9µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=21.3±2.1µM)&&Human myelogenous leukemia K562 (IC50=23.7±2.3µM)&&Human myelogenous leukemia K562/ADM (IC50=24.6±1.6µM),KKLFKKILKIL,,Linear,Free,Free,,L,dbAMP3,11
16515,dbAMP_16515,,Human breast adenocarcinoma MCF-7 (IC50=33.5±3.3µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=30.3±4.2µM)&&Human myelogenous leukemia K562 (IC50=34.5±4.0µM)&&Human myelogenous leukemia K562/ADM (IC50=36.8±3.9µM),KKLFKKILKGL,,Linear,Free,Free,,L,dbAMP3,11
16516,dbAMP_16516,,Human breast adenocarcinoma MCF-7 (IC50=36.9±4.0µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=33.7±3.9µM)&&Human myelogenous leukemia K562 (IC50=32.2±2.2µM)&&Human myelogenous leukemia K562/ADM (IC50=39.5±3.7µM),KKLFKKILKTL,,Linear,Free,Free,,L,dbAMP3,11
16517,dbAMP_16517,,Human breast adenocarcinoma MCF-7 (IC50=53.6±4.2µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=53.3±4.5µM)&&Human myelogenous leukemia K562 (IC50=57.6±3.9µM)&&Human myelogenous leukemia K562/ADM (IC50=58.3±6.2µM),KKLFKKILKQL,,Linear,Free,Free,,L,dbAMP3,11
16518,dbAMP_16518,,Human breast adenocarcinoma MCF-7 (IC50=83.2±6.7µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=79.5±6.9µM)&&Human myelogenous leukemia K562 (IC50=89.4±7.3µM)&&Human myelogenous leukemia K562/ADM (IC50=>100µM),KKLFKKILKEL,,Linear,Free,Free,,L,dbAMP3,11
16519,dbAMP_16519,,Human breast adenocarcinoma MCF-7 (IC50=77.9±6.7µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=70.7±6.3µM)&&Human myelogenous leukemia K562 (IC50=76.3±5.4µM)&&Human myelogenous leukemia K562/ADM (IC50=82.5±6.8µM),KKLFKKILKDL,,Linear,Free,Free,,L,dbAMP3,11
16520,dbAMP_16520,,Human breast adenocarcinoma MCF-7 (IC50=59.4±2.9µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=57.3±4.5µM)&&Human myelogenous leukemia K562 (IC50=60.8±5.3µM)&&Human myelogenous leukemia K562/ADM (IC50=71.2±4.7µM),KKLFKKILKRL,,Linear,Free,Free,,L,dbAMP3,11
16521,dbAMP_16521,,Human breast adenocarcinoma MCF-7 (IC50=8.6±1.3µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=10.2±1.7µM)&&Human myelogenous leukemia K562 (IC50=7.6±1.8µM)&&Human myelogenous leukemia K562/ADM (IC50=9.9±1.4µM),KKLFKKILKHL,,Linear,Free,Free,,L,dbAMP3,11
16526,dbAMP_16526,,Human breast adenocarcinoma MCF-7 (IC50=148.2±8.8µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=97.0±15.4µM),RRLFRRILRRL,,Linear,Free,Free,,L,dbAMP3,11
16527,dbAMP_16527,,Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=>200µM),CREKA,,Linear,Free,Free,,L,dbAMP3,5
16528,dbAMP_16528,,Human breast adenocarcinoma MCF-7 (IC50=74.7±8.8µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=76.2±0.8µM),CREKAKKLFKKILKKL,,Linear,Free,Free,,L,dbAMP3,16
16542,dbAMP_16542,,Escherichia coli ATCC 25922 (MIC=>200µM)&&Escherichia coli ML-35p (MIC=>200µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>200µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=>200µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>200µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=>200µM)&&Staphylococcus aureus ST1065 (MIC=>200µM)&&Streptococcus pyogenes ATCC 19615 (MIC=>200µM)&&Listeria ivanovii (MIC=>200µM)&&Enterococcus faecalis ATCC 29212 (MIC=>200µM)&&Candida albicans ATCC 90028 (MIC=>200µM)&&Candida parapsilosis ATCC 22019 (MIC=>200µM)&&Saccharomyces cerevisiae (MIC=>200µM)&&Human acute monocytic leukemia THP-1 (IC50=>60µM)&&Human hepatocellular carcinoma HepG2 (IC50=>600µM),FASGIAGMAGKLF,,Linear,Free,Free,,L,dbAMP3,13
16557,dbAMP_16557,,Staphylococcus aureus ATCC 25923 (MIC=1.56µM)&&Staphylococcus aureus ATCC 25923 (MBC=3.13µM)&&Staphylococcus aureus ATCC 33591 (MIC=1.56µM)&&Staphylococcus aureus ATCC 33591 (MBC=3.13µM)&&Escherichia coli ATCC 25922 (MIC=3.13µM)&&Escherichia coli ATCC 25922 (MBC=3.13µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.13µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=3.13µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50= 5.02±1.04µM),WRRRYRRWRRRRRWRRRPRR,,Linear,Free,Free,,L,dbAMP3,20
16592,dbAMP_16592,,Staphylococcus aureus CPCC 100520 (MIC=>159.7µM)&&Staphylococcus aureus CPCC 100520 (MBC=>159.7 µM)&&Escherichia coli CPCC 100521 (MIC=639 µM)&&Escherichia coli CPCC 100521 (MBC=>159.7µM)&&Candida albicans CPCC 400416 (MIC=>159.7µM)&&Candida albicans CPCC 400416 (MBC=>159.7 µM)&&Human hepatocellular carcinoma Huh7 (IC50=1.81µM)&&Human liver carcinoma SK-HEP-1 (IC50=0.99µM)&&Human hepatocellular carcinoma HepG2 (IC50=2.88µM),IIGPVLGLIGKALGGLL,,Linear,Free,Free,,L,dbAMP3,17
16665,dbAMP_16665,2MW0,Escherichia coli ATCC 25922 (MBC50=160µM)&&Escherichia coli ATCC 25922 (MBC99=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Staphylococcus aureus ATCC 29213 (MBC50=40µM)&&Staphylococcus aureus ATCC 29213 (MBC99=80µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=40µM)&&Candida albicans ATCC 90028 (MFC99=80µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=>>40µM),GLPVCGETCTLGTCSTQGCTCSWPICKRN,,Linear,Free,Free,,L,dbAMP3,29
16666,dbAMP_16666,,Escherichia coli ATCC 25922 (MBC50=>160µM)&&Escherichia coli ATCC 25922 (MBC99=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=>>32µM),GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD,,Linear,Free,Free,,L,dbAMP3,34
16667,dbAMP_16667,,Escherichia coli ATCC 25922 (MBC50=>160µM)&&Escherichia coli ATCC 25922 (MBC99=>160µM)&&Escherichia coli ATCC 25922 (MIC=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC50=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC99=>160µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC50=>160µM)&&Staphylococcus aureus ATCC 29213 (MBC99=>160µM)&&Staphylococcus aureus ATCC 29213 (MIC=>160µM)&&Candida albicans ATCC 90028 (MFC50=>160µM)&&Candida albicans ATCC 90028 (MFC99=>160µM)&&Candida albicans ATCC 90028 (MIC=>160µM)&&Human histiocytic lymphoma U-937/GTB (IC50=>>80µM),GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,,Linear,Free,Free,,L,dbAMP3,34
16668,dbAMP_16668,,Human skin melanoma MM96L (CC50=21.94±1.90µM)&&Human cervical carcinoma HeLa (CC50=36.92±3.25µM),GLPTCGETCTLGKCNTPKCTCNWPICYKD,,Linear,Free,Free,,L,dbAMP3,29
16670,dbAMP_16670,,Human skin melanoma MM96L (CC50=21.94±1.90µM)&&Human cervical carcinoma HeLa (CC50=36.92±3.25µM),GLPTCGETCTLGKCNTPKCTCNWPICYKN,,Linear,Free,Free,,L,dbAMP3,29
16671,dbAMP_16671,,Human skin melanoma MM96L (CC50=2.09±0.18µM)&&Human cervical carcinoma HeLa (CC50=9.83±0.78µM),GKYTCGETCFKGKCYTPGCTCSYPICKKD,,Linear,Free,Free,,L,dbAMP3,29
16672,dbAMP_16672,,Human skin melanoma MM96L (CC50=1.30±0.44µM)&&Human cervical carcinoma HeLa (CC50=19.26±1.37µM),GKPTCGETCFKGKCYTPGCTCSYPLCKKD,,Linear,Free,Free,,L,dbAMP3,29
16673,dbAMP_16673,,Human skin melanoma MM96L (CC50=2.04±0.26µM)&&Human cervical carcinoma HeLa (CC50=18.73±1.82µM),GKPICGETCFKGKCYTPGCTCSYPICKKD,,Linear,Free,Free,,L,dbAMP3,29
16674,dbAMP_16674,,Human skin melanoma MM96L (CC50=2.04±0.26µM)&&Human cervical carcinoma HeLa (CC50=18.73±1.82µM),GKPICGETCFKGKCYTPGCTCSYPICKKN,,Linear,Free,Free,,L,dbAMP3,29
16675,dbAMP_16675,,Human skin melanoma MM96L (CC50=1.58±0.48µM)&&Human cervical carcinoma HeLa (CC50=11.42±1.00µM),GLPTCGETCFKGKCYTPGCSCSYPICKKD,,Linear,Free,Free,,L,dbAMP3,29
16676,dbAMP_16676,,Human skin melanoma MM96L (CC50=1.58±0.48µM)&&Human cervical carcinoma HeLa (CC50=11.42±1.00µM),GLPTCGETCFKGKCYTPGCSCSYPICKKN,,Linear,Free,Free,,L,dbAMP3,29
16709,dbAMP_16709,,Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Candida parapsilosis ATCC 22019 (MIC=16µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=8µM)&&Human lung carcinoma A549 (LC50=18µM)&&Human colon adenocarcinoma HT29 (LC50=18µM),IVPFLLGMVPKLVCLITKKC,,Linear,Free,Free,,L,dbAMP3,20
16710,dbAMP_16710,,Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=>128µM)&&Candida parapsilosis ATCC 22019 (MIC=64µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=40µM)&&Human lung carcinoma A549 (LC50=45µM)&&Human colon adenocarcinoma HT29 (LC50=100µM),FLGAIAQALTSLLGKL,,Linear,Free,Free,,L,dbAMP3,16
16714,dbAMP_16714,,Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Escherichia coli 1 (MIC=9.38-18.75µg/ml)&&Escherichia coli (MIC=>200µg/ml)&&Shigella dysenteriae (MIC=9.38µg/ml)&&Klebsiella pneumoniae (MIC=9.38-18.75µg/ml)&&Klebsiella oxytoca (MIC=9.38µg/ml)&&Proteus vulgaris (MIC=9.38µg/ml)&&Proteus mirabilis (MIC=9.38µg/ml)&&Acinetobacter baumannii (MIC=4.69µg/ml)&&Stenotrophomonas maltophilia (MIC=18.75-37.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa (MIC=9.38-18.75µg/ml)&&Salmonella enterica subsp. enterica serovar Paratyphi A (MIC=4.69µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>200µg/ml)&&Staphylococcus aureus 1 (MIC=9.38-18.75µg/ml)&&Staphylococcus aureus (MIC=>200µg/ml)&&Bacillus cereus (MIC=9.38µg/ml)&&Bacillus subtilis (MIC=2.35µg/ml)&&Enterococcus faecium (MIC=9.38µg/ml)&&Nocardia asteroides (MIC=>200µg/ml)&&Enterococcus faecalis (MIC=>200µg/ml)&&Staphylococcus epidermidis (MIC=9.38µg/ml)&&Candida albicans 1 (MIC=9.38-18.75µg/ml)&&Candida albicans (MIC=>200µg/ml)&&Candida glabrata 1 (MIC=9.38µg/ml)&&Candida glabrata (MIC=75µg/ml)&&Aspicilia cinerea (MIC=18.75µg/ml)&&Aeromonas sobria (MIC=37.5µg/ml)&&Aeromonas hydrophila (MIC=9.38µg/ml)&&Aeromonas veronii (MIC=18.75µg/ml)&&Vibrio harveyi (MIC=9.38µg/ml)&&Vibrio parahaemolyticus (MIC=4.69µg/ml)&&Vibrio anguillarum (MIC=9.38µg/ml)&&Vibrio cholerae (MIC=9.38µg/ml)&&Human gastric cancer BGC-823 (26±0.9% Cell death =200µg/ml)&&Vibrio vulnificus (MIC=4.69µg/ml)&&Vibrio splendidus (MIC=4.69-9.38µg/ml),RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR,,Linear,Free,Free,,L,dbAMP3,38
16715,dbAMP_16715,,Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Escherichia coli 1 (MIC=18.75µg/ml)&&Escherichia coli (MIC=9.38µg/ml)&&Shigella dysenteriae (MIC=9.38µg/ml)&&Klebsiella pneumoniae 1 (MIC=>200µg/ml)&&Klebsiella pneumoniae (MIC=9.38-18.75µg/ml)&&Klebsiella oxytoca (MIC=9.38µg/ml)&&Proteus vulgaris (MIC=>200µg/ml)&&Proteus mirabilis (MIC=4.69µg/ml)&&Acinetobacter baumannii 1 (MIC=18.75µg/ml)&&Acinetobacter baumannii (MIC=>200µg/ml)&&Stenotrophomonas maltophilia (MIC=9.38µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa (MIC=9.38-18.75µg/ml)&&Salmonella enterica subsp. enterica serovar Paratyphi A (MIC=9.38µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=37.5µg/ml)&&Staphylococcus aureus 1 (MIC=9.38-18.75µg/ml)&&Staphylococcus aureus (MIC=37.5µg/ml)&&Bacillus cereus (MIC=18.75µg/ml)&&Bacillus subtilis (MIC=2.35µg/ml)&&Enterococcus faecium (MIC=18.75µg/ml)&&Nocardia asteroides (MIC=9.38µg/ml)&&Enterococcus faecalis (MIC=9.38µg/ml)&&Staphylococcus epidermidis (MIC=18.75µg/ml)&&Candida albicans 1 (MIC=9.38-18.75µg/ml)&&Candida albicans (MIC=37.5µg/ml)&&Candida glabrata 1 (MIC=9.38µg/ml)&&Candida glabrata (MIC=37.5µg/ml)&&Aspicilia cinerea (MIC=18.75µg/ml)&&Aeromonas sobria (MIC=9.38µg/ml)&&Aeromonas hydrophila (MIC=9.38µg/ml)&&Aeromonas veronii (MIC=9.38µg/ml)&&Vibrio harveyi (MIC=9.38µg/ml)&&Vibrio parahaemolyticus (MIC=4.69µg/ml)&&Vibrio anguillarum (MIC=4.69µg/ml)&&Vibrio cholerae (MIC=18.75µg/ml)&&Human gastric cancer BGC-823 (58±1.5% Cell death=200µg/ml)&&Vibrio vulnificus (MIC=9.38µg/ml)&&Vibrio splendidus (MIC=4.69µg/ml)&&Vibrio parahaemolyticus ATCC 17802 (MIC=4.69µg/ml),TRRKFWKKVLNGALKIAPFLLG,,Linear,Free,Free,,L,dbAMP3,22
16716,dbAMP_16716,,Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Escherichia coli 1 (MIC=4.69µg/ml)&&Escherichia coli (MIC=9.38-18.75µg/ml)&&Shigella dysenteriae (MIC=37.5µg/ml)&&Klebsiella pneumoniae (MIC=9.38µg/ml)&&Klebsiella oxytoca (MIC=>200µg/ml)&&Proteus vulgaris (MIC=>200µg/ml)&&Proteus mirabilis (MIC=9.38µg/ml)&&Acinetobacter baumannii (MIC=>200µg/ml)&&Stenotrophomonas maltophilia (MIC=>200µg/ml)&&Stenotrophomonas maltophilia 2 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=37.5µg/ml)&&Pseudomonas aeruginosa (MIC=18.75µg/ml)&&Salmonella enterica subsp. enterica serovar Paratyphi A (MIC=37.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>200µg/ml)&&Staphylococcus aureus 1 (MIC=>200µg/ml)&&Staphylococcus aureus (MIC=37.5µg/ml)&&Staphylococcus aureus 4 (MIC=9.38µg/ml)&&Bacillus cereus (MIC=>200µg/ml)&&Bacillus subtilis (MIC=9.38µg/ml)&&Enterococcus faecium (MIC=>200µg/ml)&&Nocardia asteroides (MIC=18.75µg/ml)&&Enterococcus faecalis (MIC=>200µg/ml)&&Staphylococcus epidermidis (MIC=>200µg/ml)&&Candida albicans (MIC=>200µg/ml)&&Candida glabrata 1 (MIC=>200µg/ml)&&Candida glabrata (MIC=37.5µg/ml)&&Aspicilia cinerea (MIC=>200µg/ml)&&Aeromonas sobria (MIC=37.5µg/ml)&&Aeromonas hydrophila (MIC=37.5µg/ml)&&Aeromonas veronii (MIC=75µg/ml)&&Vibrio harveyi (MIC=37.5µg/ml)&&Vibrio parahaemolyticus (MIC=37.5µg/ml)&&Vibrio anguillarum (MIC=18.75µg/ml)&&Vibrio cholerae (MIC=37.5µg/ml)&&Human gastric cancer BGC-823 (58±1.8% Cell death=200µg/ml),TRWLWLLRGGLKAAGWGIRAHLNRNQ,,Linear,Free,Free,,L,dbAMP3,26
16720,dbAMP_16720,,Escherichia coli ATCC 25922 (MIC=4-8µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Escherichia coli CGSC 5167 (MIC=0.03-0.06µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=8-16µM)&&Acinetobacter baumannii ATCC 19606 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2-4µM)&&Helicobacter pylori ATCC 43504 (MIC=>80µM)&&Candida albicans ATCC 90028 (MIC=4-8µM)&&Cryptococcus neoformans ATCC 208821 (MIC=0.5-1µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=51.0±4.6µM)&&Human skin melanoma MM96L (CC50=4.6±0.2µM)&&Human cervical carcinoma HeLa (CC50=>64µM)&&Human breast adenocarcinoma MCF-7 (CC50=37.5±3.3µM)&&Human myelogenous leukemia K562 (CC50=1.4±0.2µM)&&Human promyelocytic leukemia HL-60 (CC50=38.5±4.8µM),GXRRLXYKQRXVTYXRGR,,Linear,Free,Free,,L,dbAMP3,18
16722,dbAMP_16722,,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=4-16µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1-2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Candida albicans ATCC 90028 (MIC=4µM)&&Cryptococcus neoformans ATCC 208821 (MIC=0.5-1µM)&&Human gastric adenocarcinoma CRL-1739 (CC50=46.2±7.6µM)&&Human skin melanoma MM96L (CC50=2.3±0.2µM)&&Human cervical carcinoma HeLa (CC50=36.2±2.8µM)&&Human breast adenocarcinoma MCF-7 (CC50=29.0±3.7µM)&&Human myelogenous leukemia K562 (CC50=6.4±0.6µM)&&Human promyelocytic leukemia HL-60 (CC50=33.3±7.4µM),KXRRYXYRQRXVTYXRGR,,Linear,Free,Free,,L,dbAMP3,18
16766,dbAMP_16766,,Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=64µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=64µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=64µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=4µg/ml)&&Staphylococcus aureus (MIC=32-64µg/ml)&&Staphylococcus aureus (MIC=2-4µg/ml)&&Staphylococcus aureus (MIC=32µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=256µg/ml)&&Candida albicans ATCC 10231 (MIC=8µg/ml)&&Candida glabrata ATCC 15126 (MIC=4µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=4µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=4µg/ml)&&Human cervical carcinoma HeLa (IC50=25.5±2.9µg/ml),CKKKC,,Linear,Free,Free,,L,dbAMP3,5
16767,dbAMP_16767,,Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=4-8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µg/ml)&&Candida albicans ATCC 10231 (MIC=32µg/ml)&&Candida glabrata ATCC 15126 (MIC=64µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=8µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=3.6±0.5µg/ml),KKKR,,Linear,Free,Free,,L,dbAMP3,4
16768,dbAMP_16768,,Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=2-8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µg/ml)&&Candida albicans ATCC 10231 (MIC=32µg/ml)&&Candida glabrata ATCC 15126 (MIC=64µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=8µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=6.2±2.7µg/ml),KKRK,,Linear,Free,Free,,L,dbAMP3,4
16769,dbAMP_16769,,Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus (MIC=8-32µg/ml)&&Staphylococcus aureus (MIC=2µg/ml)&&Staphylococcus aureus (MIC=16-32µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=16-32µg/ml)&&Staphylococcus aureus (MIC=2-4µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=256µg/ml)&&Candida albicans ATCC 10231 (MIC=16µg/ml)&&Candida glabrata ATCC 15126 (MIC=8µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=4µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=4µg/ml)&&Human cervical carcinoma HeLa (IC50=21.9±4.5µg/ml),CKKRKC,,Linear,Free,Free,,L,dbAMP3,6
16770,dbAMP_16770,,Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (=2-4µg/ml)&&Staphylococcus aureus (MIC=2-4µg/ml)&&Staphylococcus aureus (MIC=4-8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans ATCC 10231 (MIC=8µg/ml)&&Candida glabrata ATCC 15126 (MIC=64µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=8µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=8.4±1.7µg/ml),RKKK,,Linear,Free,Free,,L,dbAMP3,4
16771,dbAMP_16771,,Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=16-32µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-4µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=512µg/ml)&&Candida albicans ATCC 10231 (MIC=2µg/ml)&&Candida glabrata ATCC 15126 (MIC=8µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=4µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=2µg/ml)&&Human cervical carcinoma HeLa (IC50=38.8±4.4µg/ml),CRKKKC,,Linear,Free,Free,,L,dbAMP3,6
16772,dbAMP_16772,,Micrococcus luteus A270 (MIC=12.5µM)&&Escherichia coli SBS 363 (MIC=12.5µM)&&Salmonella enterica subsp. arizonae ATCC 13314 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µM)&&Candida albicans MDM8 (MIC=12.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=>50µM),SLLSLIRLLIT,,Linear,Free,Free,,L,dbAMP3,11
16773,dbAMP_16773,,Micrococcus luteus A270 (MIC=0.4µM)&&Escherichia coli SBS 363 (MIC=1.6µM)&&Salmonella enterica subsp. arizonae ATCC 13314 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µM)&&Candida albicans MDM8 (MIC=0.4µM)&&Human breast adenocarcinoma MCF-7 (IC50=12.5µM),SLLSLIRKLLT,,Linear,Free,Free,,L,dbAMP3,11
16774,dbAMP_16774,,Fusarium oxysporum f.sp. vasinfectum (IC50=8.3±2.1µM)&&Fusarium graminearum (IC50=2µM)&&Verticillium dahliae (IC50=>10µM)&&Berkeleyomyces basicola (IC50=7µM)&&Aspergillus nidulans (IC50=5µM)&&Puccinia coronata f.sp. avenae (IC50=4µM)&&Puccinia sorghi (IC50=5µM)&&Human histiocytic lymphoma U-937 (5.9±1.3% Cell death=10µM),RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC,,Linear,Free,Free,,L,dbAMP3,47
16775,dbAMP_16775,,Fusarium oxysporum f.sp. vasinfectum (IC50=0.16±0.04µM)&&Fusarium graminearum (IC50=0.28±0.03µM)&&Colletotrichum graminicola (IC50=2.0±0.4µM)&&Aspergillus flavus 5310 (IC50=3.5±2.28µM)&&Aspergillus parasiticus 4467 (IC50=3.7±1.17µM)&&Aspergillus niger 5181 (IC50=2.2±1.22µM)&&Candida albicans DAY185 (IC50=2.0±0.16µM)&&Cryptococcus neoformans var. grubii H99 (IC50=1.6±0.56µM)&&Cryptococcus gattii WM276 (IC50=1.6±0.37µM)&&Human histiocytic lymphoma U-937 (22.2±2.4% Cell death=10µM),RECKTESHRFKGPCITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
16776,dbAMP_16776,,Fusarium oxysporum f.sp. vasinfectum (IC50=3.2±0.78µM)&&Human histiocytic lymphoma U-937 (7.9±2.4% Cell death=10µM),RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
16777,dbAMP_16777,,Fusarium oxysporum f.sp. vasinfectum (IC50=1.4±0.13µM)&&Human histiocytic lymphoma U-937 (44.6±8.5% Cell death=10µM),RECKTESNTFPGICITKPPCRKACLTEGFTDGHCSKILRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
16778,dbAMP_16778,,Fusarium oxysporum f.sp. vasinfectum (IC50=0.8±0.13µM)&&Human histiocytic lymphoma U-937 (20.0±1.4% Cell death=10µM),RECKTESNTFPGICITKPPCRKACISEKFSGGDCSKILRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
16779,dbAMP_16779,,Fusarium oxysporum f.sp. vasinfectum (IC50=2.7±0.30µM)&&Human histiocytic lymphoma U-937 (13.7±8.1% Cell death=10µM),RECKTESNTFPGICITKPPCRKACISEKFTDGHCRGFRRRCLCTKPC,,Linear,Free,Free,,L,dbAMP3,47
16780,dbAMP_16780,,Fusarium oxysporum f.sp. vasinfectum (IC50=0.8±0.12µM)&&Human histiocytic lymphoma U-937 (43.1±7.2% Cell death=10µM),RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCFCTRPC,,Linear,Free,Free,,L,dbAMP3,47
16782,dbAMP_16782,,Staphylococcus aureus NCIM 2901 (MIC=2µg/ml)&&Staphylococcus aureus NCIM 2901 (MBC=8µg/ml)&&Staphylococcus aureus NCIM 5021 (MIC=16µg/ml)&&Staphylococcus aureus NCIM 5021 (MBC=>64µg/ml)&&Staphylococcus aureus NCIM 2127 (MIC=8µg/ml)&&Staphylococcus aureus NCIM 2127 (MBC=32µg/ml)&&Staphylococcus aureus 15 (MIC=16µg/ml)&&Staphylococcus aureus 15 (MBC=16µg/ml)&&Staphylococcus aureus 16 (MIC=32µg/ml)&&Staphylococcus aureus 16 (MBC=>64-256µg/ml)&&Staphylococcus aureus 19 (MIC=64µg/ml)&&Staphylococcus aureus 19 (MBC=256µg/ml)&&Staphylococcus aureus 20 (MIC=8µg/ml)&&Staphylococcus aureus 20 (MBC=32µg/ml)&&Staphylococcus aureus 21 (MIC=512µg/ml)&&Staphylococcus aureus 21 (MBC=>512µg/ml)&&Streptococcus pyogenes (MIC=16µg/ml)&&Streptococcus pyogenes (MBC=>64µg/ml)&&Enterococcus faecalis ATCC 51299 (MIC=>64µg/ml)&&Enterococcus faecalis ATCC 51299 (MBC=>64µg/ml)&&Enterococcus faecium NCIM 5443 (MIC=>64µg/ml)&&Enterococcus faecium NCIM 5443 (MBC=>64µg/ml)&&Enterococcus faecalis ATCC 14506 (MIC=>64µg/ml)&&Enterococcus faecalis ATCC 14506 (MBC=>64µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=192µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=280µg/ml),FTVAXFI,,Linear,Free,Free,,L,dbAMP3,7
16792,dbAMP_16792,,Human cervical carcinoma HeLa (IC50=3.7±0.1µM)&&Human breast adenocarcinoma MCF-7 (IC50=2.5±0.3µM)&&Human lung carcinoma A549 (IC50=4.3±0.2µM),RLLRLLRRLLRLLR,,Linear,Free,Free,,L,dbAMP3,14
16793,dbAMP_16793,,Human cervical carcinoma HeLa (IC50=4.2±0.2µM)&&Human breast adenocarcinoma MCF-7 (IC50=4.5±0.3µM)&&Human lung carcinoma A549 (IC50=4.8±0.6µM),RLLRLLRLRRLLRL,,Linear,Free,Free,,L,dbAMP3,14
16794,dbAMP_16794,,Human cervical carcinoma HeLa (IC50=34.5±1.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=51.3±2.2µM)&&Human lung carcinoma A549 (IC50=39.7±2.4µM),KLLKLLKLKKLLKL,,Linear,Free,Free,,L,dbAMP3,14
16807,dbAMP_16807,,Human colon adenocarcinoma SW1116 (62.73±5.66% Inhibition=50µg/ml)&&Human hepatocarcinoma SMMC-7721 (59.37±10.57% Inhibition=50µg/ml)&&Human cervical carcinoma HeLa (56.81±36.34% Inhibition=50µg/ml)&&Human hepatocellular carcinoma HepG2 (55.98±24.38% Inhibition=50µg/ml)&&Human gastric cancer BGC-823 (50.85±5.77% Inhibition=50µg/ml)&&Human lung carcinoma A549 (50.64±20.54% Inhibition=50µg/ml),LLRHVVKILSKYL,,Linear,Free,Free,,L,dbAMP3,13
16808,dbAMP_16808,,Human colon adenocarcinoma SW1116 (72.69±4.60% Inhibition=50µg/ml)&&Human hepatocarcinoma SMMC-7721 (70.39±4.00% Inhibition=50µg/ml)&&Human cervical carcinoma HeLa (73.09±2.04% Inhibition=50µg/ml)&&Human hepatocellular carcinoma HepG2 (60.22±4.58% Inhibition=50µg/ml)&&Human gastric cancer BGC-823 (62.49±1.84% Inhibition=50µg/ml)&&Human lung carcinoma A549 (47.26±2.75% Inhibition=50µg/ml),RGDLLRHVVKILEKYL,,Linear,Free,Free,,L,dbAMP3,16
16809,dbAMP_16809,,Human colon adenocarcinoma SW1116 (81.465±2.99% Inhibition=50µg/ml)&&Human hepatocarcinoma SMMC-7721 (86.175±4.15% Inhibition=50µg/ml)&&Human cervical carcinoma HeLa (78.045±5.48% Inhibition=50µg/ml)&&Human hepatocellular carcinoma HepG2 (73.07±3.23% Inhibition=50µg/ml)&&Human gastric cancer BGC-823 (73.705±5.53% Inhibition=50µg/ml)&&Human lung carcinoma A549 (52.50±11.62% Inhibition=50µg/ml),RGDLLRHVVKILSKYL,,Linear,Free,Free,,L,dbAMP3,16
16873,dbAMP_16873,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=4µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Staphylococcus aureus NCTC 12493 (MBC=4µM)&&Candida albicans NCYC 1467 (MIC=2µM)&&Candida albicans NCYC 1467 (MBC=2µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=64µM)&&Human squamous lung carcinoma NCI-H157 (IC50=2.85µM),FLSLIPKIATGIAALAKHL,,Linear,Free,Free,,L,dbAMP3,19
16874,dbAMP_16874,,Staphylococcus aureus NCTC 10788 (MIC=8µg/ml)&&Staphylococcus aureus NCTC 10788 (MBC=8µg/ml)&&Escherichia coli NCTC 10418 (MIC=128µg/ml)&&Escherichia coli NCTC 10418 (MBC=>512µg/ml)&&Candida albicans NCYC 1467 (MIC=8µg/ml)&&Candida albicans NCYC 1467 (MBC=8µg/ml)&&Human lung carcinoma NCI-H460 (IC50=4.3µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.9µM)&&Human glioblastoma U251-MG (IC50=1.8µM),FFSMIPKIAGGIASLVKNL,,Linear,Free,Free,,L,dbAMP3,19
16875,dbAMP_16875,,Staphylococcus aureus NCTC 10788 (MIC=8µg/ml)&&Escherichia coli NCTC 10418 (MIC=32µg/ml)&&Candida albicans NCYC 1467 (MIC=4µg/ml)&&Enterococcus faecalis NCTC 12697 (MIC=32µg/ml)&&Staphylococcus aureus NCTC 12493 (MIC=8µg/ml)&&Human squamous lung carcinoma NCI-H157 (IC50=6.73µM),FLSLIPKIAGGIAALAKHL,,Linear,Free,Free,,L,dbAMP3,19
16884,dbAMP_16884,,Escherichia coli NCTC 10418 (MIC=16µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Staphylococcus aureus NCTC 10788 (MBC=64µM)&&Staphylococcus aureus NCTC 12493 (MIC=>512µM)&&Staphylococcus aureus NCTC 12493 (MBC=>512µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=64µM)&&Candida albicans NCYC 1467 (MIC=16µM)&&Candida albicans NCYC 1467 (MBC=32µM)&&Human breast adenocarcinoma MCF-7 (IC50=0.69µM)&&Human squamous lung carcinoma NCI-H157 (IC50=2.01µM)&&Human glioblastoma U251-MG (IC50=2.36µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=9.94µM)&&Human prostate adenocarcinoma PC-3 (IC50=11.8µM),ALWKEVLKNAGKAALNEINNLVQ,,Linear,Free,Free,,L,dbAMP3,23
16885,dbAMP_16885,,Staphylococcus aureus NCTC 10788 (MIC=64µg/ml)&&Staphylococcus aureus NCTC 12493 (MIC=64µg/ml)&&Enterococcus faecalis NCTC 12697 (MIC=512µg/ml)&&Escherichia coli NCTC 10418 (MIC=>512µg/ml)&&Candida albicans NCYC 1467 (MIC=256µg/ml)&&Human squamous lung carcinoma NCI-H157 (IC50=14.10µM)&&Staphylococcus aureus NCTC 10788 (MBC=16µM)&&Enterococcus faecalis NCTC 12697 (MBC=>512µM)&&Staphylococcus aureus NCTC 12493 (MBC=128µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MFC=32µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=28.48µM)&&Human squamous lung carcinoma NCI-H157 (LD50=37.61µM)&&Human prostate adenocarcinoma PC-3 (LD50=37.96µM)&&Human colon adenocarcinoma HCT 116 (LD50=36.64µM)&&Human breast adenocarcinoma MCF-7 (LD50=24.05µM)&&Human glioblastoma U251-MG (LD50=34.67µM),FLSLIPAAISAVSALANHF,,Linear,Free,Free,,L,dbAMP3,19
16903,dbAMP_16903,,Staphylococcus aureus ATCC 33591 (MIC=16µg/ml)&&Staphylococcus aureus USA 300 (MIC=8µg/ml)&&Staphylococcus aureus RN4220 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=32µg/ml)&&Staphylococcus aureus NCTC 12493 (MIC=16µg/ml)&&Staphylococcus aureus MRSA-15 (MIC=32µg/ml)&&Klebsiella pneumoniae NCTC 13442 (MIC=16µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=16µg/ml)&&Klebsiella pneumoniae Q14-0095 (MIC=32µg/ml)&&Klebsiella pneumoniae Q14-0285 (MIC=16µg/ml)&&Acinetobacter baumannii Q13-0717 (MIC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=32µg/ml)&&Pseudomonas aeruginosa Q14-0208 (MIC=16µg/ml)&&Pseudomonas aeruginosa Q14-0890 (MIC=32µg/ml)&&Pseudomonas aeruginosa Q12-0535 (MIC=64µg/ml)&&Escherichia coli K-12 (MIC=32µg/ml)&&Escherichia coli (MIC=64µg/ml)&&Campylobacter jejuni (MIC=64µg/ml)&&Campylobacter jejuni NCTC 11351 (MIC=64µg/ml)&&Campylobacter jejuni NCTC 11161 (MIC=4µg/ml)&&Campylobacter jejuni ATCC 33292 (MIC=4µg/ml)&&Salmonella typhimurium SL1344 (MIC=32µg/ml)&&Enterococcus faecalis JH-2-2 (MIC=32µg/ml)&&Listeria monocytogenes NCTC 11994 (MIC=32µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=45.9µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=32-16µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=256-64µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=64-16µg/ml),LPRRNRWSKIWKKVVTVFS,,Linear,Free,Free,,L,dbAMP3,19
16905,dbAMP_16905,,Staphylococcus aureus ATCC 33591 (MIC=64µg/ml)&&Staphylococcus aureus USA 300 (MIC=64µg/ml)&&Staphylococcus aureus RN4220 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=128µg/ml)&&Staphylococcus aureus NCTC 12493 (MIC=64µg/ml)&&Staphylococcus aureus MRSA-15 (MIC=32µg/ml)&&Staphylococcus aureus Q14-0320 (MIC=128µg/ml)&&Klebsiella pneumoniae NCTC 13442 (MIC=32µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µg/ml)&&Klebsiella pneumoniae Q14-0095 (MIC=32µg/ml)&&Klebsiella pneumoniae Q14-0285 (MIC=64µg/ml)&&Acinetobacter baumannii Q13-0717 (MIC=32µg/ml)&&Acinetobacter baumannii Q12-0809 (MIC=16µg/ml)&&Acinetobacter baumannii Q12-0867 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=32µg/ml)&&Pseudomonas aeruginosa Q14-0208 (MIC=32µg/ml)&&Pseudomonas aeruginosa Q14-0890 (MIC=16µg/ml)&&Pseudomonas aeruginosa Q12-0535 (MIC=128µg/ml)&&Escherichia coli K-12 (MIC=64µg/ml)&&Escherichia coli (MIC=128µg/ml)&&Campylobacter jejuni NCTC 11351 (MIC=128µg/ml)&&Campylobacter jejuni NCTC 11161 (MIC=256µg/ml)&&Campylobacter jejuni ATCC 33292 (MIC=64µg/ml)&&Campylobacter jejuni (=64-128µg/ml)&&Salmonella typhimurium SL1344 (MIC=64µg/ml)&&Enterococcus faecalis JH-2-2 (MIC=64µg/ml)&&Listeria monocytogenes NCTC 11994 (MIC=32µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=24.4µg/ml),NRFTARFRRTPWRLCLQFRQ,,Linear,Free,Free,,L,dbAMP3,20
16988,dbAMP_16988,,Micrococcus luteus 004 (IC50=46µM)&&Bacillus megaterium ATCC 14581 (IC50=36µM)&&Bacillus subtilis 60015 (IC50=80µM)&&Staphylococcus aureus (IC50=83µM)&&Escherichia coli ATCC 23716 (IC50=>100µM)&&Enterobacter cloacae (IC50=>100µM)&&Human histiocytic lymphoma U-937 (LC50=80µM)&&Jurkat cancer cells (LC50=60µM),GFIATLCTKVLDFGIDKLIQLIEDK,,Linear,Free,Free,,L,dbAMP3,25
16999,dbAMP_16999,,Micrococcus luteus 004 (IC50=0.7µM)&&Bacillus megaterium ATCC 14581 (IC50=0.5µM)&&Bacillus subtilis 60015 (IC50=1.5µM)&&Staphylococcus aureus (IC50=3.3µM)&&Escherichia coli ATCC 23716 (IC50=6.2µM)&&Enterobacter cloacae (IC50=21µM)&&Human histiocytic lymphoma U-937 (LC=50µM)&&Jurkat cancer cells (LC50=8µM),GEILCNLCTGLINTLENLLTTKRKRQQ,,Linear,Free,Free,,L,dbAMP3,27
17014,dbAMP_17014,,Staphylococcus aureus NCTC 10788 (MIC=128µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Candida albicans NCPF 1467 (MIC=>512µM)&&Staphylococcus aureus ATCC 12493 (MIC=>512µM)&&Human squamous lung carcinoma NCI-H157 (IC50=60.2µM)&&Human prostate adenocarcinoma PC-3 (IC50=133.6µM)&&Human glioblastoma U251-MG (IC50=86.42µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=193.3µM)&&Human breast adenocarcinoma MCF-7 (IC50=302.1µM),FLPLLLAGLPSFLCLVFKKC,,Linear,Free,Free,,L,dbAMP3,20
17015,dbAMP_17015,,Staphylococcus aureus NCTC 10788 (MIC=16µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Candida albicans NCPF 1467 (MIC=8µM)&&Staphylococcus aureus ATCC 12493 (MIC=8µM)&&Human squamous lung carcinoma NCI-H157 (IC50=8.2µM)&&Human prostate adenocarcinoma PC-3 (IC50=28.4µM)&&Human glioblastoma U251-MG (IC50=14.8µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=19.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=41.6µM),FLPKLLAGLPSFLCLVFKKC,,Linear,Free,Free,,L,dbAMP3,20
17016,dbAMP_17016,,Staphylococcus aureus NCTC 10788 (MIC=16µM)&&Escherichia coli NCTC 10418 (MIC=512µM)&&Candida albicans NCPF 1467 (MIC=16µM)&&Staphylococcus aureus ATCC 12493 (MIC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=6.9µM)&&Human prostate adenocarcinoma PC-3 (IC50=16.0µM)&&Human glioblastoma U251-MG (IC50=9.2µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=58.1µM)&&Human breast adenocarcinoma MCF-7 (IC50=310.6µM),FLPLLLAGLPKFLCLVFKKC,,Linear,Free,Free,,L,dbAMP3,20
17062,dbAMP_17062,,Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli UB1005 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Salmonella enterica subsp. enterica serovar Pullorum C79-13 (MIC=2µM)&&Salmonella enterica subsp. enterica serovar Typhimurium C77-31 (MIC=4µM)&&Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus ATCC 29213 (MIC=8µM)&&Staphylococcus aureus ATCC 43300 (MIC=2µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Enterococcus faecalis ATCC 29212 (MIC=4µM)&&Bacillus subtilis CMCC 63501 (MIC=4µM)&&Human hepatocellular carcinoma HepG2 (87.5% Killing=128µM)&&Human hepatocellular carcinoma HepG2 (20% Killing=64µM),GKEFKRIVKWPWWPWRR,,Linear,Free,Free,,L,dbAMP3,17
17063,dbAMP_17063,,Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli UB1005 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Salmonella enterica subsp. enterica serovar Pullorum C79-13 (MIC=8µM)&&Salmonella enterica subsp. enterica serovar Typhimurium C77-31 (MIC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus aureus ATCC 43300 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Enterococcus faecalis ATCC 29212 (MIC=16µM)&&Bacillus subtilis CMCC 63501 (MIC=8µM)&&Human hepatocellular carcinoma HepG2 (25% Killing=64µM)&&Human hepatocellular carcinoma HepG2 (80% Killing=128µM),GKEFKRIVGRIYRLCCR,,Linear,Free,Free,,L,dbAMP3,17
17067,dbAMP_17067,,Escherichia coli BW25113 (MIC=1.2±0.4µM)&&Escherichia coli BW25113 del-sbmA (MIC=2.3±1.3µM)&&Escherichia coli BW25113 del-yjiL (MIC=1.9±1.1µM)&&Escherichia coli BW25113 del-sbmA/del-yjiL (MIC=6.4±2.2µM)&&Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=0.5µM)&&Enterococcus faecium ATCC 19434 (MIC=64µM)&&Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=2µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pantoea agglomerans (MIC=1µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=1µM)&&Candida albicans ATCC 90029 (MIC=2µM)&&Human chronic B cell leukemia MEC-1 (50% Killing=32µM),RRIRFRPPYLPRPGRRPRFPPPFPIPRIPRIP,,Linear,Free,Free,,L,dbAMP3,32
17071,dbAMP_17071,,Escherichia coli BW25113 (MIC=7±1.9µM)&&Escherichia coli BW25113 del-sbmA (MIC=4µM)&&Escherichia coli BW25113 del-yjiL (MIC=8µM)&&Escherichia coli BW25113 del-sbmA/del-yjiL (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (35% Killing=32µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Enterococcus faecium ATCC 19434 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=4µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pantoea agglomerans (MIC=16µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=8µM)&&Candida albicans ATCC 90029 (MIC=8µM),RRIPFWPPNWPGPWLPPWSPPDFRIPRILRKR,,Linear,Free,Free,,L,dbAMP3,32
17101,dbAMP_17101,,Escherichia coli ATCC 25922 (MIC=0.25-0.5µM)&&Escherichia coli ATCC 25922 (MBC=0.5-1µM)&&Escherichia coli (MIC=4µM)&&Escherichia coli (MBC=8µM)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5-1µM)&&Acinetobacter baumannii ATCC 19606 (MBC=1µM)&&Acinetobacter baumannii (MIC=0.5µM)&&Acinetobacter baumannii (MBC=1µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=2µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=2µM)&&Klebsiella pneumoniae (MIC=4µM)&&Klebsiella pneumoniae (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=4µM)&&Pseudomonas aeruginosa (MIC=2-4µM)&&Pseudomonas aeruginosa (MBC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8-16µM)&&Staphylococcus aureus ATCC 25923 (MBC=8-16µM)&&Staphylococcus aureus (MIC=4-8µM)&&Staphylococcus aureus (MBC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=8-16µM)&&Staphylococcus aureus ATCC 25923 (MBC=8-16µM)&&Human chronic B cell leukemia MEC-1 (IC50=>50µM),KIAKGALKALKIAKVALKAL,,Linear,Free,Free,,L,dbAMP3,20
17102,dbAMP_17102,,Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Escherichia coli (MIC=64µM)&&Escherichia coli (MBC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1-2µM)&&Acinetobacter baumannii ATCC 19606 (MBC=2µM)&&Acinetobacter baumannii (MIC=>64µM)&&Acinetobacter baumannii (MBC=>64µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=2-4µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=4µM)&&Klebsiella pneumoniae (MIC=8µM)&&Klebsiella pneumoniae (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8-16µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16-32µM)&&Pseudomonas aeruginosa (MIC=8-16µM)&&Pseudomonas aeruginosa (MBC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=16-32µM)&&Staphylococcus aureus ATCC 25923 (MBC=32µM)&&Staphylococcus aureus (MIC=16µM)&&Staphylococcus aureus (MBC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=16-32µM)&&Staphylococcus aureus ATCC 25923 (MBC=32µM)&&Human chronic B cell leukemia MEC-1 (IC50=>50µM),KIAKGALKALKIAKGALKAL,,Linear,Free,Free,,L,dbAMP3,20
17104,dbAMP_17104,,Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Escherichia coli (MIC=32-64µM)&&Escherichia coli (MBC=64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2µM)&&Acinetobacter baumannii ATCC 19606 (MBC=2µM)&&Acinetobacter baumannii (MIC=32-64µM)&&Acinetobacter baumannii (MBC=64µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=16µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=32µM)&&Klebsiella pneumoniae (MIC=16µM)&&Klebsiella pneumoniae (MBC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16µM)&&Pseudomonas aeruginosa (MIC=16-32µM)&&Pseudomonas aeruginosa (MBC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MBC=32µM)&&Staphylococcus aureus (MIC=16µM)&&Staphylococcus aureus (MBC=16-32µM)&&Staphylococcus aureus ATCC 25923 (MIC=16-32µM)&&Staphylococcus aureus ATCC 25923 (MBC=32µM)&&Human chronic B cell leukemia MEC-1 (IC50=13±1µM),KIGKALGKALKALGKALGKA,,Linear,Free,Free,,L,dbAMP3,20
17106,dbAMP_17106,,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Escherichia coli ATCC 25922 (MBC=2-4µM)&&Escherichia coli (MIC=32µM)&&Escherichia coli (MBC=32µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2µM)&&Acinetobacter baumannii ATCC 19606 (MBC=2µM)&&Acinetobacter baumannii (MIC=16-32µM)&&Acinetobacter baumannii (MBC=32µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=2-4µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=4µM)&&Klebsiella pneumoniae (MIC=16-32µM)&&Klebsiella pneumoniae (MBC=32-64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8-16µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16µM)&&Pseudomonas aeruginosa (MIC=32µM)&&Pseudomonas aeruginosa (MBC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MBC=4µM)&&Staphylococcus aureus (MIC=2-4µM)&&Staphylococcus aureus (MBC=4-8µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MBC=4µM)&&Human chronic B cell leukemia MEC-1 (IC50=14±1µM),KIALKALKALKALGKALKAL,,Linear,Free,Free,,L,dbAMP3,20
17113,dbAMP_17113,,Human hepatocellular carcinoma HepG2 (IC50=9.18±0.0014µg/ml)&&Human colon adenocarcinoma HT29 (IC50=9.61±0.0007µg/ml)&&Human hepatocellular carcinoma HepG2 (76.72% Cell death=100µg/ml)&&Human colon adenocarcinoma HT29 (90.84% Cell death=100µg/ml),FYPFG,,Linear,Free,Free,,L,dbAMP3,5
17157,dbAMP_17157,,Escherichia coli ATCC 25922 (MIC=8-16µM)&&Jurkat T-cell leukemia (IC50=10.0µM),FPVTWRWWRWWRG,,Linear,Free,Free,,L,dbAMP3,13
17158,dbAMP_17158,,Escherichia coli ATCC 25922 (MIC=2µM)&&Jurkat T-cell leukemia (IC50=14.5µM),VKKFAWWWAFLKK,,Linear,Free,Free,,L,dbAMP3,13
17159,dbAMP_17159,,Escherichia coli ATCC 25922 (MIC=32µM)&&Jurkat T-cell leukemia (IC50=27.6µM),VKKFAWWWPFLKK,,Linear,Free,Free,,L,dbAMP3,13
17160,dbAMP_17160,,Escherichia coli ATCC 25922 (MIC=4µM)&&Jurkat T-cell leukemia (IC50=15.1µM),VKKFPWWWAFLKK,,Linear,Free,Free,,L,dbAMP3,13
17186,dbAMP_17186,6CL3,Escherichia coli ATCC 25922 (MIC=0.71µM)&&Escherichia coli ATCC 25922 (MBC=0.71µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.85µM)&&Staphylococcus aureus ATCC 25923 (MBC=2.85µM)&&Aggregatibacter actinomycetemcomitans ATCC 29522 (MIC=11.4µM)&&Aggregatibacter actinomycetemcomitans ATCC 29522 (MBC=11.4µM)&&Streptococcus sanguinis ATCC 10556 (MIC=5.7µM)&&Streptococcus sanguinis ATCC 10556 (MBC=5.7µM)&&Human glioblastoma U87-MG (IC50=29.20 ± 7.96µM)&&Human neuroblastoma SH-SY5Y (IC50=93.80 ± 2.17µM)&&Human astrocytoma U373-MG (IC50=20.94 ± 5.18µM),IWLTALKFLGKNLGKLAKQQLAKL,,Linear,Free,Free,,L,dbAMP3,24
17198,dbAMP_17198,,Staphylococcus aureus MR (MIC=>128µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>128µg/ml)&&Salmonella typhimurium CMCC 50097 (MIC=>128µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=766.9µM)&&Human hepatocellular carcinoma HepG2 (MIC=405.0µM),NVLLWG,,Linear,Free,Free,,L,dbAMP3,6
17289,dbAMP_17289,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=2µM)&&Escherichia coli NCTC 10418 (MIC=4µM)&&Escherichia coli NCTC 10418 (MBC=8µM)&&Candida albicans NCTC 1467 (MIC=4µM)&&Candida albicans NCTC 1467 (MBC=4µM)&&Staphylococcus aureus ATCC 12493 (MIC=4µM)&&Staphylococcus aureus ATCC 12493 (MBC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16µM)&&Enterococcus faecalis NCTC 12697 (MIC=8µM)&&Enterococcus faecalis NCTC 12697 (MBC=8µM)&&Human squamous lung carcinoma NCI-H157 (IC50=13.57µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=27.70µM)&&Human prostate adenocarcinoma PC-3 (IC50=6.29µM)&&Human glioblastoma U251-MG (IC50=36.65µM)&&Human breast adenocarcinoma MCF-7 (IC50=25.27µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=4µM)&&Escherichia coli (MIC=4µM),LNLKALLAVAKKIL,,Linear,Free,Free,,L,dbAMP3,14
17290,dbAMP_17290,,Staphylococcus aureus NCTC 10788 (MIC=32µM)&&Staphylococcus aureus NCTC 10788 (MBC=64µM)&&Escherichia coli NCTC 10418 (MIC=32µM)&&Escherichia coli NCTC 10418 (MBC=128µM)&&Candida albicans NCTC 1467 (MIC=32µM)&&Candida albicans NCTC 1467 (MBC=128µM)&&Staphylococcus aureus ATCC 12493 (MIC=128µM)&&Staphylococcus aureus ATCC 12493 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Enterococcus faecalis NCTC 12697 (MIC=128µM)&&Enterococcus faecalis NCTC 12697 (MBC=128µM)&&Human squamous lung carcinoma NCI-H157 (IC50=7.02µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=13.87µM)&&Human prostate adenocarcinoma PC-3 (IC50=13.87µM)&&Human glioblastoma U251-MG (IC50=8.56µM)&&Human breast adenocarcinoma MCF-7 (IC50=13.66µM),CLNLKALLAVAKKILC,,Linear,Free,Free,,L,dbAMP3,16
17292,dbAMP_17292,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=4µM)&&Escherichia coli NCTC 10418 (MIC=2µM)&&Escherichia coli NCTC 10418 (MBC=2µM)&&Candida albicans NCTC 1467 (MIC=2µM)&&Candida albicans NCTC 1467 (MBC=2µM)&&Staphylococcus aureus ATCC 12493 (MIC=4µM)&&Staphylococcus aureus ATCC 12493 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=8µM)&&Enterococcus faecalis NCTC 12697 (MBC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=2.79µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=3.86µM)&&Human prostate adenocarcinoma PC-3 (IC50=3.86µM)&&Human glioblastoma U251-MG (IC50=3.36µM)&&Human breast adenocarcinoma MCF-7 (IC50=3.70µM),RKKRRQRRRLNLKALLAVAKKIL,,Linear,Free,Free,,L,dbAMP3,23
17345,dbAMP_17345,,Human breast adenocarcinoma MCF-7 (IC50=25.0µM)&&Micrococcus luteus A270 (MIC=1.56µM)&&Escherichia coli SBS 363 (MIC=3.12µM)&&Candida albicans MDM8 (MIC=1.56µM),SLLPLIRKLIT,,Linear,Free,Free,,L,dbAMP3,11
17357,dbAMP_17357,,Human breast adenocarcinoma MCF-7 (IC50=50µM)&&Micrococcus luteus A270 (MIC=0.5µM)&&Escherichia coli SBS 363 (MIC=1.56µM)&&Candida albicans MDM8 (MIC=0.78µM),RLLSLIRKLIT,,Linear,Free,Free,,L,dbAMP3,11
17358,dbAMP_17358,,Human breast adenocarcinoma MCF-7 (IC50=50.0µM)&&Micrococcus luteus A270 (MIC=0.78µM)&&Escherichia coli SBS 363 (MIC=1.56µM)&&Candida albicans MDM8 (MIC=0.78µM),SFLSLIRKLIT,,Linear,Free,Free,,L,dbAMP3,11
17359,dbAMP_17359,,Human breast adenocarcinoma MCF-7 (IC50=>50µM)&&Micrococcus luteus A270 (MIC=1.56µM)&&Escherichia coli SBS 363 (MIC=12.5µM)&&Candida albicans MDM8 (MIC=1.56µM),SLLSLFRKLIT,,Linear,Free,Free,,L,dbAMP3,11
17360,dbAMP_17360,,Human breast adenocarcinoma MCF-7 (IC50=50.0µM)&&Micrococcus luteus A270 (MIC=1.56µM)&&Escherichia coli SBS 363 (MIC=3.12µM)&&Candida albicans MDM8 (MIC=1.56µM),SLLSLFRKLI,,Linear,Free,Free,,L,dbAMP3,10
17361,dbAMP_17361,,Human breast adenocarcinoma MCF-7 (IC50=25.0µM),SLLSLIRKLIW,,Linear,Free,Free,,L,dbAMP3,11
17519,dbAMP_17519,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=8µM)&&Staphylococcus aureus NCTC 12493 (MBC=32µM)&&Enterococcus faecalis NCTC 12697 (MIC=128µM)&&Enterococcus faecalis NCTC 12697 (MBC=256µM)&&Escherichia coli NCTC 10418 (MIC=4µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=32µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=128µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MBC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=>100µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>100µM)&&Human glioblastoma U251-MG (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM),ALWKDLLKNVGKAAGKAVLNKVTDMVNQ,,Linear,Free,Free,,L,dbAMP3,28
17520,dbAMP_17520,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=4µM)&&Staphylococcus aureus NCTC 12493 (MBC=16µM)&&Enterococcus faecalis NCTC 12697 (MIC=64µM)&&Enterococcus faecalis NCTC 12697 (MBC=128µM)&&Escherichia coli NCTC 10418 (MIC=4µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MBC=16µM)&&Human squamous lung carcinoma NCI-H157 (IC50=8.43µM)&&Human prostate adenocarcinoma PC-3 (IC50=21.6µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>100µM)&&Human glioblastoma U251-MG (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM),ALWKSLLKNVGKAAGKAALNAVTDMVNQ,,Linear,Free,Free,,L,dbAMP3,28
17521,dbAMP_17521,,Staphylococcus aureus NCTC 10788 (MIC=64µM)&&Staphylococcus aureus NCTC 10788 (MBC=128µM)&&Staphylococcus aureus NCTC 12493 (MIC=128µM)&&Staphylococcus aureus NCTC 12493 (MBC=128µM)&&Enterococcus faecalis NCTC 12697 (MIC=256µM)&&Enterococcus faecalis NCTC 12697 (MBC=>512µM)&&Escherichia coli NCTC 10418 (MIC=64µM)&&Escherichia coli NCTC 10418 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=256µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=128µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=32µM)&&Candida albicans NCYC 1467 (MBC=64µM)&&Human squamous lung carcinoma NCI-H157 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>100µM)&&Human glioblastoma U251-MG (IC50=>100µM),ALWKSLLKNVGKA,,Linear,Free,Free,,L,dbAMP3,13
17522,dbAMP_17522,,Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Staphylococcus aureus NCTC 12493 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MBC=16µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=128µM)&&Escherichia coli NCTC 10418 (MIC=4µM)&&Escherichia coli NCTC 10418 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=16µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=32µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=256µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MBC=8µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.21µM)&&Human prostate adenocarcinoma PC-3 (IC50=6.75µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>100µM)&&Human glioblastoma U251-MG (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM),GRKKRRQRRRGALWKSLLKNVGKA,,Linear,Free,Free,,L,dbAMP3,24
17525,dbAMP_17525,,Escherichia coli ATCC 25922 (MBC50=<6.25µM)&&Escherichia coli ATCC 25922 (MBC90=<6.25µM)&&Staphylococcus aureus ATCC 25923 (MBC50=<6.25µM)&&Staphylococcus aureus ATCC 25923 (MBC90=<6.25µM)&&Staphylococcus aureus BCRC 80277 (MBC50=0.5µM)&&Staphylococcus aureus BCRC 80277 (MBC90=1µM)&&Acinetobacter baumannii (MBC50=0.5µM)&&Acinetobacter baumannii (MBC90=1µM)&&Human hepatocellular carcinoma HepG2 (20% Killing=50µM),GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR,,Linear,Free,Free,,L,dbAMP3,34
17564,dbAMP_17564,,Mouse lymphoma A20 (IC50=37.3±1.5µM)&&Murine squamous cell oral carcinoma AT84 (IC50=31.0±1.0µM),KKWWKKWWK,,Linear,Free,Free,,L,dbAMP3,9
17565,dbAMP_17565,,Mouse lymphoma A20 (IC50=12.3±1.5µM)&&Murine squamous cell oral carcinoma AT84 (IC50=25.3±4.2µM),KKWWKKXWK,,Linear,Free,Free,,L,dbAMP3,9
17566,dbAMP_17566,,Mouse lymphoma A20 (IC50=8.3±1.2µM)&&Murine squamous cell oral carcinoma AT84 (IC50=11.0±0µM)&&Human promyelocytic leukemia HL-60 (IC50=2.1±0.4µM)&&Human promyelocytic leukemia HL-60/ADR (IC50=3.0±0.9µM)&&Human breast adenocarcinoma MCF-7 (IC50=2.2±0.6µM)&&Human breast adenocarcinoma MCF-7/mdr (IC50=2.5±1.0µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=6.4±2.0µM)&&Human ovarian adenocarcinoma IGROV1/CDDP (IC50=3.2±1.6µM)&&Human myelogenous leukemia K562 (IC50=3.0±0.3µM)&&Human myelogenous leukemia K562/Gleevec (IC50=3.0±0.3µM)&&Human B-lymphoma RAJI (IC50=4.9±1.0µM)&&Human histiocytic lymphoma U-937 (IC50=1.2±0.4µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=2.6±1.2µM)&&Human neuroblastoma SH-SY5Y (IC50=3.3±1.5µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=3.6±0.6µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=3.1±0.4µM)&&Human colon adenocarcinoma Colo205 (IC50=2.6±0.9µM)&&Human colon adenocarcinoma HCT 116 (IC50=3.4±0.8µM)&&Human colon adenocarcinoma HCT-15 (IC50=3.8±2.4µM)&&Human colon adenocarcinoma HT29 (IC50=3.3±0.3µM)&&Human renal carcinoma A498 (IC50=2.9±1.7µM)&&Human hepatocellular carcinoma HepG2 (IC50=6.7±1.9µM)&&Human liver carcinoma SK-HEP-1 (IC50=5.1±2.7µM)&&Human lung carcinoma A549 (IC50=2.8±0.7µM)&&Human lung carcinoma NCI-H460 (IC50=3.4±1.2µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=7.2±1.0µM)&&Human pancreatic adenocarcinoma BxPC-3 (IC50=3.7±0.9µM)&&Human pancreatic carcinoma Panc-1 (IC50=3.8±2.1µM)&&Human prostate cancer DU145 (IC50=3.9±0.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=4.4±0.2µM)&&Human epidermoid carcinoma A431 (IC50=3.2±0.4µM)&&Human skin melanoma SK-MEL-2 (IC50=5.2±1.2µM),KKWWKKWXK,,Linear,Free,Free,,L,dbAMP3,9
17584,dbAMP_17584,,Mouse lymphoma A20 (IC50=12.0±0µM)&&Murine squamous cell oral carcinoma AT84 (IC50=15.0±1.0µM),KKWXKKWXK,,Linear,Free,Free,,L,dbAMP3,9
17587,dbAMP_17587,,Mouse lymphoma A20 (IC50=6.7±1.2µM)&&Murine squamous cell oral carcinoma AT84 (IC50=11.3±2.1µM)&&Human promyelocytic leukemia HL-60 (IC50=6.7±3.7µM)&&Human promyelocytic leukemia HL-60/ADR (IC50=6.0±4.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=5.5±0.9µM)&&Human breast adenocarcinoma MCF-7/mdr (IC50=6.6±2.8µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=11.1±3.4µM)&&Human ovarian adenocarcinoma IGROV1/CDDP (IC50=5.5±2.2µM)&&Human myelogenous leukemia K562 (IC50=7.0±0.8µM)&&Human myelogenous leukemia K562/Gleevec (IC50=7.7±1.6µM)&&Human B-lymphoma RAJI (IC50=11.3±3.4µM)&&Human histiocytic lymphoma U-937 (IC50=2.6±0.9µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=5.6±0.7µM)&&Human neuroblastoma SH-SY5Y (IC50=5.4±1.4µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=7.6±1.1µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=8.0±1.0µM)&&Human colon adenocarcinoma Colo205 (IC50=6.7±2µM)&&Human colon adenocarcinoma HCT 116 (IC50=4.8±3.1µM)&&Human colon adenocarcinoma HCT-15 (IC50=7.5±3.6µM)&&Human colon adenocarcinoma HT29 (IC50=11.5±4µM)&&Human renal carcinoma A498 (IC50=5.7±2.1µM)&&Human hepatocellular carcinoma HepG2 (IC50=16.6±3.2µM)&&Human liver carcinoma SK-HEP-1 (IC50=6.3±3.6µM)&&Human lung carcinoma A549 (IC50=7.3±0.9µM)&&Human lung carcinoma NCI-H460 (IC50=9.3±3.2µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=7.4±1.7µM)&&Human pancreatic adenocarcinoma BxPC-3 (IC50=6.2±2.7µM)&&Human pancreatic carcinoma Panc-1 (IC50=12.5±7.1 µM)&&Human prostate cancer DU145 (IC50=6.8±1.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=9.8±4.0µM)&&Human epidermoid carcinoma A431 (IC50=5.5±2.1µM)&&Human skin melanoma SK-MEL-2 (IC50=10.6±2.0µM),RRWXRRWWR,,Linear,Free,Free,,L,dbAMP3,9
17588,dbAMP_17588,,Mouse lymphoma A20 (IC50=16.0±3.0µM)&&Murine squamous cell oral carcinoma AT84 (IC50=21.0±1.7µM)&&Human promyelocytic leukemia HL-60 (IC50=8.0±1.1µM)&&Human promyelocytic leukemia HL-60/ADR (IC50=10.5±3.1µM)&&Human breast adenocarcinoma MCF-7 (IC50=8.9±2.8µM)&&Human breast adenocarcinoma MCF-7/mdr (IC50=11.0±4.4µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=19.6±8.7µM)&&Human ovarian adenocarcinoma IGROV1/CDDP (IC50=6.4±2.6µM)&&Human myelogenous leukemia K562 (IC50=8.2±1.3µM)&&Human myelogenous leukemia K562/Gleevec (IC50=9.0±2.1µM)&&Human B-lymphoma RAJI (IC50=12.5±3.5µM)&&Human histiocytic lymphoma U-937 (IC50=5.3±2.0µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=7.8±1.3µM)&&Human neuroblastoma SH-SY5Y (IC50=12.7±1.5µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=13±3.1µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=14.1±3.5µM)&&Human colon adenocarcinoma Colo205 (IC50=8.7±1.8µM)&&Human colon adenocarcinoma HCT 116 (IC50=10.3±3.1µM)&&Human colon adenocarcinoma HCT-15 (IC50=12.0±3.2µM)&&Human colon adenocarcinoma HT29 (IC50=11.0±2.1µM)&&Human renal carcinoma A498 (IC50=13.9±4.2µM)&&Human hepatocellular carcinoma HepG2 (IC50=20.1±4.1µM)&&Human liver carcinoma SK-HEP-1 (IC50=15.6±9.5µM)&&Human lung carcinoma A549 (IC50=10.4±3.7µM)&&Human lung carcinoma NCI-H460 (IC50=9.0±1.3µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=18.1±5.1µM)&&Human pancreatic adenocarcinoma BxPC-3 (IC50=17.9±3.7µM)&&Human pancreatic carcinoma Panc-1 (IC50=17.1±4.0µM)&&Human prostate cancer DU145 (IC50=12.4±2.8µM)&&Human prostate adenocarcinoma PC-3 (IC50=14.1±1.9µM)&&Human epidermoid carcinoma A431 (IC50=11.7±4.8µM)&&Human skin melanoma SK-MEL-2 (IC50=18.4±4.1µM),WKKWXKKWK,,Linear,Free,Free,,L,dbAMP3,9
17589,dbAMP_17589,,Mouse lymphoma A20 (IC50=13.5±0.9µM),KWWKKWXK,,Linear,Free,Free,,L,dbAMP3,8
17590,dbAMP_17590,,Mouse lymphoma A20 (IC50=20.3±2.9µM),WWKKWXK,,Linear,Free,Free,,L,dbAMP3,7
17592,dbAMP_17592,,Mouse lymphoma A20 (IC50=247±13µM),WKKWXK,,Linear,Free,Free,,L,dbAMP3,6
17627,dbAMP_17627,,Bacillus cereus (MEC=1.9µg/ml)&&Staphylococcus aureus RM4220 (MEC=1.08µg/ml)&&Streptococcus iniae FP5229 (MEC=0.57µg/ml)&&Streptococcus mutans (MEC=0.008µg/ml)&&Pseudomonas aeruginosa KCTC 2004 (MEC=2.12µg/ml)&&Vibrio anguillarum (MEC=>125µg/ml)&&Vibrio harveyi KCCM 40866 (MEC=>125µg/ml)&&Candida albicans KCTC 7965 (MEC=2.11µg/ml)&&Human cervical carcinoma HeLa (99% Killing=25-50µg/ml)&&Human lung carcinoma A549 (99% Killing=25-50µg/ml)&&Human colon adenocarcinoma HCT 116 (94-99% Killing=25-50µg/ml),WLWKAIWKLLT,,Linear,Free,Free,,L,dbAMP3,11
17628,dbAMP_17628,,Bacillus cereus (MEC=1.8µg/ml)&&Staphylococcus aureus RM4220 (MEC=1.37µg/ml)&&Streptococcus iniae FP5229 (MEC=1.79µg/ml)&&Streptococcus mutans (MEC=1.7µg/ml)&&Pseudomonas aeruginosa KCTC 2004 (MEC=1.92µg/ml)&&Vibrio anguillarum (=>125µg/ml)&&Vibrio harveyi KCCM 40866 (MEC=>125µg/ml)&&Candida albicans KCTC 7965 (MEC=2.16µg/ml)&&Human cervical carcinoma HeLa (95-99% Killing=25-50µg/ml)&&Human lung carcinoma A549 (97-99% Killing=25-50µg/ml)&&Human colon adenocarcinoma HCT 116 (92-94% Killing=25-50µg/ml),WLWKAIWKLLK,,Linear,Free,Free,,L,dbAMP3,11
17664,dbAMP_17664,,Salmonella typhimurium TA100 &&Micrococcus luteus DSM 20030 &&Human cervical carcinoma HeLa,GLRKRLRKFRNK,,Linear,Free,Free,,L,dbAMP3,12
17665,dbAMP_17665,,Salmonella typhimurium TA100 &&Micrococcus luteus DSM 20030 &&Human cervical carcinoma HeLa,KCVRQNNKRVCK,,Linear,Free,Free,,L,dbAMP3,12
17666,dbAMP_17666,,Micrococcus luteus DSM 20030 (MIC=13.47µM)&&Salmonella typhimurium TA100 (MIC=12.64µM)&&Human cervical carcinoma HeLa (40% Killing=50µM)&&Human cervical carcinoma HeLa (75% Killing=100µM),KCVRQNNKRVCKGLRKRLRKFRNK,,Linear,Free,Free,,L,dbAMP3,24
17677,dbAMP_17677,,Human cervical carcinoma HeLa (IC50=31.8±1.9µM)&&Human breast adenocarcinoma MCF-7 (IC50=30.8±4.1µM)&&Human colon adenocarcinoma HT29 (IC50=72.1±0.1µM)&&Jurkat cancer cells (IC50=7.3±1.7µM)&&Human myelogenous leukemia K562 (IC50=>30µM),GLLEALAELLEGLRKRLRKFRNKIKEK,,Linear,Free,Free,,L,dbAMP3,27
17678,dbAMP_17678,,Human cervical carcinoma HeLa (IC50=29.4±3.9µM)&&Human breast adenocarcinoma MCF-7 (IC50=39.3±9.4µM)&&Human colon adenocarcinoma HT29 (IC50=90.9±0.2µM)&&Jurkat cancer cells (IC50=7.9±0.8µM)&&Human myelogenous leukemia K562 (IC50=>30µM),GLLEALAELLEGRKKRRQRRRPPQ,,Linear,Free,Free,,L,dbAMP3,24
17730,dbAMP_17730,,Staphylococcus aureus NCTC 10788 (MIC=10µM)&&Staphylococcus aureus NCTC 10788 (MBC=100µM)&&Escherichia coli NCTC 10418 (MIC=10µM)&&Escherichia coli NCTC 10418 (MBC=100µM)&&Candida albicans NCPF 1467 (MIC=100µM)&&Human glioblastoma U251-MG (IC50=5.419µM),ALWKTMLKKLGTVALHAGKAALGAVADTISQ,,Linear,Free,Free,,L,dbAMP3,31
17764,dbAMP_17764,,Penicillium expansum (MIC=12.5µg/ml)&&Aspergillus niger (MIC=12.5µg/ml)&&Fusarium culmorum (MIC=6.25µg/ml)&&Fusarium culmorum (MIC=25µg/ml)&&Fusarium culmorum (MIC=12.5µg/ml)&&Fusarium culmorum (MIC=100µg/ml)&&Fusarium culmorum (81.6±15.2% Inhibition=6.25µg/ml)&&Fusarium culmorum (80.7±6.4% Inhibition=25µg/ml)&&Human colon adenocarcinoma Caco-2 (60% Killing=200µg/ml)&&Murine macrophage cells RAW 264.7 (94.2% Killing=200µg/ml),KKFFRAWWARRFLK,,Linear,Free,Free,,L,dbAMP3,14
17765,dbAMP_17765,,Staphylococcus aureus NCTC 10788 (MIC=>512µM)&&Staphylococcus aureus NCTC 10788 (MBC=>512µM)&&Staphylococcus aureus ATCC 12493 (MIC=>512µM)&&Staphylococcus aureus ATCC 12493 (MBC=>512µM)&&Escherichia coli NCTC 10418 (MIC=512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Enterococcus faecalis NCTC 12697 (MIC=>512µM)&&Enterococcus faecalis NCTC 12697 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Candida albicans NCTC 1467 (MIC=>512µM)&&Candida albicans NCTC 1467 (MBC=>512µM)&&Human prostate adenocarcinoma PC-3 (IC50=792.60µM)&&Human squamous lung carcinoma NCI-H157 (IC50=58.18µM)&&Human breast adenocarcinoma MDA-MB-435 (IC50=179.00µM)&&Human glioblastoma U251-MG (IC50=278.30µM)&&Human breast adenocarcinoma MCF-7 (IC50=316.90µM),GIMDTVKNAAKNLAGQLLDKLKCSITAC,,Linear,Free,Free,,L,dbAMP3,28
17776,dbAMP_17776,,Human skin melanoma MM96L (50% Cell death=12.3±0.6µM)&&Human cervical carcinoma HeLa (50% Cell death=8.1±0.4µM)&&Human myelogenous leukemia K562 (50% Cell death=3.2±0.2µM),GLPVCGETCVGGTCYTPGCTCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
17777,dbAMP_17777,,Human skin melanoma MM96L &&Human myelogenous leukemia K562 &&Human cervical carcinoma HeLa,GLPVCGETCVGGTCDTPGCTCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
17781,dbAMP_17781,,Human skin melanoma MM96L &&Human myelogenous leukemia K562 &&Human cervical carcinoma HeLa,GLPVCGETCVGGTCNYPGCTCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
17784,dbAMP_17784,,Human cervical carcinoma HeLa (50% Cell death=43.8±0.5µM),GLPVCGETCVGGTCNSPGCTCSWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
17787,dbAMP_17787,,Human skin melanoma MM96L &&Human myelogenous leukemia K562 &&Human cervical carcinoma HeLa,GLPVCGETCVGGTCNTPGCTCSYPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
17788,dbAMP_17788,2MN1,Human skin melanoma MM96L (50% Cell death=12.2±0.6µM)&&Human cervical carcinoma HeLa (50% Cell death=9.8±0.5µM),GLPVCGETCVGGTCNTPGCTCSWWPVCTRN,,Linear,Free,Free,,L,dbAMP3,30
17799,dbAMP_17799,,Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus aureus ATCC 29213 (MBC=16µM)&&Staphylococcus aureus (MIC=64µM)&&Staphylococcus aureus (MBC=64µM)&&Enterococcus faecalis ATCC 29212 (MIC=>64µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>64µM)&&Human chronic B cell leukemia MEC-1 (IC50=105µM),LVPFIGRTLGGLLARF,,Linear,Free,Free,,L,dbAMP3,16
17803,dbAMP_17803,,Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus ATCC 29213 (MBC=4µM)&&Staphylococcus aureus (MIC=8µM)&&Staphylococcus aureus (MBC=16µM)&&Enterococcus faecalis ATCC 29212 (MIC=16µM)&&Enterococcus faecalis ATCC 29212 (MBC=16µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=32µM)&&Acinetobacter baumannii ATCC 19606 (MBC=64µM)&&Human chronic B cell leukemia MEC-1 (IC50=44µM),LLGAALSALSSVIPSVISWFQK,,Linear,Free,Free,,L,dbAMP3,22
17807,dbAMP_17807,,Escherichia coli ML-35p (MIC=0.25µM)&&Klebsiella pneumoniae CI 287 (MIC=2µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.5µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus aureus 209P (MIC=2µM)&&Bacillus subtilis B-886 (MIC=0.5µM)&&Micrococcus luteus B-1314 (MIC=0.5µM)&&Human promyelocytic leukemia HL-60 (IC50=2.5±0.1µM)&&Human cervical carcinoma HeLa (IC50=6±0.2µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=9.9±0.1µM)&&Human lung carcinoma A549 (IC50=7.3±0.5µM),RRGCFRVCYRGFCFQRCR,,Linear,Free,Free,,L,dbAMP3,18
17808,dbAMP_17808,6HN9,Micrococcus luteus B-1314 (MIC=0.125µM)&&Micrococcus luteus B-1314 (MIC=0.25µM)&&Bacillus subtilis B-886 (MIC=0.062µM)&&Bacillus subtilis B-886 (MIC=0.25µM)&&Bacillus licheniformis VK21 (MIC=0.125µM)&&Bacillus licheniformis VK21 (MIC=0.25µM)&&Bacillus megaterium VKM41 (MIC=>16µM)&&Staphylococcus aureus 209P (MIC=2µM)&&Staphylococcus aureus 209P (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MIC=2µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Rhodococcus sp. SS1 (MIC=0.125µM)&&Rhodococcus sp. SS1 (MIC=0.25µM)&&Escherichia coli BL21(DE3) (MIC=2µM)&&Escherichia coli BL21(DE3) (MIC=32µM)&&Escherichia coli C600 (MIC=32µM)&&Escherichia coli C600 (MIC=>32µM)&&Escherichia coli ML-35p (MIC=16µM)&&Escherichia coli ML-35p (MIC=>32µM)&&Acinetobacter baumannii (MIC=32µM)&&Acinetobacter baumannii (MIC=>32µM)&&Pseudomonas aeruginosa PAO1 (MIC=32µM)&&Pseudomonas aeruginosa PAO1 (MIC=>32µM)&&Human cervical carcinoma HeLa (85% Killing=32µM),GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,,Linear,Free,Free,,L,dbAMP3,33
17809,dbAMP_17809,,Micrococcus luteus B-1314 (MIC=>16µM)&&Bacillus subtilis B-886 (MIC=>16µM)&&Bacillus licheniformis VK21 (MIC=>16µM)&&Bacillus megaterium VKM41 (MIC=>16µM)&&Staphylococcus aureus 209P (MIC=>16µM)&&Staphylococcus aureus ATCC 29213 (MIC=>16µM)&&Rhodococcus sp. SS1 (MIC=>16µM)&&Escherichia coli BL21(DE3) (MIC=>64µM)&&Escherichia coli C600 (MIC=>64µM)&&Escherichia coli ML-35p (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Pseudomonas aeruginosa PAO1 (MIC=>64µM)&&Human cervical carcinoma HeLa (60% Killing=32µM),GFWSSVWDGAKNVGTAI,,Linear,Free,Free,,L,dbAMP3,17
17810,dbAMP_17810,,Micrococcus luteus B-1314 (MIC=16µM)&&Micrococcus luteus B-1314 (MIC=>16µM)&&Bacillus subtilis B-886 (MIC=16µM)&&Bacillus subtilis B-886 (MIC=>16µM)&&Bacillus licheniformis VK21 (MIC=8µM)&&Bacillus licheniformis VK21 (MIC=>128µM)&&Bacillus megaterium VKM41 (MIC=>16µM)&&Staphylococcus aureus 209P (MIC=>16µM)&&Staphylococcus aureus ATCC 29213 (MIC=>128µM)&&Rhodococcus sp. SS1 (MIC=>16µM)&&Escherichia coli BL21(DE3) (MIC=>64µM)&&Escherichia coli C600 (MIC=>64µM)&&Escherichia coli ML-35p (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Pseudomonas aeruginosa PAO1 (MIC=>128µM)&&Human cervical carcinoma HeLa (75% Killing=32µM),IKNAKVCVYAVCVSHK,,Linear,Free,Free,,L,dbAMP3,16
17857,dbAMP_17857,,Micrococcus luteus B-1314 (MIC=0.25µM)&&Micrococcus luteus B-1314 (MIC=0.5µM)&&Bacillus subtilis B-886 (MIC=0.25µM)&&Bacillus subtilis B-886 (MIC=1µM)&&Enterococcus faecalis ATCC 29212 (MIC=4µM)&&Enterococcus faecalis ATCC 29212 (MIC=>8µM)&&Staphylococcus aureus ATCC 29213 (MIC=1µM)&&Staphylococcus aureus ATCC 29213 (MIC=2µM)&&Staphylococcus aureus 209P (MIC=0.06µM)&&Staphylococcus aureus 209P (MIC=0.5µM)&&Escherichia coli C600 (MIC=0.06µM)&&Escherichia coli C600 (MIC=0.125µM)&&Escherichia coli ML-35p (MIC=0.06µM)&&Pseudomonas aeruginosa PAO1 (MIC=0.25µM)&&Pseudomonas aeruginosa PAO1 (MIC=1µM)&&Acinetobacter baumannii 2675 (MIC=0.03µM)&&Acinetobacter baumannii 2675 (MIC=0.25µM)&&Klebsiella pneumoniae 287 (MIC=0.125µM)&&Klebsiella pneumoniae 287 (MIC=0.5µM)&&Enterobacter cloacae 4172 (MIC=0.125µM)&&Enterobacter cloacae 4172 (MIC=0.25µM)&&Escherichia coli 1057 (MIC=0.125µM)&&Human promyelocytic leukemia HL-60 (IC50=3.39±0.15µM)&&Human breast adenocarcinoma SK-BR-3 (IC50=5.63±1.05µM)&&Human epidermoid carcinoma A431 (IC50=6.49±0.09µM)&&Mouse skin melanoma B16-F10 (IC50=4.82±1.01µM)&&Escherichia coli BL21(DE3) (MIC=0.06µM)&&Escherichia coli 214 (MIC=0.06µM),GRFKRFRKKLKRLWHKVGPFVGPILHY,,Linear,Free,Free,,L,dbAMP3,27
17859,dbAMP_17859,,Yersinia ruckeri 4319/03 (MIC=50µM)&&Yersinia ruckeri 4319/03 (IC50=0.023µM)&&Aeromonas hydrophila 4387/12 (MIC=300µM)&&Aeromonas hydrophila 4387/12 (IC50=7.2µM)&&Aeromonas sobria 02/12 (MIC=100µM)&&Aeromonas sobria 02/12 (IC50=28.6µM)&&Aeromonas salmonicida 4387/12 (MIC=50µM)&&Aeromonas salmonicida 4387/12 (IC50=<3.125µM)&&Bacillus subtilis ATCC 6333 (MIC=5µM)&&Bacillus subtilis ATCC 6333 (IC50=0.76µM)&&Staphylococcus aureus ATCC 6538 (MIC=>300µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=300µM)&&Pseudomonas aeruginosa ATCC 9027 (IC50=54.4µM)&&Escherichia coli ATCC 8739 (MIC=>300µM)&&Escherichia coli ATCC 8739 (IC50=46.6µM)&&Salmonella sp. (MIC=300µM)&&Salmonella sp. (IC50=116.8µM)&&Candida albicans ATCC 10231 (MIC=75µM)&&Candida albicans ATCC 10231 (IC50=36.9µM)&&Human lung carcinoma NCI-H460 (IC50=14.97±1.16µM),HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK,,Linear,Free,Free,,L,dbAMP3,38
17891,dbAMP_17891,,Escherichia coli D31 (MIC=0.94µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=1.88µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1.88µM)&&Staphylococcus aureus ATCC 27660 (MIC=0.94µM)&&Human cervical carcinoma HeLa (21% Cytotoxicity=15µM),KKLIKVWAKGFKKAKKLFKGIG,,Linear,Free,Free,,L,dbAMP3,22
17892,dbAMP_17892,,Human cervical carcinoma HeLa (52% Cytotoxicity=15µM)&&Escherichia coli D31 (MIC=0.94µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=1.88µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1.88µM)&&Staphylococcus aureus ATCC 27660 (MIC=0.47µM),KKLIKVFAKGWKKAKKLFKGIG,,Linear,Free,Free,,L,dbAMP3,22
17893,dbAMP_17893,,Human cervical carcinoma HeLa (52% Cytotoxicity=15µM)&&Escherichia coli D31 (MIC=0.94µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=1.88µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1.88µM)&&Staphylococcus aureus ATCC 27660 (MIC=0.97µM),KKLIKVFAKGFKKAKKLWKGIG,,Linear,Free,Free,,L,dbAMP3,22
17894,dbAMP_17894,,Human cervical carcinoma HeLa (8% Cytotoxicity=15µM)&&Escherichia coli D31 (MIC=1.88µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=3.75µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=15µM)&&Staphylococcus aureus ATCC 27660 (MIC=>15µM),XXLIXVWAXGFXXAXXLFXGIG,,Linear,Free,Free,,L,dbAMP3,22
17895,dbAMP_17895,,Human cervical carcinoma HeLa (12% Cytotoxicity=15µM)&&Escherichia coli D31 (MIC=>15µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>15µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>15µM)&&Staphylococcus aureus ATCC 27660 (MIC=>15µM),KKAAKAWAKGAKKAKKLAKGAG,,Linear,Free,Free,,L,dbAMP3,22
17907,dbAMP_17907,,Staphylococcus aureus NCTC 10788 (MIC=5µM)&&Staphylococcus aureus NCTC 10788 (MBC=5µM)&&Escherichia coli NCTC 10418 (MIC=200µM)&&Escherichia coli NCTC 10418 (MIC=>200µM)&&Candida albicans NCPF 1467 (MIC=15µM)&&Candida albicans NCPF 1467 (MBC=20µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=0.5µM),FLSLLPHIASGIASLVSKF,,Linear,Free,Free,,L,dbAMP3,19
17915,dbAMP_17915,,Staphylococcus aureus NCTC 10788 (MIC=5µM)&&Staphylococcus aureus NCTC 10788 (MBC=10µM)&&Escherichia coli NCTC 10418 (MIC=200µM)&&Escherichia coli NCTC 10418 (MBC=200µM)&&Candida albicans NCPF 1467 (MIC=20µM)&&Candida albicans NCPF 1467 (MBC=20µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=0.29µM),FLSLIPHIASGIASLVKNF,,Linear,Free,Free,,L,dbAMP3,19
17916,dbAMP_17916,,Staphylococcus aureus NCTC 10788 (MIC=>200µM)&&Staphylococcus aureus NCTC 10788 (MBC=>200µM)&&Escherichia coli NCTC 10418 (MIC=>200µM)&&Escherichia coli NCTC 10418 (MBC=>200µM)&&Candida albicans NCPF 1467 (MIC=200µM)&&Candida albicans NCPF 1467 (MBC=>200µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=208µM),FLSLIPHIVSGVAALANHL,,Linear,Free,Free,,L,dbAMP3,19
17926,dbAMP_17926,,Xanthomonas citri (MIC=32µM)&&Xanthomonas citri (MBC=32µM)&&Sinorhizobium meliloti USDA 1002 (MIC=64µM)&&Sinorhizobium meliloti USDA 1002 (MBC=64µM)&&Agrobacterium tumefaciens GV3101 (MIC=64µM)&&Methylobacterium sp. (MIC=64µM)&&Methylobacterium sp. (MBC=64µM)&&Galleria mellonella (5.5±0.46% Killing=128µM)&&Human glioblastoma U87-MG (<30% Killing=128µM),IETFLKQLRSAANKIVGL,,Linear,Free,Free,,L,dbAMP3,18
17927,dbAMP_17927,,Sinorhizobium meliloti USDA 1002 (MIC=64µM)&&Sinorhizobium meliloti USDA 1002 (MBC=64µM)&&Galleria mellonella (6.25±0.59% Killing=128µM)&&Human glioblastoma U87-MG (<30% Killing=128µM),LESLASSAVRTANKARAKL,,Linear,Free,Free,,L,dbAMP3,19
17930,dbAMP_17930,,Escherichia coli ATCC 25922 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=250.25µg/ml)&&Staphylococcus aureus (MIC=197.50µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=9.40µg/ml)&&Cutibacterium acnes ATCC 6919 (MIC=5.86µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=15.6µg/ml)&&Candida albicans ATCC 2002 (MIC=23.4µg/ml)&&Human lung carcinoma NCI-H460 (IC50=3.58±0.58µM)&&Human lung carcinoma A549 (IC50=4.54±0.32µM)&&Rat pheochromocytoma PC12 (IC50=6.32±0.97µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=5.20±0.18µM)&&Murine macrophage cells RAW 264.7 (IC50=1.79±0.27µM)&&Human Influenza A Virus H5N1 PsV (IC50 E=1.29-4.59µM)&&Human Influenza A Virus H5N1 PsV (IC90 E=5.07-29.29µM)&&Human Influenza A Virus H1N1 (IC50 E=4.08±0.39µM)&&Human lung carcinoma A549 (50% Cytotoxicity=24.51±1.89µM),GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC,,Linear,Free,Free,,L,dbAMP3,49
17931,dbAMP_17931,,Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Escherichia coli (MIC=9.38µg/ml)&&Shigella sp. (MIC=2.34µg/ml)&&Klebsiella pneumoniae (MIC=9.38-18.75µg/ml)&&Klebsiella oxytoca (MIC=4.69µg/ml)&&Proteus mirabilis (MIC=9.38µg/ml)&&Stenotrophomonas maltophilia (MIC=75µg/ml)&&Stenotrophomonas maltophilia 090223 (MIC=9.38µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa 1411 (MIC=9.38µg/ml)&&Pseudomonas aeruginosa 08031014 (MIC=18.75µg/ml)&&Salmonella enterica subsp. enterica serovar Paratyphi A (MIC=9.38µg/ml)&&Staphylococcus aureus 08032706 (MIC=18.75µg/ml)&&Staphylococcus aureus 08032810 (MIC=9.38µg/ml)&&Staphylococcus aureus 1307 (MIC=4.69µg/ml)&&Bacillus cereus (MIC=2.34µg/ml)&&Bacillus subtilis (MIC=9.38µg/ml)&&Enterococcus faecium 1299 (MIC=9.38µg/ml)&&Nocardia asteroides (MIC=9.38µg/ml)&&Staphylococcus epidermidis (MIC=18.75µg/ml)&&Candida albicans 08022710 (MIC=18.75µg/ml)&&Candida albicans 08030102 (MIC=9.38µg/ml)&&Arcyria cinerea (MIC=9.38µg/ml)&&Candida glabrata 08A802 (MIC=9.38µg/ml)&&Candida glabrata (MIC=75µg/ml)&&Vibrio harveyi (MIC=18.75µg/ml)&&Vibrio parahaemolyticus (MIC=18.75µg/ml)&&Vibrio brasiliensis (MIC=18.75µg/ml)&&Vibrio cholerae (MIC=18.75µg/ml)&&Edwardsiella tarda (MIC=37.5µg/ml)&&Aeromonas sobria (MIC=9.38µg/ml)&&Aeromonas hydrophila (MIC=9.38µg/ml)&&Aeromonas veronii (MIC=18.75µg/ml)&&Murine macrophage cells RAW 264.7 (15.95% Killing=100µg/ml)&&Mouse skin melanoma B16 (60.72% Killing=100µg/ml)&&Human breast cancer (51.17% Killing=100µg/ml)&&Human gastric cancer SGC-7901 (48.81% Killing=100µg/ml),TRGRWGRFKRRAGRFIRRNRWQIISTGLKLIG,,Linear,Free,Free,,L,dbAMP3,32
17934,dbAMP_17934,,Periplaneta americana (23±6% Killing=0.003µg/g)&&Periplaneta americana (66±9% Killing=0.006µg/g)&&Periplaneta americana (93±5% Killing=0.009µg/g)&&Periplaneta americana (100% Killing=>0.012µg/g)&&Tenebrio molitor (13±5% Killing=0.003µg/g)&&Tenebrio molitor (33±5% Killing=0.006µg/g)&&Tenebrio molitor (63±8% Killing=0.009µg/g)&&Tenebrio molitor (86±9% Killing=0.012µg/g)&&Tenebrio molitor (100% Killing=0.015µg/g)&&Human lymphoblastic leukemia Molt-4 (IC50=3.0µg/ml)&&Human T-cell leukemia C8166 (IC50=1.5µg/ml)&&Human bladder cancer BIU-87 (IC50=12µg/ml)&&Human bladder carcinoma T24 (IC50=12µg/ml)&&Human lung carcinoma A549 (IC50=6µg/ml)&&Human lung carcinoma Calu-6 (IC50=24µg/ml),CLGENVPCDKDRPNCCSRYECLEPTGYGWWYASYYCYKKRS,,Linear,Free,Free,,L,dbAMP3,41
17935,dbAMP_17935,,Escherichia coli ATCC 25922 (MIC=37.5µg/ml)&&Escherichia coli (MIC=18.75-37.5µg/ml)&&Klebsiella pneumoniae (MIC=37.5-75µg/ml)&&Klebsiella oxytoca (MIC=75µg/ml)&&Stenotrophomonas maltophilia (MIC=75µg/ml)&&Pseudomonas aeruginosa 08031014 (MIC=37.5µg/ml)&&Staphylococcus aureus 1307 (MIC=75µg/ml)&&Candida albicans 08022710 (MIC=37.5µg/ml)&&Candida albicans 08030809 (MIC=75µg/ml)&&Murine macrophage cells RAW 264.7 (10.98% Killing=100µg/ml)&&Mouse skin melanoma B16 (38.41% Killing=100µg/ml)&&Human breast cancer (73.24% Killing=100µg/ml)&&Human gastric cancer SGC-7901 (20.15% Killing=100µg/ml),KKPSKKPKPQAMTFPKVTVEYFPASFSTAALTVPED,,Linear,Free,Free,,L,dbAMP3,36
17941,dbAMP_17941,,Human glioblastoma U87-MG (IC50=14.5±1.6µM)&&Human glioblastoma U251-MG (IC50=29.4±1.3µM)&&Botrytis cinerea (MIC=>100µg/ml)&&Alternaria solani (MIC=>100µg/ml)&&Alternaria alternata (MIC=>100µg/ml)&&Colletotrichum gloeosporioides (MIC=>100µg/ml)&&Fusarium solani (MIC=>100µg/ml)&&Fusarium oxysporum (MIC=>100µg/ml)&&Fusarium graminearum (MIC=>100µg/ml),LX,,Linear,Free,Free,,L,dbAMP3,2
17961,dbAMP_17961,,Candida albicans SC5314 (IC50=>50µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=1.7µM)&&Aspergillus fumigatus CBS 117202 (IC50=5.3µM)&&Escherichia coli K12 MG1655 (IC50=28.1µM)&&Escherichia coli K12 MG1655 (MIC=50µM)&&Escherichia coli UTI89 (IC50=>50µM)&&Escherichia coli UTI89 (MIC=>50µM)&&Staphylococcus epidermidis (IC50=>50µM)&&Staphylococcus epidermidis (MIC=>50µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=>50µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>50µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KKIGQKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17962,dbAMP_17962,,Candida albicans SC5314 (IC50=23.9µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=3.7µM)&&Aspergillus fumigatus CBS 117202 (IC50=19.4µM)&&Escherichia coli K12 MG1655 (IC50=2.3µM)&&Escherichia coli K12 MG1655 (MIC=6.25µM)&&Escherichia coli UTI89 (IC50=1.5µM)&&Escherichia coli UTI89 (MIC=6.25µM)&&Staphylococcus epidermidis (IC50=15.1µM)&&Staphylococcus epidermidis (MIC=29µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=23.3µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=50µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KKIWQKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17964,dbAMP_17964,,Candida albicans SC5314 (IC50=21.6µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=5.9µM)&&Aspergillus fumigatus CBS 117202 (IC50=19.5µM)&&Escherichia coli K12 MG1655 (IC50=2.9µM)&&Escherichia coli K12 MG1655 (MIC=6.25µM)&&Escherichia coli UTI89 (IC50=2.0µM)&&Escherichia coli UTI89 (MIC=6.25µM)&&Staphylococcus epidermidis (IC50=11.0µM)&&Staphylococcus epidermidis (MIC=25µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=15.8µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=25µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KRIWQKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17965,dbAMP_17965,,Candida albicans SC5314 (IC50=25.6µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=4.3µM)&&Aspergillus fumigatus CBS 117202 (IC50=18.8µM)&&Escherichia coli K12 MG1655 (IC50=3.5µM)&&Escherichia coli K12 MG1655 (MIC=7µM)&&Escherichia coli UTI89 (IC50=1.9µM)&&Escherichia coli UTI89 (MIC=6.25µM)&&Staphylococcus epidermidis (IC50=11.8µM)&&Staphylococcus epidermidis (MIC=50µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=12.3µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=29µM)&&Human hepatocellular carcinoma HepG2 (EC50=50µM),KKIWQRIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17966,dbAMP_17966,,Candida albicans SC5314 (IC50=>50µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=15.7µM)&&Aspergillus fumigatus CBS 117202 (IC50=34.1µM)&&Escherichia coli K12 MG1655 (IC50=8.3µM)&&Escherichia coli K12 MG1655 (MIC=12.5µM)&&Escherichia coli UTI89 (IC50=5.2µM)&&Escherichia coli UTI89 (MIC=12.5µM)&&Staphylococcus epidermidis (IC50=>50µM)&&Staphylococcus epidermidis (MIC=>50µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=>50µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>50µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KKIWQKIRNFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17967,dbAMP_17967,,Candida albicans SC5314 (IC50=22.9µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=7.2µM)&&Aspergillus fumigatus CBS 117202 (IC50=15.9µM)&&Escherichia coli K12 MG1655 (IC50=>50µM)&&Escherichia coli K12 MG1655 (MIC=>50µM)&&Escherichia coli UTI89 (IC50=>50µM)&&Escherichia coli UTI89 (MIC=>50µM)&&Staphylococcus epidermidis SAM 0020 (IC50=4.0µM)&&Staphylococcus epidermidis (MIC=7.5µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=17.4µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=50µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KKIWQKIKRFFQKL,,Linear,Free,Free,,L,dbAMP3,14
17968,dbAMP_17968,,Candida albicans SC5314 (IC50=24.4µM)&&Candida glabrata BG2 (IC50=>50µM)&&Fusarium oxysporum 5176 (IC50=6.9µM)&&Aspergillus fumigatus CBS 117202 (IC50=13.2µM)&&Escherichia coli K12 MG1655 (IC50=10.6µM)&&Escherichia coli K12 MG1655 (MIC=50µM)&&Escherichia coli UTI89 (IC50=6.6µM)&&Escherichia coli UTI89 (MIC=25µM)&&Staphylococcus epidermidis (IC50=4.8µM)&&Staphylococcus epidermidis (MIC=12.5µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (IC50=26.8µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>50µM)&&Human hepatocellular carcinoma HepG2 (EC50=>50µM),KKIWQKIKNFFRKL,,Linear,Free,Free,,L,dbAMP3,14
17987,dbAMP_17987,,Escherichia coli JM109 (MIC=1.2-2.5µM)&&Staphylococcus aureus CGMCC 1.282 (MIC=1.2-2.5µM)&&Bacillus subtilis CGMCC 1.15792 (MIC=2.5-5µM)&&Salmonella typhimurium CGMCC 1.1190 (MIC=1.2-2.5µM)&&Human hepatocarcinoma SMMC-7721 (19.14% Inhibition=100µg/ml),GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM,,Linear,Free,Free,,L,dbAMP3,39
18034,dbAMP_18034,,Escherichia coli ATCC 25922 (MIC=6.25µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=1.6µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=50µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>50µg/ml)&&Escherichia coli ATCC 25922 (MIC=>50µg/ml)&&Human lung carcinoma A549 (IC50=>50µM)&&Human squamous oral carcinoma OECM-1 (IC50=>50µM)&&Human Lung adenocarcinoma PC-9 (IC50=>50µM)&&Human tongue carcinoma SAS (IC50=>50µM)&&Human oral cancer C9 (IC50=>50µM)&&Escherichia coli ATCC 25922 (MIC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>50µg/ml)&&Enterococcus faecium BCRC 15B0132 (MIC=>64µg/ml)&&Acinetobacter baumannii BCRC 14B0091 (MIC=>64µg/ml)&&Acinetobacter baumannii BCRC 14B0097 (MIC=>64µg/ml)&&Acinetobacter baumannii BCRC 14B0100 (MIC=>64µg/ml)&&Escherichia coli BCRC 13B0198 (MIC=64µg/ml)&&Escherichia coli BCRC 13B0207 (MIC=>64µg/ml),KKWRKWLAKK,,Linear,Free,Free,,L,dbAMP3,10
18035,dbAMP_18035,,Escherichia coli ATCC 25922 (MIC=3.1µg/ml)&&Escherichia coli ATCC 25922 (MIC=6.25µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.25µg/ml)&&Human lung carcinoma A549 (IC50=22µM)&&Human squamous oral carcinoma OECM-1 (IC50=20µM)&&Human Lung adenocarcinoma PC-9 (IC50=13µM)&&Human tongue carcinoma SAS (IC50=28µM)&&Human oral cancer C9 (IC50=25µM),XXKKWRKWLAKK,,Linear,Free,Free,,L,dbAMP3,12
18036,dbAMP_18036,,Escherichia coli ATCC 25922 (MIC=3.1µg/ml)&&Escherichia coli ATCC 25922 (MIC=6.25µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.25µg/ml)&&Human lung carcinoma A549 (IC50=20µM)&&Human squamous oral carcinoma OECM-1 (IC50=19µM)&&Human Lung adenocarcinoma PC-9 (IC50=12µM)&&Human tongue carcinoma SAS (IC50=25µM)&&Human oral cancer C9 (IC50=26µM),KKKKRRXXKKWRKWLAKK,,Linear,Free,Free,,L,dbAMP3,18
18037,dbAMP_18037,,Escherichia coli ATCC 25922 (MIC=6.25µg/ml)&&Escherichia coli ATCC 25922 (MIC=12.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=1.6µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µg/ml)&&Human lung carcinoma A549 (IC50=23µM)&&Human squamous oral carcinoma OECM-1 (IC50=18µM)&&Human Lung adenocarcinoma PC-9 (IC50=10µM)&&Human tongue carcinoma SAS (IC50=26µM)&&Human oral cancer C9 (IC50=25µM),KKKKKKXXKKWRKWLAKK,,Linear,Free,Free,,L,dbAMP3,18
18038,dbAMP_18038,,Mouse skin melanoma B16 (IC50=3.9±0.02µM)&&Human gastric cancer SGC-7901 (IC50= 4.8±0.0µM)&&Human hepatocellular carcinoma HepG2 (IC50=5.8±0.36µM)&&Human cervical carcinoma HeLa (IC50= 1.8±0.02µM),FKKLKKLFSKLWNWKRKKRRQRRR,,Linear,Free,Free,,L,dbAMP3,24
18061,dbAMP_18061,,Human cervical carcinoma HeLa (IC50=1.35±0.06µM)&&Human prostate adenocarcinoma PC-3 (IC50=6.31±0.099µM)&&Human malignant melanoma MM170 (IC50=1.75±0.06µM),RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,,Linear,Free,Free,,L,dbAMP3,47
18062,dbAMP_18062,,Human cervical carcinoma HeLa (IC50=0.70±0.07µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.86±0.14µM)&&Human malignant melanoma MM170 (IC50=0.87±0.04µM),RQCKAESNTFTGICIAKPPCRKACIREKFTDGHCSKVLRRCLCTKRC,,Linear,Free,Free,,L,dbAMP3,47
18063,dbAMP_18063,,Human cervical carcinoma HeLa (IC50=3.32±0.09µM)&&Human prostate adenocarcinoma PC-3 (IC50=12.41±0.14µM)&&Human malignant melanoma MM170 (IC50=3.27±0.12µM),RQCKRESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,,Linear,Free,Free,,L,dbAMP3,47
18070,dbAMP_18070,,Staphylococcus aureus NCTC 10788 (MIC=8µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Staphylococcus aureus NCTC 12493 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=128µM)&&Escherichia coli NCTC 10418 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=256µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=512µM)&&Candida albicans NCYC 1467 (MIC=16µM)&&Candida albicans NCYC 1467 (MFC=32µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=32.41µM)&&Human squamous lung carcinoma NCI-H157 (LD50=41.73µM)&&Human prostate adenocarcinoma PC-3 (LD50=32.89µM)&&Human colon adenocarcinoma HCT 116 (LD50=35.16µM)&&Human breast adenocarcinoma MCF-7 (LD50=45.69µM)&&Human glioblastoma U251-MG (LD50=33.65µM),FLSLIPKAISAVSALANHF,,Linear,Free,Free,,L,dbAMP3,19
18071,dbAMP_18071,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=64µM)&&Enterococcus faecalis NCTC 12697 (MBC=64µM)&&Staphylococcus aureus NCTC 12493 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=64µM)&&Escherichia coli NCTC 10418 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=256µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=512µM)&&Candida albicans NCYC 1467 (MIC=8µM)&&Candida albicans NCYC 1467 (MFC=16µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=19.56µM)&&Human squamous lung carcinoma NCI-H157 (LD50=35.34µM)&&Human prostate adenocarcinoma PC-3 (LD50=35.11µM)&&Human colon adenocarcinoma HCT 116 (LD50=37.4µM)&&Human breast adenocarcinoma MCF-7 (LD50=26.49µM)&&Human glioblastoma U251-MG (LD50=36.46µM),FLSLIPKAISAISALANHF,,Linear,Free,Free,,L,dbAMP3,19
18072,dbAMP_18072,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Staphylococcus aureus NCTC 12493 (MIC=32µM)&&Staphylococcus aureus NCTC 12493 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MFC=4µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=3.994µM)&&Human squamous lung carcinoma NCI-H157 (LD50=2.865µM)&&Human prostate adenocarcinoma PC-3 (LD50=9.164µM)&&Human colon adenocarcinoma HCT 116 (LD50=11.71µM)&&Human breast adenocarcinoma MCF-7 (LD50=10.48µM)&&Human glioblastoma U251-MG (LD50=10.85µM),FLSLIPKAISAISALINHF,,Linear,Free,Free,,L,dbAMP3,19
18073,dbAMP_18073,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=64µM)&&Staphylococcus aureus NCTC 12493 (MIC=128µM)&&Staphylococcus aureus NCTC 12493 (MBC=256µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=32µM)&&Candida albicans NCYC 1467 (MFC=128µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=4.802µM)&&Human squamous lung carcinoma NCI-H157 (LD50=2.265µM)&&Human prostate adenocarcinoma PC-3 (LD50=9.35µM)&&Human colon adenocarcinoma HCT 116 (LD50=6.779µM)&&Human breast adenocarcinoma MCF-7 (LD50=15.01µM)&&Human glioblastoma U251-MG (LD50=9.547µM),FLSLIPKIISAISALINHF,,Linear,Free,Free,,L,dbAMP3,19
18074,dbAMP_18074,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=16µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Staphylococcus aureus NCTC 12493 (MIC=64µM)&&Staphylococcus aureus NCTC 12493 (MBC=128µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=32µM)&&Candida albicans NCYC 1467 (MFC=128µM)&&Human breast adenocarcinoma MDA-MB-435S (LD50=3.553µM)&&Human squamous lung carcinoma NCI-H157 (LD50=3.614µM)&&Human prostate adenocarcinoma PC-3 (LD50=4.256µM)&&Human colon adenocarcinoma HCT 116 (LD50=4.421µM)&&Human breast adenocarcinoma MCF-7 (LD50=3.753µM)&&Human glioblastoma U251-MG (LD50=4.059µM),FLSLIPKIISAISALIKHF,,Linear,Free,Free,,L,dbAMP3,19
18076,dbAMP_18076,,Escherichia coli ESBL  (MIC=6.25µg/ml)&&Escherichia coli ESBL  (MBC=25µg/ml)&&Klebsiella pneumoniae (MIC=12.5±5.1µg/ml)&&Klebsiella pneumoniae (MBC=25µg/ml)&&Acinetobacter baumannii (MIC=6.25±3.1µg/ml)&&Acinetobacter baumannii (MBC=12.5±6.5µg/ml)&&Pseudomonas aeruginosa (MIC=12.5µg/ml)&&Pseudomonas aeruginosa (MBC=25µg/ml)&&Staphylococcus aureus (MIC=25±10.2µg/ml)&&Staphylococcus aureus (MBC=50µg/ml)&&Staphylococcus epidermidis (MIC=25µg/ml)&&Staphylococcus epidermidis (MBC=50±10.2µg/ml)&&Enterococcus sp. (MIC=25±10.2µg/ml)&&Enterococcus sp. (MBC=50µg/ml)&&Human epithelial carcinoma OVCAR-5 (0% Killing=64µM)&&Human lung carcinoma A549 (0% Killing=64µM)&&Human myelogenous leukemia K562 (9.09% Killing=64µM)&&Human hepatocellular carcinoma Huh7 (7.94% Killing=64µM)&&Human cervical carcinoma HeLa (0% Killing=64µM)&&Human prostate adenocarcinoma PC-3 (4.39% Killing=64µM)&&Human neuroblastoma SH-SY5Y (0% Killing=64µM),WFGKLYRGKTKVVKKVKGLLKG,,Linear,Free,Free,,L,dbAMP3,22
18089,dbAMP_18089,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=4µM)&&Staphylococcus aureus NCTC 12493 (MBC=16µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Escherichia coli NCTC 10418 (MBC=64µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Staphylococcus aureus (MIC=8µM)&&Staphylococcus aureus (MBC=32µM)&&Pseudomonas aeruginosa (MIC=>512µM)&&Pseudomonas aeruginosa (MBC=>512µM)&&Human lung adenocarcinoma NCI-H23 (30% Killing=32µM)&&Human lung adenocarcinoma NCI-H23 (65% Killing=64µM)&&Human lung adenocarcinoma NCI-H23 (95% Killing=128µM),FIVPSIFLLKKAFCIALKKC,,Linear,Free,Free,,L,dbAMP3,20
18113,dbAMP_18113,,Escherichia coli ATCC 25922 (MIC=>128µM)&&Escherichia coli ATCC 25922 (MBC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>128µM)&&Staphylococcus aureus ATCC 29213 (MIC=128µM)&&Staphylococcus aureus ATCC 29213 (MBC=>128µM)&&Enterococcus faecalis (MIC=>128µM)&&Enterococcus faecalis (MBC=>128µM)&&Escherichia coli ATCC BAA-2523 (MIC=>128µM)&&Escherichia coli ATCC BAA-2523 (MBC=>128µM)&&Pseudomonas aeruginosa (MIC=>128µM)&&Pseudomonas aeruginosa (MBC=>128µM)&&Staphylococcus aureus ATCC 43300 (MIC=128µM)&&Staphylococcus aureus ATCC 43300 (MBC=>128µM)&&Enterococcus faecalis VR (MIC=>128µM)&&Enterococcus faecalis VR (MBC=>128µM)&&Human breast adenocarcinoma MDA-MB-231 (5% Killing=100µM),QLGKKKHRRRPSKKKRHW,,Linear,Free,Free,,L,dbAMP3,18
18114,dbAMP_18114,,Human breast adenocarcinoma MDA-MB-231 (25% Killing=100µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Escherichia coli ATCC 25922 (MBC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>128µM)&&Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MBC=>128µM)&&Enterococcus faecalis (MIC=32µM)&&Enterococcus faecalis (MBC=>128µM)&&Escherichia coli ATCC BAA-2523 (MIC=>128µM)&&Escherichia coli ATCC BAA-2523 (MBC=>128µM)&&Pseudomonas aeruginosa (MIC=128µM)&&Pseudomonas aeruginosa (MBC=>128µM)&&Staphylococcus aureus ATCC 43300 (MIC=16µM)&&Staphylococcus aureus ATCC 43300 (MBC=128µM)&&Enterococcus faecalis VR (MIC=16µM)&&Enterococcus faecalis VR (MBC=128µM),QLGRRRHRRRPSRRRRHW,,Linear,Free,Free,,L,dbAMP3,18
18117,dbAMP_18117,,Human colon adenocarcinoma HCT 116-/-p53 &&Human colon adenocarcinoma HCT 116 &&Human cervical carcinoma HeLa &&Acute myeloid leukemia AML-3 &&Acute myeloid leukemia AML-2,AAVALLPAVLLALLAPMPFSTGKRIMLGE,,Linear,Free,Free,,L,dbAMP3,29
18118,dbAMP_18118,,Acute myeloid leukemia AML-2 (100% Killing=10µM)&&Acute myeloid leukemia AML-3 (90% Killing=10µM)&&Human cervical carcinoma HeLa (100% Killing=50µM)&&Human colon adenocarcinoma HCT 116 (30% Killing=10µM)&&Human colon adenocarcinoma HCT 116-/-p53 (30% Killing=10µM),AAVALLPAVLLALLAPQLGKKKHRRRPSKKKRHW,,Linear,Free,Free,,L,dbAMP3,34
18119,dbAMP_18119,,Human breast adenocarcinoma MCF-7 (10% Killing=10µM)&&Human breast adenocarcinoma MCF-7 (50% Killing=50µM)&&Human breast adenocarcinoma MDA-MB-231 (40% Killing=10µM)&&Human breast adenocarcinoma MDA-MB-231 (90% Killing=50µM)&&Human multiple myeloma OPM-2 (30% Killing=50µM),LTVSPWYGCGQLGKKKHRRRPSKKKRHW,,Linear,Free,Free,,L,dbAMP3,28
18120,dbAMP_18120,,Human breast adenocarcinoma MCF-7 (45% Killing=10µM)&&Human breast adenocarcinoma MCF-7 (100% Killing=50µM)&&Human breast adenocarcinoma MDA-MB-231 (78% Killing=10µM)&&Human breast adenocarcinoma MDA-MB-231 (100% Killing=50µM),LTVSPWYGCGQLGRRRHRRRPSRRRRHW,,Linear,Free,Free,,L,dbAMP3,28
18121,dbAMP_18121,,Human breast adenocarcinoma MDA-MB-231 &&Human breast adenocarcinoma MCF-7,MPFSTGKRIMLGE,,Linear,Free,Free,,L,dbAMP3,13
18122,dbAMP_18122,,Human breast adenocarcinoma MCF-7 (18% Killing=10µM)&&Human breast adenocarcinoma MCF-7 (30% Killing=100µM)&&Human breast adenocarcinoma MDA-MB-231 (10% Killing=100µM)&&Human multiple myeloma OPM-2 (0% Killing=50µM),LTVSPWYGCGMPFSTGKRIMLGE,,Linear,Free,Free,,L,dbAMP3,23
18123,dbAMP_18123,,Human multiple myeloma OPM-2 (78% Killing=10µM)&&Human multiple myeloma OPM-2 (100% Killing=50µM)&&Human breast adenocarcinoma MDA-MB-231 (100% Killing=10µM),LTVSPWYGCGKLAKLAKKLAKLAK,,Linear,Free,Free,,L,dbAMP3,24
18124,dbAMP_18124,,Human colon adenocarcinoma HCT 116 (100% Killing=10µM)&&Human colon adenocarcinoma HCT 116-/-p53 (100% Killing=10µM),AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW,,Linear,Free,Free,,L,dbAMP3,34
18125,dbAMP_18125,,Human colon adenocarcinoma HCT 116 (78% Killing=10µM)&&Human colon adenocarcinoma HCT 116 (100% Killing=50µM)&&Human colon adenocarcinoma HCT 116-/-p53 (65% Killing=10µM)&&Human colon adenocarcinoma HCT 116-/-p53 (100% Killing=50µM),AAVALLPAVLLALLAPQLGKKILAARPSKKKRHW,,Linear,Free,Free,,L,dbAMP3,34
18161,dbAMP_18161,,Staphylococcus pseudintermedius C22963 (MIC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus pseudintermedius C22963 (MIC=32µM)&&Human hepatocellular carcinoma HepG2 (IC50=355µM),XXXXKKK,,Linear,Free,Free,,L,dbAMP3,7
18233,dbAMP_18233,,Escherichia coli CCT 1457 (MIC=4µg/ml)&&Escherichia coli ATCC 11775 (MIC=16µg/ml)&&Escherichia coli ATCC 25922 (MIC=31µg/ml)&&Pseudomonas aeruginosa ATCC 15422 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 13388 (MIC=8µg/ml)&&Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 10708 (MIC=31µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=8µg/ml)&&Staphylococcus aureus CCT 2580 (MIC=4µg/ml)&&Staphylococcus aureus CCT 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µg/ml)&&Streptococcus pneumoniae ATCC 11733 (MIC=1µg/ml)&&Streptococcus mutans AU159 (MIC=8µg/ml)&&Bacillus cereus ATCC 11778 (MIC=31µg/ml)&&Bacillus thuringiensis ATCC 10792 (MIC=31µg/ml)&&Enterococcus faecium CCT 5079 (MIC=1µg/ml)&&Enterococcus hirae ATCC 10541 (MIC=16µg/ml)&&Rhodococcus equi ATCC 25729 (MIC=2µg/ml)&&Micrococcus luteus ATCC 4698 (MIC=2µg/ml)&&Cryptococcus neoformans ATCC 90112 (MIC=31.2µg/ml)&&Cryptococcus gattii ATCC 56990 (MIC=15.6µg/ml)&&Paracoccidioides brasiliensis (MIC=7.8µg/ml)&&Paracoccidioides lutzii ATCC MYA-826 (MIC=15.6µg/ml)&&Human glioblastoma U87-MG (IC50=>500µg/ml)&&Candida albicans ATCC 90028 (MIC=15.62µg/ml),INWLKIAKKVKGML,,Linear,Free,Free,,L,dbAMP3,14
18473,dbAMP_18473,,Human breast adenocarcinoma MCF-7 (EC50=9.8µM)&&Human lung carcinoma A549 (EC50=8.6µM),ALFGILKKAFGKILTIFAGLPGVV,,Linear,Free,Free,,L,dbAMP3,24
18475,dbAMP_18475,,Human breast adenocarcinoma MCF-7 (EC50=4.5µM)&&Human lung carcinoma A549 (EC50=11.3µM),GLGDFIKAIAKHLGPLIGILPSKLKVAA,,Linear,Free,Free,,L,dbAMP3,28
18476,dbAMP_18476,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLKDPLKSVAKHLVK,,Linear,Free,Free,,L,dbAMP3,15
18477,dbAMP_18477,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLVMLVKKAGLT,,Linear,Free,Free,,L,dbAMP3,12
18478,dbAMP_18478,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),IIFGVIKALSG,,Linear,Free,Free,,L,dbAMP3,11
18479,dbAMP_18479,,Human breast adenocarcinoma MCF-7 (EC50=2.6µM)&&Human lung carcinoma A549 (EC50=10.7µM),FLGPTIGKIAKFILKHIVGLGDAALV,,Linear,Free,Free,,L,dbAMP3,26
18480,dbAMP_18480,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GIVTILKGAVGVILGGL,,Linear,Free,Free,,L,dbAMP3,17
18481,dbAMP_18481,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLFKIISGIA,,Linear,Free,Free,,L,dbAMP3,10
18482,dbAMP_18482,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLGMIAHGV,,Linear,Free,Free,,L,dbAMP3,9
18483,dbAMP_18483,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLWKILKKGA,,Linear,Free,Free,,L,dbAMP3,10
18495,dbAMP_18495,6DMZ,Candida albicans ATCC 90028 (IC50=1.1±0.5µM)&&Candida albicans ATCC 90028 (IC50=3.0±0.2µM)&&Candida auris (IC50=3.4±0.5µM)&&Candida auris (IC50=1.6±0.4µM)&&Candida glabrata ATCC 90030 (IC50=1.2±0.4µM)&&Candida glabrata ATCC 90030 (IC50=2.0±1.0µM)&&Candida krusei (IC50=0.9±0.1µM)&&Candida krusei (IC50=1.7±0.4µM)&&Candida parapsilosis (IC50=1.3±0.6µM)&&Candida parapsilosis (IC50=1.5±0.4µM)&&Candida tropicalis ATCC 750 (IC50=0.5±0.1µM)&&Candida tropicalis ATCC 750 (IC50=0.7±0.2µM)&&Fusarium graminearum PH-1 (IC50=1.0±0.7µM)&&Escherichia coli (IC50=1±0.2µM)&&Escherichia coli (IC50=0.3±0.1µM)&&Staphylococcus aureus ATCC 9144 (IC50=1.5±0.3µM)&&Bacillus subtilis (IC50=0.4±0.2µM)&&Pseudomonas aeruginosa PAO1 (IC50=1.7±0.1µM)&&Human prostate adenocarcinoma PC-3 (35% Killing=50µM)&&Human histiocytic lymphoma U-937 (95% Killing=50µM),RTCQSQSHRFRGPCLRRSNCANVCRTEGFPGGRCRGFRRRCFCTTHC,,Linear,Free,Free,,L,dbAMP3,47
18498,dbAMP_18498,,Human breast adenocarcinoma MCF-7 (EC50=2.3µM)&&Human lung carcinoma A549 (EC50=4.6µM),GLFAILKKLVNLVG,,Linear,Free,Free,,L,dbAMP3,14
18499,dbAMP_18499,,Human breast adenocarcinoma MCF-7 (EC50=27.7µM)&&Human lung carcinoma A549 (EC50=36.3µM),GLFKIISKLAKKA,,Linear,Free,Free,,L,dbAMP3,13
18500,dbAMP_18500,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLPLFLKKLGSAV,,Linear,Free,Free,,L,dbAMP3,13
18501,dbAMP_18501,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=69.3µM),GLWGVIKALGGHVG,,Linear,Free,Free,,L,dbAMP3,14
18502,dbAMP_18502,,Human breast adenocarcinoma MCF-7 (EC50=15.5µM)&&Human lung carcinoma A549 (EC50=>100µM),GLLALLGELAEHLGSKI,,Linear,Free,Free,,L,dbAMP3,17
18503,dbAMP_18503,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GTFAIIQ,,Linear,Free,Free,,L,dbAMP3,7
18506,dbAMP_18506,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GDGDIMKGIAGH,,Linear,Free,Free,,L,dbAMP3,12
18507,dbAMP_18507,,Human breast adenocarcinoma MCF-7 (EC50=>100µM)&&Human lung carcinoma A549 (EC50=>100µM),GLPQIISKVVKT,,Linear,Free,Free,,L,dbAMP3,12
18519,dbAMP_18519,,Escherichia coli K12 MG1655 (MIC=32µg/ml)&&Acinetobacter baumannii MTCC 9829 (MIC=16µg/ml)&&Shigella boydii MTCC 11947 (MIC=32µg/ml)&&Shigella flexneri MTCC 1457 (MIC=8µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=32µg/ml)&&Salmonella enterica MTCC 9844 (MIC=16µg/ml)&&Klebsiella pneumoniae MTCC 7407 (MIC=32µg/ml)&&Klebsiella oxytoca MTCC 2275 (MIC=16µg/ml)&&Pseudomonas aeruginosa MTCC 3542 (MIC=>128µg/ml)&&Proteus vulgaris MTCC 1771 (MIC=128µg/ml)&&Proteus mirabilis MTCC 3158 (MIC=>128µg/ml)&&Citrobacter koseri MTCC 1657 (MIC=16µg/ml)&&Citrobacter freundii MTCC 1658 (MIC=16µg/ml)&&Neisseria mucosa MTCC 1772 (MBC=16µg/ml)&&Vibrio cholerae MTCC 3904 (MIC=64µg/ml)&&Pluralibacter gergoviae MTCC 3826 (MIC=128µg/ml)&&Haemophilus influenzae MTCC 621 (MIC=8µg/ml)&&Alcaligenes faecalis MTCC 1937 (MIC=32µg/ml)&&Bordetella bronchiseptica MTCC 6837 (MIC=4µg/ml)&&Klebsiella aerogenes MTCC 111 (MIC=32µg/ml)&&Stenotrophomonas maltophilia MTCC 1890 (MIC=16µg/ml)&&Micrococcus luteus MTCC 425 (MBC=2µg/ml)&&Staphylococcus aureus MTCC 3160 (MIC=16µg/ml)&&Staphylococcus haemolyticus MTCC 3383 (MIC=16µg/ml)&&Enterococcus faecalis MTCC 439 (MIC=64µg/ml)&&Corynebacterium glutamicum MTCC 2679 (MIC=4µg/ml)&&Corynebacterium pseudotuberculosis MTCC 3158 (MBC=128µg/ml)&&Alkalihalobacillus alcalophilus MTCC 860 (MIC=16µg/ml)&&Mycobacterium smegmatis mc2-155 (MBC=64µg/ml)&&Candida albicans MTCC 425 (MBC=128µg/ml)&&Escherichia coli (MBC50=8µg/ml)&&Acinetobacter baumannii (MBC50=8µg/ml)&&Klebsiella pneumoniae (MBC50=16µg/ml)&&Pseudomonas aeruginosa (MBC50=64µg/ml)&&Enterococcus faecalis (MBC50=32µg/ml)&&Staphylococcus sp. MR-CNS (MBC50=8µg/ml)&&Staphylococcus sp. MS-CNS (MBC50=8µg/ml)&&Staphylococcus aureus (MBC50=16µg/ml)&&Human cervical carcinoma HeLa (IC50=>128µg/ml),YLARAIRRTLARLLL,,Linear,Free,Free,,L,dbAMP3,15
18522,dbAMP_18522,,Escherichia coli K12 MG1655 (MIC=4µg/ml)&&Acinetobacter baumannii MTCC 9829 (MIC=4µg/ml)&&Shigella boydii MTCC 11947 (MIC=2µg/ml)&&Shigella flexneri MTCC 1457 (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=8µg/ml)&&Salmonella enterica MTCC 9844 (MIC=8µg/ml)&&Klebsiella pneumoniae MTCC 7407 (MIC=32µg/ml)&&Klebsiella oxytoca MTCC 2275 (MIC=16µg/ml)&&Pseudomonas aeruginosa MTCC 3542 (MIC=32µg/ml)&&Proteus vulgaris MTCC 1771 (MIC=16µg/ml)&&Proteus mirabilis MTCC 3158 (MIC=>128µg/ml)&&Citrobacter koseri MTCC 1657 (MIC=8µg/ml)&&Citrobacter freundii MTCC 1658 (MIC=32µg/ml)&&Neisseria mucosa MTCC 1772 (MBC=16µg/ml)&&Vibrio cholerae MTCC 3904 (MIC=64µg/ml)&&Pluralibacter gergoviae MTCC 3826 (MIC=64µg/ml)&&Haemophilus influenzae MTCC 621 (MIC=2µg/ml)&&Alcaligenes faecalis MTCC 1937 (MIC=64µg/ml)&&Bordetella bronchiseptica MTCC 6837 (MIC=1µg/ml)&&Klebsiella aerogenes MTCC 111 (MIC=16µg/ml)&&Stenotrophomonas maltophilia MTCC 1890 (MIC=16µg/ml)&&Micrococcus luteus MTCC 425 (MBC=2µg/ml)&&Staphylococcus aureus MTCC 3160 (MIC=128µg/ml)&&Staphylococcus haemolyticus MTCC 3383 (MIC=8µg/ml)&&Enterococcus faecalis MTCC 439 (MIC=128µg/ml)&&Corynebacterium glutamicum MTCC 2679 (MIC=2µg/ml)&&Corynebacterium pseudotuberculosis MTCC 3158 (MBC=>128µg/ml)&&Alkalihalobacillus alcalophilus MTCC 860 (MIC=32µg/ml)&&Mycobacterium smegmatis mc2-155 (MBC=64µg/ml)&&Candida albicans MTCC 425 (MBC=64µg/ml)&&Escherichia coli (MBC50=4µg/ml)&&Acinetobacter baumannii (MBC50=2µg/ml)&&Klebsiella pneumoniae (MBC50=64µg/ml)&&Pseudomonas aeruginosa (MBC50=8µg/ml)&&Enterococcus faecalis (MBC50=>128µg/ml)&&Staphylococcus sp. MR-CNS (MBC50=8µg/ml)&&Staphylococcus sp. MS-CNS (MBC50=8µg/ml)&&Staphylococcus aureus (MBC=32µg/ml)&&Human cervical carcinoma HeLa (IC50=48µg/ml),SWKKFFKKARSLPKLF,,Linear,Free,Free,,L,dbAMP3,16
18586,dbAMP_18586,,Escherichia coli ATCC 25922 (MIC=4.69µg/ml)&&Escherichia coli (MIC=4.69-9.38µg/ml)&&Shigella dysenteriae (MIC=1.17µg/ml)&&Klebsiella pneumoniae (MIC=9.38-18.75µg/ml)&&Serratia marcescens (MIC=>200µg/ml)&&Klebsiella oxytoca (MIC=18.75µg/ml)&&Proteus vulgaris (MIC=18.75µg/ml)&&Proteus mirabilis (MIC=18.75µg/ml)&&Acinetobacter baumannii (MIC=18.75µg/ml)&&Stenotrophomonas maltophilia (MIC=18.75µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=9.38µg/ml)&&Pseudomonas aeruginosa (MIC=2.34µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>200µg/ml)&&Staphylococcus aureus (MIC=4.69-9.38µg/ml)&&Bacillus cereus (MIC=9.38µg/ml)&&Bacillus subtilis (MIC=4.69µg/ml)&&Enterococcus faecium (MIC=2.34µg/ml)&&Enterococcus faecium (95% Killing=2.34µg/ml)&&Nocardia asteroides (MIC=2.34µg/ml)&&Enterococcus faecalis (MIC=75µg/ml)&&Staphylococcus epidermidis (MIC=9.38µg/ml)&&Candida albicans (MIC=9.38µg/ml)&&Candida glabrata (MIC=9.38µg/ml)&&Cryptococcus neoformans (MIC=18.75µg/ml)&&Vibrio harveyi (MIC=>200µg/ml)&&Vibrio brasiliensis (MIC=18.75µg/ml)&&Vibrio cholerae (MIC=18.75µg/ml)&&Aeromonas sobria (MIC=9.38µg/ml)&&Aeromonas veronii (MIC=9.38µg/ml)&&Edwardsiella tarda (MIC=18.75µg/ml)&&Human lung carcinoma A549 (IC50=50µg/ml)&&Human breast adenocarcinoma MCF-7 (45% Killing=80µg/ml)&&Mouse skin melanoma B16 (45% Killing=80µg/ml)&&Mouse breast cancer 4T1 (IC50=50µg/ml)&&Murine macrophage cells RAW 264.7 (IC50=703.2µg/ml),RRSRFGRFFKKVRKQLGRVLRHSRITVGGRMRF,,Linear,Free,Free,,L,dbAMP3,33
18653,dbAMP_18653,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=15µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>80µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=74µg/ml)&&Human colon adenocarcinoma SW480 (LD50=8µg/ml)&&Human melanoma BMKC (LD50=94µg/ml)&&Human lung carcinoma H1299 (LD50=84µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=150µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=125µg/ml),FALAKLAKKAKAKLKKALKAL,,Linear,Free,Free,,L,dbAMP3,21
18655,dbAMP_18655,,Pseudomonas aeruginosa ATCC 10145 (IC50=>250µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=250µg/ml)&&Escherichia coli ATCC 2592 (IC50=>250µg/ml)&&Escherichia coli ATCC 2592 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Candida albicans ATCC 10231 (IC50=>250µg/ml)&&Candida albicans ATCC 10231 (MIC=>250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=>250µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=>250µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (83% Killing=500µg/ml),KFAKKFAK,,Linear,Free,Free,,L,dbAMP3,8
18656,dbAMP_18656,,Pseudomonas aeruginosa ATCC 10145 (IC50=>500µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=500µg/ml)&&Escherichia coli ATCC 2592 (IC50=>250µg/ml)&&Escherichia coli ATCC 2592 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Candida albicans ATCC 10231 (IC50=262µg/ml)&&Candida albicans ATCC 10231 (MIC=280-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=22µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=125-250µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (77% Killing=500µg/ml),KFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,12
18657,dbAMP_18657,,Pseudomonas aeruginosa ATCC 10145 (IC50=85µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Escherichia coli ATCC 2592 (IC50=46µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Candida albicans ATCC 10231 (IC50=70µg/ml)&&Candida albicans ATCC 10231 (MIC=90-125µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=5.3µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=6.0-8.0µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (76% Killing=500µg/ml),KFAKKFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,16
18658,dbAMP_18658,,Pseudomonas aeruginosa ATCC 10145 (IC50=5.5µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=6µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>250µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Candida albicans ATCC 10231 (IC50=66µg/ml)&&Candida albicans ATCC 10231 (MIC=90-125µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=5µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=8-16µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (89% Killing=500µg/ml),KFAKKFAKKFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,20
18659,dbAMP_18659,,Pseudomonas aeruginosa ATCC 10145 (IC50=5.6µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=4µg/ml)&&Escherichia coli ATCC 2592 (MIC=8-16µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=38.7µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Candida albicans ATCC 10231 (IC50=72µg/ml)&&Candida albicans ATCC 10231 (MIC=80-125µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=5.8µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=16-32µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=457.3µg/ml)&&Human cervical carcinoma HeLa (30.5% Killing=500µg/ml),KFAKKFAKKFAKKFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,24
18660,dbAMP_18660,,Pseudomonas aeruginosa ATCC 10145 (IC50=12.2µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=8µg/ml)&&Escherichia coli ATCC 2592 (MIC=32-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=108.8µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Candida albicans ATCC 10231 (IC50=82µg/ml)&&Candida albicans ATCC 10231 (MIC=100-125µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=9.1µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=204.1µg/ml)&&Human cervical carcinoma HeLa (13% Killing=500µg/ml),KFAKKFAKKFAKKFAKKFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,28
18661,dbAMP_18661,,Pseudomonas aeruginosa ATCC 10145 (IC50=19µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=20µg/ml)&&Escherichia coli ATCC 2592 (IC50=12µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=40µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=31µg/ml)&&Candida albicans ATCC 10231 (IC50=105µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=4.1µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=8-16µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=249µg/ml)&&Human cervical carcinoma HeLa (18.2% Killing=500µg/ml),KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK,,Linear,Free,Free,,L,dbAMP3,32
18664,dbAMP_18664,,Pseudomonas aeruginosa ATCC 10145 (IC50=25µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=31µg/ml)&&Escherichia coli ATCC 2592 (IC50=12µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=15µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (IC50=114µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=35µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=159µg/ml)&&Human cervical carcinoma HeLa (22.1% Killing=500µg/ml),RFARRFARRFARRFARRFARRFAR,,Linear,Free,Free,,L,dbAMP3,24
18665,dbAMP_18665,,Pseudomonas aeruginosa ATCC 10145 (IC50=20µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=125µg/ml)&&Escherichia coli ATCC 2592 (IC50=8µg/ml)&&Escherichia coli ATCC 2592 (MIC=32-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=31µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (IC50=172µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=45µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=106µg/ml)&&Human cervical carcinoma HeLa (12.4% Killing=500µg/ml),RFARRFARRFARRFARRFARRFARRFAR,,Linear,Free,Free,,L,dbAMP3,28
18666,dbAMP_18666,,Pseudomonas aeruginosa ATCC 10145 (IC50=30µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=12µg/ml)&&Escherichia coli ATCC 2592 (MIC=32-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=20µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=144µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=32µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=71µg/ml)&&Human cervical carcinoma HeLa (9.5% Killing=500µg/ml),RFARRFARRFARRFARRFARRFARRFARRFAR,,Linear,Free,Free,,L,dbAMP3,32
18667,dbAMP_18667,,Pseudomonas aeruginosa ATCC 10145 (IC50=21µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=11µg/ml)&&Escherichia coli ATCC 2592 (MIC=17-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=108µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=250µg/ml)&&Candida albicans ATCC 10231 (IC50=110µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=7.6µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=16-32µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=359µg/ml)&&Human cervical carcinoma HeLa (28.3% Killing=500µg/ml),FAKKFAKKFAKKFAKKFAKKFAKK,,Linear,Free,Free,,L,dbAMP3,24
18668,dbAMP_18668,,Pseudomonas aeruginosa ATCC 10145 (IC50=21µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=25µg/ml)&&Escherichia coli ATCC 2592 (IC50=8µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=41µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=225µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=11µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=16-32µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=33µg/ml)&&Human cervical carcinoma HeLa (7.3% Killing=500µg/ml),AKKFAKKFAKKFAKKFAKKFAKKF,,Linear,Free,Free,,L,dbAMP3,24
18669,dbAMP_18669,,Pseudomonas aeruginosa ATCC 10145 (IC50=33µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=7µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=136µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=63µg/ml)&&Candida albicans ATCC 10231 (IC50=107µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=12µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (76.4% Killing=500µg/ml),KKFAKKFAKKFAKKFAKKFAKKFA,,Linear,Free,Free,,L,dbAMP3,24
18670,dbAMP_18670,,Pseudomonas aeruginosa ATCC 10145 (IC50=27µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=49µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=69µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=211µg/ml)&&Candida albicans ATCC 10231 (MIC=>500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=55µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=31µg/ml)&&Human cervical carcinoma HeLa (0% Killing=500µg/ml),LKKLLKKLLKKLLKKLLKKL,,Linear,Free,Free,,L,dbAMP3,20
18671,dbAMP_18671,,Pseudomonas aeruginosa ATCC 10145 (IC50=58µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=65µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=31µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=98µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=213µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=93µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=>125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=26µg/ml)&&Human cervical carcinoma HeLa (0% Killing=500µg/ml),LKKLLKKLLKKLLKKLLKKLLKKL,,Linear,Free,Free,,L,dbAMP3,24
18672,dbAMP_18672,,Pseudomonas aeruginosa ATCC 10145 (IC50=96µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=41µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=252µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=199µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=85µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=100-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=25µg/ml)&&Human cervical carcinoma HeLa (0% Killing=500µg/ml),LKKLLKKLLKKLLKKLLKKLLKKLLKKL,,Linear,Free,Free,,L,dbAMP3,28
18673,dbAMP_18673,,Pseudomonas aeruginosa ATCC 10145 (IC50=61µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=37µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=80µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=179µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=56µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=23µg/ml)&&Human cervical carcinoma HeLa (0.1% Killing=500µg/ml),LKKLLKKLLKKLLKKLLKKLLKKLLKKLLKKL,,Linear,Free,Free,,L,dbAMP3,32
18674,dbAMP_18674,,Pseudomonas aeruginosa ATCC 10145 (IC50=250µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=63µg/ml)&&Escherichia coli ATCC 2592 (IC50=>1000µg/ml)&&Escherichia coli ATCC 2592 (MIC=>1000µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=>500µg/ml)&&Candida albicans ATCC 10231 (MIC=>500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=67µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=125-250µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (76.8% Killing=500µg/ml),KFAFKFAFKFAFKFAFKFAFKFAFKFAF,,Linear,Free,Free,,L,dbAMP3,28
18675,dbAMP_18675,,Pseudomonas aeruginosa ATCC 10145 (IC50=87µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=63µg/ml)&&Escherichia coli ATCC 2592 (MIC=>125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=133µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=63µg/ml)&&Candida albicans ATCC 10231 (IC50=183µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=55µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=30µg/ml)&&Human cervical carcinoma HeLa (0% Killing=500µg/ml),KFFKKFFKKFFKKFFKKFFKKFFKKFFK,,Linear,Free,Free,,L,dbAMP3,28
18676,dbAMP_18676,,Pseudomonas aeruginosa ATCC 10145 (IC50=>250µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=125µg/ml)&&Escherichia coli ATCC 2592 (IC50=261µg/ml)&&Escherichia coli ATCC 2592 (MIC=500µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=250µg/ml)&&Candida albicans ATCC 10231 (IC50=262µg/ml)&&Candida albicans ATCC 10231 (MIC=>500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=41µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (90% Killing=500µg/ml),KAAKKAAKKAAKKAAKKAAKKAAKKAAK,,Linear,Free,Free,,L,dbAMP3,28
18677,dbAMP_18677,,Pseudomonas aeruginosa ATCC 10145 (IC50=99µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=26µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=60µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=>500µg/ml)&&Candida albicans ATCC 10231 (MIC=>250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=28µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=>63µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (>87.9% Killing=500µg/ml),KKAKKKAKKKAKKKAKKKAKKKAKKKAK,,Linear,Free,Free,,L,dbAMP3,28
18678,dbAMP_18678,,Pseudomonas aeruginosa ATCC 10145 (IC50=74µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=125µg/ml)&&Escherichia coli ATCC 2592 (IC50=39µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=322µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=>500µg/ml)&&Candida albicans ATCC 10231 (IC50=164µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=33µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=40-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (77.8% Killing=500µg/ml),KFKKFKKFKKFKKFKKFK,,Linear,Free,Free,,L,dbAMP3,18
18679,dbAMP_18679,,Pseudomonas aeruginosa ATCC 10145 (IC50=87µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=125µg/ml)&&Escherichia coli ATCC 2592 (IC50=18µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=141µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=>500µg/ml)&&Candida albicans ATCC 10231 (IC50=175µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=26µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=40-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (80.9% Killing=500µg/ml),KFKKFKKFKKFKKFKKFKKFK,,Linear,Free,Free,,L,dbAMP3,21
18680,dbAMP_18680,,Pseudomonas aeruginosa ATCC 10145 (IC50=145µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=>125µg/ml)&&Escherichia coli ATCC 2592 (IC50=20µg/ml)&&Escherichia coli ATCC 2592 (MIC=32-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=72µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=500µg/ml)&&Candida albicans ATCC 10231 (IC50=113µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=25µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=40-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (84.2% Killing=500µg/ml),KFKKFKKFKKFKKFKKFKKFKKFK,,Linear,Free,Free,,L,dbAMP3,24
18681,dbAMP_18681,,Pseudomonas aeruginosa ATCC 10145 (IC50=68µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=63µg/ml)&&Escherichia coli ATCC 2592 (IC50=14µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=92µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=500µg/ml)&&Candida albicans ATCC 10231 (IC50=194µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=39µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (80.7% Killing=500µg/ml),KFKKFKKFKKFKKFKKFKKFKKFKKFK,,Linear,Free,Free,,L,dbAMP3,27
18682,dbAMP_18682,,Pseudomonas aeruginosa ATCC 10145 (IC50=31µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=10µg/ml)&&Escherichia coli ATCC 2592 (MIC=12-16µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=59µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=500µg/ml)&&Candida albicans ATCC 10231 (IC50=104µg/ml)&&Candida albicans ATCC 10231 (MIC=125-250µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=30µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=40-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (56.8% Killing=500µg/ml),KFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,,Linear,Free,Free,,L,dbAMP3,30
18688,dbAMP_18688,,Pseudomonas aeruginosa ATCC 10145 (IC50=79µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=29µg/ml)&&Escherichia coli ATCC 2592 (MIC=32-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=500µg/ml)&&Candida albicans ATCC 10231 (IC50=208µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=2.8µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=4-8µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (100% Killing=500µg/ml),FKAFKAFKAFKAFKAFKA,,Linear,Free,Free,,L,dbAMP3,18
18689,dbAMP_18689,,Pseudomonas aeruginosa ATCC 10145 (IC50=23µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=63µg/ml)&&Escherichia coli ATCC 2592 (IC50=7µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=>500µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=500µg/ml)&&Candida albicans ATCC 10231 (IC50=203µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=3.2µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=4-8µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (100% Killing=500µg/ml),FKAFKAFKAFKAFKAFKAFKA,,Linear,Free,Free,,L,dbAMP3,21
18690,dbAMP_18690,,Pseudomonas aeruginosa ATCC 10145 (IC50=19µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=7µg/ml)&&Escherichia coli ATCC 2592 (MIC=16-32µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=74µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=199µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=3.9µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=16-32µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (60.4% Killing=500µg/ml),FKAFKAFKAFKAFKAFKAFKAFKA,,Linear,Free,Free,,L,dbAMP3,24
18691,dbAMP_18691,,Pseudomonas aeruginosa ATCC 10145 (IC50=16µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=20µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=4µg/ml)&&Escherichia coli ATCC 2592 (IC50=4µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=17µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=125µg/ml)&&Candida albicans ATCC 10231 (IC50=195µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=16µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=389µg/ml)&&Human cervical carcinoma HeLa (20.9% Killing=500µg/ml),FKAFKAFKAFKAFKAFKAFKAFKAFKA,,Linear,Free,Free,,L,dbAMP3,27
18692,dbAMP_18692,,Pseudomonas aeruginosa ATCC 10145 (IC50=27µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=9µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=12µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (IC50=182µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=20µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=234µg/ml)&&Human cervical carcinoma HeLa (15% Killing=500µg/ml),FKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,,Linear,Free,Free,,L,dbAMP3,30
18696,dbAMP_18696,,Pseudomonas aeruginosa ATCC 10145 (IC50=111µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=37µg/ml)&&Escherichia coli ATCC 2592 (MIC=45-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=78µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=250-500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (IC50=166µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=0.8µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=2-4µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=309µg/ml)&&Human cervical carcinoma HeLa (29.6% Killing=500µg/ml),LKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,14
18697,dbAMP_18697,,Pseudomonas aeruginosa ATCC 10145 (IC50=125µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=130µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=16µg/ml)&&Escherichia coli ATCC 2592 (IC50=65µg/ml)&&Escherichia coli ATCC 2592 (MIC=>125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=56µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (IC50=162µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=9.7µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-63µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=122µg/ml)&&Human cervical carcinoma HeLa (43.5% Killing=500µg/ml),LKLKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,16
18698,dbAMP_18698,,Pseudomonas aeruginosa ATCC 10145 (IC50=74µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=80µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=35µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=50µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=250-500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (IC50=216µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=4.9µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=137µg/ml)&&Human cervical carcinoma HeLa (46% Killing=500µg/ml),LKLKLKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,18
18699,dbAMP_18699,,Pseudomonas aeruginosa ATCC 10145 (IC50=47µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8.166µg/ml)&&Escherichia coli ATCC 2592 (IC50=127µg/ml)&&Escherichia coli ATCC 2592 (MIC=150-250µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=29µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=<=16µg/ml)&&Candida albicans ATCC 10231 (IC50=187µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=3µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (65% Killing=500µg/ml),LKLKLKLKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,20
18700,dbAMP_18700,,Pseudomonas aeruginosa ATCC 10145 (IC50=51µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=62µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=50µg/ml)&&Escherichia coli ATCC 2592 (MIC=>125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=111µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (IC50=185µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=26µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=202µg/ml)&&Human cervical carcinoma HeLa (43.8% Killing=500µg/ml),LKLKLKLKLKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,22
18701,dbAMP_18701,,Pseudomonas aeruginosa ATCC 10145 (IC50=41µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=45µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=4µg/ml)&&Escherichia coli ATCC 2592 (IC50=23µg/ml)&&Escherichia coli ATCC 2592 (MIC=62-125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=85µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (IC50=175µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=22µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=32-62µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=49µg/ml)&&Human cervical carcinoma HeLa (60% Killing=500µg/ml),LKLKLKLKLKLKLKLKLKLKLKLK,,Linear,Free,Free,,L,dbAMP3,24
18705,dbAMP_18705,,Pseudomonas aeruginosa ATCC 10145 (IC50=109µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=4µg/ml)&&Escherichia coli ATCC 2592 (IC50=15µg/ml)&&Escherichia coli ATCC 2592 (MIC=31-62µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=90µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=250-500µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=7.8µg/ml)&&Candida albicans ATCC 10231 (IC50=182µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=1.8µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=4-8µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (86.5% Killing=500µg/ml),LRLRLRLRLRLRLR,,Linear,Free,Free,,L,dbAMP3,14
18706,dbAMP_18706,,Pseudomonas aeruginosa ATCC 10145 (IC50=>250µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=4µg/ml)&&Escherichia coli ATCC 2592 (IC50=70µg/ml)&&Escherichia coli ATCC 2592 (MIC=>125µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=28µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (IC50=195µg/ml)&&Candida albicans ATCC 10231 (MIC=250-500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=21µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (96.7% Killing=500µg/ml),LRLRLRLRLRLRLRLRLR,,Linear,Free,Free,,L,dbAMP3,18
18707,dbAMP_18707,,Pseudomonas aeruginosa ATCC 10145 (IC50=>250µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>250µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=8µg/ml)&&Escherichia coli ATCC 2592 (IC50=96µg/ml)&&Escherichia coli ATCC 2592 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 33591 (IC50=39µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=125-250µg/ml)&&Staphylococcus aureus ATCC 6538 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (IC50=>500µg/ml)&&Candida albicans ATCC 10231 (MIC=>500µg/ml)&&Cryptococcus neoformans ATCC 32045 (IC50=3.3µg/ml)&&Cryptococcus neoformans ATCC 32045 (MIC=62-125µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=>500µg/ml)&&Human cervical carcinoma HeLa (66.6% Killing=500µg/ml),LALALALALALALALALALALA,,Linear,Free,Free,,L,dbAMP3,22
18721,dbAMP_18721,,Human pancreatic carcinoma Panc-1 (EC50=6.4±0.2µM)&&Human pancreatic carcinoma Panc-1 (EC50=9.1±3µM),GIKKWLHSAKKFGKKFVKKIXNS,,Linear,Free,Free,,L,dbAMP3,23
18722,dbAMP_18722,,Human pancreatic carcinoma Panc-1 (EC50=2.7±0.5µM)&&Human pancreatic carcinoma Panc-1 (EC50=14.7±0.6µM),GIKXWLHSAKKFGXKFVKKIXNS,,Linear,Free,Free,,L,dbAMP3,23
18723,dbAMP_18723,,Human pancreatic carcinoma Panc-1 (EC50=2.5±0.1µM)&&Human pancreatic carcinoma Panc-1 (EC50=35.7±0.7µM),GIKXWLHSAXKFGXKFVKXIXNS,,Linear,Free,Free,,L,dbAMP3,23
18724,dbAMP_18724,,Human pancreatic carcinoma Panc-1 (EC50=2.5±0.4µM)&&Human pancreatic carcinoma Panc-1 (EC50=55±1.8µM),GIKXWLHSAXXFGXKFVXXIXNS,,Linear,Free,Free,,L,dbAMP3,23
18725,dbAMP_18725,,Human pancreatic carcinoma Panc-1 (EC50=5.2±0.8µM)&&Human pancreatic carcinoma Panc-1 (EC50=61.4±1.7µM),GIXXWLHSAXXFGXXFVXXIXNS,,Linear,Free,Free,,L,dbAMP3,23
18767,dbAMP_18767,,Escherichia coli ML-35p (MIC=4-8µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli M15 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4-8µM)&&Listeria monocytogenes EGD (MIC=2µM)&&Staphylococcus aureus 710A (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus ATCC 33591 (MIC=>16µM)&&Staphylococcus aureus (MIC=>16µM)&&Staphylococcus intermedius (MIC=>16µM)&&Pseudomonas aeruginosa (MIC=>16µM)&&Acinetobacter baumannii (MIC=16µM)&&Human myelogenous leukemia K562 (IC50=37.7µM),RWCRRYRVRVRGVLVYAYVCW,,Linear,Free,Free,,L,dbAMP3,21
18768,dbAMP_18768,,Escherichia coli ML-35p (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=>16µM)&&Escherichia coli M15 (MIC=>16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>16µM)&&Listeria monocytogenes EGD (MIC=8µM)&&Staphylococcus aureus 710A (MIC=>16µM)&&Staphylococcus aureus ATCC 25923 (MIC=>16µM)&&Staphylococcus aureus ATCC 33591 (MIC=>16µM)&&Staphylococcus aureus (MIC=>16µM)&&Staphylococcus intermedius (MIC=>16µM)&&Pseudomonas aeruginosa (MIC=>16µM)&&Acinetobacter baumannii (MIC=>16µM)&&Human myelogenous leukemia K562 (IC50=18µM),RRWCVYAYVRVRGVRVYAYVCW,,Linear,Free,Free,,L,dbAMP3,22
18769,dbAMP_18769,,Escherichia coli ML-35p (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli M15 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Listeria monocytogenes EGD (MIC=1µM)&&Staphylococcus aureus 710A (MIC=2-4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 33591 (MIC=4-8µM)&&Staphylococcus aureus (MIC=16µM)&&Staphylococcus intermedius (MIC=8µM)&&Pseudomonas aeruginosa (MIC=16µM)&&Acinetobacter baumannii (MIC=2µM)&&Human myelogenous leukemia K562 (IC50=11.6µM),WCRRYRVLVRGVLVRYRRCW,,Linear,Free,Free,,L,dbAMP3,20
18776,dbAMP_18776,,Escherichia coli ML-35p (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli M15 (MIC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Listeria monocytogenes EGD (MIC=2µM)&&Staphylococcus aureus 710A (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 33591 (MIC=2µM)&&Staphylococcus aureus (MIC=4µM)&&Staphylococcus intermedius (MIC=4µM)&&Pseudomonas aeruginosa (MIC=2µM)&&Acinetobacter baumannii (MIC=2µM)&&Human myelogenous leukemia K562 (IC50=9.3µM),RFCVYAYVRVRGVLVRYRRCF,,Linear,Free,Free,,L,dbAMP3,21
18777,dbAMP_18777,,Escherichia coli ML-35p (MIC=1-2µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli M15 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Listeria monocytogenes EGD (MIC=2µM)&&Staphylococcus aureus 710A (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 33591 (MIC=4µM)&&Staphylococcus aureus (MIC=8-16µM)&&Staphylococcus intermedius (MIC=8µM)&&Pseudomonas aeruginosa (MIC=4-8µM)&&Acinetobacter baumannii (MIC=4µM)&&Human myelogenous leukemia K562 (IC50=>40µM),RWXVYAYVRVRGVLVRYRRXW,,Linear,Free,Free,,L,dbAMP3,21
18794,dbAMP_18794,,Escherichia coli JW0013 (MIC=0.012±0.003µM)&&Escherichia coli MC1041 (MIC=0.024±0.006µM)&&Escherichia coli J2210 (MIC=0.034±0.017µM)&&Escherichia coli JJ2489 (MIC=0.034±0.017µM)&&Escherichia coli BW25113 (MIC=0.012±0.003µM)&&Escherichia coli BW25113 (MIC=0.192±0.044µM)&&Escherichia coli BW25113 (MIC=0.384±0.080µM)&&Escherichia coli JW0368 del-sbmA (MIC=0.096±0.023µM)&&Escherichia coli JW2778 del-ygdD (MIC=0.024±0.006µM)&&Escherichia coli (MIC=0.048±0.011µM)&&Salmonella enterica subsp. enterica serovar Enteritidis MH91989 (MIC=0.031±0.014µM)&&Salmonella typhimurium SL1344 (MIC=0.034±0.017µM)&&Salmonella enterica serovar Tennessee (MIC=0.024±0.006µM)&&Salmonella enterica subsp. enterica serovar Newport (MIC=0.017±0.009µM)&&Salmonella enterica subsp. enterica serovar Infantis (MIC=0.024±0.006µM)&&Human epidermoid carcinoma A431 (30% Cytotoxicity=10µM)&&Human breast adenocarcinoma MDA-MB-231 (10% Cytotoxicity=10µM),GNNKPVYRPQPRPPHPRL,,Linear,Free,Free,,L,dbAMP3,18
18802,dbAMP_18802,,Escherichia coli JW0013 (MIC=0.037±0.008µM)&&Escherichia coli MC1041 (MIC=0.075±0.018µM)&&Escherichia coli J2210 (MIC=0.075±0.018µM)&&Escherichia coli JJ2489 (MIC=0.078±0.064µM)&&Escherichia coli BW25113 (MIC=0.037±0.008µM)&&Escherichia coli BW25113 (MIC=0.150±0.034µM)&&Escherichia coli BW25113 (MIC=0.300±0.070µM)&&Escherichia coli JW0368 del-sbmA (MIC=0.300±0.070µM)&&Escherichia coli JW2778 del-ygdD (MIC=0.104±0.053µM)&&Escherichia coli (MIC=0.150±0.034µM)&&Escherichia coli (MIC=0.208±0.106µM)&&Salmonella enterica subsp. enterica serovar Enteritidis MH91989 (MIC=0.150±0.034µM)&&Salmonella typhimurium SL1344 (MIC=0.075±0.018µM)&&Salmonella enterica serovar Tennessee (MIC=0.075±0.018µM)&&Salmonella enterica subsp. enterica serovar Newport (MIC=0.037±0.008µM)&&Salmonella enterica subsp. enterica serovar Infantis (MIC=0.098±0.045µM)&&Human epidermoid carcinoma A431 (8% Cytotoxicity=10µM),VDKGSYRPRPTPPKPIYNRN,,Linear,Free,Free,,L,dbAMP3,20
18841,dbAMP_18841,,Escherichia coli BL21AI (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Salmonella enterica SALMOVAC (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=32µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µg/ml)&&Staphylococcus aureus DSM 6247 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Human neuroblastoma SH-SY5Y (12% Killing=600µg/ml)&&Human cervical carcinoma HeLa (20% Killing=600µg/ml),VXKPPYLPRPRWPRXIYNX,,Linear,Free,Free,,L,dbAMP3,19
18842,dbAMP_18842,,Escherichia coli BL21AI (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Salmonella enterica SALMOVAC (MIC=2µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=8µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µg/ml)&&Staphylococcus aureus DSM 6247 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Human neuroblastoma SH-SY5Y (12% Killing=600µg/ml)&&Human hepatocellular carcinoma HepG2 (5% Killing=600µg/ml)&&Human cervical carcinoma HeLa (15% Killing=600µg/ml),VXKPPYLPRPRWXRXXYNX,,Linear,Free,Free,,L,dbAMP3,19
18869,dbAMP_18869,,Staphylococcus aureus NCTC 10788 (MIC=16µg/ml)&&Escherichia coli NCTC 10418 (MIC=32µg/ml)&&Candida albicans NCYC 1467 (MIC=64µg/ml)&&Human lung carcinoma NCI-H460 (IC50=3.47µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=2.32µM)&&Human colon adenocarcinoma HCT 116 (IC50=2.02µM)&&Human glioblastoma U251-MG (IC50=18.9µM),GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC,,Linear,Free,Free,,L,dbAMP3,33
18870,dbAMP_18870,,Human colon adenocarcinoma DLD-1 (IC50=50.1µM)&&Human colon adenocarcinoma DKS8 (IC50=9.8µM)&&Human colon adenocarcinoma HCT 116 (IC50=35.4µM)&&Human colon adenocarcinoma HKE3 (IC50=50.2µM),GALKGCWTKSIPPKPCK,,Linear,Free,Free,,L,dbAMP3,17
18893,dbAMP_18893,,Bacillus coagulans ATCC 7050 (MIC=25µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=50µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=6.15µg/ml)&&Escherichia coli MG1655 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=12.5µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=50µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=100µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=>100µg/ml),LAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,17
18894,dbAMP_18894,,Bacillus coagulans ATCC 7050 (MIC=12.5µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=100µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=12.5µg/ml)&&Escherichia coli MG1655 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=25µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=>100µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=50µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=>100µg/ml),KIAGLAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,21
18895,dbAMP_18895,,Bacillus coagulans ATCC 7050 (MIC=12.5µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=50µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=12.5µg/ml)&&Escherichia coli MG1655 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=25µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=25µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=50µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=>100µg/ml),WIAGLAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,21
18896,dbAMP_18896,,Bacillus coagulans ATCC 7050 (MIC=12.5µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=50µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=25µg/ml)&&Escherichia coli MG1655 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=12.5µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=25µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=50µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=96.1±1.22µg/ml),RIAGLAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,21
18897,dbAMP_18897,,Bacillus coagulans ATCC 7050 (MIC=25µg/ml)&&Bacillus subtilis MTCC 14416 (MIC=50µg/ml)&&Staphylococcus aureus MTCC 9542 (MIC=>100µg/ml)&&Escherichia coli MG1655 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µg/ml)&&Vibrio cholerae (MIC=25µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=100µg/ml)&&Human epidermoid carcinoma A431 (50% Cytotoxicity=>100µg/ml),HIAGLAANFLPQILCKIARKC,,Linear,Free,Free,,L,dbAMP3,21
18901,dbAMP_18901,,Bacillus cereus MCCB 101 (MIC=>50µM)&&Bacillus cereus MCCB 101 (MBC=>50µM)&&Staphylococcus aureus MTCC 3061 (MIC=50µM)&&Staphylococcus aureus MTCC 3061 (MBC=>50µM)&&Edwardsiella tarda MTCC 2400 (MIC=>50µM)&&Edwardsiella tarda MTCC 2400 (MBC=>50µM)&&Pseudomonas aeruginosa MCCB 119 (MIC=25µM)&&Pseudomonas aeruginosa MCCB 119 (MBC=50µM)&&Aeromonas hydrophila MCCB 113 (MIC=>50µM)&&Aeromonas hydrophila MCCB 113 (MBC=>50µM)&&Escherichia coli MTCC 483 (MIC=>50µM)&&Escherichia coli MTCC 483 (MBC=>50µM)&&Vibrio cholerae MCCB 129 (MIC=50µM)&&Vibrio cholerae MCCB 129 (MBC=>50µM)&&Vibrio vulnificus WV13 (MIC=25µM)&&Vibrio vulnificus WV13 (MBC=25µM)&&Vibrio proteolyticus M10W1 (MIC=>50µM)&&Vibrio proteolyticus M10W1 (MBC=>50µM)&&Vibrio alginolyticus VKF44 (MIC=>50µM)&&Vibrio alginolyticus VKF44 (MBC=>50µM)&&Vibrio parahaemolyticus MCCB 133 (MIC=25µM)&&Vibrio parahaemolyticus MCCB 133 (MBC=50µM)&&Human lung carcinoma NCI-H460 (IC50=22.670±13.939µM)&&Human epidermoid cancer Hep2 (IC50=31.274±24.531µM),SRSSRAGLQFPVGRIHRLLRK,,Linear,Free,Free,,L,dbAMP3,21
19012,dbAMP_19012,,Staphylococcus aureus NCTC 10788 (MIC=128µM)&&Staphylococcus aureus NCTC 10788 (MBC=128µM)&&Staphylococcus aureus ATCC 12493 (MIC=256µM)&&Staphylococcus aureus ATCC 12493 (MBC=512µM)&&Escherichia coli NCTC 10418 (MIC=128µM)&&Escherichia coli NCTC 10418 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=256µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=256µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MBC=8µM)&&Human lung carcinoma NCI-H460 (50% Killing=100µM)&&Human squamous lung carcinoma NCI-H157 (50% Killing=100µM)&&Human lung adenocarcinoma NCI-H838 (5% Killing=100µM)&&Human lung adenocarcinoma NCI-H23 (10% Killing=100µM)&&Human colon adenocarcinoma HT29 (5% Killing=100µM),RKKRRQRRRCWTKSIPPKPC,,Linear,Free,Free,,L,dbAMP3,20
19033,dbAMP_19033,,Escherichia coli BL21 (MIC=2.5µM)&&Escherichia coli ESBL  (MIC=12µM)&&Bacillus subtilis 168 (MIC=5µM)&&Staphylococcus aureus (MIC=7.5µM)&&Human cervical carcinoma HeLa (IC50=16µM)&&Human epidermoid cancer Hep2 (IC50=25µM),IIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,13
19034,dbAMP_19034,,Escherichia coli BL21 (MIC=20µM)&&Escherichia coli ESBL  (MIC=20µM)&&Bacillus subtilis 168 (MIC=2.5µM)&&Staphylococcus aureus (MIC=20µM)&&Human cervical carcinoma HeLa (IC50=35µM)&&Human epidermoid cancer Hep2 (15% Killing=40µM),GIIKKIIKKIIKK,,Linear,Free,Free,,L,dbAMP3,13
19035,dbAMP_19035,,Escherichia coli BL21 (MIC=30µM)&&Escherichia coli ESBL  (MIC=20µM)&&Bacillus subtilis 168 (MIC=5µM)&&Staphylococcus aureus (MIC=30µM)&&Human cervical carcinoma HeLa (20% Killing=40µM)&&Human epidermoid cancer Hep2 (IC50=120µM)&&Candida albicans SC5314 (MIC=800±28µM)&&Candida tropicalis ATCC 750 (MIC=100±8µM)&&Candida parapsilosis ATCC 22019 (MIC=1600±280µM)&&Candida krusei ATCC 6258 (MIC=100±7µM)&&Cryptococcus neoformans ATCC 208821 (MIC=25±2µM),IIKKIIKKIIKK,,Linear,Free,Free,,L,dbAMP3,12
19037,dbAMP_19037,,Staphylococcus aureus ATCC 25923 (MIC=28µM)&&Staphylococcus aureus ATCC 25923 (MBC=28µM)&&Enterococcus faecalis ATCC 51299 (MIC=14µM)&&Enterococcus faecalis ATCC 51299 (MBC=14µM)&&Enterococcus faecalis (MIC=3.5µM)&&Enterococcus faecalis (MBC=7µM)&&Bacillus subtilis ATCC 6633 (MIC=0.656µM)&&Bacillus subtilis ATCC 6633 (MBC=0.875µM)&&Bacillus megaterium ATCC 13632 (MIC=<=0.014µM)&&Bacillus megaterium ATCC 13632 (MBC=<=0.014µM)&&Streptococcus pneumoniae ATCC 33400 (MIC=>28µM)&&Streptococcus pneumoniae ATCC 33400 (MBC=>28µM)&&Staphylococcus aureus ATCC 43300 (MIC=>28µM)&&Staphylococcus aureus ATCC 43300 (MBC=>28µM)&&Staphylococcus aureus ATCC 29213 (MIC=>28µM)&&Staphylococcus aureus ATCC 29213 (MBC=>28µM)&&Staphylococcus epidermidis (MIC=7µM)&&Staphylococcus epidermidis (MBC=7µM)&&Escherichia coli ATCC 25922 (MIC=14µM)&&Escherichia coli ATCC 25922 (MBC=14µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=28µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=28µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=7µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=7µM)&&Pseudomonas aeruginosa ATCC 10145 (MIC=>28µM)&&Pseudomonas aeruginosa ATCC 10145 (MBC=>28µM)&&Human skin melanoma MM96L (100% Killing=50-200µg/ml)&&Human melanoma A2058 (90% Killing=50µg/ml)&&Human skin melanoma SK-Mel-28 (70% Killing=50µg/ml),XCRRLCYRNRCVTYCRGR,,Linear,Free,Free,,L,dbAMP3,18
19039,dbAMP_19039,6PIN,Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli DC2 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=2-8µM)&&Staphylococcus aureus ATCC 6538 (MIC=8µM)&&Human skin melanoma MM96L (50% Cell death=1.3±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=1.4±0.1µM)&&Human metastatic melanoma WM164 (50% Cell death=2.7±0.1µM)&&Human cervical carcinoma HeLa (50% Cell death=6.7±0.6µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=2.7±0.3µM)&&Human myelogenous leukemia K562 (50% Cell death=2.0±0.1µM)&&Human breast adenocarcinoma MCF-7 (50% Cell death=6.4±0.6µM),KWCFRVCYRGICYRRCRG,,Linear,Free,Free,,L,dbAMP3,18
19041,dbAMP_19041,6PIO,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Escherichia coli DC2 (MIC=4-8µM)&&Staphylococcus aureus ATCC 25923 (MIC=2-8µM)&&Staphylococcus aureus ATCC 6538 (MIC=8µM)&&Human skin melanoma MM96L (50% Cell death=1.1±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=0.8±0.04µM)&&Human metastatic melanoma WM164 (50% Cell death=2.4±0.3µM)&&Human cervical carcinoma HeLa (50% Cell death=7.2±0.4µM),RWCFRVCYRGICYRKCRG,,Linear,Free,Free,,L,dbAMP3,18
19042,dbAMP_19042,6PIP,Escherichia coli ATCC 25922 (MIC=1-2µM)&&Escherichia coli DC2 (MIC=4-8µM)&&Staphylococcus aureus ATCC 25923 (MIC=2-8µM)&&Staphylococcus aureus ATCC 6538 (MIC=8µM)&&Human skin melanoma MM96L (50% Cell death=1.7±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=0.9±0.03µM)&&Human metastatic melanoma WM164 (50% Cell death=1.3±0.1µM)&&Human cervical carcinoma HeLa (50% Cell death=9.3±0.4µM),KWCFRVCYRGICYRKCRG,,Linear,Free,Free,,L,dbAMP3,18
19051,dbAMP_19051,,Escherichia coli NCTC 10418 (MIC=12.49µM)&&Escherichia coli NCTC 10418 (MBC=99.88µM)&&Staphylococcus aureus NCTC 10788 (MIC=3.12µM)&&Staphylococcus aureus NCTC 10788 (MBC=49.94µM)&&Candida albicans NCPF 1467 (MIC=3.12µM)&&Candida albicans NCPF 1467 (MBC=24.97µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.6µM)&&Human prostate adenocarcinoma PC-3 (IC50=4.0µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=4.3µM)&&Human glioblastoma U251-MG (IC50=4.8µM)&&Human breast adenocarcinoma MCF-7 (IC50=2.0µM),FLPAIAGLAAKFLPKIFCAITKKC,,Linear,Free,Free,,L,dbAMP3,24
19052,dbAMP_19052,,Escherichia coli NCTC 10418 (MIC=25.11µM)&&Escherichia coli NCTC 10418 (MBC=50.22µM)&&Staphylococcus aureus NCTC 10788 (MIC=6.28µM)&&Staphylococcus aureus NCTC 10788 (MBC=50.22µM)&&Candida albicans NCPF 1467 (MIC=3.14µM)&&Candida albicans NCPF 1467 (MBC=12.55µM)&&Human squamous lung carcinoma NCI-H157 (IC50=5.9µM)&&Human prostate adenocarcinoma PC-3 (IC50=5.9µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=3.5µM)&&Human glioblastoma U251-MG (IC50=3.9µM)&&Human breast adenocarcinoma MCF-7 (IC50=3.4µM),FLPAIAGVAAKFLPKIFCAITKKC,,Linear,Free,Free,,L,dbAMP3,24
19069,dbAMP_19069,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli KPC 001812446 (MIC=16-32µM)&&Escherichia coli BL21 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=>32µM)&&Staphylococcus aureus ATCC 12600 (MIC=32µM)&&Staphylococcus aureus (MIC=>32µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>32µM)&&Klebsiella pneumoniae KPC 001825971 (MIC=>32µM)&&Acinetobacter baumannii (MIC=>32µM)&&Enterobacter cloacae (MIC=>32µM)&&Enterococcus faecalis ATCC 19433 (MIC=4-8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>32µM)&&Pseudomonas aeruginosa PAO1 (MIC=32µM)&&Pseudomonas aeruginosa PA14 (MIC=32µM)&&Pseudomonas aeruginosa H1001 (MIC=20µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=100µM)&&Human colon adenocarcinoma HT29 (IC50=100µM),KKLRLKIAFK,,Linear,Free,Free,,L,dbAMP3,10
19072,dbAMP_19072,,Escherichia coli DH5alpha (MIC=6µM)&&Bacillus subtilis 168 (MIC=2µM)&&Human cervical carcinoma HeLa (IC50=35µM)&&Human promyelocytic leukemia HL-60 (IC50=10µM),GXXKKXXKKXXKKX,,Linear,Free,Free,,L,dbAMP3,14
19106,dbAMP_19106,,Escherichia coli DH5alpha (MIC=6µM)&&Bacillus subtilis 168 (MIC=2µM)&&Human cervical carcinoma HeLa (IC50=28µM)&&Human promyelocytic leukemia HL-60 (IC50=13µM),GLLKKLLKKLLKKL,,Linear,Free,Free,,L,dbAMP3,14
19107,dbAMP_19107,,Escherichia coli DH5alpha (MIC=125µM)&&Bacillus subtilis 168 (MIC=65µM)&&Human cervical carcinoma HeLa (10% Killing=50µM)&&Human promyelocytic leukemia HL-60 (12% Killing=50µM),GVVKKVVKKVVKKV,,Linear,Free,Free,,L,dbAMP3,14
19121,dbAMP_19121,,Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=4µM)&&Micrococcus luteus ATCC 10420 (MIC=2µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Human pancreatic carcinoma Panc-1 (IC50=9µM)&&Human lung carcinoma A549 (IC50=9µM),FLGALWKALSKLL,,Linear,Free,Free,,L,dbAMP3,13
19122,dbAMP_19122,,Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=8µM)&&Micrococcus luteus ATCC 10420 (MIC=2µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Human pancreatic carcinoma Panc-1 (IC50=39µM)&&Human lung carcinoma A549 (IC50=22µM),FLGALWHALSKLL,,Linear,Free,Free,,L,dbAMP3,13
19124,dbAMP_19124,,Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=8µM)&&Micrococcus luteus ATCC 10420 (MIC=4µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Human pancreatic carcinoma Panc-1 (IC50=54µM)&&Human lung carcinoma A549 (IC50=31µM),FLGALWKALSHLL,,Linear,Free,Free,,L,dbAMP3,13
19125,dbAMP_19125,,Human pancreatic carcinoma Panc-1 (IC50=>120µM)&&Human lung carcinoma A549 (IC50=59µM)&&Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=64µM)&&Micrococcus luteus ATCC 10420 (MIC=8µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM),FLGALWHALSHLL,,Linear,Free,Free,,L,dbAMP3,13
19170,dbAMP_19170,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 12493 (MIC=8µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Staphylococcus aureus NCTC 12493 (MBC=16µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=32µM)&&Candida albicans NCYC 1467 (MFC=16µM)&&Human glioblastoma U251-MG (IC50=0.05766µM)&&Human squamous lung carcinoma NCI-H157 (IC50=0.19µM)&&Human breast adenocarcinoma MDA-MB-435S (MIC=0.11µM)&&Human breast adenocarcinoma MCF-7 (IC50=0.67µM)&&Human prostate adenocarcinoma PC-3 (IC50=0.44µM),ALWKTLLKHVGKAAGKAALNAVTDMVNQ,,Linear,Free,Free,,L,dbAMP3,28
19178,dbAMP_19178,,Human hepatocellular carcinoma HepG2 (IC50=25µM)&&Human cervical carcinoma HeLa (IC50=10µM)&&Human promyelocytic leukemia HL-60 (IC50=17µM)&&Jurkat cancer cells (IC50=25µM),AIIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,14
19179,dbAMP_19179,,Human epidermoid cancer Hep2 (IC50=22µM)&&Human cervical carcinoma HeLa (IC50=14µM)&&Human promyelocytic leukemia HL-60 (IC50=25µM)&&Jurkat cancer cells (IC50=23µM),EIIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,14
19180,dbAMP_19180,,Human epidermoid cancer Hep2 (IC50=22µM)&&Human cervical carcinoma HeLa (IC50=5µM)&&Human promyelocytic leukemia HL-60 (IC50=8µM)&&Jurkat cancer cells (IC50=20µM),KIIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,14
19181,dbAMP_19181,,Human epidermoid cancer Hep2 (IC50=15µM)&&Human cervical carcinoma HeLa (IC50=8µM)&&Human promyelocytic leukemia HL-60 (IC50=13µM)&&Jurkat cancer cells (IC50=15µM),VIIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,14
19182,dbAMP_19182,,Human epidermoid cancer Hep2 (IC50=>40µM)&&Human cervical carcinoma HeLa (IC50=>40µM)&&Human promyelocytic leukemia HL-60 (IC50=>40µM)&&Jurkat cancer cells (IC50=>40µM),GIIKKIIKKIIKKA,,Linear,Free,Free,,L,dbAMP3,14
19184,dbAMP_19184,,Human epidermoid cancer Hep2 (IC50=>40µM)&&Human cervical carcinoma HeLa (IC50=>40µM)&&Human promyelocytic leukemia HL-60 (IC50=>40µM)&&Jurkat cancer cells (IC50=>40µM),GIIKKIIKKIIKKE,,Linear,Free,Free,,L,dbAMP3,14
19185,dbAMP_19185,,Human epidermoid cancer Hep2 (IC50=>40µM)&&Human cervical carcinoma HeLa (IC50=>40µM)&&Human promyelocytic leukemia HL-60 (IC50=>40µM)&&Jurkat cancer cells (IC50=>40µM),GIIKKIIKKIIKKK,,Linear,Free,Free,,L,dbAMP3,14
19186,dbAMP_19186,,Human epidermoid cancer Hep2 (IC50=10µM)&&Human cervical carcinoma HeLa (IC50=12µM)&&Human promyelocytic leukemia HL-60 (IC50=10µM)&&Jurkat cancer cells (IC50=15µM),GIIKKIIKKIIKKV,,Linear,Free,Free,,L,dbAMP3,14
19187,dbAMP_19187,,Escherichia coli KCTC 1682 (MIC=2µM)&&Salmonella typhimurium KCTC 1926 (MIC=2µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4µM)&&Bacillus subtilis KCTC 3068 (MIC=0.5µM)&&Staphylococcus aureus KCTC 1621 (MIC=1µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=0.5µM)&&Human cervical carcinoma HeLa (IC50=24µM),VRRFKWWWKFLRR,,Linear,Free,Free,,L,dbAMP3,13
19242,dbAMP_19242,,Pseudomonas aeruginosa PAO1 (MBC=2.50±0.08µM)&&Pseudomonas aeruginosa PAO1 (ED50=1.34±0.16µM)&&Human hepatocellular carcinoma HepG2 (IC50=74.43±1.91µM)&&Escherichia coli BW25113 (MIC=1.56µM)&&Acinetobacter baumannii ATCC 15308 (MIC=1.56µM)&&Pseudomonas sp. ATCC 15915 (MIC=1.56µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=12.5µM)&&Shigella flexneri ATCC 29903 (MIC=3.13µM)&&Escherichia coli CFT073 (MIC=3.13-6.25µM)&&Pseudomonas aeruginosa (MIC=12.5-25µM)&&Salmonella typhimurium (MIC=6.25µM)&&Acinetobacter baumannii (MIC=0.78-1.56µM)&&Escherichia coli BW25113 (MBC=1.56µM)&&Acinetobacter baumannii ATCC 15308 (MBC=1.56µM)&&Pseudomonas sp. ATCC 15915 (MBC=1.56µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MBC=12.5µM)&&Shigella flexneri ATCC 29903 (MBC=3.13µM)&&Pseudomonas sp. ATCC 15915 (MIC=25µM),RPFTRAQWFAIQHISPRTIAMRAINNYRWR,,Linear,Free,Free,,L,dbAMP3,30
19243,dbAMP_19243,,Pseudomonas aeruginosa PAO1 (ED50=0.55±0.07µM)&&Human hepatocellular carcinoma HepG2 (IC50=95.78±6.37µM),RPFIRAQWFAIQHISPRTIAMRAINNYRWR,,Linear,Free,Free,,L,dbAMP3,30
19244,dbAMP_19244,,Pseudomonas aeruginosa PAO1 (ED50=0.25±0.02µM)&&Human hepatocellular carcinoma HepG2 (IC50=171.55±1.23µM),RPFTRAQIFAIQHISPRTIAMRAINNYRWR,,Linear,Free,Free,,L,dbAMP3,30
19245,dbAMP_19245,,Pseudomonas aeruginosa PAO1 (ED50=0.44±0.07µM)&&Human hepatocellular carcinoma HepG2 (IC50=59.64±6.17µM),RPFTRAQWFAIIHISPRTIAMRAINNYRWR,,Linear,Free,Free,,L,dbAMP3,30
19251,dbAMP_19251,,Candida albicans ATCC 90028 (MFC=4.25±0.3µM)&&Candida albicans ATCC 90028 (IC50=2.08±0.27µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),KPPQFTKAQWFAIQHISLNPPKSTIAMKAINNYKWKSKNQNTFLK,,Linear,Free,Free,,L,dbAMP3,45
19252,dbAMP_19252,,Candida albicans ATCC 90028 (MFC=2.83±0.1µM)&&Candida albicans ATCC 90028 (IC50=1.62±0.32µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),RPRGMTSSQWFRIQHMQPSPQASNSAMRNINRHTRRSRDLNTFLH,,Linear,Free,Free,,L,dbAMP3,45
19257,dbAMP_19257,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=15µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=30µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=62µg/ml)&&Human colon adenocarcinoma SW480 (LD50=5µg/ml)&&Human melanoma BMKC (LD50=27µg/ml)&&Human lung carcinoma H1299 (LD50=64µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=82µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=41µg/ml),FALAAKALKKLAKKLKKLAKKAL,,Linear,Free,Free,,L,dbAMP3,23
19260,dbAMP_19260,,Bacillus subtilis KCTC 3068 (MIC=8µM)&&Staphylococcus aureus KCTC 1621 (MIC=16-32µM)&&Enterococcus faecalis KCTC 2011 (MIC=16µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=16µM)&&Escherichia coli KCTC 1682 (MIC=32µM)&&Salmonella typhimurium KCTC 1926 (MIC=16-32µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=32µM)&&Proteus vulgaris KCTC 2433 (MIC=32-64µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=20µM)&&Escherichia coli ATCC 25922 (MIC=20µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=40µM)&&Jurkat T-cell leukemia (IC50=16.8µM),GIGKWLHSAKKFGKAFVGEIMNS,,Linear,Free,Free,,L,dbAMP3,23
19264,dbAMP_19264,,Escherichia coli UB1005 (MIC=2µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=8µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=8µg/ml)&&Pseudomonas aeruginosa (MIC=16µg/ml)&&Pseudomonas aeruginosa M76 (MIC=8µg/ml)&&Pseudomonas aeruginosa M917 (MIC=32µg/ml)&&Pseudomonas aeruginosa M1251 (MIC=8µg/ml)&&Pseudomonas aeruginosa M1426 (MIC=8µg/ml)&&Pseudomonas aeruginosa R70 (MIC=2µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Candida albicans (MIC=32µg/ml)&&Pseudomonas stutzeri (MIC=2µg/ml)&&Pseudomonas fluorescens (MIC=8µg/ml)&&Ralstonia pickettii (MIC=4µg/ml)&&Stenotrophomonas maltophilia (MIC=1µg/ml)&&Achromobacter xylosoxidans (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=15µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=15µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=190µg/ml)&&Human colon adenocarcinoma SW480 (LD50=250µg/ml)&&Human melanoma BMKC (LD50=445µg/ml)&&Human lung carcinoma H1299 (LD50=320µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=570µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=270µg/ml),FAKKLAKKLKKLAKKLAK,,Linear,Free,Free,,L,dbAMP3,18
19269,dbAMP_19269,,Escherichia coli UB1005 (MIC=4µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=8µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=8µg/ml)&&Pseudomonas aeruginosa M76 (MIC=32µg/ml)&&Pseudomonas aeruginosa M917 (MIC=128µg/ml)&&Pseudomonas aeruginosa M1251 (MIC=16µg/ml)&&Pseudomonas aeruginosa M1426 (MIC=16µg/ml)&&Pseudomonas aeruginosa R70 (MIC=16µg/ml)&&Staphylococcus aureus (MIC=8µg/ml)&&Candida albicans (MIC=64µg/ml)&&Pseudomonas stutzeri (MIC=2µg/ml)&&Pseudomonas fluorescens (MIC=8µg/ml)&&Ralstonia pickettii (MIC=4µg/ml)&&Stenotrophomonas maltophilia (MIC=4µg/ml)&&Achromobacter xylosoxidans (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MBC=>80µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=26µg/ml)&&Human colon adenocarcinoma SW480 (LD50=38µg/ml)&&Human melanoma BMKC (LD50=85µg/ml)&&Human lung carcinoma H1299 (LD50=72µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=145µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=38µg/ml),FALALKALKKLLKKLKKLAKKAL,,Linear,Free,Free,,L,dbAMP3,23
19292,dbAMP_19292,,Escherichia coli UB1005 (MIC=4µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=4µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=8µg/ml)&&Pseudomonas aeruginosa (MIC=8-16µg/ml)&&Pseudomonas aeruginosa M76 (MIC=16µg/ml)&&Pseudomonas aeruginosa M917 (MIC=32µg/ml)&&Pseudomonas aeruginosa M1251 (MIC=8µg/ml)&&Pseudomonas aeruginosa M1426 (MIC=8µg/ml)&&Pseudomonas aeruginosa R70 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=4µg/ml)&&Candida albicans (MIC=16µg/ml)&&Pseudomonas stutzeri (MIC=8µg/ml)&&Pseudomonas fluorescens (MIC=16µg/ml)&&Ralstonia pickettii (MIC=16µg/ml)&&Stenotrophomonas maltophilia (MIC=2µg/ml)&&Achromobacter xylosoxidans (MIC=64µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=16µg/ml)&&Human colon adenocarcinoma SW480 (LD50=14µg/ml)&&Human melanoma BMKC (LD50=16µg/ml)&&Human lung carcinoma H1299 (LD50=7µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=15µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=47µg/ml),FAKLLAKALKKLL,,Linear,Free,Free,,L,dbAMP3,13
19301,dbAMP_19301,,Staphylococcus aureus NCTC 10788 (MIC=16µM)&&Staphylococcus aureus NCTC 10788 (MBC=32µM)&&Staphylococcus aureus NCTC 12493 (MIC=32µM)&&Staphylococcus aureus NCTC 12493 (MBC=64µM)&&Enterococcus faecalis NCTC 12697 (MIC=16µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=32µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=16µM)&&Candida albicans NCYC 1467 (MIC=64µM)&&Candida albicans NCYC 1467 (MFC=128µM)&&Human breast adenocarcinoma MCF-7 (IC50=7.44µM)&&Human glioblastoma U251-MG (IC50=49.51µM)&&Human squamous lung carcinoma NCI-H157 (IC50=25.51µM)&&Human prostate adenocarcinoma PC-3 (IC50=21.78µM)&&Human pancreatic carcinoma Panc-1 (IC50=28.95µM),GLWSKIKDAAKTAGKAALGFVNEMV,,Linear,Free,Free,,L,dbAMP3,25
19302,dbAMP_19302,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=4µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Staphylococcus aureus NCTC 12493 (MBC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=2µM)&&Enterococcus faecalis NCTC 12697 (MBC=4µM)&&Escherichia coli NCTC 10418 (MIC=2µM)&&Escherichia coli NCTC 10418 (MBC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=4µM)&&Candida albicans NCYC 1467 (MIC=4µM)&&Candida albicans NCYC 1467 (MFC=8µM)&&Human breast adenocarcinoma MCF-7 (IC50=8.64µM)&&Human glioblastoma U251-MG (IC50=18.51µM)&&Human squamous lung carcinoma NCI-H157 (IC50=9.88µM)&&Human prostate adenocarcinoma PC-3 (IC50=9.97µM)&&Human pancreatic carcinoma Panc-1 (IC50=11.17µM),GLWSKIKKAAKTAGKAALGFVNKMV,,Linear,Free,Free,,L,dbAMP3,25
19321,dbAMP_19321,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Jurkat T-cell leukemia (IC50=19.3µM),VRRFPYWWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19323,dbAMP_19323,,Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MBC=8µM)&&Jurkat T-cell leukemia (IC50=11.4µM),VRRFPWYWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19324,dbAMP_19324,,Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli ATCC 25922 (MBC=4µM)&&Jurkat T-cell leukemia (IC50=12.0µM),VRRFPWWYPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19325,dbAMP_19325,,Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MBC=32µM)&&Jurkat T-cell leukemia (IC50=32.2µM),VRRFPYYWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19326,dbAMP_19326,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Jurkat T-cell leukemia (IC50=25.6µM),VRRFPWYYPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19327,dbAMP_19327,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Jurkat T-cell leukemia (IC50=35.4µM),VRRFPYWYPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19328,dbAMP_19328,,Escherichia coli ATCC 25922 (MIC=32-64µM)&&Escherichia coli ATCC 25922 (MBC=32-64µM)&&Jurkat T-cell leukemia (IC50=36.5µM),VRRFPAWWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19329,dbAMP_19329,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MBC=16µM)&&Jurkat T-cell leukemia (IC50=48.2µM),VRRFPWAWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19330,dbAMP_19330,,Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MBC=8µM)&&Jurkat T-cell leukemia (IC50=22.8µM),VRRFPWWAPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19331,dbAMP_19331,,Escherichia coli ATCC 25922 (MIC=64-128µM)&&Escherichia coli ATCC 25922 (MBC=64-128µM)&&Jurkat T-cell leukemia (IC50=>=65µM),VRRFPAAWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19332,dbAMP_19332,,Escherichia coli ATCC 25922 (MIC=64-128µM)&&Escherichia coli ATCC 25922 (MBC=64-128µM)&&Jurkat T-cell leukemia (IC50=>=65µM),VRRFPWAAPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19334,dbAMP_19334,,Escherichia coli ATCC 25922 (MIC=64-128µM)&&Escherichia coli ATCC 25922 (MBC=64-128µM)&&Jurkat T-cell leukemia (IC50=>=65µM),VRRFPAWAPFLRR,,Linear,Free,Free,,L,dbAMP3,13
19341,dbAMP_19341,,Human breast adenocarcinoma MCF-7 (EC50=56±3µM),YIWARAERVWLWWGKFLSL,,Linear,Free,Free,,L,dbAMP3,19
19342,dbAMP_19342,,Human breast adenocarcinoma MCF-7 (EC50=47±4µM),DLFKQLQRLFLGILYCLYKIW,,Linear,Free,Free,,L,dbAMP3,21
19343,dbAMP_19343,,Human breast adenocarcinoma MCF-7 (EC50=95±4µM),AIKKFGPLAKIVAKV,,Linear,Free,Free,,L,dbAMP3,15
19344,dbAMP_19344,,Human breast adenocarcinoma MCF-7 (EC50=34±4µM),KVWKIKKNIRRLLHGIKRGWKG,,Linear,Free,Free,,L,dbAMP3,22
19345,dbAMP_19345,,Human breast adenocarcinoma MCF-7 (EC50=101±4µM),GFWARIGKVFAAVKNL,,Linear,Free,Free,,L,dbAMP3,16
19346,dbAMP_19346,,Human breast adenocarcinoma MCF-7 (EC50=45.5±0.8µM),AFLYRLTRQIRPWWRWLYKW,,Linear,Free,Free,,L,dbAMP3,20
19347,dbAMP_19347,,Human breast adenocarcinoma MCF-7 (EC50=50±10µM),RIWGKHSRYIKIVKRLIQ,,Linear,Free,Free,,L,dbAMP3,18
19348,dbAMP_19348,,Human breast adenocarcinoma MCF-7 (EC50=16.1±0.3µM),QIWHKIRKLWQIIKDGF,,Linear,Free,Free,,L,dbAMP3,17
19349,dbAMP_19349,,Human breast adenocarcinoma MCF-7 (EC50=4µM)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=15µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=10µg/ml)&&Candida albicans ATCC 10231 (MFC=>40µg/ml)&&Human colon adenocarcinoma SW480 (LD50=30µg/ml)&&Human melanoma BMKC (LD50=56µg/ml)&&Human lung carcinoma H1299 (LD50=57µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=19µg/ml),FAKKLAKLAKKLAKLALAL,,Linear,Free,Free,,L,dbAMP3,19
19350,dbAMP_19350,,Human breast adenocarcinoma MCF-7 (EC50=4µM)&&Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human colon adenocarcinoma SW480 (LD50=12µg/ml)&&Human melanoma BMKC (LD50=36µg/ml)&&Human lung carcinoma H1299 (LD50=37µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=20µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=12µg/ml),FALALKALKKLAKKLKKLAKKAL,,Linear,Free,Free,,L,dbAMP3,23
19351,dbAMP_19351,,Human breast adenocarcinoma MCF-7 (EC50=5µM)&&Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=10µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Human colon adenocarcinoma SW480 (LD50=54µg/ml)&&Human melanoma BMKC (LD50=100µg/ml)&&Human lung carcinoma H1299 (LD50=52µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=130µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=18µg/ml),KWKLFKKALKKLKKALKKAL,,Linear,Free,Free,,L,dbAMP3,20
19381,dbAMP_19381,,Human melanoma A375 (LC50=4.2±0.2µM)&&Human Melanoma SBcl-2 (LC50=2.5±0.1µM)&&Human metastatic melanoma WM164 (LC50=4.7±0.2µM)&&Human rhabdomyosarcoma TE671 (10% Killing=20µM)&&Human glioblastoma U251-MG (80% Killing=20µM),PFWRIRIRRPRRIRIRWFP,,Linear,Free,Free,,L,dbAMP3,19
19382,dbAMP_19382,,Human melanoma A375 (LC50=21.0±1.2µM)&&Human Melanoma SBcl-2 (LC50=16.0±0.5µM)&&Human metastatic melanoma WM164 (95% Killing=20µM)&&Human rhabdomyosarcoma TE671 (90% Killing=20µM)&&Human glioblastoma U251-MG (95% Killing=20µM),RWKRINRQWFFWQRNIRKWR,,Linear,Free,Free,,L,dbAMP3,20
19383,dbAMP_19383,,Human melanoma A375 (LC50=12.3±1.3µM)&&Human Melanoma SBcl-2 (LC50=5.0±0.4µM),PFWRRRIRIRRRRIRIRRRWFP,,Linear,Free,Free,,L,dbAMP3,22
19384,dbAMP_19384,,Human melanoma A375 (LC50=9.3±0.8µM)&&Human Melanoma SBcl-2 (LC50=9.4±0.5µM)&&Human metastatic melanoma WM164 (95% Killing=20µM)&&Human rhabdomyosarcoma TE671 (85% Killing=20µM)&&Human glioblastoma U251-MG (85% Killing=20µM),FWQRRIRRWRRFWQRRIRRWRR,,Linear,Free,Free,,L,dbAMP3,22
19385,dbAMP_19385,,Human melanoma A375 (LC50=8.4±0.5µM)&&Human Melanoma SBcl-2 (LC50=4.6±0.2µM)&&Human metastatic melanoma WM164 (95% Killing=20µM)&&Human glioblastoma U251-MG (90% Killing=20µM),WWRRWWRRWRRWWRRWWR,,Linear,Free,Free,,L,dbAMP3,18
19406,dbAMP_19406,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (19% Killing=32µM),RWRPPIRRPPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19410,dbAMP_19410,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (18% Killing=32µM),RFRWPIRRPPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19413,dbAMP_19413,,Escherichia coli BW25113 (MIC=32µM)&&Human chronic B cell leukemia MEC-1 (19% Killing=32µM),RFRPPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19414,dbAMP_19414,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (19% Killing=32µM),RFRPPIRRPPIRPPFWP,,Linear,Free,Free,,L,dbAMP3,17
19415,dbAMP_19415,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (5% Killing=32µM)&&Escherichia coli BW25113 del-sbmA (MIC=64µM)&&Escherichia coli BW25113 del-sbmA (MBC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=64µM)&&Acinetobacter baumannii ATCC 19606 (MBC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MBC=>64µM)&&Escherichia coli (MIC=2-8µM)&&Escherichia coli BW25113 (MBC=64µM),RFRPPIRRPPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19416,dbAMP_19416,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (5% Killing=32µM),RFRPPIRRPPIRPPFYW,,Linear,Free,Free,,L,dbAMP3,17
19418,dbAMP_19418,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (9% Killing=32µM),RFRRPIRRPPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19419,dbAMP_19419,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (7% Killing=32µM),RFRWPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19420,dbAMP_19420,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (8% Killing=32µM),RWRWPIRRPPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19421,dbAMP_19421,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (10% Killing=32µM),RWRWPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19422,dbAMP_19422,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (2% Killing=32µM),RFRWPIRRRPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19424,dbAMP_19424,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (16% Killing=32µM),RWRRPIRRPPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19425,dbAMP_19425,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (11% Killing=32µM),RWRRPIRRPPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19426,dbAMP_19426,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (17% Killing=32µM),RWRRPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19427,dbAMP_19427,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (1% Killing=32µM),RWRRPIRRRPIRPPFYP,,Linear,Free,Free,,L,dbAMP3,17
19428,dbAMP_19428,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (14% Killing=32µM)&&Escherichia coli BW25113 del-sbmA (MIC=8µM)&&Escherichia coli BW25113 del-sbmA (MBC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=16µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=48µM)&&Acinetobacter baumannii ATCC 19606 (MIC=4µM)&&Acinetobacter baumannii ATCC 19606 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=64µM)&&Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MBC=>64µM)&&Escherichia coli (MIC=1-8µM)&&Escherichia coli BW25113 (MBC=4µM),RWRWPIRRPPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19429,dbAMP_19429,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (16% Killing=32µM),RFRWPIRRRPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19430,dbAMP_19430,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (22% Killing=32µM),RFRWPIRRRPIRPPFYW,,Linear,Free,Free,,L,dbAMP3,17
19431,dbAMP_19431,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (19% Killing=32µM)&&Escherichia coli BW25113 del-sbmA (MIC=4µM)&&Escherichia coli BW25113 del-sbmA (MBC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2µM)&&Acinetobacter baumannii ATCC 19606 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=48µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MBC=32µM)&&Escherichia coli (MIC=1-2µM),RWRRPIRRRPIRPPFYW,,Linear,Free,Free,,L,dbAMP3,17
19432,dbAMP_19432,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (1% Killing=32µM),RWRRPIRRRPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19433,dbAMP_19433,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (9% Killing=32µM),RWRRPIRRRPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19434,dbAMP_19434,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (28% Killing=32µM),RFRWPIRRRPIRPPWYR,,Linear,Free,Free,,L,dbAMP3,17
19435,dbAMP_19435,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (10% Killing=32µM),RFRRPIRRRPIRPPFWR,,Linear,Free,Free,,L,dbAMP3,17
19436,dbAMP_19436,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (20% Killing=32µM),RFRWPIRRRPIRPPFWR,,Linear,Free,Free,,L,dbAMP3,17
19437,dbAMP_19437,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (5% Killing=32µM),RFRRPIRRRPIRPPWYR,,Linear,Free,Free,,L,dbAMP3,17
19438,dbAMP_19438,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (5% Killing=32µM),RRRRPIRRRPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19439,dbAMP_19439,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (9% Killing=32µM),RWRRPIRRRPIRPPWYR,,Linear,Free,Free,,L,dbAMP3,17
19441,dbAMP_19441,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (22% Killing=32µM),RWRRPWRRRPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19442,dbAMP_19442,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (41% Killing=32µM),RWRWPIRRRPIRPPWYR,,Linear,Free,Free,,L,dbAMP3,17
19443,dbAMP_19443,,Escherichia coli BW25113 (MIC=4µM)&&Human chronic B cell leukemia MEC-1 (27% Killing=32µM),RWRWPIRRRPIRPPFWR,,Linear,Free,Free,,L,dbAMP3,17
19444,dbAMP_19444,,Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (23% Killing=32µM),RRRRPWRRRPIRPPFYW,,Linear,Free,Free,,L,dbAMP3,17
19445,dbAMP_19445,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (13% Killing=32µM),RFRRPIRRRPIRPPFYR,,Linear,Free,Free,,L,dbAMP3,17
19446,dbAMP_19446,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (25% Killing=32µM),RWRPPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19447,dbAMP_19447,,Escherichia coli BW25113 (MIC=12µM)&&Human chronic B cell leukemia MEC-1 (32% Killing=32µM),RFRRPIRRPPIRPPWYP,,Linear,Free,Free,,L,dbAMP3,17
19449,dbAMP_19449,,Escherichia coli BW25113 (MIC=16µM)&&Human chronic B cell leukemia MEC-1 (5% Killing=32µM),RRRRPIRRRPIRPPWYR,,Linear,Free,Free,,L,dbAMP3,17
19525,dbAMP_19525,,Escherichia coli DH5alpha (MIC=10µM)&&Staphylococcus aureus SH1000 (MIC=1-10µM)&&Human breast adenocarcinoma MCF-7 (EC50=25µM),WGKFFAGVKKLTKAILAVRA,,Linear,Free,Free,,L,dbAMP3,20
19526,dbAMP_19526,,Staphylococcus aureus SH1000 &&Human breast adenocarcinoma MCF-7 &&Escherichia coli DH5alpha,WDPYFAGVKKLTKAILGEIA,,Linear,Free,Free,,L,dbAMP3,20
19527,dbAMP_19527,,Escherichia coli DH5alpha (MIC=1-10µM)&&Staphylococcus aureus SH1000 (MIC=1-10µM)&&Human breast adenocarcinoma MCF-7 (EC50=25µM),WGKFFAGVKKLTKAILGEIA,,Linear,Free,Free,,L,dbAMP3,20
19536,dbAMP_19536,,Human hepatocellular carcinoma HepG2 (IC50=21.2±0.8µM)&&Human prostate adenocarcinoma PC-3 (IC50=20.3±1.0µM)&&Human endometrial adenocarcinoma EJ (IC50=21.6±1.2µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MIC=16µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM),IDWKKLLDAAKQIX,,Linear,Free,Free,,L,dbAMP3,14
19578,dbAMP_19578,,Acinetobacter baumannii (MIC=>32µM)&&Enterobacter cloacae (MIC=>32µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli KPC 001812446 (MIC=8µM)&&Escherichia coli BL21 (MIC=2µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=8µM)&&Klebsiella pneumoniae KPC 001825971 (MIC=>32µM)&&Staphylococcus aureus ATCC 25923 (MIC=>32µM)&&Staphylococcus aureus ATCC 12600 (MIC=4µM)&&Staphylococcus aureus MR (MIC=>32µM)&&Pseudomonas aeruginosa PA14 (MIC=4µM)&&Pseudomonas aeruginosa PAO1 (MIC=4µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human colon adenocarcinoma HT29 (IC50=>100µM),KILKRLAAKIKKIL,,Linear,Free,Free,,L,dbAMP3,14
19579,dbAMP_19579,,Acinetobacter baumannii (MIC=>32µM)&&Enterobacter cloacae (MIC=>32µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Escherichia coli KPC 001812446 (MIC=8µM)&&Escherichia coli BL21 (MIC=2µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>32µM)&&Klebsiella pneumoniae KPC 001825971 (MIC=>32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus ATCC 12600 (MIC=4µM)&&Staphylococcus aureus MR (MIC=8µM)&&Pseudomonas aeruginosa PA14 (MIC=4µM)&&Pseudomonas aeruginosa PAO1 (MIC=4µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human colon adenocarcinoma HT29 (IC50=>100µM),INLKKLAARIKKKI,,Linear,Free,Free,,L,dbAMP3,14
19589,dbAMP_19589,,Corynebacterium glutamicum ATCC 13032 (MIC=0.8µM)&&Staphylococcus aureus ATCC 9144 (MIC=200µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=6.3µM)&&Candida albicans ATCC 10231 (MIC=100µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=25µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTVDKVRNAGRK,,Linear,Free,Free,,L,dbAMP3,16
19590,dbAMP_19590,,Corynebacterium glutamicum ATCC 13032 (MIC=0.8µM)&&Staphylococcus aureus ATCC 9144 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=3.1µM)&&Escherichia coli ATCC 25922 (MIC=3.1µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTVAKVRNAGRK,,Linear,Free,Free,,L,dbAMP3,16
19593,dbAMP_19593,,Corynebacterium glutamicum ATCC 13032 (MIC=0.4µM)&&Staphylococcus aureus ATCC 9144 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µM)&&Escherichia coli ATCC 25922 (MIC=3.1µM)&&Candida albicans ATCC 10231 (MIC=6.3µM)&&Aureobasidium pullulans (MIC=12.5µM)&&Rhodotorula sp. (MIC=3.1µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19595,dbAMP_19595,,Corynebacterium glutamicum ATCC 13032 (MIC=0.8µM)&&Staphylococcus aureus ATCC 9144 (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.3µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=12.5µM)&&Human melanoma A2058 (IC50=>100µM),AWWRRTVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19596,dbAMP_19596,,Corynebacterium glutamicum ATCC 13032 (MIC=3.1µM)&&Staphylococcus aureus ATCC 9144 (MIC=100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=200µM)&&Escherichia coli ATCC 25922 (MIC=50µM)&&Candida albicans ATCC 10231 (MIC=50µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=25µM)&&Human melanoma A2058 (IC50=>200µM),GAWRRTVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19597,dbAMP_19597,,Corynebacterium glutamicum ATCC 13032 (MIC=0.8µM)&&Staphylococcus aureus ATCC 9144 (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=100µM)&&Escherichia coli ATCC 25922 (MIC=100µM)&&Candida albicans ATCC 10231 (MIC=50µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=25µM)&&Human melanoma A2058 (IC50=>200µM),GWARRTVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19598,dbAMP_19598,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Staphylococcus aureus ATCC 9144 (MIC=50µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=6.3µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=50µM)&&Human melanoma A2058 (IC50=>200µM),GWWARTVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19599,dbAMP_19599,,Corynebacterium glutamicum ATCC 13032 (MIC=0.8µM)&&Staphylococcus aureus ATCC 9144 (MIC=100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Escherichia coli ATCC 25922 (MIC=6.3µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=25µM)&&Rhodotorula sp. (MIC=12.5µM)&&Human melanoma A2058 (IC50=>200µM),GWWRATVAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19601,dbAMP_19601,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Staphylococcus aureus ATCC 9144 (MIC=100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=25µM)&&Rhodotorula sp. (MIC=12.5µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTAAKVRK,,Linear,Free,Free,,L,dbAMP3,12
19602,dbAMP_19602,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Staphylococcus aureus ATCC 9144 (MIC=100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6.3µM)&&Escherichia coli ATCC 25922 (MIC=6.3µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=25µM)&&Rhodotorula sp. (MIC=12.5µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTVAAVRK,,Linear,Free,Free,,L,dbAMP3,12
19604,dbAMP_19604,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Staphylococcus aureus ATCC 9144 (MIC=100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Candida albicans ATCC 10231 (MIC=25µM)&&Aureobasidium pullulans (MIC=50µM)&&Rhodotorula sp. (MIC=12.5µM)&&Human melanoma A2058 (IC50=>200µM),GWWRRTVAKVAK,,Linear,Free,Free,,L,dbAMP3,12
19642,dbAMP_19642,,Human breast adenocarcinoma MCF-7 (IC50=15.7±1.5µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=18.2±1.3µM)&&Human myelogenous leukemia K562 (IC50=17.9±1.4µM)&&Human myelogenous leukemia K562/ADM (IC50=19.1±2.1µM),KKLFKKILKYLK,,Linear,Free,Free,,L,dbAMP3,12
19659,dbAMP_19659,,Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MBC=>32µM)&&Staphylococcus aureus (MIC=>32µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MBC=>32µM)&&Escherichia coli (MIC=>32µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>32µM)&&Acinetobacter baumannii (MIC=>32µM)&&Human bladder carcinoma T24 (IC50=>100µM),SNGYRPAYRPAYRPSYRP,,Linear,Free,Free,,L,dbAMP3,18
19660,dbAMP_19660,,Staphylococcus aureus ATCC 29213 (MIC=2µM)&&Staphylococcus aureus ATCC 29213 (MBC=4µM)&&Staphylococcus aureus (MIC=32µM)&&Staphylococcus aureus (MBC=>32µM)&&Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli ATCC 25922 (MBC=1µM)&&Escherichia coli (MIC=2µM)&&Escherichia coli (MBC=2µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2µM)&&Acinetobacter baumannii ATCC 19606 (MBC=4µM)&&Acinetobacter baumannii (MIC=2µM)&&Acinetobacter baumannii (MBC=4µM)&&Human bladder carcinoma T24 (IC50=>100µM),SNVYRPPPYRPVYRPLRRPGYRP,,Linear,Free,Free,,L,dbAMP3,23
19661,dbAMP_19661,,Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MBC=32µM)&&Staphylococcus aureus (MIC=>32µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Escherichia coli ATCC 25922 (MBC=>32µM)&&Escherichia coli (MIC=>32µM)&&Acinetobacter baumannii ATCC 19606 (MIC=8µM)&&Acinetobacter baumannii ATCC 19606 (MBC=8µM)&&Acinetobacter baumannii (MIC=8µM)&&Acinetobacter baumannii (MBC=8µM)&&Human bladder carcinoma T24 (IC50=>100µM),FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH,,Linear,Free,Free,,L,dbAMP3,31
19665,dbAMP_19665,,Corynebacterium glutamicum ATCC 13032 (MIC=0.4µM)&&Bacillus subtilis ATCC 23857 (MIC=0.4µM)&&Staphylococcus aureus ATCC 9144 (MIC=6.3µM)&&Escherichia coli ATCC 25922 (MIC=0.8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.6µM)&&Human melanoma A2058 (IC50=1.4µM)&&Bacillus megaterium (MIC=0.5µg/ml)&&Micrococcus luteus (MIC=8.0µg/ml)&&Aureobasidium pullulans (MIC=92.6µg/ml)&&Candida albicans ATCC 10231 (MIC=46.3µg/ml)&&Rhodotorula sp. (MIC=23.2µg/ml),GPKTKAACKXACKLATCGKKPGGWKCKLCELGCDAV,,Linear,Free,Free,,L,dbAMP3,36
19666,dbAMP_19666,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Bacillus subtilis ATCC 23857 (MIC=1.6µM)&&Staphylococcus aureus ATCC 9144 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25.0µM)&&Human melanoma A2058 (IC50=4.1µM),GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG,,Linear,Free,Free,,L,dbAMP3,35
19667,dbAMP_19667,,Corynebacterium glutamicum ATCC 13032 (MIC=1.6µM)&&Bacillus subtilis ATCC 23857 (MIC=3.1µM)&&Staphylococcus aureus ATCC 9144 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=25.0µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µM)&&Human melanoma A2058 (IC50=27.4µM),GIKEXLCNMACAQTVCKKSGGPLCDTCQAACKALG,,Linear,Free,Free,,L,dbAMP3,35
19668,dbAMP_19668,,Corynebacterium glutamicum ATCC 13032 (MIC=25.0µM)&&Bacillus subtilis ATCC 23857 (MIC=25.0µM)&&Staphylococcus aureus ATCC 9144 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µM)&&Human melanoma A2058 (IC50=>50.0µM),GIKEXLCNXACAQTVCKKSGGPLCDTCQAACKALG,,Linear,Free,Free,,L,dbAMP3,35
19694,dbAMP_19694,,Staphylococcus aureus NCTC 12493 (MIC=>512µM)&&Staphylococcus aureus NCTC 12493 (MBC=>512µM)&&Enterococcus faecalis NCTC 12697 (MIC=64µM)&&Enterococcus faecalis NCTC 12697 (MBC=256µM)&&Staphylococcus aureus NCTC 10788 (MIC=64µM)&&Staphylococcus aureus NCTC 10788 (MBC=256µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=256µM)&&Candida albicans NCYC 1467 (MBC=512µM)&&Zika virus (ZIKV) (IC50 I=3.408±0.738µM)&&Human cervical carcinoma HeLa (<10% Cytotoxicity=20µM)&&Human hepatocellular carcinoma Huh7 (<10% Cytotoxicity=20µM),GFSSLFKAGAKYLLKQVGKAGAQQLACKAANNC,,Linear,Free,Free,,L,dbAMP3,33
19737,dbAMP_19737,,Escherichia coli ATCC 25922 (MIC=0.75µg/ml)&&Escherichia coli ATCC 25922 (MIC=<=0.25µg/ml)&&Escherichia coli ATCC 25922 (MIC=0.375µg/ml)&&Escherichia coli ATCC 25922 (MIC=0.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=3µg/ml)&&Bacillus cereus ATCC 10876 (MIC=30µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=2µg/ml)&&Human breast adenocarcinoma MCF-7 (10.8% Cytotoxicity=16µg/ml)&&Human breast adenocarcinoma MCF-7 (21% Cytotoxicity=32µg/ml)&&Human breast adenocarcinoma MCF-7 (57.6% Cytotoxicity=64µg/ml),VKRTKRGARRGLTKVLKKIFGSIVKKAVSKGV,,Linear,Free,Free,,L,dbAMP3,32
19738,dbAMP_19738,,Escherichia coli ATCC 25922 (MIC=5µg/ml)&&Escherichia coli ATCC 25922 (MIC=<=1.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=2.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=7.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=9µg/ml)&&Escherichia coli ATCC 25922 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=>32µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>32µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>32µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=1.5µg/ml)&&Bacillus cereus ATCC 10876 (MIC=6µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=2µg/ml)&&Human breast adenocarcinoma MCF-7 (15.4% Cytotoxicity=16µg/ml)&&Human breast adenocarcinoma MCF-7 (71.6% Cytotoxicity=32µg/ml)&&Human breast adenocarcinoma MCF-7 (89.7% Cytotoxicity=64µg/ml),WYQLIRTFGNLIHQKYRKLLEAYRKLRD,,Linear,Free,Free,,L,dbAMP3,28
19739,dbAMP_19739,,Escherichia coli ATCC 25922 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>32µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>32µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=>32µg/ml)&&Bacillus cereus ATCC 10876 (MIC=>32µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=>32µg/ml)&&Human breast adenocarcinoma MCF-7 (7% Cytotoxicity=16-64µg/ml),VRRSKRGIKVPSFVKKVLKDVVSESIS,,Linear,Free,Free,,L,dbAMP3,27
19778,dbAMP_19778,,Escherichia coli ATCC 25922 (MIC=0.625µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=0.625µM)&&Staphylococcus aureus ATCC 29213 (MIC=1.25µM)&&Candida albicans ATCC 90028 (MIC=2.5µM)&&Human histiocytic lymphoma U-937/GTB (IC50=5.1µM),AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,,Linear,Free,Free,,L,dbAMP3,32
19781,dbAMP_19781,,Escherichia coli ATCC 25922 (MIC=0.625µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=0.625µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.625µM)&&Candida albicans ATCC 90028 (MIC=1.25µM)&&Human histiocytic lymphoma U-937/GTB (IC50=1µM),AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG,,Linear,Free,Free,,L,dbAMP3,32
19798,dbAMP_19798,,Human histiocytic lymphoma U-937/GTB (12% Killing=100µM)&&Escherichia coli ATCC 25922 (MIC=1.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.25µM)&&Staphylococcus aureus ATCC 29213 (MIC=2.5µM)&&Candida albicans ATCC 90028 (MIC=2.5µM),KRIVARIKAFLR,,Linear,Free,Free,,L,dbAMP3,12
19799,dbAMP_19799,,Human histiocytic lymphoma U-937/GTB (25% Killing=100µM)&&Escherichia coli ATCC 25922 (MIC=1.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.25µM)&&Staphylococcus aureus ATCC 29213 (MIC=2.5µM)&&Candida albicans ATCC 90028 (MIC=2.5µM),KRIVKRIKKFLR,,Linear,Free,Free,,L,dbAMP3,12
19822,dbAMP_19822,,Human hepatocellular carcinoma HepG2 (IC50=26.6µM)&&Human cervical carcinoma HeLa (IC50=34.7µM),LPIP,,Linear,Free,Free,,L,dbAMP3,4
19830,dbAMP_19830,,Escherichia coli DH5alpha (MIC90=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC90=5µM)&&Staphylococcus aureus ATCC 25923 (MIC90=50µM)&&Klebsiella pneumoniae ATCC 13883 (MIC90=3µM)&&Candida albicans SC5314 (MIC90=1µM)&&Cryptococcus neoformans var. grubii H99 (MIC90=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC50=15µM)&&Candida albicans SC5314 (MIC50=15µM)&&Human cervical carcinoma HeLa (10% Killing=100µM),LRKVRRLLRRL,,Linear,Free,Free,,L,dbAMP3,11
19831,dbAMP_19831,,Escherichia coli DH5alpha (MIC90=5µM)&&Staphylococcus aureus ATCC 25923 (MIC=10µM)&&Klebsiella pneumoniae ATCC 13883 (MIC90=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC90=5µM)&&Candida albicans SC5314 (MIC90=2.5µM)&&Cryptococcus neoformans var. grubii H99 (MIC90=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC50=10µM)&&Candida albicans SC5314 (MIC50=15µM)&&Human cervical carcinoma HeLa (80% Killing=100µM),LRKVWRWLRRL,,Linear,Free,Free,,L,dbAMP3,11
19832,dbAMP_19832,,Escherichia coli DH5alpha (MIC90=5µM)&&Staphylococcus aureus ATCC 25923 (MIC90=15µM)&&Klebsiella pneumoniae ATCC 13883 (MIC90=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC90=5µM)&&Candida albicans SC5314 (MIC90=1µM)&&Cryptococcus neoformans var. grubii H99 (MIC90=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC50=10µM)&&Candida albicans SC5314 (MIC50=15µM)&&Human cervical carcinoma HeLa (0% Killing=100µM),LRKFRRLLRRL,,Linear,Free,Free,,L,dbAMP3,11
19833,dbAMP_19833,,Escherichia coli DH5alpha (MIC90=15µM)&&Staphylococcus aureus ATCC 25923 (MIC90=10µM)&&Klebsiella pneumoniae ATCC 13883 (MIC90=10µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC90=2.5µM)&&Candida albicans SC5314 (MIC90=1µM)&&Cryptococcus neoformans var. grubii H99 (MIC90=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC50=10µM)&&Candida albicans SC5314 (MIC50=10µM)&&Human cervical carcinoma HeLa (85% Killing=100µM),LRRLRRLLRRL,,Linear,Free,Free,,L,dbAMP3,11
19852,dbAMP_19852,,Murine fibrosarcoma MethA (EC50=>211µM)&&Human mammary carcinoma MT-1 (EC50=186µM)&&Human colon adenocarcinoma HT29 (EC50=>211µM),KAAKKWAKAAKKWAKAWKKAA,,Linear,Free,Free,,L,dbAMP3,21
19853,dbAMP_19853,,Murine fibrosarcoma MethA (EC50=>211µM)&&Human mammary carcinoma MT-1 (EC50=173µM)&&Human colon adenocarcinoma HT29 (EC50=>211µM),KAAKKWAKAWKKAAKAWKKAA,,Linear,Free,Free,,L,dbAMP3,21
19854,dbAMP_19854,,Murine fibrosarcoma MethA (EC50=>211µM)&&Human mammary carcinoma MT-1 (EC50=128µM)&&Human colon adenocarcinoma HT29 (EC50=>211µM),KAAKKAWKAWKKAAKAWKKAA,,Linear,Free,Free,,L,dbAMP3,21
19855,dbAMP_19855,,Murine fibrosarcoma MethA (EC50=155µM)&&Human mammary carcinoma MT-1 (EC50=68µM)&&Human colon adenocarcinoma HT29 (EC50=173µM),KAAKKAWKAAKKAAKWWKKAA,,Linear,Free,Free,,L,dbAMP3,21
19856,dbAMP_19856,,Murine fibrosarcoma MethA (EC50=42µM)&&Human mammary carcinoma MT-1 (EC50=28µM)&&Human colon adenocarcinoma HT29 (EC50=67µM),KAAKKAWKWAKKAAKWAKKAA,,Linear,Free,Free,,L,dbAMP3,21
19857,dbAMP_19857,,Murine fibrosarcoma MethA (EC50=17µM)&&Human mammary carcinoma MT-1 (EC50=16µM)&&Human colon adenocarcinoma HT29 (EC50=31µM),KWWKKAAKAAKKAAKAAKKWA,,Linear,Free,Free,,L,dbAMP3,21
19858,dbAMP_19858,,Murine fibrosarcoma MethA (EC50=15µM)&&Human mammary carcinoma MT-1 (EC50=15µM)&&Human colon adenocarcinoma HT29 (EC50=21µM),KAAKKAWKAAKKAWKAWKKAA,,Linear,Free,Free,,L,dbAMP3,21
19859,dbAMP_19859,,Murine fibrosarcoma MethA (EC50=19µM)&&Human mammary carcinoma MT-1 (EC50=14µM)&&Human colon adenocarcinoma HT29 (EC50=23µM),KWAKKAAKWAKKAAKWAKKAA,,Linear,Free,Free,,L,dbAMP3,21
19860,dbAMP_19860,,Murine fibrosarcoma MethA (EC50=9µM)&&Human mammary carcinoma MT-1 (EC50=16µM)&&Human colon adenocarcinoma HT29 (EC50=13µM),KAWKKAWKAAKKAWKAAKKAA,,Linear,Free,Free,,L,dbAMP3,21
19861,dbAMP_19861,,Murine fibrosarcoma MethA (EC50=>211µM)&&Human mammary carcinoma MT-1 (EC50=>211µM)&&Human colon adenocarcinoma HT29 (EC50=>211µM),AAKKWAKAKKWAKAKKWAKAA,,Linear,Free,Free,,L,dbAMP3,21
19874,dbAMP_19874,,SARS-CoV (IC50 F=>5µM)&&MERS-CoV (IC50 F=>5µM)&&HCoV-229E (IC50 F=5.70µM)&&HCoV-NL63 (IC50 F=>5µM)&&HCoV-OC43 (IC50 F=>5µM)&&Vesicular Stomatitis Virus (VSV) (IC50 F=>10µM)&&HCoV-229E PsV (IC50 I=3.32µM)&&HCoV-229E (IC50 REP=13.24µM)&&HCoV-229E (IC50 REP=12.7µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=1000µM)&&Human lung carcinoma A549 (0% Cytotoxicity=1000µM),AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ,,Linear,Free,Free,,L,dbAMP3,56
19875,dbAMP_19875,,SARS-CoV (IC50 F=>5µM)&&MERS-CoV (IC50 F=>5µM)&&HCoV-229E (IC50 F=0.13±0.02µM)&&HCoV-229E (IC50 REP=0.56µM)&&HCoV-NL63 (IC50 F=0.51±0.06µM)&&HCoV-OC43 (IC50 F=>5µM)&&Vesicular Stomatitis Virus (VSV) (IC50 F=>10µM)&&HCoV-229E PsV (IC50 I=0.53µM)&&HCoV-229E (IC50 REP=1.96µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=1000µM)&&Human lung carcinoma A549 (0% Cytotoxicity=1000µM),VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL,,Linear,Free,Free,,L,dbAMP3,50
19886,dbAMP_19886,,Human adenocarcinoma TZM-bl (IC50=>100µg/ml),SLIGGLVSAFK,,Linear,Free,Free,,L,dbAMP3,11
19891,dbAMP_19891,,MERS-CoV (IC50 F=4.47±1.7µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=2.38±0.9µM),AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXK,,Linear,Free,Free,,L,dbAMP3,37
19892,dbAMP_19892,,MERS-CoV (IC50 F=>10µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=74.5±6.8µM),VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXK,,Linear,Free,Free,,L,dbAMP3,37
19893,dbAMP_19893,,MERS-CoV (IC50 F=3.11±0.9µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXK,,Linear,Free,Free,,L,dbAMP3,37
19894,dbAMP_19894,,MERS-CoV (IC50 F=6.26±2.1µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=19.8±1.6µM),YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXK,,Linear,Free,Free,,L,dbAMP3,37
19895,dbAMP_19895,,MERS-CoV (IC50 F=0.24±0.08µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=4.04±0.4µM),LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXK,,Linear,Free,Free,,L,dbAMP3,37
19896,dbAMP_19896,,MERS-CoV (IC50 F=0.1±0.02µM)&&Human Influenza A Virus H1N1 (EC50=1.96±0.28µM)&&Human Influenza A Virus H3N2 (EC50=6.38±1.06µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=88.8±28µM),IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXK,,Linear,Free,Free,,L,dbAMP3,37
19897,dbAMP_19897,,MERS-CoV (IC50 F=0.52±0.4µM)&&Human Influenza A Virus H1N1 (EC50=3.15±1.79µM)&&Human Influenza A Virus H3N2 (EC50=12.9±5.55µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXK,,Linear,Free,Free,,L,dbAMP3,37
19898,dbAMP_19898,,MERS-CoV (IC50 F=10.6±2.4µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXK,,Linear,Free,Free,,L,dbAMP3,37
19899,dbAMP_19899,,MERS-CoV (IC50 F=1.68±0.47µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXK,,Linear,Free,Free,,L,dbAMP3,37
19900,dbAMP_19900,,MERS-CoV (IC50 F=0.11±0.02µM)&&MERS-CoV PsV (IC50 I=0.13±0.1µM)&&Human Influenza A Virus H1N1 (EC50=1.73±0.81µM)&&Human Influenza A Virus H3N2 (EC50=0.7±0.09µM)&&Human Influenza A Virus H1N1 (EC50=4.36±3.1µM)&&Human Influenza A Virus H1N1 (EC50=3.03±1.1µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXK,,Linear,Free,Free,,L,dbAMP3,37
19901,dbAMP_19901,,MERS-CoV (IC50 F=0.45±0.13µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=4.54±0.6µM),IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXK,,Linear,Free,Free,,L,dbAMP3,37
19902,dbAMP_19902,,MERS-CoV (IC50 F=2.93±0.95µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM),IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXK,,Linear,Free,Free,,L,dbAMP3,37
19915,dbAMP_19915,,MERS-CoV (IC50 F=0.63±0.05µM)&&MERS-CoV PsV (IC50 I=2.8±0.74µM)&&Cov-Q1020H PsV (IC50 I=4.15±0.25µM)&&Cov-Q1020R PsV (IC50 I=2.49±0.18µM)&&MERS-CoV PsV (IC50 I=2.57±0.24µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM)&&Human lung carcinoma Calu-3 (50% Cytotoxicity=>100µM),LDLTYEXLSLQXVVKXLNESY,,Linear,Free,Free,,L,dbAMP3,21
19918,dbAMP_19918,,Porcine epidemic diarrhea virus (PEDcoV) (IC50 REP=1.11µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=40µM),PLDVFNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVET,,Linear,Free,Free,,L,dbAMP3,55
19919,dbAMP_19919,,Porcine epidemic diarrhea virus (PEDcoV) (IC50 REP=2.96µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=40µM),FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVE,,Linear,Free,Free,,L,dbAMP3,50
19920,dbAMP_19920,,Porcine epidemic diarrhea virus (PEDcoV) (IC50 REP=4.77µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=40µM),FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDL,,Linear,Free,Free,,L,dbAMP3,43
19921,dbAMP_19921,,Porcine epidemic diarrhea virus (PEDcoV) (IC50 REP=12.98µM)&&Human hepatocellular carcinoma Huh7 (0% Cytotoxicity=40µM),LKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWL,,Linear,Free,Free,,L,dbAMP3,41
19994,dbAMP_19994,,Hepatitis C virus (HCV) PsV (IC50 E=0.16µM)&&Hepatitis C virus (HCV) JFH-1 (IC50 E=0.1µM)&&Vesicular Stomatitis Virus (VSV) PsV (IC50 E=>1µM)&&Human hepatocellular carcinoma Huh-7.5.1 cells (50% Cell death=80µM)&&Human hepatocellular carcinoma HepG2 (50% Cell death=85µM)&&Human cervical carcinoma HeLa (50% Cell death=45µM),CWVRLGRYLLRRLKTLFT,,Linear,Free,Free,,L,dbAMP3,18
20002,dbAMP_20002,,Hepatitis C virus (HCV) (IC50 I=0.005µM)&&Human hepatocellular carcinoma Huh7.5/CD81 (50% Cell death=>0.1µM),QGSWFGCTWMNSTGF,,Linear,Free,Free,,L,dbAMP3,15
20003,dbAMP_20003,,Hepatitis C virus (HCV) (IC50 I=0.005µM)&&Human hepatocellular carcinoma Huh7.5/CD81 (50% Cell death=>0.1µM),FGCTWMNSTGFTKTC,,Linear,Free,Free,,L,dbAMP3,15
20004,dbAMP_20004,,Hepatitis C virus (HCV) (IC50 I=0.006µM)&&Human hepatocellular carcinoma Huh7.5/CD81 (50% Cell death=>0.1µM),GLLHLHQNIVDVQYM,,Linear,Free,Free,,L,dbAMP3,15
20005,dbAMP_20005,,Hepatitis C virus (HCV) (IC50 I=0.007µM)&&Human hepatocellular carcinoma Huh7.5/CD81 (50% Cell death=>0.1µM),LHQNIVDVQYMYGLS,,Linear,Free,Free,,L,dbAMP3,15
20070,dbAMP_20070,,HSV-1 (IC50 REP=290µM)&&HSV-1 McIntyre strain (IC50 REP=360µM)&&Coxsackie virus 971 PT  B2  (IC50 REP=230µM)&&Coxsackie virus B2 (IC50 REP=170µM)&&Human epidermoid cancer Hep2 (-=NAµg/ml),GHGQHGVHG,,Linear,Free,Free,,L,dbAMP3,9
20098,dbAMP_20098,,Staphylococcus aureus AB94004 (MIC=0.16µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.08µM)&&Bacillus subtilis AB91021 (MIC=10µM)&&Bacillus thuringiensis AB92037 (MIC=20µM)&&Micrococcus luteus AB93113 (MIC=0.16µM)&&Staphylococcus aureus P1381 (MIC=0.63µM)&&Staphylococcus epidermidis P1389 (MIC=0.31µM)&&Escherichia coli AB94012 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Hepatitis B virus (HBV) (IC50 REP=1.26µM)&&Human hepatocellular carcinoma HepG2.2.15 (50% Cytotoxicity=167.82µM)&&Human hepatocellular carcinoma HepG2 (50% Cytotoxicity=154.24µM),GFGCPFNQGQCHKHCQSIRRRGGYCDGFLKTRCVCYR,,Linear,Free,Free,,L,dbAMP3,37
20113,dbAMP_20113,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=4µM)&&Staphylococcus aureus NCTC 12493 (MIC=4µM)&&Staphylococcus aureus NCTC 12493 (MBC=4µM)&&Escherichia coli NCTC 10418 (MIC=8µM)&&Escherichia coli NCTC 10418 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=32µM)&&Candida albicans NCPE 1467 (MIC=4µM)&&Candida albicans NCPE 1467 (MBC=8µM)&&Human squamous lung carcinoma NCI-H157 (IC50=2.987µM)&&Human glioblastoma U251-MG (IC50=7.985µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=1.197µM)&&Human prostate adenocarcinoma PC-3 (IC50=9.854µM)&&Chromobacterium violaceum ATCC 12472 (MIC=205.2µM)&&Chromobacterium violaceum ATCC 12472 (MBC=205.2µM)&&Staphylococcus aureus ATCC 43300 (MIC=51.3µM)&&Staphylococcus aureus ATCC 43300 (MBC=205.2µM)&&Enterococcus faecalis NCTC 12697 (MIC=12.8µM)&&Enterococcus faecalis NCTC 12697 (MBC=205.2µM)&&Human lung adenocarcinoma NCI-H23 (IC50=8.52±1.02µM),FLGALFKVASKLVPAAICSISKKC,,Linear,Free,Free,,L,dbAMP3,24
20121,dbAMP_20121,,HIV-1 NL4-3 (IC50 I=0.02015266µM)&&HIV-1 JRCSF (IC50 I=0.00181452µM)&&HIV-1 HxB2 (IC50 F=0.000361µM)&&HIV-1 NL4-3 PsV (IC50 E=0.000392µM)&&HIV-1 (IC50 I=0.000182-0.029186µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=800.8±62.29µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=366.3±119.08µM),YTSLIHSLIEESQNQQEKNEQELLELDX,,Linear,Free,Free,,L,dbAMP3,28
20122,dbAMP_20122,,HIV-1 NL4-3 (IC50 I=0.00006743µM)&&HIV-1 JRCSF (IC50 I=0.00002338µM)&&HIV-1 HxB2 (IC50 F=0.000021µM)&&HIV-1 NL4-3 PsV (IC50 E=0.000007µM)&&HIV-1 (IC50 I=0.000012-0.000078µM)&&HIV-1 NL4-3 D36G (IC50 I=<0.00001µM)&&HIV-1 NL4-3 (IC50 I=0.00106-0.13612µM)&&HIV-2 ROD (IC50 I=0.00009µM)&&HIV-2 (IC50 I=0.00581µM)&&Simian immunodeficiency virus (SIV) PsV (IC50 I=0.00006µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=106.4±2.72µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=138.37±6.55µM),YTSLIEELIKKSEEQQKKNEEELKKLEX,,Linear,Free,Free,,L,dbAMP3,28
20123,dbAMP_20123,,HIV-1 NL4-3 (IC50 I=0.00002468µM)&&HIV-1 JRCSF (IC50 I=0.00002275µM)&&HIV-1 HxB2 (IC50 F=0.000021µM)&&HIV-1 NL4-3 PsV (IC50 E=0.000006µM)&&HIV-1 (IC50 I=0.000013-0.000072µM)&&HIV-1 NL4-3 D36G (IC50 I=<0.00001µM)&&HIV-1 NL4-3 (IC50 I=0.0004-0.01207µM)&&HIV-2 ROD (IC50 I=0.00009µM)&&HIV-2 (IC50 I=0.00084µM)&&Simian immunodeficiency virus (SIV) PsV (IC50 I=0.00003-0.00006µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=434.03±90.38µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=135.07±32.3µM),LEANIEELLKKAEEQQKKNEEELKKLEX,,Linear,Free,Free,,L,dbAMP3,28
20124,dbAMP_20124,,HIV-1 NL4-3 (IC50 I=0.00000049µM)&&HIV-1 JRCSF (IC50 I=0.00000454µM)&&HIV-1 PsV (IC50 I=0.00000291µM)&&HIV-1 NL4-3 D36G (IC50 I=0.000002µM)&&HIV-1 NL4-3 (IC50 I=0.000002µM)&&HIV-1 NL4-3 (IC50 I=0.000002-0.000041µM)&&HIV-2 ROD (IC50 I=0.000032µM)&&HIV-2 (IC50 I=0.00002µM)&&HIV-1 (IC50 F=0.00000855µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=19.65µM)&&Human T-cell leukemia C8166 (50% Cytotoxicity=19.19µM)&&Human histiocytic lymphoma U-937 (50% Cytotoxicity=9.97µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=12.34µM)&&Simian immunodeficiency virus (SIV) (IC50 I=0.000004-0.000006µM),WEQKIEELLKKAEEQQKKNEEELKKLEKC,,Linear,Free,Free,,L,dbAMP3,29
20162,dbAMP_20162,,Respiratory syncytial virus (RSV) (IC50 I=0.74±0.27µM)&&Human hepatocellular carcinoma HepG2 (15% Cytotoxicity=12µM)&&Human hepatocellular carcinoma HepG2 (40% Cytotoxicity=25µM),EKIXQSLXFIXKSDXLLHNV,,Linear,Free,Free,,L,dbAMP3,20
20163,dbAMP_20163,,Respiratory syncytial virus (RSV) (IC50 I=0.59±0.13µM)&&Human hepatocellular carcinoma HepG2 (0% Cytotoxicity=12µM)&&Human hepatocellular carcinoma HepG2 (5% Cytotoxicity=25µM)&&Respiratory syncytial virus (RSV) (IC50 REP=8.3µM)&&Respiratory syncytial virus (RSV) (IC50 REP=0.86µM)&&Respiratory syncytial virus (RSV) (IC50 REP=0.47µM),EXINXSLXFIRXSDELLHNV,,Linear,Free,Free,,L,dbAMP3,20
20199,dbAMP_20199,,HIV-1 HxB2 (IC50 F=0.000085µM)&&HIV-1 NL4-3 PsV (IC50 E=0.000043µM)&&HIV-1 JRCSF (IC50 I=0.000126µM)&&HIV-1 PsV (IC50 I=0.000144µM)&&Human adenocarcinoma TZM-bl (50% Cytotoxicity=193.63±13.92µM)&&Human T cell leukemia MT-4 (50% Cytotoxicity=164.47±37.69µM),IEELIKKSEEQQKKNEEELKKLEX,,Linear,Free,Free,,L,dbAMP3,24
20250,dbAMP_20250,,Escherichia coli ATCC 25922 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=8µM)&&Klebsiella pneumoniae (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Enterococcus faecalis ATCC 29212 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Enterococcus casseliflavus ATCC 700327 (MIC=4µM)&&Trypanosoma cruzi (IC50=6.32µM)&&Mouse skin melanoma B16-F10 (IC50=12.8µM)&&Human breast adenocarcinoma MCF-7 (IC50=15.3µM)&&Chikungunya virus (CHIKV) (IC50 I=17µM)&&DENV-4 (IC50 I=20.8µM)&&Yellow fever virus (YFV) (IC50 I=21.8µM),FLGAILKIGHALAKTVLPMVTNAFKPKQ,,Linear,Free,Free,,L,dbAMP3,28
20265,dbAMP_20265,,Pseudomonas aeruginosa ATCC 27853 (MBC=100µg/ml)&&Staphylococcus aureus ATCC 29213 (MBC=100µg/ml)&&Human cervical carcinoma HeLa (20% Killing=256µg/ml)&&Bacillus subtilis ATCC 6633 (MBC=90µg/ml)&&Enterococcus faecium ATCC 19434 (MBC=85µg/ml)&&Streptomyces sindenensis ATCC 12392 (MBC=95µg/ml)&&Enterococcus faecalis ATCC 19433 (MBC=85µg/ml)&&Streptococcus pneumoniae NCCP 14585 (MBC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=85µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MBC=100µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=100µg/ml)&&Klebsiella aerogenes ATCC 13048 (MBC=90µg/ml)&&Staphylococcus aureus ATCC 33591 (MBC=100µg/ml)&&Pseudomonas aeruginosa (MBC=110µg/ml)&&Acinetobacter baumannii (MBC=110µg/ml)&&Klebsiella pneumoniae (MBC=100µg/ml)&&Staphylococcus aureus NCCP 15872 (MBC=120µg/ml)&&Enterococcus  faecium NCCP 11522 (MBC=100µg/ml),KTMMQSGGTFGTFMAIGMGIR,,Linear,Free,Free,,L,dbAMP3,21
20278,dbAMP_20278,,Staphylococcus aureus ATCC 33591 (MIC=>500µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>500µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 22108 (MIC=6.25µg/ml)&&Human hepatocellular carcinoma HepG2 (20% Killing=100µg/ml),RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK,,Linear,Free,Free,,L,dbAMP3,37
20343,dbAMP_20343,,Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Candida albicans ATCC 10231 (MFC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=140µg/ml)&&Human colon adenocarcinoma SW480 (LD50=210µg/ml)&&Human melanoma BMKC (LD50=300µg/ml)&&Human lung carcinoma H1299 (LD50=170µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=260µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=280µg/ml),FAKKLAKKLKKLAKLALAL,,Linear,Free,Free,,L,dbAMP3,19
20344,dbAMP_20344,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=15µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=72µg/ml)&&Human colon adenocarcinoma SW480 (LD50=62µg/ml)&&Human melanoma BMKC (LD50=140µg/ml)&&Human lung carcinoma H1299 (LD50=125µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=190µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=65µg/ml),VALALKALKKALKKLKKALKKAL,,Linear,Free,Free,,L,dbAMP3,23
20345,dbAMP_20345,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=15µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=15µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=21µg/ml)&&Human colon adenocarcinoma SW480 (LD50=35µg/ml)&&Human melanoma BMKC (LD50=53µg/ml)&&Human lung carcinoma H1299 (LD50=24µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=62µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=9µg/ml),FALALKKALKALKKAL,,Linear,Free,Free,,L,dbAMP3,16
20346,dbAMP_20346,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=15µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=15µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=17µg/ml)&&Human colon adenocarcinoma SW480 (LD50=13µg/ml)&&Human melanoma BMKC (LD50=21µg/ml)&&Human lung carcinoma H1299 (LD50=33µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=35µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=10µg/ml),FAKKLAKLAKKLLAL,,Linear,Free,Free,,L,dbAMP3,15
20347,dbAMP_20347,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=>40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=130µg/ml)&&Human colon adenocarcinoma SW480 (LD50=435µg/ml)&&Human melanoma BMKC (LD50=510µg/ml)&&Human lung carcinoma H1299 (LD50=420µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=620µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=310µg/ml),FAKKLAKLAKKALAL,,Linear,Free,Free,,L,dbAMP3,15
20348,dbAMP_20348,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=760µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=435µg/ml),FALAKKALKKAKKAL,,Linear,Free,Free,,L,dbAMP3,15
20349,dbAMP_20349,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=10µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=98µg/ml)&&Human colon adenocarcinoma SW480 (LD50=120µg/ml)&&Human melanoma BMKC (LD50=290µg/ml)&&Human lung carcinoma H1299 (LD50=245µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=185µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=140µg/ml),FAKKLAKKLKKLAKLALAK,,Linear,Free,Free,,L,dbAMP3,19
20350,dbAMP_20350,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=55µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=30µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=140µg/ml)&&Human colon adenocarcinoma SW480 (LD50=32µg/ml)&&Human melanoma BMKC (LD50=47µg/ml)&&Human lung carcinoma H1299 (LD50=72µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=22µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=45µg/ml),FAKKLAKLALKLAKL,,Linear,Free,Free,,L,dbAMP3,15
20351,dbAMP_20351,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=80µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=260µg/ml)&&Human colon adenocarcinoma SW480 (LD50=180µg/ml)&&Human melanoma BMKC (LD50=160µg/ml)&&Human lung carcinoma H1299 (LD50=330µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=160µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=170µg/ml),FAKKLAKKLAKLAL,,Linear,Free,Free,,L,dbAMP3,14
20353,dbAMP_20353,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=300µg/ml)&&Human colon adenocarcinoma SW480 (LD50=160µg/ml)&&Human melanoma BMKC (LD50=150µg/ml)&&Human lung carcinoma H1299 (LD50=290µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=280µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=280µg/ml),FAKKLKKLAKLAKKL,,Linear,Free,Free,,L,dbAMP3,15
20354,dbAMP_20354,,Staphylococcus aureus ATCC 6538 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=575µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=700µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKALKALKKL,,Linear,Free,Free,,L,dbAMP3,12
20362,dbAMP_20362,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (MFC=10µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=23µg/ml)&&Human colon adenocarcinoma SW480 (LD50=47µg/ml)&&Human melanoma BMKC (LD50=43µg/ml)&&Human lung carcinoma H1299 (LD50=17µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=44µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=32µg/ml),VAKLLAKLAKKLL,,Linear,Free,Free,,L,dbAMP3,13
20363,dbAMP_20363,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=50µg/ml)&&Candida albicans ATCC 10231 (MFC=30µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=40µg/ml)&&Human colon adenocarcinoma SW480 (LD50=100µg/ml)&&Human melanoma BMKC (LD50=115µg/ml)&&Human lung carcinoma H1299 (LD50=140µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=77µg/ml),FAKLLAKLAKKL,,Linear,Free,Free,,L,dbAMP3,12
20364,dbAMP_20364,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=15µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=25µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=32µg/ml)&&Human colon adenocarcinoma SW480 (LD50=46µg/ml)&&Human melanoma BMKC (LD50=40µg/ml)&&Human lung carcinoma H1299 (LD50=7µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=33µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=54µg/ml),VAKKLAKLAKKLAKLAL,,Linear,Free,Free,,L,dbAMP3,17
20365,dbAMP_20365,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=15µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=15µg/ml)&&Candida albicans ATCC 10231 (MFC=30µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=60µg/ml)&&Human melanoma BMKC (LD50=90µg/ml)&&Human lung carcinoma H1299 (LD50=80µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=190µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=90µg/ml),FAKLLAKLAKKAL,,Linear,Free,Free,,L,dbAMP3,13
20366,dbAMP_20366,,Staphylococcus aureus ATCC 6538 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=55µg/ml)&&Candida albicans ATCC 10231 (MFC=30µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=500µg/ml)&&Human colon adenocarcinoma SW480 (LD50=215µg/ml)&&Human melanoma BMKC (LD50=205µg/ml)&&Human lung carcinoma H1299 (LD50=370µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=300µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=435µg/ml),FAKLLKLAAKKLL,,Linear,Free,Free,,L,dbAMP3,13
20367,dbAMP_20367,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=740µg/ml)&&Human melanoma BMKC (LD50=740µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=830µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKKLL,,Linear,Free,Free,,L,dbAMP3,10
20368,dbAMP_20368,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLAKALL,,Linear,Free,Free,,L,dbAMP3,10
20369,dbAMP_20369,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=31µg/ml)&&Human colon adenocarcinoma SW480 (LD50=42µg/ml)&&Human melanoma BMKC (LD50=155µg/ml)&&Human lung carcinoma H1299 (LD50=180µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=81µg/ml),FAKKLAKKLL,,Linear,Free,Free,,L,dbAMP3,10
20370,dbAMP_20370,,Staphylococcus aureus ATCC 6538 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLAKKLL,,Linear,Free,Free,,L,dbAMP3,9
20371,dbAMP_20371,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=80µg/ml)&&Human melanoma BMKC (LD50=35µg/ml)&&Human lung carcinoma H1299 (LD50=30µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=30µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=46µg/ml),FAKALKALLKALKAL,,Linear,Free,Free,,L,dbAMP3,15
20372,dbAMP_20372,,Staphylococcus aureus ATCC 6538 (MIC=15µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>55µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>55µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=475µg/ml)&&Human colon adenocarcinoma SW480 (LD50=345µg/ml)&&Human melanoma BMKC (LD50=250µg/ml)&&Human lung carcinoma H1299 (LD50=450µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=210µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=470µg/ml),FAKLLAKLAKAKL,,Linear,Free,Free,,L,dbAMP3,13
20373,dbAMP_20373,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=30µg/ml)&&Candida albicans ATCC 10231 (MFC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=90µg/ml)&&Human colon adenocarcinoma SW480 (LD50=145µg/ml)&&Human melanoma BMKC (LD50=200µg/ml)&&Human lung carcinoma H1299 (LD50=130µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=140µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=170µg/ml),FAKLLAKLAKLKL,,Linear,Free,Free,,L,dbAMP3,13
20374,dbAMP_20374,,Staphylococcus aureus ATCC 6538 (MIC=15µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=>55µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>55µg/ml)&&Candida albicans ATCC 10231 (MFC=>55µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=465µg/ml)&&Human colon adenocarcinoma SW480 (LD50=340µg/ml)&&Human melanoma BMKC (LD50=460µg/ml)&&Human lung carcinoma H1299 (LD50=670µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=260µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=660µg/ml),FAKKLAKKLAKAL,,Linear,Free,Free,,L,dbAMP3,13
20375,dbAMP_20375,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>55µg/ml)&&Candida albicans ATCC 10231 (MFC=30µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=42µg/ml)&&Human colon adenocarcinoma SW480 (LD50=17µg/ml)&&Human melanoma BMKC (LD50=24µg/ml)&&Human lung carcinoma H1299 (LD50=80µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=74µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=54µg/ml),FAKKLAKKLAKLL,,Linear,Free,Free,,L,dbAMP3,13
20376,dbAMP_20376,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>55µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>55µg/ml)&&Candida albicans ATCC 10231 (MFC=50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=970µg/ml)&&Human colon adenocarcinoma SW480 (LD50=400µg/ml)&&Human melanoma BMKC (LD50=750µg/ml)&&Human lung carcinoma H1299 (LD50=860µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=380µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=675µg/ml),FAKKLAKKLAKAAL,,Linear,Free,Free,,L,dbAMP3,14
20377,dbAMP_20377,,Staphylococcus aureus ATCC 6538 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=125µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLAKKAKLAKKL,,Linear,Free,Free,,L,dbAMP3,15
20378,dbAMP_20378,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=540µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=830µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLKKLAKKL,,Linear,Free,Free,,L,dbAMP3,12
20379,dbAMP_20379,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=15µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=29µg/ml)&&Human colon adenocarcinoma SW480 (LD50=35µg/ml)&&Human melanoma BMKC (LD50=76µg/ml)&&Human lung carcinoma H1299 (LD50=64µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=97µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=28µg/ml),KTKLFKKFAKKLAKKLKKLAKKL,,Linear,Free,Free,,L,dbAMP3,23
20380,dbAMP_20380,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=5µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=15µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=23µg/ml)&&Human colon adenocarcinoma SW480 (LD50=51µg/ml)&&Human melanoma BMKC (LD50=46µg/ml)&&Human lung carcinoma H1299 (LD50=25µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=670µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=83µg/ml),FAKALAKLAKKLL,,Linear,Free,Free,,L,dbAMP3,13
20388,dbAMP_20388,,Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human lung carcinoma H1299 (LD50=320µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=690µg/ml),FAKLLAKLAKKAA,,Linear,Free,Free,,L,dbAMP3,13
20389,dbAMP_20389,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=65µg/ml)&&Human melanoma BMKC (LD50=11µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml),FAKLLALALKLKL,,Linear,Free,Free,,L,dbAMP3,13
20390,dbAMP_20390,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=820µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKLAKAKA,,Linear,Free,Free,,L,dbAMP3,13
20391,dbAMP_20391,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=>50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKLAKAKG,,Linear,Free,Free,,L,dbAMP3,13
20392,dbAMP_20392,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=96µg/ml)&&Human colon adenocarcinoma SW480 (LD50=125µg/ml)&&Human melanoma BMKC (LD50=94µg/ml)&&Human lung carcinoma H1299 (LD50=53µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=175µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=52µg/ml),FAKKLAKKLKKLAKKLAKLALALKALALKAL,,Linear,Free,Free,,L,dbAMP3,31
20393,dbAMP_20393,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=95µg/ml)&&Human colon adenocarcinoma SW480 (LD50=120µg/ml)&&Human melanoma BMKC (LD50=94µg/ml)&&Human lung carcinoma H1299 (LD50=54µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=180µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=28µg/ml),FAKKLAKKLKKLAKKLIGAVLKV,,Linear,Free,Free,,L,dbAMP3,23
20395,dbAMP_20395,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=300µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=250µg/ml)&&Human colon adenocarcinoma SW480 (LD50=170µg/ml)&&Human melanoma BMKC (LD50=160µg/ml)&&Human lung carcinoma H1299 (LD50=340µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=170µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=730µg/ml),FAKLLAKALKLKL,,Linear,Free,Free,,L,dbAMP3,13
20396,dbAMP_20396,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=10µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=25µg/ml)&&Candida albicans ATCC 10231 (MFC=15µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=60µg/ml)&&Human colon adenocarcinoma SW480 (LD50=57µg/ml)&&Human melanoma BMKC (LD50=60µg/ml)&&Human lung carcinoma H1299 (LD50=27µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=43µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=66µg/ml),FAKLLAKALKKAL,,Linear,Free,Free,,L,dbAMP3,13
20397,dbAMP_20397,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=46µg/ml)&&Human colon adenocarcinoma SW480 (LD50=90µg/ml)&&Human melanoma BMKC (LD50=75µg/ml)&&Human lung carcinoma H1299 (LD50=150µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=70µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=330µg/ml),FAKLLAKALKKL,,Linear,Free,Free,,L,dbAMP3,12
20398,dbAMP_20398,,Staphylococcus aureus ATCC 6538 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=635µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml),KIAKVALAKLGIGAVLKVLTTGL,,Linear,Free,Free,,L,dbAMP3,23
20399,dbAMP_20399,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=620µg/ml)&&Human colon adenocarcinoma SW480 (LD50=570µg/ml)&&Human melanoma BMKC (LD50=690µg/ml)&&Human lung carcinoma H1299 (LD50=920µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=700µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLAKLAKKL,,Linear,Free,Free,,L,dbAMP3,12
20400,dbAMP_20400,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),MPKEKVFLKIEKMGRNIRN,,Linear,Free,Free,,L,dbAMP3,19
20401,dbAMP_20401,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=80µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLAKLAKKLAKAL,,Linear,Free,Free,,L,dbAMP3,16
20402,dbAMP_20402,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>50µg/ml)&&Candida albicans ATCC 10231 (MFC=>50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=180µg/ml)&&Human colon adenocarcinoma SW480 (LD50=325µg/ml)&&Human melanoma BMKC (LD50=400µg/ml)&&Human lung carcinoma H1299 (LD50=95µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=540µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKKLLAKALKL,,Linear,Free,Free,,L,dbAMP3,12
20403,dbAMP_20403,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=35µg/ml)&&Human colon adenocarcinoma SW480 (LD50=27µg/ml)&&Human melanoma BMKC (LD50=26µg/ml)&&Human lung carcinoma H1299 (LD50=8µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=7µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=11µg/ml),FAKFLAKFLKKAL,,Linear,Free,Free,,L,dbAMP3,13
20404,dbAMP_20404,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=500µg/ml)&&Human colon adenocarcinoma SW480 (LD50=800µg/ml)&&Human melanoma BMKC (LD50=445µg/ml)&&Human lung carcinoma H1299 (LD50=470µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=660µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=640µg/ml),FAKLLFKALKKAL,,Linear,Free,Free,,L,dbAMP3,13
20410,dbAMP_20410,,Staphylococcus aureus NCTC 10788 (MIC=16-32µM)&&Staphylococcus aureus NCTC 10788 (MBC=32-64µM)&&Escherichia coli NCTC 10418 (MIC=>512µM)&&Escherichia coli NCTC 10418 (MBC=>512µM)&&Candida albicans NCYC 1467 (MIC=64-128µM)&&Candida albicans NCYC 1467 (MFC=128µM)&&Staphylococcus aureus NCTC 12493 (MIC=32-64µM)&&Staphylococcus aureus NCTC 12493 (MBC=64-128µM)&&Enterococcus faecalis NCTC 12697 (MIC=128µM)&&Enterococcus faecalis NCTC 12697 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>512µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>512µM)&&Human glioblastoma U251-MG (IC50=13.20µM)&&Human prostate adenocarcinoma LNCaP (IC50=3.79µM)&&Human lung adenocarcinoma NCI-H838 (IC50=10.03µM)&&Human lung carcinoma NCI-H460 (IC50=1.67µM)&&Human squamous lung carcinoma NCI-H157 (IC50=21.54µM)&&Human lung adenocarcinoma NCI-H23 (IC50=4.52µM),FIQHLIPLIPHAIQGIKDIF,,Linear,Free,Free,,L,dbAMP3,20
20411,dbAMP_20411,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Candida albicans ATCC 10231 (MFC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=150µg/ml)&&Human colon adenocarcinoma SW480 (LD50=180µg/ml)&&Human melanoma BMKC (LD50=115µg/ml)&&Human lung carcinoma H1299 (LD50=50µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=190µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=240µg/ml),FAKLLAKFLKKAL,,Linear,Free,Free,,L,dbAMP3,13
20424,dbAMP_20424,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=15µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=730µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKAFKKAL,,Linear,Free,Free,,L,dbAMP3,13
20425,dbAMP_20425,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=>1000µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLFAKAFKKAL,,Linear,Free,Free,,L,dbAMP3,13
20426,dbAMP_20426,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=10µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=70µg/ml)&&Human colon adenocarcinoma SW480 (LD50=115µg/ml)&&Human melanoma BMKC (LD50=135µg/ml)&&Human lung carcinoma H1299 (LD50=74µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=87µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=330µg/ml),FAKLLAKALKKFL,,Linear,Free,Free,,L,dbAMP3,13
20427,dbAMP_20427,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=25µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=15µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=54µg/ml)&&Human colon adenocarcinoma SW480 (LD50=46µg/ml)&&Human melanoma BMKC (LD50=36µg/ml)&&Human lung carcinoma H1299 (LD50=33µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=30µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=140µg/ml),FAKLLAKALKKFAL,,Linear,Free,Free,,L,dbAMP3,14
20428,dbAMP_20428,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=200µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=730µg/ml)&&Human colon adenocarcinoma SW480 (LD50=630µg/ml)&&Human melanoma BMKC (LD50=660µg/ml)&&Human lung carcinoma H1299 (LD50=620µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=810µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKLAKKFAL,,Linear,Free,Free,,L,dbAMP3,14
20429,dbAMP_20429,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>200µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Candida albicans ATCC 10231 (MFC=50µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=400µg/ml)&&Human colon adenocarcinoma SW480 (LD50=800µg/ml)&&Human melanoma BMKC (LD50=670µg/ml)&&Human lung carcinoma H1299 (LD50=460µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=830µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLFAKLAKKFAL,,Linear,Free,Free,,L,dbAMP3,14
20430,dbAMP_20430,,Escherichia coli ATCC 25922 (MBC=30µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=30µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=25µg/ml)&&Candida albicans ATCC 10231 (MFC=15µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=360µg/ml)&&Human colon adenocarcinoma SW480 (LD50=570µg/ml)&&Human melanoma BMKC (LD50=700µg/ml)&&Human lung carcinoma H1299 (LD50=830µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=780µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=800µg/ml),FKLAFKLAKKAFL,,Linear,Free,Free,,L,dbAMP3,13
20431,dbAMP_20431,,Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=615µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=635µg/ml)&&Human lung carcinoma H1299 (LD50=>1000µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=940µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=>1000µg/ml),FAKLLAKLAK,,Linear,Free,Free,,L,dbAMP3,10
20432,dbAMP_20432,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=8µg/ml)&&Candida albicans ATCC 10231 (MFC=15µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=18µg/ml)&&Human colon adenocarcinoma SW480 (LD50=9µg/ml)&&Human melanoma BMKC (LD50=10µg/ml)&&Human lung carcinoma H1299 (LD50=30µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=14µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=10µg/ml),FAKLLAKLAKKVL,,Linear,Free,Free,,L,dbAMP3,13
20433,dbAMP_20433,,Staphylococcus aureus ATCC 6538 (MIC=10µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=90µg/ml)&&Human colon adenocarcinoma SW480 (LD50=125µg/ml)&&Human melanoma BMKC (LD50=220µg/ml)&&Human lung carcinoma H1299 (LD50=76µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=220µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=145µg/ml),FAKLLAKLAKKIL,,Linear,Free,Free,,L,dbAMP3,13
20434,dbAMP_20434,,Staphylococcus aureus ATCC 6538 (MIC=15µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=10µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=40µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=54µg/ml)&&Human colon adenocarcinoma SW480 (LD50=80µg/ml)&&Human melanoma BMKC (LD50=155µg/ml)&&Human lung carcinoma H1299 (LD50=115µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=215µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=310µg/ml),FAKLWAKLAFGKGIGKVGKKLL,,Linear,Free,Free,,L,dbAMP3,22
20435,dbAMP_20435,,Staphylococcus aureus ATCC 6538 (MIC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=500µg/ml)&&Human colon adenocarcinoma SW480 (LD50=600µg/ml)&&Human melanoma BMKC (LD50=530µg/ml)&&Human lung carcinoma H1299 (LD50=450µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=400µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=900µg/ml),FAKLWAKLAKKL,,Linear,Free,Free,,L,dbAMP3,12
20436,dbAMP_20436,,Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=50µg/ml)&&Saccharomyces cerevisiae (MFC=50µg/ml)&&Escherichia coli ATCC 25922 (MBC=10µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=25µg/ml)&&Candida albicans ATCC 10231 (MFC=25µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=310µg/ml)&&Human colon adenocarcinoma SW480 (LD50=285µg/ml)&&Human melanoma BMKC (LD50=250µg/ml)&&Human lung carcinoma H1299 (LD50=225µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=275µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=350µg/ml),FALALKALKKAL,,Linear,Free,Free,,L,dbAMP3,12
20456,dbAMP_20456,,Escherichia coli JCM 5491 (MIC=128µg/ml)&&Salmonella enterica JCM 1652 (MIC=128µg/ml)&&Pseudomonas aeruginosa JCM 6119 (MIC=128µg/ml)&&Candida albicans JCM 2085 (MIC=128µg/ml)&&Xanthomonas oryzae pv. oryzae MAFF 311018 (MIC=8µg/ml)&&Clavibacter michiganensis subsp. michiganensis MAFF 301254 (MIC=16µg/ml)&&Pyricularia oryzae MAFF 101511 (MIC=128µg/ml)&&Human hepatocellular carcinoma HepG2 (95.3% Killing=32µg/ml),SLFSLIKAGAKFLGKNMLKQGPQYPACKVSKDSENVNWKS,,Linear,Free,Free,,L,dbAMP3,40
20457,dbAMP_20457,,Salmonella enterica JCM 1652 (22% Inhibition=128µg/ml)&&Pseudomonas aeruginosa JCM 6119 (22% Inhibition=128µg/ml)&&Candida albicans JCM 2085 (70% Inhibition=128µg/ml)&&Clavibacter michiganensis subsp. michiganensis MAFF 301254 (60% Inhibition=128µg/ml)&&Pyricularia oryzae MAFF 101511 (10% Inhibition=128µg/ml)&&Human hepatocellular carcinoma HepG2 (80.3% Killing=32µg/ml),GLISTIWNTASNVAGTLTDSVKCKFKKC,,Linear,Free,Free,,L,dbAMP3,28
20458,dbAMP_20458,,Pseudomonas aeruginosa JCM 6119 (22% Inhibition=128µg/ml)&&Staphylococcus aureus JCM 2874 (18% Inhibition=128µg/ml)&&Candida albicans JCM 2085 (70% Inhibition=128µg/ml)&&Xanthomonas oryzae pv. oryzae MAFF 311018 (MIC=128µg/ml)&&Clavibacter michiganensis subsp. michiganensis MAFF 301254 (MIC=16µg/ml)&&Pyricularia oryzae MAFF 101511 (MIC=128µg/ml)&&Human hepatocellular carcinoma HepG2 (50.5% Killing=32µg/ml),FIFLPIFRRPVS,,Linear,Free,Free,,L,dbAMP3,12
20482,dbAMP_20482,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Escherichia coli NCTC 10418 (MIC=16µM)&&Escherichia coli NCTC 10418 (MBC=32µM)&&Candida albicans NCTC 1467 (MIC=16µM)&&Candida albicans NCTC 1467 (MFC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=128µM)&&Staphylococcus aureus NCTC 12493 (MIC=8µM)&&Staphylococcus aureus NCTC 12493 (MBC=16µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=64µM)&&Human prostate adenocarcinoma PC-3 (IC50=5.87µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=3.47µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.37µM)&&Human colon adenocarcinoma HCT 116 (IC50=2.599µM),FALGAVTKVLPKLFCLITRKC,,Linear,Free,Free,,L,dbAMP3,21
20483,dbAMP_20483,,Staphylococcus aureus NCTC 10788 (MIC=>128µM)&&Staphylococcus aureus NCTC 10788 (MBC=>128µM)&&Escherichia coli NCTC 10418 (MIC=64µM)&&Escherichia coli NCTC 10418 (MBC=64µM)&&Candida albicans NCTC 1467 (MIC=>128µM)&&Candida albicans NCTC 1467 (MFC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>128µM)&&Staphylococcus aureus NCTC 12493 (MIC=>128µM)&&Staphylococcus aureus NCTC 12493 (MBC=>128µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>128µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>128µM)&&Human prostate adenocarcinoma PC-3 (IC50=186.9µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=214.7µM)&&Human squamous lung carcinoma NCI-H157 (IC50=278.9µM)&&Human colon adenocarcinoma HCT 116 (IC50=342.8µM),FALGAVTCLIRTKCKVLPKLF,,Linear,Free,Free,,L,dbAMP3,21
20484,dbAMP_20484,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Escherichia coli NCTC 10418 (MIC=>128µM)&&Escherichia coli NCTC 10418 (MBC=>128µM)&&Candida albicans NCTC 1467 (MIC=64µM)&&Candida albicans NCTC 1467 (MFC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>128µM)&&Staphylococcus aureus NCTC 12493 (MIC=8µM)&&Staphylococcus aureus NCTC 12493 (MBC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=>128µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=>128µM)&&Human prostate adenocarcinoma PC-3 (IC50=5.425µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=2.243µM)&&Human squamous lung carcinoma NCI-H157 (IC50=2.811µM)&&Human colon adenocarcinoma HCT 116 (IC50=3.583µM),FALGAVTKVLYKLFCLITRKC,,Linear,Free,Free,,L,dbAMP3,21
20485,dbAMP_20485,,Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Pseudomonas aeruginosa 119 (MIC=8µM)&&Pseudomonas aeruginosa 124 (MIC=8µM)&&Pseudomonas aeruginosa 86 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µM)&&Acinetobacter baumannii ATCC 19606 (MIC=64µM)&&Staphylococcus aureus ATCC 25923 (MIC=128µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=16µM)&&Human cervical carcinoma HeLa (20% Killing=256µM),XLLKRIKTLL,,Linear,Free,Free,,L,dbAMP3,10
20487,dbAMP_20487,,Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Pseudomonas aeruginosa 119 (MIC=8µM)&&Pseudomonas aeruginosa 124 (MIC=16µM)&&Pseudomonas aeruginosa 86 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=128µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>128µM)&&Staphylococcus aureus ATCC 25923 (MIC=128µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=128µM)&&Human cervical carcinoma HeLa (30% Killing=256µM),GLLKRIKXLL,,Linear,Free,Free,,L,dbAMP3,10
20493,dbAMP_20493,,Staphylococcus epidermidis NBRC 12993 (MIC=100µg/ml)&&Micrococcus luteus NBRC 3333 (MIC=25µg/ml)&&Escherichia coli NBRC 3972 (MIC=12.5µg/ml)&&Pseudomonas putida NBRC 100650 (MIC=25µg/ml)&&Aspergillus oryzae NBRC 100959 (MIC=25µg/ml)&&Candida viswanathii NBRC 10321 (MIC=25µg/ml)&&Human cervical carcinoma HeLa (10% Killing=572µg/ml),RKIKVYLPRMK,,Linear,Free,Free,,L,dbAMP3,11
20496,dbAMP_20496,,Staphylococcus epidermidis NBRC 12993 (MIC=25µg/ml)&&Micrococcus luteus NBRC 3333 (MIC=3.125µg/ml)&&Escherichia coli NBRC 3972 (MIC=6.25µg/ml)&&Aspergillus oryzae NBRC 100959 (MIC=12.5µg/ml)&&Saccharomyces cerevisiae (MIC=12.5µg/ml)&&Human cervical carcinoma HeLa (<10% Cytotoxicity=300µM),RKIKRYLRRMI,,Linear,Free,Free,,L,dbAMP3,11
20535,dbAMP_20535,,Enterococcus faecalis ATCC 29212 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µM)&&Enterococcus casseliflavus ATCC 700327 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=4µM)&&Trypanosoma cruzi (IC50=15.9µM)&&Mouse skin melanoma B16-F10 (IC50=10.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=13.7µM)&&Human cervical carcinoma HeLa (IC50=11.1µM),FIGTLIPLALGALTKLFK,,Linear,Free,Free,,L,dbAMP3,18
20658,dbAMP_20658,,Escherichia coli ATCC 25922 (MIC=6µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Enterococcus faecium ATCC 19434 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=2µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pantoea agglomerans (MIC=8µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=2µM)&&Candida albicans ATCC 90029 (MIC=4µM)&&Escherichia coli BW25113 (MIC=8µM)&&Escherichia coli BW25113 (MIC=4µM)&&Escherichia coli BW25113 del-sbmA (MIC=2µM)&&Escherichia coli BW25113 del-sbmA (MIC=2µM)&&Human chronic B cell leukemia MEC-1 (40% Killing=32µM),RRIPFWPPNLPGPRRPPWFLPDFRIPRIPRKR,,Linear,Free,Free,,L,dbAMP3,32
20659,dbAMP_20659,,Escherichia coli ATCC 25922 (MIC=6µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Enterococcus faecium ATCC 19434 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=8µM)&&Acinetobacter baumannii ATCC 19606 (MIC=4µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Pantoea agglomerans (MIC=8µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=4µM)&&Candida albicans ATCC 90029 (MIC=8µM)&&Escherichia coli BW25113 (MIC=8µM)&&Escherichia coli BW25113 (MIC=1µM)&&Escherichia coli BW25113 del-sbmA (MIC=8µM)&&Escherichia coli BW25113 del-sbmA (MIC=1µM)&&Human chronic B cell leukemia MEC-1 (80% Killing=32µM),RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR,,Linear,Free,Free,,L,dbAMP3,32
20660,dbAMP_20660,,Escherichia coli ATCC 25922 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=32µM)&&Enterococcus faecium ATCC 19434 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii ATCC 19606 (MIC=16µM)&&Acinetobacter baumannii ATCC 19606 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Pantoea agglomerans (MIC=64µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=24µM)&&Candida albicans ATCC 90029 (MIC=32µM)&&Escherichia coli BW25113 (MIC=24µM)&&Escherichia coli BW25113 (MIC=16µM)&&Escherichia coli BW25113 del-sbmA (MIC=16µM)&&Escherichia coli BW25113 (MIC=8µM)&&Human chronic B cell leukemia MEC-1 (32% Killing=32µM),RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ,,Linear,Free,Free,,L,dbAMP3,31
20671,dbAMP_20671,,Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=0.5µM)&&Enterococcus faecium ATCC 19434 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=0.5µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Pantoea agglomerans (MIC=0.5µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=1µM)&&Candida albicans ATCC 90029 (MIC=1.5µM)&&Escherichia coli BW25113 (MIC=1µM)&&Escherichia coli BW25113 (MIC=0.5µM)&&Escherichia coli BW25113 del-sbmA (MIC=2µM)&&Escherichia coli BW25113 del-sbmA (MIC=0.5µM)&&Human chronic B cell leukemia MEC-1 (95% Killing=32µM),RRIRFRPPRLPRPRPRPWIPPRFPFPRIPGKR,,Linear,Free,Free,,L,dbAMP3,32
20672,dbAMP_20672,,Escherichia coli ATCC 25922 (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=0.5µM)&&Escherichia coli BW25113 (MIC=1µM)&&Escherichia coli BW25113 (MIC=0.5µM)&&Escherichia coli BW25113 del-sbmA (MIC=1.5µM)&&Escherichia coli BW25113 del-sbmA (MIC=0.5µM)&&Enterococcus faecium ATCC 19434 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=0.5µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1µM)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Pantoea agglomerans (MIC=0.5µM)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=0.5µM)&&Candida albicans ATCC 90029 (MIC=2µM)&&Human chronic B cell leukemia MEC-1 (90% Killing=32µM),RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR,,Linear,Free,Free,,L,dbAMP3,32
20703,dbAMP_20703,,Staphylococcus aureus ATCC 12600 (MIC=31.25µM)&&Staphylococcus aureus ATCC BAA-2312 (MIC=31.25µM)&&Enterococcus faecium ATCC 19434 (MIC=62.5µM)&&Enterococcus faecalis ATCC 51299 (MIC=250µM)&&Escherichia coli ATCC 35218 (MIC=31.25µM)&&Klebsiella pneumoniae ATCC 49472 (MIC=62.5µM)&&Klebsiella pneumoniae ATCC BAA-2814 (MIC=62.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=62.5µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=62.5µM)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=6.25µM)&&Bacillus megaterium Bm11 (MIC=0.78µM)&&Escherichia coli ATCC 25922 (MIC=6.25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6.25µM)&&Candida parapsilosis ATCC 22019 (MIC=25µM)&&Human lung carcinoma A549 (LC50=35±1µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=51±16µM)&&Human colon adenocarcinoma HT29 (LC50=69±10µM),GIFDVLKNLAKGVITSLAS,,Linear,Free,Free,,L,dbAMP3,19
20704,dbAMP_20704,1BBI,Human colon adenocarcinoma HT29 (IC50=48.3±3.5µM)&&Fusarium graminearum PH-1 (MIC=10µM)&&Candida albicans DAY185 (MIC=20µM),DDESSKPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKPSEDDKEN,,Linear,Free,Free,,L,dbAMP3,71
20752,dbAMP_20752,,Pseudomonas aeruginosa ATCC 27853 (MIC=>5µg/ml)&&Listeria monocytogenes ATCC BAA-679 (MIC=>5µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=>20µg/ml)&&Zika virus (ZIKV) (IC50 I=88.05µg/ml)&&HIV-1 NL4-3 (IC50 I=80.58µg/ml)&&Human adenocarcinoma TZM-bl (IC50=40.16µg/ml),KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ,,Linear,Free,Free,,L,dbAMP3,34
20796,dbAMP_20796,,Human prostate adenocarcinoma PC-3 (IC50=42.4µM)&&Human prostate cancer DU145 (IC50=46.7µM)&&Human prostate adenocarcinoma LNCaP (IC50=41.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=39.3µM),GLFDVIKKVASVIGPLG,,Linear,Free,Free,,L,dbAMP3,17
20797,dbAMP_20797,,Human prostate adenocarcinoma PC-3 (IC50=42.6µM)&&Human prostate cancer DU145 (IC50=44.9µM)&&Human prostate adenocarcinoma LNCaP (IC50=55.1µM),GLFDVIKKVASVIGPLGIAGQGGD,,Linear,Free,Free,,L,dbAMP3,24
20799,dbAMP_20799,,Staphylococcus aureus MR (MIC=30µg/ml)&&Bacillus cereus ATCC 1015 (MIC=30µg/ml)&&Staphylococcus epidermidis ATCC 1114 (MIC=30µg/ml)&&Leuconostoc mesenteroides ATCC 1059 (MIC=10µg/ml)&&Human breast adenocarcinoma MCF-7 (30% Killing=20µg/ml)&&Human breast adenocarcinoma MCF-7 (65% Killing=30µg/ml)&&Human lung carcinoma A549 (35% Killing=20µg/ml)&&Human lung carcinoma A549 (50% Killing=30µg/ml),FLPLIGKLLSGLY,,Linear,Free,Free,,L,dbAMP3,13
20800,dbAMP_20800,,Human lung carcinoma A549 (35% Killing=50µg/ml)&&Human lung carcinoma A549 (40% Killing=100µg/ml)&&Human lung carcinoma A549 (55% Killing=200µg/ml),TTKKEELEKKKKT,,Linear,Free,Free,,L,dbAMP3,13
20801,dbAMP_20801,,Human melanoma A375 (LC50=125.0±16.8µM)&&Human Melanoma SBcl-2 (LC50=10.7±0.2µM)&&Human metastatic melanoma WM164 (LC50=20.9±3.9µM),FQWQRNIRKVRPRVKRINRQWQF,,Linear,Free,Free,,L,dbAMP3,23
20802,dbAMP_20802,,Human melanoma A375 (LC50=2.7±0.9µM)&&Human Melanoma SBcl-2 (LC50=<1µM)&&Human metastatic melanoma WM164 (LC50=4.6±0.1µM),FWRIRIRRPRRIRIRWF,,Linear,Free,Free,,L,dbAMP3,17
20803,dbAMP_20803,,Human melanoma A375 (LC50=6.3±0.3µM)&&Human Melanoma SBcl-2 (LC50=<1µM)&&Human metastatic melanoma WM164 (LC50=4.4±0.2µM),PFWRIRIRRPFWRIRIRR,,Linear,Free,Free,,L,dbAMP3,18
20804,dbAMP_20804,,Human melanoma A375 (LC50=6.6±0.3µM)&&Human Melanoma SBcl-2 (LC50=3.4±0.4µM)&&Human metastatic melanoma WM164 (LC50=5.0±0.1µM),PWRIRIRRPRRIRIWP,,Linear,Free,Free,,L,dbAMP3,16
20805,dbAMP_20805,,Human melanoma A375 (LC50=<1µM)&&Human Melanoma SBcl-2 (LC50=<1µM)&&Human metastatic melanoma WM164 (LC50=3.6±0.7µM),PWRIRIRRRRIRIRWPPWRIRIRR,,Linear,Free,Free,,L,dbAMP3,24
20806,dbAMP_20806,,Human melanoma A375 (LC50=4.8±0.4µM)&&Human Melanoma SBcl-2 (LC50=4.7±0.3µM)&&Human metastatic melanoma WM164 (LC50=3.8±0.3µM),RRWFWRRRRWFWRR,,Linear,Free,Free,,L,dbAMP3,14
20807,dbAMP_20807,,Human breast adenocarcinoma MCF-7 (IC50=12.7±2.5µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=31.1±5.1µM)&&Human myelogenous leukemia K562 (IC50=26.5±0.9µM)&&Human myelogenous leukemia K562/ADM (IC50=19.3±0.8µM)&&Human cervical carcinoma HeLa (IC50=9.8±1.5µM),VKRFKKFFRKLKKSVL,,Linear,Free,Free,,L,dbAMP3,16
20808,dbAMP_20808,,Human breast adenocarcinoma MCF-7 (IC50=10.5±1.2µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=30.2±2.4µM)&&Human myelogenous leukemia K562 (IC50=20.4±3.3µM)&&Human myelogenous leukemia K562 (IC50=20.7±1.1µM)&&Human cervical carcinoma HeLa (IC50=10.2±0.8µM),VKRFKKFFRKLKKSVLL,,Linear,Free,Free,,L,dbAMP3,17
20809,dbAMP_20809,,Human breast adenocarcinoma MCF-7 (IC50=7.0±0.2µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=10.3±0.3µM)&&Human myelogenous leukemia K562 (IC50=15.1±1.1µM)&&Human myelogenous leukemia K562/ADM (IC50=12.9±0.3µM)&&Human cervical carcinoma HeLa (IC50=6.5±0.3µM),LVKRFKKFFRKLKKSVLL,,Linear,Free,Free,,L,dbAMP3,18
20810,dbAMP_20810,,Human breast adenocarcinoma MCF-7 (IC50=16.9±2.1µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=40.6±5.1µM)&&Human myelogenous leukemia K562 (IC50=17.9±0.2µM)&&Human myelogenous leukemia K562/ADM (IC50=22.7±0.5µM)&&Human cervical carcinoma HeLa (IC50=10.7±0.5µM),VRRFRRFFRRLRRSV,,Linear,Free,Free,,L,dbAMP3,15
20811,dbAMP_20811,,Human breast adenocarcinoma MCF-7 (IC50=7.5±0.9µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=16.8±0.8µM)&&Human myelogenous leukemia K562 (IC50=20.4±0.7µM)&&Human myelogenous leukemia K562/ADM (IC50=10.5±0.7µM)&&Human cervical carcinoma HeLa (IC50=3.3±1.1µM),VRRFRRFFRRLRRSVL,,Linear,Free,Free,,L,dbAMP3,16
20812,dbAMP_20812,,Human breast adenocarcinoma MCF-7 (IC50=3.8±0.4µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=15.1±1.0µM)&&Human myelogenous leukemia K562 (IC50=8.5±1.1µM)&&Human myelogenous leukemia K562/ADM (IC50=10.3±0.3µM)&&Human cervical carcinoma HeLa (IC50=7.9±0.9µM),VRRFRRFFRRLRRSVLL,,Linear,Free,Free,,L,dbAMP3,17
20813,dbAMP_20813,,Human breast adenocarcinoma MCF-7 (IC50=5.9±0.1µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=14.3±0.2µM)&&Human myelogenous leukemia K562 (IC50=6.9±0.2µM)&&Human myelogenous leukemia K562/ADM (IC50=7.6±0.3µM)&&Human cervical carcinoma HeLa (IC50=4.2±0.8µM),LVRRFRRFFRRLRRSVLL,,Linear,Free,Free,,L,dbAMP3,18
20814,dbAMP_20814,,Human breast adenocarcinoma MCF-7 (IC50=22.5±3.3µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=65.2±4.2µM)&&Human myelogenous leukemia K562 (IC50=24.4±3.3µM)&&Human myelogenous leukemia K562/ADM (IC50=54.8±6.1µM)&&Human cervical carcinoma HeLa (IC50=15.4±0.1µM),VKRFKKFFLKLKSV,,Linear,Free,Free,,L,dbAMP3,14
20815,dbAMP_20815,,Human breast adenocarcinoma MCF-7 (IC50=31.1±2.2µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=43.6±1.1µM)&&Human myelogenous leukemia K562 (IC50=33.4±1.1µM)&&Human myelogenous leukemia K562/ADM (IC50=55.6±3.3µM)&&Human cervical carcinoma HeLa (IC50=16.5±0.4µM),VKRFKLFFRKLKSV,,Linear,Free,Free,,L,dbAMP3,14
20816,dbAMP_20816,,Human breast adenocarcinoma MCF-7 (IC50=16.2±3.8µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=21.5±2.7µM)&&Human myelogenous leukemia K562 (IC50=25.6±3.3µM)&&Human myelogenous leukemia K562/ADM (IC50=43.5±4.2µM)&&Human cervical carcinoma HeLa (IC50=13.5±1.4µM),VRRFRRFFLRLRRSV,,Linear,Free,Free,,L,dbAMP3,15
20817,dbAMP_20817,,Human breast adenocarcinoma MCF-7 (IC50=11.5±0.5µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=35.7±1.5µM)&&Human myelogenous leukemia K562 (IC50=9.46±0.5µM)&&Human myelogenous leukemia K562/ADM (IC50=23.2±1.7µM)&&Human cervical carcinoma HeLa (IC50=19.0±1.1µM),VRRFRLFFRRLRRSV,,Linear,Free,Free,,L,dbAMP3,15
20818,dbAMP_20818,,Human breast adenocarcinoma MCF-7 (IC50=1.037µM)&&Human melanoma A375 (IC50=2.607µM)&&Human glioblastoma U87-MG (IC50=3.115µM),FLFKLIKHAIKGLIKAFK,,Linear,Free,Free,,L,dbAMP3,18
20831,dbAMP_20831,,Hepatitis B virus (HBV) (EC50=12.8±2.0µM)&&Hepatitis B virus (HBV) (EC90=85.6±9.5µM)&&Human hepatocellular carcinoma HepG2.2.15 (IC50=135.4±22.3µM)&&Human hepatocellular carcinoma HepG2.2.15 (LC50=457.9±41.0µM),RRRRRRRXPTSNHSPTSCPPTCPGYRWMCLRRF,,Linear,Free,Free,,L,dbAMP3,33
20832,dbAMP_20832,,Hepatitis B virus (HBV) (EC50=2.5±1.0µM)&&Hepatitis B virus (HBV) (EC90=8.6±3.2µM)&&Human hepatocellular carcinoma HepG2.2.15 (IC50=287.5±27.1µM)&&Human hepatocellular carcinoma HepG2.2.15 (LC50=828.7±50.3µM),RRRRRRRXGSLLGRMKGA,,Linear,Free,Free,,L,dbAMP3,18
20833,dbAMP_20833,,Hepatitis B virus (HBV) (EC50=6.5±1.5µM)&&Hepatitis B virus (HBV) (EC90=41.4±8.7µM)&&Human hepatocellular carcinoma HepG2 (IC50=152.2±24.1µM)&&Human hepatocellular carcinoma HepG2 (LC50=515.9±43.8µM),RRRRRRRXPLSPPLRNTHPQAMQWNSTTF,,Linear,Free,Free,,L,dbAMP3,29
20834,dbAMP_20834,,Hepatitis B virus (HBV) (EC50=3.0±1.0µM)&&Hepatitis B virus (HBV) (EC90=10.9±3.4µM)&&Human hepatocellular carcinoma HepG2.2.15 (IC50=556.8±43.0µM),RRRRRRRXLDPAFR,,Linear,Free,Free,,L,dbAMP3,14
20835,dbAMP_20835,,HIV-1 IIIB (IC50 I=6.22±0.75µM)&&HIV-1 IIIB (IC90 I=23.83±1.74µM)&&HIV-1 RF (IC50 I=4.29±0.42µM)&&HIV-1 RF (IC90 I=9.86±2.08µM)&&HIV-1 BaL (IC50 I=6.47±0.85µM)&&HIV-1 BaL (IC90 I=15.46±3.71µM)&&HIV-1 A17 (IC50 I=10.55±1.56µM)&&HIV-1 A17 (IC90 I=38.46±0.62µM)&&HIV-1 92UG029 (IC50 I=13.85±1.34µM)&&HIV-1 92UG029 (IC90 I=36.51±19.39µM)&&HIV-1 93BR020 (IC50 I=6.60±1.60µM)&&HIV-1 93BR020 (IC90 I=17.27±2.72µM)&&HIV-1 RU570 (IC50 I=9.79±2.49µM)&&HIV-1 RU570 (IC90 I=39.97±9.65µM)&&Human T cell leukemia MT-2 (50% Cytotoxicity=>135µM),ITFXDLLXYYGP,,Linear,Free,Free,,L,dbAMP3,12
20843,dbAMP_20843,,Candida albicans SC5314 (MIC=>256µg/ml)&&Candida glabrata CBS 138 (MIC=>256µg/ml)&&Cryptococcus neoformans var. grubii H99 (MIC=>256µg/ml)&&Cryptococcus deuterogattii R265 (MIC=>256µg/ml)&&Human lung carcinoma A549 (<5% Cytotoxicity=8µg/ml),LLCLDGTRKPVTEAQSCHLAVAPNHAVVSR,,Linear,Free,Free,,L,dbAMP3,30
20876,dbAMP_20876,,Human lung carcinoma A549 (EC50=9±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=5.7±0.7µM),KIFKKFKTIIKKVWRIFGRF,,Linear,Free,Free,,L,dbAMP3,20
20877,dbAMP_20877,,Human lung carcinoma A549 (EC50=49±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=27.4±0.5µM),RVFKKFHPIYHRVWRLWGHL,,Linear,Free,Free,,L,dbAMP3,20
20878,dbAMP_20878,,Human lung carcinoma A549 (EC50=17.0±0.6µM)&&Human breast adenocarcinoma MCF-7 (EC50=10±2µM),HIIKKIRTWYRKAWHVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20879,dbAMP_20879,,Human lung carcinoma A549 (EC50=14±3µM)&&Human breast adenocarcinoma MCF-7 (EC50=10±1µM),KLYKKFRHILKKVWHYVGKI,,Linear,Free,Free,,L,dbAMP3,20
20880,dbAMP_20880,,Human lung carcinoma A549 (EC50=15.0±0.1µM)&&Human breast adenocarcinoma MCF-7 (EC50=11±2µM),KYIRHLKTWFKKVFKLIGEV,,Linear,Free,Free,,L,dbAMP3,20
20881,dbAMP_20881,,Human lung carcinoma A549 (EC50=17.4±0.1µM)&&Human breast adenocarcinoma MCF-7 (EC50=12.4±0.4µM),KIFKKFKDFLKKIFQYLGKV,,Linear,Free,Free,,L,dbAMP3,20
20883,dbAMP_20883,,Human lung carcinoma A549 (EC50=18±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=12±3µM),HIFKKVKTYWKKLFRILGRF,,Linear,Free,Free,,L,dbAMP3,20
20884,dbAMP_20884,,Human lung carcinoma A549 (EC50=52±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=39±3µM),RLIKRLKTFVRKTWKWVGHF,,Linear,Free,Free,,L,dbAMP3,20
20885,dbAMP_20885,,Human lung carcinoma A549 (EC50=17±4µM)&&Human breast adenocarcinoma MCF-7 (EC50=11.9±0.1µM),RFLKHFKTVYKRYWKVLGRL,,Linear,Free,Free,,L,dbAMP3,20
20886,dbAMP_20886,,Human lung carcinoma A549 (EC50=22±4µM)&&Human breast adenocarcinoma MCF-7 (EC50=18.9±0.2µM),KLIHRLKTVFKKVWHFLGHL,,Linear,Free,Free,,L,dbAMP3,20
20887,dbAMP_20887,,Human lung carcinoma A549 (EC50=83±11µM)&&Human breast adenocarcinoma MCF-7 (EC50=56±5µM),HRIRQLKTTIKKFWEIWPKI,,Linear,Free,Free,,L,dbAMP3,20
20888,dbAMP_20888,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=91±2µM),QVFKKFRPFYRRPWELFGKL,,Linear,Free,Free,,L,dbAMP3,20
20889,dbAMP_20889,,Human lung carcinoma A549 (EC50=20±1µM)&&Human breast adenocarcinoma MCF-7 (EC50=11.6±0.8µM),QIIKKIRTWYRKAWHVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20890,dbAMP_20890,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=65±3µM),TLYKKFRHFLKKPWHVVGKI,,Linear,Free,Free,,L,dbAMP3,20
20891,dbAMP_20891,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=>100µM),HYIRHLKTWFHKPFKLIGKV,,Linear,Free,Free,,L,dbAMP3,20
20892,dbAMP_20892,,Human lung carcinoma A549 (EC50=14.8±0.7µM)&&Human breast adenocarcinoma MCF-7 (EC50=10.4±0.8µM),KIFKKFKDWFKKAFHVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20893,dbAMP_20893,,Human lung carcinoma A549 (EC50=12.4±0.1µM)&&Human breast adenocarcinoma MCF-7 (EC50=9.3±0.2µM),QIFKKVKTWYKKAFQILGRL,,Linear,Free,Free,,L,dbAMP3,20
20894,dbAMP_20894,,Human lung carcinoma A549 (EC50=15±1µM)&&Human breast adenocarcinoma MCF-7 (EC50=11.2±0.7µM),RLIKRIKTWYRKAWKVVGKF,,Linear,Free,Free,,L,dbAMP3,20
20895,dbAMP_20895,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=>100µM),RFLKHLHTYYERAWHVIGHL,,Linear,Free,Free,,L,dbAMP3,20
20896,dbAMP_20896,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=>100µM),HLIHRLHTYWHKPWHYLGKL,,Linear,Free,Free,,L,dbAMP3,20
20897,dbAMP_20897,,Human lung carcinoma A549 (EC50=40±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=28.6±0.1µM),QRIRQLHTWIKKAWHIWPKI,,Linear,Free,Free,,L,dbAMP3,20
20898,dbAMP_20898,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=76±15µM),QVVKKIRTWYHKAWHVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20899,dbAMP_20899,,Human lung carcinoma A549 (EC50=20±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=13±1µM),QLIHKIRTWYRKAWHVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20900,dbAMP_20900,,Human lung carcinoma A549 (EC50=9±1µM)&&Human breast adenocarcinoma MCF-7 (EC50=7±1µM),HLLKKWRTWLRKAWHIVGKV,,Linear,Free,Free,,L,dbAMP3,20
20901,dbAMP_20901,,Human lung carcinoma A549 (EC50=>100µM)&&Human breast adenocarcinoma MCF-7 (EC50=68±5µM),QVLKKVRTWYRKAFHVIGKV,,Linear,Free,Free,,L,dbAMP3,20
20902,dbAMP_20902,,Human lung carcinoma A549 (EC50=29.3±0.9µM)&&Human breast adenocarcinoma MCF-7 (EC50=16±2µM),QLLKKVRTWYRKAWHLYGKV,,Linear,Free,Free,,L,dbAMP3,20
20903,dbAMP_20903,,Human lung carcinoma A549 (EC50=10.6±0.8µM)&&Human breast adenocarcinoma MCF-7 (EC50=6.5±0.2µM),QLIKKLRTWYRKAWHVLGKL,,Linear,Free,Free,,L,dbAMP3,20
20904,dbAMP_20904,,Human lung carcinoma A549 (EC50=12±2µM)&&Human breast adenocarcinoma MCF-7 (EC50=8±1µM),QIIKKVRTWIKKAWHLIGKI,,Linear,Free,Free,,L,dbAMP3,20
20905,dbAMP_20905,,Human lung carcinoma A549 (EC50=16.5±0.2µM)&&Human breast adenocarcinoma MCF-7 (EC50=11.0±0.2µM),QYLRRVRTWLRRAWHILGKV,,Linear,Free,Free,,L,dbAMP3,20
20906,dbAMP_20906,,Human lung carcinoma A549 (EC50=28±3µM)&&Human breast adenocarcinoma MCF-7 (EC50=13±1µM),QLLKKIRTWYRKAWHVYGKV,,Linear,Free,Free,,L,dbAMP3,20
20907,dbAMP_20907,,Human lung carcinoma A549 (EC50=36±7µM)&&Human breast adenocarcinoma MCF-7 (EC50=16.9±0.8µM),QIYKKYRTWYRKAWKVLGKV,,Linear,Free,Free,,L,dbAMP3,20
20908,dbAMP_20908,,Human lung carcinoma A549 (EC50=8.3±2.0µM)&&Human breast adenocarcinoma MCF-7 (EC50=4.4±1.3µM),FLWIKLGKLAGAVLKLILGLKKVV,,Linear,Free,Free,,L,dbAMP3,24
20909,dbAMP_20909,,Human lung carcinoma A549 (EC50=18.4±0.7µM)&&Human breast adenocarcinoma MCF-7 (EC50=7.0±0.5µM),KWVKKVHNWLRRWIKVFEALFG,,Linear,Free,Free,,L,dbAMP3,22
20910,dbAMP_20910,,Human lung carcinoma A549 (EC50=>50µM)&&Human breast adenocarcinoma MCF-7 (EC50=19.0±1.8µM),AWLKRIKKFLKALFWVWVW,,Linear,Free,Free,,L,dbAMP3,19
20923,dbAMP_20923,,Bacillus subtilis 168 (MIC=<0.6µM)&&Staphylococcus aureus USA 300 (MIC=7µM)&&Staphylococcus aureus NRS 72 (MIC=5µM)&&Pseudomonas aeruginosa PAO1 (MIC=20µM)&&Escherichia coli DH5alpha (MIC=10µM)&&Mycobacterium tuberculosis H37Ra (MIC=20µM)&&Human lung carcinoma A549 (IC50=11.9µM)&&Human epithelial carcinoma OVCAR-3 (IC50=8.6µM)&&Human ovarian cancer NCI/ADR-RES (IC50=14µM)&&Human bladder carcinoma T24 (IC50=15.3µM),LWKRWVGVWRKWL,,Linear,Free,Free,,L,dbAMP3,13
20924,dbAMP_20924,,Bacillus subtilis 168 (MIC=>80µM)&&Staphylococcus aureus USA 300 (MIC=>80µM)&&Staphylococcus aureus NRS 72 (MIC=>80µM)&&Pseudomonas aeruginosa PAO1 (MIC=>80µM)&&Escherichia coli DH5alpha (MIC=>80µM)&&Mycobacterium tuberculosis H37Ra (MIC=>80µM)&&Human lung carcinoma A549 (IC50=>100µM)&&Human epithelial carcinoma OVCAR-3 (IC50=>100µM)&&Human ovarian cancer NCI/ADR-RES (IC50=>100µM)&&Human bladder carcinoma T24 (IC50=>100µM),RWGKWFKKNSHLS,,Linear,Free,Free,,L,dbAMP3,13
20925,dbAMP_20925,,Escherichia coli ML-35p (MIC=4µM)&&Acinetobacter baumannii 7226/16 (MIC=8µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=4-8µM)&&Pseudomonas aeruginosa 522/17 (MIC=16µM)&&Escherichia coli ESBL 521/17 (MIC=8µM)&&Staphylococcus aureus 1399/17 (MIC=4-8µM)&&Staphylococcus aureus SG511 (MIC=0.5µM)&&Staphylococcus aureus ATCC 33591 (MIC=8µM)&&Human myelogenous leukemia K562 (IC50=20±3.4µM)&&Human histiocytic lymphoma U-937 (IC50=3.2±0.4µM),RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL,,Linear,Free,Free,,L,dbAMP3,30
20926,dbAMP_20926,,Escherichia coli ML-35p (MIC=4µM)&&Acinetobacter baumannii 7226/16 (MIC=8-16µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=8µM)&&Pseudomonas aeruginosa 522/17 (MIC=16µM)&&Escherichia coli ESBL 521/17 (MIC=4µM)&&Staphylococcus aureus 1399/17 (MIC=8µM)&&Staphylococcus aureus SG511 (MIC=0.5µM)&&Staphylococcus aureus ATCC 33591 (MIC=8µM)&&Human myelogenous leukemia K562 (IC50=13.7±2.3µM)&&Human histiocytic lymphoma U-937 (IC50=4.1±0.3µM),RFRLPFRRPWPIRIHPPPFYPWPFRRFL,,Linear,Free,Free,,L,dbAMP3,28
20927,dbAMP_20927,,Escherichia coli ML-35p (MIC=4µM)&&Acinetobacter baumannii 7226/16 (MIC=8µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=2µM)&&Pseudomonas aeruginosa 522/17 (MIC=8-16µM)&&Escherichia coli ESBL 521/17 (MIC=2µM)&&Staphylococcus aureus 1399/17 (MIC=4µM)&&Staphylococcus aureus SG511 (MIC=0.5µM)&&Staphylococcus aureus ATCC 33591 (MIC=16µM)&&Human myelogenous leukemia K562 (IC50=25±3.5µM)&&Human histiocytic lymphoma U-937 (IC50=11.5±0.5µM),RFRLPFRRPPIRIPPPFYPPFRRFL,,Linear,Free,Free,,L,dbAMP3,25
20928,dbAMP_20928,,Escherichia coli ML-35p (MIC=64µM)&&Acinetobacter baumannii 7226/16 (MIC=32µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=64µM)&&Pseudomonas aeruginosa 522/17 (MIC=128µM)&&Escherichia coli ESBL 521/17 (MIC=32µM)&&Staphylococcus aureus 1399/17 (MIC=32µM)&&Staphylococcus aureus SG511 (MIC=8µM)&&Staphylococcus aureus ATCC 33591 (MIC=64-128µM)&&Human myelogenous leukemia K562 (IC50=39.4±2.3µM)&&Human histiocytic lymphoma U-937 (IC50=17±1.1µM),RIHPPPFYPPFRRFL,,Linear,Free,Free,,L,dbAMP3,15
20929,dbAMP_20929,,Escherichia coli ML-35p (MIC=4µM)&&Acinetobacter baumannii 7226/16 (MIC=16µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=8µM)&&Pseudomonas aeruginosa 522/17 (MIC=64µM)&&Escherichia coli ESBL 521/17 (MIC=4µM)&&Staphylococcus aureus 1399/17 (MIC=32µM)&&Staphylococcus aureus SG511 (MIC=4µM)&&Staphylococcus aureus ATCC 33591 (MIC=64µM)&&Human myelogenous leukemia K562 (IC50=28±6.5µM)&&Human histiocytic lymphoma U-937 (IC50=>64µM),RFRLPFRRPPIRIHPPPFY,,Linear,Free,Free,,L,dbAMP3,19
20930,dbAMP_20930,,Escherichia coli ML-35p (MIC=8µM)&&Acinetobacter baumannii 7226/16 (MIC=16µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=16µM)&&Pseudomonas aeruginosa 522/17 (MIC=64µM)&&Escherichia coli ESBL 521/17 (MIC=16µM)&&Staphylococcus aureus 1399/17 (MIC=128µM)&&Staphylococcus aureus SG511 (MIC=2µM)&&Staphylococcus aureus ATCC 33591 (MIC=16µM)&&Human myelogenous leukemia K562 (IC50=33.6±4.1µM)&&Human histiocytic lymphoma U-937 (IC50=>64µM),RFRLPFRRPPIRIH,,Linear,Free,Free,,L,dbAMP3,14
20931,dbAMP_20931,,Escherichia coli ML-35p (MIC=1µM)&&Acinetobacter baumannii 7226/16 (MIC=8µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=8µM)&&Pseudomonas aeruginosa 522/17 (MIC=16µM)&&Escherichia coli ESBL 521/17 (MIC=2µM)&&Staphylococcus aureus 1399/17 (MIC=4µM)&&Staphylococcus aureus SG511 (MIC=0.5µM)&&Staphylococcus aureus ATCC 33591 (MIC=8µM)&&Human myelogenous leukemia K562 (IC50=39.4±6.6µM)&&Human histiocytic lymphoma U-937 (IC50=>64µM)&&Escherichia coli ML-35p (MIC=3.1µM)&&Escherichia coli ESBL 521/17 (MIC=6.2µM)&&Acinetobacter baumannii 7226/16 (MIC=12.5µM)&&Pseudomonas aeruginosa 522/17 (MIC=16µM)&&Klebsiella pneumoniae ESBL 344/17 (MIC=6.2µM)&&Staphylococcus aureus 1399/17 (MIC=6.2µM),RFRRFRLPFRRPPIRIH,,Linear,Free,Free,,L,dbAMP3,17
21049,dbAMP_21049,,Staphylococcus aureus SH1000 (MIC=3.3µM)&&Staphylococcus aureus ATCC 43300 (MIC=>20µM)&&Escherichia coli ATCC 25922 (MIC=>20µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>20µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>20µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>20µM)&&Candida albicans ATCC 90028 (MIC=>20µM)&&Cryptococcus neoformans ATCC 208821 (MIC=>20µM)&&Human breast adenocarcinoma MCF-7 (EC50=12±1µM),GLFDIVKKVLKLLK,,Linear,Free,Free,,L,dbAMP3,14
21117,dbAMP_21117,,Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans ATCC 10231 (MIC=4µg/ml)&&Candida glabrata ATCC 15126 (MIC=4µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=2µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=2µg/ml)&&Human cervical carcinoma HeLa (IC50=17.9±2.1µg/ml),CKKKKC,,Linear,Free,Free,,L,dbAMP3,6
21120,dbAMP_21120,,Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans ATCC 10231 (MIC=16µg/ml)&&Candida glabrata ATCC 15126 (MIC=32µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=1µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=2µg/ml)&&Human cervical carcinoma HeLa (IC50=3±0.6µg/ml),KRKK,,Linear,Free,Free,,L,dbAMP3,4
21121,dbAMP_21121,,Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=256µg/ml)&&Candida albicans ATCC 10231 (MIC=2µg/ml)&&Candida glabrata ATCC 15126 (MIC=4µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=1µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=2µg/ml)&&Human cervical carcinoma HeLa (IC50=27.5±3.4µg/ml),CKRKKC,,Linear,Free,Free,,L,dbAMP3,6
21122,dbAMP_21122,,Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µg/ml)&&Candida albicans ATCC 10231 (MIC=32µg/ml)&&Candida glabrata ATCC 15126 (MIC=16µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=8µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=3±0.4µg/ml),RRKK,,Linear,Free,Free,,L,dbAMP3,4
21123,dbAMP_21123,,Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=256µg/ml)&&Candida albicans ATCC 10231 (MIC=16µg/ml)&&Candida glabrata ATCC 15126 (MIC=4µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=4µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=4µg/ml)&&Human cervical carcinoma HeLa (IC50=20.9±2.1µg/ml),CRRKKC,,Linear,Free,Free,,L,dbAMP3,6
21137,dbAMP_21137,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM),FTILKKLKSFIK,,Linear,Free,Free,,L,dbAMP3,12
21138,dbAMP_21138,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=4µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=200µM),KLVKKLLKKYITF,,Linear,Free,Free,,L,dbAMP3,13
21139,dbAMP_21139,,Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Acinetobacter baumannii (MIC=8µM)&&Human lung carcinoma A549 (50% Cytotoxicity=12.5µM)&&Human colon adenocarcinoma Caco-2 (50% Cytotoxicity=25µM),LARFVLRILKYGFK,,Linear,Free,Free,,L,dbAMP3,14
21140,dbAMP_21140,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM),IPLLRKGKKIIWW,,Linear,Free,Free,,L,dbAMP3,13
21141,dbAMP_21141,,Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=16µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii (MIC=32µM)&&Human lung carcinoma A549 (50% Cytotoxicity=50µM),GLKKVIKLLRPLL,,Linear,Free,Free,,L,dbAMP3,13
21142,dbAMP_21142,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=200µM),ILKPKLWKLTVVARKIIK,,Linear,Free,Free,,L,dbAMP3,18
21143,dbAMP_21143,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>64µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM),IVIKSLGKFLKNVGGFAG,,Linear,Free,Free,,L,dbAMP3,18
21144,dbAMP_21144,,Pseudomonas aeruginosa ATCC 9027 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Escherichia coli ATCC 25922 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Acinetobacter baumannii (MIC=64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=25µM)&&Human colon adenocarcinoma Caco-2 (50% Cytotoxicity=12.5µM),FKLVWKLLKKLALKL,,Linear,Free,Free,,L,dbAMP3,15
21145,dbAMP_21145,,Staphylococcus aureus ATCC 25923 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Acinetobacter baumannii (MIC=32µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM),ITKWLLNAIKKGFKL,,Linear,Free,Free,,L,dbAMP3,15
21146,dbAMP_21146,,Pseudomonas aeruginosa ATCC 9027 (MIC=>64µM)&&Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Acinetobacter baumannii (MIC=64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM),IHKLVKLWLNLGKKF,,Linear,Free,Free,,L,dbAMP3,15
21147,dbAMP_21147,,Staphylococcus aureus ATCC 25923 (MIC=>64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>64µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Acinetobacter baumannii (MIC=>64µM)&&Human lung carcinoma A549 (50% Cytotoxicity=>200µM)&&Human colon adenocarcinoma Caco-2 (50% Cytotoxicity=>200µM),LFSIIWKLNRKLIKA,,Linear,Free,Free,,L,dbAMP3,15
21151,dbAMP_21151,,Staphylococcus aureus ATCC BAA-1683 (MIC=125µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=125µg/ml)&&Escherichia coli (MIC=500µg/ml)&&Human cervical carcinoma HeLa (18% Killing=100µg/ml)&&Human lung carcinoma A549 (23% Killing=100µg/ml),EKKRLLKWWR,,Linear,Free,Free,,L,dbAMP3,10
21152,dbAMP_21152,,Staphylococcus aureus ATCC BAA-1683 (MIC=62.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=31.25µg/ml)&&Escherichia coli (MIC=250µg/ml)&&Human cervical carcinoma HeLa (20% Killing=100µg/ml)&&Human lung carcinoma A549 (20% Killing=100µg/ml),KWWKLLRKKR,,Linear,Free,Free,,L,dbAMP3,10
21159,dbAMP_21159,,Human breast adenocarcinoma MCF-7 (IC50=30.8±3.4µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=36.1±6.7µM)&&Human myelogenous leukemia K562 (IC50=33.6±4.2µM)&&Human myelogenous leukemia K562/ADM (IC50=39.6±5.7µM),KKLFKKILKYLKK,,Linear,Free,Free,,L,dbAMP3,13
21160,dbAMP_21160,,Human breast adenocarcinoma MCF-7 (IC50=25.3±3.2µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=28.4±3.1µM)&&Human myelogenous leukemia K562 (IC50=47.4±12.5µM)&&Human myelogenous leukemia K562/ADM (IC50=>100µM),KKLFKKILKYLKKL,,Linear,Free,Free,,L,dbAMP3,14
21161,dbAMP_21161,,Human breast adenocarcinoma MCF-7 (IC50=5.9±0.2µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=6.3±0.4µM)&&Human myelogenous leukemia K562 (IC50=6.6±0.5µM)&&Human myelogenous leukemia K562/ADM (IC50=7.7±0.4µM),LKKLFKKILKYL,,Linear,Free,Free,,L,dbAMP3,12
21162,dbAMP_21162,,Human breast adenocarcinoma MCF-7 (IC50=27.3±2.4µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=28.2±2.7µM)&&Human myelogenous leukemia K562 (IC50=26.5±1.5µM)&&Human myelogenous leukemia K562/ADM (IC50=28.3±2.3µM),LKKLFKKILKYLK,,Linear,Free,Free,,L,dbAMP3,13
21163,dbAMP_21163,,Human breast adenocarcinoma MCF-7 (IC50=18.4±1.5µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=20.7±1.6µM)&&Human myelogenous leukemia K562 (IC50=19.2±2.3µM)&&Human myelogenous leukemia K562/ADM (IC50=22.7±2.3µM),LKKLFKKILKYLKK,,Linear,Free,Free,,L,dbAMP3,14
21164,dbAMP_21164,,Human breast adenocarcinoma MCF-7 (IC50=77.3±5.6µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=97.3±11.4µM)&&Human myelogenous leukemia K562 (IC50=73.7±6.1µM)&&Human myelogenous leukemia K562/ADM (IC50=>100µM),KKLFKKILKY,,Linear,Free,Free,,L,dbAMP3,10
21165,dbAMP_21165,,Human breast adenocarcinoma MCF-7 (IC50=7.6±1.4µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=10.9±1.2µM)&&Human myelogenous leukemia K562 (IC50=7.7±1.2µM)&&Human myelogenous leukemia K562/ADM (IC50=8.1±0.9µM),LKKLFKKILKY,,Linear,Free,Free,,L,dbAMP3,11
21166,dbAMP_21166,,Human breast adenocarcinoma MCF-7 (IC50=38.3±2.5µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=30.6±5.7µM)&&Human myelogenous leukemia K562 (IC50=60.7±5.4µM)&&Human myelogenous leukemia K562/ADM (IC50=83.7±5.3µM),KLKKLFKKILKY,,Linear,Free,Free,,L,dbAMP3,12
21171,dbAMP_21171,,Klebsiella aerogenes ATCC 13048 (MIC=>256µM)&&Klebsiella aerogenes ATCC 13048 (MBC=>256µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>256µM)&&Klebsiella pneumoniae ATCC 700603 (MBC=>256µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.5µM)&&Staphylococcus aureus ATCC 29213 (MBC=6.5µM)&&Micrococcus luteus ATCC 14452 (MIC=7.5µM)&&Micrococcus luteus ATCC 14452 (MBC=14µM)&&Listeria monocytogenes ATCC 7611 (MIC=8µM)&&Listeria monocytogenes ATCC 7611 (MBC=15.5µM)&&Lacticaseibacillus casei ATCC 334 (MIC=>256µM)&&Lacticaseibacillus casei ATCC 334 (MBC=>256µM)&&Saccharomyces cerevisiae ATCC 204508 (MIC=32µM)&&Saccharomyces cerevisiae ATCC 204508 (MBC=64µM)&&Pichia pastoris GS115 (MIC=16µM)&&Pichia pastoris GS115 (MBC=32µM)&&Human colon adenocarcinoma HCT 116 (IC50=40.83µM)&&Human gastric cancer MGC-803 (IC50=31.55µM)&&Human nasopharyngeal carcinoma C666-1 (IC50=18.27µM)&&Murine macrophage cells RAW 264.7 (<5% Killing=64µM)&&Murine macrophage cells RAW 264.7 (12% Killing=128µM)&&Murine macrophage cells RAW 264.7 (28% Killing=256µM),AFALIAGALYRIFHRR,,Linear,Free,Free,,L,dbAMP3,16
21179,dbAMP_21179,6M56,SARS-CoV-2 (IC50 I=0.9µg/ml)&&MERS-CoV (IC50 I=2.2µg/ml)&&SARS-CoV (IC50 I=4.2µg/ml)&&Human Influenza A Virus H1N1 (IC50 I=0.6µg/ml)&&Human Influenza A Virus H7N9 (IC50 I=0.9µg/ml)&&Human rhinovirus (HRV) (IC50 I=5.7µg/ml)&&Human parainfluenza virus 3 ( HPIV3) (IC50 I=>25µg/ml)&&Human lung carcinoma A549 (50% Cytotoxicity=>300µg/ml),NGAICWGPCPTAFRQIGNCGRFRVRCCRIR,,Linear,Free,Free,,L,dbAMP3,30
21186,dbAMP_21186,,Staphylococcus aureus NCTC 10788 (MIC=4µM)&&Staphylococcus aureus NCTC 10788 (MBC=8µM)&&Staphylococcus aureus ATCC 6538 (MIC=2µM)&&Staphylococcus aureus ATCC 6538 (MBC=4µM)&&Staphylococcus aureus (MIC=8µM)&&Staphylococcus aureus (MBC=16µM)&&Staphylococcus aureus ATCC 12493 (MIC=4µM)&&Staphylococcus aureus ATCC 12493 (MBC=8µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Escherichia coli NCTC 10418 (MIC=32µM)&&Escherichia coli NCTC 10418 (MBC=64µM)&&Escherichia coli ATCC BAA-2340 (MIC=64µM)&&Escherichia coli ATCC BAA-2340 (MBC=128µM)&&Escherichia coli ATCC 8739 (MIC=128µM)&&Escherichia coli ATCC 8739 (MBC=256µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=128µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=256µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=>512µM)&&Pseudomonas aeruginosa (MIC=>512µM)&&Pseudomonas aeruginosa (MBC=>512µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=128µM)&&Klebsiella pneumoniae ATCC BAA-1705 (MIC=256µM)&&Klebsiella pneumoniae ATCC BAA-1705 (MBC=512µM)&&Klebsiella pneumoniae ATCC BAA-2342 (MIC=128µM)&&Klebsiella pneumoniae ATCC BAA-2342 (MBC=256µM)&&Candida albicans NCYC 1467 (MIC=8µM)&&Candida albicans NCYC 1467 (MBC=16µM)&&Human breast adenocarcinoma MCF-7 (IC50=14.4µM)&&Human squamous lung carcinoma NCI-H157 (IC50=6.41µM)&&Human glioblastoma U251-MG (IC50=7.22µM),FLSLIPKIAGGIAALVKNL,,Linear,Free,Free,,L,dbAMP3,19
21188,dbAMP_21188,,Escherichia coli ATCC 25922 (MIC=250µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=250µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=>250µg/ml)&&Candida albicans FRR 5580 (MIC=125µg/ml)&&Escherichia coli ATCC 25922 (MIC=>250µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>250µg/ml)&&Human cervical carcinoma HeLa (IC50=32µg/ml),FPVTWRWWKWWKGKFPVTWRWWKWWKG,,Linear,Free,Free,,L,dbAMP3,27
21189,dbAMP_21189,,Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µg/ml)&&Candida albicans FRR 5580 (MIC=250µg/ml)&&Human cervical carcinoma HeLa (IC50=250µg/ml),RRRRWRWWRWWRR,,Linear,Free,Free,,L,dbAMP3,13
21190,dbAMP_21190,,Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans FRR 5580 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=>=250µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>=250µg/ml)&&Human cervical carcinoma HeLa (IC50=>250µg/ml),RWWKWW,,Linear,Free,Free,,L,dbAMP3,6
21191,dbAMP_21191,,Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans FRR 5580 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MIC=>=250µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>=250µg/ml)&&Human cervical carcinoma HeLa (IC50=>250µg/ml),RWWKWWK,,Linear,Free,Free,,L,dbAMP3,7
21192,dbAMP_21192,,Escherichia coli ATCC 25922 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=32µg/ml)&&Candida albicans FRR 5580 (MIC=64µg/ml)&&Human cervical carcinoma HeLa (IC50=250µg/ml),WRWWKWWK,,Linear,Free,Free,,L,dbAMP3,8
21228,dbAMP_21228,,Escherichia coli CMCC 44102 (MIC=37.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Shigella flexneri ATCC 12022 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa CMCC 10104 (MIC=18.75µg/ml)&&Vibrio parahaemolyticus (MIC=18.75µg/ml)&&Klebsiella pneumoniae (MIC=9.38µg/ml)&&Acinetobacter baumannii (MIC=>100µg/ml)&&Vibrio harveyi (MIC=9.38µg/ml)&&Vibrio splendidus (MIC=9.38µg/ml)&&Aeromonas sobria (MIC=37.5µg/ml)&&Vibrio alginolyticus (MIC=>100µg/ml)&&Vibrio vulnificus (MIC=>100µg/ml)&&Aeromonas hydrophila (MIC=>100µg/ml)&&Staphylococcus aureus CMCC 26003 (MIC=18.75µg/ml)&&Bacillus subtilis CMCC 63501 (MIC=37.5µg/ml)&&Clostridium perfringens ATCC 13124 (MIC=18.75µg/ml)&&Bacillus cereus CMCC 63301 (MIC=>100µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=>100µg/ml)&&Staphylococcus epidermidis (MIC=>100µg/ml)&&Enterococcus faecium (MIC=>100µg/ml)&&Candida albicans CMCC 98001 (MIC=>100µg/ml)&&Candida albicans 1 (MIC=>100µg/ml)&&Candida glabrata (MIC=>100µg/ml)&&Mouse skin melanoma B16-F10 (55.9% Killing=200µg/ml),KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,,Linear,Free,Free,,L,dbAMP3,34
21229,dbAMP_21229,,Escherichia coli CMCC 44102 (MIC=18.75µg/ml)&&Escherichia coli ATCC 25922 (MIC=9.38µg/ml)&&Shigella flexneri ATCC 12022 (MIC=18.75µg/ml)&&Pseudomonas aeruginosa CMCC 10104 (MIC=>100µg/ml)&&Vibrio parahaemolyticus (MIC=9.38µg/ml)&&Klebsiella pneumoniae (MIC=>100µg/ml)&&Acinetobacter baumannii (MIC=>100µg/ml)&&Vibrio harveyi (MIC=75µg/ml)&&Vibrio splendidus (MIC=75µg/ml)&&Aeromonas sobria (MIC=>100µg/ml)&&Vibrio alginolyticus (MIC=>100µg/ml)&&Vibrio vulnificus (MIC=>100µg/ml)&&Aeromonas hydrophila (MIC=37.5µg/ml)&&Staphylococcus aureus CMCC 26003 (MIC=9.38µg/ml)&&Bacillus subtilis CMCC 63501 (MIC=37.5µg/ml)&&Clostridium perfringens ATCC 13124 (MIC=37.5µg/ml)&&Bacillus cereus CMCC 63301 (MIC=>100µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=>100µg/ml)&&Staphylococcus epidermidis (MIC=>100µg/ml)&&Enterococcus faecium (MIC=>100µg/ml)&&Candida albicans CMCC 98001 (MIC=>100µg/ml)&&Candida albicans 1 (MIC=>100µg/ml)&&Candida glabrata (MIC=>100µg/ml)&&Mouse skin melanoma B16-F10 (33.1% Killing=200µg/ml),EGCNILCLLKRKVKAVKNVVKNVVKSVVG,,Linear,Free,Free,,L,dbAMP3,29
21234,dbAMP_21234,7JGX,Bacillus megaterium ATCC 13632 (MIC=32-64µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=32-128µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=>128µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>=128µg/ml)&&Staphylococcus aureus VRSA1 (MIC=>128µg/ml)&&Streptococcus pneumoniae ATCC 700677 (MIC=>128µg/ml)&&Enterococcus faecium ATCC 35667 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=>256µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=>256µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=>256µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µg/ml)&&Candida albicans ATCC 90028 (MIC=>128µg/ml)&&Candida tropicalis ATCC 750 (MIC=>128µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=16-32µg/ml)&&Human skin melanoma MM96L (50% Killing=>32µM)&&Human colon adenocarcinoma HCT 116 (50% Killing=>32µM),IFWLFRGKADVAL,,Linear,Free,Free,,L,dbAMP3,13
21235,dbAMP_21235,7JHF,Bacillus megaterium ATCC 13632 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=16µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=16µg/ml)&&Staphylococcus aureus VRSA1 (MIC=16µg/ml)&&Streptococcus pneumoniae ATCC 700677 (MIC=32µg/ml)&&Enterococcus faecium ATCC 35667 (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MIC=128µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=256µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=128µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>256µg/ml)&&Candida albicans ATCC 90028 (MIC=>128µg/ml)&&Candida tropicalis ATCC 750 (MIC=32µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=32µg/ml)&&Human skin melanoma MM96L (50% Killing=16±1.2µM)&&Human colon adenocarcinoma HCT 116 (50% Killing=9.8±1.2µM),IFGTILGFLKGL,,Linear,Free,Free,,L,dbAMP3,12
21244,dbAMP_21244,,Escherichia coli (MIC=1.67µg/ml)&&Salmonella enterica (MIC=6.5µg/ml)&&Staphylococcus aureus (MIC=3.3µg/ml)&&Bacillus subtilis (MIC=4.2µg/ml)&&Staphylococcus aureus (MIC=8.3µg/ml)&&Human gastric cancer SGC-7901 (IC50=37µg/ml),V,,Linear,Free,Free,,L,dbAMP3,1
21314,dbAMP_21314,,Bacillus subtilis ATCC 6633 (LC=120µM)&&Staphylococcus aureus 42D (LC=>120µM)&&Escherichia coli ML-35 (LC=>120µM)&&Jurkat T-cell leukemia (IC50=12.3µM),CVRRFPWWWPFLRRC,,Linear,Free,Free,,L,dbAMP3,15
21317,dbAMP_21317,,Human skin melanoma MM96L (IC50=5.4±0.3µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=5.7±0.4µM)&&Human breast adenocarcinoma MCF-7 (IC50=16.0±0.5µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=15.9±2.3µM)&&Human myelogenous leukemia K562 (IC50=8.2±0.4µM),GARELRRLERELRRLEGGGGGGGKLAALKFKLLWLKLAC,,Linear,Free,Free,,L,dbAMP3,39
21318,dbAMP_21318,,Human skin melanoma MM96L (IC50=>64µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>32µM)&&Human breast adenocarcinoma MCF-7 (IC50=>64µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>64µM)&&Human myelogenous leukemia K562 (IC50=36.7±1.9µM),GARELRRLERELRRLEGGGGGGGKLAALKAKLLWLKLAC,,Linear,Free,Free,,L,dbAMP3,39
21319,dbAMP_21319,,Human skin melanoma MM96L (IC50=5.3±0.5µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=7.1±0.6µM),GARELRRLERELRRLEKGGGGGGKLAALKFKLLWLKLAC,,Linear,Free,Free,,L,dbAMP3,39
21320,dbAMP_21320,,Human skin melanoma MM96L (IC50=>64µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=>64µM)&&Human breast adenocarcinoma MCF-7 (IC50=>64µM)&&Human myelogenous leukemia K562 (IC50=>64µM),GARELRRLERELRRLEKGGGGGGKLAALTFEHYWAQLTSC,,Linear,Free,Free,,L,dbAMP3,40
21328,dbAMP_21328,,Human metastatic melanoma WM164 (50% Cell death=4.3±0.3µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=3.5±0.4µM)&&Human myelogenous leukemia K562 (50% Cell death=2.5±0.1µM)&&Human cervical carcinoma HeLa (50% Cell death=13.4±1.9µM),KWCFKVCYKGICYKKCKG,,Linear,Free,Free,,L,dbAMP3,18
21329,dbAMP_21329,,Human skin melanoma MM96L (50% Cell death=2.0±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=3.0±0.2µM)&&Human metastatic melanoma WM164 (50% Cell death=3.9±0.2µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=18.9±0.9µM)&&Human myelogenous leukemia K562 (50% Cell death=2.7±0.2µM)&&Human cervical carcinoma HeLa (50% Cell death=22.5±2.1µM),KSCFRVCYRGICYRRCRG,,Linear,Free,Free,,L,dbAMP3,18
21330,dbAMP_21330,,Human skin melanoma MM96L (50% Cell death=>32µM)&&Human malignant melanoma HT-144 (50% Cell death=>64µM)&&Human metastatic melanoma WM164 (50% Cell death=>32µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=>32µM)&&Human myelogenous leukemia K562 (50% Cell death=>32µM)&&Human cervical carcinoma HeLa (50% Cell death=>32µM),KWCFRVCSRGSCYRRCRG,,Linear,Free,Free,,L,dbAMP3,18
21331,dbAMP_21331,,Human skin melanoma MM96L (50% Cell death=17.3±1.0µM)&&Human malignant melanoma HT-144 (50% Cell death=27.8±2.2µM)&&Human metastatic melanoma WM164 (50% Cell death=28.2±2.0µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=>64µM)&&Human myelogenous leukemia K562 (50% Cell death=13.2±0.9µM)&&Human breast adenocarcinoma MCF-7 (50% Cell death=>32µM)&&Human cervical carcinoma HeLa (50% Cell death=>32µM),KWCSRVCYRGICSRRCRG,,Linear,Free,Free,,L,dbAMP3,18
21332,dbAMP_21332,,Human breast adenocarcinoma MDA-MB-435S (50% Cell death=5.3±0.6µM),KWCFRVCYSGICYRRCRG,,Linear,Free,Free,,L,dbAMP3,18
21334,dbAMP_21334,,Human skin melanoma MM96L (50% Cell death=1.7±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=2.3±0.2µM)&&Human metastatic melanoma WM164 (50% Cell death=2.7±0.1µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=3.5±0.3µM)&&Human cervical carcinoma HeLa (50% Cell death=7.5±0.3µM),KWCFRVCYRGICYSRCRG,,Linear,Free,Free,,L,dbAMP3,18
21335,dbAMP_21335,,Human skin melanoma MM96L (50% Cell death=1.8±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=1.2±0.1µM)&&Human metastatic melanoma WM164 (50% Cell death=1.8±0.1µM)&&Human breast adenocarcinoma MDA-MB-435S (50% Cell death=4.5±0.3µM)&&Human cervical carcinoma HeLa (50% Cell death=12.2±0.4µM),KWCFRVCYRGICYRRCSG,,Linear,Free,Free,,L,dbAMP3,18
21336,dbAMP_21336,,Human malignant melanoma HT-144 (50% Cell death=11.8±0.9µM)&&Human metastatic melanoma WM164 (50% Cell death=11.1±0.9µM)&&Human myelogenous leukemia K562 (50% Cell death=4.8±0.3µM),KWCFRVCYSGICYSRCSG,,Linear,Free,Free,,L,dbAMP3,18
21337,dbAMP_21337,,Human skin melanoma MM96L (50% Cell death=1.0±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=3.2±0.1µM)&&Human metastatic melanoma WM164 (50% Cell death=2.7±0.2µM)&&Human myelogenous leukemia K562 (50% Cell death=1.7±0.1µM)&&Human cervical carcinoma HeLa (50% Cell death=6.7±1.1µM),KWCFRVCYRGICYRRCRK,,Linear,Free,Free,,L,dbAMP3,18
21338,dbAMP_21338,,Human skin melanoma MM96L (50% Cell death=1.3±0.1µM)&&Human malignant melanoma HT-144 (50% Cell death=3.2±0.1µM)&&Human metastatic melanoma WM164 (50% Cell death=2.9±0.2µM)&&Human myelogenous leukemia K562 (50% Cell death=1.9±0.1µM)&&Human cervical carcinoma HeLa (50% Cell death=5.1±0.3µM),KWCFRVCYRGFCYRRCRK,,Linear,Free,Free,,L,dbAMP3,18
21345,dbAMP_21345,,Mycobacterium tuberculosis H37Rv (MIC=0.02µM)&&Mycobacterium tuberculosis H37Rv (MBC=0.4µM)&&Mycobacterium tuberculosis ATCC 35838 (MIC=0.038µM)&&Mycobacterium tuberculosis ATCC 35822 (MIC=<0.004µM)&&Mycobacterium tuberculosis ATCC 35820 (MIC=0.078µM)&&Mycobacterium tuberculosis ATCC 35827 (MIC=0.005µM)&&Mycobacterium tuberculosis ATCC 35826 (MIC=<0.004µM)&&Mycobacterium smegmatis ATCC 700084 (MIC=0.073µM)&&Mycobacterium abscessus ATCC 19977 (MIC=0.42µM)&&Mycobacterium abscessus ATCC 19977 (MBC=1.2µM)&&Mycobacterium chelonae subsp. chelonae ATCC 35752 (MIC=4.24µM)&&Mycobacterium marinum ATCC 927 (MIC=<0.02µM)&&Mycobacterium bovis ATCC 35734 (MIC=<0.02µM)&&Mycobacterium kansasii ATCC 12478 (MIC=0.04µM)&&Mycobacterium avium ATCC 15769 (MIC=1.75µM)&&Escherichia coli ATCC 25922 (MIC=>10µM)&&Staphylococcus aureus ATCC 29213 (MIC=>10µM)&&Candida albicans ATCC 10231 (MIC=>10µM)&&Human breast adenocarcinoma MDA-MB-435 (IC50=12µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=7.7µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=14µM),XXXAXLX,,Linear,Free,Free,,L,dbAMP3,7
21393,dbAMP_21393,,Bacillus cereus (MIC=25µg/ml)&&Escherichia coli (MIC=50µg/ml)&&Leuconostoc lactis (MIC=3µg/ml)&&Listeria innocua (MIC=12µg/ml)&&Micrococcus luteus (MIC=6µg/ml)&&Pasteurella multocida (MIC=100µg/ml)&&Staphylococcus aureus (MIC=12µg/ml)&&Staphylococcus epidermidis (MIC=6µg/ml)&&Streptococcus uberis (MIC=25µg/ml)&&Human lung carcinoma A549 (IC50=4.8±1.8µM)&&Human cervical carcinoma HeLa (IC50=2.2±0.3µM),GLFAVIKKVASVIKGL,,Linear,Free,Free,,L,dbAMP3,16
21439,dbAMP_21439,,Staphylococcus aureus SA113 (MIC=32µg/ml)&&Staphylococcus aureus SA113 (MIC=>256µg/ml)&&Staphylococcus aureus SA113 (MBC=256µg/ml)&&Staphylococcus aureus SA113 (MBC=>256µg/ml)&&Staphylococcus aureus Del-mprF (MIC=0.5µg/ml)&&Staphylococcus aureus Del-mprF (MIC=1µg/ml)&&Staphylococcus aureus Del-mprF (MBC=4µg/ml)&&Staphylococcus aureus Del-mprF (MBC=8µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MIC=0.5µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MIC=4µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MBC=2µg/ml)&&Staphylococcus aureus Del-mprFpRBsyn (MBC=8µg/ml)&&Staphylococcus aureus (MIC=64µg/ml)&&Staphylococcus aureus (MIC=32µg/ml)&&Staphylococcus aureus (MBC=128µg/ml)&&Staphylococcus aureus (MBC=128µg/ml)&&Escherichia coli ML-35p (MIC=1µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli M15 (MIC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1-2µM)&&Listeria monocytogenes EGD (MIC=2µM)&&Staphylococcus aureus 710A (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 33591 (MIC=2µM)&&Staphylococcus aureus (MIC=4µM)&&Staphylococcus intermedius (MIC=4µM)&&Pseudomonas aeruginosa (MIC=2-4µM)&&Acinetobacter baumannii (MIC=1µM)&&Human myelogenous leukemia K562 (IC50=7.7µM),KWCVYAYVKVKGVLVKYKKCW,,Linear,Free,Free,,L,dbAMP3,21
21489,dbAMP_21489,,Human lung carcinoma A549 (IC50=>100µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=>100µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=>100µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=>100µg/ml)&&Escherichia coli DH5alpha (MIC=>100µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=>100µg/ml),LLAGLAANFLPTIICKISYKC,,Linear,Free,Free,,L,dbAMP3,21
21490,dbAMP_21490,,Human lung carcinoma A549 (IC50=>100µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=>100µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=>100µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=>100µg/ml)&&Escherichia coli DH5alpha (MIC=>100µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=>100µg/ml),FAGLAANFLPTIICKISYKC,,Linear,Free,Free,,L,dbAMP3,20
21491,dbAMP_21491,,Human lung carcinoma A549 (IC50=13.71±2.12µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=18.63±0.99µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=18.18±3.31µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=18.10±2.13µg/ml)&&Escherichia coli DH5alpha (MIC=50µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=100µg/ml),FLKLLKKLAAKFLPTIICKISYKC,,Linear,Free,Free,,L,dbAMP3,24
21492,dbAMP_21492,,Human lung carcinoma A549 (IC50=9.09±3.95µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=5.43±0.15µg/ml)&&Escherichia coli DH5alpha (MIC=3.125µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=25µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=25µg/ml),FLKLLKKLAAKFL,,Linear,Free,Free,,L,dbAMP3,13
21493,dbAMP_21493,,Human lung carcinoma A549 (IC50=13.94±3.96µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=13.27±4.27µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=15.07±1.59µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=17.56±6.23µg/ml)&&Escherichia coli DH5alpha (MIC=6.25µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=25µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=25µg/ml),FLKLLKKLAAKLF,,Linear,Free,Free,,L,dbAMP3,13
21494,dbAMP_21494,,Human lung carcinoma A549 (IC50=8.01±1.32µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=5.01±0.42µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=5.40±0.91µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=5.25±0.63µg/ml)&&Escherichia coli DH5alpha (MIC=>100µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=25µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=9µg/ml)&&Micrococcus luteus ATCC 4698 (MIC=3µg/ml)&&Escherichia coli DH5alpha (MIC=140µg/ml)&&Human lung carcinoma A549 (IC50=9±1µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MBC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=4µM)&&Staphylococcus aureus ATCC 29213 (MBC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=2µM)&&Staphylococcus aureus ATCC 43300 (MIC=4µM)&&Staphylococcus aureus ATCC 43300 (MBC=8µM)&&Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=2µM)&&Micrococcus luteus ATCC 10420 (MIC=2µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM)&&Human pancreatic carcinoma Panc-1 (IC50=11µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM),FLGALFKALSKLL,,Linear,Free,Free,,L,dbAMP3,13
21495,dbAMP_21495,,Human lung carcinoma A549 (IC50=24.58±3.24µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=28.90±5.19µg/ml)&&Human hepatocellular carcinoma Hep 3B (IC50=30.79±3.11µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=32.23±9.12µg/ml)&&Escherichia coli DH5alpha (MIC=100µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=50µg/ml),FLKLLAGLLKNFA,,Linear,Free,Free,,L,dbAMP3,13
21499,dbAMP_21499,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Candida albicans ATCC 900280 (MIC=16µM)&&Human hepatocellular carcinoma HepG2 (LC50=40µM),XFLGTLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21500,dbAMP_21500,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Candida albicans ATCC 900280 (MIC=16µM)&&Human hepatocellular carcinoma HepG2 (LC50=55µM),HXLGTLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21501,dbAMP_21501,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Candida albicans ATCC 900280 (MIC=16µM)&&Human hepatocellular carcinoma HepG2 (LC50=40µM),HFXGTLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21502,dbAMP_21502,,Escherichia coli ATCC 25726 (MIC=64µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Candida albicans ATCC 900280 (MIC=8µM)&&Human hepatocellular carcinoma HepG2 (LC50=25µM),HFLXTLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21503,dbAMP_21503,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Candida albicans ATCC 900280 (MIC=8µM)&&Human hepatocellular carcinoma HepG2 (LC50=40µM),HFLGXLVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21504,dbAMP_21504,,Escherichia coli ATCC 25726 (MIC=128µM)&&Staphylococcus aureus ATCC 25923 (MIC=128µM)&&Candida albicans ATCC 900280 (MIC=64µM)&&Human hepatocellular carcinoma HepG2 (LC50=>200µM),HFLGTXVNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21505,dbAMP_21505,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Candida albicans ATCC 900280 (MIC=16µM)&&Human hepatocellular carcinoma HepG2 (LC50=22µM),HFLGTLXNLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21506,dbAMP_21506,,Escherichia coli ATCC 25726 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Candida albicans ATCC 900280 (MIC=8µM)&&Human hepatocellular carcinoma HepG2 (LC50=10µM),HFLGTLVXLAKKIL,,Linear,Free,Free,,L,dbAMP3,14
21507,dbAMP_21507,,Escherichia coli ATCC 25726 (MIC=32µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Candida albicans ATCC 900280 (MIC=8µM)&&Human hepatocellular carcinoma HepG2 (LC50=10µM),HFLGTLVNLXKKIL,,Linear,Free,Free,,L,dbAMP3,14
21508,dbAMP_21508,,Escherichia coli ATCC 25726 (MIC=64µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Candida albicans ATCC 900280 (MIC=64µM)&&Human hepatocellular carcinoma HepG2 (LC50=130µM),HFLGTLVNLAKKIX,,Linear,Free,Free,,L,dbAMP3,14
21547,dbAMP_21547,,Staphylococcus aureus ATCC 6538 (MIC=25µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=240µg/ml)&&Human colon adenocarcinoma SW480 (LD50=440µg/ml)&&Human melanoma BMKC (LD50=600µg/ml)&&Human lung carcinoma H1299 (LD50=370µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=302µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=570µg/ml),WALAL,,Linear,Free,Free,,L,dbAMP3,5
21587,dbAMP_21587,,Human glioblastoma U251-MG (IC50=45.21µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GYPICGESCVGGICNIPGCSCSWPVCTTN,,Linear,Free,Free,,L,dbAMP3,29
21588,dbAMP_21588,,Human glioblastoma U251-MG (IC50=46.96µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPICGETCVGGTCNTPGCFCTWPVCTRN,,Linear,Free,Free,,L,dbAMP3,29
21589,dbAMP_21589,,Human glioblastoma U251-MG (IC50=51.65µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPVCGETCFTGSCYTPGCSCNWPVCNRN,,Linear,Free,Free,,L,dbAMP3,29
21590,dbAMP_21590,,Human glioblastoma U251-MG (IC50=54.39µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPVCGETCVGGTCNTPGCSCSWPVCFRN,,Linear,Free,Free,,L,dbAMP3,29
21591,dbAMP_21591,,Human glioblastoma U251-MG (IC50=6.31µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=2.74µg/ml)&&Human lung carcinoma A549 (IC50=3.58µg/ml)&&Human prostate cancer DU145 (IC50=3.44µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=5.36µg/ml),GTLPCGESCVWIPCISSVVGCACKSKVCYKD,,Linear,Free,Free,,L,dbAMP3,31
21654,dbAMP_21654,,Pseudomonas aeruginosa PAO1 (MIC=125µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=250µg/ml)&&Pseudomonas aeruginosa PAK (MIC=250µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=500µg/ml)&&Pseudomonas aeruginosa M2 (MIC=250µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=125µg/ml)&&Human lung carcinoma A549 (IC50=53.1±0.06µM)&&Human melanoma A375 (IC50=58.7±0.08µM)&&Human breast adenocarcinoma MCF-7 (IC50=62.3±0.08µM)&&Human colon adenocarcinoma SW1116 (IC50=>83.6µM)&&Human rhabdomyosarcoma (IC50=>83.6µM)&&Human lung carcinoma H1299 (IC50=14.0±0.02µM)&&Mouse skin melanoma B16 (IC50=62.6±0.07µM)&&Human cervical carcinoma HeLa (IC50=58.6±0.07µM)&&Staphylococcus aureus ATCC 25923 (MIC=>125µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=125µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Human gastric cancer SGC-7901 (IC50=78.87µM),KWKSFAKTFKSAKKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
21780,dbAMP_21780,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Inhibition=40µM),KKKKKFLLLQ,,Linear,Free,Free,,L,dbAMP3,10
21782,dbAMP_21782,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KKKKLFKLLQ,,Linear,Free,Free,,L,dbAMP3,10
21783,dbAMP_21783,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KKKLKFKLLQ,,Linear,Free,Free,,L,dbAMP3,10
21784,dbAMP_21784,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KKLKKFKLLQ,,Linear,Free,Free,,L,dbAMP3,10
21785,dbAMP_21785,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((4±0.11)% Growth inhibition=40µM),KLKKKFKLLQ,,Linear,Free,Free,,L,dbAMP3,10
21786,dbAMP_21786,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),LKKKKFKLLQ,,Linear,Free,Free,,L,dbAMP3,10
21787,dbAMP_21787,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((4±0.07)% Growth inhibition=40µM),KKKKLFLKLQ,,Linear,Free,Free,,L,dbAMP3,10
21788,dbAMP_21788,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((2±0.08)% Growth inhibition=40µM),KKKLKFLKLQ,,Linear,Free,Free,,L,dbAMP3,10
21789,dbAMP_21789,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((22±0.08)% Growth inhibition=40µM),KKLKKFLKLQ,,Linear,Free,Free,,L,dbAMP3,10
21790,dbAMP_21790,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((14±0.05)% Growth inhibition=40µM),KLKKKFLKLQ,,Linear,Free,Free,,L,dbAMP3,10
21792,dbAMP_21792,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((13±0.05)% Growth inhibition=40µM),LKKKKFLKLQ,,Linear,Free,Free,,L,dbAMP3,10
21793,dbAMP_21793,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((9±0.11)% Growth inhibition=40µM),KKKLLFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21794,dbAMP_21794,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((25±0.03)% Growth inhibition=40µM),KKLKLFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21795,dbAMP_21795,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((27±0.11)% Growth inhibition=40µM),KLKKLFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21796,dbAMP_21796,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((8±0.21)% Growth inhibition=40µM),LKKKLFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21797,dbAMP_21797,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((6±0.10)% Growth inhibition=40µM),KKKKLFLLKQ,,Linear,Free,Free,,L,dbAMP3,10
21798,dbAMP_21798,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((23±0.08)% Growth inhibition=40µM),KKKLKFLLKQ,,Linear,Free,Free,,L,dbAMP3,10
21799,dbAMP_21799,,Pseudomonas syringae pv. syringae EPS 94 (MIC=3.1-6.2µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (11±0.08% Inhibition=40µM),KKLKKFLLKQ,,Linear,Free,Free,,L,dbAMP3,10
21802,dbAMP_21802,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (17±0.10% Inhibition =40µM),KLKKKFLLKQ,,Linear,Free,Free,,L,dbAMP3,10
21803,dbAMP_21803,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((9±0.09)% Growth inhibition=40µM),LKKKKFLLKQ,,Linear,Free,Free,,L,dbAMP3,10
21804,dbAMP_21804,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((14±0.15)% Growth inhibition=40µM),KKKLLFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21805,dbAMP_21805,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((9±0.06)% Growth inhibition =40µM),KKLKLFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21817,dbAMP_21817,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((17±0.05)% Growth inhibition=40µM),KLKKLFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21818,dbAMP_21818,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 (5±0.24% Inhibition=40µM),LKKKLFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21820,dbAMP_21820,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (19±0.01% Inhibition=40µM),KKLLKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21821,dbAMP_21821,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (12±0.02% Inhibition=40µM),LKKLKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21835,dbAMP_21835,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (7±0.08% Inhibition=40µM),KLLKKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21836,dbAMP_21836,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (4±0.07% Inhibition=40µM),LKLKKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21840,dbAMP_21840,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (8±0.03% Inhibition=40µM),LLKKKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
21841,dbAMP_21841,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (22±0.06% Inhibition=40µM),KKKLLFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21842,dbAMP_21842,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (15±0.20% Inhibition=40µM),KKLKLFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21843,dbAMP_21843,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (18±0.18% Inhibition=40µM),KLKKLFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21845,dbAMP_21845,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (3±0.15% Inhibition=40µM),LKKKLFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21846,dbAMP_21846,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((29±0.05)% Growth inhibition=40µM),KKLLKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21847,dbAMP_21847,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KLKLKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21848,dbAMP_21848,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),LKKLKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21849,dbAMP_21849,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KLLKKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21856,dbAMP_21856,,Pseudomonas syringae pv. syringae EPS 94 (MIC=3.1-6.2µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=50-75µM)&&Human breast adenocarcinoma MDA-MB-231 ((7±0.17)% Growth inhibition=40µM),LKLKKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21857,dbAMP_21857,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=75-100µM)&&Human breast adenocarcinoma MDA-MB-231 ((12±0.19)% Growth inhibition=40µM),LLKKKFLKKQ,,Linear,Free,Free,,L,dbAMP3,10
21858,dbAMP_21858,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=25-50µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((19±0.09)% Growth inhibition=40µM),KKLLLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21859,dbAMP_21859,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((11±0.22)% Growth inhibition=40µM),KLKLLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21860,dbAMP_21860,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),LKKLLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21861,dbAMP_21861,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((28±0.05)% Growth inhibition=40µM),KLLKLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21862,dbAMP_21862,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((1±0.26)% Growth inhibition=40µM),LKLKLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21863,dbAMP_21863,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5 µM)&&Erwinia amylovora PMV 6076 (MIC=50-75µM)&&Human breast adenocarcinoma MDA-MB-231 ((2±0.13)% Growth inhibition=40µM),LLKKLFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21864,dbAMP_21864,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((20±0.26)% Growth inhibition=40µM),KLLLKFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21865,dbAMP_21865,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((16±0.31)% Growth inhibition=40µM),LKLLKFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21866,dbAMP_21866,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((16±0.15)% Growth inhibition=40µM),LLKLKFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21867,dbAMP_21867,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((5±0.24)% Growth inhibition=40µM),LLLKKFKKKQ,,Linear,Free,Free,,L,dbAMP3,10
21868,dbAMP_21868,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=1.6-3.1µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((50±0.10)% Growth inhibition=40µM)&&Human pancreatic carcinoma Panc-1 (IC50=32.5±11µM)&&Human epidermoid carcinoma A431 (IC50=28.0±3µM)&&Human cervical carcinoma HeLa (IC50=22.5±0µM)&&Human hepatocellular carcinoma HepG2 (IC50=32.5±4µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=31.2±5µM),KKLLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21869,dbAMP_21869,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((23±0.17)% Growth inhibition=40µM),KLKLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21870,dbAMP_21870,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((13±0.08)% Growth inhibition=40µM),LKKLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21871,dbAMP_21871,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((95±0.01)% Growth inhibition=40µM)&&Human pancreatic carcinoma Panc-1 (IC50=18.5±8µM)&&Human epidermoid carcinoma A431 (IC50=21.5±8µM)&&Human cervical carcinoma HeLa (IC50=23.0±3µM)&&Human hepatocellular carcinoma HepG2 (IC50=20.5±6µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=22.0±0µM),KLLKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21872,dbAMP_21872,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((59±0.08)% Growth inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=40.0±7µM)&&Human cervical carcinoma HeLa (IC50=24.5±0.7µM)&&Human hepatocellular carcinoma HepG2 (IC50=34.5±2µM)&&Human epidermoid carcinoma A431 (IC50=35.0±7µM)&&Human pancreatic carcinoma Panc-1 (IC50=51.0±6µM),LKLKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21873,dbAMP_21873,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=1.6-3.1µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((60±0.07)% Growth inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=40.7±3µM)&&Human cervical carcinoma HeLa (IC50=38.5±4µM)&&Human hepatocellular carcinoma HepG2 (IC50=44.0±3µM)&&Human epidermoid carcinoma A431 (IC50=47.5±4µM)&&Human pancreatic carcinoma Panc-1 (IC50=44.5±0.7µM),LLKKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21875,dbAMP_21875,,Candida albicans TIMM 1768 (MIC=20µM)&&Trichosporon beigelii KCTC 7707 (MIC=10µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=10µM)&&Jurkat cancer cells (IC50=19µM)&&Human gastric carcinoma SNU 601 (IC50=28µM),RIIDLLWRVWRPQKPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21876,dbAMP_21876,,Candida albicans TIMM 1768 (MIC=10-20µM)&&Trichosporon beigelii KCTC 7707 (MIC=10µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=10µM)&&Jurkat cancer cells (IC50=20µM)&&Human gastric carcinoma SNU 601 (IC50=30µM),RIIDLLWRVRRPWKPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21877,dbAMP_21877,,Candida albicans TIMM 1768 (MIC=10-20µM)&&Trichosporon beigelii KCTC 7707 (MIC=10-20µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=10-20µM)&&Jurkat cancer cells (IC50=29µM)&&Human gastric carcinoma SNU 601 (IC50=39µM),RIIDLLWRVRRPQWPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21878,dbAMP_21878,,Candida albicans TIMM 1768 (MIC=10µM)&&Trichosporon beigelii KCTC 7707 (MIC=20µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=10-20µM)&&Jurkat cancer cells (IC50=23µM)&&Human gastric carcinoma SNU 601 (IC50=37µM),RIIDLLWRVRRPWWPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21879,dbAMP_21879,,Candida albicans TIMM 1768 (MIC=10µM)&&Trichosporon beigelii KCTC 7707 (MIC=20µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=20µM)&&Jurkat cancer cells (IC50=16µM)&&Human gastric carcinoma SNU 601 (IC50=21µM),RIIDLLWRVWRPWKPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21880,dbAMP_21880,,Candida albicans TIMM 1768 (MIC=2.5-5µM)&&Trichosporon beigelii KCTC 7707 (MIC=5-10µM)&&Saccharomyces cerevisiae KCTC 7296 (MIC=2.5-5µg/ml)&&Jurkat cancer cells (IC50=11µM)&&Human gastric carcinoma SNU 601 (IC50=10µM),RIIDLLWRVWRPWWPKFVTVWVR,,Linear,Free,Free,,L,dbAMP3,23
21881,dbAMP_21881,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=50-75µM)&&Human breast adenocarcinoma MDA-MB-231 ((88±0.01)% Growth inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=32.2±7µM)&&Human cervical carcinoma HeLa (IC50=30.5±12µM)&&Human hepatocellular carcinoma HepG2 (IC50=42.2±2µM)&&Human epidermoid carcinoma A431 (IC50=24.5±0.7µM)&&Human pancreatic carcinoma Panc-1 (IC50=41.5±11µM),KLLLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21882,dbAMP_21882,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((22±0.09)% Growth inhibition=40µM),KKKLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21883,dbAMP_21883,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((14±0.01)% Growth inhibition=40µM),LLLKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21885,dbAMP_21885,,Pseudomonas syringae pv. syringae EPS 94 (MIC=6.2-12.5µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),LKKKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21886,dbAMP_21886,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=25-50µM)&&Human breast adenocarcinoma MDA-MB-231 ((20±0.05)% Growth inhibition=40µM),LKLLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21887,dbAMP_21887,,Pseudomonas syringae pv. syringae EPS 94 (MIC=3.1-6.2µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=6.2-12.5µM)&&Human breast adenocarcinoma MDA-MB-231 (70±0.01% inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=32.5±0.5µM)&&Human cervical carcinoma HeLa (IC50=29.5±2µM)&&Human hepatocellular carcinoma HepG2 (IC50=46.0±3µM)&&Human epidermoid carcinoma A431 (IC50=50.0±10µM)&&Human pancreatic carcinoma Panc-1 (IC50=40.0±3µM)&&Fusarium oxysporum f. sp. lycopersici ATCC 201829 (MIC=<3.1µM)&&Penicillium expansum EPS 26 (MIC=>50µM),KKLKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21888,dbAMP_21888,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((18±0.09)% Growth inhibition=40µM),LLKLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21889,dbAMP_21889,,Pseudomonas syringae pv. syringae EPS 94 (MIC=3.1-6.2µM)&&Xanthomonas vesicatoria 2133-2 (MIC=3.1-6.2µM)&&Erwinia amylovora PMV 6076 (MIC=12.5-25µM)&&Human breast adenocarcinoma MDA-MB-231 ((56±0.06)% Growth inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=53.2±13µM)&&Human cervical carcinoma HeLa (IC50=35.0±1µM)&&Human hepatocellular carcinoma HepG2 (IC50=>60µM)&&Human epidermoid carcinoma A431 (IC50=49.5±6µM)&&Human pancreatic carcinoma Panc-1 (IC50=57.5±6µM),KLKKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21891,dbAMP_21891,,Pseudomonas syringae pv. syringae EPS 94 (MIC=25-50µM)&&Xanthomonas vesicatoria 2133-2 (MIC=12.5-25µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((11±0.27)% Growth inhibition=40µM),LLLLKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21892,dbAMP_21892,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 ((63±0.02)% Growth inhibition=40µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=40.5±9µM)&&Human cervical carcinoma HeLa (IC50=54.0±6µM)&&Human hepatocellular carcinoma HepG2 (IC50=46.0±8µM)&&Human epidermoid carcinoma A431 (IC50=35.5±2µM)&&Human pancreatic carcinoma Panc-1 (IC50=43.5±0.7µM),KKKKKFKKLQ,,Linear,Free,Free,,L,dbAMP3,10
21894,dbAMP_21894,,Escherichia coli KCTC 1682 (MIC=3.12µM)&&Salmonella typhimurium KCTC 1926 (MIC=1.56µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=0.78µM)&&Bacillus subtilis KCTC 1918 (MIC=3.12µM)&&Streptococcus pyogenes KCTC 3096 (MIC=3.12µM)&&Staphylococcus aureus KCTC 1621 (MIC=1.56µM)&&Candida albicans TIMM 1768 (MIC=6.25µM)&&Aspergillus fumigatus KCTC 4165 (MIC=12.5µM)&&Human lung carcinoma A549 (IC50=25µM)&&Human myelogenous leukemia K562 (IC50=34µM)&&Jurkat cells E6-1 (IC50=20µM),GKKLKKIGQKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,18
21895,dbAMP_21895,,Escherichia coli KCTC 1682 (MIC=12.5µM)&&Salmonella typhimurium KCTC 1926 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.12µM)&&Bacillus subtilis KCTC 1918 (MIC=12.5µM)&&Streptococcus pyogenes KCTC 3096 (MIC=25.0µM)&&Staphylococcus aureus KCTC 1621 (MIC=12.5µM)&&Candida albicans TIMM 1768 (MIC=25.0µM)&&Aspergillus fumigatus KCTC 4165 (MIC=25.0µM)&&Human lung carcinoma A549 (IC50=88µM)&&Human myelogenous leukemia K562 (IC50=85µM)&&Jurkat cells E6-1 (IC50=66µM),GEKLKKIGKKIKNFFQKL,,Linear,Free,Free,,L,dbAMP3,18
21896,dbAMP_21896,,Escherichia coli KCTC 1682 (MIC=25.0µM)&&Salmonella typhimurium KCTC 1926 (MIC=12.5µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=6.25µM)&&Bacillus subtilis KCTC 1918 (MIC=25.0µM)&&Streptococcus pyogenes KCTC 3096 (MIC=25.0µM)&&Staphylococcus aureus KCTC 1621 (MIC=25.0µM)&&Candida albicans TIMM 1768 (MIC=50µM)&&Aspergillus fumigatus KCTC 4165 (MIC=25.0µM)&&Human lung carcinoma A549 (IC50=93µM)&&Human myelogenous leukemia K562 (IC50=100µM)&&Jurkat cells E6-1 (IC50=78µM),GEKLKKIGQKIKKFFQKL,,Linear,Free,Free,,L,dbAMP3,18
21897,dbAMP_21897,,Escherichia coli KCTC 1682 (MIC=6.25µM)&&Salmonella typhimurium KCTC 1926 (MIC=6.25µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=3.12µM)&&Bacillus subtilis KCTC 1918 (MIC=6.25µM)&&Streptococcus pyogenes KCTC 3096 (MIC=12.5µM)&&Staphylococcus aureus KCTC 1621 (MIC=6.25µM)&&Candida albicans TIMM 1768 (MIC=25.0µM)&&Aspergillus fumigatus KCTC 4165 (MIC=25.0µM)&&Human lung carcinoma A549 (IC50=>100µM)&&Human myelogenous leukemia K562 (IC50=>100µM)&&Jurkat cells E6-1 (IC50=>100µM),GEKLKKIGQKIKNFFKKL,,Linear,Free,Free,,L,dbAMP3,18
21990,dbAMP_21990,,Staphylococcus epidermidis (MIC=230µM)&&Bacillus subtilis (MIC=58µM)&&Pseudomonas aeruginosa (MIC=58µM)&&Escherichia coli ATCC 8739 (MIC=116µM)&&Human epidermoid cancer Hep2 (IC50=800µM)&&Human colon adenocarcinoma HCT-15 (IC50=800µM),AWXLFDDGV,,Linear,Free,Free,,L,dbAMP3,9
22001,dbAMP_22001,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=15.8µM)&&Escherichia coli B (MIC=7.2µM)&&Pseudomonas aeruginosa (MIC=65.0µM)&&Human cervical carcinoma HeLa S3 (IC50=15±1µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM),GMWSKILGHLIK,,Linear,Free,Free,,L,dbAMP3,12
22002,dbAMP_22002,,Bacillus subtilis 168 (MIC=2.2µM)&&Staphylococcus aureus (MIC=100µM)&&Escherichia coli B (MIC=28.3µM)&&Pseudomonas aeruginosa (MIC=93.0µM)&&Human cervical carcinoma HeLa S3 (IC50=>100µM),GMWSKILGHLKR,,Linear,Free,Free,,L,dbAMP3,12
22003,dbAMP_22003,,Bacillus subtilis 168 (MIC=0.9µM)&&Staphylococcus aureus (MIC=9.2µM)&&Escherichia coli B (MIC=3.7µM)&&Pseudomonas aeruginosa (MIC=26.3µM)&&Human cervical carcinoma HeLa S3 (IC50=9±1µM)&&Human colon adenocarcinoma SW480 (IC50=>50µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=30±10µM),GMWSKILGKLIR,,Linear,Free,Free,,L,dbAMP3,12
22005,dbAMP_22005,,Bacillus subtilis 168 (MIC=0.9µM)&&Staphylococcus aureus (MIC=3.7µM)&&Escherichia coli B (MIC=2.3µM)&&Pseudomonas aeruginosa (MIC=13.5µM)&&Human cervical carcinoma HeLa S3 (IC50=4±2µM)&&Human colon adenocarcinoma SW480 (IC50=18±2µM)&&Candida albicans F7-39/IDE99 (MIC=3.7±0.5µM),GMWSKILKHLIR,,Linear,Free,Free,,L,dbAMP3,12
22006,dbAMP_22006,,Bacillus subtilis 168 (MIC=0.9µM)&&Staphylococcus aureus (MIC=8.4µM)&&Escherichia coli B (MIC=1.8µM)&&Pseudomonas aeruginosa (MIC=16.3µM)&&Human cervical carcinoma HeLa S3 (IC50=9±1µM)&&Human colon adenocarcinoma SW480 (IC50=44±5µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM)&&Candida albicans F7-39/IDE99 (MIC=20±14µM)&&Candida glabrata CG196/98IDE (MIC=40±16µM)&&Candida krusei CK802/97 (MIC=30±10µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=30±10µM)&&Candida tropicalis CT14/HK (MIC=39±25µM)&&Candida albicans F7-39/IDE99 (MIC=4.5±0.5µM)&&Candida albicans F7-39/IDE99 (MIC=7.5±2.5µM)&&Candida glabrata CG196/98IDE (MIC=25±5µM)&&Candida glabrata CG196/98IDE (MIC=30±10µM)&&Candida krusei CK802/97 (MIC=15±5µM)&&Candida krusei CK802/97 (MIC=20µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=15±5µM)&&Candida tropicalis CT14/HK (MIC=5µM)&&Candida tropicalis CT14/HK (MIC=10µM)&&Candida tropicalis CT14/HK (MIC=13±8µM),GMWKKILGHLIR,,Linear,Free,Free,,L,dbAMP3,12
22007,dbAMP_22007,,Bacillus subtilis 168 (MIC=2.0µM)&&Staphylococcus aureus (MIC=23.3µM)&&Escherichia coli B (MIC=3.7µM)&&Pseudomonas aeruginosa (MIC=71.7µM)&&Human cervical carcinoma HeLa S3 (IC50=43±14µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM)&&Candida albicans F7-39/IDE99 (MIC=7.4±1.8µM),GKWSKILGHLIR,,Linear,Free,Free,,L,dbAMP3,12
22008,dbAMP_22008,,Bacillus subtilis 168 (MIC=2.1µM)&&Staphylococcus aureus (MIC=41.7µM)&&Escherichia coli B (MIC=6.3µM)&&Pseudomonas aeruginosa (MIC=73.3µM)&&Human cervical carcinoma HeLa S3 (IC50=35±3µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM),KMWSKILGHLIR,,Linear,Free,Free,,L,dbAMP3,12
22009,dbAMP_22009,,Bacillus subtilis 168 (MIC=0.8µM)&&Staphylococcus aureus (MIC=15.0µM)&&Escherichia coli B (MIC=2.3µM)&&Pseudomonas aeruginosa (MIC=13.1µM)&&Human cervical carcinoma HeLa S3 (IC50=13±2µM)&&Human colon adenocarcinoma SW480 (IC50=>60µM)&&Candida albicans F7-39/IDE99 (MIC=24±12µM)&&Candida glabrata CG196/98IDE (MIC=87±9µM)&&Candida krusei CK802/97 (MIC=28±8µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=45±5µM)&&Candida tropicalis CT14/HK (MIC=50±31µM)&&Candida albicans F7-39/IDE99 (MIC=7±2µM)&&Candida albicans F7-39/IDE99 (MIC=9±1µM)&&Candida glabrata CG196/98IDE (MIC=40µM)&&Candida glabrata CG196/98IDE (MIC=70±10µM)&&Candida krusei CK802/97 (MIC=13±4µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=30±14µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=20µM)&&Candida parapsilosis Z150/119/IDE99 (MIC=40µM)&&Candida tropicalis CT14/HK (MIC=7.5±2.5µg/ml)&&Candida tropicalis CT14/HK (MIC=20µM),GMWKKILGKLIR,,Linear,Free,Free,,L,dbAMP3,12
22010,dbAMP_22010,,Bacillus subtilis 168 (MIC=1.7µM)&&Staphylococcus aureus (MIC=21.7µM)&&Escherichia coli B (MIC=2.3µM)&&Pseudomonas aeruginosa (MIC=28.3µM)&&Human cervical carcinoma HeLa S3 (IC50=22±3µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM),GKWSKILGKLIR,,Linear,Free,Free,,L,dbAMP3,12
22011,dbAMP_22011,,Bacillus subtilis 168 (MIC=1.2µM)&&Staphylococcus aureus (MIC=28.3µM)&&Escherichia coli B (MIC=2.7µM)&&Pseudomonas aeruginosa (MIC=30.0µM)&&Human cervical carcinoma HeLa S3 (IC50=>100µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Candida albicans F7-39/IDE99 (MIC=5.3±0.5µM),GKWKKILGHLIR,,Linear,Free,Free,,L,dbAMP3,12
22018,dbAMP_22018,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=7.7µM)&&Escherichia coli B (MIC=3.0µM)&&Pseudomonas aeruginosa (MIC=20.2µM)&&Human cervical carcinoma HeLa S3 (IC50=14±2µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM)&&Candida albicans F7-39/IDE99 (MIC=5.0±0.5µM),GMWSKLLGHLLR,,Linear,Free,Free,,L,dbAMP3,12
22019,dbAMP_22019,,Bacillus subtilis 168 (MIC=1.2µM)&&Staphylococcus aureus (MIC=6.3µM)&&Escherichia coli B (MIC=2.7µM)&&Pseudomonas aeruginosa (MIC=13.8µM)&&Human cervical carcinoma HeLa S3 (IC50=>40µM)&&Human colon adenocarcinoma SW480 (IC50=38±6µM),GKWMSLLKKILK,,Linear,Free,Free,,L,dbAMP3,12
22022,dbAMP_22022,,Bacillus subtilis 168 (MIC=0.8µM)&&Staphylococcus aureus (MIC=4.5µM)&&Escherichia coli B (MIC=2.5µM)&&Pseudomonas aeruginosa (MIC=10.7µM)&&Human cervical carcinoma HeLa S3 (IC50=6±1µM)&&Human colon adenocarcinoma SW480 (IC50=35±5µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM)&&Candida albicans F7-39/IDE99 (MIC=4.5±0.5µM),GKWMKLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22023,dbAMP_22023,,Bacillus subtilis 168 (MIC=1.2µM)&&Staphylococcus aureus (MIC=20.0µM)&&Escherichia coli B (MIC=3.7µM)&&Pseudomonas aeruginosa (MIC=34.2µM)&&Human cervical carcinoma HeLa S3 (IC50=14±2µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=>40µM),GKWKSLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22026,dbAMP_22026,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=12.2µM)&&Escherichia coli B (MIC=5.0µM)&&Pseudomonas aeruginosa (MIC=25.0µM)&&Human cervical carcinoma HeLa S3 (IC50=14±2µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM),GKWMSLLKHIWK,,Linear,Free,Free,,L,dbAMP3,12
22027,dbAMP_22027,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=13.8µM)&&Escherichia coli B (MIC=3.5µM)&&Pseudomonas aeruginosa (MIC=25.0µM)&&Human cervical carcinoma HeLa S3 (IC50=16±4µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM),GKWMSLLKHWLK,,Linear,Free,Free,,L,dbAMP3,12
22028,dbAMP_22028,,Bacillus subtilis 168 (MIC=1.4µM)&&Staphylococcus aureus (MIC=27.0µM)&&Escherichia coli B (MIC=8.0µM)&&Pseudomonas aeruginosa (MIC=32.5µM)&&Human cervical carcinoma HeLa S3 (IC50=30±5µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM),GKWMSLWKHILK,,Linear,Free,Free,,L,dbAMP3,12
22033,dbAMP_22033,,Bacillus subtilis 168 (MIC=1.5µM)&&Staphylococcus aureus (MIC=43.3µM)&&Escherichia coli B (MIC=5.8µM)&&Pseudomonas aeruginosa (MIC=30.0µM)&&Human cervical carcinoma HeLa S3 (IC50=34µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM),GKFMSLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22036,dbAMP_22036,,Bacillus subtilis 168 (MIC=1.1µM)&&Staphylococcus aureus (MIC=6.4µM)&&Escherichia coli B (MIC=4.0µM)&&Pseudomonas aeruginosa (MIC=21.8µM)&&Human cervical carcinoma HeLa S3 (IC50=23±3µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM)&&Candida albicans F7-39/IDE99 (MIC=6.8±0.9µM),GKWMSFLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22039,dbAMP_22039,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=5.3µM)&&Escherichia coli B (MIC=2.7µM)&&Pseudomonas aeruginosa (MIC=38.3µM)&&Human cervical carcinoma HeLa S3 (IC50=13±3µM)&&Human colon adenocarcinoma SW480 (IC50=>60µM)&&Candida albicans F7-39/IDE99 (MIC=7±2.2µM),GKWMTLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22042,dbAMP_22042,,Bacillus subtilis 168 (MIC=0.9µM)&&Staphylococcus aureus (MIC=5.5µM)&&Escherichia coli B (MIC=1.8µM)&&Pseudomonas aeruginosa (MIC=31.7µM)&&Human cervical carcinoma HeLa S3 (IC50=14±3µM)&&Human colon adenocarcinoma SW480 (IC50=40µM)&&Candida albicans F7-39/IDE99 (MIC=8.7±1.9µM)&&Human lung carcinoma A549 (IC50=5.1±1.6µM)&&Human cervical carcinoma HeLa (IC50=2.0±0.4µM),GKWLSLLKHILK,,Linear,Free,Free,,L,dbAMP3,12
22094,dbAMP_22094,,Human cervical carcinoma HeLa S3 (IC50=7±1µM)&&Human colon adenocarcinoma SW480 (IC50=>40µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=18µM),VNWKKILGKIKKVVK,,Linear,Free,Free,,L,dbAMP3,15
22098,dbAMP_22098,,Human cervical carcinoma HeLa S3 (IC50=9±4µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=9µM),KNWKKILGKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
22099,dbAMP_22099,,Human cervical carcinoma HeLa S3 (IC50=8±1µM)&&Human colon adenocarcinoma SW480 (IC50=48µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=4±1µM),VNWKKIILGKIIKVVK,,Linear,Free,Free,,L,dbAMP3,16
22100,dbAMP_22100,,Human cervical carcinoma HeLa S3 (IC50=7±1µM)&&Human colon adenocarcinoma SW480 (IC50=42µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=9±3µM),VNFKKLLGKLLKVVK,,Linear,Free,Free,,L,dbAMP3,15
22102,dbAMP_22102,,Human cervical carcinoma HeLa S3 (IC50=6±1µM),VNXKKLLGKLLKVVK,,Linear,Free,Free,,L,dbAMP3,15
22103,dbAMP_22103,,Human cervical carcinoma HeLa S3 (IC50=9µM),VNWRRILGRIIRVVR,,Linear,Free,Free,,L,dbAMP3,15
22104,dbAMP_22104,,Human cervical carcinoma HeLa S3 (IC50=3µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=7±2µM),KNWKKILKKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
22105,dbAMP_22105,,Human cervical carcinoma HeLa S3 (IC50=3±1µM)&&Human colon adenocarcinoma SW480 (IC50=28µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=8±2µM),VNWKKXLGKXIKXVK,,Linear,Free,Free,,L,dbAMP3,15
22106,dbAMP_22106,,Human cervical carcinoma HeLa S3 (IC50=11±7µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=25±4µM),KNWKKXLKKXIKXVK,,Linear,Free,Free,,L,dbAMP3,15
22107,dbAMP_22107,,Human cervical carcinoma HeLa S3 (IC50=3±1µM)&&Human colon adenocarcinoma SW480 (IC50=20µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=5±2µM),VNWXXILGXIIXVVX,,Linear,Free,Free,,L,dbAMP3,15
22108,dbAMP_22108,,Human cervical carcinoma HeLa S3 (IC50=5±1µM)&&Human colon adenocarcinoma SW480 (IC50=30µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=6µM),VYWKKILGKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
22109,dbAMP_22109,,Human cervical carcinoma HeLa S3 (IC50=13±2µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=18µM),VNWKKVLGKVVKVVK,,Linear,Free,Free,,L,dbAMP3,15
22111,dbAMP_22111,,Human cervical carcinoma HeLa S3 (IC50=5±2µM)&&Human colon adenocarcinoma SW480 (IC50=37µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=5±3µM),NKWKKILGKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
22112,dbAMP_22112,,Human cervical carcinoma HeLa S3 (IC50=5±1µM)&&Human colon adenocarcinoma SW480 (IC50=13µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=4±1µM),VNWKKVLAKIIKVVK,,Linear,Free,Free,,L,dbAMP3,15
22113,dbAMP_22113,,Human cervical carcinoma HeLa S3 (IC50=9±2µM)&&Human colon adenocarcinoma SW480 (IC50=11±1µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=22µM)&&Bacillus subtilis 168 (MIC=1.5µM)&&Staphylococcus aureus (MIC=2.3µM)&&Escherichia coli B (MIC=3.8µM)&&Pseudomonas aeruginosa (MIC=50.0µM)&&Candida albicans F7-39/IDE99 (MIC=10.0µM),LFGMALKLLKKVL,,Linear,Free,Free,,L,dbAMP3,13
22115,dbAMP_22115,,Human cervical carcinoma HeLa S3 (IC50=10±1µM)&&Human colon adenocarcinoma SW480 (IC50=35±4µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=25±3µM)&&Bacillus subtilis 168 (MIC=1.7µM)&&Staphylococcus aureus (MIC=11.5µM)&&Escherichia coli B (MIC=7.2µM)&&Pseudomonas aeruginosa (MIC=25.0µM)&&Candida albicans F7-39/IDE99 (MIC=12.5µM),GFGMALXLLXXVL,,Linear,Free,Free,,L,dbAMP3,13
22116,dbAMP_22116,,Human cervical carcinoma HeLa S3 (IC50=9±3µM)&&Human colon adenocarcinoma SW480 (IC50=17±2µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=22±4µM),GFGMALRLLRRVL,,Linear,Free,Free,,L,dbAMP3,13
22119,dbAMP_22119,,Escherichia coli ATCC 25922 (MIC=<=0.005µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>=0.619µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=0.145µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=<=0.005µM)&&Shigella sonnei ATCC 25931 (MIC=<=0.005µM)&&Human acute monocytic leukemia THP-1 (IC50=45µM),CVKVKVKVGSGVKVKVKVC,,Linear,Free,Free,,L,dbAMP3,19
22210,dbAMP_22210,,Salmonella typhimurium (LC=10µM)&&Jurkat cancer cells (LC90=20µM),QRSVSNAATRVCRTGRSRWRDVCRNFMRR,,Linear,Free,Free,,L,dbAMP3,29
22215,dbAMP_22215,,Salmonella typhimurium (LC=10µM)&&Jurkat cancer cells (20% Cell death=20µM),RDVCRNFMRRYQSRVIQGLV,,Linear,Free,Free,,L,dbAMP3,20
22217,dbAMP_22217,,Salmonella typhimurium (LC=10µM)&&Jurkat cancer cells (LC50=20µM),GRSRWRDVCRNFMRR,,Linear,Free,Free,,L,dbAMP3,15
22398,dbAMP_22398,,Candida albicans (IC50=<50µg/ml)&&Candida guilliermondii (IC50=<50µg/ml)&&Saccharomyces cerevisiae (IC50=<100µg/ml)&&Leishmania amazonensis (70% Inhibition=300µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=0.82±0.14µM),KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC,,Linear,Free,Free,,L,dbAMP3,47
22465,dbAMP_22465,,Human prostate adenocarcinoma LNCaP (50% Cell death=10µM)&&Human prostate adenocarcinoma PC-3 (25% Cell death=10µM)&&Human prostate cancer DU145 (25% Cell death=10µM),KPPPWVPV,,Linear,Free,Free,,L,dbAMP3,8
22467,dbAMP_22467,,Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Escherichia coli ATCC 25922 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=2.4µM),GIPCAESCVWIPCTITALMGCSCKNNVCYNN,,Linear,Free,Free,,L,dbAMP3,31
22468,dbAMP_22468,,Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Escherichia coli ATCC 25922 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=>15µM),GIPCAESCVWIPCTITALXGCSCKNNVCYNN,,Linear,Free,Free,,L,dbAMP3,31
22469,dbAMP_22469,,Escherichia coli ATCC 25922 (MIC=>80µM)&&Staphylococcus aureus ATCC 12600 (MIC=>80µM)&&Staphylococcus epidermidis ATCC 14990 (MIC=>80µM)&&Human cervical carcinoma HeLa (IC50=>15µM),IPCGESCVWIPCISGXFGCSCKDKVCYS,,Linear,Free,Free,,L,dbAMP3,28
22498,dbAMP_22498,,Staphylococcus aureus ATCC 25923 (MIC=64µM)&&Staphylococcus epidermidis RP62A/1 (MIC=16µM)&&Staphylococcus epidermidis RP62A (MIC=32µM)&&Escherichia coli ATCC 25726 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=128µM)&&Acinetobacter baumannii NM8 (MIC=16µM)&&Stenotrophomonas maltophilia B32/4 (MIC=32µM)&&Candida albicans ATCC 90028 (MIC=32µM)&&Human lung carcinoma A549 (LC50=100µM),ILKKLLSTAAGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
22499,dbAMP_22499,,Human lung carcinoma A549 (LC50=30µM)&&Staphylococcus aureus ATCC 25923 (MIC=16µM)&&Staphylococcus epidermidis RP62A/1 (MIC=8µM)&&Staphylococcus epidermidis RP62A (MIC=16µM)&&Escherichia coli ATCC 25726 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=128µM)&&Acinetobacter baumannii NM8 (MIC=32µM)&&Stenotrophomonas maltophilia B32/4 (MIC=64µM)&&Candida albicans ATCC 90028 (MIC=32µM),ILGKLLSTAAGLLKNL,,Linear,Free,Free,,L,dbAMP3,16
22500,dbAMP_22500,,Human lung carcinoma A549 (LC50=12µM),ILGKLLSWAAGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
22501,dbAMP_22501,,Human lung carcinoma A549 (LC50=21µM),ILGKLLSTWAGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
22502,dbAMP_22502,,Human lung carcinoma A549 (LC50=7µM),ILGKLLSTAWGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
22514,dbAMP_22514,,Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Escherichia coli ATCC 25726 (MIC=6µM)&&Human lung carcinoma A549 (LC50=3µM)&&Staphylococcus aureus 127/08 (MIC=6µM)&&Staphylococcus aureus V4180 (MIC=3µM)&&Staphylococcus aureus T4/6 (MIC=5µM)&&Acinetobacter baumannii NM8 (MIC=3µM)&&Acinetobacter baumannii NM35 (MIC=1.5µM)&&Stenotrophomonas maltophilia B32/1 (MIC=3µM)&&Stenotrophomonas maltophilia B32/4 (MIC=1.5µM),GFSSIFRGVAKFASKGLGKKLAKLGVKLVACKISKQC,,Linear,Free,Free,,L,dbAMP3,37
22515,dbAMP_22515,,Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Escherichia coli ATCC 25726 (MIC=50µM)&&Human lung carcinoma A549 (LC50=26µM)&&Staphylococcus aureus 127/08 (MIC=50µM)&&Staphylococcus aureus 145/08 (MIC=100µM)&&Acinetobacter baumannii NM8 (MIC=12.5µM)&&Stenotrophomonas maltophilia B32/1 (MIC=12.5µM)&&Stenotrophomonas maltophilia B32/4 (MIC=6µM),GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS,,Linear,Free,Free,,L,dbAMP3,37
22525,dbAMP_22525,6G4V,Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Escherichia coli ATCC 25922 (MIC=50µM)&&Candida albicans ATCC 90028 (MIC=25µM)&&Human hepatocellular carcinoma HepG2 (LC50=10µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=13µM)&&Klebsiella pneumoniae KK3 9904 (MIC=>40µM)&&Enterobacter cloacae HNTCC 53001 (MIC=40µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=40µM)&&Proteus mirabilis ATCC 25933 (MIC=>40µM)&&Staphylococcus epidermidis RP62A (MIC=5µM)&&Enterococcus faecalis ATCC 29212 (MIC=20µM)&&Streptococcus group B HNTCC 80130 (MIC=10µM)&&Candida albicans (MIC=40µM)&&Candida parapsilosis ATCC 22019 (MIC=40µM)&&Candida parapsilosis (MIC=>40µM)&&Candida tropicalis (MIC=20µM)&&Candida tropicalis B51a/5 (MIC=10µM)&&Candida krusei ATCC 6258 (MIC=>40µM)&&Candida krusei (MIC=>40µM),FLPILASLAAKFGPKLFSLVTKKS,,Linear,Free,Free,,L,dbAMP3,24
22526,dbAMP_22526,,Staphylococcus aureus ATCC 25923 (MIC=1.5µM)&&Escherichia coli ATCC 25922 (MIC=12.5µM)&&Candida albicans ATCC 90028 (MIC=3µM)&&Human hepatocellular carcinoma HepG2 (LC50=4µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=7µM)&&Staphylococcus aureus T4/6 (MIC=2µM)&&Staphylococcus aureus 127/08 (MIC=1µM)&&Staphylococcus aureus 127/08 (MBC=8µM)&&Acinetobacter baumannii NM8 (MIC=4µM)&&Acinetobacter baumannii NM35 (MIC=8µM)&&Acinetobacter baumannii NM8 (MBC=8µM)&&Acinetobacter baumannii NM35 (MBC=16µM),FLPILASLAAKFGPKLFXLVTKKX,,Linear,Free,Free,,L,dbAMP3,24
22528,dbAMP_22528,,Human lung carcinoma A549 (LC50=1.4±0.2µM)&&Escherichia coli ATCC 25726 (MIC=12.5µM)&&Acinetobacter baumannii (MIC=6.25µM)&&Stenotrophomonas maltophilia (MIC=3.1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=6.25µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus epidermidis RP62A (MIC=1.6µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.6µM)&&Candida albicans ATCC 90028 (MIC=50µM),IKLSKETKDNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
22529,dbAMP_22529,,Human lung carcinoma A549 (LC50=1.1±0.1µM)&&Escherichia coli ATCC 25726 (MIC=3.1µM)&&Acinetobacter baumannii (MIC=3.1µM)&&Stenotrophomonas maltophilia (MIC=1.6µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=6.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µM)&&Staphylococcus epidermidis RP62A (MIC=1.6µM)&&Staphylococcus epidermidis RP62A/1 (MIC=0.8µM)&&Candida albicans ATCC 90028 (MIC=100µM),IKLSKKTKDNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
22530,dbAMP_22530,,Human lung carcinoma A549 (LC50=1.3±0.2µM)&&Escherichia coli ATCC 25726 (MIC=6.25µM)&&Acinetobacter baumannii (MIC=3.1µM)&&Stenotrophomonas maltophilia (MIC=3.1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=6.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=6.25µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µM)&&Staphylococcus epidermidis RP62A (MIC=1.6µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.6µM)&&Candida albicans ATCC 90028 (MIC=50µM),IKLSKETKKNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
22549,dbAMP_22549,,Human cervical carcinoma HeLa (IC50=4.1µM),XLPICGETCVLGTCYTPGCRCQYPICVR,,Linear,Free,Free,,L,dbAMP3,28
22550,dbAMP_22550,,Escherichia coli ATCC 25922 (MIC=2.5µM)&&Human cervical carcinoma HeLa (IC50=6.0µM),XLPICGETCVLGRCYTPNCRCQYPICVR,,Linear,Free,Free,,L,dbAMP3,28
22552,dbAMP_22552,,Staphylococcus aureus ATCC 12600 &&Human cervical carcinoma HeLa &&Escherichia coli ATCC 25922 &&Candida tropicalis 750 &&Candida albicans 11006,XAFCGETCLLGKCYTPGCSCHTGICLK,,Linear,Free,Free,,L,dbAMP3,27
22553,dbAMP_22553,,Staphylococcus aureus ATCC 12600 &&Human cervical carcinoma HeLa &&Escherichia coli ATCC 25922 &&Candida tropicalis 750 &&Candida albicans 11006,XAFCGETCLLGTCYTPGCRCTAGICLK,,Linear,Free,Free,,L,dbAMP3,27
22554,dbAMP_22554,,Human cervical carcinoma HeLa (IC50=10µM),XLPICGETCVLGTCYTPGCSCAYPICAR,,Linear,Free,Free,,L,dbAMP3,28
22555,dbAMP_22555,,Human cervical carcinoma HeLa (IC50=5.7µM),XLPICGETCVLGTCYTPGCSCAYPICVR,,Linear,Free,Free,,L,dbAMP3,28
22556,dbAMP_22556,,Human cervical carcinoma HeLa (IC50=7.7µM),XAFCGETCVLGTCYTPGCSCNFGICLK,,Linear,Free,Free,,L,dbAMP3,27
22557,dbAMP_22557,,Staphylococcus aureus ATCC 12600 &&Human cervical carcinoma HeLa &&Escherichia coli ATCC 25922 &&Candida tropicalis 750 &&Candida albicans 11006,XDCGETCVLGTCYTPGCSCSAYPLCV,,Linear,Free,Free,,L,dbAMP3,26
22560,dbAMP_22560,,Human skin melanoma MM96L (IC50=4.91±0.04µM)&&Human cervical carcinoma HeLa (IC50=15.5±0.06µM)&&Human gastric cancer BGC-823 (IC50=1.75±0.05µM),GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,,Linear,Free,Free,,L,dbAMP3,30
22561,dbAMP_22561,,Human skin melanoma MM96L (IC50=1.03±0.03µM)&&Human cervical carcinoma HeLa (IC50=6.35±0.31µM)&&Human gastric cancer BGC-823 (IC50=2.91±0.06µM),GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,,Linear,Free,Free,,L,dbAMP3,31
22565,dbAMP_22565,,Human lung carcinoma A549 (IC50=>160µM)&&Human lung carcinoma A549 (IC50=42±2µM)&&Escherichia coli ATCC 25404 (MIC=>64µM)&&Escherichia coli O157 (MIC=>64µM)&&Salmonella typhimurium (MIC=>64µM)&&Listeria monocytogenes (MIC=64µM)&&Micrococcus luteus ATCC 10420 (MIC=8µM)&&Staphylococcus epidermidis ATCC 9709 (MIC=16µM)&&Staphylococcus aureus ATCC 29213 (MIC=8µM)&&Staphylococcus aureus ATCC 43300 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=1µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MIC=>8µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Human pancreatic carcinoma Panc-1 (IC50=>120µM),FLGALFHALSHLL,,Linear,Free,Free,,L,dbAMP3,13
22566,dbAMP_22566,,Human lung carcinoma A549 (IC50=3±1µM)&&Human lung carcinoma A549 (IC50=4±1µM),PAWRKAFRWAWRMLKKAA,,Linear,Free,Free,,L,dbAMP3,18
22567,dbAMP_22567,,Human lung carcinoma A549 (IC50=19±3µM)&&Human lung carcinoma A549 (IC50=10±2µM),PAWHHAFHWAWRMLKKAA,,Linear,Free,Free,,L,dbAMP3,18
22568,dbAMP_22568,,Human lung carcinoma A549 (IC50=12±2µM)&&Human lung carcinoma A549 (IC50=7±2µM),PAWRKAFRWAWHMLHHAA,,Linear,Free,Free,,L,dbAMP3,18
22569,dbAMP_22569,,Human lung carcinoma A549 (IC50=>80µM)&&Human lung carcinoma A549 (IC50=12±2µM),PAWRHAFHWAWHMLHKAA,,Linear,Free,Free,,L,dbAMP3,18
22570,dbAMP_22570,,Human lung carcinoma A549 (IC50=56±3µM)&&Human lung carcinoma A549 (IC50=44±3µM),GLFAVIHKVASVIGGL,,Linear,Free,Free,,L,dbAMP3,16
22571,dbAMP_22571,,Human lung carcinoma A549 (IC50=97±4µM)&&Human lung carcinoma A549 (IC50=61±3µM),GLFAVIKHVASVIGGL,,Linear,Free,Free,,L,dbAMP3,16
22572,dbAMP_22572,,Human lung carcinoma A549 (IC50=156±7µM)&&Human lung carcinoma A549 (IC50=36±2µM),GLFAVIHHVASVIGGL,,Linear,Free,Free,,L,dbAMP3,16
22595,dbAMP_22595,,Escherichia coli DH5alpha (MIC=125±5.6µM)&&Bacillus subtilis 168 (MIC=30±2.5µM)&&Human cervical carcinoma HeLa (IC50=160±7.6µM)&&Human promyelocytic leukemia HL-60 (IC50=>500µM),GIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,10
22596,dbAMP_22596,,Escherichia coli DH5alpha (MIC=2±0.5µM)&&Bacillus subtilis 168 (MIC=0.5±0.1µM)&&Human cervical carcinoma HeLa (IC50=4±2.3µM)&&Human promyelocytic leukemia HL-60 (IC50=10±2.5µM),GIIKKIIKKIIKKIIKKI,,Linear,Free,Free,,L,dbAMP3,18
22756,dbAMP_22756,,Micrococcus luteus ATCC 9341 (MIC=0.4µM)&&Escherichia coli ATCC 25922 (MIC=16µM)&&Jurkat T-cell leukemia (IC50=9.5µM),ILPWKWPWWPWKK,,Linear,Free,Free,,L,dbAMP3,13
22855,dbAMP_22855,,Pseudomonas syringae pv. syringae EPS 94 (MIC=2.5-5.0µM)&&Xanthomonas campestris pv. Vesicatoria 2133-2 (MIC=<2.5µM)&&Erwinia amylovora PMV 6076 (MIC=2.5-5.0µM)&&Human breast adenocarcinoma MCF-7 (IC50=40.0±3.4µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=24.2±7.2µM),LKLFKKILKFL,,Linear,Free,Free,,L,dbAMP3,11
22856,dbAMP_22856,,Pseudomonas syringae pv. syringae EPS 94 (MIC=5.0-7.5µM)&&Xanthomonas campestris pv. Vesicatoria 2133-2 (MIC=2.5-5.0µM)&&Erwinia amylovora PMV 6076 (MIC=5.0-7.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=29.2±4.2µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=22.7±1.5µM),LKLFKKILKYL,,Linear,Free,Free,,L,dbAMP3,11
22858,dbAMP_22858,,Escherichia coli KCTC 1682 (MIC=4µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=8µM)&&Salmonella typhimurium KCTC 1926 (MIC=4µM)&&Bacillus subtilis KCTC 3068 (MIC=8µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=4µM)&&Staphylococcus aureus KCTC 1621 (MIC=4µM)&&Human lung carcinoma A549 (IC50=0.6µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=0.6µM)&&Human skin melanoma SK-MEL-2 (IC50=0.7µM),KWKKLLKKLLKLLKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22890,dbAMP_22890,,Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Escherichia coli ATCC 25922 (MBC=16µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=4µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=4µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MIC=128µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MBC=128µg/ml)&&Brucella abortus 9.49 (per-) (MIC=2µg/ml)&&Brucella abortus 9.49 (per-) (MBC=32µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MIC=8µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MBC=8µg/ml)&&Yersinia pestis KIM pYV (MIC=32µg/ml)&&Yersinia pestis KIM pYV (MBC=32µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=256µg/ml)&&Staphylococcus aureus ATCC 43300 (MBC=256µg/ml)&&Escherichia coli ATCC 23716 (MIC=8µg/ml)&&Escherichia coli ATCC 23716 (MBC=8µg/ml)&&Escherichia coli ATCC 23716 (MIC=25µg/ml)&&Escherichia coli ATCC 23716 (MBC=50µg/ml)&&Human cervical carcinoma HeLa ((21.1±4.0)% Cytotoxicity=100µg/ml),KISKKIMRTFLRRILTGKK,,Linear,Free,Free,,L,dbAMP3,19
22892,dbAMP_22892,,Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Escherichia coli ATCC 25922 (MBC=16µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=8µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=8µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MIC=4µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MBC=4µg/ml)&&Brucella abortus 9.49 (per-) (MIC=8µg/ml)&&Brucella abortus 9.49 (per-) (MBC=32µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MIC=32µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MBC=128µg/ml)&&Yersinia pestis KIM pYV (MIC=64µg/ml)&&Yersinia pestis KIM pYV (MBC=128µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 43300 (MBC=32µg/ml)&&Escherichia coli ATCC 23716 (MIC=16µg/ml)&&Escherichia coli ATCC 23716 (MBC=16µg/ml)&&Human cervical carcinoma HeLa ((6.6±7.9)% Cytotoxicity=100µg/ml),RILRGVSRRIMRRILTGRR,,Linear,Free,Free,,L,dbAMP3,19
22895,dbAMP_22895,,Escherichia coli ATCC 25922 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MBC=128µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=256µg/ml)&&Acinetobacter baumannii ATCC 19606 (MBC=256µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MIC=16µg/ml)&&Bordetella bronchiseptica CUN 11844-99 (MBC=32µg/ml)&&Brucella abortus 9.49 (per-) (MIC=16µg/ml)&&Brucella abortus 9.49 (per-) (MBC=>256µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MIC=256µg/ml)&&Pseudomonas aeruginosa CUN 4158-02 (MBC=256µg/ml)&&Yersinia pestis KIM pYV (MIC=256µg/ml)&&Yersinia pestis KIM pYV (MBC=256µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=>256µg/ml)&&Staphylococcus aureus ATCC 43300 (MBC=>256µg/ml)&&Escherichia coli ATCC 23716 (MIC=16µg/ml)&&Escherichia coli ATCC 23716 (MBC=16µg/ml)&&Escherichia coli ATCC 23716 (MIC=12.5µg/ml)&&Escherichia coli ATCC 23716 (MBC=12.5µg/ml)&&Human cervical carcinoma HeLa ((6.4±3.0)% Cytotoxicity=100µg/ml),KISKKIMRTFLRR,,Linear,Free,Free,,L,dbAMP3,13
22935,dbAMP_22935,,Escherichia coli (MIC=50µg/ml)&&Staphylococcus aureus (MIC=20-25µg/ml)&&Escherichia coli (MBC=100µg/ml)&&Staphylococcus aureus (MBC=25µg/ml)&&Escherichia coli ATCC 25922 (MIC=16-32µM)&&Escherichia coli ATCC 25922 (MBC=16-32µM)&&Jurkat T-cell leukemia (IC50=>=65µM),VRRFPYYYPFLRR,,Linear,Free,Free,,L,dbAMP3,13
22938,dbAMP_22938,,Escherichia coli (MIC=20µg/ml)&&Staphylococcus aureus (MIC=4µg/ml)&&Escherichia coli (MBC=20µg/ml)&&Staphylococcus aureus (MBC=7µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Jurkat T-cell leukemia (IC50=16.2µM),VRRFAWWWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
22939,dbAMP_22939,,Escherichia coli (MIC=20µg/ml)&&Staphylococcus aureus (MIC=5µg/ml)&&Escherichia coli (MBC=40µg/ml)&&Staphylococcus aureus (MBC=17.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=2-4µM)&&Jurkat T-cell leukemia (IC50=6.8µM),VRRFPWWWAFLRR,,Linear,Free,Free,,L,dbAMP3,13
22970,dbAMP_22970,,Escherichia coli KCTC 1682 (MIC=2µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=2µM)&&Salmonella typhimurium KCTC 1926 (MIC=2µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=1µM)&&Staphylococcus aureus KCTC 1621 (MIC=2µM)&&Human lung carcinoma A549 (IC50=2.0µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=1.7µM)&&Human skin melanoma SK-MEL-2 (IC50=2.1µM),KWKKLLKKXLKLLKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22971,dbAMP_22971,,Escherichia coli KCTC 1682 (MIC=4µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4µM)&&Salmonella typhimurium KCTC 1926 (MIC=4µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=2µM)&&Staphylococcus aureus KCTC 1621 (MIC=4µM)&&Human lung carcinoma A549 (IC50=1.0µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=0.9µM)&&Human skin melanoma SK-MEL-2 (IC50=1.3µM),KWKKLLKKLXKLLKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22972,dbAMP_22972,,Escherichia coli KCTC 1682 (MIC=4µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4µM)&&Salmonella typhimurium KCTC 1926 (MIC=4µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=4µM)&&Staphylococcus aureus KCTC 1621 (MIC=4µM)&&Human lung carcinoma A549 (IC50=0.6µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=0.5µM)&&Human skin melanoma SK-MEL-2 (IC50=0.6µM),KWKKLLKKLLXLLKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22973,dbAMP_22973,,Escherichia coli KCTC 1682 (MIC=2µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=2µM)&&Salmonella typhimurium KCTC 1926 (MIC=2µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=1µM)&&Staphylococcus aureus KCTC 1621 (MIC=2µM)&&Human lung carcinoma A549 (IC50=75.5µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=31.9µM)&&Human skin melanoma SK-MEL-2 (IC50=38.7µM),KWKKLLKKXLKLXKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22974,dbAMP_22974,,Escherichia coli KCTC 1682 (MIC=4µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=4µM)&&Salmonella typhimurium KCTC 1926 (MIC=2µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=2µM)&&Staphylococcus aureus KCTC 1621 (MIC=2µM)&&Human lung carcinoma A549 (IC50=1.0µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=0.7µM)&&Human skin melanoma SK-MEL-2 (IC50=1.1µM),KWKKLLXKLLXLLKKLLK,,Linear,Free,Free,,L,dbAMP3,18
22981,dbAMP_22981,,Escherichia coli ATCC 25922 (MIC=0.5-1µM)&&Escherichia coli ML-35 (MIC=1µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=2µM)&&Serratia marcescens ATCC 8100 (MIC=4µM)&&Staphylococcus aureus ATCC 25923 (MIC=>128µM)&&Escherichia coli HB101 (MIC=0.5µM)&&Escherichia coli TOP 10 (MIC=4.6µM)&&Escherichia coli ATCC 25922 (MIC=2.8µM)&&Escherichia coli BW25113 (MIC=7.4µM)&&Escherichia coli BW25113 del-sbmA (MIC=52.1µM)&&Escherichia coli (MIC50=7.5µM)&&Human cervical carcinoma HeLa (IC50=1460µM),RRIRPRPPRLPRPRPRPLPFPRP,,Linear,Free,Free,,L,dbAMP3,23
23041,dbAMP_23041,,Human promyelocytic leukemia HL-60 (50% Cell death=16µg/ml),GWKDWFRKAKKVGKTVGGLALNHYL,,Linear,Free,Free,,L,dbAMP3,25
23042,dbAMP_23042,,Human promyelocytic leukemia HL-60 (50% Cell death=128µg/ml),GIRKWFKKAAHVGKEVGKVALNACL,,Linear,Free,Free,,L,dbAMP3,25
23043,dbAMP_23043,,Human promyelocytic leukemia HL-60 (50% Cell death=16µg/ml),GLKKWFKKAVHVGKKVGKVALNAYL,,Linear,Free,Free,,L,dbAMP3,25
23044,dbAMP_23044,,Human promyelocytic leukemia HL-60 (50% Cell death=32µg/ml),GWRKWIKKATHVGKHIGKAALDAYI,,Linear,Free,Free,,L,dbAMP3,25
23045,dbAMP_23045,,Human promyelocytic leukemia HL-60 (50% Cell death=32µg/ml),GCKKWFKKAAHVGKNVGKVALNAYL,,Linear,Free,Free,,L,dbAMP3,25
23046,dbAMP_23046,,Human promyelocytic leukemia HL-60 (50% Cell death=64µg/ml),GIRKWFKKAAHVGKKVGKVALNAYL,,Linear,Free,Free,,L,dbAMP3,25
23302,dbAMP_23302,,Acute myeloid leukemia AML-2 (IC50=50µM)&&Human promyelocytic leukemia HL-60 (IC50=53µM)&&Jurkat cancer cells (IC50=47µM)&&Human gastric carcinoma SNU 601 (IC50=37µM)&&Human breast adenocarcinoma MCF-7 (IC50=55µM),MWKWFHNVLSSWQLLADKRPARDYNRK,,Linear,Free,Free,,L,dbAMP3,27
23303,dbAMP_23303,,Acute myeloid leukemia AML-2 (IC50=29µM)&&Human promyelocytic leukemia HL-60 (IC50=20µM)&&Jurkat cancer cells (IC50=23µM)&&Human gastric carcinoma SNU 601 (IC50=25µM)&&Human breast adenocarcinoma MCF-7 (IC50=<10µM),MWKWFHNVLSWWWLLADKRPARDYNRK,,Linear,Free,Free,,L,dbAMP3,27
23304,dbAMP_23304,,Acute myeloid leukemia AML-2 (IC50=67µM)&&Human promyelocytic leukemia HL-60 (IC50=52µM)&&Jurkat cancer cells (IC50=50µM)&&Human gastric carcinoma SNU 601 (IC50=50µM)&&Human breast adenocarcinoma MCF-7 (IC50=38µM),MRKWFHNVLSSGQLLADKWPAWDYNWK,,Linear,Free,Free,,L,dbAMP3,27
23305,dbAMP_23305,,Acute myeloid leukemia AML-2 (IC50=50µM)&&Human promyelocytic leukemia HL-60 (IC50=51µM)&&Jurkat cancer cells (IC50=46µM)&&Human gastric carcinoma SNU 601 (IC50=37µM)&&Human breast adenocarcinoma MCF-7 (IC50=29µM),MWKEFHNVLSSGQLLADKRWARWYNRW,,Linear,Free,Free,,L,dbAMP3,27
23306,dbAMP_23306,,Acute myeloid leukemia AML-2 (IC50=>70µM)&&Human promyelocytic leukemia HL-60 (IC50=>70µM)&&Jurkat cancer cells (IC50=>70µM)&&Human gastric carcinoma SNU 601 (IC50=>70µM)&&Human breast adenocarcinoma MCF-7 (IC50=>70µM),MWKWFHNVLSSGQLLADKWWAWWYNWW,,Linear,Free,Free,,L,dbAMP3,27
23307,dbAMP_23307,,HIV-1 (102% PR activity=1µM)&&Rous sarcoma virus (39.2% PR activity=1µM),MENRWQVM,,Linear,Free,Free,,L,dbAMP3,8
23308,dbAMP_23308,,HIV-1 (105% PR activity=1µM)&&Rous sarcoma virus (48% PR activity=1µM),RIRTWKSLVKHHM,,Linear,Free,Free,,L,dbAMP3,13
23316,dbAMP_23316,,HIV-1 (138% PR activity=1µM)&&Rous sarcoma virus (114% PR activity=1µM),YVSGKARG,,Linear,Free,Free,,L,dbAMP3,8
23317,dbAMP_23317,,HIV-1 (112% PR activity=1µM)&&Rous sarcoma virus (88.2% PR activity=1µM),ISSEVHIPL,,Linear,Free,Free,,L,dbAMP3,9
23372,dbAMP_23372,,Escherichia coli TG1 (IC50=80µM)&&Escherichia coli MG1655 (MIC=12.5µg/ml)&&Staphylococcus aureus 15981 (MIC=25µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=12.5µg/ml)&&Human cervical carcinoma HeLa (50% Cytotoxicity=24.12µg/ml)&&HSV-2 (EC50=5.41µM)&&HSV-2 Roi2 (EC50=9.63µM),ALWDTLLKKVLKAAAKAALDAVLVGANA,,Linear,Free,Free,,L,dbAMP3,28
23417,dbAMP_23417,,Escherichia coli (IC50=101.37µg/ml)&&Escherichia coli (MIC=258.11µg/ml)&&Escherichia coli (IC50=106.49µg/ml)&&Escherichia coli (MIC=231.8µg/ml)&&Klebsiella pneumoniae (IC50=158.66µg/ml)&&Klebsiella pneumoniae (MIC=323.67µg/ml)&&Corynebacterium striatum (IC50=30.44-102.76µg/ml)&&Corynebacterium striatum (MIC=234.53-257.77µg/ml)&&Human colon adenocarcinoma SW620 (70.84±14.6% Cytotoxicity=256µg/ml),TLLKKVLKAAAKAALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,24
23469,dbAMP_23469,,Bacillus subtilis (MIC=6.3µg/ml)&&Micrococcus luteus (MIC=6.3µg/ml)&&Staphylococcus aureus (MIC=3.1µg/ml)&&Staphylococcus epidermidis (MIC=12.5µg/ml)&&Escherichia coli (MIC=12.5µg/ml)&&Shigella dysenteriae (MIC=50µg/ml)&&Salmonella typhimurium (MIC=100µg/ml)&&Klebsiella pneumoniae (MIC=25µg/ml)&&Proteus mirabilis (MIC=>200µg/ml)&&Pseudomonas aeruginosa (MIC=200µg/ml)&&Human renal carcinoma A498 (IC50=138.06µg/ml)&&Human lung carcinoma A549 (IC50=145.72µg/ml)&&Human colon adenocarcinoma HCT 116 (IC50=113.31µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=183.74µg/ml)&&Human gastric cancer MKN 45 (IC50=34.96µg/ml)&&Human liver carcinoma NCI-H630 (IC50=41.85µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=43.64µg/ml)&&Human skin melanoma SK-MEL-2 (IC50=47.47µg/ml)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=38.28µg/ml),FLGALFKVASKVLPSVKCAITKKC,,Linear,Free,Free,,L,dbAMP3,24
23478,dbAMP_23478,,Escherichia coli ML-35p (MIC=4µM)&&Staphylococcus aureus ATCC 700699 (MIC=10µM)&&Plasmodium falciparum (IC50=10µM)&&Candida albicans ATCC 90028 (MIC=31.25µM)&&Candida parapsilosis ATCC 22019 (MIC=125.00µM)&&Candida krusei ATCC 6258 (MIC=31.25µM)&&Candida tropicalis ATCC 750 (MIC=15.62µM)&&Candida dubliniensis ATCC MAY-646 (MIC=125.00µM)&&Candida glabrata ATCC 90030 (MIC=250.00µM)&&Candida kefyr ATCC 2512 (MIC=31.25µM)&&Candida albicans Gu4 (MIC=62.50µM)&&Candida albicans Gu5 (MIC=62.50µM)&&Candida albicans F2 (MIC=62.50µM)&&Candida albicans F5 (MIC=62.50µM)&&Cryptococcus neoformans (MIC=9.04µM)&&Aspergillus niger (MIC=72.32µM)&&Aspergillus flavus NCIM 519 (MIC=144.64µM)&&Aspergillus fumigatus NCIM 902 (MIC=72.32µM)&&Fusarium oxysporum (MIC=72.32µM)&&Neurospora crassa (MIC=72.32µM)&&Human cervical carcinoma HeLa (50% Killing=45µM),KWXWKXVKXAK,,Linear,Free,Free,,L,dbAMP3,11
23479,dbAMP_23479,,Escherichia coli ML-35p (MIC=75µM)&&Staphylococcus aureus ATCC 700699 (MIC=>125µM)&&Plasmodium falciparum (IC50=>40µM)&&Candida albicans ATCC 90028 (MIC=7.81µM)&&Candida parapsilosis ATCC 22019 (MIC=62.50µM)&&Candida krusei ATCC 6258 (MIC=31.25µM)&&Candida tropicalis ATCC 750 (MIC=15.62µM)&&Candida dubliniensis ATCC MAY-646 (MIC=125.00µM)&&Candida glabrata ATCC 90030 (MIC=125.00µM)&&Candida kefyr ATCC 2512 (MIC=31.25µM)&&Candida albicans Gu4 (MIC=31.25µM)&&Candida albicans Gu5 (MIC=31.25µM)&&Candida albicans F2 (MIC=31.25µM)&&Candida albicans F5 (MIC=31.25µM)&&Cryptococcus neoformans (MIC=3.94µM)&&Aspergillus niger (MIC=63.10µM)&&Aspergillus flavus NCIM 519 (MIC=126.2µM)&&Aspergillus fumigatus NCIM 902 (MIC=63.10µM)&&Fusarium oxysporum (MIC=63.10µM)&&Neurospora crassa (MIC=63.10µM)&&Human cervical carcinoma HeLa (50% Killing=32µM),KAXWKXVKXAK,,Linear,Free,Free,,L,dbAMP3,11
23480,dbAMP_23480,,Escherichia coli ML-35p (MIC=15µM)&&Staphylococcus aureus ATCC 700699 (MIC=35µM)&&Plasmodium falciparum (IC50=15µM)&&Candida albicans ATCC 90028 (MIC=3.91µM)&&Candida parapsilosis ATCC 22019 (MIC=31.25µM)&&Candida krusei ATCC 6258 (MIC=15.62µM)&&Candida tropicalis ATCC 750 (MIC=3.91µM)&&Candida dubliniensis ATCC MAY-646 (MIC=31.25µM)&&Candida glabrata ATCC 90030 (MIC=125.00µM)&&Candida kefyr ATCC 2512 (MIC=3.91µM)&&Candida albicans Gu4 (MIC=15.62µM)&&Candida albicans Gu5 (MIC=15.62µM)&&Candida albicans F2 (MIC=15.62µM)&&Candida albicans F5 (MIC=15.62µM)&&Cryptococcus neoformans (MIC=4.21µM)&&Aspergillus niger (MIC=67.31µM)&&Aspergillus flavus NCIM 519 (MIC=67.31µM)&&Aspergillus fumigatus NCIM 902 (MIC=33.66µM)&&Fusarium oxysporum (MIC=67.31µM)&&Neurospora crassa (MIC=67.31µM)&&Human cervical carcinoma HeLa (50% Killing=23µM),KWXWKXAKXAK,,Linear,Free,Free,,L,dbAMP3,11
23519,dbAMP_23519,,Corynebacterium glutamicum CGMCC 1.1886 (MIC=12µM)&&Staphylococcus aureus CGMCC 1.0363 (MIC=12µM)&&Escherichia coli ATCC 25922 (MIC=24µM)&&Aeromonas hydrophila CGMCC 1.0927 (MIC=12µM)&&Pseudomonas stutzeri CGMCC 1.1803 (MIC=12µM)&&Vibrio alginolyticus CGMCC 1.1833 (MIC=>48µM)&&Vibrio parahaemolyticus CGMCC 1.1615 (MIC=>48µM)&&Human hepatocellular carcinoma HepG2 (40% Killing=25µM),QSHLSMCSVCCNCCKNYKGCGFCCRF,,Linear,Free,Free,,L,dbAMP3,26
23520,dbAMP_23520,,Corynebacterium glutamicum CGMCC 1.1886 (MIC=3-6µM)&&Staphylococcus aureus CGMCC 1.0363 (MIC=1.5-3µM)&&Escherichia coli ATCC 25922 (MIC=6-12µM)&&Aeromonas hydrophila CGMCC 1.0927 (MIC=1.5-3µM)&&Pseudomonas stutzeri CGMCC 1.1803 (MIC=3-6µM)&&Vibrio alginolyticus CGMCC 1.1833 (MIC=>48µM)&&Vibrio parahaemolyticus CGMCC 1.1615 (MIC=>48µM)&&Human hepatocellular carcinoma HepG2 (40% Killing=5µM),MGSSHHHHHHSSGLVPRGSHMIPVNGVTELEEAASNDTPVAARHEMSMQSWMMPNHIREKRQSHLSMCSVCCNCCKNYKGCGFCCRF,,Linear,Free,Free,,L,dbAMP3,87
23629,dbAMP_23629,,Escherichia coli BL2 (MIC=0.62±0.07µM)&&Pseudomonas sp. ATCC 15915 (MIC=0.6±0.1µM)&&Acinetobacter baumannii ATCC 15308 (MIC=0.6±0.1µM)&&Staphylococcus aureus ATCC 502A (MIC=0.62±0.07µM)&&Micrococcus luteus ATCC 7468 (MIC=1.5±0.3µM)&&Enterococcus faecium ATCC 19434 (MIC=0.87±0.07µM)&&Mycobacterium vaccae ATCC 15483 (MIC=10.0±0.5µM)&&Mycobacterium vaccae ATCC 15483 (IC50=4.2±0.2µM)&&Candida albicans ATCC 90028 (MFC=0.62±0.20µM)&&Candida albicans ATCC 90028 (IC50=0.22±0.05µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,,Linear,Free,Free,,L,dbAMP3,45
23636,dbAMP_23636,,Bacillus subtilis (MIC=12.5µg/ml)&&Micrococcus luteus (MIC=50µg/ml)&&Staphylococcus aureus (MIC=12.5µg/ml)&&Staphylococcus epidermidis (MIC=25µg/ml)&&Escherichia coli (MIC=25µg/ml)&&Shigella dysenteriae (MIC=25µg/ml)&&Salmonella typhimurium (MIC=100µg/ml)&&Klebsiella pneumoniae (MIC=12.5µg/ml)&&Proteus mirabilis (MIC=>200µg/ml)&&Pseudomonas aeruginosa (MIC=200µg/ml)&&Human renal carcinoma A498 (IC50=214.33µg/ml)&&Human lung carcinoma A549 (IC50=418.15µg/ml)&&Human colon adenocarcinoma HCT 116 (IC50=144.37µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=198.87µg/ml)&&Human gastric cancer MKN 45 (IC50=142.72µg/ml)&&Human liver carcinoma NCI-H630 (IC50=129.54µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=174.15µg/ml)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=150.45µg/ml),FLGALFKWASK,,Linear,Free,Free,,L,dbAMP3,11
23916,dbAMP_23916,,Mycobacterium tuberculosis lux (MIC90=2.4µM)&&Mycobacterium tuberculosis lux (MIC50=1.2µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.4µM)&&Pseudomonas aeruginosa H103 (MIC=5.7µM)&&Escherichia coli UB1005 (MIC=1.4µM)&&Salmonella enterica serovar Typhimurium (MIC=2.9µM)&&Candida albicans (MIC=5.7µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.9µM)&&Mycobacterium abscessus ATCC 19977 (MIC=>50µg/ml)&&Mycobacterium abscessus subsp. massiliense (MIC=>50µg/ml)&&Human acute monocytic leukemia THP-1 (IC50=25.2µM),ILRWKWRWWRWRR,,Linear,Free,Free,,L,dbAMP3,13
23917,dbAMP_23917,,Mycobacterium tuberculosis lux (MIC90=2.8µM)&&Mycobacterium tuberculosis lux (MIC50=0.9µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.7µM)&&Pseudomonas aeruginosa H103 (MIC=11.2µM)&&Escherichia coli UB1005 (MIC=1.4µM)&&Salmonella enterica serovar Typhimurium (MIC=2.8µM)&&Candida albicans (MIC=5.6µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.8µM)&&Human acute monocytic leukemia THP-1 (IC50=73.0µM),RWRRKWWWW,,Linear,Free,Free,,L,dbAMP3,9
23918,dbAMP_23918,,Mycobacterium tuberculosis lux (MIC90=3.6µM)&&Mycobacterium tuberculosis lux (MIC50=0.9µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.8µM)&&Pseudomonas aeruginosa H103 (MIC=5.4µM)&&Escherichia coli UB1005 (MIC=2.7µM)&&Salmonella enterica serovar Typhimurium (MIC=2.7µM)&&Candida albicans (MIC=5.4µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.4µM)&&Human acute monocytic leukemia THP-1 (IC50=152.6µM),RRWWKWWWR,,Linear,Free,Free,,L,dbAMP3,9
23920,dbAMP_23920,,Mycobacterium tuberculosis lux (MIC90=4.2µM)&&Mycobacterium tuberculosis lux (MIC50=2.1µM)&&Mycobacterium smegmatis mc2-6 (MIC90=6.4µM)&&Pseudomonas aeruginosa H103 (MIC=4.6µM)&&Escherichia coli UB1005 (MIC=4.6µM)&&Salmonella enterica serovar Typhimurium (MIC=4.6µM)&&Candida albicans (MIC=4.6µM)&&Staphylococcus epidermidis (MIC=1.2µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.2µM)&&Enterococcus faecalis ATCC 29212 (MIC=4.6µM)&&Human acute monocytic leukemia THP-1 (IC50=90.4µM),KWKWWWRKI,,Linear,Free,Free,,L,dbAMP3,9
23921,dbAMP_23921,,Mycobacterium tuberculosis lux (MIC90=4.5µM)&&Mycobacterium tuberculosis lux (MIC50=1.5µM)&&Mycobacterium smegmatis mc2-6 (MIC90=3.0µM)&&Pseudomonas aeruginosa H103 (MIC=9.8µM)&&Escherichia coli UB1005 (MIC=1.2µM)&&Salmonella enterica serovar Typhimurium (MIC=4.9µM)&&Candida albicans (MIC=9.8µM)&&Staphylococcus epidermidis (MIC=1.2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.4µM)&&Enterococcus faecalis ATCC 29212 (MIC=9.8µM)&&Human acute monocytic leukemia THP-1 (IC50=96.1Unknown Unit),RLKRWWKFL,,Linear,Free,Free,,L,dbAMP3,9
23922,dbAMP_23922,,Mycobacterium tuberculosis lux (MIC90=4.6µM)&&Mycobacterium tuberculosis lux (MIC50=1.7µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.6µM)&&Pseudomonas aeruginosa H103 (MIC=10.3µM)&&Escherichia coli UB1005 (MIC=2.6µM)&&Salmonella enterica serovar Typhimurium (MIC=5.2µM)&&Candida albicans (MIC=2.6µM)&&Staphylococcus epidermidis (MIC=0.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.6µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.2µM)&&Human acute monocytic leukemia THP-1 (IC50=147.5µM),RWWRWRKWW,,Linear,Free,Free,,L,dbAMP3,9
23923,dbAMP_23923,,Mycobacterium tuberculosis lux (MIC90=5.2µM)&&Mycobacterium tuberculosis lux (MIC50=2.0µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.2µM)&&Pseudomonas aeruginosa H103 (MIC=46.9µM)&&Escherichia coli UB1005 (MIC=2.9µM)&&Salmonella enterica serovar Typhimurium (MIC=5.9µM)&&Candida albicans (MIC=5.9µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=11.7µM)&&Human acute monocytic leukemia THP-1 (IC50=83.4µM),KRWWWWRFR,,Linear,Free,Free,,L,dbAMP3,9
23924,dbAMP_23924,,Mycobacterium tuberculosis lux (MIC90=5.3µM)&&Mycobacterium tuberculosis lux (MIC50=2.0µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.3µM)&&Pseudomonas aeruginosa H103 (MIC=43.2µM)&&Escherichia coli UB1005 (MIC=2.7µM)&&Salmonella enterica serovar Typhimurium (MIC=5.4µM)&&Candida albicans (MIC=5.4µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=10.8µM)&&Human acute monocytic leukemia THP-1 (IC50=84.4µM),KRWWRKWWR,,Linear,Free,Free,,L,dbAMP3,9
23927,dbAMP_23927,,Mycobacterium tuberculosis lux (MIC90=5.9µM)&&Mycobacterium tuberculosis lux (MIC50=0.7µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.2µM)&&Pseudomonas aeruginosa H103 (MIC=46.1µM)&&Escherichia coli UB1005 (MIC=5.8µM)&&Salmonella enterica serovar Typhimurium (MIC=23.1µM)&&Candida albicans (MIC=11.5µM)&&Staphylococcus epidermidis (MIC=2.9µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.9µM)&&Enterococcus faecalis ATCC 29212 (MIC=11.5µM)&&Human acute monocytic leukemia THP-1 (IC50=189.3µM),WFKMRWWGR,,Linear,Free,Free,,L,dbAMP3,9
23929,dbAMP_23929,,Mycobacterium tuberculosis lux (MIC90=6.1µM)&&Mycobacterium tuberculosis lux (MIC50=2.3µM)&&Mycobacterium smegmatis mc2-6 (MIC90=15.3µM)&&Pseudomonas aeruginosa H103 (MIC=4.6µM)&&Escherichia coli UB1005 (MIC=0.6µM)&&Salmonella enterica serovar Typhimurium (MIC=2.3µM)&&Candida albicans (MIC=4.6µM)&&Staphylococcus epidermidis (MIC=0.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.2µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.3µM)&&Human acute monocytic leukemia THP-1 (IC50=49.0µM),KFKWWRMLI,,Linear,Free,Free,,L,dbAMP3,9
23930,dbAMP_23930,,Mycobacterium tuberculosis lux (MIC90=7.8µM)&&Mycobacterium tuberculosis lux (MIC50=1.3µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.6µM)&&Pseudomonas aeruginosa H103 (MIC=86.3µM)&&Escherichia coli UB1005 (MIC=2.7µM)&&Salmonella enterica serovar Typhimurium (MIC=2.7µM)&&Candida albicans (MIC=5.4µM)&&Staphylococcus epidermidis (MIC=1.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.3µM)&&Enterococcus faecalis ATCC 29212 (MIC=10.8µM)&&Human acute monocytic leukemia THP-1 (IC50=167.2µM),RIKRWWWWR,,Linear,Free,Free,,L,dbAMP3,9
23931,dbAMP_23931,,Mycobacterium tuberculosis lux (MIC90=8.0µM)&&Mycobacterium tuberculosis lux (MIC50=4.0µM)&&Mycobacterium smegmatis mc2-6 (MIC90=6.7µM)&&Pseudomonas aeruginosa H103 (MIC=13.2µM)&&Escherichia coli UB1005 (MIC=1.6µM)&&Salmonella enterica serovar Typhimurium (MIC=3.3µM)&&Candida albicans (MIC=13.2µM)&&Staphylococcus epidermidis (MIC=1.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.3µM)&&Enterococcus faecalis ATCC 29212 (MIC=3.3µM)&&Human acute monocytic leukemia THP-1 (IC50=171.5µM),RWRWWWRVY,,Linear,Free,Free,,L,dbAMP3,9
23932,dbAMP_23932,,Mycobacterium tuberculosis lux (MIC90=8.2µM)&&Mycobacterium tuberculosis lux (MIC50=3.1µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.1µM)&&Pseudomonas aeruginosa H103 (MIC=32.0µM)&&Escherichia coli UB1005 (MIC=8.0µM)&&Salmonella enterica serovar Typhimurium (MIC=4.0µM)&&Candida albicans (MIC=8.0µM)&&Staphylococcus epidermidis (MIC=1.0µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.0µM)&&Enterococcus faecalis ATCC 29212 (MIC=16.0µM)&&Human acute monocytic leukemia THP-1 (IC50=65.8µM),HQFRFRFRVRRK,,Linear,Free,Free,,L,dbAMP3,12
23933,dbAMP_23933,,Mycobacterium tuberculosis lux (MIC90=8.8µM)&&Mycobacterium tuberculosis lux (MIC50=3.6µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.1µM)&&Pseudomonas aeruginosa H103 (MIC=19.1µM)&&Escherichia coli UB1005 (MIC=2.4µM)&&Salmonella enterica serovar Typhimurium (MIC=9.6µM)&&Candida albicans (MIC=19.1µM)&&Staphylococcus epidermidis (MIC=1.2µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.4µM)&&Enterococcus faecalis ATCC 29212 (MIC=9.6µM)&&Human acute monocytic leukemia THP-1 (IC50=186.7µM),LKRRWKWWI,,Linear,Free,Free,,L,dbAMP3,9
23934,dbAMP_23934,,Mycobacterium tuberculosis lux (MIC90=9.0µM)&&Mycobacterium tuberculosis lux (MIC50=1.1µM)&&Mycobacterium smegmatis mc2-6 (MIC90=3.8µM)&&Pseudomonas aeruginosa H103 (MIC=22.5µM)&&Escherichia coli UB1005 (MIC=2.8µM)&&Salmonella enterica serovar Typhimurium (MIC=11.3µM)&&Candida albicans (MIC=5.6µM)&&Staphylococcus epidermidis (MIC=1.4µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.4µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.6µM)&&Human acute monocytic leukemia THP-1 (IC50=192.8Unknown Unit),RLWWKIWLK,,Linear,Free,Free,,L,dbAMP3,9
23935,dbAMP_23935,,Mycobacterium tuberculosis lux (MIC90=11.9µM)&&Mycobacterium tuberculosis lux (MIC50=1.1µM)&&Mycobacterium smegmatis mc2-6 (MIC90=1.3µM)&&Pseudomonas aeruginosa H103 (MIC=15.3µM)&&Escherichia coli UB1005 (MIC=3.8µM)&&Salmonella enterica serovar Typhimurium (MIC=7.6µM)&&Candida albicans (MIC=7.6µM)&&Staphylococcus epidermidis (MIC=1.0µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.9µM)&&Enterococcus faecalis ATCC 29212 (MIC=3.8µM)&&Human acute monocytic leukemia THP-1 (IC50=190.8µM),FFIYVWRRR,,Linear,Free,Free,,L,dbAMP3,9
23936,dbAMP_23936,,Mycobacterium tuberculosis lux (MIC90=13.7µM)&&Mycobacterium tuberculosis lux (MIC50=1.1µM)&&Mycobacterium smegmatis mc2-6 (MIC90=0.3µM)&&Pseudomonas aeruginosa H103 (MIC=16.0µM)&&Escherichia coli UB1005 (MIC=2.0µM)&&Salmonella enterica serovar Typhimurium (MIC=4.0µM)&&Candida albicans (MIC=16.0µM)&&Staphylococcus epidermidis (MIC=2.0µM)&&Staphylococcus aureus ATCC 25923 (MIC=4.0µM)&&Enterococcus faecalis ATCC 29212 (MIC=16.0µM)&&Human acute monocytic leukemia THP-1 (IC50=219.0µM),IRMRIRVLL,,Linear,Free,Free,,L,dbAMP3,9
23937,dbAMP_23937,,Mycobacterium tuberculosis lux (MIC90=17.0µM)&&Mycobacterium tuberculosis lux (MIC50=0.7µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.2µM)&&Pseudomonas aeruginosa H103 (MIC=25.7µM)&&Escherichia coli UB1005 (MIC=3.2µM)&&Salmonella enterica serovar Typhimurium (MIC=6.4µM)&&Candida albicans (MIC=6.4µM)&&Staphylococcus epidermidis (MIC=1.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.6µM)&&Enterococcus faecalis ATCC 29212 (MIC=6.4µM)&&Human acute monocytic leukemia THP-1 (IC50=181.0µM),LRFILWWKR,,Linear,Free,Free,,L,dbAMP3,9
23938,dbAMP_23938,,Mycobacterium tuberculosis lux (MIC90=17.0µM)&&Mycobacterium tuberculosis lux (MIC50=1.4µM)&&Mycobacterium smegmatis mc2-6 (MIC90=1.6µM)&&Pseudomonas aeruginosa H103 (MIC=10.7µM)&&Escherichia coli UB1005 (MIC=1.3µM)&&Salmonella enterica serovar Typhimurium (MIC=2.7µM)&&Candida albicans (MIC=10.7µM)&&Staphylococcus epidermidis (MIC=1.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.3µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.7µM)&&Human acute monocytic leukemia THP-1 (IC50=181.8µM),RWWIRIRWH,,Linear,Free,Free,,L,dbAMP3,9
23939,dbAMP_23939,,Mycobacterium tuberculosis lux (MIC90=17.6µM)&&Mycobacterium tuberculosis lux (MIC50=3.7µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.2µM)&&Pseudomonas aeruginosa H103 (MIC=11.0µM)&&Escherichia coli UB1005 (MIC=2.7µM)&&Salmonella enterica serovar Typhimurium (MIC=11.0µM)&&Candida albicans (MIC=21.9µM)&&Staphylococcus epidermidis (MIC=2.7-1.4µM)&&Staphylococcus aureus ATCC 25923 (MIC=5.5µM)&&Enterococcus faecalis ATCC 29212 (MIC=21.9µM)&&Human acute monocytic leukemia THP-1 (IC50=47.0µM),RRRWWKLMM,,Linear,Free,Free,,L,dbAMP3,9
23940,dbAMP_23940,,Mycobacterium tuberculosis lux (MIC90=17.7µM)&&Mycobacterium tuberculosis lux (MIC50=0.7µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.2µM)&&Pseudomonas aeruginosa H103 (MIC=21.4µM)&&Escherichia coli UB1005 (MIC=0.7µM)&&Salmonella enterica serovar Typhimurium (MIC=5.4µM)&&Candida albicans (MIC=10.7µM)&&Staphylococcus epidermidis (MIC=1.3-0.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.3µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.4µM)&&Human acute monocytic leukemia THP-1 (IC50=94.5µM),LRRWIRIRW,,Linear,Free,Free,,L,dbAMP3,9
23941,dbAMP_23941,,Mycobacterium tuberculosis lux (MIC90=17.8µM)&&Mycobacterium tuberculosis lux (MIC50=2.2µM)&&Mycobacterium smegmatis mc2-6 (MIC90=3.7µM)&&Pseudomonas aeruginosa H103 (MIC=21.9µM)&&Escherichia coli UB1005 (MIC=27.0µM)&&Salmonella enterica serovar Typhimurium (MIC=5.5µM)&&Candida albicans (MIC=21.9µM)&&Staphylococcus epidermidis (MIC=1.4-0.5µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.4µM)&&Enterococcus faecalis ATCC 29212 (MIC=10.9µM)&&Human acute monocytic leukemia THP-1 (IC50=190.2µM),RKFRWWVIR,,Linear,Free,Free,,L,dbAMP3,9
23942,dbAMP_23942,,Mycobacterium tuberculosis lux (MIC90=29.8µM)&&Mycobacterium tuberculosis lux (MIC50=7.4µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.0µM)&&Pseudomonas aeruginosa H103 (MIC=8.0µM)&&Escherichia coli UB1005 (MIC=4.0µM)&&Salmonella enterica serovar Typhimurium (MIC=4.0µM)&&Candida albicans (MIC=16.0µM)&&Staphylococcus epidermidis (MIC=0.5µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.0µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.0µM)&&Human acute monocytic leukemia THP-1 (IC50=158.8µM),RLRRIVVIRVFR,,Linear,Free,Free,,L,dbAMP3,12
23943,dbAMP_23943,,Mycobacterium tuberculosis lux (MIC90=33.2µM)&&Mycobacterium tuberculosis lux (MIC50=1.0µM)&&Mycobacterium smegmatis mc2-6 (MIC90=16.6µM)&&Pseudomonas aeruginosa H103 (MIC=12.5µM)&&Escherichia coli UB1005 (MIC=1.6µM)&&Salmonella enterica serovar Typhimurium (MIC=6.3µM)&&Candida albicans (MIC=12.5µM)&&Staphylococcus epidermidis (MIC=3.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µM)&&Enterococcus faecalis ATCC 29212 (MIC=12.5µM)&&Human acute monocytic leukemia THP-1 (IC50=176.9µM),RRYHWRIYI,,Linear,Free,Free,,L,dbAMP3,9
23944,dbAMP_23944,,Mycobacterium tuberculosis lux (MIC90=34.5µM)&&Mycobacterium tuberculosis lux (MIC50=2.2µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.9µM)&&Pseudomonas aeruginosa H103 (MIC=5.2µM)&&Escherichia coli UB1005 (MIC=0.7µM)&&Salmonella enterica serovar Typhimurium (MIC=2.6µM)&&Candida albicans (MIC=10.5µM)&&Staphylococcus epidermidis (MIC=1.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.6µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.2µM)&&Human acute monocytic leukemia THP-1 (IC50=91.9µM),RKWKIKWYW,,Linear,Free,Free,,L,dbAMP3,9
23945,dbAMP_23945,,Mycobacterium tuberculosis lux (MIC90=51.5µM)&&Mycobacterium tuberculosis lux (MIC50=19.3µM)&&Mycobacterium smegmatis mc2-6 (MIC90=0.8µM)&&Pseudomonas aeruginosa H103 (MIC=5.4µM)&&Escherichia coli UB1005 (MIC=1.3µM)&&Salmonella enterica serovar Typhimurium (MIC=2.7µM)&&Candida albicans (MIC=10.8µM)&&Staphylococcus epidermidis (MIC=1.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.7µM)&&Human acute monocytic leukemia THP-1 (IC50=206.0µM),WKWRVRVTI,,Linear,Free,Free,,L,dbAMP3,9
23946,dbAMP_23946,,Mycobacterium tuberculosis lux (MIC90=109.3µM)&&Mycobacterium tuberculosis lux (MIC50=10.9µM)&&Mycobacterium smegmatis mc2-6 (MIC90=38.3µM)&&Pseudomonas aeruginosa H103 (MIC=>86.5µM)&&Escherichia coli UB1005 (MIC=86.5µM)&&Salmonella enterica serovar Typhimurium (MIC=>86.5µM)&&Candida albicans (MIC=86.5µM)&&Staphylococcus epidermidis (MIC=43.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=86.5µM)&&Enterococcus faecalis ATCC 29212 (MIC=>86.5µM)&&Human acute monocytic leukemia THP-1 (IC50=174.9µM),NWRKLYRRK,,Linear,Free,Free,,L,dbAMP3,9
23949,dbAMP_23949,,Mycobacterium tuberculosis lux (MIC90=130.0µM)&&Mycobacterium tuberculosis lux (MIC50=16.2µM)&&Mycobacterium smegmatis mc2-6 (MIC90=16.2µM)&&Pseudomonas aeruginosa H103 (MIC=>92.8µM)&&Escherichia coli UB1005 (MIC=2.9µM)&&Salmonella enterica serovar Typhimurium (MIC=>92.8µM)&&Candida albicans (MIC=>92.8µM)&&Staphylococcus epidermidis (MIC=1.4µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.9µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.9µM)&&Human acute monocytic leukemia THP-1 (IC50=173.3µM),YKFRWRIYI,,Linear,Free,Free,,L,dbAMP3,9
23950,dbAMP_23950,,Mycobacterium tuberculosis lux (MIC90=141.0µM)&&Mycobacterium tuberculosis lux (MIC50=8.8µM)&&Mycobacterium smegmatis mc2-6 (MIC90=8.8µM)&&Pseudomonas aeruginosa H103 (MIC=165-80.3µM)&&Escherichia coli UB1005 (MIC=20.6µM)&&Salmonella enterica serovar Typhimurium (MIC=20.6µM)&&Candida albicans (MIC=41.2µM)&&Staphylococcus epidermidis (MIC=2.6µM)&&Enterococcus faecalis ATCC 29212 (MIC=10.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.6µM)&&Human acute monocytic leukemia THP-1 (IC50=188.0µM),KRKKRFKWW,,Linear,Free,Free,,L,dbAMP3,9
23962,dbAMP_23962,,Escherichia coli ATCC 25922 (MIC=5.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=20µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Jurkat T-cell leukemia (IC50=12.0µM),FPVTWKWWKWWKG,,Linear,Free,Free,,L,dbAMP3,13
23964,dbAMP_23964,,Escherichia coli ATCC 25922 (MIC=6.0µM)&&Staphylococcus aureus ATCC 25923 (MIC=<3.0µM)&&Jurkat T-cell leukemia (IC50=>=65µM),FRVTWRTKWWKG,,Linear,Free,Free,,L,dbAMP3,12
23968,dbAMP_23968,,Mycobacterium vaccae ATCC 15483 (MIC=20.0±0.8µM)&&Mycobacterium vaccae ATCC 15483 (IC50=9.5±0.3µM)&&Escherichia coli BL2 (MIC=1.2µM)&&Pseudomonas sp. ATCC 15915 (MIC=1.2µM)&&Acinetobacter baumannii ATCC 15308 (MIC=1.2µM)&&Staphylococcus aureus ATCC 502A (MIC=10µM)&&Micrococcus luteus ATCC 7468 (MIC=5µM)&&Enterococcus faecium ATCC 19434 (MIC=2.5µM)&&Candida albicans ATCC 90028 (MFC=0.93±0.2µM)&&Candida albicans ATCC 90028 (IC50=0.45±0.1µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH,,Linear,Free,Free,,L,dbAMP3,45
23975,dbAMP_23975,,Bacillus subtilis MTCC 2756 (MIC=250µg/ml)&&Bacillus subtilis MTCC 2756 (MBC=500µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=125µg/ml)&&Staphylococcus aureus MTCC 902 (MBC=250µg/ml)&&Escherichia coli MTCC 2622 (MIC=500µg/ml)&&Escherichia coli MTCC 2622 (MBC=1000µg/ml)&&Staphylococcus simulans MTCC 3610 (MIC=125µg/ml)&&Staphylococcus simulans MTCC 3610 (MBC=125µg/ml)&&Aspergillus flavus MTCC 183 (MIC=16µg/ml)&&Candida albicans MTCC 277 (MIC=16µg/ml)&&Fusarium oxysporum MTCC 284 (MIC=8µg/ml)&&Rhizoctonia solani MTCC 4634 (MIC=32µg/ml)&&Penicillium expansum MTCC 2006 (MIC=32µg/ml)&&Goffeauzyma gastrica MTCC 1715 (MIC=64µg/ml)&&Candida tropicalis MTCC 184 (MIC=64µg/ml)&&Human myelogenous leukemia K562 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM)&&Human cervical carcinoma HeLa (IC50=>200µM)&&Human hepatocellular carcinoma HepG2 (IC50=>200µM)&&Human lung carcinoma A549 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Bacillus subtilis ATCC 23857 (MIC=256µg/ml)&&Staphylococcus aureus ATCC 12600 (MIC=128µg/ml)&&Staphylococcus simulans ATCC 27848 (MIC=128µg/ml)&&Escherichia coli ATCC 35218 (MIC=512µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=16µg/ml)&&Candida albicans ATCC 10231 (MIC=16µg/ml)&&Goffeauzyma gastrica ATCC 32042 (MIC=64µg/ml)&&Fusarium oxysporum ATCC 14838 (MIC=8µg/ml)&&Rhizoctonia solani ATCC 10182 (MIC=32µg/ml)&&Penicillium expansum ATCC 16104 (MIC=32µg/ml)&&Alternaria brassicae ATCC 66981 (MIC=64µg/ml),WL,,Linear,Free,Free,,L,dbAMP3,2
24165,dbAMP_24165,5V0Y,Escherichia coli ATCC 25922 (MIC=0.25-0.5µg/ml)&&Escherichia coli ATCC 25404 (MIC=0.5µg/ml)&&Klebsiella aerogenes ATCC 13048 (MIC=1µg/ml)&&Enterobacter cloacae ATCC 13047 (MIC=1µg/ml)&&Shigella sonnei ATCC 11060 (MIC=0.5µg/ml)&&Citrobacter freundii ATCC 8090 (MIC=1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=0.5-1µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=1µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=1µg/ml)&&Aeromonas salmonicida ATCC 14174 (MIC=2µg/ml)&&Acinetobacter lwoffii ATCC 15309 (MIC=0.25µg/ml)&&Moraxella catarrhalis ATCC 25238 (MIC=<0.06µg/ml)&&Candida albicans ATCC 10231 (MIC=4µg/ml)&&Candida albicans ATCC 28517 (MIC=8µg/ml)&&Candida albicans ATCC 18804 (MIC=8µg/ml)&&Candida tropicalis DSM 11953 (MIC=2µg/ml)&&Candida glabrata DSM 11226 (MIC=16µg/ml)&&Cryptococcus neoformans DSM 11959 (MIC=1µg/ml)&&Pichia pastoris ATCC 201178 (MIC=4µg/ml)&&Pichia pastoris ATCC 20864 (MIC=2µg/ml)&&Saccharomyces cerevisiae DSM 1333 (MIC=8µg/ml)&&Aspergillus niger ATCC 9642 (MIC=8µg/ml)&&Trichophyton mentagrophytes DSM 4870 (MIC=8µg/ml)&&Escherichia coli ATCC 700926 (MIC=0.25µg/ml)&&Escherichia coli MB4902 (MIC=0.125µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=1µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=4µg/ml)&&Klebsiella pneumoniae ATCC BAA-2146 (MIC=4µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=64µg/ml)&&Candida albicans ATCC 90028 (MIC=64µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=8µg/ml)&&Human hepatocellular carcinoma HepG2 (IC50=>300µg/ml)&&Escherichia coli ATCC 25922 (MIC=0.5µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=1µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=0.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µg/ml)&&Bacillus subtilis ATCC 6051 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=>32µg/ml),GFCWYVCVYRNGVRVCYRRCN,,Linear,Free,Free,,L,dbAMP3,21
24238,dbAMP_24238,,Staphylococcus epidermidis ATCC 12228 (MIC=23µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MBC=23µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi DMST 22842 (MIC=23µg/ml)&&Escherichia coli ATCC 25922 (MIC=11µg/ml)&&Escherichia coli ATCC 25922 (MBC=11µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=46µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=91µg/ml)&&Vibrio cholerae non-O1 (MIC=11µg/ml)&&Vibrio cholerae non-O139 (MIC=11µg/ml)&&Escherichia coli O157:H7 (MIC=11µg/ml)&&Human cervical carcinoma HeLa (IC50=53.41±1.0µM)&&Human cervical carcinoma CaSki (IC50=30.81±0.2µM)&&Human colon adenocarcinoma HCT 116 (IC50=50µM),NGVQPKYKWWKWWKKWW,,Linear,Free,Free,,L,dbAMP3,17
24274,dbAMP_24274,,Escherichia coli BL2 (MIC=9µM)&&Pseudomonas sp. ATCC 15915 (MIC=9µM)&&Acinetobacter baumannii ATCC 15308 (MIC=9µM)&&Staphylococcus aureus ATCC 502A (MIC=5µM)&&Micrococcus luteus ATCC 7468 (MIC=9µM)&&Enterococcus faecium ATCC 19434 (MIC=5µM)&&Candida albicans ATCC 90028 (MFC=3.75±0.50µM)&&Candida albicans ATCC 90028 (IC50=2.10±0.20µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH,,Linear,Free,Free,,L,dbAMP3,48
24275,dbAMP_24275,,Escherichia coli BL2 (MIC=>10µM)&&Pseudomonas sp. ATCC 15915 (MIC=>10µM)&&Acinetobacter baumannii ATCC 15308 (MIC=>10µM)&&Staphylococcus aureus ATCC 502A (MIC=>10µM)&&Micrococcus luteus ATCC 7468 (MIC=>10µM)&&Enterococcus faecium ATCC 19434 (MIC=10µM)&&Candida albicans ATCC 90028 (MFC=>20µM)&&Candida albicans ATCC 90028 (IC50=>20µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL,,Linear,Free,Free,,L,dbAMP3,45
24277,dbAMP_24277,,Escherichia coli BL2 (MIC=0.3µM)&&Pseudomonas sp. ATCC 15915 (MIC=0.4µM)&&Acinetobacter baumannii ATCC 15308 (MIC=0.5µM)&&Staphylococcus aureus ATCC 502A (MIC=0.3µM)&&Micrococcus luteus ATCC 7468 (MIC=1.2µM)&&Enterococcus faecium ATCC 19434 (MIC=0.8µM)&&Candida albicans ATCC 90028 (MFC=4±0.50µM)&&Candida albicans ATCC 90028 (IC50=1.8±0.3µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH,,Linear,Free,Free,,L,dbAMP3,47
24278,dbAMP_24278,,Escherichia coli BL2 (MIC=>10µM)&&Pseudomonas sp. ATCC 15915 (MIC=>10µM)&&Acinetobacter baumannii ATCC 15308 (MIC=>10µM)&&Staphylococcus aureus ATCC 502A (MIC=>10µM)&&Micrococcus luteus ATCC 7468 (MIC=>10µM)&&Enterococcus faecium ATCC 19434 (MIC=>10µM)&&Candida albicans ATCC 90028 (MFC=>20µM)&&Candida albicans ATCC 90028 (IC50=>20µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH,,Linear,Free,Free,,L,dbAMP3,47
24279,dbAMP_24279,,Escherichia coli BL2 (MIC=1.2µM)&&Pseudomonas sp. ATCC 15915 (MIC=1.2µM)&&Acinetobacter baumannii ATCC 15308 (MIC=1.2µM)&&Staphylococcus aureus ATCC 502A (MIC=5µM)&&Micrococcus luteus ATCC 7468 (MIC=2.5µM)&&Enterococcus faecium ATCC 19434 (MIC=2.5µM)&&Candida albicans ATCC 90028 (MFC=2±0.5µM)&&Candida albicans ATCC 90028 (IC50=1.8±0.2µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH,,Linear,Free,Free,,L,dbAMP3,45
24280,dbAMP_24280,,Escherichia coli BL2 (MIC=>10µM)&&Pseudomonas sp. ATCC 15915 (MIC=10µM)&&Acinetobacter baumannii ATCC 15308 (MIC=>10µM)&&Staphylococcus aureus ATCC 502A (MIC=>10µM)&&Micrococcus luteus ATCC 7468 (MIC=>10µM)&&Enterococcus faecium ATCC 19434 (MIC=>10µM)&&Candida albicans ATCC 90028 (MFC=>10µM)&&Candida albicans ATCC 90028 (IC50=>10µM)&&Human acute monocytic leukemia THP-1 (IC50=>50µM),KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH,,Linear,Free,Free,,L,dbAMP3,45
24336,dbAMP_24336,,Staphylococcus aureus (MIC=3±1.4µM)&&Staphylococcus epidermidis (MIC=4.3±2µM)&&Pseudomonas aeruginosa (MIC=58±16µM)&&Escherichia coli (MIC=24±17.1µM)&&Human cervical carcinoma HeLa (EC50=6µM)&&Human epidermoid carcinoma A431 (EC50=6µM)&&Human promyelocytic leukemia HL-60 (EC50=11µM)&&Human lung carcinoma A549 (EC50=7µM),XKLXGGLXGIX,,Linear,Free,Free,,L,dbAMP3,11
24338,dbAMP_24338,,Staphylococcus aureus (MIC=5.3±2.1µM)&&Staphylococcus epidermidis (MIC=4.7±1.6µM)&&Pseudomonas aeruginosa (MIC=57±16µM)&&Escherichia coli (MIC=32±17.5µM)&&Human cervical carcinoma HeLa (EC50=10µM)&&Human epidermoid carcinoma A431 (EC50=7.5µM)&&Human promyelocytic leukemia HL-60 (EC50=8µM)&&Human lung carcinoma A549 (EC50=10µM),XGLXGGLXKIX,,Linear,Free,Free,,L,dbAMP3,11
24360,dbAMP_24360,,Human lung carcinoma A549 (IC50=1.15±0.20µM)&&Human breast adenocarcinoma MCF-7 (IC50=1.43±0.65µM)&&Human colon adenocarcinoma LoVo (IC50=0.98±0.02µM)&&Human carcinoma HeLa-KB (IC50=3.73±1.0µM),PG,,Linear,Free,Free,,L,dbAMP3,2
24361,dbAMP_24361,,Human esophageal carcinoma Eca 109 (30% Inhibition=20µM)&&Human cervical carcinoma HeLa S3 (40% Inhibition=20µM)&&Human pancreatic carcinoma Panc-1 (34% Inhibition=20µM),PP,,Linear,Free,Free,,L,dbAMP3,2
24363,dbAMP_24363,,Bacillus subtilis (<30% Inhibition=500µM)&&Candida albicans (47.0% Inhibition=500µM)&&Human colon adenocarcinoma HT29 (38% Inhibition=10µM)&&Human colon adenocarcinoma HT29 (70% Inhibition=100µM)&&Human cervical carcinoma HeLa (48% Inhibition=10µM)&&Human cervical carcinoma HeLa (68% Inhibition=100µM)&&Human breast adenocarcinoma MCF-7 (52% Inhibition=10µM)&&Human breast adenocarcinoma MCF-7 (82% Inhibition=100µM),HG,,Linear,Free,Free,,L,dbAMP3,2
24379,dbAMP_24379,,Klebsiella pneumoniae (LC=0.39±0.015µM)&&Escherichia coli (LC=0.49±0.002µM)&&Pseudomonas aeruginosa (LC=1.48±0.021µM)&&Human promyelocytic leukemia HL-60 (IC50=7.5±0.5µM)&&Human myelogenous leukemia K562 (IC50=10.2±0.7µM)&&Jurkat cells E6-1 (IC50=2.4±0.3µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=8.6±0.5µM),KWKVFKKIEKMGRNIRNGIVKAGPKWKVFKKIEK,,Linear,Free,Free,,L,dbAMP3,34
24478,dbAMP_24478,,Vibrio anguillarum FT1801 (MIC=0.8µM)&&Escherichia coli ATCC 25922 (MIC=1.6µM)&&Corynebacterium glutamicum ATCC 13032 (MIC=0.4µM)&&Staphylococcus aureus ATCC 9144 (MIC=3.1µM)&&Botrytis cinerea 101 (MIC=50µM)&&Penicillium roqueforti (MIC=6.3µM)&&Saccharomyces cerevisiae (MIC=6.3µM)&&Candida albicans ATCC 10231 (MIC=6.3µM)&&Staphylococcus aureus ATCC 12600 (MBC=25µM)&&Staphylococcus aureus ATCC 12600 (MBC=25µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=50µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=100µg/ml)&&Human acute monocytic leukemia THP-1 (50% Cell death=100µg/ml),GXFKKTFHKVSHAVKSGIHAGQRGCSALGF,,Linear,Free,Free,,L,dbAMP3,30
24498,dbAMP_24498,2IGR,Human gastric adenocarcinoma AGS (IC50=5.6±0.5µM)&&Human promyelocytic leukemia HL-60 (IC50=6.7±1.1µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=4.4±0.3µM)&&Human lung carcinoma NCI-H520 (IC50=22.7±0.2µM)&&Human lung carcinoma NCI-H661 (IC50=35.9±0.2µM)&&Escherichia coli ATCC 25922 (MIC=128µg/ml),KWKVFKKIEKKWKVFKKIEKAGPKWKVFKKIEK,,Linear,Free,Free,,L,dbAMP3,33
24521,dbAMP_24521,,Human promyelocytic leukemia HL-60 &&Human lung carcinoma A549 &&Human hepatocarcinoma SMMC-7721 &&Human colon adenocarcinoma SW4801 &&Human breast adenocarcinoma MCF-7 &&Fusarium solani &&Bacillus subtilis &&Bacillus anthracis,YPFX,,Linear,Free,Free,,L,dbAMP3,4
24522,dbAMP_24522,,Human gastric adenocarcinoma AGS (IC50=>500µM),KYLNFAKWLKGANLAKYANA,,Linear,Free,Free,,L,dbAMP3,20
24530,dbAMP_24530,,Human fibrosarcoma HT1080 (IC50=281µg/ml)&&Human breast adenocarcinoma MDA-MB-435 (IC50=393µg/ml)&&Human breast adenocarcinoma MDA-MB-435/alphavbeta3shRNA (IC50=565µg/ml),CNGRCGGKLAKLAKKLAKLAK,,Linear,Free,Free,,L,dbAMP3,21
24563,dbAMP_24563,,Escherichia coli ATCC 25922 (MIC=3µM)&&Escherichia coli ML-35p (MIC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=6µM)&&Acinetobacter baumannii ATCC 19606 (MIC=3µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=3µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ST1065 (MIC=3µM)&&Streptococcus pyogenes ATCC 19615 (MIC=1µM)&&Staphylococcus aureus ATCC 43300 (MIC=3µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=3µM)&&Listeria ivanovii (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=6µM)&&Candida albicans ATCC 90028 (MIC=6µM)&&Candida parapsilosis ATCC 22019 (MIC=25µM)&&Saccharomyces cerevisiae (MIC=3µM)&&Leishmania infantum (promastigote) (MIC=10µM)&&Human acute monocytic leukemia THP-1 (IC50=48µM)&&Human hepatocellular carcinoma HepG2 (LC50=358µM)&&Legionella feeleii ATCC 35072 (MIC=3.12µM)&&Legionella longbeachae ATCC 33484 (MIC=3.12µM)&&Legionella pneumophila ATCC 33155 (MIC=3.12µM)&&Legionella pneumophila Paris (MIC=3.12µM)&&HSV-1 (IC50 REP=2.5µM),FLKGIVGMLGKLF,,Linear,Free,Free,,L,dbAMP3,13
24646,dbAMP_24646,,Human lung carcinoma A549 (IC50=71.0±0.19µM)&&Human melanoma A375 (IC50=59.8±0.15µM)&&Human breast adenocarcinoma MCF-7 (IC50=70.8±0.18µM)&&Human colon adenocarcinoma SW1116 (IC50=>83.6µM)&&Human rhabdomyosarcoma (IC50=>83.6µM)&&Human lung carcinoma H1299 (IC50=15.6±0.05µM)&&Mouse skin melanoma B16 (IC50=63.5±0.15µM)&&Human cervical carcinoma HeLa (IC50=64.7±0.15µM),KWKSFLKTFKSAKKTVLHTAAKAISS,,Linear,Free,Free,,L,dbAMP3,26
24647,dbAMP_24647,,Human lung carcinoma A549 (IC50=>83.6µM)&&Human melanoma A375 (IC50=>83.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=>83.6µM)&&Human colon adenocarcinoma SW1116 (IC50=>83.6µM)&&Human rhabdomyosarcoma (IC50=>83.6µM)&&Human lung carcinoma H1299 (IC50=16.4±0.06µM)&&Mouse skin melanoma B16 (IC50=>83.6µM)&&Human cervical carcinoma HeLa (IC50=>83.6µM),KWKSFLKTFKSAKKTVAHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
24648,dbAMP_24648,,Human lung carcinoma A549 (IC50=>83.6µM)&&Human melanoma A375 (IC50=>83.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=>83.6µM)&&Human colon adenocarcinoma SW1116 (IC50=>83.6µM)&&Human rhabdomyosarcoma (IC50=>83.6µM)&&Human lung carcinoma H1299 (IC50=37.7±0.10µM)&&Mouse skin melanoma B16 (IC50=>83.6µM)&&Human cervical carcinoma HeLa (IC50=>83.6µM),KWKSFLKTFKSAKKTVAHTAAKAISS,,Linear,Free,Free,,L,dbAMP3,26
24649,dbAMP_24649,,Human lung carcinoma A549 (IC50=>83.6µM)&&Human melanoma A375 (IC50=>83.6µM)&&Human breast adenocarcinoma MCF-7 (IC50=>83.6µM)&&Human colon adenocarcinoma SW1116 (IC50=>83.6µM)&&Human rhabdomyosarcoma (IC50=>83.6µM)&&Human lung carcinoma H1299 (IC50=>83.6µM)&&Mouse skin melanoma B16 (IC50=>83.6µM)&&Human cervical carcinoma HeLa (IC50=>83.6µM)&&Staphylococcus aureus ATCC 25923 (MIC=125µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=125µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=125µM)&&Escherichia coli ATCC 25922 (MIC=125µM)&&Human gastric cancer SGC-7901 (IC50=>125µM),KWKSFAKTFKSAKKTVAHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
24838,dbAMP_24838,,Escherichia coli ATCC 8739 (MIC=30µM)&&Staphylococcus aureus ATCC 25923 (MIC=>115µM)&&Trichophyton mentagrophytes (MIC=115µM)&&Trichophyton rubrum (MIC=115µM)&&Candida parapsilosis ATCC 22019 (MIC=>115µM)&&Human colon adenocarcinoma Caco-2 (ED50=60µM)&&Human colon adenocarcinoma HCT 116 (ED50=>115µM)&&Human breast adenocarcinoma MCF-7 (ED50=115µM)&&HSV-1 (ED50=90µM)&&HSV-2 (ED50=90µM)&&HSV-1 (90% Inhibition=200µg/ml),HTASDAAAAAALTAANAAAAAAASMA,,Linear,Free,Free,,L,dbAMP3,26
24840,dbAMP_24840,,Staphylococcus aureus ATCC 33591 (MIC=>256µM)&&Escherichia coli ATCC 25922 (MIC=>256µM)&&Human cervical carcinoma HeLa (50% Cell death=>1000µM),FQNRRMKWKK,,Linear,Free,Free,,L,dbAMP3,10
24885,dbAMP_24885,,Jurkat T-cell leukemia (IC50=9.6µM),VRRFPXXXPFLRR,,Linear,Free,Free,,L,dbAMP3,13
24886,dbAMP_24886,,Escherichia coli ATCC 25922 (MIC=4-8µM)&&Escherichia coli ATCC 25922 (MBC=4-8µM)&&Bacillus subtilis 168 (MIC=2µM)&&Bacillus subtilis 168 (MBC=2µM)&&Jurkat T-cell leukemia (IC50=16.1µM),VRRFPXWWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
24887,dbAMP_24887,,Escherichia coli ATCC 25922 (MIC=8µM)&&Escherichia coli ATCC 25922 (MBC=8µM)&&Bacillus subtilis 168 (MIC=1µM)&&Bacillus subtilis 168 (MBC=1µM)&&Jurkat T-cell leukemia (IC50=15.1µM),VRRFPWXWPFLRR,,Linear,Free,Free,,L,dbAMP3,13
24888,dbAMP_24888,,Escherichia coli ATCC 25922 (MIC=4-8µM)&&Escherichia coli ATCC 25922 (MBC=4-8µM)&&Bacillus subtilis 168 (MIC=1µM)&&Bacillus subtilis 168 (MBC=1µM)&&Jurkat T-cell leukemia (IC50=10.7µM),VRRFPWWXPFLRR,,Linear,Free,Free,,L,dbAMP3,13
24903,dbAMP_24903,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),MPRRRRSSSRPVRRRRRPRVSRRRRRRGGRRR,,Linear,Free,Free,,L,dbAMP3,32
24904,dbAMP_24904,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=2µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILIKRK,,Linear,Free,Free,,L,dbAMP3,11
24905,dbAMP_24905,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILILIL,,Linear,Free,Free,,L,dbAMP3,11
24906,dbAMP_24906,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),ILILILILKRK,,Linear,Free,Free,,L,dbAMP3,11
24907,dbAMP_24907,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILIGSG,,Linear,Free,Free,,L,dbAMP3,11
24908,dbAMP_24908,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),GSGILILIKRK,,Linear,Free,Free,,L,dbAMP3,11
24909,dbAMP_24909,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKSGSGSKRK,,Linear,Free,Free,,L,dbAMP3,11
24927,dbAMP_24927,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=36µM),KRKRKILILIKRK,,Linear,Free,Free,,L,dbAMP3,13
24928,dbAMP_24928,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=2µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RKRKILILIKRK,,Linear,Free,Free,,L,dbAMP3,12
24929,dbAMP_24929,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=4µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RKILILIKRK,,Linear,Free,Free,,L,dbAMP3,10
24930,dbAMP_24930,,Escherichia coli DH5alpha (MIC=32µM)&&Staphylococcus xylosus (MIC=16µM)&&Human histiocytic lymphoma U-937 (LD50=58µM),KILILIKRK,,Linear,Free,Free,,L,dbAMP3,9
24931,dbAMP_24931,,Escherichia coli DH5alpha (MIC=64µM)&&Staphylococcus xylosus (MIC=64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),ILILIKRK,,Linear,Free,Free,,L,dbAMP3,8
24932,dbAMP_24932,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),LILIKRK,,Linear,Free,Free,,L,dbAMP3,7
24933,dbAMP_24933,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),ILIKRK,,Linear,Free,Free,,L,dbAMP3,6
24934,dbAMP_24934,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),LIKRK,,Linear,Free,Free,,L,dbAMP3,5
25007,dbAMP_25007,,Escherichia coli ATCC 25922 (MIC=12µM)&&Escherichia coli ML-35p (MIC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=50µM)&&Acinetobacter baumannii ATCC 19606 (MIC=25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=6µM)&&Staphylococcus aureus ST1065 (MIC=6µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3µM)&&Listeria ivanovii (MIC=6µM)&&Enterococcus faecalis ATCC 29212 (MIC=50µM)&&Candida albicans ATCC 90028 (MIC=12µM)&&Candida parapsilosis ATCC 22019 (MIC=25µM)&&Saccharomyces cerevisiae (MIC=6µM)&&Leishmania infantum (promastigote) (IC50=57µM)&&Human acute monocytic leukemia THP-1 (IC50=55µM),FLKGIKGMLGKLF,,Linear,Free,Free,,L,dbAMP3,13
25009,dbAMP_25009,,Escherichia coli ATCC 25922 (MIC=12µM)&&Escherichia coli ML-35p (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=6µM)&&Staphylococcus aureus ST1065 (MIC=6µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3µM)&&Listeria ivanovii (MIC=12µM)&&Enterococcus faecalis ATCC 29212 (MIC=50µM)&&Candida albicans ATCC 90028 (MIC=12µM)&&Candida parapsilosis ATCC 22019 (MIC=25µM)&&Saccharomyces cerevisiae (MIC=6µM)&&Leishmania infantum (promastigote) (IC50=46µM)&&Human acute monocytic leukemia THP-1 (IC50=60µM),FLKGIVGKLGKLF,,Linear,Free,Free,,L,dbAMP3,13
25010,dbAMP_25010,,Escherichia coli ATCC 25922 (MIC=6µM)&&Escherichia coli ML-35p (MIC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=6µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=6µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ST1065 (MIC=3µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3µM)&&Listeria ivanovii (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=12µM)&&Candida albicans ATCC 90028 (MIC=6µM)&&Candida parapsilosis ATCC 22019 (MIC=25µM)&&Saccharomyces cerevisiae (MIC=3µM)&&Leishmania infantum (promastigote) (IC50=28µM)&&Human acute monocytic leukemia THP-1 (LC50=61µM)&&Human hepatocellular carcinoma HepG2 (LC50=376µM),FLKGIVGMLGKLL,,Linear,Free,Free,,L,dbAMP3,13
25011,dbAMP_25011,,Escherichia coli ATCC 25922 (MIC=12µM)&&Escherichia coli ML-35p (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=50µM)&&Acinetobacter baumannii ATCC 19606 (MIC=25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=50µM)&&Staphylococcus aureus ATCC 25923 (MIC=12µM)&&Staphylococcus aureus ST1065 (MIC=12µM)&&Streptococcus pyogenes ATCC 19615 (MIC=6µM)&&Listeria ivanovii (MIC=12µM)&&Enterococcus faecalis ATCC 29212 (MIC=100µM)&&Candida albicans ATCC 90028 (MIC=12µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=6µM)&&Leishmania infantum (promastigote) (IC50=56µM)&&Human acute monocytic leukemia THP-1 (IC50=51µM)&&Human hepatocellular carcinoma HepG2 (LC50=295µM),FLKGIKGMLGKLL,,Linear,Free,Free,,L,dbAMP3,13
25012,dbAMP_25012,,Escherichia coli ATCC 25922 (MIC=3µM)&&Escherichia coli ML-35p (MIC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Salmonella enterica subsp. enterica serovar Enteritidis (MIC=6µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=3µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ST1065 (MIC=3µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3µM)&&Listeria ivanovii (MIC=3µM)&&Enterococcus faecalis ATCC 29212 (MIC=6µM)&&Candida albicans ATCC 90028 (MIC=6µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=6µM)&&Leishmania infantum (promastigote) (IC50=26µM)&&Human acute monocytic leukemia THP-1 (LC50=25µM),FLKGIVGMLGKLW,,Linear,Free,Free,,L,dbAMP3,13
25014,dbAMP_25014,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=1µM)&&Human histiocytic lymphoma U-937 (LD50=61µM),KRKILILIKRKRK,,Linear,Free,Free,,L,dbAMP3,13
25015,dbAMP_25015,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=2µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILIKRKR,,Linear,Free,Free,,L,dbAMP3,12
25016,dbAMP_25016,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILIKR,,Linear,Free,Free,,L,dbAMP3,10
25017,dbAMP_25017,,Escherichia coli DH5alpha (MIC=32µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILIK,,Linear,Free,Free,,L,dbAMP3,9
25019,dbAMP_25019,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILI,,Linear,Free,Free,,L,dbAMP3,8
25020,dbAMP_25020,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILIL,,Linear,Free,Free,,L,dbAMP3,7
25021,dbAMP_25021,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILI,,Linear,Free,Free,,L,dbAMP3,6
25022,dbAMP_25022,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKIL,,Linear,Free,Free,,L,dbAMP3,5
25026,dbAMP_25026,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=1µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILILILIKRK,,Linear,Free,Free,,L,dbAMP3,13
25027,dbAMP_25027,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=16µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKLILIKRK,,Linear,Free,Free,,L,dbAMP3,10
25028,dbAMP_25028,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKILIKRK,,Linear,Free,Free,,L,dbAMP3,9
25029,dbAMP_25029,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKLIKRK,,Linear,Free,Free,,L,dbAMP3,8
25030,dbAMP_25030,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKIKRK,,Linear,Free,Free,,L,dbAMP3,7
25032,dbAMP_25032,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=16µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKKRK,,Linear,Free,Free,,L,dbAMP3,6
25033,dbAMP_25033,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKGKRK,,Linear,Free,Free,,L,dbAMP3,7
25034,dbAMP_25034,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKGSGKRK,,Linear,Free,Free,,L,dbAMP3,9
25042,dbAMP_25042,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RKRKLILILIKRKR,,Linear,Free,Free,,L,dbAMP3,14
25043,dbAMP_25043,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KRKLILKRILIKRK,,Linear,Free,Free,,L,dbAMP3,14
25044,dbAMP_25044,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RKLILKRKRILIKR,,Linear,Free,Free,,L,dbAMP3,14
25045,dbAMP_25045,,Escherichia coli DH5alpha (MIC=32µM)&&Staphylococcus xylosus (MIC=16µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KLILKRKRKRILIK,,Linear,Free,Free,,L,dbAMP3,14
25046,dbAMP_25046,,Escherichia coli DH5alpha (MIC=>64µM)&&Staphylococcus xylosus (MIC=>64µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM)&&Escherichia coli K-12 (MIC=64µM)&&Staphylococcus aureus ATCC 12600 (MIC=>128µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µM),LILKRKRKRKRILI,,Linear,Free,Free,,L,dbAMP3,14
25047,dbAMP_25047,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=2µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RRRIIIIIRRR,,Linear,Free,Free,,L,dbAMP3,11
25048,dbAMP_25048,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KKKIIIIIKKK,,Linear,Free,Free,,L,dbAMP3,11
25049,dbAMP_25049,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=1µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RRRLLLLLRRR,,Linear,Free,Free,,L,dbAMP3,11
25050,dbAMP_25050,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KKKLLLLLKKK,,Linear,Free,Free,,L,dbAMP3,11
25051,dbAMP_25051,,Escherichia coli DH5alpha (MIC=32µM)&&Staphylococcus xylosus (MIC=2µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RRRVVVVVRRR,,Linear,Free,Free,,L,dbAMP3,11
25052,dbAMP_25052,,Escherichia coli DH5alpha (MIC=64µM)&&Staphylococcus xylosus (MIC=8µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KKKVVVVVKKK,,Linear,Free,Free,,L,dbAMP3,11
25053,dbAMP_25053,,Escherichia coli DH5alpha (MIC=4µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),RRRFFFFFRRR,,Linear,Free,Free,,L,dbAMP3,11
25054,dbAMP_25054,,Escherichia coli DH5alpha (MIC=16µM)&&Staphylococcus xylosus (MIC=4µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KKKFFFFFKKK,,Linear,Free,Free,,L,dbAMP3,11
25055,dbAMP_25055,,Escherichia coli DH5alpha (MIC=8µM)&&Staphylococcus xylosus (MIC=0.5µM)&&Human histiocytic lymphoma U-937 (LD50=>64µM),KKKIIIIIIKKK,,Linear,Free,Free,,L,dbAMP3,12
25056,dbAMP_25056,,Escherichia coli NCTC 10418 (MIC=19.6µM)&&Escherichia coli NCTC 10418 (MBC=39.2µM)&&Staphylococcus aureus NCTC 10788 (MIC=39.2µM)&&Staphylococcus aureus NCTC 10788 (MBC=78.4µM)&&Candida albicans NCPF 1467 (MIC=39.2µM)&&Candida albicans NCPF 1467 (MBC=78.4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=19.6µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=78.4µM)&&Human glioblastoma U251-MG (IC50=15.08µM),GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ,,Linear,Free,Free,,L,dbAMP3,31
25057,dbAMP_25057,,Escherichia coli NCTC 10418 (MIC=5.0µM)&&Escherichia coli NCTC 10418 (MBC=20.2µM)&&Staphylococcus aureus NCTC 10788 (MIC=5.0µM)&&Staphylococcus aureus NCTC 10788 (MBC=10.1µM)&&Candida albicans NCPF 1467 (MIC=10.1µM)&&Candida albicans NCPF 1467 (MBC=20.2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10.1µM)&&Human glioblastoma U251-MG (IC50=13.43µM)&&Human squamous lung carcinoma NCI-H157 (IC50=6.43µM)&&Human prostate adenocarcinoma PC-3 (IC50=3.17µM),GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI,,Linear,Free,Free,,L,dbAMP3,33
25089,dbAMP_25089,,Bacillus subtilis (MIC=6.3µg/ml)&&Micrococcus luteus (MIC=25µg/ml)&&Staphylococcus aureus (MIC=3.1µg/ml)&&Staphylococcus epidermidis (MIC=12.5µg/ml)&&Escherichia coli (MIC=25µg/ml)&&Shigella dysenteriae (MIC=12.5µg/ml)&&Salmonella typhimurium (MIC=50µg/ml)&&Klebsiella pneumoniae (MIC=12.5µg/ml)&&Proteus mirabilis (MIC=>200µg/ml)&&Pseudomonas aeruginosa (MIC=100µg/ml)&&Human renal carcinoma A498 (IC50=73.26µg/ml)&&Human lung carcinoma A549 (IC50=106.27µg/ml)&&Human colon adenocarcinoma HCT 116 (IC50=30.48µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=77.29µg/ml)&&Human gastric cancer MKN 45 (IC50=82.70µg/ml)&&Human liver carcinoma NCI-H630 (IC50=75.92µg/ml)&&Human prostate adenocarcinoma PC-3 (IC50=123.81µg/ml)&&Human skin melanoma SK-MEL-2 (IC50=30.48µg/ml)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=92.15µg/ml),FLGWLFKVASK,,Linear,Free,Free,,L,dbAMP3,11
25090,dbAMP_25090,,Human esophageal carcinoma Eca 109 (60% Inhibition=20µM)&&Human cervical carcinoma HeLa S3 (60% Inhibition=20µM)&&Human pancreatic carcinoma Panc-1 (37% Inhibition=20µM)&&Fusarium fujikuroi (ED50=1779.04±0.33µg/ml)&&Fusarium fujikuroi (EC90=3202.28±0.39µg/ml)&&Fusarium verticillioides (ED50=1806.15±0.44µg/ml)&&Fusarium verticillioides (EC90=3305.67±0.48µg/ml)&&Staphylococcus aureus NRRLB-767 (MIC=50µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=40µg/ml),PV,,Linear,Free,Free,,L,dbAMP3,2
25091,dbAMP_25091,,Bacillus subtilis ATCC 6633 (MIC=6.3µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=6.3µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=6.3µg/ml)&&Escherichia coli ATCC 25922 (MIC=25µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=12.5µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=100µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>200µg/ml)&&Human renal carcinoma A498 (IC50=22.88µM)&&Human lung carcinoma A549 (IC50=20.36µM)&&Human colon adenocarcinoma HCT 116 (IC50=24.63µM)&&Human gastric cancer MKN 45 (MIC=24.31µM)&&Human prostate adenocarcinoma PC-3 (IC50=46.51µM)&&Human skin melanoma SK-MEL-2 (IC50=13.97µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=22.06µM),FLGWLFKWAWK,,Linear,Free,Free,,L,dbAMP3,11
25141,dbAMP_25141,,Human  glioblastoma T67 (EC50=8µM)&&Human cervical carcinoma HeLa (EC50=5µM),XGLXGGLXRIX,,Linear,Free,Free,,L,dbAMP3,11
25152,dbAMP_25152,,Bacillus subtilis ATCC 6633 (MIC=3.1µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=6.3µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=3.1µg/ml)&&Escherichia coli ATCC 25922 (MIC=>200µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=200µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>200µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>200µg/ml)&&Human renal carcinoma A498 (IC50=22.59µM)&&Human lung carcinoma A549 (IC50=15.88µM)&&Human colon adenocarcinoma HCT 116 (IC50=14.80µM)&&Human gastric cancer MKN 45 (IC50=13.77µM)&&Human prostate adenocarcinoma PC-3 (IC50=24.32µM)&&Human skin melanoma SK-MEL-2 (IC50=13.16µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=14.58µM),FLWWLFKWAWK,,Linear,Free,Free,,L,dbAMP3,11
25158,dbAMP_25158,,Bacillus subtilis ATCC 6633 (MIC=6.3µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=12.5µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=6.3µg/ml)&&Escherichia coli ATCC 25922 (MIC=12.5µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=25µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=50µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µg/ml)&&Human renal carcinoma A498 (IC50=41.21µM)&&Human lung carcinoma A549 (IC50=25.20µM)&&Human colon adenocarcinoma HCT 116 (IC50=27.00µM)&&Human gastric cancer MKN 45 (IC50=26.70µM)&&Human prostate adenocarcinoma PC-3 (IC50=47.69µM)&&Human skin melanoma SK-MEL-2 (IC50=27.39µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=24.76µM),FLGWLFKWAKK,,Linear,Free,Free,,L,dbAMP3,11
25166,dbAMP_25166,,Bacillus subtilis ATCC 6633 (MIC=3.1µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=3.1µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=6.3µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=6.3µg/ml)&&Escherichia coli ATCC 25922 (MIC=12.5µg/ml)&&Shigella dysenteriae ATCC 9752 (MIC=25µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=50µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µg/ml)&&Human renal carcinoma A498 (IC50=21.48µM)&&Human lung carcinoma A549 (IC50=14.53µM)&&Human colon adenocarcinoma HCT 116 (IC50=14.80µM)&&Human gastric cancer MKN 45 (IC50=22.51µM)&&Human prostate adenocarcinoma PC-3 (IC50=29.10µM)&&Human skin melanoma SK-MEL-2 (IC50=22.25µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=12.55µM),FLKWLFKWAKK,,Linear,Free,Free,,L,dbAMP3,11
25188,dbAMP_25188,,Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ST1065 (MIC=6.25µM)&&Staphylococcus aureus ATCC 43300 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=25µM)&&Streptococcus pyogenes ATCC 19615 (MIC=1.56µM)&&Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli ML-35p (MIC=30µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=200µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6.25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=25µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=6.25µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=18.5µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=13.3µM)&&Leishmania braziliensis MHOM/BR/75/M2904 (IC50=15.0µM)&&Human acute monocytic leukemia THP-1 (IC50=22.5µM),FLSLIPHIVSGVASLAKHF,,Linear,Free,Free,,L,dbAMP3,19
25190,dbAMP_25190,,Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ST1065 (MIC=6.25µM)&&Staphylococcus aureus ATCC 43300 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=50µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3.12µM)&&Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli ML-35p (MIC=25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6.25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=25µM)&&Candida parapsilosis ATCC 22019 (MIC=50µM)&&Saccharomyces cerevisiae (MIC=12.5µM)&&Leishmania infantum MHOM/MA/67/ITMAP-263 (IC50=22.0µM)&&Leishmania major MHOM/SU/73/5ASKH (IC50=18.0µM)&&Leishmania braziliensis MHOM/BR/75/M2904 (IC50=17.2µM)&&Human acute monocytic leukemia THP-1 (IC50=23µM),FLSMIPHIVSGVAALAKHL,,Linear,Free,Free,,L,dbAMP3,19
25198,dbAMP_25198,,Klebsiella aerogenes ATCC 13048 (MIC=>39µM)&&Acinetobacter baumannii ATCC 15149 (MIC=2.46µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 15277 (MIC=2.46µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2.46µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=19.67µM)&&Enterococcus faecalis ATCC 29212 (MIC=19.67µM)&&Staphylococcus aureus USA 300 (MIC=39.35µM)&&Clostridioides difficile ATCC 43255 (MIC=2.46µM)&&Staphylococcus aureus ATCC 25923 (MIC=19.67µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=39.35µM)&&Neisseria gonorrhoeae ATCC 49226 (MIC=0.61µM)&&Bacillus anthracis NR-3838 (MIC=2.46µM)&&Francisella tularensis NR-643 (MIC=19.67µM)&&Yersinia pestis NR641 (MIC=>39µM)&&Burkholderia pseudomallei NCTC 8016 (MIC=>39µM)&&Mycobacterium tuberculosis H37Ra (MIC=4.92µM)&&Mycobacterium tuberculosis SRI 1377 (MIC=4.92µM)&&Human pancreatic adenocarcinoma CFPAC-1 (IC50=>7.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=6.2µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=>7.5µM)&&Human colon adenocarcinoma Colo205 (IC50=5.4µM)&&Human colon adenocarcinoma DLD-1 (IC50=>7.5µM)&&Human melanoma UACC-62 (IC50=2.6µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=7.3µM)&&Human renal carcinoma A498 (IC50=3.0µM)&&Human prostate adenocarcinoma PC-3 (IC50=>7.5µM)&&Human lung carcinoma A549 (IC50=7.2µM)&&Human lung carcinoma NCI-H69 (IC50=1.9µM)&&Human lymphoma RL (IC50=2.0µM),GFXGXKKXGXFXGXGKKXKKKK,,Linear,Free,Free,,L,dbAMP3,22
25201,dbAMP_25201,,Klebsiella aerogenes ATCC 13048 (MIC=43.75µM)&&Acinetobacter baumannii ATCC 15149 (MIC=2.73µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 15277 (MIC=5.47µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1.37µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=43.75µM)&&Enterococcus faecalis ATCC 29212 (MIC=21.87µM)&&Staphylococcus aureus USA 300 (MIC=43.75µM)&&Clostridioides difficile ATCC 43255 (MIC=1.37µM)&&Staphylococcus aureus ATCC 25923 (MIC=10.94µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=21.87µM)&&Neisseria gonorrhoeae ATCC 49226 (MIC=2.73µM)&&Bacillus anthracis NR-3838 (MIC=1.37µM)&&Francisella tularensis NR-643 (MIC=21.87µM)&&Yersinia pestis NR641 (MIC=>44µM)&&Burkholderia pseudomallei NCTC 8016 (MIC=>44µM)&&Mycobacterium tuberculosis H37Ra (MIC=21.87µM)&&Mycobacterium tuberculosis SRI 1377 (MIC=5.47µM)&&Human pancreatic adenocarcinoma CFPAC-1 (IC50=>7.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=7.3µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=>7.5µM)&&Human colon adenocarcinoma Colo205 (IC50=6.7µM)&&Human colon adenocarcinoma DLD-1 (IC50=>7.5µM)&&Human melanoma UACC-62 (IC50=6.4µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=>7.5µM)&&Human renal carcinoma A498 (IC50=4.2µM)&&Human prostate adenocarcinoma PC-3 (IC50=>7.5µM)&&Human lung carcinoma A549 (IC50=7.2µM)&&Human lung carcinoma NCI-H69 (IC50=2.2µM)&&Human lymphoma RL (IC50=3.7µM),KKKKGFXGXKXGXFXGXGKX,,Linear,Free,Free,,L,dbAMP3,20
25203,dbAMP_25203,,Escherichia coli ATCC 25922 (MIC=>100µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=>100µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=>100µM)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=12.5µM)&&Streptococcus pyogenes ATCC 19615 (MIC=6.25µM)&&Listeria ivanovii (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=12.5µM)&&Candida albicans ATCC 90028 (MIC=>100µM)&&Candida parapsilosis ATCC 22019 (MIC=>100µM)&&Saccharomyces cerevisiae (MIC=25µM)&&Human acute monocytic leukemia THP-1 (IC50=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=50µM)&&Staphylococcus aureus ATCC 25923 (MIC=>100µM),XFFLSRIF,,Linear,Free,Free,,L,dbAMP3,8
25206,dbAMP_25206,,Escherichia coli ATCC 25922 (MIC=6.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Acinetobacter baumannii ATCC 19606 (MIC=6.25µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=100µM)&&Staphylococcus aureus ATCC 25923 (MIC=3µM)&&Staphylococcus aureus ATCC BAA-44 (MIC=3µM)&&Streptococcus pyogenes ATCC 19615 (MIC=3µM)&&Listeria ivanovii (MIC=6.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=25µM)&&Candida albicans ATCC 90028 (MIC=100µM)&&Candida parapsilosis ATCC 22019 (MIC=100µM)&&Saccharomyces cerevisiae (MIC=12.5µM)&&Human acute monocytic leukemia THP-1 (IC50=121µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ATCC 25923 (MIC=6.25µM)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µM)&&Escherichia coli ATCC 25922 (MIC=50µM)&&Escherichia coli ATCC 25922 (MIC=50µM)&&Escherichia coli ATCC 25922 (MIC=>100µM),FXFLRRIF,,Linear,Free,Free,,L,dbAMP3,8
25216,dbAMP_25216,,Enterococcus faecalis ATCC 29212 (MIC=>128µg/ml)&&Enterococcus faecalis (MIC=>128µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>128µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Streptococcus pyogenes (MIC=64µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µg/ml)&&Pseudomonas aeruginosa (MIC=>128µg/ml)&&Klebsiella pneumoniae (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Escherichia coli (MIC=>128µg/ml)&&Acinetobacter baumannii (MIC=>128µg/ml)&&Human cervical carcinoma HeLa S3 (IC50=>10µM)&&Candida parapsilosis ATCC 22019 (MIC=>71.9µg/ml)&&Candida krusei ATCC 6258 (MIC=71.9µg/ml)&&Candida tropicalis LABMIC 0109 (MIC=35.95µg/ml)&&Candida albicans LABMIC 0107 (MIC=35.95µg/ml)&&Candida albicans LABMIC 0108 (MIC=71.9µg/ml)&&Candida parapsilosis LABMIC 0113 (MIC=35.95µg/ml)&&Candida tropicalis LABMIC 0112 (MIC=17.98µg/ml)&&Candida albicans LABMIC 0101 (MIC=17.98µg/ml)&&Papiliotrema laurentii LABMIC 0404 (MIC=35.95µg/ml)&&Microsporum canis LABMIC 0401 (MIC=17.98µg/ml)&&Trichophyton rubrum LABMIC 0203 (MIC=>71.9µg/ml)&&Trypanosoma cruzi Y (EC50=>100µM)&&Trypanosoma cruzi Y (EC50=33.1±15µM),KRFKKFFKKVKKSV,,Linear,Free,Free,,L,dbAMP3,14
25224,dbAMP_25224,,Enterococcus faecalis ATCC 29212 (MIC=>128µg/ml)&&Enterococcus faecalis (MIC=>128µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>128µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Streptococcus pyogenes (MIC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µg/ml)&&Pseudomonas aeruginosa (MIC=64µg/ml)&&Klebsiella pneumoniae (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=0.25µg/ml)&&Escherichia coli (MIC=8µg/ml)&&Acinetobacter baumannii (MIC=4µg/ml)&&Human cervical carcinoma HeLa S3 (IC50=1µM)&&Human histiocytic lymphoma U-937 (IC50=6.25µM)&&Human acute monocytic leukemia THP-1 (IC50=25µM)&&Jurkat cells E6-1 (IC50=>100µM)&&Human acute monocytic leukemia MONO-MAC-6 (IC50=>100µM)&&Candida parapsilosis ATCC 22019 (MIC=94.8µg/ml)&&Candida krusei ATCC 6258 (MIC=11.85µg/ml)&&Candida tropicalis LABMIC 0109 (MIC=23.7µg/ml)&&Candida albicans LABMIC 0107 (MIC=23.7µg/ml)&&Candida parapsilosis LABMIC 0113 (MIC=11.85µg/ml)&&Candida tropicalis LABMIC 0112 (MIC=11.85µg/ml)&&Papiliotrema laurentii LABMIC 0404 (MIC=11.85µg/ml)&&Microsporum canis LABMIC 0401 (MIC=>94.8µg/ml)&&Trichophyton rubrum LABMIC 0203 (MIC=>94.8µg/ml)&&Trypanosoma cruzi Y (EC50=>100µM)&&Trypanosoma cruzi Y (EC50=9.5±2µM)&&Escherichia coli ATCC 25922 (MIC=2µg/ml)&&Escherichia coli ATCC 25922 (MBC=2µg/ml)&&Escherichia coli KPC 001812446 (MIC=2µg/ml)&&Escherichia coli KPC 001812446 (MBC=2µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=2µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MBC=2µg/ml)&&Klebsiella pneumoniae KPC 001825971 (MIC=8µg/ml)&&Klebsiella pneumoniae KPC 001825971 (MBC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>128µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>200µM),KKRLKKIFKKPMVIGVTIPF,,Linear,Free,Free,,L,dbAMP3,20
25270,dbAMP_25270,,Pseudomonas aeruginosa DSM 1117 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 1117 (MIC=64µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=256µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=8µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=64µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=16µg/ml)&&Human cervical carcinoma HeLa (IC50=640±150µg/ml),XWXWXRPVYXPRPRPPHPRL,,Linear,Free,Free,,L,dbAMP3,20
25272,dbAMP_25272,,Pseudomonas aeruginosa DSM 1117 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 1117 (MIC=32µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=128µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=16µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=32µg/ml)&&Human cervical carcinoma HeLa (IC50=230 ± 90µg/ml),XWXWXWXRPVYXPRPRPPHPRL,,Linear,Free,Free,,L,dbAMP3,22
25273,dbAMP_25273,,Pseudomonas aeruginosa DSM 1117 (MIC=8µg/ml)&&Pseudomonas aeruginosa DSM 1117 (MIC=32µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=256µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=8µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=128µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=8µg/ml)&&Human cervical carcinoma HeLa (IC50=>600µg/ml),XIXIXRPVYXPRPRPPHPRL,,Linear,Free,Free,,L,dbAMP3,20
25274,dbAMP_25274,,Pseudomonas aeruginosa DSM 1117 (MIC=8µg/ml)&&Pseudomonas aeruginosa DSM 1117 (MIC=64µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 3227 (MIC=128µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=128µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=16µg/ml)&&Human cervical carcinoma HeLa (IC50=>600µg/ml),XIXIXIXRPVYXPRPRPPHPRL,,Linear,Free,Free,,L,dbAMP3,22
25309,dbAMP_25309,,Escherichia coli C600 (MIC=6µM)&&Bacillus subtilis VKM B-501 (MIC=1.5µM)&&Staphylococcus aureus 209P (MIC=36µM)&&Human myelogenous leukemia K562 (EC50=18µM),GLFGKLQKKFGRKAISYAVKKARGKH,,Linear,Free,Free,,L,dbAMP3,26
25320,dbAMP_25320,,Escherichia coli C600 (MIC=6µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=18µM)&&Human myelogenous leukemia K562 (EC50=18µM),GLFGKLIKKKGRKAISYAVKKARGKH,,Linear,Free,Free,,L,dbAMP3,26
25329,dbAMP_25329,,Escherichia coli C600 (MIC=3µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=1.5µM)&&Human myelogenous leukemia K562 (EC50=0.7µM),GLFGKLIKKFLRKAISYAVKKARGKH,,Linear,Free,Free,,L,dbAMP3,26
25331,dbAMP_25331,,Staphylococcus aureus ATCC 25923 (MIC=125µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=125µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=125µM)&&Escherichia coli ATCC 25922 (MIC=64µM)&&Human cervical carcinoma HeLa (IC50=73.66µM)&&Human lung carcinoma A549 (IC50=109.68µM)&&Human gastric cancer SGC-7901 (IC50=92.04µM)&&Mouse skin melanoma B16 (IC50=120.44µM),KWKSFLKTFKSAEKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
25332,dbAMP_25332,,Escherichia coli TOP 10 (MIC=2.5µM)&&Escherichia coli TOP 10 (MBC=2.5µM)&&Staphylococcus aureus (MIC=5µM)&&Staphylococcus aureus (MBC=5µM)&&Vibrio parahaemolyticus (MIC=2.5µM)&&Vibrio parahaemolyticus (MBC=2.5µM)&&Escherichia coli O157 (100% Killing=10µM)&&Staphylococcus aureus (100% Killing=2µM)&&Vibrio parahaemolyticus OS4 (100% Killing=10µM)&&Human lung carcinoma A549 (73.5% Killing=20µM)&&Mouse neuroblastoma cells N2a (65.6% Killing=20µM),FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA,,Linear,Free,Free,,L,dbAMP3,45
25336,dbAMP_25336,,Escherichia coli C600 (MIC=6µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=36µM)&&Human myelogenous leukemia K562 (EC50=>36µM),GKLIKKFGRKAISYAVKKARGKH,,Linear,Free,Free,,L,dbAMP3,23
25339,dbAMP_25339,,Escherichia coli C600 (MIC=1.5µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=6µM)&&Human myelogenous leukemia K562 (EC50=>36µM),GFFGKRKEYFKKFGASFKRRFANLKKRL,,Linear,Free,Free,,L,dbAMP3,28
25343,dbAMP_25343,,Escherichia coli C600 (MIC=1.5µM)&&Bacillus subtilis VKM B-501 (MIC=0.7µM)&&Staphylococcus aureus 209P (MIC=3µM)&&Human myelogenous leukemia K562 (EC50=>36µM),GKMKEYFKKFGASFKRRFANLKKRL,,Linear,Free,Free,,L,dbAMP3,25
25348,dbAMP_25348,,Jurkat cancer cells (LD50=5.39µM)&&Legionella pneumophila Lens (MIC=1.19µM),MQFITDLIKKAVDFFKGLFDNK,,Linear,Free,Free,,L,dbAMP3,22
25349,dbAMP_25349,,Jurkat cancer cells (LD50=8.79µM)&&Legionella pneumophila Lens (MIC=1.23µM),MQFITDLIKKAVDVFKGLFGNK,,Linear,Free,Free,,L,dbAMP3,22
25355,dbAMP_25355,,Human lung carcinoma A549 (IC50=2.5±0.5µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=4.3±0.2µM)&&Human colon adenocarcinoma HT29 (IC50=5.6±0.4µM),GIFPIFAKLLGKVIKVASSLISKGRTK,,Linear,Free,Free,,L,dbAMP3,27
25356,dbAMP_25356,,Escherichia coli ATCC 25922 (MIC=1.5µM)&&Escherichia coli ATCC 25922 (MBC=1.5µM)&&Escherichia coli (MIC=6µM)&&Escherichia coli (MBC=12µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=3µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=3µM)&&Klebsiella pneumoniae (MIC=12µM)&&Klebsiella pneumoniae (MBC=24µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1.5µM)&&Acinetobacter baumannii ATCC 19606 (MBC=1.5-3µM)&&Acinetobacter baumannii (MIC=1.5-3µM)&&Acinetobacter baumannii (MBC=3µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=12µM)&&Pseudomonas aeruginosa (MIC=6µM)&&Pseudomonas aeruginosa (MBC=12µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.75µM)&&Staphylococcus aureus ATCC 29213 (MBC=1.5µM)&&Staphylococcus aureus (MIC=1.5µM)&&Staphylococcus aureus (MBC=1.5µM)&&Escherichia coli ATCC 25922 (MIC=2µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=8µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>32µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=2µg/ml)&&Candida albicans ATCC 90028 (MIC=>32µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=0.75µM)&&Staphylococcus aureus ATCC 25923 (MBC=1.5µM)&&Human chronic B cell leukemia MEC-1 (IC50=9±3µM),KIAKVALKALKIAKVALKAL,,Linear,Free,Free,,L,dbAMP3,20
25357,dbAMP_25357,,Escherichia coli ATCC 25922 (MIC=0.75µM)&&Escherichia coli ATCC 25922 (MBC=0.75µM)&&Escherichia coli (MIC=12µM)&&Escherichia coli (MBC=24µM)&&Klebsiella pneumoniae ATCC 13883 (MIC=3µM)&&Klebsiella pneumoniae ATCC 13883 (MBC=3µM)&&Klebsiella pneumoniae (MIC=12µM)&&Klebsiella pneumoniae (MBC=24µM)&&Acinetobacter baumannii ATCC 19606 (MIC=1.5µM)&&Acinetobacter baumannii ATCC 19606 (MBC=1.5µM)&&Acinetobacter baumannii (MIC=1.5µM)&&Acinetobacter baumannii (MBC=1.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=6µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=12µM)&&Pseudomonas aeruginosa (MIC=3µM)&&Pseudomonas aeruginosa (MBC=6µM)&&Staphylococcus aureus ATCC 29213 (MIC=0.5-1µM)&&Staphylococcus aureus ATCC 29213 (MBC=1.5µM)&&Staphylococcus aureus (MIC=3µM)&&Staphylococcus aureus (MBC=3µM)&&Escherichia coli ATCC 25922 (MIC=3µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=16µg/ml)&&Acinetobacter baumannii ATCC 19606 (MIC=1µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>32µg/ml)&&Staphylococcus aureus ATCC 43300 (MIC=16µg/ml)&&Candida albicans ATCC 90028 (MIC=>32µg/ml)&&Cryptococcus neoformans ATCC 208821 (MIC=6µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=0.5-1µM)&&Staphylococcus aureus ATCC 25923 (MBC=1.5µM)&&Human chronic B cell leukemia MEC-1 (IC50=20±3µM),KIAKVALKALKIAKGALKAL,,Linear,Free,Free,,L,dbAMP3,20
25381,dbAMP_25381,,Escherichia coli K-12 (MIC=12.5-25µM)&&Staphylococcus epidermidis 1457 (MIC=12.5µM)&&Bacillus subtilis 168 (MIC=6.2µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 300 (MBC=12.5µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 300 (MIC=6.2µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 300 (MIC=25µM)&&Candida albicans ATCC 10231 (MIC=12.5µM)&&Candida glabrata ATCC 2001 (MIC=12.5µM)&&Candida tropicalis ATCC 13803 (MIC=3.1-6.2µM)&&Human cervical carcinoma HeLa (LC50=100µM),WWWLKRIW,,Linear,Free,Free,,L,dbAMP3,8
25383,dbAMP_25383,,Escherichia coli K-12 (MIC=12.5-25µM)&&Staphylococcus epidermidis 1457 (MIC=6.2µM)&&Bacillus subtilis 168 (MIC=6.2µM)&&Staphylococcus aureus USA 300 (MIC=3.1-6.2µM)&&Staphylococcus aureus USA 300 (MBC=>25µM)&&Staphylococcus aureus USA 300 (MIC=3.1µM)&&Staphylococcus aureus USA 300 (MIC=12.5µM)&&Staphylococcus aureus USA 300 (MIC=3.1-6.2µM)&&Staphylococcus aureus USA 300 (MIC=12.5µM)&&Candida albicans ATCC 10231 (MIC=6.2µM)&&Candida glabrata ATCC 2001 (MIC=6.2-12.5µM)&&Candida tropicalis ATCC 13803 (MIC=1.6µM)&&Human cervical carcinoma HeLa (LC50=70µM),WWWLKKIW,,Linear,Free,Free,,L,dbAMP3,8
27064,dbAMP_27064,,Pseudomonas aeruginosa PAO1 (MIC=31.3µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=250µg/ml)&&Pseudomonas aeruginosa PAK (MIC=125µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa M2 (MIC=31.3µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=7.8µg/ml)&&Pseudomonas aeruginosa (MIC=8µg/ml)&&Escherichia coli UB1005 (MIC=2.5µg/ml)&&Escherichia coli DC2 (MIC=1.6µg/ml)&&Salmonella typhimurium C587 (MIC=4.0µg/ml)&&Salmonella typhimurium C610 (MIC=1.3µg/ml)&&Pseudomonas aeruginosa H187 (MIC=8.0µg/ml)&&Pseudomonas aeruginosa H188 (MIC=5.0µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=64.0µg/ml)&&Staphylococcus aureus SAP 0017 (MIC=64.0µg/ml)&&Staphylococcus epidermidis C621 (MIC=5.0µg/ml)&&Bacillus subtilis C971 (MIC=1.6µg/ml)&&Enterococcus faecalis C625 (MIC=64.0µg/ml)&&Corynebacterium xerosis C875 (MIC=1.3µg/ml)&&Staphylococcus aureus C622 (MIC=>64µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=32µg/ml)&&Escherichia coli DH5alpha (MIC=1µg/ml)&&Escherichia coli K91BK (MIC=>100µM)&&Bacillus subtilis var. niger ATCC 9372 (MIC=7.87±0.79µM)&&Bacillus subtilis var. niger ATCC 9372 (IC50=3.94±0.20µM)&&Bacillus anthracis Sterne 34F2 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Bacillus subtilis ATCC 49619 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=500µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=128µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=32µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=8µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=16µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=8µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=128µg/ml)&&Escherichia coli (MIC=4µg/ml)&&Pseudomonas aeruginosa (MIC=16µg/ml)&&Klebsiella pneumoniae ATCC 700603 (MIC=4µg/ml)&&Klebsiella pneumoniae (MIC=8µg/ml)&&Staphylococcus aureus (MIC=128µg/ml)&&Streptococcus pneumoniae (MIC=8µg/ml)&&Streptococcus alpha-hemolytic   (MIC=64µg/ml)&&Streptococcus beta-hemolytic (MIC=64µg/ml)&&Human lung carcinoma A549 (IC50=33.1±1.17µM)&&Human melanoma A375 (IC50=17.8±0.62µM)&&Human breast adenocarcinoma MCF-7 (IC50=15.8±0.54µM)&&Human colon adenocarcinoma SW1116 (IC50=11.1±0.37µM)&&Human rhabdomyosarcoma (IC50=25.2±0.84µM)&&Human lung carcinoma H1299 (IC50=4.7±0.16µM)&&Mouse skin melanoma B16 (IC50=11.5±0.40µM)&&Human cervical carcinoma HeLa (IC50=10.4±0.37µM)&&Escherichia coli ATCC 25922 (MIC=1µg/ml)&&Escherichia coli DH5alpha (MIC=2µg/ml),KWKSFLKTFKSAKKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
27092,dbAMP_27092,,Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=1µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=16µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=2µg/ml)&&Staphylococcus aureus ATCC 6538P (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 9144 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12598 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=16µg/ml)&&Staphylococcus aureus (MIC=2-4µg/ml)&&Staphylococcus aureus (MIC=16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus aureus (MIC=8-16µg/ml)&&Staphylococcus aureus (MIC=1-2µg/ml)&&Staphylococcus epidermidis ATCC 14990 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=128µg/ml)&&Candida albicans ATCC 10231 (MIC=4µg/ml)&&Candida glabrata ATCC 15126 (MIC=4µg/ml)&&Yarrowia lipolytica PCM 2680-FY (MIC=2µg/ml)&&Candida tropicalis PCM 2709-FY (MIC=2µg/ml)&&Human cervical carcinoma HeLa (IC50=30.4±2.5µg/ml),CKKKRC,,Linear,Free,Free,,L,dbAMP3,6
27115,dbAMP_27115,,Human breast adenocarcinoma MDA-MB-231 (CC50=>30µM)&&Human breast carcinoma JIMT-1 (CC50=>30µM)&&Human prostate cancer DU145 (CC50=>30µM)&&Human pancreatic carcinoma Mia PaCa-2 (CC50=>30µM),XGX,,Linear,Free,Free,,L,dbAMP3,3
27154,dbAMP_27154,,Mouse lymphoma A20 (IC50=13.0±1.0µM)&&Murine squamous cell oral carcinoma AT84 (IC50=17.7±3.1µM)&&Human promyelocytic leukemia HL-60 (IC50=6.1±1.8µM)&&Human promyelocytic leukemia HL-60/ADR (IC50=7.0±3.7µM)&&Human breast adenocarcinoma MCF-7 (IC50=6.8±2.8µM)&&Human breast adenocarcinoma MCF-7/mdr (IC50=8.4±2.7µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=13.4±1.6µM)&&Human ovarian adenocarcinoma IGROV1/CDDP (IC50=6.6±2.6µM)&&Human myelogenous leukemia K562 (IC50=7.24±0.4µM)&&Human myelogenous leukemia K562/Gleevec (IC50=7.9±2.9µM)&&Human B-lymphoma RAJI (IC50=16.1±4.9µM)&&Human histiocytic lymphoma U-937 (IC50=3.8±1.2µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=7.6±1.2µM)&&Human neuroblastoma SH-SY5Y (IC50=7.8±2.6µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=10.8±2.3µM)&&Human breast adenocarcinoma MDA-MB-435S (IC50=11.4±1.4µM)&&Human colon adenocarcinoma Colo205 (IC50=4.9±2.0µM)&&Human colon adenocarcinoma HCT 116 (IC50=7.6±2.5µM)&&Human colon adenocarcinoma HCT-15 (IC50=13.9±8.8µM)&&Human colon adenocarcinoma HT29 (IC50=10.5±2.9µM)&&Human renal carcinoma A498 (IC50=7.9±4.2µM)&&Human hepatocellular carcinoma HepG2 (IC50=14.8±4.8µM)&&Human liver carcinoma SK-HEP-1 (IC50=12.6±2.3µM)&&Human lung carcinoma A549 (IC50=10.3±2.5µM)&&Human lung carcinoma NCI-H460 (IC50=11.2±3.7µM)&&Human ovarian adenocarcinoma SK-OV-3 (IC50=17.7±2.8µM)&&Human pancreatic adenocarcinoma BxPC-3 (IC50=8.9±1.2µM)&&Human pancreatic carcinoma Panc-1 (IC50=10.8±6.3µM)&&Human prostate cancer DU145 (IC50=8.8±4.1µM)&&Human prostate adenocarcinoma PC-3 (IC50=9.3±0.7µM)&&Human epidermoid carcinoma A431 (IC50=7.2±0.7µM)&&Human skin melanoma SK-MEL-2 (IC50=13.4±2.4µM),KKXWKKWWK,,Linear,Free,Free,,L,dbAMP3,9
27155,dbAMP_27155,,Mouse lymphoma A20 (IC50=9.3±1.2µM)&&Murine squamous cell oral carcinoma AT84 (IC50=11.0±1.0µM),KKWXKKWWK,,Linear,Free,Free,,L,dbAMP3,9
27156,dbAMP_27156,,Mouse lymphoma A20 (IC50=67.7±13.2µM)&&Murine squamous cell oral carcinoma AT84 (IC50=154±29µM),XXWXXXWWX,,Linear,Free,Free,,L,dbAMP3,9
27158,dbAMP_27158,,Staphylococcus aureus LAC (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Human prostate cancer DU145 (10% Killing=100µM)&&Human lymphoblastic leukemia CCRF-CEM (10% Killing=100µM),AAAARRRR,,Linear,Free,Free,,L,dbAMP3,8
27159,dbAMP_27159,,Staphylococcus aureus LAC (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Human lymphoblastic leukemia CCRF-CEM (12% Killing=100µM),LLLLRRRR,,Linear,Free,Free,,L,dbAMP3,8
27160,dbAMP_27160,,Staphylococcus aureus LAC (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Human prostate cancer DU145 (10% Killing=100µM)&&Human lymphoblastic leukemia CCRF-CEM (15% Killing=100µM),IIIIRRRR,,Linear,Free,Free,,L,dbAMP3,8
27161,dbAMP_27161,,Staphylococcus aureus LAC (MIC=>128µg/ml)&&Escherichia coli ATCC 25922 (MIC=>128µg/ml)&&Human prostate cancer DU145 (10% Killing=100µM)&&Human lymphoblastic leukemia CCRF-CEM (25% Killing=100µM),YYYYRRRR,,Linear,Free,Free,,L,dbAMP3,8
27195,dbAMP_27195,,Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli ST131 (MIC=2µM)&&Klebsiella pneumoniae ST258 (MIC=4µM)&&Human hepatocellular carcinoma HepG2 (IC50=19±3µM),KKWRKWLKWLAKK,,Linear,Free,Free,,L,dbAMP3,13
27198,dbAMP_27198,,Staphylococcus pseudintermedius C22963 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=16µg/ml)&&Pseudomonas aeruginosa 26314 (MIC=32µg/ml)&&Human cervical carcinoma HeLa (IC50=462µM),KKLKXFX,,Linear,Free,Free,,L,dbAMP3,7
27201,dbAMP_27201,,Staphylococcus pseudintermedius C22963 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=32µg/ml)&&Pseudomonas aeruginosa 26314 (MIC=>64µg/ml)&&Human cervical carcinoma HeLa (IC50=783µM),XFXLKKK,,Linear,Free,Free,,L,dbAMP3,7
27205,dbAMP_27205,,Staphylococcus aureus (MIC=6.67±1.33µg/ml)&&Escherichia coli (MIC=4.0±0.0µg/ml)&&Klebsiella pneumoniae (MIC=4.0±0.0µg/ml)&&Pseudomonas aeruginosa (MIC=16.0±0.0µg/ml)&&Acinetobacter baumannii (MIC=0.42±0.08µg/ml)&&Candida albicans (MIC=21.33±5.33µg/ml)&&Cryptococcus neoformans (MIC=0.67±0.17µg/ml)&&Human astrocytoma U373-MG (20% Killing=30µM)&&Human astrocytoma U373-MG (LD50=9.44µM)&&Rat leukemia cells RBL-2H3 (EC50=7.53µM),INLKKLAKLXKKIL,,Linear,Free,Free,,L,dbAMP3,14
27209,dbAMP_27209,,Human astrocytoma U373-MG (LD50=>100µM)&&Rat leukemia cells RBL-2H3 (EC50=>100µM),LIKKXLKALKKLNI,,Linear,Free,Free,,L,dbAMP3,14
27214,dbAMP_27214,,Staphylococcus aureus ATCC 29213 (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Pseudomonas aeruginosa PAO1 H103 (MIC=32µg/ml)&&Human cervical carcinoma HeLa (IC50=118µg/ml),XXXXXXXXX,,Linear,Free,Free,,L,dbAMP3,9
27219,dbAMP_27219,,Human breast adenocarcinoma MCF-7 (IC50=2.9±0.3µM)&&Human breast adenocarcinoma MCF-7/ADM (IC50=3.0±0.2µM)&&Human myelogenous leukemia K562 (IC50=3.1±0.3µM)&&Human myelogenous leukemia K562/ADM (IC50=3.7±0.3µM)&&Human hepatocellular carcinoma HepG2 (IC50=4.7±0.4µM),GGKKLFKKILKYL,,Linear,Free,Free,,L,dbAMP3,13
27226,dbAMP_27226,,Candida albicans ATCC 10231 (MIC=>250µg/ml)&&Candida albicans ATCC 10231 (MIC50=>250µg/ml)&&Candida krusei DSM 6128 (MIC=250µg/ml)&&Candida krusei DSM 6128 (MIC50=250µg/ml)&&Candida glabrata DSM 11226 (MIC=>250µg/ml)&&Candida glabrata DSM 11226 (MIC50=>250µg/ml)&&Candida tropicalis (MIC=>250µg/ml)&&Candida tropicalis (MIC50=>250µg/ml)&&Candida albicans ATCC 10231 (MFC=125µg/ml)&&Candida albicans ATCC 10231 (MIC50=125µg/ml)&&Candida krusei DSM 6128 (MFC=125µg/ml)&&Candida krusei DSM 6128 (MIC50=31µg/ml)&&Candida glabrata DSM 11226 (MFC=>125µg/ml)&&Candida glabrata DSM 11226 (MIC50=>125µg/ml)&&Candida tropicalis (MFC=8µg/ml)&&Candida tropicalis (MIC50=4µg/ml)&&Candida albicans ATCC 10231 (MFC=4µg/ml)&&Candida albicans ATCC 10231 (MIC50=4µg/ml)&&Candida krusei DSM 6128 (MFC=8µg/ml)&&Candida krusei DSM 6128 (MIC50=8µg/ml)&&Candida glabrata DSM 11226 (MFC=31µg/ml)&&Candida glabrata DSM 11226 (MIC50=16µg/ml)&&Candida tropicalis (MFC=2µg/ml)&&Candida tropicalis (MIC50=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=63µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC50=63µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC50=4µg/ml)&&Bacillus subtilis ATCC 6633 (MIC50=125µg/ml)&&Bacillus subtilis ATCC 6633 (MIC90=125µg/ml)&&Bacillus cereus PCM 2003 (MIC=>250µg/ml)&&Bacillus cereus PCM 2003 (MIC50=>250µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Escherichia coli ATCC 25922 (MIC50=16µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MIC=125µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MIC50=125µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC50=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=2µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC50=1µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MBC=2µg/ml)&&Bacillus subtilis ATCC 6633 (MIC50=4µg/ml)&&Bacillus subtilis ATCC 6633 (MBC=2µg/ml)&&Bacillus cereus PCM 2003 (MIC50=4µg/ml)&&Bacillus cereus PCM 2003 (MBC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC50=2µg/ml)&&Escherichia coli ATCC 25922 (MBC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MIC50=2µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MBC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC50=>125µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>125µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC50=>125µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MBC=125µg/ml)&&Bacillus subtilis ATCC 6633 (MIC50=>125µg/ml)&&Bacillus subtilis ATCC 6633 (MBC=>125µg/ml)&&Bacillus cereus PCM 2003 (MIC50=>125µg/ml)&&Bacillus cereus PCM 2003 (MBC=>125µg/ml)&&Escherichia coli ATCC 25922 (MIC50=125µg/ml)&&Escherichia coli ATCC 25922 (MBC=>125µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MIC50=>125µg/ml)&&Pseudomonas aeruginosa ATCC 27857 (MBC=>125µg/ml)&&Human hepatocellular carcinoma HepG2 (15% Cytotoxicity=200µM),CFQWKRAMRKVR,,Linear,Free,Free,,L,dbAMP3,12
27227,dbAMP_27227,,Escherichia coli ATCC 25922 (MBC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=50µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>80µg/ml)&&Candida albicans ATCC 10231 (MFC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=105µg/ml)&&Human colon adenocarcinoma SW480 (LD50=100µg/ml)&&Human melanoma BMKC (LD50=140µg/ml)&&Human lung carcinoma H1299 (LD50=127µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=170µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=66µg/ml),FAKKLAKLAKKLAKLAL,,Linear,Free,Free,,L,dbAMP3,17
27228,dbAMP_27228,,Escherichia coli UB1005 (MIC=4µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=4µg/ml)&&Pseudomonas aeruginosa (MIC=8µg/ml)&&Pseudomonas aeruginosa M76 (MIC=4µg/ml)&&Pseudomonas aeruginosa M917 (MIC=16µg/ml)&&Pseudomonas aeruginosa M1251 (MIC=4µg/ml)&&Pseudomonas aeruginosa M1426 (MIC=8µg/ml)&&Pseudomonas aeruginosa R70 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=4µg/ml)&&Candida albicans (MIC=8µg/ml)&&Pseudomonas stutzeri (MIC=4µg/ml)&&Pseudomonas fluorescens (MIC=8µg/ml)&&Stenotrophomonas maltophilia (MIC=2µg/ml)&&Achromobacter xylosoxidans (MIC=64µg/ml)&&Human breast adenocarcinoma MCF-7 (EC50=6µM)&&Staphylococcus aureus ATCC 6538 (MIC=5µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=25µg/ml)&&Escherichia coli ATCC 25922 (MBC=8µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=15µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=4µg/ml)&&Candida albicans ATCC 10231 (MFC=15µg/ml)&&Human colon adenocarcinoma SW480 (LD50=9µg/ml)&&Human melanoma BMKC (LD50=7µg/ml)&&Human lung carcinoma H1299 (LD50=6µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=15µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=12µg/ml),FAKLLAKLAKKLL,,Linear,Free,Free,,L,dbAMP3,13
27229,dbAMP_27229,,Escherichia coli UB1005 (MIC=6.4µg/ml)&&Escherichia coli DC2 (MIC=5.0µg/ml)&&Salmonella typhimurium C587 (MIC=32.0µg/ml)&&Salmonella typhimurium C610 (MIC=10.1µg/ml)&&Pseudomonas aeruginosa H187 (MIC=12.7µg/ml)&&Pseudomonas aeruginosa H188 (MIC=32.0µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=32.0µg/ml)&&Staphylococcus aureus SAP 0017 (MIC=25.4µg/ml)&&Staphylococcus epidermidis C621 (MIC=8.0µg/ml)&&Bacillus subtilis C971 (MIC=3.2µg/ml)&&Enterococcus faecalis C625 (MIC=32.0µg/ml)&&Corynebacterium xerosis C875 (MIC=2.5µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Human cervical carcinoma HeLa (IC50=4.86µM)&&Human lung carcinoma A549 (IC50=2.80µM)&&Human gastric cancer SGC-7901 (IC50=2.0µM)&&Mouse skin melanoma B16 (IC50=3.51µM),KWKSFLKTFKSALKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
27230,dbAMP_27230,,Escherichia coli UB1005 (MIC=2.5µg/ml)&&Escherichia coli DC2 (MIC=2.5µg/ml)&&Salmonella typhimurium C587 (MIC=6.4µg/ml)&&Salmonella typhimurium C610 (MIC=2.0µg/ml)&&Pseudomonas aeruginosa H187 (MIC=6.4µg/ml)&&Pseudomonas aeruginosa H188 (MIC=10.1µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16.0µg/ml)&&Staphylococcus aureus SAP 0017 (MIC=12.7µg/ml)&&Staphylococcus epidermidis C621 (MIC=4.0µg/ml)&&Bacillus subtilis C971 (MIC=2.5µg/ml)&&Enterococcus faecalis C625 (MIC=50.8µg/ml)&&Corynebacterium xerosis C875 (MIC=1.6µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=8µM)&&Human cervical carcinoma HeLa (IC50=12.18µM)&&Human lung carcinoma A549 (IC50=12.07µM)&&Human gastric cancer SGC-7901 (IC50=4.27µM)&&Mouse skin melanoma B16 (IC50=5.61µM),KWKSFLKTFKSASKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
27235,dbAMP_27235,,Human breast adenocarcinoma MCF-7 (IC50=2.3±0.1µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=2.0±0.1µM)&&Human myelogenous leukemia K562 (IC50=3.9±0.2µM)&&Human myelogenous leukemia K562/ADM (IC50=4.2±0.5µM)&&Human prostate cancer DU145 (IC50=3.9±0.5µM),VKRFKKFFRKLKKSV,,Linear,Free,Free,,L,dbAMP3,15
27236,dbAMP_27236,,Mycobacterium tuberculosis lux (MIC90=7.4µM)&&Mycobacterium tuberculosis lux (MIC50=2.8µM)&&Mycobacterium smegmatis mc2-6 (MIC90=3.7µM)&&Pseudomonas aeruginosa H103 (MIC=6.0µM)&&Escherichia coli UB1005 (MIC=1.5µM)&&Salmonella enterica serovar Typhimurium (MIC=1.5µM)&&Candida albicans (MIC=3.0µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=1.5µM)&&Human acute monocytic leukemia THP-1 (IC50=14.8µM),FIKWKFRWWKWRK,,Linear,Free,Free,,L,dbAMP3,13
27238,dbAMP_27238,,Mycobacterium tuberculosis lux (MIC90=3.1µM)&&Mycobacterium tuberculosis lux (MIC50=0.9µM)&&Mycobacterium smegmatis mc2-6 (MIC90=4.9µM)&&Pseudomonas aeruginosa H103 (MIC=11.1µM)&&Escherichia coli UB1005 (MIC=2.8µM)&&Salmonella enterica serovar Typhimurium (MIC=5.6µM)&&Candida albicans (MIC=5.6µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=11.1µM)&&Human acute monocytic leukemia THP-1 (IC50=79.2µM),KRWWKWWRR,,Linear,Free,Free,,L,dbAMP3,9
27241,dbAMP_27241,,Pseudomonas aeruginosa PAO1 H103 (MIC=4.1µg/ml)&&Pseudomonas aeruginosa 9 (MIC=32µg/ml)&&Pseudomonas aeruginosa 198 (MIC=17µg/ml)&&Pseudomonas aeruginosa H1030 (MIC=8.3µg/ml)&&Pseudomonas aeruginosa H1027 (MIC=4.1µg/ml)&&Stenotrophomonas maltophilia ATCC 13637 (MIC=2.1µg/ml)&&Enterobacter cloacae 218R (MIC=65µg/ml)&&Escherichia coli ESBL 63103 (MIC=8.3µg/ml)&&Escherichia coli ESBL 64771 (MIC=4.1µg/ml)&&Klebsiella pneumoniae ESBL 61962 (MIC=130µg/ml)&&Klebsiella pneumoniae ESBL 63575 (MIC=32µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4.1µg/ml)&&Staphylococcus aureus C623 (MIC=4.1µg/ml)&&Enterococcus faecalis ATCC 29212 (MIC=17µg/ml)&&Enterococcus faecalis W61950 (MIC=65µg/ml)&&Enterococcus faecium mic80 (MIC=4.1µg/ml)&&Enterococcus faecium t62764 (MIC=1µg/ml)&&Mycobacterium tuberculosis lux (MIC90=4.1µM)&&Mycobacterium tuberculosis lux (MIC50=1.0µM)&&Mycobacterium smegmatis mc2-6 (MIC90=5.4µM)&&Pseudomonas aeruginosa H103 (MIC=42.3µM)&&Escherichia coli UB1005 (MIC=5.3µM)&&Salmonella enterica serovar Typhimurium (MIC=10.6µM)&&Candida albicans (MIC=10.6µM)&&Staphylococcus epidermidis (MIC=1.3µM)&&Human acute monocytic leukemia THP-1 (IC50=173.9µM)&&Mycobacterium tuberculosis H37Rv (MIC=>75µg/ml)&&Mycobacterium tuberculosis H37Rv (MIC=9µg/ml)&&Mycobacterium smegmatis MTCC 994 (MIC=>75µg/ml)&&Mycobacterium smegmatis MTCC 994 (MIC=18.75µg/ml),KIWWWWRKR,,Linear,Free,Free,,L,dbAMP3,9
27262,dbAMP_27262,,Human glioblastoma U251-MG (IC50=74.39µg/ml)&&Human breast adenocarcinoma MDA-MB-231 (IC50=>10µg/ml)&&Human lung carcinoma A549 (IC50=>10µg/ml)&&Human prostate cancer DU145 (IC50=>10µg/ml)&&Human hepatocarcinoma BEL-7402 (IC50=>10µg/ml),GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,,Linear,Free,Free,,L,dbAMP3,30
27299,dbAMP_27299,,Human lung carcinoma A549 (LC50=35µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus epidermidis RP62A/1 (MIC=4µM)&&Staphylococcus epidermidis RP62A (MIC=4µM)&&Escherichia coli ATCC 25726 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=64µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=64µM)&&Acinetobacter baumannii NM8 (MIC=64µM)&&Stenotrophomonas maltophilia B32/4 (MIC=64µM)&&Candida albicans ATCC 90028 (MIC=128µM),ILGKLLKTAAGLLSNL,,Linear,Free,Free,,L,dbAMP3,16
27300,dbAMP_27300,,Human lung carcinoma A549 (LC50=20µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus epidermidis RP62A/1 (MIC=4µM)&&Staphylococcus epidermidis RP62A (MIC=4µM)&&Escherichia coli ATCC 25726 (MIC=32µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=32µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=32µM)&&Acinetobacter baumannii NM8 (MIC=8µM)&&Stenotrophomonas maltophilia B32/4 (MIC=32µM)&&Candida albicans ATCC 90028 (MIC=16µM),ILGKLLSTAAKLLSNL,,Linear,Free,Free,,L,dbAMP3,16
27301,dbAMP_27301,,Human lung carcinoma A549 (LC50=13µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=18µM)&&Human colon adenocarcinoma HT29 (LC50=32µM)&&Human hepatocellular carcinoma HepG2 (LC50=17µM)&&Escherichia coli ATCC 25726 (MIC=>256µM)&&Staphylococcus aureus ATCC 25923 (MIC=32µM)&&Staphylococcus epidermidis RP62A/1 (MIC=8µM)&&Staphylococcus epidermidis RP62A (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=>128µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=>128µM)&&Acinetobacter baumannii NM8 (MIC=>128µM)&&Stenotrophomonas maltophilia B32/4 (MIC=>128µM)&&Candida albicans ATCC 90028 (MIC=>128µM),ILGKLLSTAAGLLSKL,,Linear,Free,Free,,L,dbAMP3,16
27302,dbAMP_27302,,Human lung carcinoma A549 (LC50=20µM)&&Staphylococcus aureus ATCC 25923 (MIC=4µM)&&Staphylococcus epidermidis RP62A/1 (MIC=2µM)&&Staphylococcus epidermidis RP62A (MIC=2µM)&&Escherichia coli ATCC 25726 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=16µM)&&Acinetobacter baumannii NM8 (MIC=4µM)&&Stenotrophomonas maltophilia B32/4 (MIC=4µM)&&Candida albicans ATCC 90028 (MIC=8µM),ILGKLLKTAAKLLSNL,,Linear,Free,Free,,L,dbAMP3,16
27303,dbAMP_27303,,Human lung carcinoma A549 (LC50=6µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=10µM)&&Human colon adenocarcinoma HT29 (LC50=18µM)&&Human hepatocellular carcinoma HepG2 (LC50=8µM)&&Escherichia coli ATCC 25726 (MIC=16µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM),ILGKLLSTAAKLLSKL,,Linear,Free,Free,,L,dbAMP3,16
27304,dbAMP_27304,,Human lung carcinoma A549 (LC50=6µM),ILGKLLSTAWGLLSKL,,Linear,Free,Free,,L,dbAMP3,16
27305,dbAMP_27305,,Human lung carcinoma A549 (LC50=1.2±0.1µM)&&Escherichia coli ATCC 25726 (MIC=6.25µM)&&Acinetobacter baumannii (MIC=6.25µM)&&Stenotrophomonas maltophilia (MIC=1.6µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=6.25µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=12.5µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.6µM)&&Staphylococcus epidermidis RP62A (MIC=0.8µM)&&Staphylococcus epidermidis RP62A/1 (MIC=0.8µM)&&Candida albicans ATCC 90028 (MIC=100µM),IKLSPKTKDNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
27306,dbAMP_27306,,Human lung carcinoma A549 (LC50=1.1±0.1µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=2.9±0.5µM)&&Human colon adenocarcinoma HT29 (LC50=6.5±1.2µM)&&Human hepatocellular carcinoma HepG2 (LC50=3.9±0.1µM)&&Escherichia coli ATCC 25726 (MIC=6.25µM)&&Acinetobacter baumannii (MIC=3.1µM)&&Stenotrophomonas maltophilia (MIC=3.1µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=12.5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=25µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=3.1µM)&&Staphylococcus epidermidis RP62A (MIC=1.6µM)&&Staphylococcus epidermidis RP62A/1 (MIC=0.8µM)&&Candida albicans ATCC 90028 (MIC=50µM),IKLSPETKKNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
27310,dbAMP_27310,,Human  glioblastoma T67 (EC50=13µM),XGLXGGLXGIX,,Linear,Free,Free,,L,dbAMP3,11
27311,dbAMP_27311,,Fusarium oxysporum f. sp. lycopersici ATCC 201829 (MIC=0.6-1.2µM)&&Penicillium expansum EPS 26 (MIC=>100µM)&&Aspergillus niger CECT 2694 (MIC=20-25µM)&&Rhizopus stolonifer CECT 2344 (MIC=50-100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>200µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=>200µM),KKLFKKILKKL,,Linear,Free,Free,,L,dbAMP3,11
27314,dbAMP_27314,,Staphylococcus aureus USA 100 (MIC=3.125µM)&&Staphylococcus aureus USA 300 (MIC=3.125-6.25µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=3.125µM)&&Candida albicans ATCC 90028 (MIC=>100µM)&&Staphylococcus aureus ATCC BAA-1556 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-1556 (MBC=12.5µM)&&Staphylococcus aureus ATCC BAA-1708 (MIC=6.25µM)&&Staphylococcus aureus USA 200 (MIC=6.25µM)&&Staphylococcus aureus USA 400 (MIC=6.25µM)&&Staphylococcus aureus USA 500 (MIC=6.25µM)&&Staphylococcus aureus ATCC BAA-2762 (MIC=6.25µM)&&Staphylococcus aureus ATCC 700699 (MIC=6.25µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli ST131 (MIC=2µM)&&Klebsiella pneumoniae ST258 (MIC=4µM)&&Human hepatocellular carcinoma HepG2 (IC50=34±8µM),KWRRWIRWL,,Linear,Free,Free,,L,dbAMP3,9
27349,dbAMP_27349,,Trueperella pyogenes (MIC=25µg/ml)&&Staphylococcus aureus (MIC=12.5µg/ml)&&Bacillus subtilis (MIC=25µg/ml)&&Klebsiella pneumoniae (MIC=6µg/ml)&&Pseudomonas aeruginosa (MIC=6µg/ml)&&Escherichia coli (MIC=12.5µg/ml)&&Candida albicans (MIC=6µg/ml)&&Aspergillus niger (MIC=25µg/ml)&&Microsporum audouinii (MIC=6µg/ml)&&Trichophyton mentagrophytes (MIC=6µg/ml)&&Dalton's lymphoma ascites (IC50=10.6µM)&&Ehrlich's ascites carcinoma (IC50=14.6µM),YPLPFIP,,Linear,Free,Free,,L,dbAMP3,7
27353,dbAMP_27353,,Bacillus subtilis MTCC 2756 (MIC=4µg/ml)&&Bacillus subtilis MTCC 2756 (MBC=8µg/ml)&&Staphylococcus aureus MTCC 902 (MIC=8µg/ml)&&Staphylococcus aureus MTCC 902 (MBC=8µg/ml)&&Escherichia coli MTCC 2622 (MIC=8µg/ml)&&Escherichia coli MTCC 2622 (MBC=16µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MIC=16µg/ml)&&Pseudomonas aeruginosa MTCC 2642 (MBC=16µg/ml)&&Staphylococcus epidermidis MTCC 435 (MIC=2µg/ml)&&Staphylococcus epidermidis MTCC 435 (MBC=2µg/ml)&&Proteus mirabilis MTCC 425 (MIC=2µg/ml)&&Proteus mirabilis MTCC 425 (MBC=2µg/ml)&&Vibrio cholerae MTCC 3905 (MIC=0.5µg/ml)&&Vibrio cholerae MTCC 3905 (MBC=1µg/ml)&&Klebsiella pneumoniae MTCC 109 (MIC=16µg/ml)&&Klebsiella pneumoniae MTCC 109 (MBC=16µg/ml)&&Staphylococcus simulans MTCC 3610 (MIC=16µg/ml)&&Staphylococcus simulans MTCC 3610 (MBC=32µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi MTCC 3216 (MIC=1µg/ml)&&Salmonella enterica subsp. enterica serovar Typhi MTCC 3216 (MBC=1µg/ml)&&Human colon adenocarcinoma HCT 116 (IC50=>50µg/ml)&&Aspergillus flavus MTCC 183 (MIC=32µg/ml)&&Candida albicans MTCC 277 (MIC=16µg/ml)&&Fusarium oxysporum MTCC 284 (MIC=2µg/ml)&&Rhizoctonia solani MTCC 4634 (MIC=2µg/ml)&&Penicillium expansum MTCC 2006 (MIC=4µg/ml)&&Candida tropicalis MTCC 184 (MIC=8µg/ml)&&Goffeauzyma gastrica MTCC 1715 (MIC=8µg/ml)&&Trichophyton rubrum MTCC 296 (MIC=4µg/ml)&&Human lung carcinoma A549 (IC50=>=100µM)&&Human ovarian adenocarcinoma A2780 (IC50=>100µM)&&Human ovarian adenocarcinoma A2780CisR (IC50=>100µM)&&Human cervical carcinoma HeLa (IC50=100µM)&&Human hepatocellular carcinoma HepG2 (IC50=>200µM)&&Human breast adenocarcinoma MCF-7 (IC50=100µM)&&Bacillus subtilis ATCC 23857 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 12600 (MIC=8µg/ml)&&Staphylococcus epidermidis ATCC 51625 (MIC=2µg/ml)&&Staphylococcus simulans ATCC 27848 (MIC=16µg/ml)&&Escherichia coli ATCC 35218 (MIC=8µg/ml)&&Klebsiella pneumoniae ATCC 43816 (MIC=16µg/ml)&&Proteus mirabilis ATCC 21100 (MIC=16µg/ml)&&Pseudomonas aeruginosa ATCC 10145 (MIC=16µg/ml)&&Aspergillus flavus ATCC 204304 (MIC=32µg/ml)&&Candida albicans ATCC 10231 (MIC=16µg/ml)&&Goffeauzyma gastrica ATCC 32042 (MIC=8µg/ml)&&Trichophyton rubrum ATCC 28191 (MIC=4µg/ml)&&Fusarium oxysporum ATCC 14838 (MIC=2µg/ml)&&Rhizoctonia solani ATCC 10182 (MIC=2µg/ml)&&Penicillium expansum ATCC 16104 (MIC=4µg/ml)&&Alternaria brassicae ATCC 66981 (MIC=8µg/ml),WF,,Linear,Free,Free,,L,dbAMP3,2
27411,dbAMP_27411,,Mycobacterium tuberculosis H37Rv (MIC50=0.69µM)&&Mycobacterium tuberculosis H37Rv (MIC90=44.33µM)&&Mycobacterium tuberculosis (MIC50=2.77µM)&&Mycobacterium tuberculosis (MIC90=44.33µM)&&Human acute monocytic leukemia THP-1 (IC50=7.74µM),WKWLKKWIK,,Linear,Free,Free,,L,dbAMP3,9
27412,dbAMP_27412,,Mycobacterium tuberculosis lux (MIC90=2.6µM)&&Mycobacterium tuberculosis lux (MIC50=1.3µM)&&Mycobacterium smegmatis mc2-6 (MIC90=2.2µM)&&Pseudomonas aeruginosa H103 (MIC=5.7µM)&&Escherichia coli UB1005 (MIC=1.4µM)&&Salmonella enterica serovar Typhimurium (MIC=5.7µM)&&Candida albicans (MIC=2.9µM)&&Staphylococcus epidermidis (MIC=0.7µM)&&Staphylococcus aureus ATCC 25923 (MIC=0.7µM)&&Enterococcus faecalis ATCC 29212 (MIC=2.9µM)&&Mycobacterium abscessus ATCC 19977 (MIC=3.1µg/ml)&&Mycobacterium abscessus subsp. massiliense (MIC=1.6µg/ml)&&Human acute monocytic leukemia THP-1 (IC50=56.4µM),ILPWKWRWWKWRR,,Linear,Free,Free,,L,dbAMP3,13
27414,dbAMP_27414,,Mycobacterium tuberculosis H37Rv (MIC50=2.64µM)&&Mycobacterium tuberculosis H37Rv (MIC90=84.56µM)&&Mycobacterium tuberculosis (MIC50=2.64µM)&&Mycobacterium tuberculosis (MIC90=84.56µM)&&Human acute monocytic leukemia THP-1 (IC50=17.08µM),WRKFWKYLK,,Linear,Free,Free,,L,dbAMP3,9
27415,dbAMP_27415,,Mycobacterium tuberculosis H37Rv (MIC50=2.41µM)&&Mycobacterium tuberculosis H37Rv (MIC90=38.51µM)&&Mycobacterium tuberculosis (MIC50=77.02µM)&&Mycobacterium tuberculosis (MIC90=87.00µM)&&Human acute monocytic leukemia THP-1 (IC50=24.29µM),RLWWWWRRK,,Linear,Free,Free,,L,dbAMP3,9
27416,dbAMP_27416,,Mycobacterium tuberculosis H37Rv (MIC50=5.07µM)&&Mycobacterium tuberculosis H37Rv (MIC90=>81.17µM)&&Mycobacterium tuberculosis (MIC50=20.29µM)&&Mycobacterium tuberculosis (MIC90=>81.17µM)&&Human acute monocytic leukemia THP-1 (IC50=40.80µM),RIRRWKFRW,,Linear,Free,Free,,L,dbAMP3,9
27422,dbAMP_27422,,Mycobacterium tuberculosis H37Rv (MIC50=2.80µM)&&Mycobacterium tuberculosis H37Rv (MIC90=89.71µM)&&Mycobacterium tuberculosis (MIC50=11.21µM)&&Mycobacterium tuberculosis (MIC90=89.71µM)&&Human acute monocytic leukemia THP-1 (IC50=42.91µM),RQRRVVIWW,,Linear,Free,Free,,L,dbAMP3,9
27445,dbAMP_27445,,Escherichia coli ATCC 25922 (MIC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Candida albicans ATCC 14053 (MIC=16µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=24.3±0.2µM)&&Human cervical carcinoma HeLa (IC50=>=50µM)&&Human colon adenocarcinoma HCT 116 (IC50=15.1±0.1µM),XX,,Linear,Free,Free,,L,dbAMP3,2
27447,dbAMP_27447,,Human breast adenocarcinoma MCF-7 (IC50=0.00009µM)&&Human prostate adenocarcinoma LNCaP (IC50=0.00065±0.0003µM)&&Human prostate carcinoma C4-2 (IC50=0.0017±0.0009µM)&&Human prostate adenocarcinoma PC-3 (IC50=0.0019±0.0007µM)&&Human prostate adenocarcinoma PC-3dR (IC50=0.0046±0.0003µM),XXX,,Linear,Free,Free,,L,dbAMP3,3
27449,dbAMP_27449,,Human colon adenocarcinoma HT29 (IC50=0.00028µM)&&Human neuroblastoma IMR-32 (IC50=0.00031µM)&&Paradendryphiella salina (LC50=200µg/ml),XXXXX,,Linear,Free,Free,,L,dbAMP3,5
27471,dbAMP_27471,,Human Astrocytoma SF-268 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human lung carcinoma NCI-H460 (IC50=>100µM)&&Human hepatocellular carcinoma HepG2 (IC50=>100µM),WX,,Linear,Free,Free,,L,dbAMP3,2
27480,dbAMP_27480,,Human cervical carcinoma HeLa (EC50=3µM)&&Human  glioblastoma T67 (EC50=1µM),XGLXGKLXGIX,,Linear,Free,Free,,L,dbAMP3,11
27482,dbAMP_27482,,Staphylococcus aureus NCTC 4163 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>200µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=>200µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=100µg/ml)&&Bacillus cereus ATCC 11778 (MIC=>200µg/ml)&&Enterococcus hirae ATCC 10541 (MIC=>200µg/ml)&&Micrococcus luteus ATCC 9341 (MIC=200µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=200µg/ml)&&Candida albicans ATCC 10231 (MIC=200µg/ml)&&Candida albicans ATCC 90028 (MIC=200µg/ml)&&Candida albicans SN250 (MIC=200µg/ml)&&Candida parapsilosis ATCC 22019 (MIC=200µg/ml)&&Human lung carcinoma A549 (IC50=0.90±0.03µM)&&Human breast adenocarcinoma MCF-7 (IC50=2.70±0.54µM)&&Human colon adenocarcinoma LoVo (IC50=0.73±0.13µM)&&Human carcinoma HeLa-KB (IC50=4.65±0.75µM),GG,,Linear,Free,Free,,L,dbAMP3,2
27483,dbAMP_27483,,Escherichia coli ATCC 25922 (MIC=4µM)&&Jurkat T-cell leukemia (IC50=9.6µM),VXXFPWWWPFLXX,,Linear,Free,Free,,L,dbAMP3,13
27500,dbAMP_27500,,Escherichia coli (MIC=4-8µg/ml)&&Staphylococcus aureus (MIC=4-8µg/ml)&&Escherichia coli KCTC 1682 (MIC=7.5µM)&&Salmonella typhimurium KCTC 1926 (MIC=15µM)&&Pseudomonas aeruginosa KCTC 1637 (MIC=15µM)&&Staphylococcus aureus KCTC 1621 (MIC=15µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=7.5µM)&&Bacillus subtilis KCTC 3068 (MIC=15µM)&&Enterococcus faecium (MIC=7.5µM)&&Enterococcus faecalis (MIC=3.8µM)&&Enterococcus faecium VR (MIC=7.5µM)&&Enterococcus faecalis VR (MIC=7.5µM)&&Staphylococcus aureus MR (MIC=15µM)&&Enterococcus faecium KCCM 12118 (MIC=8µg/ml)&&Enterococcus faecalis KCCM 29212 (MIC=2µg/ml)&&Enterococcus faecium ATCC 51559 (MIC=4µg/ml)&&Enterococcus faecalis ATCC 51575 (MIC=2µg/ml)&&Staphylococcus aureus KCCM 40510 (MIC=16µg/ml)&&Candida albicans (MIC=8µM)&&Human pancreatic adenocarcinoma CAPAN-1 (IC50=62µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=>100µM)&&Human Pancreatic adenocarcinoma SNU-410 (IC50=40.8µM)&&Human hepatocellular carcinoma HepG2 (IC50=>100µM)&&Human liver carcinoma SK-HEP-1 (IC50=77µM),LLCIALRKK,,Linear,Free,Free,,L,dbAMP3,9
27505,dbAMP_27505,,Human breast adenocarcinoma MCF-7 (IC50=2.5±0.2µM)&&Human breast adenocarcinoma MCF-7/Taxol (IC50=3.2±0.1µM)&&Human myelogenous leukemia K562 (IC50=3.4±0.1µM)&&Human myelogenous leukemia K562/ADM (IC50=3.3±0.3µM)&&Human prostate cancer DU145 (IC50=4.0±0.4µM),GGVKRFKKFFRKLKKSV,,Linear,Free,Free,,L,dbAMP3,17
27532,dbAMP_27532,,Bacillus subtilis PS832 (MIC=8µM)&&Bacillus subtilis PS832 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Escherichia coli DL7 (MIC=32µM)&&Escherichia coli DL7 (MIC=16µM)&&Klebsiella aerogenes ATCC 13048 (MIC=>64µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=>300µM)&&Mycobacterium tuberculosis H37Rv (MIC=>300µM)&&Escherichia coli MG1655 (MIC=64µM)&&Escherichia coli MG1655 (MIC=64µM)&&Escherichia coli MG1655 del-recA (MIC=32µM)&&Escherichia coli MG1655 del-recA (MIC=32µM)&&Human cervical carcinoma HeLa (10% Killing=128µM),RAGLQFPVGRVHRLLRK,,Linear,Free,Free,,L,dbAMP3,17
27561,dbAMP_27561,,Human breast adenocarcinoma MDA-MB-231 (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human colon adenocarcinoma HCT 116 (IC50=>100µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=>100µM)&&Human prostate adenocarcinoma PC-3 (IC50=>100µM),KP,,Linear,Free,Free,,L,dbAMP3,2
27577,dbAMP_27577,,Human  glioblastoma T67 (EC50=8µM)&&Human cervical carcinoma HeLa (EC50=9µM),XRLXGGLXGIX,,Linear,Free,Free,,L,dbAMP3,11
27578,dbAMP_27578,,Human  glioblastoma T67 (EC50=10µM)&&Human cervical carcinoma HeLa (EC50=6µM),XGLXKKLXGIX,,Linear,Free,Free,,L,dbAMP3,11
27584,dbAMP_27584,,Klebsiella aerogenes ATCC 13048 (MIC=42.44µM)&&Acinetobacter baumannii ATCC 15149 (MIC=2.65µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 15277 (MIC=42.44µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2.65µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=5.31µM)&&Enterococcus faecalis ATCC 29212 (MIC=5.31µM)&&Staphylococcus aureus USA 300 (MIC=5.31µM)&&Clostridioides difficile ATCC 43255 (MIC=5.31µM)&&Staphylococcus aureus ATCC 25923 (MIC=2.65µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=>43µM)&&Neisseria gonorrhoeae ATCC 49226 (MIC=5.31µM)&&Bacillus anthracis NR-3838 (MIC=2.65µM)&&Francisella tularensis NR-643 (MIC=21.22µM)&&Yersinia pestis NR641 (MIC=>43µM)&&Burkholderia pseudomallei NCTC 8016 (MIC=>43µM)&&Mycobacterium tuberculosis H37Ra (MIC=21.22µM)&&Mycobacterium tuberculosis SRI 1377 (MIC=>43µM)&&Human pancreatic adenocarcinoma CFPAC-1 (IC50=>7.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=>7.5µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=>7.5µM)&&Human colon adenocarcinoma Colo205 (IC50=>7.5µM)&&Human colon adenocarcinoma DLD-1 (IC50=>7.5µM)&&Human melanoma UACC-62 (IC50=>7.5µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=>7.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=>7.5µM)&&Human lung carcinoma A549 (IC50=>7.5µM)&&Human lung carcinoma NCI-H69 (IC50=7.1µM)&&Human lymphoma RL (IC50=3.7µM)&&Human renal carcinoma A498 (IC50=>7.5µM),GFXGXRXGXFXGXGRXRRRR,,Linear,Free,Free,,L,dbAMP3,20
27588,dbAMP_27588,,Klebsiella aerogenes ATCC 13048 (MIC=>45µM)&&Acinetobacter baumannii ATCC 15149 (MIC=>45µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 15277 (MIC=11.22µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=5.61µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=44.84µM)&&Enterococcus faecalis ATCC 29212 (MIC=>45µM)&&Staphylococcus aureus USA 300 (MIC=>45µM)&&Clostridioides difficile ATCC 43255 (MIC=1.4µM)&&Staphylococcus aureus ATCC 25923 (MIC=44.48µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=>45µM)&&Neisseria gonorrhoeae ATCC 49226 (MIC=11.21µM)&&Bacillus anthracis NR-3838 (MIC=22.42µM)&&Francisella tularensis NR-643 (MIC=22.42µM)&&Yersinia pestis NR641 (MIC=>45µM)&&Burkholderia pseudomallei NCTC 8016 (MIC=>45µM)&&Mycobacterium tuberculosis H37Ra (MIC=22.42µM)&&Mycobacterium tuberculosis SRI 1377 (MIC=11.21µM)&&Human pancreatic adenocarcinoma CFPAC-1 (IC50=>7.5µM)&&Human breast adenocarcinoma MCF-7 (IC50=>7.5µM)&&Human ovarian adenocarcinoma IGROV1 (IC50=>7.5µM)&&Human colon adenocarcinoma Colo205 (IC50=>7.5µM)&&Human colon adenocarcinoma DLD-1 (IC50=>7.5µM)&&Human melanoma UACC-62 (IC50=>7.5µM)&&Human pancreatic carcinoma Mia PaCa-2 (IC50=>7.5µM)&&Human renal carcinoma A498 (IC50=>7.5µM)&&Human prostate adenocarcinoma PC-3 (IC50=>7.5µM)&&Human lung carcinoma A549 (IC50=>7.5µM)&&Human lung carcinoma NCI-H69 (IC50=5.9µM)&&Human lymphoma RL (IC50=6.7µM),GFXGXKXGXFXGXGKXKKKK,,Linear,Free,Free,,L,dbAMP3,20
27650,dbAMP_27650,,Human lung carcinoma A549 (IC50=>100µM)&&Human epithelial carcinoma KB (IC50=>100µM)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human breast adenocarcinoma MDA-MB-436 (IC50=>100µM),KVKVKVKVPPTKVKVKVK,,Linear,Free,Free,,L,dbAMP3,18
27653,dbAMP_27653,,Pseudomonas aeruginosa PAO1 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=125µg/ml)&&Pseudomonas aeruginosa PAK (MIC=62.5µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=125µg/ml)&&Pseudomonas aeruginosa M2 (MIC=62.5µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=62.5µg/ml)&&Human cervical carcinoma HeLa (IC50=1.71±0.07µM)&&Human lung carcinoma A549 (IC50=9.7±0.24µM)&&Human melanoma A375 (IC50=8.7±0.20µM)&&Human breast adenocarcinoma MCF-7 (IC50=6.2±0.13µM)&&Human colon adenocarcinoma SW1116 (IC50=4.3±0.08µM)&&Human rhabdomyosarcoma (IC50=6.4±0.16µM)&&Human lung carcinoma H1299 (IC50=4.1±0.1µM)&&Mouse skin melanoma B16 (IC50=4.4±0.12µM)&&Staphylococcus aureus ATCC 25923 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=4µM)&&Human gastric cancer SGC-7901 (IC50=2.96µM),KWKSFLKTFKSLKKTVLHTLLKAISS,,Linear,Free,Free,,L,dbAMP3,26
27654,dbAMP_27654,,Pseudomonas aeruginosa PAO1 (MIC=500µg/ml)&&Pseudomonas aeruginosa WR5 (MIC=500µg/ml)&&Pseudomonas aeruginosa PAK (MIC=500µg/ml)&&Pseudomonas aeruginosa PA14 (MIC=500µg/ml)&&Pseudomonas aeruginosa M2 (MIC=500µg/ml)&&Pseudomonas aeruginosa CP204 (MIC=500µg/ml)&&Human lung carcinoma A549 (IC50=9.2±0.13µM)&&Human melanoma A375 (IC50=7.2±0.12µM)&&Human breast adenocarcinoma MCF-7 (IC50=5.7±0.07µM)&&Human colon adenocarcinoma SW1116 (IC50=3.5±0.06µM)&&Human rhabdomyosarcoma (IC50=5.5±0.07µM)&&Human lung carcinoma H1299 (IC50=2.7±0.38µM)&&Mouse skin melanoma B16 (IC50=4.6±0.07µM)&&Human cervical carcinoma HeLa (IC50=2.2±0.02µM),KWKSFLKTFKSLKKTVLHTLLKLISS,,Linear,Free,Free,,L,dbAMP3,26
27667,dbAMP_27667,,Human cervical carcinoma HeLa S3 (IC50=4µM)&&Human colon adenocarcinoma SW480 (IC50=15µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=6µM),VNWKKLLGKLLKVVK,,Linear,Free,Free,,L,dbAMP3,15
27686,dbAMP_27686,,Human cervical carcinoma HeLa S3 (IC50=16±3µM)&&Human colon adenocarcinoma SW480 (IC50=16µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=17µM)&&Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=4.7µM)&&Escherichia coli B (MIC=4.7µM)&&Pseudomonas aeruginosa (MIC=38.3µM)&&Candida albicans F7-39/IDE99 (MIC=10.0µM),AFGMALKLLKKVL,,Linear,Free,Free,,L,dbAMP3,13
27923,dbAMP_27923,,Human cervical carcinoma HeLa S3 (IC50=8±1µM)&&Human colon adenocarcinoma SW480 (IC50=13±3µM)&&Human lymphoblastic leukemia CCRF-CEM (IC50=14±4µM)&&Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=5.0µM)&&Escherichia coli B (MIC=2.3µM)&&Pseudomonas aeruginosa (MIC=11.3µM)&&Candida albicans F7-39/IDE99 (MIC=4.3µM),GFKMALKLLKKVL,,Linear,Free,Free,,L,dbAMP3,13
27936,dbAMP_27936,2N6M,Pseudomonas aeruginosa (MIC=4µM)&&Pseudomonas aeruginosa R1 (MIC=2µM)&&Pseudomonas aeruginosa ME (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 19660 (MIC=16µM)&&Staphylococcus epidermidis (MIC=8µM)&&Staphylococcus hominis (MIC=1µM)&&Staphylococcus aureus (MIC=64µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=1µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=1µM)&&Candida albicans (MIC=2-4µM)&&Pseudomonas aeruginosa PAO1 (MIC=4µM)&&Pseudomonas aeruginosa (MIC=4µM)&&Human lung carcinoma A549 (50% cell death=150µM)&&Murine macrophage cells RAW 264.7 (50% cell death=64µM)&&Pseudomonas aeruginosa (MBC=1µM)&&Corynebacterium jeikeium ATCC BAA-949 (MIC=0.125µM)&&Corynebacterium jeikeium ATCC BAA-949 (MBC=0.25µM)&&Murine macrophage cells RAW 264.7 (50% Killing=64µM)&&Human lung carcinoma A549 (20% Killing=64µM)&&Pseudomonas aeruginosa PAO1 (MIC=4.4µg/ml)&&Pseudomonas aeruginosa AA43 (MIC=8.8µg/ml),GIFSKLAGKKIKNLLISGLKG,,Linear,Free,Free,,L,dbAMP3,21
27960,dbAMP_27960,,Bacillus subtilis 168 (MIC=1.3µM)&&Staphylococcus aureus (MIC=60.0µM)&&Escherichia coli B (MIC=1.8µM)&&Pseudomonas aeruginosa (MIC=14.2µM)&&Human cervical carcinoma HeLa S3 (IC50=30±3µM)&&Human colon adenocarcinoma SW480 (IC50=>100µM)&&Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli ST131 (MIC=2µM)&&Klebsiella pneumoniae ST258 (MIC=32µM)&&Human hepatocellular carcinoma HepG2 (IC50=175±38µM),GKWKKILGKLIR,,Linear,Free,Free,,L,dbAMP3,12
27970,dbAMP_27970,,Skin Cancer (IC50= 5 M)&&Prostate Cancer (IC50= 5 M)&&Ovarian Cancer (IC50= 5 M)&&Lung Cancer (IC50= 5 M)&&Liver Cancer (IC50= 5 M)&&Leukemia Cancer (IC50= 5 M)&&Colon Cancer (IC50= 5 M)&&Breast Cancer (IC50= 5 M)&&Brain Tumor (IC50= 5 M),GLFDVIKKVASVIKGL,,Linear,Free,Free,,L,dbAMP3,16
28163,dbAMP_28163,,Escherichia coli ATCC 23716 (MIC=8µg/ml)&&Escherichia coli ATCC 23716 (MBC=8µg/ml)&&Human cervical carcinoma HeLa ((6.5±17.3)% Cytotoxicity=100µg/ml),KILRGVSKKIMRTFLRRISKDILTGKK,,Linear,Free,Free,,L,dbAMP3,27
28179,dbAMP_28179,,Pseudomonas syringae pv. syringae EPS 94 (MIC=12.5-25µM)&&Xanthomonas vesicatoria 2133-2 (MIC=6.2-12.5µM)&&Erwinia amylovora PMV 6076 (MIC=>100µM)&&Human breast adenocarcinoma MDA-MB-231 (0% Growth inhibition=40µM),KLKLKFKLKQ,,Linear,Free,Free,,L,dbAMP3,10
28230,dbAMP_28230,,Escherichia coli UB1005 (MIC=2.5µg/ml)&&Escherichia coli DC2 (MIC=2.5µg/ml)&&Salmonella typhimurium C587 (MIC=6.4µg/ml)&&Salmonella typhimurium C610 (MIC=2.5µg/ml)&&Pseudomonas aeruginosa H187 (MIC=5.0µg/ml)&&Pseudomonas aeruginosa H188 (MIC=6.4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=8.0µg/ml)&&Staphylococcus aureus SAP 0017 (MIC=5.0µg/ml)&&Staphylococcus epidermidis C621 (MIC=3.2µg/ml)&&Bacillus subtilis C971 (MIC=2.0µg/ml)&&Enterococcus faecalis C625 (MIC=16.0µg/ml)&&Corynebacterium xerosis C875 (MIC=2.0µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=4-8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=2-4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Escherichia coli ATCC 25922 (MIC=2-4µM)&&Human cervical carcinoma HeLa (IC50=5.52µM)&&Human lung carcinoma A549 (IC50=6.83µM)&&Human gastric cancer SGC-7901 (IC50=2.33µM)&&Mouse skin melanoma B16 (IC50=3.62µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=4µM)&&Streptococcus pneumoniae ATCC 49619 (MIC=2µM),KWKSFLKTFKSAAKTVLHTALKAISS,,Linear,Free,Free,,L,dbAMP3,26
28342,dbAMP_28342,,Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=100µg/ml)&&Saccharomyces cerevisiae (MFC=>200µg/ml)&&Escherichia coli ATCC 25922 (MBC=50µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=>60µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=75µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=540µg/ml)&&Human colon adenocarcinoma SW480 (LD50=>1000µg/ml)&&Human melanoma BMKC (LD50=>1000µg/ml)&&Human lung carcinoma H1299 (LD50=720µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=>1000µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=630µg/ml)&&Escherichia coli UB1005 (MIC=1µg/ml)&&Salmonella enterica serovar Typhimurium (MIC=4µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=16µg/ml)&&Pseudomonas aeruginosa M76 (MIC=8µg/ml)&&Pseudomonas aeruginosa M917 (MIC=16µg/ml)&&Pseudomonas aeruginosa M1251 (MIC=4µg/ml)&&Pseudomonas aeruginosa M1426 (MIC=8µg/ml)&&Pseudomonas aeruginosa R70 (MIC=4µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Candida albicans (MIC=>128µg/ml)&&Pseudomonas stutzeri (MIC=4µg/ml)&&Pseudomonas fluorescens (MIC=8µg/ml)&&Ralstonia pickettii (MIC=8µg/ml)&&Stenotrophomonas maltophilia (MIC=2µg/ml)&&Achromobacter xylosoxidans (MIC=32µg/ml),MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,,Linear,Free,Free,,L,dbAMP3,38
28381,dbAMP_28381,,Murine fibrosarcoma MethA (IC50=7.9µM)&&Human mammary carcinoma MT-1 (IC50=10µM)&&Human lung carcinoma A549 (IC50=14µM)&&Escherichia coli ATCC 25922 (MIC=2.3µM)&&Staphylococcus aureus ATCC 25923 (MIC=<1.1µM),PAWRKAFRWAKRMLKKAA,,Linear,Free,Free,,L,dbAMP3,18
28604,dbAMP_28604,,Plasmodium berghei (IC50=3.23µM)&&Human cervical carcinoma HeLa (12.58±1.23% Inhibition=10µM)&&Human cervical carcinoma HeLa (23.46±2.04% Inhibition=100µM)&&Human colon adenocarcinoma HT29 (6.87±0.76% Inhibition=10µM)&&Human colon adenocarcinoma HT29 (23.90±2.25% Inhibition=100µM)&&Human breast adenocarcinoma MCF-7 (7.00±0.56% Inhibition=10µM)&&Human breast adenocarcinoma MCF-7 (21.19±2.04% Inhibition=100µM),VG,,Linear,Free,Free,,L,dbAMP3,2
28628,dbAMP_28628,,Escherichia coli ATCC 25922 (MIC=>128µM)&&Escherichia coli ATCC 25922 (MBC=>128µM)&&Jurkat T-cell leukemia (IC50=>=65µM),VRRFPAAAPFLRR,,Linear,Free,Free,,L,dbAMP3,13
28710,dbAMP_28710,,MERS-CoV (IC50 F=0.75±0.09µM)&&MERS-CoV PsV (IC50 I=1.07±0.21µM)&&Cov-Q1020H PsV (IC50 I=1.25±0.18µM)&&Cov-Q1020R PsV (IC50 I=0.64±0.16µM)&&MERS-CoV PsV (IC50 I=0.92±0.05µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=>100µM)&&Human lung carcinoma Calu-3 (50% Cytotoxicity=>100µM),SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL,,Linear,Free,Free,,L,dbAMP3,36
28801,dbAMP_28801,,Staphylococcus aureus ATCC 6538 (MIC=8µM)&&Staphylococcus aureus ATCC 6538 (MBC=16µM)&&Staphylococcus aureus NCTC 12493 (MIC=16µM)&&Staphylococcus aureus NCTC 12493 (MBC=32µM)&&Enterococcus faecalis NCTC 12697 (MIC=128µM)&&Enterococcus faecalis NCTC 12697 (MBC=256µM)&&Escherichia coli ATCC 8739 (MIC=2µM)&&Escherichia coli ATCC 8739 (MBC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=8µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=16µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=16µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=32µM)&&Candida albicans ATCC 10231 (MIC=64µM)&&Candida albicans ATCC 10231 (MBC=128µM)&&Human prostate adenocarcinoma PC-3 (IC50=14.67µM)&&Human lung adenocarcinoma NCI-H838 (IC50=23.51µM)&&Human squamous lung carcinoma NCI-H157 (IC50=10.20µM)&&Human glioblastoma U251-MG (IC50=34.25µM),GLWSKIKNVAAAAGKAALGAL,,Linear,Free,Free,,L,dbAMP3,21
28802,dbAMP_28802,,Staphylococcus aureus ATCC 6538 (MIC=2µM)&&Staphylococcus aureus ATCC 6538 (MBC=4µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Staphylococcus aureus NCTC 12493 (MBC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=32µM)&&Enterococcus faecalis NCTC 12697 (MBC=32µM)&&Escherichia coli ATCC 8739 (MIC=1µM)&&Escherichia coli ATCC 8739 (MBC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=16µM)&&Candida albicans ATCC 10231 (MIC=32µM)&&Candida albicans ATCC 10231 (MBC=64µM)&&Human prostate adenocarcinoma PC-3 (IC50=18.99µM)&&Human lung adenocarcinoma NCI-H838 (IC50=10.11µM)&&Human squamous lung carcinoma NCI-H157 (IC50=6.143µM)&&Human glioblastoma U251-MG (IC50=32.18µM),GLWKKIKNVAAAAGKAALGAL,,Linear,Free,Free,,L,dbAMP3,21
28803,dbAMP_28803,,Staphylococcus aureus ATCC 6538 (MIC=2µM)&&Staphylococcus aureus ATCC 6538 (MBC=2µM)&&Staphylococcus aureus NCTC 12493 (MIC=2µM)&&Staphylococcus aureus NCTC 12493 (MBC=4µM)&&Enterococcus faecalis NCTC 12697 (MIC=8µM)&&Enterococcus faecalis NCTC 12697 (MBC=16µM)&&Escherichia coli ATCC 8739 (MIC=2µM)&&Escherichia coli ATCC 8739 (MBC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=8µM)&&Human prostate adenocarcinoma PC-3 (IC50=2.605µM)&&Human lung adenocarcinoma NCI-H838 (IC50=1.796µM)&&Human squamous lung carcinoma NCI-H157 (IC50=1.546µM)&&Human glioblastoma U251-MG (IC50=2.679µM)&&Candida albicans ATCC 10231 (MIC=256µM)&&Candida albicans ATCC 10231 (MBC=512µM),GLWKKIKNVAKAAGKAALGAL,,Linear,Free,Free,,L,dbAMP3,21
28804,dbAMP_28804,,Staphylococcus aureus ATCC 6538 (MIC=4µM)&&Staphylococcus aureus ATCC 6538 (MBC=8µM)&&Staphylococcus aureus NCTC 12493 (MIC=32µM)&&Staphylococcus aureus NCTC 12493 (MBC=64µM)&&Enterococcus faecalis NCTC 12697 (MIC=256µM)&&Enterococcus faecalis NCTC 12697 (MBC=512µM)&&Escherichia coli ATCC 8739 (MIC=2µM)&&Escherichia coli ATCC 8739 (MBC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=16µM)&&Candida albicans ATCC 10231 (MIC=64µM)&&Candida albicans ATCC 10231 (MBC=128µM)&&Human prostate adenocarcinoma PC-3 (IC50=55.65µM)&&Human lung adenocarcinoma NCI-H838 (IC50=186.1µM)&&Human squamous lung carcinoma NCI-H157 (IC50=88.28µM)&&Human glioblastoma U251-MG (IC50=593.7µM),GLWKKIKNVAKAAGKAAKGAL,,Linear,Free,Free,,L,dbAMP3,21
28805,dbAMP_28805,,Staphylococcus aureus ATCC 6538 (MIC=128µM)&&Staphylococcus aureus ATCC 6538 (MBC=128µM)&&Staphylococcus aureus NCTC 12493 (MIC=128µM)&&Staphylococcus aureus NCTC 12493 (MBC=256µM)&&Enterococcus faecalis NCTC 12697 (MIC=512µM)&&Enterococcus faecalis NCTC 12697 (MBC=>512µM)&&Escherichia coli ATCC 8739 (MIC=2µM)&&Escherichia coli ATCC 8739 (MBC=4µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=64µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=64µM)&&Pseudomonas aeruginosa ATCC 9027 (MBC=128µM)&&Candida albicans ATCC 10231 (MIC=512µM)&&Candida albicans ATCC 10231 (MBC=>512µM)&&Human prostate adenocarcinoma PC-3 (IC50=118.4µM)&&Human lung adenocarcinoma NCI-H838 (IC50=180.8µM)&&Human squamous lung carcinoma NCI-H157 (IC50=427.3µM)&&Human glioblastoma U251-MG (IC50=1499µM),WLWKKIKNVAKAAGKAAKGAL,,Linear,Free,Free,,L,dbAMP3,21
28807,dbAMP_28807,,Staphylococcus aureus NCTC 10788 (MIC=2µM)&&Staphylococcus aureus NCTC 10788 (MBC=2µM)&&Enterococcus faecalis NCTC 12697 (MIC=2µM)&&Enterococcus faecalis NCTC 12697 (MBC=2µM)&&Staphylococcus aureus ATCC 43300 (MIC=2µM)&&Staphylococcus aureus ATCC 43300 (MBC=2µM)&&Escherichia coli NCTC 10418 (MIC=2µM)&&Escherichia coli NCTC 10418 (MBC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MIC=2µM)&&Klebsiella pneumoniae ATCC 43816 (MBC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=8µM)&&Candida albicans NCYC 1467 (MIC=2µM)&&Candida albicans NCYC 1467 (MBC=2µM)&&Human lung carcinoma A549 (IC50=6.21µM)&&Human glioblastoma U251-MG (IC50=6.14µM)&&Human prostate adenocarcinoma PC-3 (IC50=3.39µM)&&Human squamous lung carcinoma NCI-H157 (IC50=3.22µM)&&Mouse skin melanoma B16-F0 (IC50=14.04µM)&&Mouse skin melanoma B16-BL6 (IC50=14.25µM),GMFTNMLKGIGKLAGKAALGAVKTLA,,Linear,Free,Free,,L,dbAMP3,26
31179,dbAMP_31179,,Staphylococcus aureus ATCC 6538 (MIC=50µM)&&Bacillus subtilis ATCC 23857 (MIC=12.5µM)&&Enterococcus faecium ATCC 19434 (MIC=>200µM)&&Escherichia coli DH5alpha (MIC=2µM)&&Escherichia coli (MIC=8µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=50µM)&&Acinetobacter baumannii ATCC 19606 (MIC=10µM)&&Acinetobacter baumannii (MIC=4-8µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=2.5µM)&&Klebsiella pneumoniae (MIC=2-8µM)&&Enterobacter cloacae ATCC 13047 (MIC=10µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=22.79µM),KQKTLKKVWKLSEKVLIFASAFAKKAGAAEATLVL,,Linear,Free,Free,,L,dbAMP3,35
31180,dbAMP_31180,,Staphylococcus aureus ATCC 6538 (MIC=20µM)&&Bacillus subtilis ATCC 23857 (MIC=5µM)&&Enterococcus faecium ATCC 19434 (MIC=10µM)&&Escherichia coli DH5alpha (MIC=10µM)&&Escherichia coli (MIC=8-16µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Acinetobacter baumannii (MIC=8µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=5µM)&&Klebsiella pneumoniae (MIC=8-501µM)&&Enterobacter cloacae ATCC 13047 (MIC=20µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=4.42µM),AMTLRKRKFAWYVLSSSLKWLIKKAKKIGVQVCGFE,,Linear,Free,Free,,L,dbAMP3,36
31181,dbAMP_31181,,Staphylococcus aureus ATCC 6538 (MIC=12.5µM)&&Bacillus subtilis ATCC 23857 (MIC=5µM)&&Enterococcus faecium ATCC 19434 (MIC=20µM)&&Escherichia coli DH5alpha (MIC=10µM)&&Escherichia coli (MIC=8-16µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Acinetobacter baumannii (MIC=8-16µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=5µM)&&Klebsiella pneumoniae (MIC=8-501µM)&&Enterobacter cloacae ATCC 13047 (MIC=20µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=8.28µM),AMTSRKRKFVWYVLSSSLKWLIKKAKKIGVQVCGFE,,Linear,Free,Free,,L,dbAMP3,36
31182,dbAMP_31182,,Staphylococcus aureus ATCC 6538 (MIC=20µM)&&Bacillus subtilis ATCC 23857 (MIC=2µM)&&Enterococcus faecium ATCC 19434 (MIC=2.5µM)&&Escherichia coli DH5alpha (MIC=20µM)&&Escherichia coli (MIC=16µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Acinetobacter baumannii (MIC=8µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=10µM)&&Klebsiella pneumoniae (MIC=8-16µM)&&Enterobacter cloacae ATCC 13047 (MIC=50µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=199.01µM),SVIWRKLFFIFIKRSGNWIKKVEKRQNLL,,Linear,Free,Free,,L,dbAMP3,29
31183,dbAMP_31183,,Staphylococcus aureus ATCC 6538 (MIC=>200µM)&&Bacillus subtilis ATCC 23857 (MIC=5µM)&&Enterococcus faecium ATCC 19434 (MIC=>100µM)&&Escherichia coli DH5alpha (MIC=100µM)&&Escherichia coli (MIC=32µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=100µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Acinetobacter baumannii (MIC=8-16µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=25µM)&&Klebsiella pneumoniae (MIC=64-501µM)&&Enterobacter cloacae ATCC 13047 (MIC=>200µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=4.42µM),DRDRPECSTMVKYEQKLPSLGKYALKRAIKIKFGRK,,Linear,Free,Free,,L,dbAMP3,36
31184,dbAMP_31184,,Staphylococcus aureus ATCC 6538 (MIC=20µM)&&Bacillus subtilis ATCC 23857 (MIC=2.5µM)&&Enterococcus faecium ATCC 19434 (MIC=100µM)&&Escherichia coli DH5alpha (MIC=25µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Enterobacter cloacae ATCC 13047 (MIC=50µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=5µM)&&Escherichia coli (MIC=250µM)&&Acinetobacter baumannii (MIC=250µM)&&Klebsiella pneumoniae (MIC=250µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=11.19µM),GINLKRKGNIMKKVKNIFHKIANADPMIWGYVMLSESK,,Linear,Free,Free,,L,dbAMP3,38
31185,dbAMP_31185,,Bacillus subtilis ATCC 23857 (MIC=5µM)&&Staphylococcus aureus ATCC 6538 (MIC=5µM)&&Enterococcus faecium ATCC 19434 (MIC=50µM)&&Escherichia coli DH5alpha (MIC=10µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=25µM)&&Acinetobacter baumannii ATCC 19606 (MIC=40µM)&&Enterobacter cloacae ATCC 13047 (MIC=100µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=20µM)&&Escherichia coli (MIC=8µM)&&Acinetobacter baumannii (MIC=16µM)&&Klebsiella pneumoniae (MIC=16µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=199.01µM),GVPMGSVIKKRRKRMAKKKHRKLLRKTRHQRRNKK,,Linear,Free,Free,,L,dbAMP3,35
31186,dbAMP_31186,,Bacillus subtilis ATCC 23857 (MIC=5µM)&&Staphylococcus aureus ATCC 6538 (MIC=50µM)&&Enterococcus faecium ATCC 19434 (MIC=10µM)&&Escherichia coli DH5alpha (MIC=20µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=50µM)&&Acinetobacter baumannii ATCC 19606 (MIC=20µM)&&Enterobacter cloacae ATCC 13047 (MIC=50µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=10µM)&&Escherichia coli (MIC=16-32µM)&&Acinetobacter baumannii (MIC=8µM)&&Klebsiella pneumoniae (MIC=32-64µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=24.49µM),RGTCYNRVGLIIRNFSKLKGKKV,,Linear,Free,Free,,L,dbAMP3,23
31187,dbAMP_31187,,Bacillus subtilis ATCC 23857 (MIC=5µM)&&Staphylococcus aureus ATCC 6538 (MIC=20µM)&&Enterococcus faecium ATCC 19434 (MIC=20µM)&&Escherichia coli DH5alpha (MIC=25µM)&&Pseudomonas aeruginosa ATCC 15692 (MIC=50µM)&&Acinetobacter baumannii ATCC 19606 (MIC=10µM)&&Enterobacter cloacae ATCC 13047 (MIC=>200µM)&&Klebsiella pneumoniae NCTC 5056 (MIC=200µM)&&Escherichia coli (MIC=16µM)&&Acinetobacter baumannii (MIC=8-16µM)&&Klebsiella pneumoniae (MIC=64-125µM)&&Human colon adenocarcinoma HCT 116 (50% Cytotoxicity=21.29µM),DKLISILSLLSKRRKADGFRVKKTQKSSAYKKRF,,Linear,Free,Free,,L,dbAMP3,34
31314,dbAMP_31314,,Escherichia coli TOP 10 (MIC=2.1µM)&&Escherichia coli ATCC 25922 (MIC=2.6µM)&&Escherichia coli BW25113 (MIC=3.6µM)&&Escherichia coli BW25113 del-sbmA (MIC=14.4µM)&&Escherichia coli (MIC50=2.9µM)&&Human cervical carcinoma HeLa (IC50=521µM),RRIRIRPPRLPRPRPRPYFMPRP,,Linear,Free,Free,,L,dbAMP3,23
31330,dbAMP_31330,,Enterococcus faecium E007 (MIC=58.64µM)&&Staphylococcus aureus ATCC 29231 (MIC=1.83µM)&&Staphylococcus aureus MW2 (MIC=1.83µM)&&Klebsiella pneumoniae WGLW2 (MIC=7.33µM)&&Acinetobacter baumannii ATCC 7978 (MIC=7.33µM)&&Pseudomonas aeruginosa PA14 (MIC=14.66µM)&&Klebsiella aerogenes ATCC 13048 (MIC=7.33µM)&&Candida albicans ATCC 10231 (MIC=7.33µM)&&Staphylococcus aureus MW2 (MIC=4µg/ml)&&Staphylococcus aureus MW2 (MIC=128µg/ml)&&Human hepatocellular carcinoma HepG2 (7% Killing=64µg/ml)&&Galleria mellonella (30% Killing=32µg/g),LWKIGKKIWRVLWNWR,,Linear,Free,Free,,L,dbAMP3,16
31332,dbAMP_31332,,Escherichia coli KCCM 11234 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=2µM)&&Bacillus cereus KCCM 21366 (MIC=4µM)&&Staphylococcus aureus KCCM 11335 (MIC=0.2µM)&&Staphylococcus aureus ATCC 33591 (MIC=2µM)&&Human acute monocytic leukemia THP-1 (80% Cytotoxicity=5µM)&&Human lung carcinoma NCI-H460 (80% Cytotoxicity=2µM),FKGLAKLLKIGLKALAKVIQ,,Linear,Free,Free,,L,dbAMP3,20
31333,dbAMP_31333,,Escherichia coli KCCM 11234 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 9027 (MIC=8µM)&&Bacillus cereus KCCM 21366 (MIC=32µM)&&Staphylococcus aureus KCCM 11335 (MIC=8µM)&&Staphylococcus aureus ATCC 33591 (MIC=32µM)&&Human acute monocytic leukemia THP-1 (35% Cytotoxicity=20µM)&&Human lung carcinoma NCI-H460 (0% Cytotoxicity=2µM),NKGLAKLLKIGLKALESVIQ,,Linear,Free,Free,,L,dbAMP3,20
31344,dbAMP_31344,,Enterococcus faecium Com15 (MIC=128µg/ml)&&Staphylococcus aureus USA 300 (MIC=128µg/ml)&&Klebsiella pneumoniae ATCC 10031 (MIC=64µg/ml)&&Acinetobacter baumannii ATCC 17978 (MIC=32µg/ml)&&Pseudomonas aeruginosa PAO1 (MIC=>128µg/ml)&&Enterobacter cloacae ATCC 13047 (MIC=>128µg/ml)&&Candida albicans ATCC 18804 (MIC=>128µg/ml)&&Human colon adenocarcinoma HT29 (LC=>128µg/ml),fxisfSSxFSViX,,Linear,Free,Free,,L,dbAMP3,13
31495,dbAMP_31495,,Cytotoxicity against three cancer cell lines ECA-109&& Hela-S3 and PANC-1,lVlL,,Linear,Free,Free,,L,dbAMP3,4
31496,dbAMP_31496,,Cytotoxicity against three cancer cell lines ECA-109&& Hela-S3 and PANC-2,lPlV,,Linear,Free,Free,,L,dbAMP3,4
31497,dbAMP_31497,,Cytotoxicity against three cancer cell lines ECA-109&& Hela-S3 and PANC-3,lIlP,,Linear,Free,Free,,L,dbAMP3,4
31498,dbAMP_31498,,Cytotoxicity against three cancer cell lines ECA-109&& Hela-S3 and PANC-6,lXPlI,,Linear,Free,Free,,L,dbAMP3,5
31532,dbAMP_31532,,Bacillus subtilis 168 (MIC=0.2µM)&&Staphylococcus aureus USA 300 (MIC=>80µM)&&Staphylococcus aureus NRS 72 (MIC=>80µM)&&Pseudomonas aeruginosa PAO1 (MIC=50µM)&&Escherichia coli DH5alpha (MIC=25µM)&&Mycobacterium tuberculosis H37Ra (MIC=2.5µM)&&Human lung carcinoma A549 (IC50=36.2µM)&&Human epithelial carcinoma OVCAR-3 (IC50=14.2µM)&&Human ovarian cancer NCI/ADR-RES (IC50=85.6µM)&&Human bladder carcinoma T24 (IC50=>100µM)&&Mycobacterium smegmatis mc2-155 (MIC=5µM)&&Klebsiella pneumoniae NCTC 9633 (MIC=>80µM)&&Acinetobacter baumannii ATCC 19606 (MIC=50µM)&&Bacillus anthracis Sterne 34F2 (MIC=>80µM)&&Haemophilus influenzae ATCC 49247 (MIC=80µM),KRWHWWRRHWVVW,,Linear,Free,Free,,L,dbAMP3,13
31664,dbAMP_31664,,Escherichia coli TOP 10 (MBC90=6.4µM)&&Staphylococcus aureus CGMCC 1.879 (MBC90=29.8µM)&&Candida albicans ATCC 10231 (MBC90=135.5µM)&&Human cervical carcinoma HeLa (0% Killing=32µM)&&Human cervical carcinoma HeLa (15% Killing=64µM)&&Human cervical carcinoma HeLa (95% Killing=128µM),KKKK,,Linear,Free,Free,,L,dbAMP3,4
31697,dbAMP_31697,,Escherichia coli BL21AI (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=32µg/ml)&&Salmonella enterica SALMOVAC (MIC=4µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=32µg/ml)&&Klebsiella pneumoniae DSM 681 (MIC=16µg/ml)&&Pseudomonas aeruginosa DSM 9644 (MIC=4µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µg/ml)&&Staphylococcus aureus DSM 6247 (MIC=4µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=16µg/ml)&&Human cervical carcinoma HeLa (25% Killing=600µg/ml),VRKPPYLPRPRWPRXIYNX,,Linear,Free,Free,,L,dbAMP3,19
31705,dbAMP_31705,,Staphylococcus aureus ATCC 29213 (MIC=8µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=16µg/ml)&&Staphylococcus aureus ATCC 29213 (MBC=32µg/ml)&&Rat hepatocellular carcinoma H-4-II-E (EC50=>100Unknown Unit),SwFkTkSk,,Linear,Free,Free,,L,dbAMP3,8
31710,dbAMP_31710,,Escherichia coli ATCC 25922 (MBC=40µg/ml)&&Pseudomonas aeruginosa ATCC 27853 (MBC=10µg/ml)&&Staphylococcus aureus ATCC 25923 (MBC=>40µg/ml)&&Candida albicans ATCC 10231 (MFC=>40µg/ml)&&Human breast adenocarcinoma MCF-7 (LD50=65µg/ml)&&Human colon adenocarcinoma SW480 (LD50=59µg/ml)&&Human melanoma BMKC (LD50=93µg/ml)&&Human lung carcinoma H1299 (LD50=54µg/ml)&&Human cervical carcinoma HeLa S3 (LD50=80µg/ml)&&Human prostate adenocarcinoma PC-3 (LD50=16µg/ml),FALALKALKKLKKALKKAL,,Linear,Free,Free,,L,dbAMP3,19
31725,dbAMP_31725,,Bacillus subtilis ATCC 43223 (MIC=3µg/ml)&&Bacillus cereus ATCC 11778 (MIC=2µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=3µg/ml)&&Listeria monocytogenes ATCC 19115 (MIC=20µg/ml)&&Enterococcus faecalis (MIC=10µg/ml)&&Streptococcus pneumoniae (MIC=10µg/ml)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=>70µg/ml)&&Staphylococcus aureus ATCC 33591 (MIC=6µg/ml)&&Escherichia coli JM109 (MIC=80µg/ml)&&Human melanoma M21 (LD50=>75µg/ml),kQrWlWlW,,Linear,Free,Free,,L,dbAMP3,8
31727,dbAMP_31727,,Escherichia coli ATCC 25726 (MIC=3.1µM)&&Staphylococcus aureus ATCC 25923 (MIC=1.6µM)&&Staphylococcus aureus (MIC=3.1-6.25µM)&&Acinetobacter baumannii (MIC=1.6µM)&&Stenotrophomonas maltophilia (MIC=0.8-3.1µM)&&Klebsiella pneumoniae (MIC=3.1-6.25µM)&&Human lung carcinoma A549 (LC50=2.1±0.1µM)&&Human breast adenocarcinoma MDA-MB-231 (LC50=5.2±0.3µM)&&Human colon adenocarcinoma HT29 (LC50=15.1±0.5µM)&&Human hepatocellular carcinoma HepG2 (LC50=4.1±0.7µM)&&Escherichia coli (MIC=3.1-6.25µM)&&Enterobacter cloacae (MIC=6.25µM)&&Citrobacter freundii (MIC=6.25µM)&&Staphylococcus aureus ATCC 29213 (MIC=3.1µM)&&Staphylococcus epidermidis RP62A (MIC=0.8µM)&&Staphylococcus epidermidis RP62A/1 (MIC=0.8µM)&&Candida albicans ATCC 90028 (MIC=100µM)&&Proteus mirabilis ATCC 25933 (MIC=>100µM),IKLSPkTKkNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
31731,dbAMP_31731,,Human acute monocytic leukemia THP-1 (IC50=>200µM)&&Staphylococcus aureus ATCC 25923 (MIC=12.5µM)&&Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=25µM)&&Staphylococcus aureus ATCC 25923 (MIC=50µM)&&Staphylococcus aureus ATCC 25923 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=25µM)&&Escherichia coli ATCC 25922 (MIC=>100µM)&&Escherichia coli ATCC 25922 (MIC=>100µM),firslfff,,Linear,Free,Free,,L,dbAMP3,8
31742,dbAMP_31742,,Staphylococcus aureus ATCC 25923 (MIC=2.5µM)&&Staphylococcus aureus 145/08 (MIC=2.5µM)&&Staphylococcus epidermidis RP62A (MIC=1.25µM)&&Staphylococcus epidermidis RP62A/1 (MIC=1.25µM)&&Staphylococcus epidermidis T6/19 (MIC=1.25µM)&&Staphylococcus epidermidis T37/8 (MIC=1.25µM)&&Enterococcus faecalis ATCC 29212 (MIC=5µM)&&Escherichia coli ATCC 25726 (MIC=2.5µM)&&Klebsiella pneumoniae ATCC 700603 (MIC=5µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=10µM)&&Acinetobacter baumannii NM8 (MIC=2.5µM)&&Acinetobacter baumannii NM35 (MIC=2.5µM)&&Acinetobacter baumannii NM75 (MIC=2.5µM)&&Acinetobacter baumannii NM109 (MIC=5µM)&&Acinetobacter baumannii NM124 (MIC=2.5µM)&&Stenotrophomonas maltophilia B32/1 (MIC=2.5µM)&&Stenotrophomonas maltophilia B32/4 (MIC=1.25µM)&&Stenotrophomonas maltophilia U8908 (MIC=2.5µM)&&Stenotrophomonas maltophilia B5/5 (MIC=2.5µM)&&Stenotrophomonas maltophilia B6/2 (MIC=1.25µM)&&Candida albicans ATCC 90028 (MIC=80µM)&&Human lung carcinoma A549 (IC50=0.9±0.3µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=2.4±0.1µM)&&Human colon adenocarcinoma HT29 (IC50=3.9±0.4µM),LKLSPKTKKTLKKVLKGAIKGAIAIASMA,,Linear,Free,Free,,L,dbAMP3,29
31746,dbAMP_31746,,Staphylococcus aureus (MIC=4±1µM)&&Staphylococcus epidermidis (MIC=6±2.8µM)&&Pseudomonas aeruginosa (MIC=32±0µM)&&Escherichia coli (MIC=32±0µM)&&Human cervical carcinoma HeLa (EC50=12.5µM)&&Human epidermoid carcinoma A431 (EC50=11µM)&&Human promyelocytic leukemia HL-60 (EC50=13µM)&&Human lung carcinoma A549 (EC50=15µM),XGLXGKLXGIL,,Linear,Free,Free,,L,dbAMP3,11
31747,dbAMP_31747,,Staphylococcus aureus (MIC=3±1.4µM)&&Staphylococcus epidermidis (MIC=1±0.5µM)&&Pseudomonas aeruginosa (MIC=>64µM)&&Escherichia coli (MIC=32±0µM)&&Human cervical carcinoma HeLa (EC50=20µM)&&Human epidermoid carcinoma A431 (EC50=16µM)&&Human promyelocytic leukemia HL-60 (EC50=15µM)&&Human lung carcinoma A549 (EC50=17µM),XGLXGGLXKIL,,Linear,Free,Free,,L,dbAMP3,11
31754,dbAMP_31754,,Staphylococcus aureus NBRC 13276 (MIC=3.125µM)&&Staphylococcus epidermidis NBRC 12298 (MIC=1.56µM)&&Escherichia coli DH5alpha (MIC=3.125µM)&&Pseudomonas aeruginosa NBRC 13275 (MIC=3.125µM)&&Human cervical carcinoma HeLa (10% Killing=100µM),GIKKFLKSXKKFVKXFK,,Linear,Free,Free,,L,dbAMP3,17
31786,dbAMP_31786,,Bacillus subtilis ATCC 6633 (MIC=34.0µM)&&Kocuria rhizophila NBRC 12708 (MIC=8.50µM)&&Proteus hauseri NBRC 3851 (MIC=17.0µM)&&Human colon adenocarcinoma HCT 116 (IC50=12.4µM)&&Human lung carcinoma A549 (IC50=15.6µM)&&Human gastric carcinoma SNU 638 (IC50=13.5µM)&&Human breast adenocarcinoma MDA-MB-231 (IC50=12.7µM)&&Human liver carcinoma SK-HEP-1 (IC50=16.8µM),XVTXVXVXXVXV,,Linear,Free,Free,,L,dbAMP3,12
31788,dbAMP_31788,,Pseudomonas aeruginosa PAO1 (MIC=64µg/ml)&&Pseudomonas aeruginosa NCGM2.S1 (MIC=128µg/ml)&&Pseudomonas aeruginosa (MIC=128µg/ml)&&Pseudomonas aeruginosa PAO4290 (MIC=128µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=8µg/ml)&&Acinetobacter baumannii (MIC=4µg/ml)&&Escherichia coli ATCC 25922 (MIC=16µg/ml)&&Escherichia coli (MIC=4µg/ml)&&Klebsiella pneumoniae ATCC 15380 (MIC=>128µg/ml)&&Klebsiella pneumoniae ATCC BAA-2146 (MIC=16µg/ml)&&Serratia marcescens NBRC 102204 (MIC=>256µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>128µg/ml)&&Human hepatocellular carcinoma HepG2 (LD50=>256µg/ml)&&Human hepatocellular carcinoma HepG2 (32% Killing=250µg/ml),Cklaklakklaklak,,Linear,Free,Free,,L,dbAMP3,15
31789,dbAMP_31789,,Pseudomonas aeruginosa PAO1 (MIC=16µg/ml)&&Pseudomonas aeruginosa NCGM2.S1 (MIC=32µg/ml)&&Pseudomonas aeruginosa (MIC=16µg/ml)&&Pseudomonas aeruginosa PAO4290 (MIC=16µg/ml)&&Acinetobacter baumannii ATCC 15308 (MIC=8µg/ml)&&Acinetobacter baumannii (MIC=8µg/ml)&&Escherichia coli ATCC 25922 (MIC=8µg/ml)&&Escherichia coli (MIC=8µg/ml)&&Klebsiella pneumoniae ATCC 15380 (MIC=128µg/ml)&&Klebsiella pneumoniae ATCC BAA-2146 (MIC=16µg/ml)&&Serratia marcescens NBRC 102204 (MIC=>256µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>128µg/ml)&&Human hepatocellular carcinoma HepG2 (LD50=192µg/ml),klaklakklaklakC,,Linear,Free,Free,,L,dbAMP3,15
31794,dbAMP_31794,,Staphylococcus aureus ATCC 29213 (MIC=16.0µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=>128µg/ml)&&Streptococcus pneumoniae NCTC 7466 (MIC=12.5µg/ml)&&Staphylococcus epidermidis (MIC=32.0µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human lung carcinoma NCI-H460 (IC50=>100µM)&&Human hepatocellular carcinoma HepG2 (IC50=>100µM),NGWLLI,,Linear,Free,Free,,L,dbAMP3,6
31795,dbAMP_31795,,Staphylococcus aureus ATCC 29213 (MIC=>128µg/ml)&&Klebsiella pneumoniae ATCC 13883 (MIC=>128µg/ml)&&Streptococcus pneumoniae NCTC 7466 (MIC=>100µg/ml)&&Staphylococcus epidermidis (MIC=>128µg/ml)&&Staphylococcus aureus (MIC=>128µg/ml)&&Human breast adenocarcinoma MCF-7 (IC50=>100µM)&&Human hepatocellular carcinoma HepG2 (IC50=>100µM)&&Human lung carcinoma NCI-H460 (IC50=>100µM),XGNIlL,,Linear,Free,Free,,L,dbAMP3,6
31796,dbAMP_31796,,Mycobacterium tuberculosis H37Rv (MIC=40µM)&&Human hepatocellular carcinoma HepG2 (IC50=>100µM),xLlVNx,,Linear,Free,Free,,L,dbAMP3,6
31817,dbAMP_31817,,Staphylococcus aureus NCTC 4163[MIC = 12.5 microg/ml]&& Staphylococcus aureus ATCC 25923[MIC = 12.5 microg/ml]&& Staphylococcus aureus ATCC 6538[MIC = 12.5 microg/ml]&& Staphylococcus aureus ATCC 29213[MIC = 12.5 microg/ml]&& Staphylococcus epidermidis ATCC 12228[MIC = 12.5 microg/ml]&& Bacillus subtilis ATCC 6633[MIC = 12.5 microg/ml]&& Bacillus cereus ATCC 11778[MIC = 50 microg/ml]&& Enterococcus hirae ATCC 10541[MIC = 100 microg/ml]&& Micrococcus luteus ATCC 10240[MIC = 12.5 microg/ml]&& Micrococcus luteus ATCC 9341[MIC = 6.25 microg/ml]&& Candida albicans ATCC 10231[MIC = 100 microg/ml]&& Candida albicans ATCC 90028[MIC = 100 microg/ml]&& Candida albicans SN250[MIC = 15.62 microg/ml]&& Candida parapsilosis ATCC 22019[MIC = 100 microg/ml]&& Escherichia coli ATCC 10538&& Escherichia coli ATCC 25922&& Escherichia coli NCTC 8196&& Proteus vulgaris NCTC 4635&& Pseudomonas aeruginosa ATCC 15442&& Pseudomonas aeruginosa NCTC 6749&& Pseudomonas aeruginosa ATCC 27853&& Bordetella bronchiseptica ATCC 4617&& Human lung carcinoma A549[IC50 = 0.08+-0.04 microM]&& Human breast adenocarcinoma MCF-7[IC50 = 0.46+-0.09 microM]&& Human colon adenocarcinoma LoVo[IC50 = 0.06+-0.01 microM]&& Human cervical carcinoma HeLa-KB[IC50 = 0.42+-0.11 microM]&& Staphylococcus aureus NCTC 4163[MIC = 50 microg/ml]&& Staphylococcus aureus ATCC 25923[MIC = 50 microg/ml]&& Staphylococcus aureus ATCC 6538[MIC = 50 microg/ml]&& Staphylococcus aureus ATCC 29213[MIC = 100 microg/ml]&& Staphylococcus epidermidis ATCC 12228[MIC = 25 microg/ml]&& Micrococcus luteus ATCC 10240[MIC = 6.25 microg/ml]&& Candida albicans ATCC 10231[MIC = 25 microg/ml]&& Candida albicans ATCC 90028[MIC = 50 microg/ml]&& Candida parapsilosis ATCC 22019[MIC = 25 microg/ml]&& Human lung carcinoma A549[IC50 = 1.31+-0.11 microM]&& Human breast adenocarcinoma MCF-7[IC50 = 1.45+-0.39 microM]&& Human colon adenocarcinoma LoVo[IC50 = 0.88+-0.14 microM]&& Human cervical carcinoma HeLa-KB[IC50 = 0.67+-0.93 microM],G,,Linear,Free,Free,,L,dbAMP3,1
31818,dbAMP_31818,,Staphylococcus aureus NCTC 4163 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 25923 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 6538 (MIC=>200µg/ml)&&Staphylococcus aureus ATCC 29213 (MIC=>200µg/ml)&&Staphylococcus epidermidis ATCC 12228 (MIC=>200µg/ml)&&Bacillus subtilis ATCC 6633 (MIC=>200µg/ml)&&Bacillus cereus ATCC 11778 (MIC=>200µg/ml)&&Enterococcus hirae ATCC 10541 (MIC=>200µg/ml)&&Micrococcus luteus ATCC 9341 (MIC=>200µg/ml)&&Micrococcus luteus ATCC 10240 (MIC=>200µg/ml)&&Candida albicans ATCC 10231 (MIC=>200µg/ml)&&Candida albicans ATCC 90028 (MIC=>200µg/ml)&&Candida albicans SN250 (MIC=125µg/ml)&&Candida parapsilosis ATCC 22019 (MIC=>200µg/ml)&&Human carcinoma HeLa-KB (IC50=3.46±0.68µM),H,,Linear,Free,Free,,L,dbAMP3,1
31820,dbAMP_31820,,Bacillus subtilis KCTC 3068[MIC = 8 microM]&& Staphylococcus aureus KCTC 1621[MIC = 16-32 microM]&& Enterococcus faecalis KCTC 2011[MIC = 16 microM]&& Staphylococcus epidermidis KCTC 1917[MIC = 16 microM]&& Escherichia coli KCTC 1682[MIC = 32 microM]&& Salmonella typhimurium KCTC 1926[MIC = 16-32 microM]&& Pseudomonas aeruginosa KCTC 1637[MIC = 32 microM]&& Proteus vulgaris KCTC 2433[MIC = 32-64 microM]&& Escherichia coli ATCC 25922[MIC = 8 microM]&& Staphylococcus epidermidis ATCC 12228[MIC = 20 microM]&& Escherichia coli ATCC 25922[MIC = 20 microM]&& Staphylococcus epidermidis ATCC 12228[MIC = 40 microM]&& Jurkat T-cell leukemia[IC50 = 16.8 microM],KKC,,Linear,Free,Free,,L,dbAMP3,3
31821,dbAMP_31821,,Staphylococcus aureus ATCC 12600 (MBC=12.5µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=>200µg/ml)&&Human acute monocytic leukemia THP-1 (10% Killing=125µg/ml),GXFKKTFHKVSHAVKSGIHA,,Linear,Free,Free,,L,dbAMP3,20
31822,dbAMP_31822,,Staphylococcus aureus ATCC 12600 (MBC=12.5µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Staphylococcus aureus ATCC 12600 (MBC=>200µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=12.5µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=25µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=100µg/ml)&&Pseudomonas aeruginosa ATCC 15442 (MBC=>200µg/ml)&&Human acute monocytic leukemia THP-1 (10% Killing=125Unknown Unit),GWFKKTFHKVSHAVKSGIHA,,Linear,Free,Free,,L,dbAMP3,20
31827,dbAMP_31827,,Mycobacterium tuberculosis (MIC90=2µM)&&Mycobacterium tuberculosis (MIC=6µM)&&Human acute monocytic leukemia THP-1 (IC50=30µM)&&Human acute monocytic leukemia THP-1 (IC90=50µM)&&Mouse lymphoma L5178Y (ED50=3.61µM),IXVILPPLXPIFG,,Linear,Free,Free,,L,dbAMP3,13
31828,dbAMP_31828,,Mycobacterium tuberculosis (MIC90=5µM)&&Mycobacterium tuberculosis (MIC=10µM)&&Human acute monocytic leukemia THP-1 (IC50=5µM)&&Human acute monocytic leukemia THP-1 (IC90=30µM)&&Mouse lymphoma L5178Y (ED50=4.14µM)&&Human cervical carcinoma HeLa (ED50=>8µM)&&Rat pheochromocytoma PC12 (ED50=>8µM),IXIILPPLXPII,,Linear,Free,Free,,L,dbAMP3,12
31829,dbAMP_31829,,Mycobacterium tuberculosis (MIC90=40µM)&&Mycobacterium tuberculosis (MIC=100µM)&&Human acute monocytic leukemia THP-1 (IC50=>100µM)&&Human acute monocytic leukemia THP-1 (IC90=>100µM)&&Mouse lymphoma L5178Y (ED50=2.92µM),HXLLPPVXPLFG,,Linear,Free,Free,,L,dbAMP3,12
31830,dbAMP_31830,,Mouse lymphoma L5178Y (ED50=>9µM)&&Human cervical carcinoma HeLa (ED50=>9µM)&&Rat pheochromocytoma PC12 (ED50=>9µM),VPVFPXPLF,,Linear,Free,Free,,L,dbAMP3,9
31831,dbAMP_31831,,Mouse lymphoma L5178Y (ED50=3.03µM),IIFPXPLXPINAI,,Linear,Free,Free,,L,dbAMP3,13
31833,dbAMP_31833,,Escherichia coli C25 (MIC=8.4µM)&&Escherichia coli C25 (IC90=4.04µM)&&Staphylococcus aureus ATCC 25923 (MIC=16.8µM)&&Staphylococcus aureus ATCC 25923 (IC90=8.09µM)&&Human lung carcinoma A549 (IC50=90.16µM),rrryiGryvrfwk,,Linear,Free,Free,,L,dbAMP3,13
31838,dbAMP_31838,,Candida albicans ATCC 90028[IC50 = 0.11 microM]&& Candida glabrata ATCC 90030[IC50 = 0.24 microM]&& Candida krusei ATCC 6258[IC50 = 0.19 microM]&& Aspergillus fumigatus ATCC 90906[IC50 = 0.14 microM]&& Plasmodium falciparum D6[IC50 = 0.34 microM]&& Mouse lymphoma L5178Y[IC50 = 5.71 microM]&& Rat pheochromocytoma PC12[IC50 = 9.55 microM],IyQaAXX,,Linear,Free,Free,,L,dbAMP3,7
31852,dbAMP_31852,,Staphylococcus aureus USA 300[MIC = 1.5 microg/ml]&& Staphylococcus aureus USA 300[MBC = 15 microg/ml]&& Staphylococcus aureus MU50[MIC = 3 microg/ml]&& Staphylococcus aureus SA113[MIC = 3 microg/ml]&& Staphylococcus aureus RN4220[MIC = 3 microg/ml]&& Enterococcus faecium BK463[MIC = 3 microg/ml]&& Enterococcus faecalis VRE366[MIC = 12 microg/ml]&& Listeria monocytogenes ATCC 19118[MIC = 6 microg/ml]&& Streptococcus pneumoniae ATCC 49619[MIC = 1.5 microg/ml]&& Bacillus subtilis 168[MIC = 4 microg/ml]&& Pseudomonas aeruginosa PAO1[MIC >50 microg/ml]&& Escherichia coli DH5alpha[MIC >50 microg/ml]&& Human promyelocytic leukemia HL-60[IC50 >50 microg/ml]&& Staphylococcus aureus NCTC 8325[MIC = 3.1 microg/ml],vWlVvX,,Linear,Free,Free,,L,dbAMP3,6
31859,dbAMP_31859,,Staphylococcus aureus ATCC 12600 (MIC=>62.5µg/ml)&&Escherichia coli ATCC 25922 (MIC=>62.5µg/ml)&&Human cervical carcinoma HeLa (0% Killing=125µg/ml)&&Human cervical carcinoma HeLa (5% Killing=250µg/ml)&&Human cervical carcinoma HeLa (13% Killing=500µg/ml),RKWWK,,Linear,Free,Free,,L,dbAMP3,5
31877,dbAMP_31877,,Escherichia coli ATCC 25922[MIC >126.5 microM]&& Acinetobacter baumannii ATCC 19606[MIC >126.5 microM]&& Enterococcus faecalis ATCC 29212[MIC >126.5 microM]&& Staphylococcus aureus ATCC 29213[MIC >126.5 microM]&& Staphylococcus aureus MR[MIC >126.5 microM]&& Micrococcus luteus SC-1[MIC >126.5 microM]&& Mycobacterium smegmatis mc2-155[MIC >126.5 microM]&& Mycobacterium tuberculosis H37Rv[MIC = 98.9 microM]&& Human cervical carcinoma HeLa[IC50 >50 microM]&& Human hepatocellular carcinoma HepG2[IC50 >50 microM]&& Human lung carcinoma A549[IC50 >50 microM]&& Human nasopharyngeal carcinoma CNE2[IC50 >50 microM]&& Human breast adenocarcinoma MCF-7[IC50 >50 microM]&& Escherichia coli ATCC 25922[MIC >124.5 microM]&& Acinetobacter baumannii ATCC 19606[MIC >124.5 microM]&& Enterococcus faecalis ATCC 29212[MIC >124.5 microM]&& Staphylococcus aureus ATCC 29213[MIC >124.5 microM]&& Staphylococcus aureus MR[MIC >124.5 microM]&& Mycobacterium smegmatis mc2-155[MIC >124.5 microM]&& Mycobacterium tuberculosis H37Rv[MIC = 2.4 microM]&& Human cervical carcinoma HeLa[IC50 = 7.1 microM]&& Human hepatocellular carcinoma HepG2[IC50 = 8.9 microM]&& Human lung carcinoma A549[IC50 = 13.8 microM]&& Human nasopharyngeal carcinoma CNE2[IC50 = 24.5 microM]&& Human breast adenocarcinoma MCF-7[IC50 = 17.4 microM]&& Escherichia coli ATCC 25922[MIC >122.9 microM]&& Acinetobacter baumannii ATCC 19606[MIC >122.9 microM]&& Enterococcus faecalis ATCC 29212[MIC >122.9 microM]&& Staphylococcus aureus ATCC 29213[MIC >122.9 microM]&& Staphylococcus aureus MR[MIC >122.9 microM]&& Micrococcus luteus SC-1[MIC >122.9 microM]&& Mycobacterium smegmatis mc2-155[MIC = 0.12 microM]&& Mycobacterium tuberculosis H37Rv[MIC = 9.6 microM]&& Human cervical carcinoma HeLa[IC50 = 3.3 microM]&& Human hepatocellular carcinoma HepG2[IC50 = 3.2 microM]&& Human lung carcinoma A549[IC50 = 3.5 microM]&& Human nasopharyngeal carcinoma CNE2[IC50 = 6.8 microM]&& Human breast adenocarcinoma MCF-7[IC50 = 4.5 microM]&& Escherichia coli ATCC 25922[MIC >121.0 microM]&& Acinetobacter baumannii ATCC 19606[MIC >121.0 microM]&& Enterococcus faecalis ATCC 29212[MIC >121.0 microM]&& Staphylococcus aureus ATCC 29213[MIC >121.0 microM]&& Staphylococcus aureus MR[MIC >121.0 microM]&& Micrococcus luteus SC-1[MIC >121.0 microM]&& Mycobacterium smegmatis mc2-155[MIC = 30.3 microM]&& Mycobacterium tuberculosis H37Rv[MIC = 1.2 microM]&& Escherichia coli ATCC 25922[MIC >124.8 microM]&& Acinetobacter baumannii ATCC 19606[MIC >124.8 microM]&& Enterococcus faecalis ATCC 29212[MIC >124.8 microM]&& Staphylococcus aureus ATCC 29213[MIC >124.8 microM]&& Staphylococcus aureus MR[MIC >124.8 microM]&& Micrococcus luteus SC-1[MIC >124.8 microM]&& Mycobacterium smegmatis mc2-155[MIC = 30.7 microM]&& Mycobacterium tuberculosis H37Rv[MIC = 0.0098 microM]&& Human cervical carcinoma HeLa[IC50 = 3.9 microM]&& Human hepatocellular carcinoma HepG2[IC50 = 4.9 microM]&& Human lung carcinoma A549[IC50 = 6.2 microM]&& Human nasopharyngeal carcinoma CNE2[IC50 = 14.9 microM]&& Human breast adenocarcinoma MCF-7[IC50 = 3.9 microM],XXLXAXX,,Linear,Free,Free,,L,dbAMP3,7
31881,dbAMP_31881,,Human histiocytic lymphoma U-937 (IC50=6.4µM)&&Human lymphoblastic leukemia Molt-4 (IC50=6.2µM)&&Human Influenza A Virus H1N1 A/WSN/33 (IC50 REP=15µM)&&Human Influenza A Virus H3N2 Hong Kong/8/68 (IC50 REP=8.1µM),Xaix,,Linear,Free,Free,,L,dbAMP3,4
31885,dbAMP_31885,,Mycoplasmopsis pulmonis MpUR1.1[MIC = 0.4 microM]&& Mycoplasmopsis pulmonis MpUR1.1[MBC = 12.5 microM]&& Spiroplasma melliferum[MIC = 6.25-12.5 microM]&& Escherichia coli CFT073[MIC = 44 microM]&& Escherichia coli CFT073imp4213[MIC = 0.25 microM]&& Enterobacter cloacae ATCC 13047[MIC = 100 microM]&& Klebsiella pneumoniae ATCC 700603[MIC >100 microM]&& Pseudomonas aeruginosa PA14[MIC >100 microM]&& Acinetobacter baumannii ATCC 17978[MIC >100 microM]&& Staphylococcus aureus USA 300[MIC >100 microM]&& Jurkat cancer cells[EC50 >50 microM]&& Mycobacterium tuberculosis H37Ra[MIC = 160 microg/ml]&& Escherichia coli TOP 10[MIC = 20 microg/ml],GXXXSX,,Linear,Free,Free,,L,dbAMP3,6
32523,dbAMP_32523,,Staphylococcus aureus (MIC=2-4µM)&&Bacillus megaterium Bm11 (MIC=2µM)&&Bacillus subtilis KCTC 3068 (MIC=4µM)&&Staphylococcus epidermidis KCTC 1917 (MIC=4µM)&&Enterococcus faecalis (MIC=8-32µM)&&Enterococcus faecium (MIC=8-32µM)&&Streptococcus agalactiae (MIC=1-4µM)&&Acinetobacter baumannii (MIC=0.5-16µM)&&Escherichia coli (MIC=2-4µM)&&Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=1µM)&&Serratia marcescens ATCC 8100 (MIC=2µM)&&Candida albicans (MIC=16µM)&&Cryptococcus neoformans (MIC=4µM)&&Staphylococcus aureus VRSA1 (MIC=>50µM)&&Escherichia coli ESBL  (MIC=>50µM)&&Pseudomonas aeruginosa (MIC=>50µM)&&Acinetobacter baumannii (MIC=>50µM)&&Klebsiella sp. (MIC=50µM)&&SARS-CoV-2 (IC50 REP=80µM)&&HSV-2 (IC50 REP=10µM)&&DENV-2 (IC50 REP=10µM)&&Human hepatocellular carcinoma Huh7 (50% Cytotoxicity=95.8 ± 1.1µM),MGRFKRFRKKFKKLFKKLS,,Linear,Free,Free,,L,dbAMP3,19
32874,dbAMP_32874,,Weissella confusa (MIC=16-32µM)&&Limosilactobacillus fermentum (MIC=2µM)&&Lacticaseibacillus casei (MIC=8-16µM)&&Limosilactobacillus oris (MIC=16-32µM)&&Lacticaseibacillus paracasei (MIC=32µM)&&Lacticaseibacillus rhamnosus (MIC=32µM)&&Ligilactobacillus salivarius (MIC=>32µM)&&Lactobacillus gasseri (MIC=>32µM)&&Lactobacillus delbrueckii subsp. delbrueckii (MIC=>32µM)&&Lactiplantibacillus plantarum (MIC=>32µM)&&Limosilactobacillus mucosae (MIC=8µM)&&Streptococcus mutans (MIC=8-16µM)&&Streptococcus sobrinus (MIC=8µM)&&Streptococcus gordonii (MIC=16-32µM)&&Streptococcus sanguinis (MIC=16-32µM)&&Porphyromonas gingivalis  (MIC=16µM)&&Human cervical carcinoma HeLa (IC50=8.1±1.6µM)&&Human prostate adenocarcinoma PC-3 (IC50=14.2±0.5µM)&&Human hepatocellular carcinoma Huh7 (IC50=8.4±1.1µM)&&Human hepatocellular carcinoma HepG2 (IC50=7.5±1.2µM),FKIGGFIKKLWRSLLA,,Linear,Free,Free,,L,dbAMP3,16
33003,dbAMP_33003,,Escherichia coli ATCC 25922 (MIC=8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Cronobacter sakazakii ATCC 29544 (MIC=32µM)&&Staphylococcus aureus ATCC 29213 (MIC=64µM)&&Bacillus subtilis ATCC 23857 (MIC=8µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=16µM)&&Staphylococcus aureus MR (MIC=64µM)&&Escherichia coli ESBL  (MIC=8µM)&&Pseudomonas aeruginosa (MIC=8µM)&&Human cervical carcinoma HeLa (<15% Killing=256µM)&&Murine macrophage cells RAW 264.7 (<15% Killing=256µM),PFRLRLRL,,Linear,Free,Free,,L,dbAMP3,8
33011,dbAMP_33011,,Escherichia coli ATCC 25922 (MIC=4µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=8µM)&&Cronobacter sakazakii ATCC 29544 (MIC=8µM)&&Staphylococcus aureus ATCC 29213 (MIC=32µM)&&Bacillus subtilis ATCC 23857 (MIC=4µM)&&Staphylococcus epidermidis ATCC 12228 (MIC=8µM)&&Staphylococcus aureus MR (MIC=32µM)&&Escherichia coli ESBL  (MIC=4µM)&&Pseudomonas aeruginosa (MIC=8µM)&&Human cervical carcinoma HeLa (<15% Killing=256µM)&&Murine macrophage cells RAW 264.7 (<15% Killing=256µM),PWRLRLRL,,Linear,Free,Free,,L,dbAMP3,8
33014,dbAMP_33014,,Escherichia coli ATCC 25922 (MIC=2µM)&&Escherichia coli ATCC 25922 (MBC=>8µM)&&Escherichia coli (MIC=2µM)&&Escherichia coli ATCC 25922 (MBC=>8µM)&&Pseudomonas aeruginosa ATCC 27853 (MIC=2µM)&&Pseudomonas aeruginosa ATCC 27853 (MBC=8µM)&&Pseudomonas sp. (MIC=2µM)&&Pseudomonas sp. (MBC=8µM)&&Pseudomonas aeruginosa (MIC=2µM)&&Pseudomonas aeruginosa (MBC=8µM)&&Staphylococcus aureus ATCC 25923 (MIC=2µM)&&Staphylococcus aureus ATCC 25923 (MBC=2µM)&&Staphylococcus aureus (MIC=4µM)&&Staphylococcus aureus (MBC=>16µM)&&Klebsiella pneumoniae (MIC=2-4µM)&&Klebsiella pneumoniae (MBC=>16µM)&&Bacillus subtilis (MIC=2µM)&&Bacillus subtilis (MBC=4µM)&&Acinetobacter sp. (MIC=2µM)&&Acinetobacter sp. (MBC=>16µM)&&Citrobacter sp. (MBC=>16µM)&&Citrobacter sp. (MIC=2µM)&&Human lung carcinoma A549 (74% Killing=8µM)&&Human breast adenocarcinoma MCF-7 (82% Killing=8µM),GKLRLIKKLWVKKWKKKGWKA,,Linear,Free,Free,,L,dbAMP3,21
33437,dbAMP_33437,,Escherichia coli (IC50=104.11µg/ml)&&Escherichia coli (MIC=267.51µg/ml)&&Escherichia coli (IC50=126.94µg/ml)&&Escherichia coli (MIC=289.28µg/ml)&&Klebsiella pneumoniae (IC50=406.55µg/ml)&&Klebsiella pneumoniae (MIC=962.11µg/ml)&&Corynebacterium striatum (IC50=92.85-119.6µg/ml)&&Corynebacterium striatum (MIC=241.66-300.1µg/ml)&&Human colon adenocarcinoma SW620 (42.19±24.29% Cytotoxicity=256µg/ml),ALWMTLLKKVLKAAAKAALNAVLVGA,,Linear,Free,Free,,L,dbAMP3,26
33438,dbAMP_33438,,Escherichia coli (IC50=98.1µg/ml)&&Escherichia coli (MIC=261.5µg/ml)&&Escherichia coli (IC50=147.48µg/ml)&&Escherichia coli (MIC=331.3µg/ml)&&Klebsiella pneumoniae (IC50=144.37µg/ml)&&Klebsiella pneumoniae (MIC=304.11µg/ml)&&Corynebacterium striatum (IC50=78.2-106.07µg/ml)&&Corynebacterium striatum (MIC=239.72-292.96µg/ml)&&Human colon adenocarcinoma SW620 (71.48±4.81% Cytotoxicity=256µg/ml),ALWMTLLKKVLKAAAKAALNAVLV,,Linear,Free,Free,,L,dbAMP3,24
33439,dbAMP_33439,,Escherichia coli (IC50=125.08µg/ml)&&Escherichia coli (MIC=285.85µg/ml)&&Escherichia coli (IC50=151.7µg/ml)&&Escherichia coli (MIC=323.52µg/ml)&&Klebsiella pneumoniae (IC50=159.16µg/ml)&&Klebsiella pneumoniae (MIC=320.45µg/ml)&&Corynebacterium striatum (IC50=101.64-118.26µg/ml)&&Corynebacterium striatum (MIC=259.92-299.42µg/ml)&&Human colon adenocarcinoma SW620 (66.21±20.07% Cytotoxicity=256µg/ml),ALWMTLLKKVLKAAAKAALNAV,,Linear,Free,Free,,L,dbAMP3,22
33440,dbAMP_33440,,Escherichia coli (IC50=104.62µg/ml)&&Escherichia coli (MIC=255.67µg/ml)&&Escherichia coli (IC50=137.48µg/ml)&&Escherichia coli (MIC=334.33µg/ml)&&Klebsiella pneumoniae (IC50=165.43µg/ml)&&Klebsiella pneumoniae (MIC=353.4µg/ml)&&Corynebacterium striatum (IC50=78.7-116µg/ml)&&Corynebacterium striatum (MIC=225.33-285.49µg/ml)&&Human colon adenocarcinoma SW620 (54.02±3.37% Cytotoxicity=256µg/ml),WMTLLKKVLKAAAKAALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,26
33441,dbAMP_33441,,Escherichia coli (IC50=154.65µg/ml)&&Escherichia coli (MIC=321.23µg/ml)&&Escherichia coli (IC50=181.68µg/ml)&&Escherichia coli (MIC=367.55µg/ml)&&Klebsiella pneumoniae (IC50=312.2µg/ml)&&Klebsiella pneumoniae (MIC=636.88µg/ml)&&Corynebacterium striatum (IC50=118.7-290.8µg/ml)&&Corynebacterium striatum (MIC=289.35-790.8µg/ml)&&Human colon adenocarcinoma SW620 (35.72±18.49% Cytotoxicity=256µg/ml),LKKVLKAAAKAALNAVLVGANA,,Linear,Free,Free,,L,dbAMP3,22
34575,dbAMP_34575,,"Cancer cell lines: A549 (IC50 = 0.98 ± 0.11 μM), HCT116 (IC50 = 1.841 ± 0.34 μM), HepG2 (IC50 = 4.54 ± 0.25 μM)",IKLSKKTKKNLKKVLKGAIKGAIAVAKMV,,Linear,Free,Free,,L,dbAMP3,29
34594,dbAMP_34594,,Gram-positive bacteria:Bacillus megaterium(MIC=0.5 µg/mL); Bacillus subtilis(MIC=1.5 µg/mL); Corynebacterium glutamicum(MIC=1.5 µg/mL); Micrococcus luteus(MIC=8.0 µg/mL); Staphylococcus aureus(MIC=23.3 µg/mL);&&Gram-negative bacteria:Escherichia coli(MIC=3.0 µg/mL); Pseudomonas aeruginosa(MIC=5.9 µg/mL);&&Fungi: Rhodotorula sp(MIC=23.2 µg/mL);Aurobasidium pollulans(MIC=92.6 µg/mL); Candida albicans(MIC=46.3 µg/mL).&&Cancer:Human melanoma A2058(IC50=1.4 μM).,GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV,,Linear,Free,Free,,L,dbAMP3,36
